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Preface 
Of the volumes of the Clio Chirurgica series, this one on liver transplantation will be the least 
encumbered by antique roots. The first mention of liver transplantation in the scientific literature was 
by Welch in 1955.' In his compendium of transplantation lore and literature, Woodruff2summarized 
what was known about hepatic transplantation to that time on less than two pages and with only two 
citations from the literature, including Welch's. Yet. less than nine years later, I authored a 545 page 
text on liver transplantation3 by which time 299 articles had been published on this subject. 
Almost all of the workers who have contributed to liver transplantation in its 32-year history still 
are living and most still are active. The hazards are obvious of assessing from this foreshortened 
perspective the contributory events to, much less the overall significance of, a new field. The 
advantages also are obvious. It was possible for me or one of the other editors personally to discuss 
with almost all of the authors the work represented in the key articles selected for this volume. Those 
who had died were well enough remembered to allow accurate reminiscences of their lives and 
times. Some of these memories are amongst the happiest that I have had, and some are amongst 
the saddest. 
In the spring of 1987, 1 was approached by Dr. Ronald Landes concerning the preparation of 
this book. Originally, Clio Chirurgica: The Liver by Professor James Robinson (F.R.C.S.. Erg.) was 
to have included a section on hepatic transplantation. However, both Dr. Landes arid Professor 
Robinson realized that the material was too extensive and important to be an appendage to another 
subject. They proposed aseparate volume, and Dr. Landes invited me to be the editor. The principal 
deterrent to accepting the invitation was my own role in the development of the fie!d. I realized that 
almost all of the key steps in developing liver transplantaticn had been taker) by three teams: Moore's 
in Boston: Calne's in Cambridge and London; and my own in Chicago (Northwestern), Denver and 
finally Pittsburgh. Subsequently, in mid-June, I met Roy Calr~e in Linz, Austria and discussed the 
matter with him. In September, I talked more briefly with Francis D. Moore. Encouraged by their 
comments, I decided to go forward. At this time a final preparatory step was taken with the 
recruitment of two co-editors who were chosen to bring to the task a more i~ternational perspective. 
The first, Carl-Gustav Groth of Stockholm had been a leader in the first successful trials of clinical 
liver transplantation in Denver. In the summer and autumn of 1967, he personally cared for these 
little recipients with a passion and tenderness that I never will forget. Dr. Groth now is Professor of 
Surgery at the Karolinska Institute and Chief of Transplantation at the Huddinge Hospital. 
The second co-editor is Dr. Leonard Makowka, a 34 year old Canadian surgeon who now is 
Associate Professor of Surgery at the University of Pittsburgh and one of the most active workers in 
liver transplantation. Dr. Makowka is the complete modern surgeon with a remarkable array of 
clinical talents combined with a powerful background in basic science including a Ph.D. With the 
articles that have been selected, a reasonably coherent picture can be constructed about the 
development of liver transplantation. For each of the sections, an overview first will be given, often 
with more complete reference to the literature than represented by the articles selected for 
reproduction. In this way, the reader who wants to work back from the reproduced articles can move 
to the overview section first and from this second level can track back through the more complete 
literature as desired. 
What may not be evident from perusal of the papers is the impact of transplantation on the field 
of hepatology. The story has unfolded since. Transplantation has made possible a fundamental 
philosophic departure in the way that health care is delivered. Until 50 or 60 years ago, practitioners 
of medicine, powerless to provide much more than sympathy, observed and presided over lethal 
disease of vital organ systems. Even with increasingly specific drugs, a rear guard strategy was all 
that could be offered for most organ specific chronic disorders. Patients with a failing liver could be 
treated with diet, medicines or a few palliative operations of questionable benefit. With the advent 
of hepatic transplantation, it became hypothetically possible for the first time in human history to 
provide exactly what was needed, a completely new liver. How high the stakes were or could be was 
well understood by those whose earlier written words are preserved in this volume. 
But immunosuppression was too poor to apply this thrilling concept widely until the 1980's. Then, 
with the improvements and cumulative progress described in this collection of articles, it became 
obvious that all future judgement in the care of liver diseases would have to be in the new perspective 
of possible eventual liver replacement. Mutilating operations in the portal hilum such as portacaval 
shunts or complex biliary drainage procedures for duct disease were virtually abandoned overnight 
in the 1980's since they jeopardized eventual candidacy for liver transplantation. 
Hepatic transplantation also had an extraordinary effect on both basic and clinical research. 
Although all liver transplantations are therapeutic, every such operatron also is an incisive 
experiment in basic physiology. With the treatment of some inborn errors of metabolism such asType 
I Glycogen Storage disease, cure of the disorder by provision with the new liver of a known missing 
enzyme was highly predictable, In other disorders such as Wilson's disease, classical hemophilia, 
hypercholesterolemia and protein C deficiency, more was learned about the true nature of the 
original disease by the discriminating study of a single human liver recipient than by hundreds of 
prior investigations 
Finally, such a simple question as what are the necessary conditions for optimal revasculariza- 
tion of a transplanted liver has led to a major breakthrough in an understanding of liver physiology 
and of the influence that the so-called hepatotrophic hormones such as insulin have upon liver 
structure, function and capacity for regeneration This subject is being treated separately in Part IV. 
Thus, transplantation in general and liver transplantation in particular became a Pandora's box 
of 20th century science. 
Thomas E. Starzl, M.D., Ph.D 
Pittsburgh, Pennsylvania 
October 22, 1987 
1 .  Welch CS: A note on transplantation of the whole liver in dogs. Transplant Bull, 2: 54, 1955 
2. Woodruff MFA: The Transplantation of Tissues and Organs, Charles C.  Thomas, Publisher, Springfield, 
Illinois, 1960, pp. 550-2 
3. Starzl TE (with the assistance of Putnam CW): Experience in Hepatic Transplantation, W.B. Saunders Co., 
Philadelph~a, 1969, pp. 3-553 
C. Stuart Welch (1  909-1 980). First 
man to perform expermental Iver trans- 
plantation. Deta~ls about the man and 
the work are in Part IV. 
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Part I 
Experimental Liver Transplantation, 
Exclusive of Immunosuppression 
There are two general approaches to transplantation of the liver. With the first, orthotopic liver 
transplantation, the host liver is removed and replaced with a homograft. The alternative technique, 
auxiliary transplantation, is the insertion of an extra liver at an ectopic site. Because the orthotopic 
procedure has been by far the most important clinically, most of this volume will be concerned with 
this operation. However, auxiliary hepatic transplantation was the first liver engraftment to be 
attempted in animals and the amount of physiologic information that came from investigation of this 
operation was enormous. As will be described in Part IV, a new field was opened. 
The distinction between creative and delusional thinking, if it can be made at all. usually 
becomes clear in distant retrospect The idea of liver replacement first surfaced in 1956 with 
Cannon's publicatton'and was tested in dogs with increasing conviction and determination during 
the next five years. The cariine model proved to be a difficult one technically, and systematic 
investigation of liver replacement was hampered seriously by the fact that it could be done 
successfully in only a few laboratories in the world. 
The technical requirements for liver transplantatton in dogs were almost too complex for simple 
categorization.~Wowever. two cardinal requirements for immediate survival emerged. The first was 
adequate preservation of the homograft during its period of devascuiarization.Vhe second was 
decompression with veno-venous bypasses of the obstructed recipient spanchnic and systemic 
venous beds during the anhepatic period when the host liver was being removed and the new liver 
was being i n ~ e r t e d . ~  
Rejection in the unmodified canine recipient. The clinical, biochemical and histopa- 
thologic events of liver rejection were described in the canine experiments performed during 1958- 
60 in BostonQnd C h i ~ a g o . ~ - ~ T h e  earliest pathologic analyses were provided by Gustave Dammin 
of Harvard and Donald Brock of Northwestern Universtty. In late 1961, the Northwestern University 
program was moved to the University of Colorado where pathology support was given by Rollo Hill 
and David Rowlands. Beginning tn the autumn of 1963, spesimens from Denver were sent to 
Professor K.A.  Porter of St. Mary's Hospital and Medical School, London. The collaboration between 
clinicians at the University of Colorado (later Pittsburgh) and Porter in London has lasted for a quarter 
of a century. The initial linkage was made in September, 1963 at a meeting at the National Science 
Foundation in Washington, D C. on the subject of renal transplantation. Porter came to Denver after 
that meeting with the objective of exarnin~ng grafted kidneys and left with a commitment as well to 
experimental hepatic pathology that was to last for the next twenty-five years. 
Porter's subsequent descriptions of the pathology of liver homografts in treated and untreated 
animals and in humans were classic. With the exception of a book chapterb and a monograph7 
published in 1969. these descriptions were parts of multi-faceted publications under the first 
authorship of ~ u r g e o n s . ~ ~ ' '  One such study correlated for the first time the alterations in hepatic 
blood flow with light microscopic and ultrastructural changes of rejectiomg 
In 1965, orthotoptc liver transplantation in the pig was described in France.12 Within a few 
months, the advantagzs of pig liver transplantation were exploited by two British teams,13 l 4  and, 
subsequently, many noteworthy fundamental studies have been published with this model. 
Graft preservation. While studying total body hypothermia for cardiac surgery in the 
1950's. Swan and Owens observed that lower temperatures protected the kidneys and other 
abdominal organs from the injury of cross-clamping of the thoracic aorta.'jThis advantage of renal 
cooling was confirmed in simpler ischemia models.'When Lillehei and his associates began their 
attempts at bowel autotransplantation and homotransplantation in 1958, they cooled the intestine by 
immersing it in cold electrolyte solut~on.'' Refrigeration through the thin-walled bowel almost was 
immediate. 
"Core-cooling" in transplantation using chilled lactated Ringer's solution for intraportal infusion 
was introduced during the efforts at liver replacement in 1958 and 195g3 It was natural to use the 
same methods to cool kidneys through the renal artery16and eventually core-cooling was adopted 
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as the initial step in the procurement and preservation of all organs.lg Cold infusates other than 
lactated Ringer's solution have been used over the years for renal homografts. These have included 
low molecular weight dextranI8 and solutions containing high potassium and high magnesium 
 concentration^^^ simulating that inside cells (Collin's-like solution). 
In 1975 and 1976, Benichou et a12' in Denver and Wall et alZ2 in Cambridge showed that with 
Collin's solution and with a plasma-like solution, respectively, dog livers could be preserved for 12 
hours or more. It became possible to ship livers from city to city instead of relying upon the previous 
practice of having the donor in the same hospital as the recipient. Recently. Jamieson et a123 at the 
University of Wisconsin have been able to pieserve canine livers reliably for 24 hours with an even 
more effective cold solution that holds promise of expanded organ-sharing between regions and 
countries, or even transcontinently. 
The alternative to infusion and cold storage is continuous perfusion. In a prototype of many later 
efforts, Marchioro et aIZ4attempted whole body or regional cadaveric perfusion in dogs using a pump 
oxygenator into which a heat exchanger was incorporated for cooling. Subsequently, ex vivo 
perfusion of dog livers for 24 hours was accomplished by Brettschneider et using whole blood 
and a simple oxgenerator that was housed along with the grafts within a hyperbaric oxygen chamber 
as described earlier for kidneys by Ackerman and Barnard.26Although several human livers were 
preserved with this method, the complexity of the approach and the potential dangers of the high 
compression oxygen chamber caused the technique to be abandoned. 
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Jack A. Cannon 
The first known efforts at experimental orthotopic transplantation of the liver were made by Dr. 
Jack Cannon who at that time was working at the new Department of Surgery, University of California, 
Los Angeles (UCLA). It was suspected that the liver might playa role in rejection. Cannon apparently 
hoped that a hepatic homograft would be more kindly received than other transplanted organs since 
it presumably would not contribute to its own rejection. The article did not have a title and descriptions 
of Cannon's procedure or even of the animal used. "Several successful operations" were mentioned 
but without survival of the recipients. 
Even for those with no interest in history, Cannon's one-page article may have the special 
fascination of the nearly empty canvas upon which acomplex mural was to quickly and unexpectedly 
appear. As summarized by Cannon only 32 years ago, in 1956 there was no identifiable reason to 
hope that any whole organ could be transplanted successfully, including the kidney, much less more 
complicated grafts such as the liver, heart or lung. Cannon's principal co-worker at this time was 
William P. Longmire, Founding Chairman of the UCLA Department of Surgery. In 1956, Cannon hired 
Paul I. Terasaki to be one of the "departmental" immunologists. Terasaki became the father of clinical 
tissue typing. 
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Brief Report 
Transplantation Bulletin 3: 7 ,  1956 
Jack A. Cannon 
Although our activities in the Tissue Transplant Laboratory at the 
University of California Medical Center, Los Angeles, in the past months 
have been distinctly curtailed due to problems of activating a new physical 
plant, we nevertheless have conducted scout experiments along two 
avenues of research in the field of tissue transplantation. 
It has seemed to us that there are two main areas where tissue 
transplantation may have wide clinlcal application. The first is in the 
transplantation of specific living tissues: skin, endwrines, bone, etc. The 
second is in the replacement of specific organs such as liver. lung, kidney, 
heart, or bowel. Admirable progress has been and is being made in the field 
of tissue preservation and storage. Little has been done in the ~nvestigat~on 
of the possibility of organ preservation or storage. 
It is our belief that a relatively simple organ, such as the lung. might 
lend itself to eventual preservation for significant time periods if the organ 
could be provided with artificial circulatory, respiratory, and homeostatic 
functions. In addition, in such a set-up. significant measures might feasibly 
be directed toward despecification of the organ. or toward obtaining 
compatibility with a given future host. With this concept in mind we have 
attempted to maintain circulation and respiration in excised whole dog 
lungs using a small pump to perfuse donor blood through the lung and a 
small automatic respirator valve to provide respiratory function. Even with 
crude apparatus, we have found it possible to maintain circulation and 
respiration with satisfactory oxygenation in isolated dog lungs for sekeral 
hours. We believe that with properly constructed apparatus to provide 
control of pressure. humidity, temperature, respiratory exchange and 
circulation, such an organ might be maintained for many days. Many 
interesting avenues of investigation might thereby be opened. 
We have conducted further scout experiments in the field of organ 
transplantation. Removal and immediate replacement of a lung or kidney 
has been successfully accomplished by many investigators. Considerable 
work has been reported on the response of homografted lung, kidney, and 
heart. It is apparent that such transplantation fail, not because of technical 
fault but because of the homograft reaction. Consequently mere transplan- 
tation of organs without some attempt at modification of the reaction 
cannot be expected to lead to encouraging results. On the other hand, the 
liver undoubtedly has a great deal to do with the production of the 
homograft reaction and probably with the inception and maintenance of 
tissue specificity. Replacement transplantation of intact liver, therefore, 
might well lead to interesting results. We have read with very great interest 
the report of Dr. C. S.  Welch in Volume 2 (2) of the Transplantation 
Bulletin. We infer from his communication that whole liver was hans- 
planted to a host whose own liver was left intact. The reported result is that 
the expected homograft reaction occurred. We have been interested in the 
possibility of replacement of the entire liver with an intact liver homograft. 
We have so far performed several "successful operations" without survival 
of the "patient." At present we are attempting to determine whether, in our 
hands. excision and autograft replacement of the liver is feasible. We have 
been using mild hypothermia, but as yet have had no survivals. We will be 
greatly interested in, and appreciative of, any comment or discussion 
pertinent to this particular problem. 
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Francis D. Moore 
In June of 1958, Dr. Francis D. Moore at the Peter Bent Brigham Hospital, Boston began a well- 
organized program of orthotopic transplantation of the canine liver. Dr. Moore was Moseley 
Professor of Surgery at Harvard. He had been one of the driving forces of the epoch-making renal 
transplant program at that institulion. Moore's career and productivity were on such a grand scale 
that one almost could imagine his accomplishments to be fictional were they not so easily verifiable. 
Of all of Moore's contributions to surgery and science, his descriptions of canine liver replacement 
will be judged by many to have been his most important. Moore presented his work at the American 
Surgical Association where it was discussed by Starzl of Northwestern University in Chicago. 
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Introduction 
The rapidly growing experience in experimental homotransp!anta- 
tion is largely based on observations of the skin, kidney, blood and bone 
marrow. 
These studies have been the pioneer ones for reasons that are clear 
historically: skiq for ~ t s  availability: kidney for its significance as a palred 
organ with a simple vascular pedlcle. the biochernical product of which can 
easily be measured: blood for its circulatory support: and bone marrow for 
its use as a replacement tissue after herilatopoietic destruction either in 
cancer treatment or as a preliminary to other transplants. 
Experiences with these tishues ma) gi \e  u, but a panlal view of the 
total histologic phenomenon. Seither >kin nor kidney is itself irnportantl) 
involved with the production of Immune globulin\ or mononuclear cells of 
the reticulocyte-lymphocyte-platma cell serles. While the bone marrowr is 
involved with both, it is difficult to recover for microscopic study after 
injection and its study is confined to eprsodic examination\ of peripheral 
areas where it alights and grow,. Eben in these areas. ~ t s  Identity 1s usually 
established by its peripheral product. rather than its local appearance. 
Studies ofother organs and tissues are therefore of great interejt in this field 
to obtain a broader and more complete picture of the b~o log~ca l  reipon\e 
to homotransplantarion. Organs ahich would particulurl) appeal as a way 
of broadening our \ ie\\ of the honiotran\plant phenomena would he organs 
involved either with a large nntlgenic rn;i\\, or those containing irnmunol- 
ogically competent cells. Examples of such are to be found in the liver and 
in the spleen. 
In the present statt of our Lnowledge. clinical homotrarisplantation 
must rest on a state of Immune tolerance achir\ed b) chirner~am. in which 
donor cells reside in the host w~thout ekclting an effect i~e  immune 
response. If such can be attamed b) destruction of the inlrnunr system (by 
irradiation or cqtotox~c drug.) foiloued b) hematopoietic restoration (b\  
bone marrow or, in ternjr of ths work herein reported. spleen), then the 
recipient can accept and hold other t~ssue\  fron? the same donor w hose cella 
are responsible for the hematopoiet~c restoration. 
The Liver 
The liver represents the largest single homogeneous antigenic mass 
of cells that can be readily transplanted in the mammal. Its parenchymatous 
cells are homogeneous structurally and are importantly involved in meta- 
bolic work. Their metabolic efflux can readily be studied and identified in 
both bile and blood. The liver is concerned with the immune process to the 
extent that the reticuloendothelial system finds representation in the 
Kupffer cells lining the hepatic sinusoids. 
Technics of transplanting liver tissue to an animal maintaining its 
own liver have been developed.:' Studies of  he transplantation of small 
llver slices might hold some promise. In these settings, the acceptance of 
the transplant is not itself essential for sunrival of the organism, and one 
cannot study the effect of the intact transplanted whole organ on the bodily 
economy. The liver, for ~ t s  very size and complex~ty of vascular arrange- 
ment, doe\ not lend itself to transplantation to some other portion of the 
body. It will clearly rest most comfortably and funct~on most normally if 
placed in its nonnal site with anastornotic restoration of its anatomic 
relationsh~ps, unharmed by vascular deprivation, and free of distortion of 
~ t s  enterlc relationship. through any kind of vascular shunt. For these 
reasons. our initlal purpose wa.; to transplant the intact liver into its 
anatornlc <ubdiaphragrnatic site.'. 
The shon-term hepatectomy suffered by the recipient dog was not 
antic~pated as a problem and did not turn out to be so. The transient anoxia 
of the transplanted liver could indeed be a major problem had it not been 
for the striking demonstration‘ that liver, of the various tissues of the body, 
most outstandingl) exhibits the phenomenon of cellular integrity while 
anoxic. if subjected simultaneously to hypothermia. 
Looming larger as a barrier than any of these problems in hepatic 
traniplantat~on was the circulatory instability of the dog who has no liver 
in place. Since the liver 1s removed together with the vena cava this dog 
suffers from pooling of blood in the kidneys, gut and loner  extremities. If 
simultaneous aortocaval occlusion is instituted for a prolonged period, a 
severe acidosis ofthe dlstal portion of the dog 1s produced w h ~ c h  will result, 
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upon reopening of the occlusive clamps, in a severe hyperkalemic hypoxic 
acidosis, cardiac arrhythmia, shock and death. This problem was solved by 
the use of two low-pressure shunt systems from lower caval and portal 
systems, respectively, to the jugular velns. 
The dog a as selected for this work because of his size, the lack of any 
evident inbreeding, and the extensive experience previously gained in 
these laboratories with kidney transplantation in the dog. Unfortunately, 
the dog's tissues harbor anaerobic organisms and for this reason control of 
infection. both in the liver. in the gastrointestinal tract, and other tlssues. 
is essential for such an operation that ma) be associated uith hypoxia or 
shock. Antibiotics were used throughout. 
1. Operative Procedure in Hepatic Homotransplantation. 
a. E,xp~r.imarital Groicp The steps involved in the development of 
this operation will not be reviewed in this paper. The procedure currently 
used. and that employed in its essentials for all of the animals later 
described, will be briefly recounted. 
Two dogs of approximately equal s i ~ e  and of either sex were used. 
Early In our experience the dogs were treated preoperatively wlth antibi- 
otlcs given by mouth but subsequently these were not comnenced until the 
day of operation. 
Anesthes~a is induced with intravenous barb~turate and the dog 
ventilated via a cuffed endotracheal tube. A minimum amount of anes- 
thetic agent (ether) is used. Continuous monitoring of a~lerlal pressure is 
maintained throughout the operation. H ~ g h  positive pressures are avoided 
in the airway. 
The recipient an~mal  IS operated updn while nornothermic. It is 
possible to do the entire operation without opening the thorax. though 
many of our earlier experiments ~nvolved a short intercostal incision on the 
right for the upper caval anastomosis. 
The vena cava below the renal veins is isolsted for the insertion of one 
of the two temporary shunts. The right adrenal is then dissected off the vena 
cava above the renal veins, the structures of the porta hepatis are identified, 
dissected free and all save the hepatic artery and portal vein are divided. 
Prior to this dissection, 2 per cent procaine ir infiltrated around the hepatic 
arteq and in the structures of the pona hepatis. a feature that appears to 
prevent hepatic outflow obstruction, to which the dog is so prone. It 
appears to make little difference to the animal's course whether or not the 
spleen is removed. In the earlier series it was removed. while in all of our 
recent animals the spleen has been left in place. 
Attention is then turned to the suprahepatic area. The vena cava is 
dissected free of the diaphragm. It is possible to dissect it completely free 
at the diaphragm and, with care. it ib possible to avoid entering the pleura. 
Isolation and division of the left phrenic vein is the most troublesome detail 
of this dissection. 
The aorta is dissected free above the celiac axls for temporary 
occlusion during transient portal vein occlusion before its shunt is opened 
and later during anastomosis. A stainless steel T-tube is then placed in the 
lower vena cava, and the shunt (114 inch internal diameter) from the cava 
to the right jugular vem is placed. The liver is then ready to be removed. 
The portal vein is then divlded and the portal blood shunted to the left 
jugular vein by a flexible plastic ("Tygon") tubing (5132 inch internal 
d~ameter). 
During this procedure, a simultaneour operation has k e n  under way 
on the donor dog. The steps taken are the same as those recounted above 
save for the fact that no preparation for a caval shunt is needed. When the 
liver is freed up. the animal is made hqpothermic bq the application of cold 
isotonic salt solution to the peritoneal cavity. We have also used immersion 
and portal perfusion of the liver for cooling after it is removed from the 
animal. The donor operation should be conducted so as to provide a liver 
whose edges are sharp. smooth and pink and that does not show any of the 
dark rounded swelling characteristic of canine hepatic ou t fou  obstruc- 
tion. When the liver is cooled to the neighborhood of 28" C. or lower. it is 
taken out with adequate segments of ~ t s  vessels. and placed in the recipient 
dog. 
The resuture of this liver in the recipient is then carried out anatomi- 
cally while the two shunts maintain venous return to the right heart. First 
the inferior venacava above the l ~ v e r  is sutured end-to-end. Then the portal 
vein is sutured end-to-end. Uporl opening the portal vein anastornosls the 
clamp above the liver is released so that perfusion of the liver now begins 
with the recipient'b own blood via the portal vein. The liier soon becomes 
quite nomal in appearance if the donor operation has been gently done. The 
total "dead time" of this liver is approximately 30-45 minutes up to this 
point. The cava below the liver is then anastomosed. The hepatic artery is 
then sutured end-to-end after gentle dilatatron of the t h o  ends. As soon as 
the bena cava is opened, the caval shunt can be removed. The bile ducts can 
be dealt with in one of several ways. The most satisfactory consists in 
cholecq stduodenostomy. 
The incisions in the neck and the abdomen are then closed. No steps 
are needed to maintain the liver immoblle in its position. It seems to be held 
v e q  firmly bq its anastonlotic arrangements and by the pressure of the 
surrounding \ iscera. 
Transfusions are giben as needed. w ~ t h  the use of ion-exchange blood 
during the anhepatic phase. Ac~dosis,  developing during transplantation, 
is effectively treated by sodium b~carbonate given intravenou<ly. 
No heparin is requrred for the maintenance of shunt-flow in the 
anhepatic dog. If the transfusion v o l ~ ~ m e  is large the dog will be found to 
have a coagulation defect at this time that makes hemostasis difficult. 
When the operation is carried out with more dispatch and with less 
bleeding. no coagulation defect I S  identifiable bq clott~ng time. prothrom- 
bin time, recalclficatlon time and clot lysis tests. 
The plane of anesthesia must be very light. It is desirable that the 
animal regain consciourne,s shortly after the operation. Animals that fail 
to do so often fail to survive the first 24 hours. 
h. Corltr.01 Gr.ou,n. Our control procedures ha\e  consisted of two 
types. 
I .  Aurorransplants. In this procedure, the same operation as that 
described above for the recipient dog is carried out. The liver is lifted out 
of the animal, cooled in a bath of isotonic solution and by perfusion, using 
chilled oxygenated blood and is then replaced in the same animal. 
2. Liver. disscc~tionr. or sham operations. In this procedure, the liver 
TARI.E 1 .  I,ji cr 7ra~rsplanlalion 
Gross Pullr~~l(~fiicol I:i~tdinfis in Dogs Srir:,i;,ing 
T ; ; , r j  Days or Lonfer 
- - . - - - - - - -- - -- - - -- 
D a y  of 
. l n ~ m a l  Dea th  Pathological Eintllngs 
-- - -- -- - 
5 - 1 8  5 .Itelectasis; snlall I ,o \~el  intussuscep- 
tiori; slightly s\vollen liver. I 
5 - 2 0  6 l lulti1)le helmtic infarcts;  hepatic 
arter!. t l ironil~osis;  1)ilateral herno- 
thorax : atelectasis. 
5 - 2 4  5 IIul t ip le  n~!.ocartlial lesions; mul- 
t i l~ l e  gastric ulcers; 1)ulrnonary 
congestion anti a t e l r c t a~ i s .  
5 - 2 8  4 H e l ~ a t i c  infarcts;  ? hel)atic ar tery  
thron1I)osis; n?!.ocarilial lesions; 
l~a r t i a l  1.V.C'. thronii)osis. 
5-35  64 Hel)atic congestion ; gastric erosions; 
jaundice; atrlectasis 
5 - 3 6  4 Gastrostoni>- Icak. ~ier i toni t i s ;  myo- 
cardial lecions; 1)ortial hepatic ar -  
ter!. throniiiosis; focal 1)ancreatic 
necrosis; renal infarcts. 
5-44 2 11) ocartlial l e s ~ o n s ,  focal hepatic 
infarcts;  focal l~ancreat ic  necrosis. 
5 - 5 0  2 Hepat ic  ar tery  thrornl~osis ;  hepatic 
necrosis. 
5 - 5 8  12 Perforateti duotierial ulcers, perito- 
n i t i s ;  I.V.C. thron11,osis i l ~ e l o ~ v  
renals) ; green, s\vollen liver. 
5 - 6 9  84 Small.  pale liver; generalized j a u ~ i -  
(lice; rerial infarcts. 
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Fig. 1 .- Li\er  function tests. Bilirubin and alkal~ne phosphatase in the autotransplant 
are on]) transiently elevated. In the homotransplant these values rise rap~dly prior to death, 
the rise in alkaline phosphatase preceding that of bilirubin. 
-. ~ -. 
is dissected up, the shunts are placed, and everyth~ng is done in the way of 
dissection. including some of the vascular anastomoses, but the liver is not 
actually removed from the animal. 
2. Results 
u .  Honlotr-~n.splurits. The homotransplant procedure has been under- 
taken in 31 animals. There have been 15 survivors over 24 hours. Eight 
have lived over four days, two have lived five days. and one each have 
survived 5-112. 6, 8 and I ?  day\. Our observat~ons on cl~nical course, liver 
function and histologic change are ba\ed on the above an~mals.  
1 .  Postoperati~~e Course. After operation the animals are maintained 
on antibiotics; cortisone was used initially but was later not found to be 
necessary. 
In animals sumlvlng the first 24 hours, acharacteristic clinical course 
was pursued. The animal regained conscioutness. regained strength and 
ability to walk about. They recognized their handlers. had adequate urine 
flow, but in most instances were unable to eat significant amounts of food. 
A few dogs had b~liary d ~ v e r \ ~ o n  through a cholecy~tostomy. and in these 
animals the bile output ranged up to 180 ml. per day. A number of animals 
succumbed during the first four d a j \  to anatomical compl~cations of the 
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Fig. 2.- Hematocrit and blood chemical values. 
The first five days show a typical biochemical profile of 
a successful homotransplant. There is an early rise in he- 
matocrit with later a gradual fall, postoperative sodium- 
potassium shift. transient rise in BUN with return to 
normal and an initially normal serum bilirubin which 
slowly rises. On the fifth day this dog developed an 
inferior vena caval thrombosis with partial occlusion of 
the renal velns. The subsequent chemical changes 
(particularly sodium. potassium and blood urea nitro- 
gen) reflect the effects of this complication. There was 
perforation of a duodenal ulcer terminally. 
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procedure, including hemorrhage and embolus from the neck incision, and 
massive hemorrhage from gastroduodenal ulcer. In those that lived beyond 
period, clinical and chemical hepatic function continued to within 24 
hours of death. 
Death was often unassociated with liver failure. was usually unac- 
companied by hypotension or shock save terminally, and was presaged in 
of instances only by increasing jaundice, starting about 24 hours 
before death (see below). The fatal terminus did not resemble a fatality 
from hepatectomy in most of the animals, and was due to a combination of 
clinical conditions shown in Table I. 
2. Chemic,ul course. In many animals the hematocrit was found to be 
elevated dunng the first 48 to 72 hours. Three factors played 
a role here. One was loss of lymph into the peritoneal cavity, although all 
visible lymphatics were ligated in the porta hepatlr. This was treated by 
infusions of saline or blood. In other instances. the elevated heinatocrit was 
due to inadequately replaced water loss or to overtransfusion of the animal 
during the operation with subsequent plasma dispersal. If the transplanted 
liver developed outflow obstruction and became swollen and dark, a very 
considerable amount of blood was required to maintain the animal in a 
normotensive state; one to two days later this animal would be found to 
have a high hematocrit. suggesting that, as hepatic outflow tract obstruc- 
tion was gradually released and splanchnic pooling abated. the animal 
became hypervolemic. lowering the blood volume towards normal by 
plasma dispersal and thus showing an elevated hematocrit. An almost 
unlimited number of chemical and hepato-functional determinations 
might be carried out in animals with transplanted livers. The following 
were selected as being of special interest. 
The blood urea nitrogen was not significantly elevated in any of 
these animals save for one in which transient renal failure played a role. Nor 
was the blood urea nitrogen abnormally low. It remained between 10 and 
25 mg.% in most of the survivors. 
The blood sugar was usually normal or elevated. The hyperglycemia 
was not regarded as a significant finding because of the concomitant 
infusion of glucose in many instances. Occasionally hypoglycemia was 
noted during the first 48 hours if the intravenous infusion was stopped. 
Alkalinephosphatase shows a progresswe increase often antedating 
the rise in bilirubin concentration (Fig. I j. 
The serum hiliruhin concentration was generally normal or slightly 
elevated during the first few postoperative days but rose steadily prior to 
death. Five out of eight dogs who had this determination canied out 48 
hours postoperatively showed values under 2.0 mg.%. By the fourth 
postoperative day only one of these eight dogs still had a bilirubin of less 
than 2.0 mg.%, and after the fifth day no animal had a serum bilirubin in 
this range. (Fig. 2). 
The Plasma albumin und globulin concentration relationships were 
measured by paper electrophoresis. A fall in albumin and a rise in alpha- 
2 globulin was characteristic. 
Cougulution studies (clotting time, recalcification time, prothrom- 
bin time and clot lysis) showed abnormalities in those animals early in the 
series in whom blood-trapping as unrelieved in limbs or portal circuits, or 
in whom hemorrhage had demanded large transfusion. As experience 
grew, no significant abnormalities in these parameters was observed until 
at or near the time of death when a bleeding tendency associated with a low 
prothrombin time became clinically evident. 
3. Histolog\. (Fig. 3-6). Anatomic findings at death, some of which 
were responsible for the fatality, are shown in Table I .  Isolated thrombo- 
sis in one or another of these vessels was not uncommon but massive 
thrombosis, either of the portal. caval or hepatic systems. was rare. In four 
animals pulmonary atelectasis was severe. In three animals major gastro- 
intestinal complications would have been fatal without other disease. 
The only organs showing pathognomonic pathologic changes were 
the liver and the heart. Where bile \*as diverted from the gastro-intestinal 
tract, gastroduodenal ulcer was common. The use of an entirely abdomi- 
nal approach has reduced the incidence of pulmonary complications. 
The histologic findings in the liver may be descnbed as an initial 
infiltration of the portal areas and subhepatic veins with mononuclear cells, 
lymphocyter and plasma cells. with dilatation of the lymphatics. There is 
maintenance of the liver architecture with minimum distortion of the 
hepatic parenchymatous cellular mass and the sinusoids themselves. As 
the lesion progresses, the portal and centrolobular areas show progres- 
sively more cellular infiltration, finally including damage to the epithelium 
of the bile ducts. In one of the eight-day survivors (X-69) change in the 
cellular detail was seen in the parenchymatous areas. This was not seen in 
other dogs. This was unaccompanied by polymorphonuclear leucocyte 
infiltration or bile stasis and included vacuoli~ation of cells and abnormal 
mitoses. If due to rejection, this response involved the parenchyma more 
than in any other dog. Interestingly, our 12-day survivor (X-58) showed 
less cellular damage than this eight-day survivor; only minimal necrosis 
was noted in the liver cells near the portal areas. 
Early in our experience, lesions were encountered in the hearts of 
these animals. They were characterized by myocardial necrosis without 
cellular infiltration or visible thrombosis, going on to small areas of 
calcification. It was later shown that these can be produced in the dog by 
long, difficult operations, particularly those producing hypotension and 
requiring blood transfusion or by hemorrhagic shock. These lesions also 
occurred in the autotransplants. 
b. Controls. Twenty-seven procedures for autotransplantation were 
instituted. Of these. ten survived 24 hours or more and seven, four days or 
more: two for four days, three for five days. one for ten days and one for 
14 days. Causes of death were analogous to those in the homotransplant 
group, though the histologic appearance of the liver was quite different. 
Of the "sham" dissections. 13 were done. Of these. nine were 
significant survivors and six lived14 days or longer, two being sacrificed 
at six and nine weeks, respectively. 
The autotransplants were initially more difficult to accomplish than 
the homotransplants because there is less vessel-length for anastomosis 
Fig. 3.- Liver autotransplantation (X-35). Fifth day. There is dilatation of lymphatics and some interstitial edema. The parenchyma 
appears normal, and there is no mononuclear cell infiltration (Hematoxylin-Eosin, 100 X). 
Fig. 4.- Liver homotransplantation (X-18). Sixth day. Marked mononuclear cell infiltration is present in the portal areas. There is 
some lymphatic dilatation. The parenchyma appears virtually normal (Hematoxyln-Eosin, 100 X). 
Fig. 5.- Liver homotransplantation (X-69). Eighth day. The liver shows many morphologic change5 in the hepatic cells themselves: 
necrosis, vacuolization, abnormal mitoses. There is also atrophy of bile duct epithelium and dilatation of the ducts. This animal showed 
a minimum of extraneous anatomical complications and a clinical picture most closely suggestive of purely hepatic disease (Hematoxylin- 
Eosin 430 X). 
Fig. 6.- Liver homotransplantation (X-58). Twelfth day. There is mononuclear infiltration and lymphatic dilatation in the portal 
areas, but the parenchymatous cells are well ~naintamed. In this animal death was due to perforated duodenal ulcer (Hematoxylin-Eosin, 
100 X). 
Fig. 7.- Spleen homotransplantation (S-12-A). Fourth day. There is a large active lymphoid follicle with many reticulum cells. The 
appearance is consistent with an immunologic response by the spleen. A few plasma cell\ are dispersed throughout the follicle 
(Hematoxylin-Eosin. 100 X). 
Fig. 8.- Spleen homotransplantation (S-12-A). Sixth daq. The follicle is packed with plasma cells and lymphocytes. No reticulum 
cells can be seen. Evidence of follicular activit) has disappeared (Hematoxylin-Eosin. 100 X). 
Fig. 9.- Spleen homotransplantation (S-12-A). Ninth da).  The lymphoid follicle has undergone involution. No reticulum necrosis 
are now apparent in the adjacent red pulp (Hematoxylin-Eosin. 100 X). 
Fig. 1 0 .  spleen homotransplantation (S-12-A). Ninth day. The red pulp is virtuall) replaced by plasma cell infiltration. Focal 
necrosis can be seen. There is intercellular vacuoliration of the ylenic  trnbecula (Hematoxylin-Eosin. 100 X). 
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and it is impossible to achieve parallel hypothemic arrangements for the 
anoxic liver without cooling the whole animal, a step that is definitely 
undesirable in this procedure. In those autotransplants and sham dissec- 
tion$ that had prolonged survival. the most striking difference in contrast 
to the transplanted dogs were to be seen in theirbetter clinical course, going 
to normal d~etary intake, and the finding of a liver which did not show 
rhe ]\mphocytic and plasma cell infiltration. degeneration of bile duct 
epli&li;rn or hepatocellular damage. In common with the homotrans- 
nlnnt,. the autotransplants showed marked d~latation of the lymphatics in 
r.--- . . 
the portal areas and in the wall of the \ublobular veins. 
T/ie Sp1rc.n 
The nature of the histologic and clinical picture involved in ho- 
motransplantat~on of the spleen is a matter of concern becau\e the spleen 
is an organ containmg a large mass of inimunolog~cally competent cells. 
~f grafted tissues react immunologically againbt the host such should be 
seen maximally in a structure such as Iqnlph node or spleen. Beyond this 
lies the poss~bility that after whole body irradiation. hematopoietic resto- 
ration might be achieved by hornostran5plantarion of the spleen from an 
"nlrradiated dog. The mass of whole spleen is many hundred-fold larger 
than any dose of cellular suspension or marro& aspirate that might be 
injected for such a purpose. The concept of hematopoietic restoration by 
intact jpleen in whole body irradiation finds its basis in the work of 
Jacobson,' in which shielding of the spleen from whole body irradiation 
resulted in hematopoietic survival and clinical resuscitation of laboratory 
rodents after massive whole body irradiation. In Jacobson's experiments, 
the shielded spleen needed to be left in the anirnal but a short time to achieve 
its hematologic effect. In adults of other species (dog, man). the spleen does 
not nonnally harbor mature, active. hernatopoietic tissue. It appears to be 
con\ertihle to a multipotential hematopoietic organ as suggested by 
changes observed in such disease as agnogenic myeloid metaplasia or 
certain myelophthisic anemias in which the bone marrow becomes aplastic 
or is destroyed and the spleen becomes an active site of hernatopoiesis. 
The present experiments were undertaken to perfect a method for 
splenic transplantation, and to view the histologic and clinical results in the 
untreated normal dog. 
1. Operative Procedure in Splenic Transplantation 
Both dogs were operated upon normothennic and no effort at 
producing hypothermia in the transplanted spleen was made in most of the 
experiments. Exper~ments demonstrated that cooling by immersion or 
perfusron results in a rapid drop of spleen temperature. should such be 
shown to be necessary. 
Before the spleen is removed from the donor. its vascular pedicle is 
isolated in such a way as to isolate the splenic artery near its origin as [sic] 
a point at which anastomosis can be done. When this artery bifurcates near 
the spleen the ana\tomotic procedure is facilitated. If its bifurcation is close 
to its origin, the operation 1s more difficult. In most of these procedures, the 
spleens were traded between two dogs. They were sutured in place by end- 
to-end anastomosis of artery and vein after gentle dilatation of the arterial 
end\. The dog'\ spleen is a large organ, occupying a larger fraction of the 
body weight and abdominal cavity than IS the case in man. When trans- 
planted to its normal site, it occupies a normal position free of torsion or 
distortion. 
Coritr-01 Autotransplants. In control animals, the spleen was re- 
moved and sutured back in place in the same dog. 
2. Results 
Splenic homotransplants were carried out in 29 dogs. In many of 
these animals (several of them earl) in our experience) the spleen did not 
become properl) vascularized, and splen~c hemorrhage or infarction 
cauted the death of the dog. There uere  ten an~mals  in whom good splenic 
vascularization was established as shown b) gross and microscopic 
appearance at biopsy and by fresh arterial bleeding after the second 
postoperative day. Many aninials underwent subsequent 5plenectomy if 
the condit~on of the spleen threatened their 5unibal. The longest survival 
of rplern Qas  in one animal at 65 days (S-I 2-B). establi\hed by biopsy and 
shou ing good vascular maintenance. 
u Clrnic ul Couue .  If splenic vasculariration was satisfactory. these 
dogs had no characterrstic clinical disturbance after their operation. They 
were not carr~ed on antibiotics and d ~ d  not require intravenous therapy after 
the first day. If the spleen became necrotic due to distortion of its blood 
supply, the animal became ill. In those animals in which venous obstruc- 
tion occurred with engorgement of the spleen. the animal might succumb 
to splenic rupture or hemorrhage. particularly after b~opsy.  B i o p s i e s 
were taken at various intervals after the operation in both homotransplants 
and autotransplants. 
b. Herrramlo~~.  No characteristic hematologic changes (hematocrit, 
white count, smear) were identified in the peripheral blood of these 
animals. Leucoc)tosis was usually present. especially when the rejection 
response in the spleen seemed to be at it5 height. 
c. Hisrolog~ (Fig. 7-10). There was a str~king d~fference in the 
histologic appearance of the homotransplanted and autotransplanted 
spleen. In those spleens that failed to achieve surgical \inhilit) early 
diffuse necrosis occurred. a picture contrasting with that of rejection. 
The rate of histologic change is variable. As an illustration, the 
histologic sequence (slower than most) in homostransplanted spleen of 
dog S-12-A included the following: 
1. (Days 2-4) Reticulum cell hyperplasia in large prominent active 
Ijmphoid follicles, compatible with a brief "graft vs. host" response. 
2. (Well established on day 6.1 Plasma cell infiltration, first in the 
follicles, then the red pulp and subcapsular area\. 
3. (Well-established by day 9.) Disappearance of reticulum cells and 
involution of follicles with intercellular vacuolization in trabeculae. Dif- 
fuse massive plasmacell infiltration, particularly in the red pulp, with focal 
areas of necrosis. 
4. Thrombosis of small vessels and complete infarct~on. 
In all the other anirnals showing rejection, necrosls was established 
at the end of one week. 
The course of one long-surviving splenic homograft is difficult to 
interpret (S-12-B). On day 36 there were follicle\ w ~ t h  active centers, 
present also on days 5 1 and 65.  The cellularity of the red pulp was reduced 
In comparison with earlier time intervals. There is the possibility that 
chimerism may have been established. There is also the possibility that the 
cells seen in the follicles and red pulp represent a repopulation of donor 
spleen with cells of the new host. 
Discu~sion 
One-stage whole organ transplantation both of the liver and of the 
spleen may be accomplished in the laboratory. The transplanted liver 
survives and functions well for a time. Although we have had several 
survivors over48 hours, we have had but afew animals whose surgical and 
clinical course was so smooth that one could feel confident that the clinical 
course was that of liver rejection. In such animals, the rejection process 
seemed initially to be focused largely on the portal areas leaving the 
parenchymatous liver cell quite free. This was reminiscent of kidney in 
which early rejection is directed at the tubular mass, leaving the glomeruli 
free of attack. 
Future work on liver transplantation in the an~mal  may take a number 
of different directions. The most important is a further extension of these 
experiments to view the unmodified rejection response more clearly. A 
second form of study will depend upon treatment of the recip~ent with 
radiation, radiomimetic drugs, with or uithout bone marrowr or splenic 
transplant, to achieve a state of tolerance in which prolonged hepatic 
survival might be achieved. A th~rd  form of experiment would consist of 
transplantation into an animal in liver failure. 
Looking to the clinical probleni, it should be noted that the liver of 
a recently deceased animal appears to maintain viabi l~t j  so long as either 
the entire body. the liver perfusate. or the liver Itself is rapidly cooled and 
maintained in the cool state.' Technics for the postmortem preservation of 
tissues will rest on the temperature coefficients for metabolic activity in 
each orgail and the mechanical detail\ of \peed of cooling. The treatment 
of cirrhosis or other liver disease by hepatic transplantation offers promise 
clinicallq on14 where there is a comparative lack of conjoint pathology in 
other organs. The treatment of metastatic carcinoma by liver transplanta- 
tion would offer salvage only in those rare patients a here the liver was the 
only site of nletastasis. 
The splen~c experiments demonstrate the histolosic nature of splenic 
rejection and the fact that the rejectron process seems to involve but a 
transient phase of graft reaction against the hoat. 
EXPERIMENTAL LIVER TRANSPLANTATION, EXCLUSIVE O F  IMMUNOSUPPRESSION 
Looking to the future of splenic transplantation in the laboratory. it 
is essential that experiments be carried out to disco\er methods'' by which 
the spleen may be converted into a more active hernatopoiet~c organ. 
Experiments of this t!pe will in \ol \e  whole bod) Irradiation or prellml- 
narj treatment with radromimetic drugi (both w ~ t h  splenic protection 
against the damaging agent). If the spleen can be con\erted to a more active 
hematopoietic organ. one ma> rea\onabi) expect that after whole body 
irradiation or the use of radiornimet~c drugs rn the recip~ent animal. one 
may achie\e iplenic acceptance 3 5  has been the case with the skin grafts 
and bone marrow. Whether or not the destructi\e therap) required as a 
preliminary rnust be so se\ere as to endanger the lrfe of the rec~p~erlt  dog 
can only be diicemcd b) further stud!. In an animal harboring and 
accepting a spleen from a donor animal. one might hope to achieve an ideal 
situtation for subsequent acceptance of other organs because such donor 
would then be a\ailable for rranbplanrat~on studles of skin. kidns). liver. 
or other organs. In this regard. ~f splenic heniatopoiesii can be ach~eved. 
one has amore f ~ t t ~ n g  donor-recipient relattorlship than I \  the cahe w ~ t h  the 
bone marrow transplantation. It is ditticult to secure enough marrow from 
a single donor (particularl! in rnan) to repopulate the deitroyed marrow 
of a potential reclplent. Multiple-donor experiments are therefore of great 
interest." 
For any of these future po\s ibi l~t~es  to become a realit), the firrt two 
steps required are those of the de\elopment of a method for surgical 
transplantation of these t u o  \iscera. and the dehcnpt~on of the normal 
course of transplantation without other treatment. Such has been the 
objective of the work hereln descrrhrd. 
Cotic Iusior~s 
Experimental whole-organ hornotran\plantat~on of the liver and of 
the spleen has been carrled out expernnenrally In the dog, transplanting 
these organs to thelr nomial anatomical positlon and blood supply. 
Control experiments habe consl\ted ot autotran\plantation of the 
organs, returning them to their nom~a l  sites. 
In both cases a satrsfactor) surgical technrque has been ach~eved 
which produces a \ iable organ. Hepatic tiypothenn~a ii an es\ential feature 
of the liver transplant. Reject~on of these \rscera rs a gradual cellular 
process, sharpl) to be differentiated from ava\cular necrosi\ or \urg~cal 
failure. 
In the caw of the I~ver.  a significant \p;irrng of !he parench)matou\ 
liver cell mass is noticed early in the rejection proce\\, the latter being 
directed in~tially entirel) towards the portal arcas and centrolobular veins. 
In the case of the spleen. the rejection process I \  diffuse, results in 
atrophy of follicles (after nn rnitial follicular stimulation), loss of follicular 
activity, and infiltratio~i of the entire spleen \\ith pla\ma cell\ that appear 
to arise from the rec~pient srnce there are no nests of acrl\e plasma-cell- 
producing areas in these spleens. 
The irnpllcat~ons of this work \\ith re,pect to therapeutic transplan- 
tation of the two organs, and future d~rections for research in this field, are 
briefly discussed. 
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Discussion 
Dr. Stephen E. Hedberg: Dr. Cole, members of the Association and 
Guests. I should first like to congratulate Dr. Moore on the presentation of 
this interesting and excellent paper. 
At Walter Reed we al\o have been ~ntere\ted in the transplantation of 
canine spleens and our work with transplantatiun of normal spleens to 
normal dog\ has tended to confimi uhat  Dr. Moore has 5hown you here 
today. 
One of our alms In spleen trnn\plantat~on has been to explore the 
possibil~t) of protecting the recip~ent anrmals against high doses of 
ronr71ng rad~ation by means of a spleen tranhplant. 
Very early in the game a e  satisfied our5elves that the nonnal spleen 
will not protect an irradiated recip~ent. Our protocol was therefore modi- 
fied. and Dr. Moore thought that you might be interested to see what we are 
doing now and in hearing about some of our earl) resulti. 
The frrst s11de IS a dragrarn of our experiment. Our donor dogs are 
females of D-negative blood type. ~mmunrzed agaln\t typho~d and diphthe- 
ria and prepared according to n method outllned by Dr\. Dunphy and 
Stanley Jacob. Two rib\ are removed, the animal is grven I50 r total body 
irrad~ation. and as soon ;is poss~ble thereafter the ribs are returned to the 
spleen of the sumr animal. 
S I X  weeks later these ribs. Implanted In the spleen. are producing 
a c t i ~ e  bone marrow 
At thl\ time a reciplcnt dog. a n~a le ,  D - p o s ~ t i ~ e  blood o p e ,  immu- 
nrred agarnst tetanus, i \  giben a \upralethnl do\e of total body irradiation. 
The following da) h ~ s  pleen 1s removed and replaced by the marrow- 
containing spleen from the female dog. The rnale dog 1s then o b w v e d  for 
prolongation of sun i \ a l  wlth respect to ~rradiated controls; his red and 
white cells are studied to note the appearance of female cells of each kind; 
h ~ s  antibodies are studled ~ l t h  respect to t)phoid, drphtheria ant1 tetanus; 
routlne hematologic work I \  done and blops~es are taken of his \pleen at 
intervals after transplantation. 
The next few slide\ are photomicrogmphs of \ections from a spleen 
at the time of transplantat~on. and of the \ame spleen five days and seven 
days after transplantation. 
This ilide shows uhat  the bone marrow looks lrke at the time of 
transplantat~on. Thl\ 1s e\\entiall) normal bone marrow and, outside the 
field of  \ ieu ~t is surrounded by 5pleen that also looks quite normal. 
The next s l ~ d e  - five days after traniplantatron - shows that tremen- 
dou\ hqperplasia has taken place in thi\ marrow. apparently in response to 
the needs of the Irradiated host. The next s l ~ d e  shows that changes have 
also taken place in the splen~c pulp. This is a clu\ter of megakaryocytes - 
found in large numbers in this trnnsplanted spleen seven days after 
transplantation. nomially found only occasionall! in the splenic pulp of the 
dog. 
The final s l ~ d e  sho\\s that. rn add~tion to megakaryocytes. the splenic 
pulp 1s producing red blood cell\: in the left upper comer are early red cell 
forms: kou can see hemoglobin in some of these nomioblasts. 
I \hould be most unwill~ng to \peculate what these findrngs mean or 
what the) ma) promise. hut certa~nl) they are of Interest to us and we intend 
to pursue them. 
Agaln. I should l ~ h e  to thank Dr. Sloore for asking me to elaborate a 
l~ttle b ~ t  on the subject of his \timulating paper. 
Dr. Thomas Starzl: Dr. Harry A.  Kaupp and I have been working on 
the problem of l ~ v e r  ~ranbplantat~on for the past 18 months. We have had 
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experience with about 80 hepatic transplants, but we were not able to 
obtain suwlval for longer than three or four days until we were encouraged 
hv Dr. Moore's results in Atlantic City last Fall. Since then, our survivals 
", 
have been longer. 
(Slide) We have removed the entire aorta from the donor animal in 
with the hepatic anery and liver graft enabl~ng us to place a large 
anastomosis in the abdominal aorta of the recipient an~mal .  We have 
provided internal biliary dramage b j  acholecjstenterostoniy below which 
is an enteroenterostom). 
(Slide) The venous reconst~tution has been done in three ways. 
Shown on the left 1s the reverse Eck fistula type of reconstruction in which 
all of the blood from the Infenor vena cava and the splanchnic system is 
deklated through the liver. This procedure has a very high immediate 
perhaps as high as 80 or 85 per cent due to inability of the liver 
to transmit the augmented venous return. 
The second method we have used for venous reconstruction is shown 
in the middle. This consists of essentially anatomlc reconstruction with the 
add~tion of a small portacaval shunt, so that if splanchnic hypertension or 
li,er engorgement debelops, decompression can occur. This is the most 
versatile method since very small dog's livers can be placed into large 
rec~pient animals. 
The maximum aunival with each of these t u o  methods has been nine 
days. A third technic (shown on the right) has employed entirely normal 
anatomic reconstruction. In t h ~ s  case. the animals have had to be carefully 
matched as to size. With this method. the maximum surv~val has been 20- 
112 days. 
(Slide) Shown here are some postoperative chemistries. and one can 
see that the chemical events parallel those demonstrated by Dr. Moore 
rather closely. The bilirubin is shown here nsing as Dr. Moore demon- 
strated, usually starting up on about the fifth day. In this particular animal, 
our longest survival, the bilirubin rose sharply. At the time we thought the 
animal was just about to reject his liker, he began to recover. The bilirubin 
fell and was st111 declining at the time of h ~ s  last chemistries. 18 days after 
surgeq and 2-112 days before death. 
We believe that many of our an~malc have died as a direct result of 
hypoglycem~a between the sixth and tenth days. This animal manifested 
a fall iri blood sugar which u a s  around 25 or 30 for four or five days. but 
no Intravenous glucose was given. He was allowed to eat. He was given 
sugar uater to drink, and the blood sugar rose back to normal levels by the 
15th postoperative day. 
(Slide) As can be seen. other chemistries including alkaline 
phosphatase and cholesterol alao manifested a return toward normal 
during the thrid postoperative week. 
(Slide) This i5 a rather poor slide which shous that there is some liver 
tissue remaining and that there is massive round cell infiltration. 
I would like to thank the Association for the pr~vilege of the floor, and 
pan~cularly Dr. Moore for the opportunity to discuss this fine paper. 
Dr. W. V. McDermott: It is always very stimulating to hear Dr. 
Moore. We try to keep our inter-university across-town lines of commu- 
nication intact, but sometimes they become fairly tenuous for periods of 
time. In our studies we have had no direct experience ~ i t h  homotransplan- 
tation of the liver. but in the course of some of our studies in the isolated 
perfused canine h e r .  replants hake been done in order to continue 
observations initiated during the period of perfusion. 
(Slide) In this expenmental plan both the isolated li\er and the donor 
animal are maintained during the perfusion. During a prolonged perfusion 
there are problems concerned with maintenance and restoration of the 
hepatectomi~ed animal, but in three of the fi\e attempts replants were 
successful after perfusion periods ranging from 1 to 2- 112 hours. In all three 
s u n  ivors liver funct~on. ammonium clearance and all standard parameters 
were entirelq normal. and the longest sunivor  is nou over three months. 
One dog was sacrificed for the purposes of the study in progress. 
M~croscopic examination shoued an entirely normal liver. These limited 
observations would support Dr. Moore's observation5 that replant and 
transplant of the liver are technically and physiologically feasible and that 
the abnormalities described, particularly in the excretoq functions of the 
liver, are a part of the rejection phenomenon and not due to any metabolic 
disorders attendant upon the operative procedure. 
I certainly congratulate Dr. Moore on this beautiful presentation. I 
will be interested in his further studies. 
Dr. Francis D. Moore (Closing): President Cole. I would like to 
thank Dr. Hedberg. Dr. Starrl and Dr. McDermott for their fascinating 
discussions. This ne\* field that 1s opening up is a large one. There is a lot 
of work to be done in it, it takes long hours. lots of animals, lots of thought 
and will need maximal support from the national agencie3. 
Every t ~ m e  somebody comes to visit our laboratory they say. "Well, 
what good is it to study all this? Where are you going to get Ilvers'?" We 
have conducted a study. which I won't show you any slides of, on 
hypothermic preservation of the postmortem liver. To make a Ions story 
short. ~f the liver is cooled fast enough. it maintains excellent metabolic 
functional capacit) up to I ?  hours after death. T h ~ s  probleni of a time- 
temperature coefficient in the postmortem survikal of individual tissues 
represents an important hor~zon in t h ~ s  field. It 1s one that the Russ~ans have 
explored with great interest. They have secured good kidney replants or 
auto-transplants after 28 hours of cooling. The rource of tissue, as I think 
Dr. Cole intimated in his Presidential Address, is here, but there is much 
to be done In understanding hou to use it right. 
Finall), I uould like to show my last slide, if I could (Slide) just to 
show jou that there's nothing neu under the sun. In 1909. Dr. Carrel with 
his penetrating insight realized that in exploring these things it was best to 
start with the simple things, so he began with replantation of the canine 
spleen. 
EXPERIMENT.AL LI\ ER TRAYSPLANTATIOh. EXCLUSIVE OF I.2.lhlL YOSUPPRESSION 
Harry A Kaupp, Jr was a senlor resident In the Northwestern 
University surgical program in 1958 and 1959 when the first work 
there with liver replacement was carried out in dogs There were two 
residents assigned to the Surgical Research Laboratory one to 
work in cardiac surgery and the other to work with one of the editors 
(TES) a junlor faculty member They flipped a coin and Kaupp lost 
He became the second author on the first papers from Chicago on 
lver transplantation After completion of tralning Kaupp began a 
private practice of vascular surgery in Allentown Peinsylvania He 
retired in 1986 and is presently living in New Hampshire 
In July of 1958, experiments with orthotopic liver transplantation in the dog were begun at 
Northwestern University ~n Chicago simultaneous with and without knowledge of hloore's work. The 
absence of early comrnuncat~on between the Boston and Chicago groups was reflected in a number 
of differences in their techniques. However, the two central objectives of effective preservation of the 
liver and decompress~on of the obstructed splanchn~c and systemic venous circulations during the 
anhepatic phase were the same. The principle of core-cooing used to preserve the liver grafts in 
the Chicago laboratories subsequently was applied to the initial cooling and preservation of all 
whole-organ grafts. The material from the Northwestern University studles was divided into two 
articles, the first essentially technical and the second describing the clinical and histopathologic 
events of rejection. 
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Reconstructive problems in canine liver homotransplantation 
with special reference to the postoperative role 
of hepatic venous flow 
Surgery, Gynecology & Obstetrics, 111 : 733-43, 1960 
T. E. Starzl, Harry A. Kaupp, Jr., Donald R. Brock, Robert E. Lazarus and Robert V. Johnson 
Although considerable experimental data have been accumulated 
concerning many organs, there have been few reports of homotransplan- 
tation of the liver. Until 1959, the only work had been done by Welch and 
his associates (9, 34), who were able to obtain function from liver 
homografts transplanted into the pelvis. Recently, Moore and his associ- 
ates presented the first accounts of successful homotransplantation of the 
canine liver to animals with total hepatectomy (21.22). Maximum survival 
after operation was 12 days. 
The techniques to be described for homotransplantation of the liver 
have previously been briefly outlined (12,28). The influence of portal flow 
upon the homografted liver has been ana ly~ed  in derail not only because 
this factor proved to be an important detenninant of success or failure but 
also because the resultant inforniation may have application in a variety of 
other experimental sltuatlons, including those involving hemorrhagic 
shock. Maximum s u n  ival after liver homotransplantation has been 20 iz 
days. 
General Methods 
Seventy-nine transplants here  performed, using healthy adult mon- 
grel dogs of 10 to 25 kilograms. In most cases, the weights of the donor and 
recipient animals were closely matched. Both dogs were anesthetized with 
25 to 30 milligrams of sodium pentobarbital per kllogram and. after 
tracheal intubation, placed on respirators. The arterial pressure of the 
recipient dog was monitored during and lmrnediately after operation with 
an arterial catheter connected to an aneroid manometer. Venous prestures 
were read directly from a water manometer attached to an induelling 
catheter. The operation was perfonned under sterile conditions b) t uo ,  or 
occasionally three surgeons. In analvi5  of results, the first 27 hepatic 
transplants were excluded from consideration because a ~ a r i e t y  of rneth- 
ads of liver preparation were used with a resultant inconstant qual~ty of 
grafts. 
PRELIMINARY STEPS IN THE RECIPIENT DOG 
The abdomen was opened with an upper midline incision. A segment 
of aorta, 1-112 to 2 centimeters in length, was mobilized just above the 
inferior mesenteric artery for later anaqtornosis. Next, the mesentery of the 
caudate lobe of the liver was incised, and the inferior vena cava encircled 
with a tape, above the entrance of the adrenal veins. The gastrohepatic 
ligament to the left of the portal triad was then doubly ligated and divided. 
Finally, common duct and gastroduodenal artery were double ligated and 
divided as close to the duodenum as possible. The portal vein was cleaned 
off toward the liver until its bifurcation was encountered, taking care to 
ligate all lymphatics on its surface. When these steps were completed, the 
only uninterrupted structures remaining in the gastrohepatic ligament were 
the hepatic artery and the portal vein. 
A portacaval shunt was then const~ucted In as inferior a position as 
was convenient (Fig. Ib). The exact ai/e and technique of this shunt varied 
with the different techniques of venous reconsrruction during implanta- 
tion. but in every case the preaence of the anastomosis was necessary for 
decompress~on of the splanchnic system during implantation of the liver. 
When the anastomosis was completed. the abdominal wound was closed 
with towel clips. and attention directed to the donor dog. 
PREPARATION OF THE DOSOR LIVER 
During this operation on the recipient, the donor dog was immersed 
In an ice bath. and the body temperature reduced to 25 to 30 degrees C. The 
abdomen of the donor dog u a \  opened through a long midline incision. The 
abdominal aorta \bas mobilifed proxin~all) to the level of the superior 
mesenterlc arter).. Ilgating and divid~ng all branches (Fig. 2).  The superior 
mesenteric arter) encircled uith a ligature but left Intact for the time 
being. 
Next. the stoniach and spleen \\ere retracted sharply to the right, and 
the celiac axis was dissected free from its origln to the trifurcation, where 
EXPERIMEYTAL LIVER TRANSPLANTATION. EXCLLSIVE OF IMMLNOSLPPRESSION 
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Fig. I.- Basic technique of homotransplantation. a. Donor liver ready for transplant. Note aortic graft removed in continuity with hepatic 
artery and liver graft. b. Recipient wtth portacaval shunt and liver removed. c. Donor liver in place. 
splenic and left gastric arteries were ligated and dikided (Fig. 2). Attention 
was then directed to the portal triad. The gaatrohepatic ligament to the left 
of the triad was first ligated and divided, and the common duct and gabtro- 
duodenal artery double ligated and divided near the duodenum. The portal 
vein was freed from its surrounding adventitia in uhich there were man) 
lymph channels uhich required ligation. In order to obtain an adequate 
length of portal vein for subsequent anaitomo\i\. the pancreatic vein u a r  
double ligated and di\ ided. Several large I! mph node\ usuall!, .itill looiel) 
connected the portal \ein and hepatic arter) inferiorly, but these \\ere 
stripped out easily uith blunt diasectlon. leablng the hepatic arter! and 
portal vein skeletonired (Fig. 2 ) .  The donor liver ua5 now read! for 
perfusion in situ. 
The previously placed ligature around the \upenor mesenteric arten 
was tied. The portal vein uas  ligated a far ~nferiorl) a\  pujsible. and the 
blunt end of a standard intravenoui infucion jet directed up the portal \ein 
to the liver. Through this. 1.000 iublc centimeter\ of cooled ( 5  to 10 
degrees C.) lactated Rlnger.5 \elution s e r e  wed for grabit) prrfu5ion of 
the liver with a preswre head of 60 to XO centlmeteri of \hater (Fig. 2 ) .  As 
soon as perfusion uab begun. the animal uas  bled to death through a 
catheter inserted into the aorta (Fig. 2) .  The collected blood uab subse- 
quently used for tran\fusion of the recipient. During the perfuiion, the 
interior of the li\er cooled to 10 to 20 degree\ C 
The liver was then rernoxed after ~ncl\ion of ths diaphragmatic 
ligaments by transectlon of the portal ~ e i n .  the upper abdominal aorta, and 
the vena ca\a  a b \ e  and k l o u  the Il\er (Fig. l a ) .  The open upper end of 
the aortlc graft %a \  l~gated. The vena c a ~ a l  cuff aho\e the liber uas  
carefully scrutinized for small hole\ a hich. if unrecognized. hill  lead to air 
embolus or hemorrhage after the liver is revascularized. A small incision 
in the gallbladder was niade at the site of the proposed cholecystenteros- 
toniy to pre\ent autolysis. The 11ver was then brought to the table of the 
recipient animal. 
Before evolvlng this method for preparation of the donor liver. a 
number of unsatisfoctorq techniques were emp1o)ed. T h e x  falled gener- 
all) either because of the use of heparln in the donor with consequent 
bleedlng after transplantat~on or because the liber uas  not cooled enough 
to u l t h m n d  the effects of ischem~a. 
HEPATECTO"\.lY I \  THE RECIPIEhT DOG AUD TRAUSPLANTA- 
TIOV OF THE DOUOR LIVER 
After rerno\al of the donor Ii\er the operdting team returned imme- 
dtatel\ to the recipient dog dnd iriterted an extern,il pol)e th~lene bjpass 
trom the ternordl tojugulC+r \e in\  (Fig 7) a \  detcnbed bb Kaupp and Starzl 
( 1  3) 4fter Ilgdt~on dnd dl\ irion o! the hep'itli arter) the \end i,i\a. abo\e 
and belou the Il\er '~nd the portdl \ e m  uere  srdsped ulth Potti clamps 
dnd the l i ~ e r  &a \  rernoksd (Fig 3) -4 bri\k tlou through the external shunt 
idused decompre\\ion ot the bloiLed \pldnchnic ds well 'I\ of the cabal 
bed5 
The cooled donor Il\er ~ L I ,  po\it~oneti In the upper p'lrt of the 
abdomen of the recipient dnimdl tF1g 1'1 and b )  -41id\tornosi\ uds  
performed uith Lontlnuout \ o  5 - 0  drtcndl silk het\\een the cuff of 
reclplent \end cd\d 31 the di,iphra~m ~ h i t h  uo, \harpl\ pulled doun  to 
idiilitdte expo\ure (Fie  4 1  dnd the 5hon iu t t  ot \sn,i i a \ ~  on the donor 
11\21. Becauv ot th limited \poie drid \host \egnlent\ ot \etsel\ .  tt u a s  
necesidn to st?\\ the po\terior rou from ~ i t h i n  the \e\,eli  (Fig 4) 
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Fig. 2 .  Preparation of donor liver. Aortic graft prepared. Perfusion 
of cooled Ringer's solution by gravlty through the ponal vein and collec- 
tion of blood from the aorta. 
Re-establishment of the portal and vena caval return was done in 
three different ways (Flg. 5) .  The choice of procedure influenced the type 
of portaca\al shunt pre\ ioudy performed (during preliminary steps in the 
recipient dog). The first method of \enous recon\truction e m p l o ~ e d  the 
princ~ple of the reberse Eck fistula (Fig. 5a).  in uhich the preliminary 
portacaval shunt was made at least 1 centimeter in length. After completion 
of the caval-caval anastornosib a b w e  the li\er. an end-to-end portal-portal 
anastomosis uas  p e f o m e d ,  and the open stump< of donor and rec~pient 
venacava belou the liver here ligated (Fig. 5a) .  With release of the clamps. 
the venous return of both the caval and splanchnic ?>sterns s e r e  d~rected 
through the 11ver (Fig. Sa). 
The second method resulted In anatomic venous reconstruction w ~ t h  
the addition of a small portacabal shunt (Fig. 5b ) .  In this ca\e, the 
preliminarq portaca\,al anastomosis was made small. 4 to 7 rn~llirneters 
long. ulthout the exclsion of an ellipse from e1tht.r cessel. .After complet- 
ing the upperca\al-cakal anastomosis, the lower ca\ al-to-ca\al and portal- 
to-portal anastomoses uere  performed in anatoniic po\ition (Figs. Ic and 
5b).  
The third method of benous reconstruct~on resulted in normal venous 
pathuals.  The preliniirian portaca\al anastorno\r\ \*a\ 8 to I O millimeters 
in length and was used onl! to decompress the portal s>\tem (via the 
external po1)ethqIene b k p a ~ s )  during the perlod of acute portal-caval 
occlusion as the li\er \ \as irnplanled. The portal-portal and louer caval- 
caval anastornohe\ %ere performed anatorn~call) w ~ t h  h o .  6-0 and No. 5 -  
0 silk respecri\elk (Fig. lc) .  Before the abdomen \\as clo\ed the portacaval 
shunt uas  taken doun  and the \enotornie\ were closed ~ i t h N o .  6-Oarterial 
s ~ l k  i F ~ g .  5c).  
Aftercompletlng the \enousanastonio,e\. the aortic graft uas  placed 
in the right para\ertehml gutter arld attached uith an end-to side anasto- 
nlosls to the recipient dog's dortd. at a iariahls d~j tance belou the renal 
anenes (Flg. Ic).  No. 6-0 arterial silk uas  used and a button of recipient 
aorta removed. 
Fig. 3.-Decompression of portal and caval venous systems during 
complete occlusion of vena cava and portal vein by external shunt from 
femoral vein to external jugular vein. 
Internal billary drainage ua5 perfomled with a cholecysto~ejunos- 
tomy, belou uhich was established a jejunojejuno\tomy (Fig. Ic). Both 
gdstrorntestinal anastomoses mere performed ui th  a tuo-layer catgut and 
silk technique. Splenectorny uas  carried out, and the abdomen was closed 
uith rnultlple layers of fine silk. 
POSTOPERATIVE CARE 
One million unit\ of aqueou\ penic~llin were given on the morning of 
operat~on and twice dail) during the entire postoperative period. As soon 
as the operntion uas  completed, a large gaztric tube uas  passed and kept 
ill position un t~ l  no longer toltrated. Frequent endotracheal aspirations or 
bronchoscopies \\ere performed until the animal uas  full? auake. 
During operation. 500 c u b ~ c  centlmeters of blood uere  generally 
glven. During the first X to 10 postoperati~e hours. it was ;ilmost always 
necessaq ro g i \ s  another 5(3U cubic centlmeters. e \en to those dogs in 
uhich no bleeding could e \ e r  be demonbtrated. Intra\enous fluids were 
usuall) adln~r~~stered for the first ? or 3 da\s.  after whlch marly dogs 
tolerated a low protein diet. If the animals stopped eating, intravenous or 
cl)sis therdp) uas  rernstitutcd. 
RESULTS 
T(11ct-rrni (. of the iic~r~o\i~iiio:-i:c~ii iir t.1. to isc lieuziu. The time between 
remo\al of the cooled donor 11\er and 11s re\a.iculx~zatlon In the recipient 
dog u a  45 mlnutec, at the least. and rn man) instances 2 hours. After more 
than 2 hours. i\chemic 1 1 ~ 1 . 1 -  rnjun occurreci uhlch almost dluays pre- 
cluded succes\ b) an! of the described means of reconstruction. When 
blood flou u a \  restored aftcr ~\chemia of longer than 2 hour,. the liver 
became tense arld dark In color. uith hi\tviogic e\idencs of intense 
conge,tiori. Death followed In a feu hours either trom hemorrhagic 
gastrosnteritlr. as d re\ult of hemorrhage iron? \mall cap,iilar rear\ in the 
dirtended I l ~ e r .  or from  cuts hspat~c fdilure. 
In preparation of the donor I ~ \ e r .  it \\ as important that the liver becool 
EXPERIMENTAL LIVER TRANSPLANTATION. EXCLUSIVE OF IMMLUOSUPPRESSION 
Fig. 4.- Technique of caval-caval anastomosis with posterior row 
being sutured from withln. 
Fig. 5.- Methods of venous reconstruction. a. Reverse Eck fistula. 
b, Anatomic reconstnictlon with small portacaval shunt. c. Complete 
anatomic reconstruction with closure of preliminar) portacaval shunt. 
before any ischemia occurred. For this reason. total body cooling (25 to 30 
degrees C.) was carried out in the donor dog before the abdomen was 
opened. In the event of accidental lschemla durlng dissection of the portal 
triad or aortic pedicle. before the liver was further cooled by perfusion. 
some protection wai afforded. 
After the liver had k e n  perfused with cold Rlnger's solution, its 
temperature was well maintained at approximatel> 10 to 16 degrees C. 
after removal. Shoun in Figure 6 i \  a typical warming c u n e  of the interior 
of a donor Ilver. In uhich the temperature rlse u a s  le\\ than 2 degrees C. 
in 1-112 hours. 
Thp i,uiut, o~j rirc ctier-nu1 h ipass  clut-rny I r i o -  rr-ci!r.ri,Iunrc~rion. In 
performing the first 20 Il\er transplant\. an extenial b!pa\s wa\ not used 
during the period of portacaval occlu\ion. since In the pre\ lous work it had 
been determined that short tern1 occlu\ion in the presence of a ponacabal 
shunt was well tolearted (291. Sunrivalj of as long a\ 6 d a > \  \+ere obtalned 
with this technique, but In \ub\equent experiment> the t.xtemal bqpa\i \+a\ 
routinely used for se\eral reason\. I h e  portaca\al occlui~on u a i  often for 
as long as 2 hours. dunng the latter pan of \\hich profound h!potension 
usually developed. At autop,). man? of the dogs had cardiac Ie.~on\ 
similar to the infarct. de\crlbrd bq Tantur~ after ten~poran ponal occlu- 
sion. Finall). hemorrhagic gastroenteritl\ pro\ sti to be a common po\top- 
erative complicat~on. and It ua s  not po\sible to hnou ~ f t h i s  u a \  due to the 
acute portal hqpe r t en~~on  during ~mplantarion or to \plarlchn~c venouj sta- 
sis which de\eloped postoperativel: 
With the external b!pa\\. \evere h)potensrori did not de\elop. Some 
fall in blood pres\ure occurred. hut the mean presjure almo\t aIu;1>i 
remalned abme  100 rn~llirlletrr\ of rnercuq The bouel remalnsd pink. 
Clotting of the ti l iconi~ed tube d ~ d  not generall) occur durlng the b>pasi.  
Acurc rift.c r (71 1 tJ!iciirs t.t.( ot irrr i i~ rr,jri n irli r/rt7 t el i,rst7 El X tisiirlii. 
T h e m - s ~ x  hepat~c tran\plant\ Mere perfomled b! the method o i  the re- 
verse Eck fistula (Fig. Sa! Onl) 1 of the 26 dog\ \ u r \ ~ \ e d  for more than 
4 daqs. The other 2 2  ,inimal, died at \ q i n g  riine, up to 4 da> i .  111 I I 
experiments as a result of ths inuhilit> of the tr:iniplanred I i ~ e r  to trari\rnit 
the requlred venouc f lou.  s i t h  con,squsnt hernorrh,~gic ga\rroenteritii 
The other earl) death, \%ere c,iu\sd b> hemorrhage ~n .? doe\,  portdl 
thrombosis in 3 dogs. atelectasls in 2 dogs, air embolui In I dog, and 
R o o m  temp.- 27°C 
1 9 .  Dog w e i g h t  - 1 8 4  
Fig. 6.- Rewarming curve of interior of donor liver exposed to room 
temperature for 1- 112 hours. 
unknown etiology in 2 dogs. 
Most of the unsuccessful experiments followed a highly characteris- 
tic pattern. After revascularization. it became obvious that sequestration of 
blood was occumng in the liver which became swollen, tense. and 
extremely dark in color. Shortly after. large amounts of lymphatic fluid 
escaped from the surface of the liver capsule. The portal vein and inferior 
vena cava distended uith preiwres as high as 250 millimeters of saline. 
Superficial lacerations in the transplanted liver began to hemorrhage. and 
frequentl) the prev~ousl> drq portal-portal or porta-caval anastomosis 
began to ooze. sometimes uncontrollably. Wlthin a few minutes, the bowel 
and stomach lost their normal pink color and assumed a faintly cyanotic 
hue. Within a few hour\, large quantities of fluid accumulated in the gut - 
at first clear and later blood-sta~ned. 
In such cases, a progressivelq lncreahing rate of blood transfusion 
was necessar) to rnalntain the blood pressure. Blood) diarrhea developed. 
and the animals died in 5 to 15 hour\, despite aggreaaike therapq. Histol- 
ogic sections of the I~ver  showed acute congestion and e a r l  dlsniption of 
hepatic cord architecture (Fig. 73). Sect~on\  of the large and small intestine. 
re\ealed marked conge\tlon and interat~tial edema of the entire wall (Fig. 
8a and b!. 
In other esperirnents. the animals sur \ .~\ed the immediate postopera- 
tlvr perlod. only to die 1 to 3 day\ po\toperativelq, usuall) from gastroin- 
testinal hemorrhage. In the\e animals. there u a s  h~stologic evldence of 
persi\tent hepatic congestion w ~ t h  distention and coalescence of sinusoids 
(Fig. 7b). Hepanc cell lo\. uas  apparent. cspeciallq In central areas. 
A s \ c ~ ~ a t e d  slough of ~n te \ t~na l  muco,o and intlammator) infiltration of 
~ntesrinal ~ 1 1 1 1  occurred (Fig. 8c) .  
Four of the 26 I~ver  transplants re\asculari/ed u ~ t h  the re\erse Eck 
fi\tula s u n  ibed longer than 3 daq s. or long enough for honlograft rejection 
to be expected to occur. \ lax~mum sur \ .~\a l  was 9 d a ~ s .  
Tumerou\ complication\ characterired t h ~ s  group of an~rnals. For- 
nlatlon vf ascite\ ~ d i  e \ c e \ s ~ \ e ,  and d~rcec t~on  f the fluid through the in- 
cision u ~ t h  wound breakdoun occurred In all long temi aurvi\als. Pneu- 
rnonitis and thrornhoi~\ of the \a\cular an,istorno,ls \+ere a1.w late causes 
of death. Onl! I of the long temi sun i \o r \  u;l, able to eat. 
f i r ?  t>fft>cr o t  unci~onii< ~.t jr io~r\  r t , ( ~ ~ ~ ~ i s i r ~ i (  rroti H rr i~ ~xic l~ i ion  of a 
p(~t ' iucuiu1 siiitrii. Flitern tran\plantc uere  perl-ornlrd h> means of 
ailatomic recon\tructlon oi'the \ e m u s  \)>tern uith the addition of a small 
portacaLa1 shunt ( F I ~ .  i b i .  The ponaca\al anaitomosls \*a\ dellberatel! 
con\tructed >mdl  - 3 to 7 rn~ll~rneter\  - \o  that a definitslq elevated 
portal p r e w r e  uould be necs\ \ap  in order for large flow\ to cross the 
,hunt. In thii ha!. 11 \+a\ hoped to decornpre\s the Il\er and jplanchnic 
circulation in the e\ent of h ~ g h  ponal pre\\iire\. u~ thou t  unnece,\ar~ly di- 
j e r t ~ n ~  portal blood from the l i ~ s r .  Fifteen 11\er\ \\ere tran\planted in this 
manner and 6 ,inimal\ \ u n  ~ ~ e d  for more than 1 dajh. Sine dog. d ~ e d  in the 
earlq postoperative period: 2 of hemorrhage. 3 of atelectasis. 2 of hemor- 
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Fig. 7.-Histologic changes in hepatic outflow block. a, Liver after 10 hours, showing congestion and early loss of architecture 
with dilated sinusoids. b, Another liver at 36 hours showing persistent congestion and marked disorganization of hepatic architec- 
ture. X 214. 
rhagic gastroenteritis, 1 as a result of portal thrombosis. An important 
contributory cause of death in many of these dogs was a distinctive 
syndrome consisting of intractable vomiting and retching which began 
immediately after operation and continued until the death of the dog. This 
was thought, but not proved, to be due to acute liver failure. 
With this technique, the acute congestion of the liver and bowel 
described for the reverse Eck fistula was seen in only 2 experiments. Gen- 
erally, the liver became soft and light in color after revascularization, and 
the bowel remained pink except in those cases in which the shunt was 
inadvertently made too small to be functional. 
Despite the obvious disadvantage of reducing the blood flow to the 
liver, this technique of reconstruction proved to be the most versatile in one 
respect. It was possible to perform transplantation without closely match- 
ing the size of the donor and recipient animals. Donors were used which 
weighed as much as 8 to 10 kilograms less than the recipient animals, a 
disparity in size which precluded success in the other two methods because 
of the development of splanchnic and hepatic congestion. 
Six of the 15 dogs with this type of venous reconstruction lived for 
more than 4 days. Only 2 animals were able to eat consistently. Maximum 
survival was 9 days. Although it is thought that homograft rejection 
occurred, a variety of other complications were found at autopsy which 
could have been independent causes of death. 
Acute effect of anatomic venous reconstruction. Eleven dogs had 
reconstitution of the liver in an anatomic manner. and 8 survived for more 
than 4 days. The causes of early death were hemorrhagic gastroenteritis in 
2 cases, and atelectasis in the third. When this technique was used, the acute 
bowel congestion described with reverse Eck fistula reconstruction was 
seldom encountered provided the weights of the donor and recipient dogs 
were closely matched. However, efforts to use significantly smaller donor 
than recipient animals resulted in acute bowel congestion and early death. 
The clinical behavior of this group of dogs was the most satisfactory 
of all techniques tried. All 8 long term dogs resumed oral intake promptly, 
usually after 2 days, and continued to eat until shortly before death, which 
was presumably due to liver rejection. The average long term survival 
exceeded that obtained with either of the other methods, as did maximum 
survival which was 20-112 days. 
Fig. 8.- Intestinal changes resulting from outflow hepatic block in dogs with reverse Eck fistula. a, Small intestine after 10 hours 
showing mucosal and submucosal congestion and submucosal edema. Note intact epithelium. X 11. b, Small intestine in another dog after 
18 hours. There is congestion and loss of epithelium of distal portions of villi. X 44. c, Small intestine in a dog dying after 36 hours. Base 
of villi have partially intact epithelium, but distal villi are edematous and congested with marked slough of epithelial covering. X 44. 
DISCUSSION 
The unusual susceptibility of the liver to anoxla has undoubtedly 
deterred progress in hepatic transplantation. Welch and asiociates (9) .  h ho 
transplanted the whole organ to the pel\ih of rec~pient dog.;, pointed out 
that the transferred tiisue could not < u n i \ e  if de\acculari7ed for more than 
30 niinutr\ under nonnotherni~c condit~on\.  Di,clohurer of the protectne 
effect of h>pothennia on the ischemic Ii\er b) R;~ffuci. Bernhard. and 
Huggins and the11 a\sociate\ ha\e made tran\platation \tudies more 
practical. 
Despite the protection of li)potliennid. undue prolongat~on of is- 
chern~a result\ in a chnracteri\tic li\er Injur! in which the re\ascularized 
organ en t r ap  large qildnritles ot hlood. The in ; ib~l~t> of hlood to escape I S  
probably due to con\rriction of \mall intraparench)rn,~l hcpatic \ems as 
shown b) De)\ach arid Thoma\ and €\ \ex.  The% \e\jels have been 
dernon\trated h) .Are! to ha\? e\traordinaril) \\ell dsieloped mu5cular 
coats in the dog. Sirnildr hepatic congc\niiri. ;iprl) ternied "blue Iner  
syndrome" or "outflo\\ block." has been tic\crikd in the dog in a \~ r i e t !  
of phqsiologic circum\tance\ including: anaph!la\i\ ,uid peptone shock 
by Ilautner and Pick. S~rnond\ .  and \Veil: reniporar) i ie\a~cular~zation of
the liver b! Hilie\ ;ind Roncoronr ;inti Sr;its anti I.ichte~i\tein: hijtamine 
injection hq Ilautner arid PILL and I3,iui.r and hi, ,i\\oci;itc,. perfusion of 
the i\olated I ~ \ e r  b) Il;ikr,i\ ,irti ,ind Tripod. Ll,lc.g3itti. 311~1 Kr\ten\ and his 
associates: endotoxin ~~t iock b! I1,lcLenn and \Veil. , ~nd  hemorrhagic 
shock bq Frank (61 and Wigger\ and their dr,ociate,. 
With tran\plantation ot the l i ~ e r .  the degree ot i\cheniic in,jury iionly 
one of the influences which contrihure to the f r a \ e  complic;ttion of outflow 
block. The most import;tnt \econdar! tactor ~j rlir vcilunie of benous blood 
which is tran\poned to the I i ~ e r .  In the norninl dog. it ha\ k e n  \honn by 
Meqer and other\ that both the splanchn~c and inferior c n \ d  \enour return 
can he d~rected through the li\er without harrntul effects. But the anosic 
transplanted I ~ \ e r  apparentl) reacts to such augmented xenous f l o ~  with 
outflow block. In contra\t, the blue li\er dr\eloped infrequentl) when 
venous mtlow w3\ nornial or uhen a decioriipre\sing ponacabal anasto- 
rnoiij was rct;iined a \  :i peml;inent feature of the reconstruction. The 
importance of regulating portal \ein intlo\\ in ;ibnrding outtlo\4 block 
during ~solated liver perfu\ion ha\ also been cornmenreti upon by McDer- 
mott and a\sociate\ ( 131. a\ well as nunlerou\ e;irlrer \\orhers. 
Another tactor contribi~tmg to tlic ~usccpt ibi l i t~  to outtlow block of 
the transplanted or the i\oIated pel-fu\ed Ii\er ma! be the \[ate of denerba- 
tion in both inktances. The confu\iiig lrter,~ture on \ a\ori~otiorcontrol of the 
liver ha\ been sumrn~trired h) Ch~ ld .  I h e  dominant ciutonornic mil uence 
appears to be j)rnpattietic. with retiiiction of the \we of the liver and 
increahed outflon upon \t~nlul;ition l'ara\)rnpatliet~c \timulation has 
resulted in I t \ \  clear finding\. Sirnilarl). epinephri~ie solutions cause 
shrlnkage of the Ii\er wit!i increa\ed hepatic \elti outflow, aa shown by 
Bauer and h i  a\\ociate\ and b) I laega~th.  while acet! lcholine h a  a less 
pronounced hut rzberse effect From thi\ ~nfomiatio~l.  i t  would seem quite 
pos\~ble  that the derienatsd li\er undergor\ \asornotor alterations uhich 
promote stasis. Such a mechani\rn. 111 add~tion to ccintr~buting to outtlow 
block. could e\pluin the nece,sit! for the 1,lri.e tr;in\fii\ions which are 
necessar! po\toperati\el!. e \en in the dogs uhich \ u n i \ e  for long term 
stud) 
The sequence of e\ent\  in thc howel iollouing outilow block in the 
tran\planted 11~i . r  I \  of intere\t hecau\e ot tlre re\enlhl,lnce oi the pathol- 
ogic changes of tho\e \eel? In irre\ersihle hernorrhag~c \tiock. For many 
yeari, the li\er ha, heen \u\pected of pla)ing ;in important role in the 
development of irre\er\ibilrt! hunierou\ ohwrvers. lnclud~ng Selkun 
(25). Wigper\. and Frirdrndn 'ind their ,i\\oci,ite\. h:i\ i. reponed increaied 
hepat~c vascular resiit'lncs attsr expcrinicntal hernorrh'ige. arid i t  hac been 
reasonable to belie\e tIi,it ion\eqticrlt \planchili< pooling anti reduction of 
circulat~n_r hlood \olume would re\ult T h ~ s  concept was apparentl! 
strengthened b!, the dernon\tr,ir~on of Fine .ind hi\ a , \o~ia te \  (7)  that 
viviperfusion of the li\er during henlorrh,i@e pre\ented the hemorrhagic 
gastroenteritis of irre\er\ible ,hock. H i l u e ~ e r .  Fine', y o u p  (6 )  also 
denionhtrated that de~onipre\\ion of the port;il \),tern with portacaval 
shunt to pre\ent irnpounii~ng of hlood in the \planchnic \!\tern did not 
prevent the intestin,~l le,ion, Suh~equentl!. drtcntion has heen focused on 
other thdn hepat~c idcror, in isre\ er\ibilit!. .uid recentl! the ir?te\tine itself 
has heen sugge\ted :I\ <in iniport,int prlniar! target org:in in \hock by 
Schweinhurg and his a\,cxlate\. Selkun, and Lillehei. 
The a e \ \ m e n t  of the r e l a t~ \ e  Importance of the l~ve r  and that of 
bobel In determ~ning irreversib~lit! of shock IS htill not settled. although 
there I \  ev~dence that both pla) an important role In the present study. an 
experimental situation \+a< pre\ent in hhich onl) the l ~ v s r  was \ubjected 
to anoxia The hlood prejsure generall! u a \  ne\er below 100 before. 
dunng, or ~mmediarel) after l i ~ e r  \+as re\aculari7ed. Yet. in the dogs 
developing ourtlo\\ hepatic hlock. \hock won  rn\ued which ultimatel~ 
w a  intractable to further tran\fu\ion and \\hich ebentuated In fatal 
hemorrhagic ga\troenterltis. 111 [hi\ \irudtion. the damage inflicted upon 
the I ~ \ e r  h) the transplantar~on \could beem to he \olel! responsible for the 
Inception and de\eloprnent of irre\er\ihle \hock. 
SI:MM4K'r' 
The honioiogous caniiie Ii\er lid\ k e n  tran\pl:inted to recipient 
an~rnal\  i r i  which total hepatectoiii! a i d  \plenectorn! have been per- 
formed. The 1onge.t \ i in i \aI  atter placement of the I ~ \ e r  hornograft h a s  
20- 112 dab \ 
Protection trorn hepatic ~\chemi'i for a\ long a \  7 hour\ \*a\ obtained 
h! cooling the tionor I~ver  to 10 to 70 degrees C The arterial supply h a s  
re\rored through a hepatic ;irter)-donic pedicle u.hich \+a\ removed in 
contlnuit! \bith the Iiber ,tnd ana\tomco\ed to the tie\cending aorta of the 
recipient. Internal hiliar! drdinage !+a\ e\t.ihl~\hed. 
The volume of \enou\ ilou traii\rnitted to the tran\planted liver has 
heen \hewn to be an irnportanr cietenninant of succe\s. When thi\ was ex- 
ce\sl\ e. 3\ \\hen both the portal and inferior cabal flows here  directed 
through the I ~ \ e r ,  hepat~c oi~t t lou block u<unll! de\eloped hith conse- 
quent fatal conge\tlon of the hepatic and jplanchnic k d s .  When the portal 
flow \\a\ nonnal or reduced. outtlow block rarel! occurred. 
An attempt has heen nude to relate the de\eIoprnent of outflow block 
as i t  occurred in the tran\planted I ~ i e r  to other iircum\tances, including 
heniorrhayic \hock. 111 v.h~ch sirn113r phenornena have heen ob\erved. 
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EXPERIMENTAL LIVER TRANSPLA\TATION, EXCLCSIVE OF IMML\OSLPPRESSION 
Studies on the rejection of the transplanted homologous dog liver 
Surgery, Gynecology & Obstetrics, 112: 135-44, 196 1 
Thomas E. Starzl. Marry A. Kaupp. Jr., Donald R. Brock and James W. Linman 
In a contemporary report, the technical problems and complications 
encountered with homotransplantation of the dog liver were described 
(15). As occurs with other vascularized homografts. the liver appeared to 
be rejected by the host after a characterictrc time interval. usually 6 to 10 
days. 
The present study is concerned with an analysis ofevents, both in the 
homografted liver and the host, in I8 clogs u hich auwived 4 or more days 
after licer transplantat~on, long enough presumabl) for hornograft rejec- 
tion to occur. This incirided postniortem and tissue itudies, as well as 
chemical and hematologic determinations during life. Strong histologic 
evidence has been obtained of uidespread participation of the host reticu- 
loendothelial systern in the rejection, quite coniparable to that seen after 
bacterial and foreign protein i~nrnunization. 
METHODS 
The techniques used for liver transplantation have been previously 
described (15). The homograft ua ,  pokitioned in the liver fossa, after 
removal of the recipient dop'c liver. and splenectorny u a s  performed. 
Arterialization and internal hiliar) drainage here  carried out with a 
unlform technique in (111 18 e-iperirnents. Venous pathua>\  uere  recon- 
structed with three variation,. ( a )  ar~atomicall). 8 c a x s :  ( b )  anatomicalij 
with the addition of a \mail portaca\aI chunt. 6 caiec: and ( c )  by diversion 
of both the splanclin~c snd Lena ca\al floi\\ through the l i ~ e r .  4 cases. 
Although the method used \*a\ profoundl) rnf1r:ential in determining earl! 
mortality. the type of venouc connectic.ii &,I\ not an important factor in 
most of parameters anal)7ed 111 ths preterit ctud?. and the re,ult$ appl) to 
all dog,, unless otherurse \tared. 
Adult mongrel dogs were u\cii. The donor m a  recipient uere  a lua>s  
chosen for oh\ i o ~ \ l )  d~tfsrent color and general appearance. In about one- 
half the experiments. the donor and recipient \rere different sexes. Blood 
studie, were obtained preopsr,iri\eI) and t.\er> 2 .  3. or 4 daks thereafter. 
and the renlo\ed blood \\a\ repiaced with imniediate tranjfusion. In a feu 
animals. tran\fu\ion\ \\ere alco :I\ en for tlie tre'itrnent of late ga\trointe\- 
tinal hemorrhage. All chem~cai \tudit.\ were \tclnilard dstemirnationc, 
made in a clinrcal I.iborator! .liiropsre, here  perlonnsti pronlptl). usuall! 
within an hour and ne\ er longer than h hour\ ~ f r e r  death. and :he specimen\ 
fixed in fomialin. Henilitoxj Iir~-c.o\in srain, \\ ere J I U  a) a uacd, and III borne 
cases additional tibsue stalns uere  employed. 
RESULTS 
Sun.i~,al. Survival times in 18 dogs are shown in Figure 5. Ninety per 
cent of the deaths occurred between the fifth and the tenth days. The longest 
aurvival was 20-112 days. Although inany other factors contributed to 
death. evidence will be presented that graft rejection played an important 
role in most cases. 
Clinic (11 hetiai,ior. The dogs uith the most sastisfactorq course were 
those with anatomic venou\ reion,truction. They were usually able to eat 
after the second postoperative day. Diet generally consisted of brown sugar 
water and bread. but soine of the dogs mere hungry for and allowed to eat 
meat. Although the dietary intake of dogs uith other than anatomic venous 
connections u a s  poor. physical activity of the ditferent groups of animals 
was frequently normal for the first 4 or 5 da>s. 
On the sixth or seventh day. jaundice developed in every experiment, 
usuallq aithin 12 to 23 hours after it \\as noted that the urine had become 
dark. Some of the dogs continued to eat, b u ~  u\uall) dietary intake was 
sharply reduced. Jaundice u a  iolIo\\ed by death in 2 to 4 day\ In all but 
I animal In uhich tlie jaundice receded dfter the eleventh day. Terminally. 
pallor of the gum, u a s  often \ em.  and vomiting a a c  common in both 
feeding and f;:\ti!ip dogs. 
The clinical behavioi of the longeqt survi\or (No. 65) iequires 
separate cornment. Jauridrce dc~e loped  in thi\ animal on the iixth day, and 
the dog appeared to he crrtrcall! 111 for 4 days. He continued to eat. 
houever. and atter the eleventh da) rmpro\ed with continued clinical and 
chemical regresrioii of the jaundice (Fig. 6)  until death after 20-112 days. 
This h a s  ths on!) unequr\ocal In\tance of improvement after sign5 of liver 
malfunctic~n had occur-red. 
Rectal temperature\ and femoral pulw r:lte\ here  taken twice a day. 
,411 animal\ had lou grade feker during most or 311 of the sur\ i\al period. 
This \\a\  e e n  b! the fir\[ da! after operation and per\iited s i thout  spikes 
(Fig. 7). There \\a\  no deviation from this pattern during the presumed 
rejectio:~ period. Corre\pontiingl!. puisc rates uere  not s u b ~ e i t  o wide 
\ar ia t~on after the irnrnctli~ite po\toperati\e taili>cardia had sub\ided (Fig. 
7 ) .  
\lo\! of the dog\ lo\[ dhoiit .25 kilogram in u c ~ g h t  per day after 
operation. In wrne case.,. the ti\\us lo\\ \*a\ rindixrbtrdl) greater. \ince the 
de\elopnienr of aiciies i ia i  often prominent. 
Blooclc~h~~niictr-\ . Fasting blood sugars were obtained before and after 
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Appearance of liver homografts at varying times after transplantation. 
Fig. 1 .- Five days: left, X 42; right, X 263. 
Fig. 2.- Nine days: above, X 42; below X 263. 
Fig. 3.- Ten days: above, X 42; below X 263. 
Fig. 4.- Twenty and one-half days: above, X 42; below, X 263. 
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-LL 
Days after I , v e r  tra?splantat~on 
Fig. 5.- Survival in dogs living more than 4 days. Note high 
mortality between fifth and tenth day. 
operation. Samples were taken in the morning, after an 8 to 12 hour 
withdrawal from food or Intravenous fluids. Initiallq. blood sugars re- 
mained at anormal level. However. at varying times, from 4 days on, blood 
sugars as low as 15 to 25 milligrams per cent were observed (Fig. 8). With 
longer suvivals. a definite correlation was evident between survival time 
and degree of hypogl~cemia (Fig. 8). In most dogs, a dropping blood sugar 
was a preterminal event. but in the longest survival the blood sugar fall 
reversed itself as other liver cheniistrie\ impro~ed  (Fig. 6). 
The time of debelopmcnt of chemical jaundice was v e q  deflnlte. By 
the fifth day, only 1 dog had a riie in bilirubin. but by the sixth da j  all tested 
dogs had become jaundiced (Fig. 9). The increase In the d~rect  bilirubin 
fraction was less but paralleled the total rlse (Fig. 9). comparable rises 
were seen with alkallne pho\phatase, starting on the fourth or fifth day (Fig. 
10). 
Total proteins were not predictably altered by transplantation. An 
example is shown In Figure 1 1  with detennmat~ons from the 20-113 day 
survivor, in which major shifts In e~ the r  the total or the albumin-globulin 
fraction did not occur. Thyniol turbidity tended to Increaye. but incon- 
stantly. Blood cholesterol rose (Fig. 12). remained stable. or fell with about 
equal frequency. Blood urea nitrogen remained normal In all dogs until 
terminally. when in 3 of 1 I animal\ \tudled a  harp rise occurred (Fig. 12). 
Fig. 6.- Blood sugars and bilirubin in 20-112 day survivor (No. 65) .  Note 
improvement in chemistries after eleventh day. 
l emp . . 
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Complete doyr after lhver tionsplantot~on 
Fig. 7.- Fever and pulse of dog 76. Animal had no complications. Cause 
of death probably homograft rejection. 
Henlutolo,qrc sruilies. Cornplete blood counts were obtained before 
and at varying times after operation. Because of transfusions, analysis of 
erythroid values has  not meaningful. All anlmals. except I .  had rises in the 
white count, sometimes as high a\ 40.000. The rise was spec~fically due to 
granulocytosis with a marked neutrophllia. No cellular abnorlnalities were 
noted in the peripheral blood. and in particular plasma cells were not seen. 
Uririe stutiies. All but 1 of the dog\ excreted adequate urine until just 
before death. In 3 of 8 animals tested. albuminuria developed after 2 to 4 
days and persisted. Analysis of bile products disclosed differences in 
urlnes collected before and after 4 complete postoperative days. In 8 
specimens collected from different animals before the fourth day, bile was 
detected In only 2. After the fourth day. 13 of 14 urines contained bile. 
Before the fourth day. half of the specimen\ contained urobilinogen (more 
than 1.0 Ehrilich unit). and after the fourth day urobil~nogen was detected 
in only 5 of 14 samples. 
Gross puthoio~ic. jiriclit~,y\. The honiografted liver had characteristic 
gross findings. It was usually larger than normal with a tan appearance and 
firm consistency. Although it had no other attachments than the various 
anahtomoses, there were no In\tanccs of dislocation of the organ from the 
I~ver  fossa. On section, the tis\ue cut with a firm and gritty sensation. The 
transected %dace had a nutn~cg appearance. such as seen with chronic 
heart failure. In ever), case, the cholecj 5tojejunoetomj ant! enteroenteros- 
tomy were intact. 
Thrornbo\l\ o f  a bn\cular anastomosis occurred in 4 of the 18 
experiments, t u ~ c c  in the aortic graft and once each in the portal vein and 
~nferior vena cava In I dog, the aortic suture line disrupted after 5 days. In 
0 1 
C 6 9 I2  5 I8 
Days after l ~ v e r  transplantatton 
Fig. 8.- Fasting blood sugars (dots) in all dogs not treated with 
intravenous glucose. Solid line connects average values for each day. Note 
that severe hypoglycemia sometimes developed as early as the fourth day. 
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Control 3 6 9 ' 12 15 I8 21 
Day. after 11~ei. tr-plant 
Fig. 12.- Cholesterol and blood urea nitrogen in dog 65. Terminal 
uremia was seen in minority of animals. 
third of the cases, a more diffuse plasma cell and mononuclear response 
was also found throughout the kidney. In addition, a moderate to marked Fig. 13.- Mediastinal lymph node from dog 65. X 82. Note cortical 
plasma cell involvement was noted in the perirenal (Fig. 14b) and periad- lhinning' 
renal tissues. 
Pulmonary abnormalities included passive congestion, pulmonary 
edema, atelectasis, and pneumonitis. However, in 15 of 18 experiments, a 
specific abnormality was noted. There was thickening of the pulmonary 
alveolar wall, apparently due to endothelial and histiocytic proliferation in 
the septa (Fig. 15). A light plasma cell infiltrate was usually present in the 
parenchyma with focal accumulations around small blood vessels. Some 
vessels had changes similar to those described in the kidney. Multinu- 
cleated giant cells were very numerous (Fig. 15). 
Bone marrow studies were made. In every experiment, increased 
numbers of plasmacells and lymphocytes were found. In some cases, these 
infiltrates were moderate, but in other dogs (Fig. 16) the relative and 
absolute increases in plasma cells and lymphocytes were striking and 
extensive. 
Skeletal muscle from the foreleg was studied in all 18 dogs. No 
diffuse or focal plasma cell response was found in any case. 
Findings in the heart and gastrointestinal tract were related partially 
to traumatic artefact. Focal myocardial infarcts often occur as a direct 
result of operation (15). In the later dogs, organizing infarcts or mononu- 
clear infiltrates were seen in all experiments. In the gastrointestinal tract, 
hyperemic sloughing and gastritis or enteritis were seen in various experi- 
ments. A diffuse plasma cell and lymphocyte infiltration was always 
present, often to a marked degree. 
Causes of death. The precise mechanism of death was often difficult 
to determine, not only because the findings with homograft rejection are 
not specific, but because of the frequent coexistence of serious postopera- 
tive complications. In 5 dogs, rejection appeared by exclusion of other 
factors to be the sole reason for death. In all dogs surviving more than 6 
days, it was thought that rejection of the homograft was in process at the 
time of death, in view of the histologic and chemical evidence of hepatic 
deterioration. 
Controls. Three types of controls were available for assessing the 
role of operative trauma or surgical artefact in the foregoing results. The 
first of these involved analysis of dogs which died after liver transplanta- 
tion as the direct result of operative trauma, in from a few hours to a day 
or so after surgery. In these animals, hepatic architecture was preserved, 
except when "outflow block" had occurred. There was no infiltrate in the 
livers. Fresh focal infarcts were found in the myocardium. The histologic 
changes in the bone marrow, kidney, lymph nodes, and lung described for 
longer surviving animals were not oresent. 
- w 
In 4 control dogs, cholecystojejunostomy with enteroenterostomy 
was performed after ligation of the common duct. The dogs were sacrificed 
at 5.~13, 14, and 15 days. Histologic studies of the liver were either normal 
or disclosed a minimal periportal polymorphonuclear infiltrate. In no case 
did bilirubin or alkaline phosphatase rise, nor were other chemistries 
changed. All other organs were normal. 
Finally, in 4 more dogs, sham operation was performed involving 
autografting the liver. The steps employed were essentially the same as 
with homograft experiments, except that the dog's own liver was returned 
to the liver fossa. Postoperative chemical studies did not show the abnor- 
malities described after homografting. The dogs did not become jaundiced 
or ill. The animals were sacrificed after 7 to 15 days. Focal myocardial 
infarcts or infiltrations were present in all 4 animals. Liver architecture was 
completely preserved, and mononuclear infiltrates were not present. The 
histologic abnormalities noted in the foregoing in the bone marrow, lung, 
kidney, and lymph nodes were not found. 
DISCUSSION 
Dempster, Moore and associates (12, 13). and other students of 
whole organ transplantation have recognized the need for delineating 
changes ascribable to the presence of a homograft from those alterations 
which result from surgical trauma. Some nonspecific artifacts were found 
in the present studies. For example, the control studies indicated that the 
lesions in the myocardium were explicable by the trauma of massive 
surgery. However, the changes in the chemistries and the consistently 
noted pathologic findings in the liver, bone marrow, kidneys, lungs, lymph 
nodes, and possibly gastrointestinal tract seem clearly related to the 
placement of the homograft. 
The metabolic studies provided a means of following the repudiation 
of the liver graft by the host animal. It has been shown by Mann and 
subsequent observers that dogs will die in I or 2 hours after hepatectomy 
if continuous intravenous glucose is not provided. Under the same condi- 
tions, continued survival after replacement of the recipient's liver with a 
homograft was incontrovertible proof of hepatic graft function. Function 
was complete initially, but measurable deterioration began on the fourth to 
sixth day, with the onset of jaundice, the rise in alkaline phosphatase, and 
the tendency toward hypoglycemia. The high direct blood bilirubin com- 
ponent, in conjunction with the elevated serum alkaline phosphatase and 
urinary bile, suggested obstructive jaundice. Since extrahepatic obstruc- 
tion was ruled out by control studies, it was concluded that obstruction was 
diffuse and intrahepatic. Such an occurrence was not hard to envision in 
view of the distorted, firm, and enlarged liver found at autopsy. In previous 
studies on liver homografts transplanted into the pelvis, Welch and his as- 
sociates (7) noted the cessation of bile flow after 4 days. From the present 
study, it appears that such an impaired liver can continue at a reduced level 
of efficiency to sustain life for many additional days. 
Comparisons are evident between the present results and those 
obtained by Simonsen and Dempster with homotransplantation of the kid- 
ney. Survival times were somewhat longer with the liver, since mean 
survival with kidneys was 4 days. Kidney transplants exhibit an immediate 
gradual functional deterioration with a rising blood urea nitrogen from the 
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Fig. 14.- Host kidney from dog 76 showing: a, perivascular mononuclear aggregate of cells and vascular changes, X 232; 
b, cellular response in perirenal tissue, X 232. Aggregates were mostly plasma cells. 
first day. The liver appeared to function normally for about 4 days, but its 
subsequent deterioration was similarly gradual. Evidence was presented 
by Dempster that the terminal event in the kidney was small vessel spasm 
with consequent inability of the organ to transmit blood, a general concept 
of rejection that has been strengthened by Edgerton's observations with 
skin grafts. Conceivably, a similar mechanism in the liver accounted, by 
means of splanchnic pooling, for the late gastrointestinal hemorrhages and 
mucosal sloughing seen in some dogs in the present study. At autopsy, both 
the kidney and liver homografts were abnormally large, pale, and firm. 
Histologic findings were also comparable in many respects. In the 
kidney, cortical changes were dominant with early perivascular and per- 
iglomemlar infiltrates, and later with edema, hemorrhage, more marked 
cellular infiltration, and structural disorganization. In the liver, aggregates 
of plasma cells and lymphocytes centered principally around the intrapar- 
enchymal portal triads, but the major parenchymal loss was frequently 
around the central veins. The ultimate degree of architectural loss was 
generally greater in the livers. 
The precise mechanism of homograft rejection is not known. As a 
result of the penetrating analyses of Medawar (10, l l ) ,  the theory of 
acquired immunity has become a widely accepted explanation. The theory 
holds that a homograft acts as an antigen to evoke an antibody response 
from the host which causes rejection of the graft and confers a permanent 
immunity to all tissues from the same donor. The interval between place- 
ment and rejection of thc graft is accounted for as the time necessary for the 
antigenic substance to get to and mobilize a response from the antibody- 
forming centers. Algire has shown that invasion of the graft with host 
lymphocytes is necessary for rejection. The principal evidence that rejec- 
tion is due to an acquired host immunity was the demonstration by 
Medawar (10) that a second graft from the same donor is rejected in an 
accelerated fashion. 
In the present study, the fate of the liver homograft has been shown 
to be comparable to other transplanted organs or free grafts in that it is 
ultimately rejected by the host. The converse, namely an effort of the 
graft's antibody mechanism to kill the host, has been the subject of lively 
interest since Simonsen and Dempster suggested the possibility with 
kidney transplants. Both Billingham and Brent's "runt disease" and 
Trentin's "secondary homologous disease" are thought to result from the 
attack of mature homografts upon fetal and irradiated hosts respectively. 
In the case of the liver, which has been shown by Berg and others to 
constitute well over half, and perhaps more than 90 per cent, of the 
splenectomized dog's reticuloendothelial system, any reaction against the 
host would be expected to be magnified. 
Fig. 15.- Host lung from dog 68 showing proliferative process in Fig. 16.- Bone marrow in dog 65, after 20-112 days. X 392. Note 
alveolar septa, and giant cells. X 225. large numbers of plasma cells. 
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From a functional vieapoint. there was no consistent ev~dence that 
any of the host organ systems were heriousl) challenged by graft initiated 
cellular or humoral antibodies. Renal and hematopo~et~c functions were 
most reliabl) monitored. Urinar) output \*a generall) good. and rises in 
blood urea nitrogen occurred terminall) In onl) 3 of 18 dogs. Pohtoperative 
granulocytic response. presumahl! of host bone marrow origin. wa5 
adequate and sometimes p r o d ~ g ~ o u \ .  Except for cornpl~cation\ related to 
surgery, cardiac or pulmonar) \)stem deter~orntion did not occur. 
Histologicall), howe~er .  host organs known to posse\s reticuloendo- 
thelial elements were univer\allq infiltrated a ~ t h  I!mphocqte\ and espe- 
cially plasma cells in the \ame general manner J\ the graft itjelf. In 
addition, active proliferat~on of f~xed me\ench!mal tt\<ue In and around 
blood vessels was prominent. a findlng u h ~ c h  1s also common in a rejecting 
graft. It would be tempting to regard the\e flndlng\ as evidence of a graft 
attack on recipient organs, espec~ally \mce \uch rnultiorgan changes have 
not been noted after placement of smaller and le\\ ~nimunologicall) active 
homografts 
Admittedly. no definite conclusion can be reached. but certain evi- 
dence at the present time is against this concept. Ac noted prev~ously, 
function of the host organ sy\temr has  not ~rnpatred. Secondly. if mononu- 
clear cells were orlglnatlng and niigratlng from the homograft to host 
tissues, one would expect a ub~qu~ tou \  d~\tribution. Inhtead. such cells 
were found onl) in those tissues which were them\elves capable of a 
reticuloendothelial rerponse. The recipient skeletal muscle. for example, 
had no infiltrate in any of the 18 animals. Flnallq. 11 has been shown by 
Bjomboe that prolonged and intense stlrnulation with various bacterial or 
protein antigens will cause a univer\al reticuloendothelial re\ponie. aston- 
ishingly s lm~lar  to that de5cribed In the present study. and Kojinla has 
shown the same thing w ~ t h  a pure lipid antlgen. Consequentl?, at present 
it seems most reasonable to believe that the histologic changes in host 
organs predon~inantl) represent an e-ihuberant response to the massive 
antigenic stimulat~on of the 11\er homograft. 
An alternative poss~blity i \  that the widerpread alterations comprise 
a composite picture in ahich both graft \ersur ho\t and ho\t Lersus graft 
reactions have played a significant role. Stud~es  in ahich elther the liver 
graft or the host are rendered immunologically defen\eles\ b j  irradiation 
should eventually clarify the Issue. 
SUMMARY 
Dogs in which livers have been replaced with hepatic homografts 
usually die in 5 to 10 days. Liver metabolism is not detectably abnormal at 
first, but gradual deterioration ot funct~on commences on the fourth or fifth 
day. 
There was histologic evidence of rejection in all dog\ dying after 4 
days. This ranged from minimal mononuclear infiltrat~on to almost com- 
plete destruction of parenchyma. In the longest survivor, 20.112 days. 
histologic changes were less profound than in man> animalr dying earlier. 
Widespread histologic changes were found in the host reticuloendo- 
thelial system, involving the bone marrow, kidneys, lungs, lymph nodes, 
and other tlssuei. Thew cona~sted of fixed tlssue prol~feration and infiltra- 
tion of mononuclear cells. principally plasma cells. These changes were 
thought to be due to a general host ret~culoendothelial response to the 
antlgenlc st~rnulu\ of the homograft. 
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CLIO CHIRURGICA 
The same principles used for orthotopic liver transplantation were extended to the transplanta- 
tion of all of the abdominal viscera as originally reported in abstract at the American College of 
Surgeons.* The perioperative mortality was 85%. The liver as part of an organ cluster was not 
rejected as vigorously as after liver transplantation alone, possibly because of the large antigen 
mass of the complex graft. Although graft-versus-host reactions were not well understood in 1960, 
these were recognized for the first time to have been caused by a solid organ graft. Twenty-seven 
years later, almost exactly the same operation was performed successfully in a child with a "short 
gut" syndrome and hepatic failure. 
* Starzl TE and Kaupp HA Jr: Mass homotransplantation of abdominal organs in dogs. Surgical Forum 1 1 : 
28-30, 1960 
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Homotransplantation of multiple visceral organs 
American Journal of Surgery, 103: 219-29, 1962 
Thomas E. Starzl, Harry A. Kaupp, Jr., Donald R. Brock, George W. Butz, Jr. and James W. Linman 
Recently, considerable information has been obtained on the behav- The abdomen was opened and the entire abdominal aorta mobilized, 
ior of liver homografts. by Moore et al. [8] and in our own laboratory [ lo ,  ligating and dividing all branches, except the superior mesenteric artery 
1 I]. The large and imtnunologically active liver homografts were rejected and coeliac axis. (Fig. 1 .) Mesenteric and other posterior parietal connec- 
in roughly the same time sequence as srnaller and less complex tlasues. In --- -- 
our studies. the manner of rejection difftred from the usual situation in that 
widespread changes were evoked in the host reticuloendothelial system, 
involving the lungs. kidney\. lymph nodes. bone marrow and other organs. 
The functional response of the transplanted iicer was substantially the 
same. both i l l  Moore's itudie\ [8] and in our our1 [I I ] .  In all our animals, i jaundice de~e ioped  by the f~ f th  da).  and the animals died from one to 
bixteen dabs later. I 
In the present study. other abdominal viwera bere  added to the liver, ~ 
to constitute a relatibely enormous multiorgan graft consistin? of the liver, 
spleen, pancreas. omentuni. \tomach. \mall bouel and colon. The behavior 
of th t  liver as a con\tituent oi the miilt~visceral graft u a s  compared with 
that previously studied u ~ t h  omotran\plant,ition of the Iiier alone. Since 
the graft contains the major portion ofthe reticuloendothelial jysteni of the 
body. particular attention was p a d  to the possiblity of a graft v e r ~ s  host 
reaction. 
METHODS 
Adult healchq tiogs from !O to 20 kg in height were u5ed in thiny- 
eight transplantation expel-inien!s. Thc animal\ ucre  deuoniied. passively 
~nimunized against d:\:rniper. :inL? prepzired fc)r \Llrser> i\ ith a t u o  or three I 
day bohel PI-eparation. ~i \ ing cathart~c, tnd 2 Srn. of neon)! clri 5uipllate per ' 
day. All recipisn! dogs \\ere krnaie\,  d:?d iiio\t donors u r r r  rn,~lzs. The ; 
donor dog3 uere  I to 5 kp. I~phrcr t hm the recipleritr. The an~inal i  were 
anesthetized uitli 75 to 30 mg. wdi~irn prntobarbital and placed on 
respirators. Arterial pre\sure\ ueri. iiionitored continuct,\I) during and 
after operation. 
Blood chernical 'inti heniatologic ~ t ~ i d i e \  ue r s  rnade before and at 
intervals after ,urger>. .After de:itil. i'oiiipl?te autcjp'ieb Mere prornptly per- 
f o m ~ e d  and the tis,ue\ prepared for hitologic \tuii:, I 
TECH\IC OF OPER l T l O \  -- -- -- 
PI~L~ /?O) .~ I I IOI I  of L)oilo). 71\111c!. L,ing :\ro biirg~cul tean?s. the Fig. 1 .- Schematic vieu of the transplanted tissues and their 
operation was started in donor driil rfi~iprfiit Jog\ :it the idme tlmt. The anatomic to the ho5t, The llssues are not shaded, donor animal h a s  first cooled to 28" to 30' C. b j  irnrnerrion in an ice bath. 
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Fig. 2.- Addition of portacaval shunt to operation depicted in Figure 
tions, including the afferent fibers to the coeliac and superior mesenteric 
ganglia, were severed. The stomach was transected at the esophagogastric 
junction (Fig. 1 )  and closed in two layers. The colon was transected in the 
descending or sig~noid portions. A No. 17 gauge needle was inserted into 
the portal vein, and the liver was perfused with 1.000 cc. iced lactated 
Ringer's solution. During the last half of the perfusion. the dog was bled 
to death. The vena cava was then transected above and below the Ilver. The 
aorta was cut free well above the coeliac axis. The specimen was irnmedi- 
ately removed and irnmersed in a bath of iced lactated Ringer's solu!ion for 
at least three mlnutes. 
Procedure in the Recip~etrr Dog. While the homograft was being 
prepared, the recipient animal was opened with a long midline abdominal 
incision. The rectum was mobillred, transected and closed in two layers 
within I or 2 cm. of the anus. (Fig. 1.) The visceral attachments to the 
Posterior parietes were severed, and the coelrac axis and superior mehen- 
teric artery were ligated and divided. The stomach was dlvided leaving a 
small cuff at the diaphragm for subsequent anastomosis to the donor 
stomach. (Fig. 1 .) The femorojugular venous bypass described by Kaupp 
et a{. 141 was inserted. and the venacava was grasped with Potts clamps and 
severed above and below the liver. The liver. ~ tonlach,  pancreas, spleen. 
small bowel. colon and omenturn were then rernnved <>/I hior. 
The donor organs were removed from the ice bath, positioned and 
revascularized. The cenacava was anastomosed above and below the liver 
(Fig. I ) ,  following which, the occluding clamps were released. The aortic 
homograft was attached to the abdominal aorta by an end to srde anatto- 
mosis, and the specimen wa\ arterralized. (Fig. 1 .) 
In five of the thirty-eight dogs. a por taca~al  anastomosis was also 
constructed between the recipient vena cava arid the donor portal \ern. 
(Fig. 2.) Gastrgintestinal continuit) was reestablrshed with a tv.o layer 
gastrogastrostomy proximally and an end colostom) distall) 
Postoperuri~,c. Care. The animals required constant nurslng care for 
the first twelve to twenty-four hours after aurgely. Frrquerit endotracheal 
Fig. 3.- Abdominal roentgenogram of Dog. KO. 18 on the sixth 
postoperative day. Dog had been on oral iritake for four da l r .  
suctioning was necessary. Large quantities of blood and fluid were 
required continuoutly durlng this period. Although demonstrable blood 
loss was often less than 300 or 400 cc.. no less than 2.000 cc, were given 
in any of the successful experiments in addition to 500 to 1,000 cc. saline 
solution. Infuqion w ~ r h  Ievoarterenol was commonly employed during the 
first few poitoperati\e hour\. The administration of intraienoui fluids was 
discontinued after the frrst t a o  days, and the dogs here  allo\\ed toeat a diet 
consisting of sugar water and bab) food. One n~illion ur11ts of aqueous 
penicillin were given ever) twelve hours untrl death. 
RESULTS 
Period ofIsc.hc~nio <If ihc Honioyr-oft. In most cases. the period of 
devascularization \bas from to YeLent) minutez. There were no sur- 
Llvors when ~jchernia exceeded ninet) nilnute\. 
Oj~ero/r\ 'r  .Morruiit\. Thirt-eight experlmenns were performed. 
Only fi+e dog\ Irved longer than taenth-four hours after operation. All ani- 
mals which did not die on the first day lived for five and a I~alf days or 
longer. The remaining thrrt) -three died a< an irnrnsdiate con\equence of 
surge?. In ever) earl! death. majsive gastrointe\tlnal hemorrhage was the 
primaq cause of death. 
E u r k  C O I I ~ S P  Ajier Hot~io;'rafii~~g. The recipient anrnial\ generally 
remained in good condition dunnp e\ rsceration. placement of the graft and 
anastomosis of the \ens c a n .  With restoration of the arterlal \upply to the 
graft. all dog5 kca rne  profoundl) h)poten\ive. u\ua!l) w ~ t h  a blood 
presure  of 60 nim. Hg or lower. desp~ts  r a p ~ d  tranqfusion. At least 1,000 
cc. of whole blood wainecessar) io restore the bloodpre,sure. Initially, the 
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Days a f t e r  t r 3 n s p l a ~ t a t 1 o n  
Fig. 4.- Development of chemrcal jaundlce with rise in alkaline 
phosphatase, seen In three of the tive long-sumiving dogs. 
color ofthe stornach and bowel w,~s pink, but after thlrty or forty minutes, 
faint cyanosis developed as blood \eclur\trat~on occurred in the graft. 
Large quantit~es of clear or strawcolored tluld tranwded the lumen of the 
gut. Lymphatics on the surface of the jtomach and intestine becanie 
distended and formed serous bl~sters. After :I tlrne, the li\er becanie dark 
in color and firmer than nonnal. Secondar) bleeding from vascular 
anaTtomoses often de~e loped .  Slow infusion \wth levoarterenol was 
sometimes effective In cornbatrng the shock state Chlorpromazine, 
Arf0nad.E reserpine and Pitressin:@ were of no value. 
After closure, a profu\e serous d~arrhra  ensued necessltatrng con- 
tinuous blood and f lu~d  therap!,. In most anlrnalj. the diarrhea became 
blood), and death followed from massive gastrointert~nal hemorrhage in 
one to twenty-four hours. In the f ~ v e  \un,lvrng dogs, the diarrhea abated 
after twelve to eighteen hours. Further inten\ive care was not required. 
In the earl) death\. heniorrhagic gclstroenteriti\ h a \  in\arinblj prej- 
ent at autopsy. Ail levels of the ga>tro~nte\trnal tract uere  ~nvolved, but the 
most profound changes were usuall!, In the duodenum. Hi\tologic studies 
showed congestion, extravautlon of blood. edema and \laughing of the 
Days  a f t e r  t r a n s p l a n t a t ~ o n  
Fig. 5.- Absence of jaund~ce In two of the five long-surviving dogs. 
Note rise in alkaline phosphatase. 
Days a f t e r  transplantat~on 
Fig. 6.- Fa~ t ing  blood sugars in the five long-surviving dogs. Note 
usual absence of pronounced hypoglycem~a. 
alimentary tract. The other graft organs were also congested. Multiple 
punched-out duodenal ulcers were common. 
The gastrolnte\tlnal hemorrhage\ were apparently not due to acute 
elevations of portal pressure. In f i ~ e  dog\. a ponacaval shunt (Fig. 2) was 
placed between the donor portal vein and the recipient vena cava. Four of 
these animals died of alinientary blced~ng. 
Mu.\~n~cr lS~rr- i~r~~i~l .  The frve dog\ surviving the immediate postopera- 
tlve period I ~ \ e d  for f i ~ e  and a half. \I*. \even. n ~ n e  and nlne da),, respec- 
tively. Fluid requirements abruptly decreased after the first day, and no 
parenteral therapy \*a\ grven after forty-eight hours. H ~ g h  carbohydrate 
diet consi\ting of brown sugar solution arid baby food was started on the 
third da) .  V o n i ~ t ~ n g  was rare until jurt before death. 
Phjsical activity of the dogs was sornewhat reduced, but otherwise 
they seemed nom~a l .  Liquid colostomy dramage was continuou5 but not 
excesrive in quantitj. Terni~nally, In all dog\ tarry or frankly bloody fecal 
dramage developed. The transit time of ingested material was rapid, and 
food was often und~gested. Abdoni~nal roentgenogram\ usua l l  did not 
show an abnonnal gas pattern. (Fig. 3.) 
Most animals were fehr~le du r~ng  therr entire cour\e. Pulse rates rose 
just before death. The dogs lost weight rapidly. After four to eight days. 
activity became sharply reduced. followed by vomiting and death in twelve 
to twenty-four hour\. 
Cl~rnirtul Stlrtlic~ In three of the five long-surv~ving dogs. jaundice 
developed on the fourth or fjfth postoperative day. (Fig. 4.) Jaundice was 
progressive and involved parallel increases in both the direct and indirect 
reacting bilirubin. Correspondrng rlses occurred in the alkaline 
phosphatase. (Fig. 4.) In the other two animals whlch libed for nine days, 
the bilirubin rema~ned wrthin nomial limits. (Fig. 5 ) .  although the alkaline 
phosphatase increased. (Fig. 5 . )  
Determ~nationc of fasting blood sugar\ were performed at frequent 
intervals postoperatively. Hypoglycernia occurred uncommonly. (Fig. 6.) 
Amylase values were abnormally high In three of f i \e  dogs. In all five 
animals, cholesterol levels rose, and in everq case at least 30 mg. per cent 
esters were present at the time of the last detemiination before death. 
Prote~n and a lbum~n:  globulin ratio5 followed an unpredictable pattern. 
Blood urea nitrogen was elevated In only one an~mal .  Calcium and 
phosphorus levels uere  within nom~a l  imits. 
In all f i \e  dogs extreme electroljte aberrations developed with 
severe hyperchloremic acidosis. Temi~nal l j .  bicarbonate fell to as low as 
7 mEq./L. and chlorides were as hrgh as 120 or 130 rnEq.L. 
C1r.~rle Stirt11r.r. Persrstent albuminuria de~e loped  b) the third day. 
The albumin loss was 4 plus at all tirnes from the third day on. Concentrat- 
ing power was retained, h o w e ~ e r .  throughout the entire course, and 
shifting urinary pH's were demonstrated as late as the eighth day. 
CLIO CHIRURGICA 
Fig. 7.- Liver after nine days, from Dog No. 18, in which jaundice did not develop. A, magnification X 65; B, magnification X 350. 
Fig. 8.- Liver after seven days, from Dog No. 4, in which jaundice developed. A, magnification X 65; B, magnification X 350. 
Fig. 9.- Donor spleen, after nine days, from Dog No. 19. A, magnification X 65; B, magnification X 350. 
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Fig. 10.- Donor lymph node from mesentery of graft in Dog No. 26. Animal lived five and a half days. A, magnification 
X 30; B, magnification X 600. 
In the three dogs with jaundice, urobilinogen disappeared from the 
urine by the fourth day, and bile appeared. In two dogs without jaundice, 
urinary bile was not detected, and urobilinogen was excreted until death. 
Hematologic Studies. Since the circulating red blood cell mass was 
maintained by blood transfusions, the peripheral erythroid values could not 
be used as parameters of myeloid erythropoietic activity or blood loss. In 
the immediate postoperative period, each animal manifested a moderate 
leukocytosis due to a relative and absolute neutrophilia. Rather prompt 
subsidence of the leukocytosis was observed. In the animals which sur- 
vived for nine days, the leukocyte counts had fallen on the sixth and seventh 
days to4.500 and 4,700 per cu. mm., respectively. On the day before death, 
the white blood cell count was 4,200 per cu. mm. in one of these dogs. 
However, it had risen to 17,000 per cu. mm. in the other. Alterations in 
thrombocytes were not detected in these relatively short-term experiments. 
Autopsy Findings. In the long-term survivals, postmortem examina- 
tions revealed abnormalities in both donor and recipient tissues. Two of the 
five dogs had small pleural effusions. Despite the fact that no intravenous 
fluid therapy was given after forthy-eight hours, each dog had severe 
generalized pulmonary edema. In two cases, there was also focal atelecta- 
sis. In all animals, the right ventricle had patchy granular areas, principally 
subepicardial. These lesions were previously shown to be due to the trauma 
of massive surgery [lo]. 
The abdominal cavities contained 250 to 800 cc. of fluid. In some 
animals, this material was serous, and in others it was bile or blood stained. 
The gastrointestinal tract had profound changes. In all cases, there were 
mucosal or submucosal hemorrhagic areas at some level of the alimentw 
tract, usually associated with slough or edema. The changes were most 
marked in the duodenum and were accompanied by multiple deep ulcers 
Fig. 11.- Small intestine of Dog No. 4, seven days after transplan- 
tation (magnification X 18). Note congestion, edema and superficial 
slough. 
in four dogs. In three dogs, the bowel was constricted; in the other two, it 
was dilated and appeared almost necrotic. In two animals, there was fat 
necrosis and other evidence of pancreatitis. 
The transplanted livers were moderately enlarged and cut with a firm 
granular sensation. The spleens were slightly enlarged, somewhat mushy 
and generally dark. The kidneys and adrenals were normal in four dogs and 
congested in the fifth. 
The gastrointestinal anastomoses healed well. There were no rup- 
tures of the suture line. Venous anastomoses remained patent, but in two 
dogs there were partially occluding thrombi at the aortic anastomoses. 
Mesenteric lymph nodes were greatly enlarged and edematous. In 
two animals, the mesenteric lymphatics were injected with methylene 
blue, but no lymphatico-venous communications could be demonstrated. 
The recipient lymph nodes, of which the mediastinal group were most 
extensively dissected, were not enlarged. 
Histologic Findings in Homografr Tissues. The architecture of the 
liver was relatively well preserved. The two dogs which lived for nine days 
and did not become jaundiced had almost normal livers. There was slight 
central cell loss in some areas, and none at all in others. (Fig. 7.) The 
periportal mononuclear infiltrate, which was so prominent with ho- 
mografts of the liver alone [I I], was absent in some sections and present 
Fig. 12.- Duodenal ulcer in Dog No. 18, after nine days 
cation X 25). 
(magnifi- 
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Fig. 13.- A, bone marrow from normal dog showing active gran- 
ulopoiesis and erythropoiesis (magnification X 900). B, marrow from Dog 
NO. 26, showing a cellular specimen with extensive replacement of normal 
myeloid elements by a reiative and absolute increase in lymphocytes, 
reticulum cells and plasma cells (magnification X 900). 
to a rather minimal degree in others. (Fig. 7.) Fatty metamorphosis which 
was thought to be due to nutritional depletion was present. 
The three dogs which survived for five and a half, six and seven days 
and in which jaundice developed had more pronounced histologic abnor- 
malities. There was a significant degree of central cell loss. (Fig. 8.) 
Penportal aggregates of mononuclear cells were more prominent. (Fig. 8.) 
However, even in this group, architectural distortion was far less than has 
been observed with transplantation of the liver alone. 
Architecture of the spleen was preserved, although considerable 
congestion was present in four of the five animals. (Fig. 9.) Malpighian 
co~uscles were present (Fig. 9). but were sometimes compressed by 
congestion of the red pulp or partially replaced with a multitude of plasma 
cells. In the dogs which survived nine days, giant cells (Fig. 9B), which 
resembled megakaryocytes, and increased numbers of normoblasts were 
Observed. In two dogs diffuse sheets of mononuclear plasmacytoid cells 
were seen in the red pulp. 
The lymph nodes in the mesentery of the graft were studied. There 
Was some distortion of the peripheral lymph channels because of the nec- 
essary ligation of the ckntral drainage pathways near the coelic and 
mesenteric ganglia. Proteinaceous material and numerous macrophages 
filled the distended lymph vessels. The cortices were anatomically pre- 
Served with demonstrable follicles. (Fig. 10.) However, the follicles were 
'educed in size and number and infiltrated with a variable number of 
plasma and reticulum cells. (Fig. 10B.) The pulp also contained an in- 
creased number of plasma and reticulum cells. Throughout the nodes m 
Fig. 14.- Lung from Dog No. 18, nine days after visceral transplan- 
tation (magnification X 350). Note pulmonary edema and proliferative 
thickening of alveolar septa. 
two dogs, anomalous plasmacytoid cells with an abundant pink cytoplasm 
were present. 
All portions of the gastrointestinal tract had similar changes, al- 
though these were most extensive in the duodenum. There was congestion 
of the entire wall of the viscus, usually with edema. (Fig. 11 .) The mucosa 
was commonly ulcerated focally (Fig. 111, and in some cases there was 
massive slough. The duodenum in four dogs had deep punctate ulcers. (Fig. 
12.) The wall was infiltrated with polymorphonuclear cells in the cases 
with slough, and there was always some degree of infiltration with 
mononuclear cells. In four of the five dogs, there was acute pancreatitis 
which was indistinguishable from that produced by a variety of experimen- 
tal methods. In the fifth animal, there was pancreatic perivascular infiltra- 
tion of plasma cells and evidence of fixed tissue proliferation. 
Histologic Findings in Recipient Tissues. Marrow examinations 
revealed cellular specimens with striking abnormalities. (Fig. 13.) Normal 
myelopoiesis was largely replaced by relative and absolute increases in 
plasma cells, lymphocytes and reticulum cells. Plasma cells comprised 
approximately 15 to 20 per cent of all nucleated cells. In addition to the 
marked decrease in erythropoiesis and granulopoiesis, megakaryocytes 
although present were relatively infrequent. 
Pulmonary edema was present in all animals. (Fig. 14.) Proliferation 
and thickening of the alveolar septa were present. In one animal, alveolar 
thickening was marked (Fig. 14), and multinucleated cells resembling 
megakaryocytes were seen. The kidneys showed no perivascular infiltra- 
tion of mononuclear cells. However, there were occasional plasma cell 
aggregates in the perirenal and periadrenal tissues. There were focal 
myocardial infarcts with varying degrees of organization. 
Recipient nodes from the mediastinum showed thinning of the cortex 
and a decreased number or total absence of follicles. (Fig. 15.) The nodes 
contained increased numbers of plasma and reticulum cells. often atv~ical. 
. . 
(Fig. 15B.) Skeletal muscle appeared normal. 
COMMENTS 
Previous studies in several laboratories have clarified the behavior of 
homografts of the individual organs which make up the complex graft used 
in the present study. The bowel [6], liver [8,11] and spleen [8] are usually 
rejected in five to ten days. The technical problems of transferring the 
multivisceral graft are less than with transplantation of the individual 
organs. Only three vascular anastomoses are involved, and these are of 
large caliber vessels. Despite this, the rate of success in obtaining dogs for 
long-term study was only five in thirty-eight, or 13 per cent. 
In the failures, the usual cause of death was congestion and hemor- 
rhage in the intestinal tract. The bowel congestion was apparently not due 
to acute portal hypertension, because the addition of portacaval shunts did 
not prevent its development. Similarly, the congestion could not be ex- 
plained by excessive ischemia. Lillehei et al. [61 have shown that segments 
of the bowel can tolerate three or four times more ischemia than was in- 
flicted under the conditions of these experiments. 
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A B 
Fig. 15.- Recipient lymph node from mediastinum of Dog No. 36 after six days. A, magnification X 30; B, magnification X 600. 
The failures may by explained by the denervation of the graft. The 
neuroanatomic state of the graft is depicted in Figure 16. All preganglionic 
fibers of the parasympathetic system were severed. The sympathetic 
ganglionic neurons were transported with the graft (Fig. 16) but were 
separated from all connections with the central nervous system. Popielski 
[9], Berger and Lium [l ,  71 and Lillehei and Wangensteen [5] have studied 
the effects of svm~athetic denervation of the bowel in dons. After 
. . - 
extirpation of the coeliac and mesenteric ganglia, mucous or bloody diar- 
rhea commonly developed. The bowel became edematous and hyperemic 
with mucosal and sub~ucosal  petechial hemorrhages and slough. These 
changes are comparable to those seen in the present study. An additional 
contributory factor may have been the obstruction to outflow of lymph in 
the graft. 
The behavior of the liver in the present studies is of interest when 
compared with the fate of single whole organ hepatic homografts as studied 
by Goodrich [3], Moore [S], Starzl [ l  11 and their associates. In both types 
of experiments, most of the dogs which survived surgery lived for five to 
ten days. The events leading to death were not, however, entirely similar. 
When the liver was transplanted alone, bile production ceased after four or 
five days and, in our experience, jaundice invariably developed by the fifth 
or sixth day. In most cases, death was thought to be due to cessation of 
Fig. 16.- State of denervation of multiple organ graft. 
function of the graft. In three of the multiorgan grafts, a similar pattern of 
early jaundice was seen. In the other two animals, however, jaundice did 
not develop during the nine days of survival. Urobilinogen persisted in the 
urine of these two dogs. 
Some differences in the histologic appearance of the two kinds of 
liver homografts were also noted. The liver, when transplanted alone, was 
in our experience [I I] commonly the site of extensive parenchymal 
destruction at the time of death. In every case, periportal aggregates of 
mononuclear cells were prominent. As pan of the multiorgan homograft, 
hepatic parenchymal destruction was extensive in only one animal. 
Mononuclear cell aggregates in the periportal area were usually not 
prominent, and in the dogs in which jaundice did not develop, this 
histologic feature was virtually nonexistent. 
The response of the host to the presence of the multiple organ graft 
also differed in some respects from the host reaction to the single organ 
liver homograft. After homografts of the liver, pulmonary edema occurred 
uncommonly [I 11. Prompt and sustained leukocytosis developed. Despite 
cortical thinning and an increased number of plasma cells, the recipient 
lymph nodes retained a recognizable architecture [I I]. In dogs with the 
multiple organ graft, pulmonary edema of such severity developed eved- 
tually that it may have been the direct cause of death in every case. The 
majority of these dogs ultimately had decreases in the white blood cell 
count. The increases in bone marrow plasma and reticulum cells were more 
striking, and there was apparent suppression of normal bone marrow 
activity. Finally, the architecture of the recipient lymph nodes was altered 
markedly. A definite cortex could rarely be identified, and the follicles 
were entirely absent in some dogs. 
The difficulty of evaluating the inter-reaction between immunologi- 
cally competent host and graft tissues has been emphasized by Billingham 
[2]. Histologic changes in donor or recipient organs could represent 
activity by either host or recipient tissues or both. Despite this limitation 
in the internretation of data. there is evidence that the relation to the host 
of the multiple organ graft is quantitatively different than that of the single 
organ liver graft. The greater degree of structural and functional preserva- 
tion of the liver in the multiple organ graft suggests mitigation of the 
rejection process. 
Conversely, evidence for a graft versus host rejection response is 
stronger in the recipients of multiple organs than in those receiving the liver 
alone. In animals receiving the liver alone, there was no evidence of 
functional deterioration of any of the host organ systems. After multiple 
organ grafts, there was evidence of host organ failure. Examples included 
suppression of bone marrow activity and the invariable development of 
pulmonary edema. However, the precise roles of graft and host tissues in 
the production of these changes cannot be ascertained from our data. 
Evaluation of the extent of host versus graft and graft versus host reactions 
will depend on studies in which either the host or the graft is rendered 
immunologically incompetent by radiation or other means. 
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SUMMARY 
It was technically possible to perform simultaneous homotransplan- 
tation of multiple visceral organs including the liver, spleen, pancreas, 
omenturn and the entire gastrointestinal tract. Arterialization of the cooled 
uas  accomplished through the donor aorta which was removed with 
;he graft and attached to that of the recipient dog. Gastrointestinal hemor- 
rhage after surger) accounted for a high operative mortality and was 
thought to be due to denervation of the graft. 
The five dogs a h ~ c h  survived the immediate trauma of surgery lived 
for five and a half to nine days. After the second da!, these animals were 
p h ~ ~ i c a l l j  active and able to resume oral alimentation. In three dogs. there 
was metabolic evidence of rejection ofthe liver. In t a o  others. jaundice did 
not develop. 
These ohsenrations were compared with chemical, hematologic and 
pathologic data obtained in prevlous experiments involving homotrans- 
plantation of the l~veralone. In some cases. there h a s  less evidence of host 
versus graft rejection after the multiple organ tran\plants. Other data in the 
present study suggested the possibility that n rignificant graft versus host 
reaction may have been an important contributory cause of death. 
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EXPERIMENTAL LIVER TRANSPLAIZTATION. EXCLUSIVE OF IMlMUNOSUPPRESSION 
In the late autumn of 1967, Dr. Carl Groth, then a fellow in 
transplantation at the University of Colorado, was photographed with 
three of the first human survivors after liver replacement. The child on 
Dr. Groth's knee l~ved for400 days before dying of metastases from the 
hepatoma for which she was originally treated. 
In unmodified dogs, the changes in hepatic blood flow caused by rejection were measured with 
a xenon washout technique. Flow invariably was reduced with rejection. The flow alterations were 
correlated by Professor K.A. Porter of St. Mary's Hospital and Medical School, London with light 
microscopic and ultrastructural changes detected in serial biopsies. A more coherent and dynamic 
view of rejection emerged from these studies. Porter still is at St. Mary's where he is Professor of 
Pathology. 
Kendrick A. Porter is Professor of Pathology, The St. Mary's 
Hospital and Medical School, London. In September 1963, Ken 
Porter and TES (then at the University of Colorado) met at a meeting 
about renal transplantation held at the National Science Foundation 
in Washington, D.C. The results being obtained with renal transplan- 
tation in Colorado were so striking that Dr. Porter came to Denver to 
review what was going on there. From that visit came a collaboration 
that has lasted for more the two decades. Dr. Porter's chapters in 
Starzl's books on renal (1964) and hepatic (1969) transplantation 
were monographs in their own right. Dr Porter's talents soon turned 
to an assessment in various experimental models of the effect upon 
liver morphology of portal venous as opposed to systemic blood. 
The histopathologic changes became the most important end 
points in many of the complex experiments that were used to 
examine the hepatotrophic hypothesis (see Part IV) As befits an 
Englishman, Dr. Porter's principal side interest is gardening. 
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Studies of blood flow and ultrastructural changes in rejecting 
and nonrejecting canine orthotopic liver homografts 
Sur;qev, 63: 658-68, 1968 
Carl G. Groth, K. A. Porter, Jean B. Qtte, Pierre M. Daloze, Thomas M. Marchioro, 
Lawrence Brettschnider, Thomas E. Starzl 
It has long been thought, on the basis of observations with vital 
microscopy, that a sudden decrease occurs in the blood flow of skin 
homografts at the time of their rejection."" There is evidence that the sarne 
is true in homotransplanted whole organs. In 1953, Dempster' dernon- 
strated a striking loss of small branches of the arterial tree in renal 
homografts which were excised during their rejection and studied by 
means of angiography. More than 1 0  years later. Kountz and associates 
and Wil1iams'"and their associate? obtained serial flow rneaiures in canine 
kidney homografts wrth a radioact~ve-hippuran technique. In untreated 
recipients. there was a decline in total renal flow which was most dramatic 
at the time of rejection. 
Shortly after. it was reported that rejection after cliriical renal 
homotran,pIantation was accompan~ed by changes uhich could be readil) 
explained only by ischemia. T!rese included a drop in urine sodlum 
concentration. an increase in urine urea and creatinine concentration. olig- 
uria, a reductron in creatinine clearance, and arterial hypertens~on.. The 
findings. which simulate those uhich can be produced experlnientally by 
partial occlusion of a renal artery. uere  in patients who had debeloped 
rejection uhile recei~ing azathroprlne therapy. The) were quickly re- 
versed with the add~tion of prednisone. Subsequerit s tud~es  in dogs have 
confirmed both that a reduction in blood flou is coincident with renal 
homograft rejection''' .'"'- and that this changc can be prevented or 
reversed ui th  appropriate inirnunoauppressi\e therapy.' 
Such studie, ha\e  raised the possibilrty that ischernla is an iniportant 
general mechanism of rejection. In the present stirdy this queition has been 
examined in liver transplants b) determining hepatic blood flow in both 
treated and untreated recipients of orthotopic homografts. In add~tion. a 
separate electron microscopic stud! u a s  made wrth \-rial Iner  biopsies 
from untreated recipients, with the special object~ve of looking for ultra\- 
tructurdl abnormalit~es In either large or small blood vessels uhich could 
explain hemodynamic changes. 
Methods 
Experimental groups. hlongrel dogs, uith an average weight of 8 
to 16 kilograms, here  immunized against hepatitis and distemper and used 
as homograft recipients. Orthotopic hepatic transplants were performed, as  
previously described,"' with pentobarbital anesthesia combined wih the 
tranquilirer. phencyclidine &drochloride. Dogs that died of technical 
complicatrons or intussusception were excluded. Serum bilirubin, alkaline 
phosphatase, serum glutamic oxalacetic Lransaminase (SCOT), serum 
glutamic pyruvic transaminase (SGPT), and complete blood counts were 
obtained frequently in all animals. The patency of vascular anastomoses 
\$a, established at autopsy. 
G I O I ~ [ J  1.  The liver flow u a s  stutiied in 10 unniodrfied recipients. In 
8 of these. serial postoperative measurements were done daily or every 
other day until the death of the animal; in the other 2. measurements were 
done only on the first posttransplant day. In 9 of these experiments the liver 
blood f l o ~  u a s  also measured in the donor animal on the day before 
transplantation. 
61.01(11?. Five recipients were adminrctered antilymphocyte globulin 
(ALG) and a~athioprine. ALG was given daily for 5 days pretransplant and 
30 days after operation: whrequent injections here  tuice a week. The 
preparation and the dosage of ALG was the sarne as in previous reports 
fro111 this institution."' Azathioprlne was given daily from the day of 
:ransplantatiun. The dose var~ed berueen I and X nig, per kilogram of body 
height per day. depending on the white blood cell count of the animal. 
Blood flou measurement< were done for as long as 19 daks, usually every 
third da? 
G I - o I ~ ~  3. Five untreated recipitnts here  used for pathologic studies. 
The donor l i ~ e r  \\as biopsied before tran\plantation. Post-operatively, 
b~opqies u r r e  obtained ever) second or third da) until death. Each tissue 
;ample u a s  drkrded into 1 pieces. The first piece was imrnedlately diced 
up into tin) fragments, fixed In osmiurn tctrox~de. processed, and embed- 
ded In .Arald~te. Sections 0 . 5 ~  thlck us re  cut. stained ui th  4 ~ u r  11, and 
exalllined b! llght micro\cop). Later. \ en .  thin sections were examined in 
a Siemens Elrni5kop 1A electron microscope. The second piece was snap- 
frozen at -70'C.. and qections cut on a crqostat were examined in ultraviolet 
light after treatment uith tluore>cein ~sothioc!,anate-conjugated antisera to 
canine IgG and complement. The third plece was fixed in 10 percent 
formalin. procetsed. and embedded In paraffin u a x .  Sect~ons  were exam- 
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Fig. 1.- The placement of indwelling catheters in the portal and 
hepatic arterial systems in the donor (A)  and the recipient animal (B). Note 
that the gastroduodenal artery in the donor is tied to ensure delivery of the 
isotope solely to the liver. 
ined by ordinary light microscopy after they had been stained with 
hematoxylin and eosin. van Gieson's method for elastic and methyl green 
pyronin. 
Flow studies. The liver blood flow was studied in the unanestheti~ed 
state by measuring the washout of the inert. radioactive gas, xenon-133. 
The procedure was essentially the same as that used by Hollenberg and 
Dougherty.' Approximately 500pc of Xe"' dissolved in 1 to 3 ml. of 
isotonic saline was rapidly injected through ~ndwelling catheters in the 
portal and the hepatic arterial systems (Fig. 1 ), giving a peak radioactivity 
over the liver of 30,000 to 100.000 counts per minute. To obtain return to 
background radioactivity between the injections. 10 to 30 minutes were 
required. The washout of the isotope was monitored externally with a 
collimated. 1 inch sodium iodide crystal scintillation detector mounted 
above the liver approximately 1 cm. from the dog. A linear rate meter and 
a recorder were used. 
To obtain the disappearance rate constant, K, the curves were 
replotted in a sem~logarithmic system where K= u, 
T 
1 - 
TI?  being the half time ofdihappearance. In most instances the first 9110 of 
the semilogarithmic plot was an apparently straight line, only the last part 
being curved (Fig. 2. A). In some others. the plot was a curved line through- 
out (Fig. 2,  B). The first type was regarded as an essentially one-compan- 
ment system, and TI was assessed directly from the ctra~ght part of the plot. 
In the other t) pe a second compartment was subtracted graphically, and T , ,  
,for this and the resulting fir\t compartment were assessed. The flow in the 
second compartment was always less than 20 percent of that ~n the first, and 
in the results only the flow values for the first compartment are given. 
Knowing K, the blood flow was calculated as follons": 
Flow (nil. per I00 Gm liver per minute)* = L X 100 x K 
P 
Where L is the partition coefficient between tisque and blood (this was 
calculated for the prebailing hematocrit according to Veall and Mallett2' 
wlth the relative solubility values of Xe " In plasma. erythrocyte, and liver 
given b) Conn.) ,  and P i s  the spec~fic gravity which for the liver is 1.02." 
If the solubility of Xe"' in liver tissue were to change during 
rejection, a systematic error would be introduced In the flow calculations. 
The relative solubility ofthe Isotope in normal and rejected liver tissue was, 
therefore, compared in two experiments. in vitro. After the livers had been 
perfused with lactated Ringer's solution until they became clear of blood, 
equal aliquots of homogeni~ed tlssue were mixed with equal amounts of 
Xen' in gas sampling tubes at 37" C. for 30 minutes. The average ratio 
between the activity in homogenates of normal liver and rejected liver 
homografts were 0.91 and 1.02, respectively. It was concluded that the 
same solub~lity value could be used throughout wlthout induclng an error 
exceeding I0 percent. 
Concomitant w ~ t h  the blood flow studies, cardiac output was meas- 
ured by an indicator dilut~on method w ~ t h  X e "  as the tracer substance.'- An 
isotonic saline solution of the isotope was Infused at a known constant rate 
(R)  into the systemic venous circulation, and samples were taken in the 
* It should be emphasized that flow values obralned on ponal and arterial 
injection (designed FPI and FAI. respectively) do not repreaent an absolute measure 
of fracttonal flow from either source, as w~ll be dtscussed later 
50.000- 
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TIME IN SECONDS TIME I N  SECONDS 
Fig. 2.- Semilogarithmic plots of typical disappearance curves following injection of Xe133. Usually most of the plot was a straight line (A). In some 
instances, however, it was a curve that could be resolved into 2 compartment, (B) .  
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artery through a cardiac catheter. After counting the activity per 
milliliter in the infused solution (I) and in the mixed venous blood (B), the 
cardiac output was calculated according to the formula: 
Cardiac output milliliters per minute =J 
B 
Results 
Liver blood flow in normal dogs. The mean FPI and FA1 in 19 
normal dogs studied with the present technique were 221k 52  (SD) 
milliliters per 100 Gm. tissue per minute and 178 f 50 (SD) ml., respec- 
tively. 
Liver blood flow in untreated recipients. In the 9 experiments in 
studies were obtained before and one day after transplantation, the 
hepatic blood flow was usually slightly lower in the recipient than it had 
previously been in the donor. The declines in FPI and FA1 were of the same 
magnitude. Part of the difference in flow could be accounted for by lower 
cardiac outputs in the recipient animals. Mean values are given in Fig. 3. 
Of the 8 dogs that were studied serially after transplantation, 7 died 
of rejection after 6 to 10 days, with a mean survival of 8 days. In these 
animals, there was a progressive deter~oration in liver function. 
postmortem microscopic examination of the livers showed typical features 
of rejection.'" decrease in liver blood flow occurred concom~tantly with 
the deterioration in hepatic function (Fig. 3 ) .  The decreaqes in FPI and FA1 
were ultimately 41 and 54 percent, respectively. The mean changes in the 
cardiac output were small (Fig. 4 )  and could not account for the changes 
in flow. 
One of the untreated recipients lived for 22 days and ultimately died 
Kith pneumonia and wasting. Until death the dog's liver chemistries were 
normal, except for an elevated alkaline phocphatase. There was no histol- 
ogic evidence of rejection. During the first 3 postoperative days, this 
animal had a subnormal liver blood flow as well as a reduced cardiac 
output. Subsequently, both values became supernormal for a few days and 
then settled within normal limits until the last day of study. 
DONOR RECIPIENT 
DAY BEFORE DAY AFTER 
TRANSPLANT TRANSPLANT 
Liver blood flow in recipients given immunosuppression. One of 
the 5 dogs treated with ALG and azathioprine died with typical features of 
rejection 13 days postoperatively. None of the remaining animals had a 
clinically diagnosed rejection during the first 20 days. One died after 14 
days of an anaphylact~c reaction during a blood transfusion. One died after 
4 months and 4 days due to an intestinal volvulus: histologically, the 
homograft was normal except for a few mononuclear cells in the portal 
tracts. The other 2 are still alive after 7 months. 
The changes In blood flou in the dog that died of early rejection were 
s im~lar  durlng the first 9 days to those in unmodified recipients; the flow 
decreased concomitantly with a deter~oration in liver function. However, 
on the elekenth posttransplantation day. the flow improved at the same 
time as the liver chemi~tries had begun to return toward norn~al.  The 
cardiac output was unchanged during these events. On the thirteenth post- 
operative day, the day of death. there was again a drop in blood flow along 
with a deterioration in liver function. At this time, cardiac output was also 
DAYS BEFORE DEATH 
Fig. 3.- Liver blood flow as measured b) portal ~njection (FPI) and 
hepatic anerial injection (FAI) in the donor and reclplent on the days before Fig. 4.- Liver blood f lou.  cardlac output. and l~ve r  function in 7 
and after transplantation. Cardiac output and liver function are also shown. unmodified reclplents that died of rejection. The mean \ d u e s  k SE are 
Mean values It SE in 9 experiment, are depicted. shown, as well as the number of obsena t~ons  (in parentheses) for each day. 
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Fig. 5.- Liver blood flow, cardiac output, and liver function in a 
recipient receiving immunosuppression. The animal died of rejection 13 
days after transplant. Note the concomitant improvement of flow and liver 
function on Day 11, indicating reversibility of the flow changes. 
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Fig. 6.- Liver blood flow, cardiac output, and liver function in 4 
recipients which received immunosuppression and had little or no evi- 
dence of rejection. Mean values f SE are given, as well as the numbers of 
observation (in parentheses). 
Fig. 7.- Biopsy, 4 days after transplantation, of an hepatic homograft in an untreated dog. Electron micrograph showing a central hepatic vein. 
Lymphocytes ( ly) ,  platelets @), and fibrin (n lie beneath the endothelial lining (end) of the vessel. Fluid and cells lie in the perivascular space @er = pericyte; 
m = macrophage; lu = lumen of vein). (Lead stain. x 2,250.) 
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markedly decreased (Fig. 5). 
The remaining 4 animals, which had little or no evidence of rejection 
judged by liver function tests, did not have any significant changes in 
blood flow or cardiac output during the study period of 13 to 19 days (Fig. 
6). 
Serial pathologic changes in rejecting liver homografts. The 5 
unmated dogs had evidence of a typical rejection, as judged by liver 
chemistries. All died in 4 to 9 days. The biopsies obtained on Day 2 showed 
slight dilatation and congestion of the centrilobular sinusoids and damage 
to a variable number of the hepatocytes in the central zones of the lobules. 
In the injured cells there was dilatation and destruction of the rough 
endoplasmi~ reticulum, clumping of swollen mitochondria, and shedding 
of cytoplasm. Macrophages containing ingested fragments of cytoplasm 
and organelles were present in the tissue spaces. These cells, together with 
neutrophil polymorphonuclear leukocytes and occasional lymphocytes, 
were common around the portal and central veins. The lymphocytes were 
ordinary, small lymphocytes, with few organelles in their cytoplasm. No 
immunoglobulins were detected at this stage. 
By the fourth day cellular infiltration was marked around the portal 
and central veins. Large lymphoid cells with pyroninophilic cytoplasm that 
was full of polyribosomes, but lacking in rough endoplasmic reticulum, 
were common and could be seen beneath the endothelium of the veins 
(Figs. 7 and 9) and in the space of Disse. Some were touching the endothe- 
lial cells. The tenuous walls of many of the centrilobular sinusoids 
appeared disrupted (Fig. 8). and fibrin lay in the venous subendothelial 
spaces (Figs. 7 and 9). A few plasma cells with abundant rough endoplas- 
mic reticulum were present, particularly in the portal tracts. The centrizo- 
nal hepatocytes were now necrotic, and in one hepatic homograft the 
centrilobular bile canaliculi lacked microvilli and contained bile plugs. 
Immunofluorescence showed no deposits of immunoglobulin G and 
complement in the vessel walls, but the cytoplasm of several of the 
infiltrating cells "stained" positively for IgG. 
The later biopsies were less instructive. Necrosis of hepatocytes was 
widespread, and large numbers of lymphoid cells, many macrophages, 
some polymorphs, and plasma cells were present in the portal and central 
zones and lying between the necrotic hepatocytes. The lumina of several 
of the central veins were completely blocked by collections of infiltrating 
mononuclear cells. Cholestasis was pronounced in the better-preserved 
peripheral areas of the lobules. In one hepatic homograft, 8 days after 
transplantation there was deposition of IgG and complement in the walls 
of several small arteries, and, ultrastructurally, a homogeneous, finely 
granular deposit was present between the endothelium and the internal 
elastic lamina. By light microscopy a few of these affected arteries showed 
"fibrinoid necrosis" of their walls. No deposits of immunoglobulin or 
complement were found in the other homografts. 
Discussion 
Techniques for liver blood flow determination during rejection must 
be independent of liver function. The measurement of the clearance of inert 
radioactive gases fulfills this requirement and has the further advantage of 
permitting daily studies with a minimum of manipulation of the animal. 
The method does not differentiate clearly between the fractional contribu- 
tion to total liver blood from the hepatic arterial and portal venous sources 
since there is variable presinusoidal or intrasinusoidal communication of 
the 2 vascular systems." Consequently, the washout of the isotope is not 
due solely to tissue perfusion by the vascular system which receives the 
Fig. 8.- Biopsy of canine hepatic homograft, 4 days after transplantation. Electron micrograph showing a centrilobular sinusoid. The endothelial lining 
(end) is ruptured at the point marked with amow. The space of Disse is wider than normal and contains a red cell (rbc) and fluid 0. A lymphoid cell ( ly)  
and two erythrocytes (rbc) are present in the lumen (lu) of the sinusoid. The adjacent hepatocytes (hep) are injured, as shown by swelling and clumping of 
their mitochondria and loss of their rough endoplasmic reticulum. (Lead stain. x 6,000.) 
45 
EXPERIMENTAL LIVER TRANSPLANTATION, EXCLUSIVE OF IMMUNOSUPPRESSION 
Fig. 9.- Biopsy of untreated canine hepatic homograft, 4 days after transplantation. Electron micrograph showing part of wall of a vein 
in a small portal tract. The wall is infiltrated by lymphocytes (ly), macrophages (m), and fibrin (f) (lu = lumen of vein; end = endothelial lining 
cells.) (Lead stain. x 6,000.) 
injection. Nevertheless, the fact that the flow values actually differ with the 
route of isotope administration indicates that the intrahepatic mixing is in- 
~ornplete.'.'~ 
The results obtained with this method after homotransplantation of 
the liver show that total liver blood flow decreases significantly at the time 
of rejection. Conversely, the decline was not seen in one untreated animal 
which did not have arejection, and it was prevented altogether in other dogs 
which received adequate immunosuppression. On one occasion, flow fell 
during rejection in a treated animal and was later restored when liver 
chemistries began to improve. 
Some indirect evaluation of the importance of relative changes in portal 
and hepatic arterial circulation can be deduced from observations of 
Hollenberg and Dougherty.' They found that total occlusion of the hepatic 
artery decreases both the FPI and FHI to about 213, while occlusion of the 
portal vein decreases FHI to approximately 113 of control values. The 
recorded changes in our animals would thus seem to be best explained by 
a decrease in both portal and arterial flow. The decrease might well, 
however, be more marked in one of these systems than in the other. 
In those animals which had clinically evident rejection, the reduction 
in liver blood flow did not precede the characteristic abnormalities of liver 
function. The temporal relation between flow alterations and the biochemi- 
cal changes was almost absolute. Thus, the order of events was not 
completely comparable to that reported in rejecting canine kidney ho- 
mografts in which renal blood flow has been noted prior to any deteriora- 
tion in f ~ n c t i o n . ~ . ' ~  
Nevertheless, the findings confirm earlier suspicions that there is an 
important component of ischemia in the rejection of liver homografts. On 
the grounds of histologic findings, it was initially suggested that blood flow 
was choked off at a sinusoidal l e ~ e l . ~ - ' ~  Subsequently, Moore and his 
associates9 proposed, on the basis on angiographic evidence, that lesions 
of larger vessels within the portal tracts were responsible for devasculari- 
zation of discrete, rather large areas of hepatic parenchyma. The hypothe- 
sis was weakened, although not refuted, by the rarity of structural abnor- 
malities of these larger vessels in the liver homografts of either treated or 
untreated  recipient^.?^ In the latter study, the possibility was raised again, 
on the basis of preliminary electronmicroscopic observations, that injury 
to the sinusoidal bed was responsible. In some areas, mononuclear cells 
were found to be fused to, and presumably damaging, the centrisinusoidal 
endothelium. The possible analogy was pointed out between these findings 
and the pentubular capillary lesions described by Kountz' and Porter" and 
their associates in rejecting renal homografts. 
The fact that blood flow is rapidly restored upon reversal of rejection 
could be explained by an initial mechanism of heightened vasomotor 
reactivity, although an attempt by Moore and his associatesq to affect the 
course of rejection by intra-arterial administration of a vasodilating agent 
was not successful. Consequently, the principal effort in the present study 
was to find an anatomic explanation for the hemodynamic changes. The 
findings with electronmicroscopy suggest that the reduced blood flow is 
mainly due to damage to the veins and sinusoidal bed of the homograft. The 
sinusoids appear to have actually disrupted, while the central veins became 
narrowed by masses of cells in their lumina and by cells and fibrin lifting 
the endothelium from the vessel wall. The portal veins showed similar 
changes in their walls, but their lumina were less frequently filled with 
infiltrating cells. Platelet aggregates were not seen in these vessels. 
These findings are compatible with the hypothesis that acute rejec- 
tion in the untreated hepatic homograft is predominantly cell mediated. We 
have no evidence that circulating antibody plays a significant role at this 
time. Deposition of IgG and complement on and in vessel walls was not 
CLIO CHIRURGICA 
apparent until 8 days after transplantation, at a time when the rejection 
process was far advanced. Paronetto and associates."' in their studies on 
auxiliary hepatic homografts without a portal blood supply, also found that 
gammaglobulin did not appear in the walls of the hepatic arteries until the 
second week after transplantation. There is still no proof that the lymphoid 
cells damage the vascular endotheliurn of the hepatic graft, but it is 
probable that this occurs. No evidence was obtalned in these orthotopic 
liver grafts of the periportal "piecemeal" necrosis described by Paronetto 
and co-workers."' 
Surnnlury 
The blood flow in orthotopic canine liver homografts was investi- 
gated in awake animals with a Xe"' washout technique. Cardiac output was 
also studled. Ten dogs which received no immunosuppressive treatment 
lived for as long as 22 days (mean 8.5 days). With the onset of rejection. 
as diagnosed by elevations in bilirubin, SGOT. and SGPT, there was a 
significant decrease in both components of liver blood tlou which could 
not be accounted for by changes in cardiac output. 
These findings were correlated with the ~mmunotluorescent and 
ultrastructural findings of five additional experiments in which biopsies of 
homografts were obtained before and every second day for 4 to 8 days after 
orthotopic l~ve r  homotransplantation to untreated recipienti. It was found 
that lymphoid cell infiltration of the graft\ commenced at about 4 day\ after 
transplantation and resulted in damage to the walls of the portal and central 
veins and to the centrilobular sinusoids. Localiration of ~mmunoglobulin 
G and comple~nent in the homograft was a rare and late phenomenon. 
Another 5 recipients were given immunosuppresiion with horse 
antilympho~:yte globulin and azathioprine. When there was no biochemi- 
cal indication of rejection. the liver blood flou was essentially unchanged 
in animals studied for as long as 19 days after transplant. The findings in 
these 3 experimental groups indicate that decreased blood flow and con- 
sequent ischemia is an important factor in the rejection of liver homografts. 
that such changes can be prevented by effective irnmunosuppres\ion, and 
that an anatomic basis for the tlou alteration< could be the disruption of the 
centrilobular sinusoldal walls and the intraluminal and subendothelial 
accumulation of host lymphoid cells in the central and portal veins. 
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This picture of Henri Garnier was taken at Garnier's winter home 
in April 1978, at the time of the Franco-American Surgical Conference 
in Marakesh, Morocco Six weeks previously, Garnier had undergone 
a cholecystectomy in Paris, at which time the liver was thought 
normal. However, ten days after this plcture was taken, symptomatic 
hepatic metastases from a bronchogenic carcinoma were discov- 
ered, Garnier d~ed  uring the following Christmas season. 
The French surgeon, Henri Garnier, dreamed of clinically applying orthotopic liver transplanta- 
tion. In his 1965 publication,* he described the techniqueof livertransplantation in pigs. In thefollow- 
up paper by Cordier, Garnier and others, Garnier documented the long survival (>35 days) of an 
animal without immunosuppression. The work was known to the English workers in Bristol and 
Cambridge. Garnier died during the Christmas season, 1978, with widespread metastases from a 
bronchogenic carcinoma. 
*Garnier H et al: CR Acad Sci (Paris), 260: 5621-23, 1965 
CLIO CHIRURGICA 
La greffe de foie orthotopique chez le porc. Premiers resultats 
Orthotopic grafting of the liver in pigs. First results 
Mem. Acad. Chir. (Paris), 92: 7 9 9 ,  1966 
Gaston Cordier, Henri Gamler, Jean-Paul Clot, P. Camplez, J.-P. Gorin, Ph. Clot, J.-P. Rassinier, 
M. Nizza and Roger LCvy 
Translated b) John Nokier 
For almost two years we have been trying to perfect the orthotopic 
grafting of the liver in pigs. 
This animal was chosen because of the relative similarity of the 
hepatic anatomy and biliary ducts with that of man. 
In the first experimental series dealing with 23 animals, we studied 
the various technical problems relating, above all, to various venous shunts 
and vascular and biliary-enteric anastomoses. These examination of these 
problems in 23 autografts performed under normothernzia have yielded 
the following results: 
- 18 peri-operative deaths 
- 4 survivors of 2, 3, 9 and 26 days, respectively 
- 1 long term survival 
This series was the subject of a communication to the Academy of 
Sciences on 24 May. 1965, communication made by our mourned mentor, 
Dean Gaston Cordier. 
Today, we will discuss the results obtained in 20 orthotopic grafrs 
with(jut anv irnrnunosuooression. 
1 .  
We have used pigs of the Large-White species that weigh an average 
of 60 kgs. 
1 .  Anesthesia.- Half an hour before the operation, the two animals 
are premeditated with an injection of 25 mg of alirnemazine (thiralkne), 
100 mg of atwax, and 114 of a mg of atropine. 
At first the animal was given fluothane for a few m~nutes  through a 
special mask. AS soon as it lost consciousness, it was placed on its back. 
A vein of the ear was catheterized enabling us to inject 0.50 g of penthotal 
and 15 mg of D-tubocurarine. After oxygenation. the animal was intu- 
bated. (sometimes not without difficulty) and placed on a R.P.R. type 
respirator (frequency 2 1  per minute and average tidal volume of 550 cm'). 
* Fo1yethylene gastric catheter was inserted. 
In several pigs we placed an indwelling urinar). catheier. The proce- 
dure was ver) difficult. but it enabled us to monitor urinar). output during 
and after the operation which was always excellent: 1,500 cm' during the 
OPeration and 2.000 during the first twenty-four hours. The urine never was 
hemorrhagic. 
Anesthesia is maintained by repeated, small injections of penthotal, 
and by perfusion at 2 per 100 of viadril in glucose solution. Because of the 
irregularity of electrical conduction of the pig heart, cardiac function is 
stabilized by pronestyl. 
Moreover, at the outset of the operation the animal receives 2.5 mg 
of heparin per kilo. 
2. Resuscitution and perioperative moni:oring.- Glucose solu- 
tion,10 per 100, and blood are perfused through a venous catheter. This 
catheter provides, among other things. a venous access for reversal of 
anesthesia. We use porcine blood taken the day before. The problem of 
blood group incompatibility is not as prominent as in man. Although the 
pig has several blood groups (more than SO), the crowmatching tech- 
niques have demonstrated the frequency of agglutination. Yet, a more 
extensive study of this problem is presently in progress. 'The E.K.G. and 
blood pressure are monitored. 
-Blood pressure is monitored by means of a catheter placed in the 
femoral artery and connected to an electronic manometer. 
-Blood loss is replaced as carefully as possible. Two phases of the 
operation are monitored with particular care: 
a )  Recipient hepatectom) because the liver weighs approxi- 
mately 1,500 g and removal of this organ results in a loss of approximately 
800 cm3 of blood. 
b) Removal of clamps and "hooking-up" of the transplanted 
liver. When the anastomoqes are complete, we perfuse 12 g of hemocaprol 
and then 8 g again at the \erq end of the operation. 
3. C'pori wkin ,?  irp. thc pig is placed under an electric blanket. As a 
matter of fact, the temperature oi the animal i i  then low, approximately 3 2  
C (normal temperature 38 C ) ,  and it seems to us that the pig tolerates 
hypothermia verq poorl?. In order to a \ e n  a decrease in temperature, as 
soon as the liver is connect-d we trdnsfure the recipient through a site other 
than the liker with blood u a m c d  in a double boiler to 30°C. 
The pig is matched continuou~ly during the first 2 1  hours. Blood 
pressure is maintained hq ~nfuriurlz of glucose solution.l0 per 100 and 30 
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per 100, to which we add insulin ( I 0  to 15 I.U.) and b j  blood transfusions. 
During the first n~gh t ,  we also mfuse 250 cm'  of THAM and 500 cm' 
of mannitol. When the outcome is favorable, the an~mal  eats again spon- 
taneously at the end of 24 hours. For about eight days. he will receive I0 
million units of penicillin. The thoracic drain is removed at 24 hours. 
4. Thc o~)errrr~~~c.pt-oroi~o/ . the s urce of many disappo~ntments, has 
been modified several time\. We repon here the protocol.used presently, 
that has been propojed by Starzl and hi\ a\sociates. The procedures are 
perfomied by two jurgical teams so that the donor liver can be transplanted 
immediately following the recipient hepatectom) 
A j  Rr,ycrr-cltrig the iionor: W ~ t h  the animal placed on its back, we 
make a r~gh t  horacoabdom~nal incision. 
The various vessels are di\sected. This prejents no problem for the 
suprahepatic vena cava a h ~ c h  as a very long intrathorac~c segment. On 
the other hand. the hubhepatlc Leln often is Lery d ~ t f ~ c u l t  because it is 
accompanied by a strlp of hepat~c parenchyma which extends inferiorly. 
At the level of the hepatic h~lurn, it I \  common to flnd rather large 
lymph nodes that shoulti be renloved. Yet, dissection of the hilum is not 
particularly difficult except In caws of ttnonialous arterle\ or bile ducts as 
with duplicate r~gh t  hepat~c arterleh and r~gh t  hepat~c ducts. 
Vessels are d~ssected 5-6 cm. and d~ssec t~on  of the hepat~c artery is 
extended to the level of or beyond the orlgln of the gastro-duodenal artery. 
After freeing the vehhels and the su\pen\ory ligament\ of the liver, a 
large cuff of diaphragm 15 prepared where the suprahepatic vena cava 
passes through it. To do so, it is necessary to tle several diaphragmatic 
vessels. 
Once the graft 1s freed. both common ~ l i ac  \ e m \  and one common 
~ l i ac  artery are canriulated for the puq)o\e of extracorporeal cooling. This 
extracorporeal circulation IS begun approx~rnately twerlty minutes before 
the recipient hepatectomy. 
B)  Regcrr-cllrry tile I . c I . I ~ I I ( , ~ J ~ .  The wine approach is used, but. first. we 
isolate the two jugular velns wh~ch .  111 \wine, are \er) large as \bell as the 
left femoral veln and the ferrioral artery on the same side in w h ~ c h  we have 
insened a catheter for mtta\uring arterial preuure. 
The dis\ect~on of the various hepatopetal and hepntoiugul vessels is 
fairly similar to that perfomied on thc donor. Also, we dissect the hepat~c 
artery uhich I \  a1hays of sufficient s i x  tci pennit ana\torno\ls. 
In panicular. b e  must exerci\e care regarding lierno\tasis since the 
animal is heparinixd and also w ~ r h  regard to l>niphat~c s t a s~s  mce there 
are man) iyniphatic\ the loss of fluid frorn which can be cons~derable. 
1 b. 0 , o p  
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Transplantation t d - C - d  
Before proceeding to the recipient hepatectomy, several shunts must 
be establ~shed. 
a) A femoro-jugular 5hunt between the left femoral vein and the left 
jugular vein in order to decompress the vena caval system below the 
clamped subhepatic vena cavu. 
b) A spleno-jugular shunt between the splenic veln and the right 
jugular vein. We still perform a splenectomy. The purpose of the shunt is 
to deconipre\s the ponal \)\tern when thi\ vese l  is clamped. Once the 
hepatectom) has been perfomled, the donor liver. cooled and ueished. is 
placed In the recipient. In order to place the graft into the circulation, 
anastomoses are performed In the following order: 
- suprahepatic beria cava: the anastomosis is made with two con- 
tinuous evertmg \uture\ of 4-0 silk, 
- subhepatic vena cava: same technique, 
- portal vein: same technique. 
- then. the hepatic artery: thi\ last anastomosis is made with 
interrupted \uture\ of 7-0 s ~ l k .  
For a time. we altered the sequence of anastomoses as  follows: 
- suprahepatic vena cava, 
- portal veln. 
- subhepatic vena cava. 
-hepatic artery 
This sequence, however, regularly resulted in a few minutes in 
ventr~cular f~br i l la t~on a d death. 
Actually, the average time of hepatic ischemia does not exceed 30 
min. on the average. The cuff of the diaphragm is then sutured with 
interrupted sutures of 1-0 flax. Biliary drainage is created either by 
cholecyrtoduodenostom). or by choledochoduodenostomy. 
As soon as the I~ver  is functioning agaln, the two shunts are clamped 
and the cannulae are removed. 
The wound IS closed one hour after the transplanted liver has k e n  
functional and after a specimen of the l~ve r  ha\ been taken in order to 
determine the state of the hepatic parenchjnla at t h ~ s  tage. 
The thorax and abdomen are drained. 
The total operative tlmc is approximately four hours and thirty 
minute\. 
C) Gruff pr-r.\c,r~,c~t~ori tl rrirzg the, i s c  hcnlii perioci rcn~ains to he 
sol\,ecl. We have resolved t h ~ s  problem b) decreasing the temperature of 
the liver by extracorporeal circulation with an oxygenated thermal ex- 
changer. 
Fig. I.- Curves of urea, cholesterol, bilirubin, transaminases. Fig. 2.- Study of glycemia in animals 007 and 001 1 
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we utilize the following circuit: 
- The pump is filled via two venous catheters introduced into the 
common iliacs after separation of the return circulation of the lower 
extremities. 
once the blood has been arterialired, it is cooled and returned by 
perfusion into one of the common iliac arteries. The catheter is passed high 
enough into the aorta to prevent too much fluid from leaking out. Also, as 
extrncorporeal circulation is initiated, we clamp the supradiaphragmatic 
aorta ~d the juprahepatic vena cava. 
perfusion is monitored by determinations of: 
-frequency of pulsation and. by means of this. the circulatory flow, 
-temperature of the cooling bath, 
- rotational speed of the oxygenator disks, 
- time of perfusion. 
- liver temperature measured by means of a thermocouple con- 
nected to a galvanometer b) a quartz thread: the probes are introduced into 
the right and left lobes. 
It should be noted that in order to prime the pump we use 3 liters of 
lsotonlc sod~um chloride, and that losses of fluid within the intracorporeal 
circuit are corrected b) additions b) equal quant~ties of the same fluid. 
Thus. the blood is considerably dlluted. 
The following condition5 are standard: 
- Outflow: 70 pulsationslniinute. or 2.15 liters 
- Bath temperature: mean, 7°C 
- Approximati\e outflow of ox)gen: 1 I IitersJmn 
-The time of perfusion IS detennined b j  surgical requirements. The 
mean IS 30 mlnutes. but in fact 1.5 minute5 are suffic~ent o bring the liver 
to the desired temperature (see graphs). 
Generallj. the temperature i\ between 18 and 2WC. It is useless to 
cool the graft more than this considering the relatively short duration of is- 
chemla. Moreover. when the liver i \  very cold it can effect cardiac function. 
Utilizing this technique, we are able to transplant a liver that is 
perfectly pink throughout. We intend to contlnue to use thit procedure. 
Results 
Our 20 attempts of orthotopic transplantation have yielded the 
following results: 
- 7 perioperat~ve death<. 
- 7 deaths within the first twenty-four hours. 
- 3 deaths after thirty-six hours, 
- 1 death after forty-eight hours. 
- 2 sur\,ivors of thirty-fi\e and twenty-one days respectively. 
1. We have an explanat~on for the 7 perioperat~ve deaths. 
A. In three case, death occurred as a result of ventricular fibrillation. 
This fibrillation has alwals appeared at the mine moment. i.e.. when we 
place the li\er in the c~rcula t~on after h a v ~ r ~ g  completed the anastomoses 
of the wprahepatic vena ca \ a  and the pvnnl vein. Removal of the clamps 
I 
Fig. 3.- Hepatic scintigraph of the control animal. 
from those two vessels causes. within a few minutes. a slowing down of the 
heart and then irreversible fibrillation in spite of the use of a defibrillator. 
This type of accident never has occurred again when we first anastomosed 
the suprahepatic vena cava and then the subhepatic vena cava before 
anastomosing the portal trunk. It is possible that, after remo\al of the 
clamps from the portal trunk. a considerable volume of refrigerated blood 
passes frorn the hepat~c parench~ma to the heart and causes fibrillation. 
When a e  first reestabl~sh continu~ty of the vena cava system, the 
liver becomes warmer progressively: ow ing to t h ~ r  fact. at the time of the 
removal of the clamp5 from the portal trunk, the hepatic parenchyma has 
reached a higher temperature. Furthermore, the blood which has gone 
through the liver is still uann .  because it is mlxed wrth blood which came 
from the infenor vena cava t>stenl.  The impact on the heart then ir small 
or altogether absent. 
B. One death was cau\ed b) a total \ol\ulus of the small intestine 
during intraoperative rnan~puiation. 
In fact, we take the meature of placing all the intestinal ansae in a 
"sniall intestine bag" In order not to he hindered h j  rhem. In this Instance, 
this resulted In an irrecerslbls volvulu\ of the srnall intestine. 
At the present time. we are sat15fic.d to protect the \mall intestine in 
cloths soaked ivith tepid raline. 
C. Three death5 are attributable to portal hypertension, and this 
constitutes one of the most diff~cult echnical problems to be reqolved. In 
fact, as is the case with dogs, pigs do not tolerate portal hypertension. 
We have tried to resolvc thi> problern b) placing a shunt between the 
splen~c vein and the r~gh t  jugular veln. but t h ~ \  procedurr is not always 
satisfactory, probably because the flow In the shunt is ~nsufficient. Little 
bq little, the srnall intestine a\surnes a verious coloration and becomes 
totally inert. 
Thank\ to supportive technique\, we are ;ible to maintain a normal 
arterial pressure In the animal, bur after a certain tlrlle it tirops progres- 
sively. Shock ensues, even when u e  had time to perform the anastomoses 
and. consequentl!,, decompress the portal \)\tern. 
In pig\, unl~ke dogs. I t  1s anatom~call) fea\ihle to establish a tempo- 
rary portacaval shunt. 
For thih reason. v.e are con\idermg the placement of a ihunt originat- 
ing directly in the portal trunk or the temporarb clamping of the superior 
mesenteric arter). 
2. This portal hyperten\tion \er> likely is the cau\e: 
A. Among the three death5 that occurred du r~ng  the first 2 1  hours, 
shock developed progressl\ely and cventuall) led to death. No significant 
hemorrhage occurred in these ln\tances although in each the bowel became 
purpli\h red. 
B. In three other case\, po\toperatl\e death &a5 related to hemor- 
rhage. As a matter of fact. ~ L I I O ~ S ?  demoristr~ited an coplous \ ,olu~ne of 
blood in the per~toneal ca\it) .  2 I~tcr\  or illore. In each caw,  we found a 
small dehiscence of the continuouh c\ertlng suture on the posterior sub- 
Fig. 4.- Hepatic scintigraph made on the twelfth day on subject 007. 
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hepatic vena cava. This anastomosis is the most difficult to perform 
because it is practically impossible to Isolate perfectly the two venous 
segments inasmuch as in certain Instances an actual sheath of hepatic 
parenchjma extends inferiorly as far az the region of the renal veins. 
Nevertheless, after unclarnpirig, the anastomores always are sealed 
perfectlj. It is po5sible that thron?bolytic phenomena are in\olved in the 
onset of this hemorrhage. 
Up to now. it has not been po\sible to examine the coagulation 
aspect, of this procedure. but shonl j  we intend to addre>\ t h ~ s  problem. 
C.  Finallj. one death within the fir\[ tuenty-four hours IS related to 
an error in postoperative care, a$ the animal was not nionitored adequately. 
3. It is more difficult to explain the three deaths that occurred bet~been 
the tuenty-fourth and thirty-sixth hourz. 
It is possible that In one of these co\es bronch~al congemon devel- 
oped and that in another case a fulminant hemorrhage took place as the 
animal struggled \\hen blood was tahen. 
We have no explanation for the third death. We lost an animal at 
forty-eight hours as a result of an acc~dent.  The pig died of suffocation. 
1. The two sur\i\ors of thirt-five and t~centy-one days have been 
studied on the biologicall): urea. cholesterol, bilirubin, imnsaniinases. 
A. The blood urea. normiilly approximately 0. IS gper  liter, never was 
markedly elevated, 0.30 in one case, 0.75 in another. 
Cholesterol. normally 1 .SO g. on the other hand. tended to remain 
relatively low. 
Bilirubin, normail) 10--I 2 mg per liter. remn~ned at the upper limit of 
the normal range until late in the postoperati\.e period. 
In the animal who lived th~r t )  -five days. tlie level\ increased from the 
twenty-eighth day to reach 27.5 iiig on tlie day of death. 
With regard to the tranbamina\es. in one cdie they remained normal, 
or sub-normal: 35 units: in the other case the) were elei-ated moderately: 
70 units (Fig. 1) .  
We also studied the level o f  iupar. nomiall) 1 g per 1000. At first, the 
levels were extremely low: 0.30 or 0.50 per 100 and reached more normal 
levels numbers, 0.80 g. around the t\\enty-fifth day (Fig. 7 ) .  
B. In one of our animals on the tenth day we performed hepatic 
scintigraphy (see plates). Thanks to the courtesj of both Professor C. Kell- 
erson and Profes5or A. Desgre/ the picture that u e  ob~aineti was close to 
that of the control animal (Fig. 3 & 4). The kupfferian clearance measure- 
ments In the transplanted animal demonjtrated cxtrernely mpid purifica- 
tion, perhaps faster that in the control animal. At autopsy. we noted that in 
both case\ anastornoses were perfectly patent. the liver was moderatly 
decreased in volume and of pale coloratiori: at autopsy the wc~pht  was 300- 
400 g less than the weight at the tlnie of transplantation. 
C. Histological study of the parenchq ma demonstrated the following 
(Dr. C. Calniettes): 
"The cel!ulnr architecture is disrupted by edema. Cells appear to be 
very retracted. sometimes irrever\ibly altered. Thew changes are diffuse. 
All the vessels contained in the fragments are dilated con\iderably. In some 
places, there are small foci of old hemorrhagic necrosis. Other samples, 
kidneys. lungs, heart, are nomial." 
Two facts should be noted: 
a) Autopsy of the animal who lived thin) -five days revealed a well- 
defined approximately 1 cm diameter perforation of the greater curvature 
of the stomach. Such a perforation also has been noted by Starzl and 
perhaps is related to certaln ulcers observed after portacaval anastomosis. 
It i,  possible that the tran\planted livzr loses its power to detoxify certain 
metabol~tes, but this remains to be proven. 
b )  The two long temi survivors seem to have been unusually long 
considering the unexpected appelvance of phenomenum of rejection. At 
first. we thought that the animals nere  "brothers", but a careful investiga- 
tion ruled out t h ~ s  h)pothesi,. 
Consequently. at present \ce hake no rat~sfactor). explanation for this 
prolvnged sumibal. except for the po\sihle role of aplenectoniy in the 
attenuation of immunologic responses. .4 more detailed study for this 
pu~pose  will be undertaken. 
Conclusions 
The authors report their experience, unique to their knowledge, 
regarding the orthotopic transplantation of the liver in pigs. 
For the time being, this experience confirms the conclusions of other 
groups that have examined this problem in dogs. 
Surely. the present re\ults on pig\ are poor, but this is due. in great 
part. to the fact there exist no or very lrttle dataconcerning experimentation 
in this animal: each step of this re\earch has raised a<  many original 
problems. 
On the other hand. since technical problerns have been overcome 
after many disappointments, it would appear that the great anatomical and 
physiological similarit) between the pig and human livers justifieq this 
study. 
We express our gratitude to Doctors F. Le Goazio, E. Besins, as well 
as to Miss A. Aurousseau, M.-J. Perrot, G.  Supemant and I. Lagoutte for 
their very valuable collaboration. 
(Study No. 8 of (lip Departmerit o/'Sur-gcr-x, C.H.7,' Pitii-Sulperri2re 
Hospuol [Professor Agrege, M. Mercadier], ~ , o r k  perfhrn~etl iri the labo- 
ratorq of upplied r.uclioiog~ of .IOU?-en-Josas [Director: M .  M. Nizza], 
Dcy~rlrnent of Sunrtun. Protection o j j  rhe C.E.A. [Director: Dr. H. 
Jammer]. Iri,\tirur cl'Imrnurzologie et de Crircino~enerique de Villjuif 
[Director: Professor G. Mathe]). 
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J. H. Peacock This picture of John Terblanche was 
taken in the surgical research laboratories 
of the University of Colorado during his sab- 
batical leave in Denver in 1977. 
J. H. Peacock was a senior lecturer at the University of Bristol in England. With him was a young 
South African surgeon, John Terblanche, now Professor and Chairman of the Department of Surgery 
in Capetown. Peacock and Terblanche were aware of Garnier's work and quickly reproduced and 
extended it. Their pig experiments provoked some of the most interesting discussions at a Colston' 
International Congress on Liver Disease held in Bristol in 1967. 
Peacock is retired and lives in Ubley, near Bristol, England. 
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Orthotopic homotransplantation of the liver in the pig 
In: Read, A. E. (ed.): The Liver. London, Butterworth & Co., Ltd., 1967, pp. 333-6 
J. H. Peacock and J. Terblanche 
The purpose of this paper, which is the first of three to deal with the 
experiences of a team in Bristol working over the last 15 months on experi- 
mental liver transplantation in the pig, is to introduce the reasons for our 
choiceof this animal, to detail some of the difficulties we have encountered 
and to give the results in a relatively small series of forty-one animals in 
which this procedure has been attempted. 
Although we have had fa~r ly  extensive experience of clinical liver 
surgery, we were new to tlie field of transplantation in general and the liver 
in particular, and as a result our alms were essentially unambitious and 
twofold only. 
1. To establish the technical experience and ancillary \ervices neces- 
sary for us to undertake liver transplantation with a reasonable degree of 
success. 
2. To study the process of rejection in the pig's liver. 
Our excuses for presenting sornewhat pre~naturel> the limited amount of 
data that u e  have available in the fonn of three papers stem partly from the 
belief that some of the difficultiea u e  have encountered are peculiar to the 
pig and as such may be of vdlue to other worker\ \\ ho may contemplate 
using this animal but mainl) from tlie fact that Profe,\or K.  Porter, who was 
to have read a paper this afternoon cannot unfortunately be here, and we 
have as aresult persuaded two other members of our group Dr\. A. C. Hunt 
and M. 0 .  Symes to extend sorneuhat the contribut~on\ they would 
otherw~se have made. 
The  pig a s  an  experimental model 
The pig was cho\en as the experinlentdl an~mal  for a number of 
reasonh. It is omnivorous. easil) obtainable. cheap to rnalntain and like 
man has no hepat~c vein sph~ricterc. \Ioreo\er. preliriiinilr) anatomical 
and b~ochemical ~nvestig;ltion\ indicated riot onl) thnt the jugular, iliac and 
splen~c veins \\ere suitable for h!-pahh \>\tern\.  but al\o that the blood 
biochemistry \\ ~ t h  rnlnor exception\ \\a, i.\\ent~ali! comparable to that of 
man. Further factori uhich ~ritluenced u\ \\ere thnt fre\h blood was 
available dail) in quantit> ,it t u o  local ,ibattolr\. and that a Un~verstt) 
School of Veter~nar) Science ex~rtcd uhicti \*a\ prepared not only to help 
US in niamtaining ,~con t~nuou \  \uppl) o ian~rnal \  but a lw  to act :IS a holding 
centre 5hould u e  be fortunate In a c h ~ c v ~ n ~  lo~ig  tenri \ur\I\or,. 
The animal\ used are outhred and equ~ \ i~ l en t  to .I random sample of 
humans. They have been obtained from two distinct sources. The recipi- 
ents are bred at the Veterinary Farm and are a cross between a Large White 
boar and a Wessex sow. The donors are bought from a number of breeders 
through local markets and are crosses between either a Large White or a 
Landrace boar and crossed Large WhiteLandrace sows. The weight of the 
animals used initially was in the region of 20-30 kg, but during the later 
stage of the programme it was found easier from the point of view of 
cannulation to use animals of a somewhat larger size and 35-40 kg animals 
are now regarded as being most auitable. 
Technique 
The transplant is undertaken b) two teams Lvorking simultaneously 
on donor and recipient animals. Anaesthes~a 1s induceti with halothane 
through a nose cone and maintained after intubation on closed circuit gas, 
oxygen and minimal halothane. Vena cab al and portal b) -pass systems are 
inserted betueen the iliac and splenic velns in thc abdomen and the two 
jugular velns in the neck. The portal by-pass 15 more critical in the pig than 
In the dog. as occlusion of the portal veln for four nilnutes can lead to 
circulatory collapje in wrne anirnals. The arterial hlood prc\sure, central 
venous preasure and E.C.G. are monitored continuou\ly and half hourly 
estimations of blood pH. 0, saturation. P C 0  and glucose are made during 
and after operation. The d6rior l i \er I prepused b) i\oiation of I [ \  major 
vessels. the hepatlc aster) bemg left attached to a 5 In. begrnent of thoracic 
aorta. The liver tcnipcrature IS lonered to between 6'-I 2' C b) perfusion 
through the portal \etn of 8 l~tre,  of ice cold Ringer lactate at 1 I~tre/niinute 
ininiediately the artenal \uppl> to the l~\ ,cr  I \ d~jconnected. Both donor and 
recipient animals are hepar~nifed u\lng n do\e of 1.5 111g/k:@od) ueight 
and on11 fresh heparinired blood I \  used for transfu\ion. All the anasto- 
mows are by \tandard techniques and hiliar) drn~nage i \  b) a chole- 
cyatoduodenostom). P r ~ o r  to closure a splenectorn> I \  pertonned. Hepatic 
out-tlou obstruction has riot beer1 \ ten  except in one anim;il in which there 
was an Increabe In <!\tsrn~c \enou\ pre\\urs due to the prs\ence o f a  large 
pulmonar) embolu\ trorn the bps\\ 11nc. 
Results 
Twent!-fi\e an~mal \  u n ~ \ r d  the trchn~cal procedure out of forty- 
one in wh~ch  ~t u a j  attempted. 111 the f ~ r \ t  ~ e r i t ) .  \s\sli  on11 \urv~ved,  
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ORTHOTOPIC HOMOTRANSPLANTATION Of THE PORCINE LIVER (ANALYSIS OF RESULTS) 
41 TRANSPLANTS ATTEMPTED 
T.\BLE 2 .  
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three of these dying w~thin  the ensuing 23 hours. This high mortality rate 
we attribute mainly to our own inexperience, to the initial use of relaxants 
which led to post-operative difficulties with respiration, to citrated blood 
which appeared to induce block of thecardiac conducting system and to not 
using heparin so that by-pass systems clotted and cardiac failure or 
pulmonary emboli ensued. In the second serie\ of twenty-one transplants, 
eighteen survived although six of these d ~ e d  within 23 hours. mainly from 
haemorrhage, which ha\ led us to reduce our heparin do\e to its present 
level. 
The survival times of the remaining sixteen animals range from 1-11 
2 days to 9-112 months. (Table I . )Two  of the early deaths at 1-112 days and 
3-112 da j s  respectively were due to intraper~toneal haemorrhage and 
thrombosis of the aortic segment respect~\,ely and as such should be 
regarded as technical failures. 
The fourteen animals left constitute the group from which informa- 
tion ha5 been obtained. Thirteen of these jurvived for periods ranging from 
3-1!2 days to 33 days and one remains alive at 9-112 months. The 
histological appearances of the livers of these animal\ together with 
biochemical data on liver function will be presented subsequently by Dr. 
Hunt. but the main caujes of death found at autopsy are shown in Table 2. 
In only two of these animals, numbers 23 and 27, were the post-mortem 
findings such that no adequate cause of death was established and liver 
rejection alone might possibly be said to have been the main cause of death. 
Two other animals died at 5.112 days from pulmonary emboli, the sources 
of which were never detected and a further an~rnal died at 28 days from a 
completely unexplained anaemia. The remaining eight animals all died of 
gastric complications. seven being due to oesophagogastric ulceration and 
severe gastro~ntestinal haemorrhage. In the eighth animal there was 
extensive and ~u lmonarv  collaase. 
Oesophagogastric ulceration in the pig is not comparable to the 
gastrointestinal haemorrhage seen in canlne iiver transplants due to hepatic 
out-flow block. as it is a species hazard which occurs naturally in pigs.: The 
area of pig's stomach, just below the cardia, is predisposed to ulceration 
owing to the fact that a long tongue of squamous oesophageal epithelium 
which is devoid of protective mucus glands extends through the cardio- 
oesophageal sphinter into the body of the stomach. Although the exact 
cause of ulceration, as in man. remains unknown experimentally the 
lesions have been induced by histamine and by withholding feeding for 
three days.' In addition they habe been produced by changes in fat content 
of the pig's diet.' 
Unfortunately it now constitutes the single greatest danger to our 
transplanted animals and experiments are currentlq proceeding to see 
whether it can be controlled. 
Summary 
To summar i~e  this the first of these three papers therefore; a series of 
sixteen pigs is presented in which orthotopic homotransplantation of the 
liver has been successfully accomplished. Two of these died at 1-112 and 
3.112 days respectively from technical complications of the operation. The 
rernainlng fourteen animals have survived for periods ranging from 3-112 
days to 9-112 months and one of these is alive today. 
No definite pattern of 11ver rejection has been established and in all 
but two of the animals a cause of death was present at autopsy other than 
liver rejection. Four of the animals have survived for periods longer than 
10 days. the survival times b e ~ n g  21, 28, 33 and 298 days respectively. 
Gastrointestinal haemorrhage due to oesophagogastric ulceration has been 
the main cause of death being directly responsible for seven of the deaths 
in this series of animals. 
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Sir Roy Calne'scontributions to liver transplan- 
tation are so well represented in this collection of 
articles that further comments would be superflu- 
ous. In 1983, Calne published a book on his expe- 
rience which was reviewed for the Annals of Sur- 
gery 200: 108. 1984 by one of the authors (Thomas 
E. Starzl) who concluded by saying . .  . the book 
provides insight and background about liver trans- 
plantation about which no new group could afford 
to be ignorant, It also has provided an accidental 
look at the creat~vity, courage in the face of terrible 
adversity, and vision of its author who is one of the 
great surgical sclentlsts of the world." 
Roy Calne, Professor and Chairman of the Department of Surgery at Cambridge University, 
extended observations on pig liver transplantation beyond those of the Paris and Bristol workers. In 
doing so, he speculated that the liver is a tolerogenic organ, a concept that still is being explored. 
Calne's group has used the pig model since for experiments in immunology, organ preservation and 
hepatic physiology. The work with pigs led to the opening of the historically important Cambridge- 
King's College (London) clinical liver unit which Calne has operated in collaboration with the 
hepatologist. Professor Roger Williams. 
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Observations of orthotopic liver transplantation in the pig 
British Medical Journal, 2: 478-80, 1967 
R. Y. Calne, H. J. 0. White, D. E. Yoffa, R. R. Maginn, R. M. Binns, J. R. Samuel and V. P. Molina 
Recent advances in renal transplantation permit excellent therapy in 
many patients, and surgeons are now turning to the possibility of clinical 
transplantation of other organs. 
Initial liver transplantation experience was obtained in the dog with 
the use of methods previously described by Moore et al. (1960) and Starzl 
et al. (1960). Following the reports of Gamier et al. (1965). Cordier et al. 
(1966). and Terblanche et al. (1067) on orthotopic liver transplantation in 
the pig, we began on this animal in July 1966. 
,Muter.lu/t and Methods 
Nineteen l ~ v e r  transplants h a ~ e  been perfonned in large white p ~ g s  
(20-30 kilograms) under halothane anae~thesia \ ia  an endotracheal tube. 
Donor and recipient were littennates In some case,; in others there was no 
relationship. The surgical technique wa\ simllar to that of Moore et al. and 
of Starrl et al.: however. tninor tnod~fications of the shunting procedure 
and arterial anastonlo\ls were incorporated In certain experiments. In the 
first 1 I operations, during the Interruption of flo\v through the portal vein 
and inferior vena Lava. blood frorn thew two cq\temc \\as \hunted via 
catheters in the splenic and left ferno~al LeIns re\pectivelq joined to a T  tube 
which connected to another catheter introduced Into the left internal 
jugular bein. In the twelfth experiment two h u n t s  here  used - one from 
the splen~c veln to the left jugular \em.  the nther from the r~gh t  renal vem 
to the right jugular bein. The right kidne]. \ \a\  renioksd In the remaining 
seven operation5 catheter\ \%ere iner ted directl> Into the cut ends of the 
portal vein and inferior vena cava 'ind connected re\pectl\ei! to the left and 
right jugular veins. In all c a w  the anlrnal$ \\ere heparin~jed while the 
shunts \%ere open and the heparin w;i( re\er\e(i with pl.otanime at the end 
of the procedure. In the operation\ uhere the \p len~c veln a a s  used, a 
splenectorn! was perfonned. 
In the flrst s ~ \  experiment, the donor liver \*a\ removed with the 
hepatic arter!. coel~ac arter). and a length of nhdorninal aona which was 
anastorno\ed end-to-s~de to the abdoni~nal aona of the reclplent It was felt 
that thi\ large ve\\el. w ~ t h  all but ~ r i e  o i  its o ~ ~ t l e t \  ligated. \ \a \  haemody- 
namicall) unsar~\fdctor) ;ind ~ t $  d i \ \ s c t ~ o ~ i  added ion\iderablg to the time 
of the donor operation. Therefore In the \ub\equsnt slperiments the 
coeliac arter> with :I Carrel patch of aort'i h a \  remo\ed ~n cont~nuity with 
the hepat~c. Ine\perlrnent\ 7-1 I. 13. 14 the coeliac 'irter) ofthe donor was 
anstomosed to the s ~ d e  of the coeliac artery of the reclpient. In experiment 
12 the coeliac artery of the donor was anastomosed to the end of the right 
renal artery after the kidney had been removed. In the remaining five 
operations the coeliac artery was anstomosed with a Carrel patch directly 
to the abdominal aorta close to the origin of the coeliac artery of the 
reclpient. In experiments 15 and 16 the coeliac artery was brought behind 
the stomach to the left side of the aorta. This resulted in tension, so in 
subsequent operations the coeliac artery was anastomosed direct to the 
right side of the aorta b) the shortest route. 
The anaerthetired donor DIE was cooled to 33" C. in a bath of iced 
1 L 
water prior to \urgey.  When the liver dissection was completed the animal 
was exsanguinated via the aorta. The blood was collected in ACD bags and 
used for transfusion into the recipient. The blood was neither @rouped nor 
cross-matched. The liver was perfused via the portal vein with 2 litres of 
Rlngerilactate solution at 1" C. with a perfusion prejsure of I metre of 
saline. During the operation and postoperatively. in addition to blood 
transfused from the donor. the recipient pig was given s o d ~ u n ~  bicarbonate 
and dextrose solut~on through an Intravenous catheter in a suitable neck 
vein. One gramrnc ofchloramphen~col was glven intravenously durlng the 
operation and 1 rnegaunit of penicillin intraniuscularly. The an~mal s  that 
survived the operation here  giken an ad lib. diet of commerc~al p~g-food 
and water: the) did not receive imrnunosuppress~ve agents. Venous 
samples of blood were taken for hiochemlcai and haernatolog~cal investi- 
gation at Irregular i n t e n d \  after operation. Postmortem examination was 
carried out on the anin~als.  The thoracic and abdominal cavltles were 
exarnmed and \ection\ of 11ver. lymph node$. cpleen In non-\plenecto- 
mifed an~mals .  lungs. \tomach. \mall inte\tlne, and kidneys were exam- 
ined h~stologicallq 
Kc\lt/ts 
The re\ults are summarized in the Table. There were six operative 
deaths. The causes are \hewn in the Table. with the exception of experi- 
ment 10, where the cau\e of death h a \  undetemi~ned. Thl\ an~mal  d ~ e d  at 
the end of the operatton while the operative incijion was being wtured. 
Five d ~ e d  w ~ t h ~ n  the first 36 hours. One of the,e animal5 had peritonit15 and 
clot in the hepatic a n e p  and donor section of aorta. In the other experi- 
ments the cduse of death was not tiercm11nt.d. but was prewmed to tx liver 
failure. In  one of thew cases the liver had k e n  p rewned  for four and a half 
hours in ice before transplantation. Two animals died at three days. One 
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had a thrombosed hepatic artery and two intussusceptions, the other had 
obstructice jaundlce following inadvertent ligation of the cystic duct 
together with the common bile duct. 
Five animals lived between 7 and 16 days. In each of these there was 
m~croscopical evidence of rejection. This cons~sted of focal necrosis of 
liver cells and round-cell infiltration of the portal triads. One of these 
anrmals died from obstructive jaundice due to ligation of the cystic duct 
with the comrnon bile duct. another of multiple sepsis after necrosis of the 
anterior wall of the stomach due to emboli~ation of the left gastric artery. 
The other three developed a syndrome of wasting and very severe anaemia 
due to bleeding from the gastrointestinal tract with melaena. The source of 
the haemorrhage was not determined with certainty in any ofthere animals. 
but it wa, thought to be from multiple superficial erosions of the gastric and 
duodenal rnucosa. 
The remaining animal lived with a transplant from its littennate for 
seven months after operation. Though it was extremely robust and ate well, 
it did not gain we~ght  to the same extent as control animals and it grew more 
hair on its skin than normal. This animal died suddenly from intestma1 
obstruction due to adhesions. The liver parenchyma was remarkably 
normal at postmortem examination. There was a minimal increase of 
fibrous tlssue in the portal triads with a light infiltration of mononuclear 
cells. 
The chemlcal and haematological examinations of the blood were 
related to the clinlcal assessment and histological findings. Thus clinical 
Jaundice was asiociated with a raised serum bilirubin. liker necrotis with 
raised S.G.O.T.. S.G.P.T. and alkaline phosphatase. and rnelaena and 
pallor with low haemoglobin. 
Or~hotopic Lb t r  Transplanfarion in the Pig 
D i ~ c  us~ror i  trnti Conc.lusions 
In common with the French and Bristol workers, we have found the 
Plg an extreniely satisfactor) experimental animal for orthotoplc liver 
transplantation experiments. The pie withitandi the surgery well and the 
appears to be rejected more \lo\* ly In the pig than in the dog, allowing 
mure time for study of the anrnials. w~thout necessity for immuno\uppres- 
therap). Halothane anaesthesia was effective: the anirnals were kept 
fairly light throughout the procedure and were usun11) on their feet within 
a few hours of the operation. In those animals 5un.ivlng more than a week 
classical l~ve r  failure did not appear to be the cause of death. H o ~ . e \ e r .  the 
fastrointe\trnal haemorrhage may well have been due to inadequate liver 
function. though the exact mechanism ha, not beer) drtemiined. I t  willcer- 
be of interest to stud) the gastric secretion, metabolism of histamine. 
'he haemodSnamics of portal venous flow. and the composition and distri- 
bution of bile in these anirnlas. Peptic ulceration is a common complication 
of orthotopic liver transplantation In dogs. The Bristol workers have also 
observed gastrointestinal haemorrhage in pigs with onhotopic liver trans- 
plants and have demonstrated superficial mucosal erosions in the caridac 
portion of the stomach. A perforated duodenal ulcer was the cause of death 
of one of the pigs in the French experiments. 
In our pig herd skin grafts are rejected aggressively when the donor 
and recipient are unrelated (Binn, 1967). and e \en in littermates rejection 
is the rule, though skin erafts may persist up to three weeks. The mecha- 
nism of acceptance of an orthotopic 11\er transplant in our longest- 
,urvivlng anlmal at seven months and a similar animal of the Bristol group 
at nine months (Peacock, personal communication) has not been deter- 
mined. Though splenectorny has little effect on the survival time of 
transplanted tissue in most \pecieh that have k e n  studled. it is possible that 
splenectom) in plgs ul th  liver transplant, may influence the outcome of 
the transplant. 
This early expenence encourages us to pursue further studies with 
liver transplantation in the pig. 
Surnmciry 
Our preliniinar) experience wlth orthotopic liver transplantation in 
the pig is reported. Of the 19 operations performed 13 animal5 <urvived the 
procedure and S I X  I I \  ed for a week or more. One p ~ g  with an orthotopic liver 
transplant from a littermate lived for ,e\en months after operntion without 
any immunosuppressive therapy and dred from intr\tinal obstruction, with 
minimal microscopical e\ idence of I i ~ e r  damage. 
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anaestheh~~ ot the pig,. dnd us  aiknou ledge the excellent technical ai\l\tance that we 
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and the .$ncultur.~l Re\earch Council at Bdbraham. We are most grateful to Dr. R. 
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Tom Marchioro was born in 1928, and grew up in Butte, 
Montana. His colorful life included jobs in mines, on construc- 
tion gangs, and in odd jobs while working h~s way through 
college and medical school. He went to St. Louis University, 
School of Medic~ne and had his residency in St. Louis Univer- 
s~ty, the Henry Ford Hospital in Detroit, and the University of 
Colorado. Many of his contributons to transplantation are 
d~stributed throughout th~s book. 
This was the first systematic attempt to preserve organs by continuous hypothermic perfusion, 
using the cadaver as the perfusion chamber and providing flow and oxygenation with a mechanical 
heartllung machine. The method was used clinically in the mid-1960's before brain death became 
a condition of organ donation. Cadavers with no heart beat could be cooled quickly and effectively 
with this technique. These first efforts at continuous perfusion formed the basis of the in situ cooling 
techniques that now are used universally as the initial step in modern-day, multiple-organ procure- 
ment (cf. Part Ill). 
Today Marchioro is a Professor of Surgery at the University of Washington and Chief of 
Transplantation. Huntley, a gifted laboratory technician and administrator, runs a floral shop in 
Golden, Colorado. Waddell, who was Chairman of the Department of Surgery at the University of 
Colorado, "retired" to Silver City, New Mexico where he has an active surgical practice in the desert 
country where he grew up. 
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Extracorporeal perfusion for obtaining postmortem homografts 
Surgery, 54: 900- 1 1, 1963 
T. L. Marchioro, R. T. Huntley, W. R. Waddell. T. E. Starzl 
Successful organ homotransplantation is dependent upon the availa- 
bility of satisfactory grafts. Paired organs. such as the kidney. may be 
obtained from living donors, whereas hepatic and cardiac grafts for human 
use can on14 be obtained post mortem. Cadaveric renal homografts have 
been largely unsuccessful to date."' !":' The major cause of earl) failure 
a a s  probahly ~schemic damage. This report describes an experimental 
method of procuring and te~iiporanly preser\ ing po\tmonem homografts 
of kidneb and liver. and docun~ents the clin~cal use of the technique in 1 
cases. 
All animals receiving renal homografts had bilateral nephrectomies. 
The donor left kidney was transferred to the right pelvis and the donor right 
kidneq to the left pelvis of the host. Each recipient received only one 
kidne). The renal arter) was anastornosed end to end to the iliac artery of 
the recipient and the renal ~ e i n  end to \ide to the ~ l i a c  v a n .  In animals 
receibin  hepatic homograft\. the li\er was transplanted orthotopically 
after recipient hepatectom). ' Postoperat~\sl!. arath~oprlne (Burroughs- 
METHODS 
Thirty-two dogs weighing 9 to 20 kilograms were used. After the 
a lntra- animals were anesthetized w ~ t h  30 mg. per kllopram of pentobarbit I ' 
venousl). the femoral vesselj on one side were exposed. Hepann. 3 mg. per 
hliogram. a a s  injected intravenously. and aortic and inferlor vena caval 
catheters were inserted through the femoral arterq and vem (Fig. 1). The 
animals here then sacrificed a i th  an overdose of pentobarbital. Respira- 
mes t  preceded cessation of hearbeat b) 5 to 15 nilnutes. Perfusion was 
subsequentlq begun one to 22 minutes after the disappearance of palpable 
pul~e.;. when it a a c  certain that the an~mal  wac dead. 
The catheter\ ae re  connected to an extracorporeal perfusion sqstem 
consisting of 3 disposable bubble ox) genator. a aingle De Bake! pump, and 
a heat exchanger (Fig. I i .  venous outtloa was b! gra~lt! drainape. The 
()\!@enator a a a  pr~med u ~ t h  lactated Ringer's solution in all experiments 
except 2 hepatic tran\plant\ 11, a hich 5 percent dextrose in water b a s  used. 
The perfu\ate a a c  precooled to 15' C, b) recirculation through the heat 
exchanger. One gram of procaine chloride \%a, added to each l ~ t r r  of the 
perfusate. In prolonged perfu\ion\. heparin I .5 rng. per K~logram. was 
added huurll. One third the origin;~l do\e of procaine a n <  added every 3 
M'ith perfus~on, of X hours or more it \+a\ frequentl! necessary to 
ddd extra pr~nling \elution to the re,enolr. 
Pilot \tudie< \\ere fir\[ performed tv detern~ine suitlibls flow rates. 
The procedure was then \tandardired w ~ t h  in~tial tloa rate\ of 40 to 60 ml. 
perkllopriini per minute. and gradual reductic>rl 10 5 to 20 ml. per kilogram 
per minute. as the esophageal temperature fell helo\+ 70-  C. Organ 
tenlperature a a j  m;iinrd~ned betwct.11 12 axid 15- C. thrr raf t~rb!  adjusting 
the of the perfusate (Fig. 2) .  
-pp - -  
Fig. 1.- Techn~que of extracorporeal cadaver perfusion. 
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Fig. 2.- Cooling curves obtained during cadaver perfusion for a 
liver homograft. Note the rapid responje of liver temperature to changes in 
perfusate temperature. 
'O1 1 
BUN 
mgm% 
---- KPIJ(I0Yt Hr. ~ e r f u b J  
 KP6(1Y,Hr. PahabJ 
Fig. 3.- BUN level after renal homografting. Note the acute 
azotemia with the homograft perfused for 10-112 hours. Early azotemia is 
minimal in the animal receiving a kidney perfused for 1-114 hours. 
Table I. R f n a l  hornograj t~  
TIME IN DKYS 
BILIRUBIN mgm Y. 
Fig. 4.- Pattems of injury in dogs observed following transplanta- 
tion of a perfused hepatic homograft, and of a liver obtained after sacrifice 
of a living donor. Total time from death to reimplantat~on for the perfused 
organ was 140 minutes as compared to 55 minutes for the graft transplanted 
immediately after sacrifice (acute transplant). 
Wellconie 57-322, Imuran) was administered to prevent rejection. Results 
were judged by function of the grafts and by subsequent histologic studies. 
In clinical use. insertion of the catheters was not done until the 
patient's death had been verified by the attending physician. In these 
instances, heparin was added to the perfusate in an amount equal to 3 mg. 
per kilogram of body weight of the proposed donor. Total time to make the 
necessary incisions, Insert the catheters, and begin perfusion has not 
exceeded 15 minutes from death in 4 clinical applications. 
RESULTS 
Pressure-flow studies. Blood pressure monitoring was found to be 
of no value in detem~ining flow adjustments. In order to maintain an 
arterial pressure of 50 to 70 mm. Hg, flow rates as great as 600 ml. per 
kilogram per minute were required. resulting in acute swelling or even 
rupture of the various organs. Flow rates were therefore arbitrarily limited 
to 40 to 60 ml. per kilogram per minute, and gradually reduced to 5 to 20 
ml. per kilogram per minute as the temperature fell to 20' C.  Under these 
conditions of perfusion, arterial pressures never exceeded 20 mm. Hg and 
were usually unobtainable. Despite the low flow perfusion, cooling was 
relatively rapid (Fig. 2).  
Degree of cooling. Five animals were cooled to 2 to 10" C. by the 
low-flow technique. These temperatures were usually reached in less than 
40 -20  45 ( t o  
2 1 "  C.) 
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45 minutes. Renal homotransplantation was then performed. Immediately 
after revascularization, the organs assumed a mottled pink and blue hue 
with islands of cyanotic tissue interspersed among areas of normal paren- 
chyma. During the next hour, the kidney gradually became grossly normal 
in appearance. Nevertheless, none of the grafts produced urine and all 5 
animals died with uremia within 2 to 3 days. 
When temperatures were kept at 15' C. or above, such mottling of the 
kidney did not occur, and urine production was prompt. In the definitive 
series to be described, temperatures were, therefore, not allowed to fall 
below 15' C. 
Table 11. Hepatic homografts 
Renal homografts. Eleven renal homografts were performed after 
cadaver perfusion of 1 to 14 hours (Table I). In 5 of the 11 cadavers, 
perfusion was carried out for 1 1 or more hours. Perfusion time for the entire 
series averaged 7 hours and 33 minutes. Revascularization in the recipient 
dog was usually completed within 30 minutes after removal of the kidney 
from the perfused cadaver. 
Ten of the 11 animals produced urine immediately and maintained 
good urinary volumes until death. The eleventh animal was anuric for 2 
days, with subsequent diuresis. 
Renal function was assessed by urine volumes and blood urea 
Dog.. no. 
Fig. 5.- Typical injury observed in livers perfused for more than 2 hours. Note the marked centrilobular congestion and parenchymal necrosis (x 32). 
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1 7 60-20 24 2, 3 N o  Hemorrhage 
2 4 3, 54 N o  Hemorrhage 
3 5 50-25 18 4, 22 N o  Hemorrhage 
4 Immediate 15.5- 2.5 17 3, N o  Hemorrhage 
5 7 32-15 28 2, 18 4 days Bile peritonitis 
6 8 33- 3 2 2 3, 38 N o  Hemorrhage 
7 4 195-45 90 3, 42 5 days Intussusception 
8 Immediate 29-12 19 8, 18 2 days Hemorrhage 
9 5 40-15 8 4, 55 3 days Hemorrhage 
10 22 27-12 10 4, 47 24 hr. Hemorrhage 
Perfusion 
started 
post mortem 
(min. )  
Flow rates 
(ml . /Kg . )  
hieh-low 
Survival 
post transplant 
Time to 
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(min.)  
Cause of  
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nitrogen (BUN) determinations. The animals receiving kidneys which had 
been perfused for 6 hours or more showed sharp postoperative rises in the 
BUN (Fig. 3). This subsequently returned toward normal. With perfusion 
of less than 6 hours, this pattern of early azotemia was not prominent (Fig. 
3). 
Survival ranged from 7 to 52 days (Table I). Mean survival time was 
19.9 days. Death most commonly resulted from pneumonitis, with 8 dogs 
dying of this complication. Six of the animals were uremic at the time of 
death. Histologic sections of the transplanted kidneys removed post 
mortem showed varying degrees of mononuclear cell infiltrates with 
minimal evidence of rejection. In no instance was there evidence of histol- 
ogic renal damage which could be directly attributed to the perfusion. 
Hepatic homografts. Hepatic homografts were transplanted in 10 
animals after perfusions ranging from 7 1 to 416 minutes (Table 11). Revas- 
cularization after removal of the liver required an additional average time 
of 72 minutes. Hevatic function after trans~lantation was inferred from the 
ability of the animal to awaken from pentobarbital anesthesia and survive 
without supplemental glucose therapy. 
Five animals survived the immediate postoperative period. Severe 
hepatic damage was observed in all, as evidenced by sharp rises in serum 
glutamic oxalacetic acid transarninase (SGOT) and bilirubin levels (Fig. 
4). Three of these animals later died of hemorrhage at 24 hours, 2 days, and 
3 days postoperatively. 
Consistent clotting defects were encountered in all animals. In- 
creased fibrinolysin, decreased plasma fibrinogen contents, and increased 
thrombin times were uniformly observed. The significance of the cloning 
defects is reflected in the high death rate from hemorrhage (Table 11). Five 
animals died from this cause either on the operating table or immediately 
postoperatively; another 3 which survived the procedure had extensive 
hemoperitoneum at autopsy. The incidence of fatal hemorrhage increased 
with increased length of perfusion of the donor liver. Six of the 8 animals 
that died from this cause had received hepatic homografts from donors that 
had been perfused in excess of 2 hours (Table 11). 
Histologic sections taken post mortem correlated well with the 
clinical observations. All livers showed moderate to marked centrilobular 
congestion and hepatic cell necrosis (Fig. 5) without evidence of rejection. 
Fig. 6.- A, Appearance of homografted cadaveric left kidney 24 days after transplantation. B, Ca- 
daveric contralateral kidney immediately after cessation of perfusion (x32). 
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Clincal use of cadaveric renal homografts. The first homograft 
was obtained from a patient who was thought to have a brain tumor, but 
who was subsequently shown at autopsy to have died of acute bacterial 
endocarditis. His blood pressure was 60 mm. Hg or less for 4 hours prior 
to death. Cadaver perfusion was not satisfactory, the maximal flow rates 
being 15 to 20 ml. per kilogram per minute. Revascularization of the 
kidney in the recipient bed was accomplished 106 minutes after death. The 
homograft functioned for 2 weeks postoperatively, although at reduced 
The BUN fell from 176 to 119 mg. percent, and then rose again 
after 12 days. Death of the host from sepsis occurred on the twenty-fourth 
day after transplantation. Histologic sections of the transplanted kidney 
showed severe interstitial hemorrhage and the presence of proteinaceous 
material in the tubules. There was minimal mononuclear infiltrate (Fig. 6). 
Sections obtained from the opposite donor kidney after perfusion revealed 
normal architecture (Fig. 6). There was no evidence that septic emboli in 
the transplanted tissue contributed to the unfavorable outcome. 
Postmortem hypothermic perfusion in the second case failed within 
a few minutes after its inception. The patient, who died of subarachnoid 
hemorrhage, was severly dehydrated terminally, and probably had a low 
blood volume. Adequate venous return could not be obtained. The kidney 
was revascularized in the recipient bed 124 minutes after death. Renal 
function did not return. Twelve days later, the graft was removed, after it 
had ruptured following relatively minor trauma to the recipient patient in 
a fall from bed. Histologic sections showed typical rejection (Fig. 7). 
Clinical use of two cadaveric hepatic homografts. The first organ 
was obtained from a 3-year-old child who died in the operating room 
during resection of a medulloblastoma. The recipient was another 3-year- 
old child with terminal biliary cirrhosis secondary to congenital atresia of 
the bile ducts. The time from death to the institution of extracorporeal 
perfusion was 15 minutes. For the preceding 30 minutes, open cardiac 
massage was performed. Initial perfusion flow rates were 30 to 50 ml. per 
kilogram per minute and cooling proceeded rapidly. Perfusion was then 
reduced to 10 to 20 ml. per kilogram per minute. After 2 hours, venous 
return began to decline and during the next 110 minutes perfusion ceased 
altogether. The temperature of the liver at the time of perfusion failure was 
15' C. After an additional 45 minutes, the liver was removed. Orthotopic 
revascularization in the recipient took 85 minutes. 
Following restoration of blood supply to the donor liver, a bleeding 
diathesis developed with hypofibrinogenemia and fibrinolysis. Despite the 
administration of fresh whole blood, fibrinogen, and epsilon-amino- 
caproic acid, the hemorrhage could not be controlled. Histologic sections 
of the transplanted liver showed well-advanced, non-specific autolysis 
which could not be attributed to ordinary postmortem changes (Fig. 8). 
The second liver homograft was obtained from a 55-year-old man 
who died from a cerebral glioma. The recipient was a 47-year-old man in 
whom a primary hepatoma had been found at operation one week earlier. 
Several measures were taken to shorten the necessary time for and to 
improve the quality of perfusion. The recipient was prepared for the 
homograft by a preliminary operation, 24 hours before definitive trans- 
plantation, at which time his own liver was freed of all attachments except 
the bile ducts and vessels. Intravenous infusions of glucose were given to 
the Prospective donor in order to maintain hepatic glycogen. Immediately 
after death had been certified, acute expansion of the intravascular volume 
was achieved by forced transfusion of whole blood and plasma. Finally, the 
thoracic aorta was occluded just above the diaphragm (Fig. 1;. 
Perfusion at 40 ml. per kilogram per minute was begun 5 minutes 
after death, and gradually reduced to 20 ml. per kilogram per minute during 
the next 45 minutes, during which time the body temperature fell to 15" C. 
Dissection and extirpation of the donor organ required 94 minutes. After 
removal, 500 C.C. of cooled lactated ~ i n ~ e r ' s  solu6on was used to wash out 
residual blood. The liver was then carried to the recipient operating room 
- 
and revascularized in the ensuing 63 minutes. Bile flow through the 
transected donor common duct was noted shortly thereafter. Epsylon- 
amino-caproic acid, fibrinogen, and fresh blood were administered during 
Bleeding was not a major problem. 
In spite of the success of perfusion and the short time from death of 
the donor to revascularization of the liver in the host, evidence of hepatic 
damage was observed in the first few postoperative days with rises of 
SGOT to as high as 1,150 units and an early rise of bilirubin to 12 mg. 
Percent. Liver function tests gradually returned toward normal until death 
Occurred on the twenty-second postoperative day as a result of multiple 
pulmonary emboli. Histologic sections of the liver showed preservation of 
architecture (Fig. 9). There was some increased fibrosis and bile stasis. NO 
damage due to perfusion was seen, nor was there unequivocal microscopic 
evidence of rejection. 
DISCUSSION 
The beneficial effects of hypothermia in preventing ischemic dam- 
age to tissue have been documented for several organs, including kid- 
ney,5.6.8.10.15 liver ,'.4.'3.16.'7 lungs: and heart9 Perfusion of isolated organs with 
Fig. 7.- A, Homografted cadaveric right kidney removed 12 days 
after transplantation. Note rejection. B, Contralateral donor kidney ob- 
tained at conclusion of perfusion (x32). 
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Fig. 8.- Photomicrograph of first clinical hepatic homograft. The patient died on the operating table. Note advanced hepatic cell necrosis (x32). 
various solutions had also been shown to prolong function. The technique 
described here incorporates the advantages of both hypothermia and 
perfusion. The practicality of the method is considerably increased by the 
use of the electrolyte- or glucose-primed disposable bubble oxygenator, 
thereby eliminating the need for blood typing. The resultant hemodilution 
reduces viscosity" and promotes increased renal blood flow.' Moreover, 
oxygen is available to the tissues in quantities equal to those obtained from 
whole blood2O The favorable effect of procaine on renal perfusion at low 
temperatures has been demonstrated by Kiser and his  colleague^.^ 
Extracorporeal perfusion in cadavers differs from that in the living 
patient. Serious organ damage resulted from overperfusion when it was 
attempted to maintain arterial pressures which would be clinically accept- 
able. Apparently there is a rapid and complete loss of vascular tone shortly 
after death, making the maintenance of significant arterial pressure impos- 
sible except with exorbitant flow rates. The use of low flows in combina- 
tion with hypothermia provides some protection against hydrostatic 
damage to the organs from the pump system. While low-flow perfusion has 
metabolic disadvantages, it has appeared to be satisfactory for short-term 
preservation. 
Although others have been able to obtain satisfactory renal function 
after storage of kidneys at low temperatures (1 to 4" C.) for as long as 8 
hours,8.I5 we were unable to do so with continuous perfusion at these 
temperatures. Renal homografts cooled below 10' C. failed to function. 
When temperature was controlled at 15" C. all renal homografts were 
functional (Table I). The use of extremely low temperatures with continu- 
ous perfusion appears to be harmful. The mechanism of injury is unknown, 
but the gross appearance of the kidneys was strongly reminiscent of 
frostbitten extremities. 
Although satisfactory cadaveric renal homografts have been consis- 
tently obtained with the use of the low-flow perfusion at temperatures of 
15' C. for as long as 14 hours after death, there are limitations to the 
method. Kidneys perfused for longer than 6 hours showed temporarily de- 
messed renal function. The liver has been shown to be even more 
susceptible to postmortem injury. This is evidenced by the high failure rate 
in the animals perfused over 2 hours (Table 11). Even with perfusion for less 
than 2 hours, serious hepatic damage occurs, as shown by elevation in 
SGOT and bilirubin levels, and by the development of coagulation defects. 
Comparing the animal results with the clinical material, it is apparent 
that success depends as much on the terminal course of the donor as it does 
on the perfusion. Renal homografts obtained from animals sacrificed with 
normal cardiovascular dynamics have been uniformly successful. Cadav- 
eric perfusion in such dogs requires no special precautions. In contrast, 
kidneys and livers obtained from patients who have had a protracted 
terminal course are variably damaged before death, resulting in unpredict- 
able function of the homografts. In addition, difficulties with perfusion 
have been encountered, apparently due to a reduced blood volume, 
inasmuch as transfusion of the cadaver partially corrects this problem. If 
flows are still inadequate, selective perfusion of the lower half of the corpse 
has been obtained by clamping the lower thoracic aorta. Despite these 
adverse factors, it is encouraging to note the fact that functional hepatic and 
renal homografts have, nevertheless, been obtained for clinical use. 
Other organs, including lung and heart, have been successfully 
transplanted in animals, from living donors. Homografts of heart and lung, 
to be clinically useful, must be obtainable from other sources. The 
technique described should be applicable with some modifications. It will 
be necessary to decompress the pulmonary circuit with left atrial or 
ventricular vents to prevent damage to the lung or overdistention of the left 
ventricle. 
SUMMARY 
Functional renal homografts have been obtained as long as 14 hours 
post mortem by a technique of extracorporeal cadaver perfusion. The 
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Fig. 9.- Photomicrograph of liver from the second clinical hepatic transplant, obtained at autopsy 22 days after transplantation. Note preservation 
of hepatic architecture. Moderate periportal fibrosis and bile stasis are present (x32). 
method has also given satisfactory liver homografts after perfusion up to 
2 hours. Details of the technique and experimental and clinical applications 
are described. Analysis of the data indicates that optimal perfusion times 
for renal homografts should not exceed 6 hours. For the liver, 2 hours 
appears to be the maximum tolerable period of perfusion. 
For clinical application, certain adjuvant measures are important. 
Perfusion failure has been encountered in human cadavers, presumably as 
a result of the presence of a reduced blood volume. This can be prevented 
by acute postmortem expansion of the intravascular volume with compat- 
ible whole blood or plasma. Proper donor selection is as important a factor 
as the method used for preservation. Indirect evidence is cited that 
Premortem tissue injury in protracted terminal disease may be a greater 
deterrent to success than the parenchymal damage which occurs during 
Postmortem perfusion. 
The extension of this technique for the procurement of other organs 
Such as heart and lung is discussed. 
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CLIO CHIRURGICA 
Lawrence Brettschneider, M.D., in 1967, worklng on a preservation 
experiment. 
Brettschneider was a young naval officer detached to the University of Colorado in 1966-8. For 
the first time, he showed that the liver could be perfused continuously ex vivo and orthotopically 
transplanted successfully as long as one or two days later. The perfusate contained whole blood; 
oxygenation was accomplished with a simple membrane oxygenator in a hyperbaric chamber. The 
method was used clinically on several occasions but eventually abandoned because of its 
complexity and potential dangers. These extraordinarily heavy hyperbaric chambers were rnanu- 
factured by the Bethlehem Steel Corporation in Pennsylvania. Brettschneider died in 1978. 
EXPERIMENTAL LIVER TRANSPLANTATION. EXCLUSIVE OF IMMUNOSUPPRESSION 
The use of combined preservation techniques for extended 
storage of orthotopic liver homografts 
Surgery, Gynecology & Obstetrics, 126: 263-74, 1968 
Lawrence Brettschneider, Pierre M. Daloze, Claude Huguet, Kenneth A. Porter, Carl G. Groth, 
Noboru Kashiwagi, David E. Hutchison and Thomas E. Starzl 
During the 12 years since homotransplantation of the whole canine 
liver was first described by Welch, there have been reports of several 
techniques of hepatic homograft preservation in dogs. Goodrich and his 
colleagues showed that livers removed at normal temperatures became 
unsuitable for transplantation within 20 or 30 minutes. The first protective 
device used in our laboratories (15)  and by Moore and his associates was 
hypothermia, induced first by whole bod] cooling of the donor to 30 
degrees C. and then perfusing the excised liver with a chilled electrolyte 
solution. With a fall in the hepatic core temperature to approximately 15 
degrees C., these organs could support the life of recipient dogs if 
revascularired as orthotopic homografts withln 2 hours. After longer 
times, there was a hlgh rate of acute failure due to outflow block of the 
transplants. a hemorrhagic diathesij. and acute liver failure. Almost 
identical conclusions about the efficacy of this simple approach were 
reached by Ono and his co-workers In experiments which did not involve 
homotransplantation. 
Subsequent efforts to extend the acceptable storage time have been 
disappointing. In dogs. Marchioro and his associates reported a method of 
hypothermic cadaveric perfusion Kith the use of an extracorporeal hear-  
lung apparatus into which a heat exchanger uaa  incorporated. Either the 
entire corpse or the lower half of the dog was perfused. Orthotopic 
homotransplantation was performed with livers removed from 2 to 8 hours 
after the sacrifice of the donor\. Eight of the 10 recipients which were 
treated with azathioprine survived operation, but all d ~ e d  uithin I to 5 days 
thereafter. Mikaeloff and Kestens and their associates used a similar 
principle in uhich hypothermlc perfusion In situ uas  Ilrnited to the liver. 
They were able to obtain long tenn recipient survival after homotransplan- 
tation of canme 11\ers retpoved as long as 6 hour5 after death. Their 
technique was an application of a method described several years earlier 
by Kesten5 and McDermott. 
More complex methods have k e n  tned. Brown and h ~ s  colleagues 
have evaluated a combination of freeling to -6 degrees C., immersion into 
a dlmethylsulfoxide or glycerol bath. and dehydration. After 1 to 5 days. 
the organs were viable but severely damaged and apparently incapable of 
supporting life as orthotopic homografts. When Moss and his co-workers 
cooled liver to -20 to -60 degrees C. for 1 to 14 days without dehydration, 
there was almost no function after the homografts were transplanted to the 
pelvis. Furthermore, all of the recipients died in 6 hours or less. 
Recently, there have been 2 repons of conservation of hepatic 
homografts for 8 to 21  hours, acombination of perfusion, hypothermia, and 
hyperbaric oxygenation being used. Slapak and hi5 associates placed 
puppy livers presemed in this way in the neck of adult recipients and found 
that bile was produced In 8 of 19 experiments. Thelr perfusing fluid didnot 
contain red blood cells. In a preliminary report from our laboratory (3). 
chron~c survival was described of adult canine recipients that received 
orthotopic hepatic homografts which had been preserved for almost a day 
after sacnfice of the donor. In these experiments. the perfusate contained 
dlluted blood. A\ will be documented. further experience has shown that 
a significant rate of survival can be attained with such conserved organs if 
attention is paid to several important details. 
METHODS 
Organs were obtained from nonrelated mongrel donors and trans- 
planted as orthotopic hon~ografts b j  a modification of prev~ously de- 
scribed technique, (Fig. 1 ). Ane\thec~n was nith pentobarbital sodium. 
supplemented w ~ t h  phencyclidine hydrochloride. The recipients were 12 
to 23 kilograms in weight. 
Each of the donor dogs, which here  of approximatrlq matching size, 
was cooled to 30 to 3 1  degrees C. In an Ice bath and sacrificed for removal 
of the liver. Just before and during donor hepatectomj. the liver wa, further 
cooled by an mtraportnl infusion with a balanced electrolbte \elution. 
uhich had been buffered to pH 7.15 and chilled to 7 degrees C. The 
constituents included 7.5  grams per hundred m ~ l l ~ l ~ t e r \  low molecular 
weight dextran. 150 milligrams per hundred rnill~liter\ glucose. 7 mil- 
liequi\alents per liter magnesium sulfate. and 50 m~l l ig ra rn~  per liter 
procaine. A total of 1,000 to 2.000 milliliter\ u a s  used. 
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Fig. 1.- Technique of orthotopic llver transplantation. The arterial supply is derived from the proximal part of the common hepatic anery by an end- 
to-end anastomosis to the proximal part of the recipient hepatic artery. The distal portlon of the recipient artery and its inferiorly directed branches are left 
undisturbed. Failure to do so may result in duodenal necrosis. 
Homografts for control experiments were transplanted as quickly as 
?o\s~ble. revascularization in the recipient usuallq being completed u ~ t h l n  
hour. Organs uhich were to be preserved for longer perrods had 
canu la i  tied Into the aorta and portal \eln ( F I ~ .  2  Inset). The homografts 
"ere rnzerted into a hjperbanc c h a m k r  uhich mas refriserated at 1 
degree5 C. Other a,pects of  the preservation trchnlque *hlch ~ncluded 
perfuilon and control ofoxlgen prebsure uere  ~ a r l e d  a\ u111 be defined in 
the different experimental groups. 
Dur~ng the subsequent trvnaplantat~on. all dog\ here  gl\en whole 
and 5 per cent gluco\e In lactated Rinfer ' i  iolutlon. In 
at least 500 milliliter\ of each uere  used, but more u a \  flven 
"hen needed. In addltinn. [he recip~ent, of pre \ened l ~ \ s r \  recelbed 100 
mlll12rami per h ~ l o ~ r a m  ep \~ lon  am~noiaproic acid. I mliilgrarn per 
kllofram protarnlne hulfate. and 20 rnillicqu~\alents \od~urn bicarbonate at 
lhe time of homograft re\a~cularrration. R e ~ a t  dose\ of these drugs *ere 
\er! often ilece\\ar! 
For all recipient dog\.  ~rnmuno\uppre\\ion w a\ pro\ ~ d e d  u ith intrd- 
mu>culal> adrnln~\tered antll)mphoc\ te globulln and orall) a d n ~ ~ n ~ s t z r e d  
arathlopnne and prcdn~\one. The antil)rnphoc!te globulin \ \a \  u\uall> 
aeberal dab\ in <id\ance of  operat~on and cont~nued all! for se\eral 
after. Ara th iop r~n~  therap! u a s  txgun at the trme oftran\plantatlon 
and giken ~ndefinitel!, In the maxlmuni doses per day uhich did not cause 
leukopenia. A 1 ueek course of predn~sone u a s  admrniztered In progres- 
s i~el !  diminiih~ng da~l! dosei u h ~ c h  were started at 3 mill~grams per 
h~losrarn on the da) of operation. 
Poatoperati\e l ~ \ e r  functron uas  rnon~tored with frequent measures 
of serum bllln~hrn. serum alhal~ne phosphataae, tclial protein, serum 
e lu tdn~~c  oxalacet~c tranhaminase. and ierum glutarn~c p!ru\ ic transami- 
naie. In [he ?Lent of death. autopales u r r e  performed u ~ t h  particular 
attentlor1 k ~ n g  i\sri to the ,tdts of the baacuiar ana\tornoae\. Homograft 
tis\ue \ \ a \  fixed In I0 per cent iornialin for ebentual stud! with light 
n?icroicop) 
Gr-i~iip I .  1 i ~ r i ~ r o / .  Thi\ group con \~ \ t ed  o i  12 doga ha\ lny homotrans- 
plantatron v ~ t h o u t  e\rsrrdrd prehendtlon. 
Gt.i~iip -7 /!\ j~t>i bur11 O.XI i.t2ridiiori riric~pc~~irsinti  M if/! ~Ii l r i~ed blood. 
T \ r en t ) - \~ \  hornopr;ift, nere  placed In the hkperbaric chamber and con- 
t inuou\ l  periu\ed uirh tresh homologous blood n ~ ~ \ s d  uith an equal 
\olunie o f a  \olut~on  den tical to [hat ernplo!ed for ~ n f u \ ~ o n .  except that it 
contained 100 n i~ l i i~ ra rns  per i~ t e r  hepdr~rl and 5 in\tead of 2.5 grams per 
hundred rn~llillter\ lou rnolecularne~ght dextrnn Durlng pre\enation. the 
pH of the petiu\,ite n a \  frequentl! rne,i\urzd. If t h ~ \  fell k l o u  7.2. it was 
corrected u ~ t h  <odium brcarbnate .4 \irnple baffle runoff irorn the organ 
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TABLE I.--RESULTS OF LIVER TESTS O N  THE FIRST DAY AFTER TRANSPLLVTATION COMPARED TO THOSE 
I N  40 YORMAL DONORS 
Group .Yo. Prrsrrz~atrnn f im r ,  
D.,non 40 - 
1 15 $$- 115 
2 A 7 10-14% 
2B 5 8- ?4i 
2R 5 11%-154, 
2 C 5 8- 0 %  
2c 3 2431-25f$ 
- 
hfcan \diics and itandarr! rlci-iatlon ezucn. 
Srrum ~ l d l a r n i r  oxa lan-  S r u m  i.lulamrc pyunc 
hrs tic t ranranrnarr  f r o r u a n ~ n n w  
26 i 48 29 f 74 
191 i 162 524 * 36' 
634 i 432 9-5 444 
353 f 220 174 i 141 
940 X 981 178R i: 1330 
291 f 208 568 i: 754 
367 f 29 472 rf: 158 
Bdirubin 
0.2 * 02 
0.7 k 1.1 
0.5 * 0 3  
1.2 f 1.7 
0.8 rt 0.6 
0.7 f 0.4 
0.5 i 0.3 
served as an oxygenator for the recirculated tluid (Fig. 2) which passed 
through a glass-wool filter and a bubble trap. Two occlusive roller pumps 
were used outside of the chamber. The oxygen compression of 40 pounds 
per square inch gauge pressure was reached within 20 minutes after 
inserting the organs. Variou{ iubgroup\ of experiments differed in the fol- 
lowing important details: 
A. low flow, r a p ~ d  ecompression. S e v e n  of the homografts were 
preserved for 10 to 14.112 hours. The portal venous and hepatic arterial 
flows were low. approximatel) 2.4 milliliters and .6 milliliter per gram per 
hour, respectively. Before removal of the honiografts from the chamber. 
hyperbaric decornpreision was carried out for an interval of 25 to 35 
minutes. 
B, low flow. slow decompression.-The perfusion rate was the same 
as that used in A but the decompression time for the chamber was slower, 
having been extended to 3 to 4 hours. Five honiografts were stored for 8 to 
9-112 hours, and 5 more for a period of 11-112 to 15-112 hours. 
C ,  higher flow, slow decompression. - The flow rate to the 2 
inflowlng vessels was doubled, approximately to 4.8 and 1.2 milliliters per 
gram liver per hour for the portal vein and hepatic artery, respectively. Five 
homografts were transplanted after prelervation for 8 to 9- 112 hours. Five 
more were preserved for 24-314 to 25-116 hours. 
Group 3, o.t?gcnurron ut uin~o.\phcric prc.c.slrrr find perj'usiorr with 
dilutrd hlood. Three homografts were preserved for 20- I14 to 25- I14 hours 
under the same conditions as in group 2C, except that 100 per cent oxygen 
was used at atmospheric pressure. 
Group 4, /i~pc,rhur-ii. oivgrnutiorr und perfirsion ~ , i t h  nonc~ellulur 
fluid The condit~ons were the same as In group 2C, except that blood was 
not added to the perfusate. Storage for the 5 homografts ranged from 21- 
114 to 24-112 hours. 
Group 5 ,  hvl,c~rhurrr. o\~gc,natron. Three homografts were preserved 
for 22.112 to 25 hours under the same conditions as in groups 2B and 2C, 
except that continuous perfu~lon was not prov~ded. In 2 Instances, the 
cooled grafts were immersed in a basin of noncellular perfusion fluid 
within the refrigerated chamber. In the other, perfusion was carried out 
with the same solution for 30 minutes at 6 milliliters per gram tissue per 
hour to ensure core cooling. The pumps were then turned off. The organ 
was not immersed in fluid. 
RESULTS 
Group I .  Two of the control dogs died of hepatic artery occlusion 
after 4 and 7 days. and 2 died of rejection in 7 and 8 days. The 8 remain- 
ing controls lived for 3 weeks or more. 6 surviving for at least 6 weeks. 
Using a maximum credit of 70 days for any individual dog, the mean 
survival time for the group was 38.7 k 29.8 days. S.D. These results 
indicated that the immunosuppress~on bemg used was effective. 
There was evidence of moderate ihchemic injurq as judged by liver 
function tests obtamed in the recipient 18 to 24 hours pomperatively 
(Table I),  but these changes Here highly rcversible. There were no unusual 
problems w ~ t h  operative hemorrhage. On the dab of transplantation, the 
dogs received 400 to 500 millll~ters of blood as well as 500 to 1,000 
milliliters electrolyte solution. 
At autopsy. the li\er homografts were similar to those from previ- 
ously reported series ( 16). In the hepatic hornografts from the 4 dogs that 
died at 7 to 21 days after rejection. there was dense infiltration by large 
lymphoid cells and plasma cells around the portal and central keins. There 
was also necrosis of the majoritj of the hepatocqtes in the central and 
middle ronei  of the l~ve r  lobule together with collapse and condensation 
of the reticulin framework of the central parts of the lobules. The hepatic 
homografts from 2 of those that survived longer were normal. In the other 
2 grafts. there were bands of condensed reticulin linking adjacent central 
veins, slight lymphoid cell infiltration in the central and portal areas, and 
plugs of bile pigment in the centrilobular bile canaliculi. 
Group 2. In the subgoup A, large numbers of gas bubbles appeared 
in the perfusion lmes during rapid decompression. Most of the homografts 
had a spongy consistency due to similar gas emboli withm the parenchyma, 
an observation which was confirmed roentgenograph~cally. The organs 
generally gained weight, the average increase durmg residence in the 
chamber being 16.6 per cent. 
After revasculariration, the livers did not develop outflow block or 
regional infarcts, and after 30 to 60 minutes, they appeared to be perfused 
relatively homogeneously. At, or just before, this time, a hemorrhagic 
diathesis was evident to some degree in every dog despite prior therapy 
with eps~lon amino-caproic acid and protamine sulfate. On the day of 
operation, at least 1,000 milliliters of blood and 2,000 to 3,000 milliliters 
of electrolyte solution were required. When insufficient quantities of the 
latter fluids were not provided, there was a drastic hemoconcentration with 
hematocrits as high as 76 per cent. 
Six of the 7 dogs survived operation; the seventh died within a few 
hours for reasons not apparent at autopsy. The remaining dogs lived for 2, 
3 .5 , s .  7 and 9 days, but their courses were not satisfactory. They were slow 
to recover from anesthesia, in some instances requiring several days to 
awaken fully. Two had generalifed convulsions within minutes after 
homograft revascularizat~on, a complication which was suspected to be 
caused by air emboli originating from the grafts. None were ever able to 
eat. In several dogs ascites and anasarca rapidly developed. Four of the 6 
dogs which survived operation eventually had perforations of the duode- 
num, esophagus, or gallbladder. 
On the day after homotransplantation, there was biochemical evi- 
dence of severe ischemic injury (Table I) which could be detected in the 
results of all the enzyme determinations. Subsequently, these values 
tended to return toward normal. An elevation in bilirubin to more than 1 
milligram per hundred milliliters was seen in only 1 dog during the first 3 
postperative days. However. there was severe and persistent depression of 
serum proteins to as low a 3.5 grams per hundred milliliters. 
Histologic examination of the homografts showed evidence of rejec- 
tion in those dogs that survived for 5 days or more, but there were no other 
unusual lesions. There was ischemic necrosis of the centrilobular hepato- 
cytes in the homograft from the dog that died 3 days after transplantation. 
Another honiogmft. examined 2 days after grafting, appeared normal. 
Ir. subgroup B. those with low flow and slow decompression, the 
gross evidenceof gas emboli was greatly reduced. The weight of theorgans 
was stable during pre,ervatlon, the average change being -0.6 per cent. 
Serious outflow block after transplantation was not observed. 
The difficulties of supportive care for these dogs was less than those 
of group 2A, as reflected by a somewhat reduced requirement for blood and 
electrolyte solution on the day of operation. Arousal from anesthesia was 
more prompt. 
Four of the 5 recipients of homografts which had been preserved for 
8 to 9-112 hours sunrived operation, but 3 of these died after 4. I 1 .  and 14 
days. One dog IS still alike after more than 4 months. With preservation for 
11-112 to 15-112 hours, the results were similar. All 5 dogs lived through 
the operation, but 4 died later after 5 .6 .6 ,  and 13 days. The other is still in 
good health after 5-112 months (Fig. 3). 
The reason for the pauclty of chronic survivors in this group was not 
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Fig. 2.- Preservation unit. The perfusion pumps are located outside of the hyperbaric chamber. The organ receptacle, the oxygenator, and the venous 
reservoir are inside. The various chamber inlets permit sampling of the perfusate, gas sterilization, and oxygen delivery and removal. The temperature is 
electronically controlled. 
initially clear. There was biochemical evidence of acute ischemic injury, 
pmicularly in the organs which had been preserved for 11-112 to 15-112 
hours (Tahle I). However. the postoperatibe changes after storage of 8 to 
9-112 hours were not significantly different than in the controls of group 1 
(Table I) and these returned toward n o m ~ a l  with approximatel) equal 
rapidity. The rapid resolution ofthe eniyme change? did not impl) a com- 
parably fast restoration of total liver function. There was a severe depres- 
,Ion of total serum proteins which had not returned to norlnal b) the fifth 
poitoperati~e day (Fip. 4). 
Onl) 2 of the 8 honiografts from experiments in which the recipients 
died in 2 ueeks or ]es\ showed evidence of acute rejection. Evidence of 
healing ischemic centrilobular heparocyle injury was present in the other 
6 li\.ers In this group. This was accompanied in 2 instances b) centrilobu- 
lar cholestasis. The degree of ischem~c lnjur) was not detectably different 
 hen preservation was for 8 to 9-11? hour> as compared to I I-112 to 15- 
112 hours. 
In group 2C. thpse M ith higher flow and slow decornpre\sion. the 
homografts pre iened for 8 to 9.112 hours lo51 an average of 4 .2  per cent 
of their weight during residence In the chamber. anti seemed gro\'d) to be 
Iexcel lent  condition. After subsequent revasculariiation. none de\el- 
Oped outflou block. The 5 dogs which received these li\ers i u r ~ l v e d  
Operation. The) required an a\eraye of 700 1nillliiter5 of blood and 1.500 
nlllllliters of e l ~ c t r o i ~ t e  solution on the day of transplantation. k o u a a l  
from anesthesia u a s  prompt. 
Two dogs died after 9 and 19 days from rejection and multple liver 
abscesses, respectively. The other 3 llved for 34, 46. and 97 days. With a 
maximum credit for indib idual dogs o f70  days. the mean iunival  was 35.6 
+ 23.9 days S. D. 
The degree of 15chemic ~ n j u n  w'hich  as detectable with liver 
function studies on the first postoperatlvs morning wa\ comparable to that 
in the control experiments (Table 11. Moreo~er .  the depre~rion in serum 
protein was not so great a\ In dogs of group\ 2.4 or 2B. and lt had retumed 
to nomial ~ i t h l n  5 da)s (Fig. 1). 
The homograft\ p r e ~ e n e d  for more than 2 1  hours under the same 
condition\ were les, sati\faitor!. During \torage. the) gamed an average 
of 3.3 per cent tveight, After transplantation. the? appeared to be well 
perfused, but an uncontrollable hemorrhagic diathe\lr developed in 2 of 
the rec~pients. In the other 3. 1 1 ~ e r  funct~on test\ on the next morning were 
more abnormal than had been the case i ~ i t h  the jhoner interval. Neverthe- 
Is\<. only 1 of theit  3 dog5 dled earl!. after X dais: another died after 46 
daqs  The third doy 15 still dIi\e dfter 1 rnonrh, (Fig. 51. 
Pathologic \tudies of the 11\er\ prear.n ed for the \honer time showed 
that 3 \bere undergoing rejection aftsr 9 and 34 daka. In both. dense 
infiltrat~ons of i!mphold csll\ a e r s  prr\rnt around the central and portal 
~ e i n c  and thsre m a ,  marked nscroil, of the central and midzonal hepato- 
c!te,. T h o  other hepatic hon?ogrcift\. from dog\ u hich bun ~ ~ e d  19 and 46 
&)a, respectl\el!. hosed \ o n e  realdual centrllobulx xarrlng with 
atrophq of the hepatocltes ~rnmediatei! adjacent to central veins and 
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Fig. 3.- The first 100 postoperative days of a dog which received an orthotopic liver homograft after preservation for 14-112 hours. The total liver 
perfusion was only 3 millimeters per gram tissue per hour, a rate thought to be inadequate. Note the early evidence of reversible ischemic injury. The later 
rise in serum glutamic pyruvic transaminase was probably due to low grade rejection. The dog is still alive after 5-112 months. This dog, as well as all others 
in the study, was treated with azathioprine, a short postoperative course of prednisone, and antilymphocyte globulin. 
increased numbers of reticulin fibers around the vein walls. Centrilobular 
cholestasis was also a feature of both 11vers. The 2 livers which were 
preserved for more than 1 day and recovered within a few hours after 
revascularization showed necrosis of the centrizonal hepatocytes but no 
other injury. The other, which was studied 8 days later, showed extenslve 
necrosis, only tho\e hepatocytes adjacent to the portal tract? surviving. 
There was no evidence of rejection. 
Group 3. The oxygen pressure ofthe perfusate was maintained at 250 
millimeters of mercury or more. The weight gain of the 3 homografts 
averaged 27.1 per cent during preservation. The l~vers  had a patchy 
discoloration. All 3 gallbladders had grossly necrotic foci in the mucosa, 
and in 2 of these extemive intramural hematomas doeloped during the 
extracorporeal perfuslon. After transplantation. severe outflow block was 
immediately evident w ~ t h  consequent extreme portal hlpertension. The 3 
recipients of these badly injured organs all died within 6 to 28 hours of 
acute hepatic failure and intra-abdominal hemorrhage. 
Histologic exammation of the 3 livers showed widespread necrosis 
of hepatocytes, onl) a few surkiving immediately beneath the capsule. 
Group 4. The honiografts w h ~ c h  lost an average of 1.9 per cent 
weight appeared grossly to be well preserved. There were no mucosal 
defects it? the gallbladder. After traniplantation, none of the livers devel- 
oped outflow block. kevertheless. 4 recipients of these organ5 died of acute 
liver failure and intra-abdominal hemorrhage within a few hours after 
operation. The fifth, which rece~ved a homograft that had been stored for 
21-114 hours, had a serum glutamic pyruv~c transamlnase of 1,600 on the 
first postoperative day but liked for 9 more day\ with poor liver function 
throughout this particular per~od.  
Onl) I of the homografts from the dog\ w h ~ c h  died early showed 
extenslve necrosis of hepatocltes. In the other 3 li \er\ .  the hepatocytes in 
the central zones of the lobule\ were dead. but the other\ looked viable. 
There were no other changes. The hornograft studied after 10 days showed 
evidence of rejection. The portal and central area5 of the lobules were 
densely Infiltrated by mononuclear cells. many of whlch possessed pyron- 
inoph~lic cjtoplasm. There was also hemorrhagic necrosls of the central 
and midzonal hepatocytes. 
Group 5.  The average weight loss of the homograft was 4 per cent. 
Slough of the gallbladder mucosa was severe in 1 of the homografts and 
minor in the others. Otherwise, the livers seemed to be in good condition. 
After transplantation, 2 of the recipients died within 12 to I8  hours 
of acute liver fa~lure. The other dog, which had a serum glutamic pymvic 
transamlnase of 2.0()0 on the first postoperative day, never fully awakened 
from anesthesia and d ~ e d  after 3- 112 day \ .  
The ho~nograft\ from dogs which died within 18 hours showed 
widespread necrosis of liver cells afftectlng all parts of the lobules. After 
3.112 days. the other organ showed centrilobular hepatocyte cholestasis. 
There were also bile casts in the larger bile ducts. 
DISCUSSION 
A quantitative biochemical analysis of the response of canine liver 
tissue to ischemia has been published by Sicular and Moore. The ability of 
liver slices to oxidize glucose normally was retained for 30 to 60 mlnutes 
after death under normothermic conditions and for several hours if the 
tissue was refrigerated. These and other studles. such as those by Van Wyk 
and his associates. provided ample proof that the injury which follows 
cessation of hepatlc circulation 1s a graded one which can be considerably 
slowed by the iniportant emergency measure of immediately coollng the 
organ. 
Unfonunatel), the provision of metabolically active hepatic tissue 
does not necessaril) mean that the organ can sustaln I~ fe ,  particularly when 
the recipient an~mal  1s made total11 dependent upon the homogrnft as is 
evident w ~ t h  orthotopic homotraniplantation. This is well illustrated by the 
results reported herein. In some experiments, the qualit) of immediate liver 
functlon was sufficient to allow prompt recovery from anesthes~a with 
subsequent long tern1 \urvival. .4t the other end of the spectrum were dogs 
which died of liver failure within just a few hour\. 
Between these extreme\ were man! examples of dogs with more or 
less grave acute hepat~c ~nsuffic~ency. The operative and postoperative 
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Fig. 4.- The effect of both preservation time and perfusion rate 
upon circulating plasma proteins. There is profound and sustained hypo- 
proteinemia in the dogs which received grafts that had been preserved 
with Ion flow perfusion as compared with the results using a higher flow 
rate. 
care of these dogs was difficult. A severe bleeding diathesis was invariable, 
which usually required multiple blood transfusions. extraordinary me- 
chanical efforts at hemostasis, and the administration of clot-promoting 
agents, such as epsilon aminocaproic acid and protamlne sulfate. The 
clotting defect, which has been shown by von Kaulla and his associates to 
be partly due to increased levels of circulatory fibrinolysins, is a complex 
one which is currently under study. 
In such instances, control of bleeding was only the first step. 
Intensive therapy was required with electrolyte solutions or plasma, 
apparently because of the rapid formation of a third fluid space particularly 
within the abdomen but also in peripheral tissues. Detoxification of the 
barbiturate anesthesia was slow. The rapid fall of serum protein levels was 
an ominous sign. There was a high incidence of acute gastrointestinal 
ulcerations. With intensive care. these dogs could often be kept alive for 
several days. but they would not eat. Almost all died in less than 10 days. 
Although the homografts which were examined at autopsy often had 
evidence of early rejection in splte of immunosuppressive therapy, the 
predominant histologic changes uere  those of heallng ischemic damage. 
In this study. a number of modifications of preservation technique 
were tried, the condition of hypothemia being identical in each instance. 
The most succes<ful method wjas w ~ t h  an adaptation of the system de- 
scribed for kidneys by Ackermann and Bamard. using a combination of 
hypothermia, hyperbaric oxqgenatlon, and divided perfusion with diluted 
blood through the portal veln and hepatic artery at a total flow rate of 6 
milliliters per gram of liver per hour. Both immediately and later, ho- 
mografts which were stored under these conditions for 8 hours performed 
approximately as well as livers transplanted w~thout  delay. When attempts 
were made to extend the preservation time to 24 hours. only 3 of 5 
recipients sun3ived operation. although 2 of these lived for at least 6-112 
postoperative weeks. 
Systemat~c variation from the protocol already mentioned were 
evaluated to determine which details of technique were important and 
which were nonessential. Every dev~ation tried led to a deterioration of the 
results. Thus, a reduction in the rate of perfus~on by half resulted in a 
demonstrably greater ihchemic injury during \torage for 8 hours. By using 
preservation for 24 hours as the test system. life-sustaining homografts 
could not k obtained if either hyperbaric oxygenation or perfusion, or 
even the blood fract~on of the perfusate, were eliminated. 
Beneficial effects of cold and perfusion for the preservation of organs 
are neither surprising nor difficult to explain. The reason for the apparently 
important role played by hyperbaric oxygenation 1s less clear. It is 
conceivable that the principal value of hyperbaria in these studies was that 
it increased the efficiency of the simple oxygenator which was kept within 
the compression chamber. Less I~kely 1s the possibility that oxygen 
diffus~on through the surface of the organs was a significant factor, since 
this is thought to occur only to a depth of a few millimeters. 
Manax and his ajsociates have suggested other intriguing hypothe- 
ses. They have drawn attention to the metabolic inhibition which accom- 
panie, high atmospheric pressure, a desirable effect which has been 
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Fig, 5,- ne course of a dog which received an orthotopic liver homograft which had been preserved for 24-314 hours. The perfusion rate was twice 
that used for the experiment shown in ~i~~~~ 3, ~h~~~ is relatively minor biochemical evidence of early ischemic injury. The dog 1s still alive after4 months. 
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EXPERIMENTAL LIVER TRANSPLANTATION. EXCLUSIVE OF IMMUNOSUPPRESSION 
demonstrated by Lyons and his colleagues to occur with nltrogen as well 
as with oxygen. Finally, mechanical influences, such as compression of the 
vascular system, maybe helpful by preventing the formation of edema. It 
is of interest in our experiments that substantial weight gain of the 
preserved organs occurred only when hyperbaric oxygenation was omitted 
and that it was only in these homografts that outflow block u a s  consistently 
observed. 
The demonstration that livers can be kept in good condition for at 
least 8 and often for 24 hours after the death of the donor may have 
important clinical implications. It should be possible with this amount of 
time to prepare a pattent to receive a homograft without the sense of 
urgency which has characterized past efforts at human liver transplanta- 
tion. Preliminary analysis of donor and recipient histocompatibility anti- 
gens could be carried out in the interval. 
However. other factors may diminish these hopes. In the laboratory, 
the timing of donor arid recipient procedures can be precisely co-ordinated. 
The homograft which is taken from a cooled donor has a blood supply until 
virtually the moment of its excision. These ideal conditions are not 
attainable with cadaveric donors. since failing organ perfusion has invari- 
ably been present for sometime before death and because the liver must 
usually be in a normothermic postmortem state for some minutes before 
cooling can be instituted. At present, the extent to which the acceptable 
margin of ischemia has been dissipated before protective measures can be 
started appears to pose a more serious problem than that of efficient 
subsequent preservation. 
SUMMARY 
Orthotopic liver transplantation was performed with homografts that 
had been preserved for 8 to 25 hours after their removal from nonrelated 
mongrel donors. The fate of the recipients was compared to that of control 
dogs which received homografts transferred as rapidly as possible from 
cooled living donors. All dogs were treated postoperatively with immuno- 
suppressive agents. 
Homografts could be effectively preserved for 8 hours and often for 
as long as 24 hours with a combination of hypothennia at 4 degrees C., 
hyperbaric ox)genation at 3-112 to 4 atmospheres, and divided perfusion 
with diluted homologous blood through the portal vein and hepatic artery 
at a total rate of 6 milliliters per gram tissue per hour. At the end of the con- 
servation period, the chamber was decompressed during 3 to 4 hours. The 
short term and long term course of 5 recipients of livers preserved for 8 
hours was not different from that of control dog,. All dogs survived 
operation, and only I dog died in less than 19 days. Three of 5 recipients 
of livers preserved for 24 hours survived operation and 1 of these is still 
alive after a period of 4 months. 
Deviations from this technique were evaluated with additional 
groups of 3 to 5 experiments in which livers were stored for 24 hours. 
Omission of perfusion or reduction of its rate by half. elimination of 
hyperbaric oxygenation, rapid chamber decompression. or failure to add 
homologous blood to the perfusate all resulted in less satisfactory results. 
The recipients of these homografts either died during operation or within 
a few hours or days thereafter. They usually had grave clotting abnormali- 
ties. evidence from serum enzyme measurements of $evere hepatocellular 
injury, retardat~on of protein s:nthesi\, and a high incidence of gastroin- 
testinal ulceration. The impression that these liver5 had suffered from is- 
chemic necrosis was confirmed by histologic studies. 
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Dr. William J. Wall at the time of his Joseph Benlchou was photographed at the alrport on 
tenure wlth Calne at Cambridge, England. the way back from Denver to France in 1977. 
LYaIl is now Chief of the Llver Transplantation 
Unit at the University of Western Ontario, 
London, Ontario. Canada. 
In his studies, Benichou showed that the liver could tolerate much more cold ischemia induced 
with lactated Ringer's solution than previously realized and that a further increment in safe storage 
time could be obtained with Collin's or plasma-like solutions. Wall showed the same thing with the 
plasma-like solution brought to Cambridge from Holland where it had been developed by Schalm. 
These two articles marked the beginning of organ shipment from distant cities. Previously, the donor 
usually was brought to the recipient hospital, and the liver was prepared in an adjacent operating 
room 
Presently, Benichou is working at the University of Kremlin-Bicetre, Paris, France, and Wall is 
Chief of Liver Transplantation at the University of Western Ontario, London, Ontario, Canada. 
EXPERIMENTAL LIVER TRANSPLANTATION, EXCLUSIVE O F  IMMUNOSUPPRESSION 
Canine and human liver preservation for 6 to 18 hr 
by cold infusion 
Transplantation, 24: 407-1 1, 1977 
Joseph Benichou, Charles G. Halgrimson, Richard Weil, 111, Lawrence J. Koep and Thomas E. Starzl 
SUMMARY 
Forty-one dog livers were presemed with cold, lactated Ringer's, 
plasma, or intracellular (Collins) solutions. Consistent survival was ob- 
tained with all three solution.r,for 9 hr. After 18 hr. the pla~niu and Collins 
solutions pernlirted sur~,ivul,  n'ith thr Collins ~olurion hating a slight 
overall ad~~untage.  The, methorl u ~ i n g  Collins .rollition has been used to 
preserve seven h~tman li1,er.r in Lox Angeles. to rran.rporr the organs to 
Denvc~r, und to tr-ansport then1 as orrhoto~~ic  ,qraftsfr.on~ 6 hr. 45 min to 10 
hr later. 
It has been well known for a decade that the preservation of whole 
animal and human livers ir poss~ble for many hr. as proved by subsequent 
life-sustaining function of the hepatic grafts in recipients (1-4, 7, 8, 10). 
The preservation methods can be div~ded into the more complicated ones 
involving continuoui or intermittent perfusion (1-4). and those using 
simple intravascular ~nfusion of cold solutions (7, 8, 1 I .  13) followed by 
cold storage. 
In this investigation. infu\ion \olut~on.; ha\e  been compared in cold 
storage experiments to deternl~ne the extent, if any. that the infusion fluid 
compo\ition affects the outcome. The rcsults have been used to design a 
successful clinical trial of liver graft preservation and transport over long 
distances. 
MATERIALS AND METHODS 
Canirrc, .strcthes. With preservation tlmes of 9 to 18 hr, three solution 
types were compared. After rernoval. the livers were washed free of blood 
w ~ t h  500 to 800 ml of lactated Ringers' \olutlon at 3 C. The fluid was 
delivered through the portal keln at I(K) cm H?O pre\\ure. This was 
followed wllh 400 to 600 rnl ot the test >olutlon at 3 C. After placing it in 
a plastic bag, the organ had riic~re teht solution poured over ~ t .  The plastic 
bag wa\ kept colt1 b> packing it in  ice. a\  i,  \tandard practlce with kidney 
preservation ( 5 ,  6) .  
There were 41 experiments that here  di\ ided Into 7 groups depend- 
ing upon the solution\ used and the trnie ofpre\er~at lon (Table I). As the 
graft vessels were b e ~ n g  ana\toiiiosed to the reciplerlt muctures. the 
preservation fluid was washed out with a slow final infusion of cold, 
lactated Ringer's solution. The transplantation technique was the one 
originally described in our laboratories (1  I), as slightly modified later (10). 
No immunosuppression was given postoperatively. 
Human studies. The seven livers were removed in six different Los 
Angeles hospitals under conditions of heart-beating brain death. Preserva- 
tion was with Collins qolution, uring the same technique as described in 
dogs but with ad.justrnents of infusing volume according to the size of the 
organ. The donors were 10 months to 33 years old. These livers were 
TABLE 1 .  C a n i n e  e x p e r i m e n t a l  g r o u p s  
Group 
A 
B, 
C l  
Dl  
B2 
c2 
D2 
Pres- 
No. erva- 
of tion 
dogs time 
(hrl 
Infusion fluid 
L a c t a t e d  R inge r ' s  
Co l l i n s  I" 
P l a s m a  so lu t ion  IIb 
L a c t a t e d  Ringer ' s  
Co l l i n s  
P l a s m a  so lu t ion  
L a c t a t e d  R inge r ' s  
" C o m m e r c i a l l y  a v a i l a b l e  solut ion (code 5A 7810) 
w h i c h .  after t h e  r ecommended  add i t i ves .  c o n t a i n s  
fo r  1 l i t e r :  p o t a s s i u m ,  115 m E q ;  su l f a t e ,  6 0  m E q ;  
m a g n e s i u m ,  6 0  m E q ;  chlor ide ,  15 m E q ;  sod ium,  1 0  
m E q ;  b i ca rcona te ,  1 0  m E q ;  a n d  phospha te ,  100 m E q .  
S h a l m ' s  so lu t ion  (8) as modified by  C a l n e  e t  a l .  
( 4 )  con ta ins :  d o g  p l a s m a ,  1 l i t e r ;  h e p a r i n ,  2,000 IU; 
hydrocor t i sone ,  250 m g ;  ampic i l l i n ,  500 mg; dex-  
t ro se ,  250 m g ;  m a g n e s i u m  su l f a t e ,  5 m l  of a 10% 
so lu t ion ;  a n d  p o t a s s i u m  phospha te ,  15 m E q .  
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TABLE 2. Data of the 7 human liver transplantations with  reservation ~ r o ~ ~ d u r e  
Age of 
OT no. 
Donor Recipient 
Recipient diagnosis 
OT113 22 months 
OT116 4years 
OT 118 43 years 
OT 125 10 months 
OT 126 7 years 
OT 127 3'12 years 
OT 128 17 months 
3 years 
7 years 
24 years 
10 months 
11 years 
5'12 years 
3l12 years 
Biliary atresia 
Neonatal hepatitis 
a,-antitrypsin deficiency 
Biliary atresia 
Biliary atresia 
a,-antitrypsin deficiency 
Biliary atresia 
initially flushed with 500 to 1.300 ml of lactated Ringer's solution and 
subsequently with 400 to 800 ml of Collins solution (Table 2). The final 
flushing of the organ with lactated Ringer's solution during implantation 
was the same as that with the dog. Transplantation was by previously 
reported techniques (10- 12). 
RESULTS 
Aninial Studies 
There was minimal acute ischemic damage of the grafts in control 
animals tP,at had immediate transplantation of cooled livers (Fig. I ). Rejec- 
tion supervened within a few days. Five of the control an~mals  lived for at 
least 7 days. 
Y lir. With preservation for 9 hr. the survival and khav io r  of the 
animalc were similar to those of the controls. Furthermore, there mere no 
differences by the criteria of postoperative behavior and mortality with 
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Fig. 1 .- The effect of preienation for 9 hr upon orthotopic liver 
graft$ in dogs. In the control experiments, tmnspla~tatlon was carried out 
immediately after flushing ith cold, lactated Ringer's soltitlon and after 
presenation for I tir or less. ~ ~ t h o u s h  imnlunosuppress~on was not used. 
One animdl in group C1 (arrow) I\ st111 al~vc. after 80 days. 
SURVIVAL :! 
(DAYS1 8 ,  
6 - 
. i  
2, 
Total ischemia 
I - 
6 hr, 45 rnin 
7 hr, 30 rnin 
8 hr, 52 rnin 
6 hr, 34 rnin 
7 hr, 20 rnin 
9 hr, 30 rnin 
10 hr 
,1 C3N-23, 11. 11 11111 11 C3-- 'u 5 PLASMA LACTATE 
SO-uTGU RINGERS 
Soluuon 
amount. 
id) 
Lac- 
tated Cd- 
Rmgeis 
500 4 0 0  
600 500 
1300 do0 
600 400 
loo0 650 
loo0 6uO 
loo0 500 
lactated Ringer's, Collins. or plasma solutions. Nevertheless, biochemical 
evidence of ischemic damage was less with Collin\ solution than with 
lactated Ringer's or plasma solutions (Fig. I ) .  
One animal survived with no immunosuppres~~on and is alive 3 
months later. 
18 hr. Recipients of three livers preserved a ~ t h  lactated Ringer's 
solution died within 1 day. With plasma and Collins \olut~on. about one- 
half of the recipients sun  i\ed the imrned~nte postoperatl\e period, in spite 
of the fact that moderate to ?evere ischemic injur) was always present (Fig. 
2). In terms of both survival and liver function. there ieerned to be a slight 
advantage with Collins solution compared with the plasma (Fig. 2). 
Hlrniun Stud~es 
Six of the seven cadaveric livers functioricd well after 6 hr. 45 rnin to 
10 hr of preservation. with prorript relief ofjauridice and generation of good 
clotting factors. The serum glutam~c-oxaloacet~c transarninase always 
rose (Fig. 3), but the increase was to above 1,000 In only t a o  of the six 
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Fig. 2.- The effect of preservation for I8  hr upon orthotopic liver 
grafts in dogs. The experimental and control conditions were the same as  
for Figure 1. 
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Fig. 3.- The course of a 7-year-old child who received a liver that 
was removed in Los Angeles. preserved for 7.112 hr, flown 1,000 miles to 
Denver by a commercial airliner. and transplanted. Initial function was 
excellent. A biopsy taken 2-112 weeks later, when homograft function 
deteriorated, was interpreted as hepatitis. The recipient is well 6 months 
postoperatively. 
patients, and in these recipients there was a return to normal within 3 to 10 
days. Five of these six patients are still alive from 3 weeks to 8 months post- 
transplant. The patient who died had normal llver fnnction but developed 
lethal cardiopulmonary complications. 
The seventh patient was 30 )ear\ old. At operation, the liver could not 
be completely revascularized because of thrombosis of the recipient's 
portal vein. The graft functioned poorly, and there was an increase of serum 
glutamic-oxaloacetic transaminase to more than 3,000 IU (normal 4 0 ) .  
Eleven days later, another donor became available. Retransplanta- 
tion was performed but the second hornograft that was transplanted with 
the usual cooling (10.1 1). w~thout prolonged preservation, behaved the 
same as the first and the patient died 2 days later. The histopathological 
changes were much the same in the first and second organs, including wide 
spread ischemic changes. 
DISCUSSION 
The intravascular infusion of cold electrolyte solut~on was the first 
effective technique of liver preservation (1 1 j. and it was not surprising that 
the same general method immediately became the standard for the quick 
cooling of kidney (91 and other organs. 
However. in the earl) experience w ~ t h  canine liver transplantation. it 
was found that dela) of more than 2 hr after this kind of cooling was not 
compatible with survival. From our present results. it is obvious that the 
time of 2 hr was a gross underestimate of what can be expected after simple 
infusion, providing other aspects of the operation and care are of high 
caliber. Even after 9 hr the results with lactated Ringer's solution alone 
were almost equal to those achieved with the complex solutions. Thus, the 
most important ingredient of success, no matter what the solution, was 
organ hypothermia. 
In our experiments. the extra value of special solutions became clear 
only with longer preservation times. At 18 hr, both the plasma solution of 
Shalm et al. ( 8 )  modified hy Wall et al. ( 13) and the Collins solution yielded 
better results than lactated Ringer's . Lambotte et al. (7) have previously 
shown the supplementar) value of Collins solution for liver presewation. 
If Collins solution is used, or for that matter the plasma solution 
preferred by Calne et al. (3). the safe time for liver preservation i\ extended 
to at least 9 hr and probably considerably beyond t h ~ s .  With this much time. 
the shipping of livers between most major American cities has become a 
real possibility. The implications of such a development were emphasized 
by Calne et al. (3) in their efforts at liver procurement in Europe. 
The precaution of final flushing with lactated Ringer's solution 
should be scrupulously taken if the Collins solution is used, In one of our 
patients. this step was omitted. When the organ was revascularired, the 
serum potahsium abruptly rose to 6.5 mEqIp 1.000 ml. followed by cardiac 
arrest from wh~ch  resuscitation fortunately was possible. The sudden 
efflux of the potassium-rich intrahepatic fluid with revasculaization of the 
unflushed graft was undoubtedly responsible. 
Ackno~~ledgn~ents .  The organ procurement was organired and 
carried out by Shawney Fine, Natalie Nanhin, Barbara Schulman. and 
Roger Sm~th .  coordinators of the Teraaki  Organ Procurement Program. 
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Medical Center arranged and carried out the organ transfer to Denver, 
Colorado. 
REFERENCES 
Belzer F. 0.. May R., Berry M.  N.. et al: 1970 J. Surg. Res. 10: 55. 
Brettschneider L..  Dalzoe P. hl.. Huger C.. et al: 1968 Surg. Gynecol. 
Obstet. 126: 263. 
Calne R. Y.. Dunn D. C..  Herbertson B. ,M.. et al: 1972 Br. Med. J .  
3 :  142. 
Calne R. Y., Dunn D. C., Herbertrun R .  M., t t  al: 1974 Trnnsplant 
Proc. 6 :  280. 
Collins G. M.. Shuggernian M. B., Terasaki P. I.: 1969 Lancet 2: 
1219. 
Fine S.  E., Clark R.  N.. F i ~ e  R. N.. et al: 1975 Transplant Proc. 7: 565. 
Lambotte L.. Pontegnie-lstace S.. Otte G. D.. et al: 1074 Transplant 
Proc. 6: 301. 
Schalm S.  W.. Terpsin J.  I*.. Pope5en D. T., et al: 1975 Surgery 78: 
1637. 
9. Starfl, T. E.: 1964 tr[~er.ie:lce 1n rcnol trunsplantotion. W .  B. 
Saunders Co.. Ph~ladelphin. 
10. Starzl. T. E.: 1969 E y ~ ~ r - r c ~ r i ~ . ~  111 lieptrric. n.trris~11unrurrorr. W.  B. 
Saunders Co.. Philadelphia. 
11. Starfl. T. E..  Kaupp H. A, .  Brock D. P.. et al: 1960 Surg. Gqnecol. 
Obstei. I1 I :  733. 
12. Starzl T. E..  Porter K .  A . Putnam C. U'.. et al: 1976 Surg, G)necol. 
Obstet. 142: 387. 
13. Wall V.  J . ,Cc~lnc R. Y.,Herbenson B. M.,et al: 1977 Transplantation 
23: 210. 
CLIO CHIRURGICA 
Simple hypothermic preservation for transporting human livers 
long distances for transplantation 
Report of 12 cases 
Transplantation, 23: 2 10- 16, 1977 
W. J. Wall, R. Y. Calne, B. M. Herbertson, P. G. Baker, D. P. Smith, J. Underwood, A. Kostakis and R. Williams 
SUMMARY 
Since 1973, 12 patients in the Cambridge-King's College Hospital 
liver transplant programme have received livers from donors dying in 
ho.~pitols considerable distances from the transplant centrp in Cambrid,qe. 
The method ofpr.eservarion used to tr.an.7por.r these liversfroni 35 to 110 
miles u'asflush perfusion uYth plasma protein fraction and hxporhemiic. 
.storage in ice. The isctiaemin times ranged,fr.om 2 hr and 42 miri and to 4 
/ir and 22 min. All o f the  rec,ipierrts had good or e.xcellent postoperati1.e 
filrlction of the grafts and h oj' the' I2  r ~ c i j ~ i e n t ~   re alive, tlie longest 
Jlcr\,i\,ul being 29 nionths. The presrn,ation techrriqtte is simple und easi!\. 
/)ortable and has given reliuble 4-hr preservation oj'the human lii7er. 
There is a shortage of donor organa in the United Kingdom ( 5 ) .  
Suitable candidates for transplantation with fatal liver disease often cannot 
wait weeks or longer for a donor to become available in their own hospital. 
We have moved the sick recipient and the transplant team to the donor 
lnstitutlon for the operation but this is not a practical procedure. These 
circumstances have made it necessary to remove l~vers  from donor$ dying 
In discant hospitals and transport them to Cambr~dge for transplantation. 
This Poses special problems for liver grafting because of the extreme 
Sensitlvit!. of this organ to ischemia and the difficulty in preserving the 
human liver for extended periods uhing simple. readily portable methods. 
In 1969 two patients in the Cambridge-King's College Hospital 
underaent orthotop~c liver transplantation using donor li\ers that 
had been transported 68 and 119 miles and were ischaem~c for 1-114 and 
'-114 hr. respect~\,ely. One recipient (OL-1.5) died from massive hepatic 
necrosis 7 da!s after operation: hepat~c insufficiency contributed to the 
death of the other patient (OL- 13). ~ l t h o u g h  man! factors were in\,olbed 
ln these two cases. poor liver preservation for these relati~el! long 
lichaemia times was a major factor in the poor function cf the grafted 
Organs. The pre\ervation method used was a modification of the technique 
by Schalm ( 2  I ). After flush perfu\ion with chilled heparinlzed 
Hartmann's solution followed by a plasma-bicarbonate-dextrose solution, 
the liver was stored in ice. This method was used successfully in the 
Cambridge-King's College Hospital liver transplant programme when 
both donor and recipient were in the same hospital and preservation times 
usually ranged from 1-112 to 3 hr (7.8). 
In order to extend the safe period of liver preservation beyond 3 hr, 
investigations in pig l ~ v e r  preservation were carried out in Cambridge 
(9.10.12,17). Modifications in volume. additives. and pH of the preserva- 
tion solutlon resulted i r ~  a perfusate that gave 12 to 17 hr of porcine liver 
preservation. and it was adopted for clinical use. The purpose of this paper 
is to report the subsequent 12 cases In the Cambridge-King's College 
Hospital series using simple hypothermic preservation In transporting 
human livers between hospitals for transplantation. 
MATERIALS A N D  ClETHODS 
Since 1973 12 human I~vers have been removed at distant hospitals 
and brought by car. plane. or helicopter to Cambr ide  for transplantation. 
The ischaemia times. d~stances travelled, and post-transplant function are 
shown in Table 1. One tran5plant team (surgeon, assistant, and one or two 
technicians) travels to the donor hoipital and starts the donor operation. 
When ~t has k e n  determined (after lapamtomy) that the liber is suitable, 
word is sent to the recipient hospital where a zecond surgeon than begins 
the recipient hepatectom). An attempt is made to cynchron~ze the two 
procedures to allou the final steps in the rerno\ al of the recip~ent liver to 
colncidr a i t h  the amval of the donor organ. 
Details of the donor operation ha\e  been d e w ~ b e d  in detail else- 
where (6). In es\encs. after c:rculator) arrect ofthe donor, the operation is 
started. The portal yein l i  cannulated \la the \uperior mesenteric vein and 
gra\ it) ~nfu\ ion at 1 rn of Harrmann's solut~on at 1 C containing heparin 
(1.000 ILlI~tre) 1s begun. The l i ~ e r  \hculd lmmsdiatel) become cold, 
asiuming a pale hro\c n colour. The steps in the donor hepatectom) proceed 
after cooling has commenced. After infusion of 1.500 to 1.000 ml of 
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TABLE 1. Data on 12 patients who rece~ved orthotopic l~ve r  transplants From donors dying in dlstant hospitals 
-. 
--- -ppp--...-. ~. . - ~p 
Doxwr l ~ v e r  
- Aye Date of t runs-  Dlaynoala (years) plant Warm an- 1)latancr Survival Cause ofdealh oxla" l a c h a r m ~ s  t r s~rbpur tud  Funct~un 
- -- 
ln t tn )  ln>tlr.) 
- - .  ~ 
1. 01.-33 43 11/11/73 Cholangiocarc~~~on~a 37 3 hr 56 nrln 54 Good 5 months Metastases 
2. 01,-34 33 2/19/74 Hepatoma 14 4 11r 20 ~ n l n  54 Good 29 ~nonths  Al~ve 
3.  01,-36 11 2/15/75 ( : ~ r r l ~ o s ~ s  + hepa- IY 4 hr 22 111111 50 Excellent 7'12 r~ronll~s Sel~sis + metas- 
tonla Lases 
4. OL-38 33 4/14/75 C~rrhosis 17 3 hr 57 rnln 62 Good 14 days Prreun~unia 
5. 01.-39 44 6/14/75 C ~ r r h o s ~ s  8 3 hr 53 nun YO Excellent 2'/2 rnonths Scpsls 
6. 01.-42 16 12/24/75 llepulo~na 2 3 11r 15 m ~ n  110 Excellent 7 ~~ lo r r t l~s  Al~ve 
7. 01,-44 44 2/4/76 llepal~rma 0 2 Iir 42 ~ I I I I I  100 Exce l l r~~ l  5'12 111~nt1is Al~ve 
8. 01,-45 35 2/12/76 CI~I I IOSIS  7 3 Irr 17 rnln 62 Good 5 rnuntt~r Al~ve 
9. 01.-47 54 3130176 Hepatonla 0 3 11r 39 1n1n 62 Excellent I 1 1 1 t 1 s  Sepsis 
10. 01.-48 48 4/12/76 Cl~olnng~ucarcinomn 0 3 hr 17 nlln 40 Excellent 3'11 nronths Al~ve 
11. 01.-50 44 5/5/76 Seco~~dary carcl- O 2 hr 46 n11n 35 (iood 5 weeks Mctirslases and 
nun~a  bowel ob- 
strucllon 
12. 01.-51 56 6/16/76 C~rrlrosis + hepa- 0 3 hr 3 rnin 54 Excellent 5 weeks Allvc 
tonla 
~ 
- .- -- - 
Time from ventilator sw~tch olT to comnirncelnent of l~vur  cool~ng. 
Hartmann's solution, the flushing solution is changed to ice-cold plasma 
protein fraction (PPF) contaming additives (Table 2). Seven hundred ml of 
PPF are administered via the portal vein and a further 300 ml via the hepatic 
artery after removal of the donor liver. The liver is placed in a plastic bag 
containing physiological saline at 3 C and then into a second plastic bag. 
It is then surrounded by ice In an insulated container. The container ltself 
measures 13 x 13- 112 x 19 inches and is easily accommodated on a car seat. 
The liver is then transported w ~ t h  the transplant team to Cambridge by the 
quickest practical route. 
It has been customary, in the United Kingdom in donors with brain 
death, to wait until the c~rculatlon has ceased before beginn~ng operation 
to remove organs. With such donors it is not unusual for the heart beat to 
continue for 15 to 30 mln after kentilator \w~ tch  off. The warm anoxia 
suffered by the liver during this waltlng penod can be considerable. 
Although this practice wa$ rigidly adhered to in the earl~ercaces. In the last 
few patients the operation has commenced immediately after ventilator 
switch off or ventilation has been continued until the 11ver has k e n  skele- 
tonized with an intact circulation (Table 1). 
After recipient hepatectomy, the donor I~\,er 1s grafted orthotop~call> 
anastomosing the suprahepatic caka, portal kein, infrahept~c a \a ,  hepatic 
artery, and bil~ary tract in that order. Postoperative liver function i \  
measured by assessment of the c l ~ n ~ c a l  state of the recipient. dally liver 
function tests (serum bilirubin. albumin. a~n~notransfera\es. alkal~ne 
phosphatase, and prothrombin tlme). bile output from tht T-tube ( ~ f  one has 
been used), the presence or absence of a bleed~ng d~athesis,  and liver scans 
and needle b~opsy when ~nd~ca ted .  Liver function tests \\ere classified ah 
excellent if mild disturbances occurred immediatelj after transplant and 
rapidly returned to normal values in a patient u h o  u a s  clinically ucll .  .A 
satisfactory clinical state with moderately abnormal livcr funct~on te,t\ in 
the first 2 to 3 ~ e e k s  uas  classed as good. Un\r~tisf;ictor~ liver function 
leading or contrlbutlng to the death of the recipient In the postoperatlve 
period would have k e n  class~fied as poor. 
TABLE 2, Composi t ion of p re se rva t ion  so lu t ion  
To each litre of PPF is added 
2.000 IU of H e p a r i n  
250 m g  of Hydrocor t i sone  
500 m g  of Ampici l l in  
6 m l  of 0.1 N HCI  
5 m l  of 10% ,Magnzsiurn s u l p h a t e  
250 m g  of dex t rose  
15 m E q  of P o t a s s i u m  p h o s p h a t e  
Illustr-uri~,e Cases 
Case 2 (OL-34). This 33-year-old woman underwent liver transplan- 
tation for hepatoma on February 19. 1974. Preoperative liver functions 
were normal. The donor died of a head injury in a hospital 54 miles away. 
Fourteen min elapsed from the time of cessation of art~ficial ventilation 
until circulatory arrest when the donor liver cool~ng was started. Arterial 
blood gases at this point shoued a pO? of 2,  $0: of 96, and pH 7.14. The 
liver was tranyported by car and was ischaernic for 4 hr 20 min. After 
transplantation she was generally well but had strikingly abnormal liver 
functlon tests as shoun in Figure 1. After an lrnmed~ate high rise and fall 
in SGOT and alkaline phosphatase. the \emm bilirubin rose steadily to 30 
mg/l00 mi on the 12th day. Cholangiographq demonstrated no obstruction 
In the biliary tree. Although the leukocyte m~gration inhibition test was 
negative. antirejection treatment w ~ t h  Solu-medrol wa\ given at this point 
but the biliruhin fell only slowlj over the next 3 weeks. The jaundice was 
considered to be because of ischaem~c damage Incurred during the agonal 
phase In the donor after ventilator suitch off. We have. houever,  no direct 
e \  idence to \ubstant~ate this hypothesis. She was dixharged 7 months 
after transplantat~on uith normal liver function tettc and is well 3 years 
later. 
C a ~ e  3 iOL-36). This 22-jear-old female undement liver trancplan- 
tatlor) for hepatoma and cirrhosis on Februar) 15. 1975. The donor liver 
was transported 50 mile\ by car and \*a, i s chaen~~c  for 4 hr and 72 min. She 
w a  intensely jaundiced preoperatively uith a bilirubin o f 5 . 2  rnd100 ml. 
Post-transplant there &a\  a drnrnatic drop in the h~lirubin to 3.3 mcJ100 ml 
bq the 3rd daq (Fig. 2).  There was ;I transient rlse In SGOTand SGPT uhich 
fell to nornial by the 7th da).  The patient s u n ~ v c d  7 rnoii(t,\ and eventually 
d ~ e d  from \ep\lr and pulmonary and hone secondar~es. 
(hse 5 (OL-391. T h ~ s  44->ear-old male underuent l~ \ e r .  transplan- 
tation for cirrho\rs on Ma) 14. 1975. The donor d ~ e d  In 'I ho\p1tal90 miles 
from Cambridge and the li\er was i\chacrn~c tor 3 hr arid 5.3 min. The 
rccip~ent u a \  well ~mmediatelq postoperat~velc and d ~ d  not become 
jaundiced until 6 ueeks after tmnsplantar~on \\hen. at exploration, he was 
found to ha\e  a \ubhepat~c ab\ces\ cornrnunlcatlng \*~ t t i  the biliarq 
anastorno\l\. He d ~ e d  of a m>ocardial rnfarct arid pulmonarq oedema 2 
day, after the \econd operation. 
Ca,\e 7 (OL-441. Thr\ 44->ear-old nl'ile underi\ei~t I ~ \ c r  ransplan- 
tation for hepatoma on Februarg 4. 1976. The donor d ~ e d  of a cerebral 
tumour I(X) m ~ l e \  d u a l  and the Ir\t.r uas  tran\ported b! pldne to Cambr- 
idge. It u a s  ischnernic for 2 hr and 12 mln tlis po\topcrat~\i. l~ve r  function 
was excellent and he had a smooth cour\e In the lio\p~tal. He was 
discharged 3 ueek\  aftel- operation and 15 \*ell 5-11? nionth\ Inter. 
RESULTS AND DlSCl  SSION 
The pwt-tran\planl I ~ \ e r  funct~on iind p'itlenr \ur\ i\al are summa- 
r ~ z e d  In Table I. Thcrc \%ere no death, trom 11\sr ta~lure  In the pmtopera- 
rive period and all had good or excellent function of the graft. Five of 12 
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Fig. 3.- Liver transplant of case 4 (OL-3). postmortem specimen. A 
portal tract and peripheral parts of surrounding liver lobules are shown. 
Apart from a slight excess of mononuclear cells in the portal tracts the 
structure of the liver is essentially normal. There was a slight excess of liver 
cells in mitosis in other areas. Haematoxylin and eosin. X 145. 
from hepatic parenchymal ischaemic damage and possibly some degree of 
intrahepatic cholestasis. Also, a considerable bilirubin load is put on the 
new liver from the large volumes of stored blood which are inevitably 
given during the operation. 
Many other causes of abnormal liver function in the postoperation 
period (sepsis, cholangitis, early rejection, and drug toxicity) can be diffi- 
cult to differentiate from liver injury resulting from the preservation 
technique or its duration. A major factor in the earlier cases in this study 
was the anoxic damage suffered by the liver cells whilst the surgeon 
anxiously waited for cessation of the circulation after ventilator switch off. 
Significant damage to the liver occurs under these circumstances and is 
manifest in the postoperative period by abnormal function, regardless of 
the excellence of the method of preservation. We believe this was the cause 
of the prolonged jaundice in case 2 (OL-34). Avoidance of this period in 
the last few cases has been reflected in less disturbance in liver function 
tests after transplantation. 
A bleeding diathesis in the recipient after liver grafting is an ominous 
sign. None of the patients in this report had an abnormal bleeding tendencv 
immediately after transplantation. The prothrombin time is-measure; 
frequently in the first 24 hr after grafting and a normal or near normal result 
is a sign of good liver function. 
The preservation method described is simple, straightforward, and 
requires no elaborate equipment. It is easily portable and has given reliable 
4-hr preservation of the human liver. This has allowed adequate time for 
the procurement of donor livers from hospitals considerable distances 
from the transplant centre. The waiting period for sick patients requiring 
liver transplantation has been shortened as a result. 
Acknowledgements. The patients in this report are part of the com- 
bined Cambridge-King's College Hospital liver transplant programme. 
We are indebted to our medical and nursing colleagues at Addenbrooke's 
and King's College Hospitals for their help in the management of these 
patients. We thank the medical and nursing personnel of each of the 
hospitals where the donor livers were removed for their cooperation and 
assistance. The illustrations were kindly prepared by the Department of 
Medical Photography at Addenbrooke's Hospital. 
Addendum. A further seven livers have been preserved by the above 
technique. All have had initial excellent function following transplanta- 
tion. The longest preservation period was 7 hr 50 min. 
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Part I1 
Immunosuppression 
IMMUNOSUPPRESSION 
Part I 1  
lmmunosuppression 
lmmunosuppression is what gives organ transplantation specificity in comparison to all other 
surgical endeavors. The techniques of immunosuppression were developed in the laboratories and 
in humans with the simpler model of renal transplantation. For the most part, the latter were applied 
with little change to the transplantation of the liver, heart. heartilung and pancreas. 
The origin of the idea. Before Medawar, there was nothing. The possibility that there was 
an immune barrier to successful transplantation of tissues and organs apparently was not part of the 
consciousness of early clinicians, or for that matter of most basic scientists. This realization awaited 
the classical studies of Medawar with rabbit skin grafts.' 
Appreciation by Medawar that rejection was an immunologic phenomenon made inevitable 
almost everything that followed. The deliberate depression of immunologic reactivity became 
feasible theoretically when total body irradiation2 3and adrenal cortical steroids4were shown to be 
immunosuppressive. The next great step was the introduction of thiopurine compounds, 6-mercap- 
topurine and its imidazole derivative, azathioprine, which inhibited heterohemagglutinin formation 
in mice,5 responsiveness to foreign proteins in rats%nd rejection of skin and renal grafts in rats7 
and dogs,g l o  respectively. 
The human kidney transplant prototype. The kind of laboratory research just cited 
proved inapplicable to organ replacement in man. Complete control of rejection with a single agent 
rarely was achieved without lethal side effects either in animals or in man as exemplified by the 
historically important trials with total body irradiation" as well as by early trials wtth 6-mercaptopurine 
and a~ath iopr ine . '~~ ' "  
Hopeful signs from the clinical experience through 1962 were footnotes to an otherwise dreary 
catalogue of failures. In 1961, Burnet, a Nobel laureate with Medawar the preceding year, wrote in 
the New England Journal of Medicine: 
Much thought has been glven to ways by whlch tissues or organs not genetically and 
antlgenetlcally identical with the patlent m~ght be made to survive and functlon in the allen 
envlronrnent On the whole the present outlook 1s highly unfavorable to success 
The modern era of transplantation was entered when it was realized that azathioprine and 
prednisone had at least additive, and possible synergistic, effects.Ia Using Ilvlng-related donors, 
renal transplantation became overnight a practical means of treating renal f a i l ~ r e . ? ~  'gother multi- 
modality techniques followed. (cf. Table I) 
The most important new variable between 1962 and 1978 was the adjuvant use of antilympho- 
cyte globulin (ALG) added to azathioprine (or to cyclophospharnide) and stero~ds.~"l t imately, it 
became possible to produce more potent and specific ALG's2' with the hybridoma techniques 
discovered by Koher and Milstein.?' However, from 1963 to 1979 with any of the methods available, 
truly acceptable results were obtained only with renal transplantation from consanguineous donors. 
Candidates for liver transplantation were faced with the bleak prospect of receiving a non-related 
(cadaveric) graft. 
The situation changed drastically for recipients of all kinds of cadaveric organs with the 
disclosure by Borel et a1'30f the phenomenal immunosuppressive qualities of cyclosporlne: with the 
initial clinical trials of this agent for cadaveric renal transplantation by Calne et al;" ?'and with the 
systematic combination of cyclosporine with sterolds and other immunosuppressive measures.26 27 
(cf. Table I) 
Application to liver transplantation. Liver transplantation at first was a passive partner 
in the development of immunosuppressive techniques. Whatever the current clinlca practice or 
current laboratory focus in renal transplantation (cf. Table I) it was passed on for secondary 
consideratton In liver transplantation and the transplantation of other extrarenal organs. In Denver, 
Colorado and in Cambridge, England, where both organs were at center stage, the delay between 
renal and hepatic trials with new drugs or practices almost disappeared. 
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TABLE 1: IMMUNOSUPPRESSIVE DRUG REGIMENS AND ADJUNCTS 
DEVELOPED WITH KIDNEY TRANSPLANTATION AND APPLIED FOR LIVERS 
Year Descr~bed Used for 
Agents and Reported Place Deflcenc~es Livers 
-
Azathioprine 1962 (1 2) Boston Ineffective, Dangerous No 
Azathloprine- 1963 (18) Denver Subopt~mal Yes 
Steroids 
Thoracic Duct 1963 (28)* Stockholm Nuisance: requires 20 to Yes** 
Dra~nage as Adjunct 30 days pretreatment 
Thymectomy 1963 (29) Denver Unproven Value Yes, Rarely 
as Adjunct in 1963 
Splenectomy 1963 (29) Denver No Longer 
as Adjunct necessary 
Yes, Once 
Commonly 
ALG as Adjunct 1966 (20) Denver Suboptimal Yes 
Cyclophosphamide 1970 (30) Denver No advantage except Yes** 
subsitute for for patients with 
azathioprine azath~opr~ne tox~city 
Total 1 979 (3 1 ,32) Palo Dangerous, extensive Yes*** 
Lymphoid Alto, preparat~on, not 
Irradiation Minneapolis quickly reversible 
Cyclosporine 1978-1 979 Cambridge Suboptimal Yes 
(24, 25) 
Cyclosporine- 1980 (26,27) Denver Nephrotoxic~ty; limits Yes 
Steroids dose: Reject~on not 
always controlled 
* It was not realrzed until much later that pretreatment for 3 to 4 weeks before transplantaton was a necessary 
condtron (33) 
*' These trals were summarized many years later with at least 10 years f o l o w ~ p  'or survvng patients (34) 
**' By Professor J A Myburgh of Johannesburg 
When cyclosporine eventually arrived on the scene two of the first 34 patients In Calne's 
CY~losporine serres were recipients of I~vers the Unlvers~ty of Colorado only about 25 renal 
reclplents were treated w ~ t h  cyclospor~ne in late 1979 and early 1980 before go!ng forward on  March 
9 1980 with the liver transplant t r~als that drast~cally changed the expectations regarding this 
Operation 2' 34 
Although lessons learned wlth the kidney eventually proved to be  appl~cabie to Iver  transplan- 
tatlon at the outset speclflc testing of lmmunosuppressve agents n canine h e r  recip~ents became 
a crucial issue The reason was the great d~ f f ~cu l t y  In the early 1960 s in obtain ng long-term survlval 
of dog h e r  rec~plents under lmmunosuppresslon w t h  total body irradatlon -or azathioprine w ~ t h  or 
wlthout sterolds j' *The concept that immune reactions d a v a g ~ g  to the Iver  ibere organ-specific 
was Part~cularly well stated by Moore et al "The poss!bil!ty ex~s ted  that sLccess was beyond hope 
of achlevement 


IMMUNOSUPPRESSION 
This is the first known attempt at immunosuppression for experimental liver transplantation. The 
experiments were performed in 1959 and 1960 when irradiation still was envisioned to play an 
important role in immunosuppression for transplantation. All efforts failed. Treatment of the graft with 
high dose irradiation did not improve the results and treatment of the recipient seemingly reduced 
the chance of perioperative survival. 
CLIO CHIRURGICA 
Canine liver homotransplants 
The effect of host and graft irradiation 
Archives of Surgcry, 85: 460-4, 1962 
T. E. Starzl, G. W. Butz, Jr., D. R. Brock, J. T. Linman and W. T. Moss 
With homografts of various tissues and organs, systemic histologic 
changes in the host animal are not usually detectable. Recently, however, 
in studying whole-organ homografts of the canine liver, widespread 
changes which were coincident with rejection were found in host organs." 
The changes consisted of round cell infiltration and mesenchymal tissue 
proliferation. They s e r e  found in bone marrow, lung, kidney, and other 
tissue and organs which are constituents of the reticuloendothelial system. 
From the information available. it was not possible to detemiine if 
these changes were part of an exaggerated host-versus-graft rejection 
Process, or if they reyulted from an attempt by the graft to repudiate the host 
(graft-versus-host reaction). In the present report, an attempt was made to 
study this point by rendering either the graft or host animal incapable of 
immunologic activity b j  preoperative ioniling irradiation. 
Methods 
Adult mongrel dogs weighing 1.5 to 20 kg. were used. The animals 
"ere dewormed and irnmunired against dlstemper and infectioui canine 
hepatitis. Using a prev~ously described technique. l~ve r  homografts Were 
transplanted with normal anatomic reconjtruction of vena cava and portal 
\elns.' The host spleen was removed. Blood chenirstry and hematologic 
data were obtained before and after operation. Autopsy was performed 
Promptly after death. 
Ionizing irradiation ~ , a \  give11 either to the prospective re~iplent 
animal or to the dog frorn uhich the liver hornograft h a s  to he obtained. All 
animals were given 1.100 r total body irrad~atron in a singlc h e .  The dose 
uas measured on the ,urfgce of the dog, including brick scatter: 700 r to  the 
nghr lateral side. 700 r to the left lateral side. Factor\ here 280 kv. h\i.. 1 
mm. Cu. 20 ma. target dog distance 167 crn. Dose rate at the surface of the 
dog 14.2 rperm~nute .  The (Jose to the center ofthe dof ' \  abdomen 
calculated to be 900 ro I ,000 r. 
Results 
Irrudiurio,i o f H i ~ \ t .  Six recipient dogs were given 1.300 r. Eight- 
een 40 hour later total hepatecton~y was performed and a liver trans- 
planted froni a nonn;il dog. All animal\ (lied within 36 hours from diffuse 
gastrointestinal hemorrhage or hemorrhagic pneumonitis. The combina- 
tion of operative trauma and irradiation appeared to preclude even tempo- 
rary success. 
Irradiuiion of G~.ufl- Twelve donor dogs were given 1,400 r. 
Eighteen hours later. their livers uere  transplanted to normal hosts. Six 
dogs died w~thin  30 hours of hemorrhagic gastroenter~tis. The other 6, 
uhich constitute the bulk of the report. recovered and uere  studied until 
their later death. 
Survival and Clrnrc;il Behavior: The 6 dogs uhich \unived the 
immedia:~ effect\ of \urger) lived for 5 .  6. 8. 9-112. I?.  and 13-112 days. 
Clin~cal behavior b a s  sirnilar to that prc\iousl) ohsencd urth the use of 
nonirradiated graft\" and u a \  characten~sd h) h e r ,  eventual lassitude, 
cessation of oral rntahe. and jaundlce 
Blood and Urlne Studie\: All dogs had profressr\c e l e~a t ion  of 
seruni bilirubin and allialins pho\phata\e after the fifth and \i\th days. 
Hypoglycemia \\a\ frequent late in the cour\e. There here  no changes in 
blood urea nitrogen. After4 to 6 du) \, bile u a \  d<tected in the ur~ne.  Before 
death. all 6 dog\ had riws In the white count to as  h ~ f h  a \  15.000 per cubic 
millimeter. 
Gross Finding\: Fintiiny \\ere \irii~lar to tho\e obtained w ~ t h  use of 
nunirradiated graft\.' The Ir\er\ uere  usuall) Iape.  firm. and erther pale or 
mottled. Ascites \\a\  \,iriabls. In 2 uf the anriii,~I\. there ul\ no obvious 
cause of death other than graft rcjcct~on. In  the other 1. rn;ts,i\e hemor- 
rhage. Ileal intos\u\ception. hernorrhapic rleitis. or duoden;il psrforation 
ue r r  iound and could ha\e heen the cau\s of death Ho\r Ilrriph nudes were 
enlarged throuyhour. 
)llcrv\cop~i. F~ndinf, .  In rhs .~nirniil\ l i i  irig 5 cia! \ or I?$\. thzre were 
no monon~iclear infiltrate\ In the l l \ s r \ .  Structurs \ \a \  \bell pre\erved. In 
6 dais. \\ell-definsd d~fEu,e and focal ~nfiItrate\ ot pia\mn cells and 
I~mphoc!tes were e\ idsnt i Fif I .A 1. 'md in longer \ur\ I \  in: animals, 
these \rere \ s p  prornineiir. .\her h (id),. \rructural pre,er\stlon varied 
from an Intact arch~tecture I Fip 1.4) to ~l r i io \ t  complete Js \ r ru~t ion (Fig. 
1B). Ths prlrnar) arzd of hepati, parench)rnal lo\\  ir  ere isrirrdl lobularand 
penportal (Fig I I .  
Histologic s\ ~dence of ho\t response was found. In 5 ~ f t h e  6 animals 
IMMUNOSUPPRESSION 
Fig. 1 .- Liver in early and late stage of rejection. A, dog No. 6: 6 days; B, dog No. 9: 9 days. Reduced about 39% from mag. x100. 
Fig. 3.- Kidney from dog No. 16, after 13-112 days. Cellular 
Fig. 2.- Lung from dog NO. 13, after 18 days. Note proliferation in infiltrate in central part of illustration is focal. Reduced about 39% from 
alveolar septa. Reduced about 39% from mag. x250. mag. x100. 
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Fig. 4.- Bone marrow after 8 days from dog No. 13 showing 
increased numbers of plasma cells and lymphocytes. Reduced about 41% 
from mag. x430. 
surviving 5 days or more, proliferative changes were found in the alveolar 
septa (Fig. 2). In the kidneys, there were focal aggregates of mononuclear 
cells (Fig. 3). Bone marrows were consistently altered. Slight to marked 
increases in plasma cells, lymphocytes, and reticulum cells were evident 
in the marrow of each animal. An example of such achange of intermediate 
severity is shown in Figure 4. 
In all the dogs, there was evidence of increased cellular activity in the 
mediastinal and mesenteric lymph nodes. The number of plasma cells were 
increased, especially in the medullary sinuses. In half of the animals, there 
was distortion or absence of the follicles (Fig. 5). In the other half, the basic 
lymph node architecture was preserved. The gastrointestinal tract, pan- 
creas, and heart showed variable changes of the type previously related, at 
least in part, to the trauma of surgery.',6 There were no changes in skeletal 
muscle. 
Controls 
Previous control studies demonstrated that the act of transplantation 
did not by itself result in major histologic changes in host or graft.6 Controls 
1" the present study were designed to determine the effect of irradiation On 
the histologic character of the liver. Nine animals were given 1,000-1,400 
'9 with the same factors of irradiation as described above, and observed 
Until death 4 to 13 days later. In all cases, the platelet and white counts fell 
precipitately after 3 to 5 days. 
The architecture of the liver was well preserved. Infiltrates did not 
Occur. However, small necrotic foci with noninflammatory response were 
found in 4 animals. Loss of basophilic staining was inconstantly noted. 
Comment 
Initially, it was hoped to perform experiments in which either the 
liver homograft or the host received a high dose of irradiation. However. 
efforts at host irradiation were unsuccessful. Irradiation injury to 
bowel, combined with the transient elevation of portal pressure 
'?plantation, resulted in irreversible intestinal injury and fatal gastroln- 
testlnal hemorrhage. 
Fig. 5.-Lymph node from dog No. 13, an 8 day survivor. Washed 
out follicular pattern is discernible. Reduced about 39% from mag. x100. 
The information gained from irradiation of the hepatic graft is useful 
in interpreting the interaction between the graft and the host. The graft was 
irradiated in situ approximately 18 hours before its removal. The calcu- 
lated dose to the liver was in excess of 1,000 r, enough to effect complete 
immunologic paralysis of the graft.l Having thus eliminated the possibility 
of a graft-versus-host reaction, the changes in both graft and host can be 
attributed to the antigenic stimulus of the graft and the resultant response 
of the host. Survival time, clinical behavior, chemical determination, and 
pathologic findings were similar to those previously reported in recipients 
of nonirradiated livers.'.6 
The origin of the cellular infiltrate in rejected homografts has been 
the source of speculation and controversy for several years. It has been 
suggested by Simonsen4 and Dempster' that the mononuclear infiltrates are 
of graft origin and represent a graft-versus-host reaction. In the present 
study, however, the histologic character of the rejected irradiated liver did 
not differ from that previously observed in nonirradiated homografts? 
These observations provide support for Hume's contention,' derived from 
studies with renal and hematopoetic homotransplants, that the cellular 
infiltrate in homografts undergoing rejection is of host origin. 
In earlier studies of nonirradiated liver homografts, various host 
organs displayed alterations which resembled those found in grafts under- 
going early rejection. The changes consisted of fixed tissue proliferation 
and round cell infiltration? It was not possible to be certain if they were part 
of the host rejection of the graft or if they represented a graft-versus-host 
reaction. The present study, employing immunologically immobilized 
hepatic grafts, provides evidence that the abnormalities in the hosts' bone 
marrow, lungs, kidneys, lymph nodes, and other tissues were due to an 
exaggerated host response to the massive antigenic stimulus of the foreign 
liver. 
Summary 
Whole organ hepatic homografts were performed after massive 
irradiation of the host animal or of the animal from which the graft was 
taken. After host irradiation, technical success with grafting was not 
achieved. 
IMMUNOSUPPRESSION 
With irradiation and consequent immunologic paralysis of the liver 
homograft, survival for as long as 13-112 days was attained. Length of 
survival, clinical behavior, chemical determinations, and pathologic find- 
ings were essentially the same with the use of irradiated as with nonirra- 
diated livers. These findings indicate that a graft-versus-host reaction is not 
of immediate significance even with as bulky a graft as the liver. Histologic 
changes in the liver graft, as well as those in various host organs, appear to 
be attributable exclusively to host activity in response to the antigenic 
stimulus of the liver. 
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This important paper introduced the chilling prospect that widespread ischemic necrosis 
cacjsed by an immunologically mediated vascular insufficiency could occur in liver homografts that 
had been well protected byazathioprinefrom cell nediated rejection. In ten experiments, the longest 
survival was 12 days. 
The concept introduced by Moore may not have been completely correct mechanistically. 
However, the article was prophetic in that infection introduced through livers damaged by ischemia 
or rejection emerged before long as a central management issue. 
The devastating role of infection was delineated early in the Colorado clinical experience. An 
experimental paper by Brettschneider et al* attempted to determine the etiology of the infections. 
The conclusion that the liver graft itself was a porous entry site for bacteria indigenous to the 
gastrointestinal tract was an early example of the so-called "translocation" of bacteria which has 
become recognized since in a variety of other conditions. By 1969. when a textbook on liver 
transplantation was completed,** the sublety of the problem was appreciaied in that powerful 
immunosuppression was envisioned as the only way to avoid "graft mediated infection." 
* Brettschnelder L, Tong J L, Boose D S, Daloze P M Smlth G V, Huguet C Elanchard H Groth C G, and 
Starzl T E Specific bacteriologic problems after orthotoplc Iver transplantaton In dogs and p g s  Arch Surg 
97 31 3-22, 1968 
** Starzl TE (with the assistance of CW Putnam): Experience In Hepatic Transplantation. W.E. Saunders Co., 
Philadelphia, 1969, pp.329-47 
IMMUNOSUPPRESSION 
Immunosuppression and vascular insufficiency 
in liver transplantation 
Annals of the New York Academy of Science, 120: 729-38, 1964 
F. D. Moore, A. G. Birtch, F. Dagher, F. Veith, J. A. Krisher, S. E. Order, W. A. Shucart, 
G. J. Dammin. N. P. Couch 
Introduction 
In the summer of 1958, these laboratories commenced work in liver 
homotransplantation. In 1959 and again n 1960.'' we were able to report 
a technique for orthotopic transplantation of the entire liver in the dog. This 
technique employed bilateral, low pressure, nonoxygenated, veno-venous 
shunts to by-pass and decompress the venous congestion produced by 
inferior vena caval and portal venous occlusion during the anhepatic phase 
of the operation. 
The clinical, biochemical, and histologic sequences of liver trans- 
plantation and rejection were defined. The process of rejection involved 
infiltration of the portal area with immunocytes, a rise In the blood bilirubin 
and alkaline phosphatase concentrations, and sudden demise at 7 to 12 
days. The host cells concerned with rejection were hea\ i l j  concentrated in 
the portal areas and around the hepatic velns with centrolohular conges- 
tion. Terminally. there was \videspread liver necrosis. 
Work prior to that time. conducted in several laboratories in this 
country. had demonstrated that rnulti~tage and partial liver transplantation 
were feasible.' Other laboratories jolnlng in this work at the same time, 
particulariy those under T. E. Starzl. further delineated the technical, 
clinical, and biochemical courhe of canine liver transplantation in the 
unmodified recipient.' " 
With increasing qucceas in kidneq honiostransplantation under 
~mmunosuppressive chemotherripy.' it became e\itient that we should 
reapproach the problem of liver transplantation, studying the effect of 
immunosuppression on the natural courje of liver rejection. 
Early in our work and in that of Starrl' it becarne clear that the 
immunocytic infiltrate of liver rejection h a s  readily abated by the use of 
azothloprine, a i th  or hithout other cheniical agents. such a\ prednisone, 
cortisone. or araserlne. 
Because of these encouraging findings, a first attempt In human liver 
transplantation was justified. and was undertaken In the spring of 1963 by 
Starzl and his co-workers in Denver.' In the fall of 196.1. In this hospital. 
we undertook the operation upon a patient jufferlng from extensive hepatic 
carcinoma. In none of these human cases has a survival of more than one 
month been obtained, despite the fact that the operation is a practical one 
technically, and that the immunocytic rejection response was virtually 
absent under chemotherapy. 
It thus became clear that in both man and in the dog the prevention 
of the immunocytic rejection response and the cellular infiltrate was not 
synonymous w ~ t h  practical success. In our experience, the longest canine 
survivors have been in the region of 12 days. Starzl et al. have reported 
animal survivors at 22 to 35 days. In both series, reasonably normal liver 
histology was maintained where blood supply was good. Failure of 
survival has been associated in our animals with the development of 
multiple areas of focal ischemic necrosis in the transplanted liver. 
The principal question in liver homotransplantatlon at this time is, 
therefore, to determine whether thls hepatic necrosis is an aspect of the 
rejection response or whether 11 represent\ merely the \ ascular and hemo- 
dynamic sequellae of transplanting a very large parenchymatous organ 
which carries only a small arterial blood supply. 
The a o r k  of Sicular et al ."casts some l~gh t  on this problem. because 
in their experimental model, the liver is not essential to survival. Long-term 
survivors are obtained in the presence of a rejected liver. Ischemic damage 
is likewise seen. 
It lr the purpose of t h ~ s  communication to report briefly our recent 
studies in hepat~c transplantation, with particular emphasis on this vascular 
component in the failure of the homograft. 
Methods 
Large mongrel dogs, donor and recipient, are prepared by the 
preliminary administrat~on of oral neomycin. In about one-half of our 
animals azothioprine (6  nig./kg.) was given to the recipient daily for three 
days prior to transplantation. In all cf them this drug has been used postop- 
eratively. Homologous blood transfusions were avoided uhenever pos- 
sible by prebleeding the recipient three days prior to operation and bank- 
ing this blood. UTe have noticed, as have others, ' that the avoidance of 
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I Alk. phos. 1 SGOT 
LT4-H I 11 1 4 6 8  1 141 5 1 Extensive lobar and focal ischemia; 
TABLE 1 
Doc LIVER HOMOGRAFTS-IMMUNOSUPPRESSION 
Number 
- - 
LT6-H 
LTll-H 
LT 12-H 
LT 14-H 
LTl5-H 
LT17-H 
- 
LT24-H* 1 12 1 62 I 120 l ~ e c h n i a l l y  unsatisfactory. 
Days Highest preterminal value 
survival 
LT22-H' 
LT-2 3 H ' 
Treated by daily portal vein dibenzyline infusions 
Post-mortem vascular findings 
3.5 
4 
7 
4 
7 
4 
homologous blood transfusions is a favorable factor in achieving the sur- 
7 
7 
vival of dogs undergoing extensive surgical operations. 
The transplantation operation is carried out under ~en to tha l  ether 
19.2 
2.7 
66 
36.6 
25.8 
21.0 
anesthesia with an endotraiheal tube. The operative tech;lique is essen- 
tially that previously described.12 The chest is not entered. Shunts of tygon 
tubing are joined from the inferior vena cava to the jugular vein and from 
the portal or splenic vein to the jugular vein on the other side. The dog 
tolerates caval or portal occlusion very poorly. A normothermic recipient 
with two functionning shunts in place provides the ideal operative setting 
for a cold liver transplant. 
The donor animal is operated upon normothermically, but the liver 
is cooled to the region of 15 to 18" C. just before transplantation. 
The homotransplantation requires about two and one-half hours. 
Anatomic restoration of vascular anatomy is by end-to-end suture. The bil- 
i q  shunt is by cholecystduodenostomy. The average ischemic period for 
hepatic arterial flow is 40 to 50 minutes and for portal flow, 40 to 60 
minutes. Tris buffer is used when the shunts are closed; essentially normal 
blood gas analyses pertained throughout. At the close of the operation. the 
animal's blood pressure, pulse, urine flow, electrocardiogram, and body 
temperature are normal. 
The spleen was removed in about half of these recipients. At the close 
of the operation, polyethylene cannulae were placed in the splenic vein and 
In the splenic artery for postoperative angiography. Post-mortem hepatic 
arteriograms were made using a mercury-barium mixture. 
Clinical management of these animals was essentially the same as 
that prior to the use of immunosuppressive chemotherapy. However, in 
these animals, azothioprine doses ranged from 4 to 8 mg.kg. ;  azaserine 
Was at doses of 0.3 mg./kg. In several of the more recent animals, large 
doses of cortisone (up to 300 mg./day) were used throughout the animal's 
course. 
To avoid excessive blood sampling, it is essential to select but a few 
blood indices of hepatic function. Alkaline phosphatase. Iran- 
Samina~e (SGOT), and bilirubin concentrations provide the best indices of 
bile duct activity, liver cell necrosis, and obstruction. respectively. A 
course has been an early elevation of the transaminase with 
restoration toward normal during the succeeding days. The alkaline 
15.5 
34.8 
phosphatase rises relentlessly beginning on the second or third day until 
one or two days prior to death when both the transaminase and the alkaline 
phosphatase rise precipitously. In contrast, the bilirubin remains normal or 
only minimally elevated throughout the course. This represents a differ- 
ence from the previously reported animals without chemotherapy, in 
whom the portal infiltrates and rising bilirubin were characteristic. 
Antibiotics (penicillin and streptomycin) were used in all animals. 
2080 
220 
1450 
3100 
720 
730 
Results 
In Table 1 is shown a list of survival times, terminal chemical 
findings, and vascular changes in 10 animals. It will be noted that we have 
had only six dogs in this recent group that survived a week or longer. 
Survivors at 5 to 12 days are up and around. taking food and fluid normally, 
with normal behavior and good clinical conditions. In some instances, 
although chemical changes have been ominous. clinical condition has 
remained satisfactory until an hour or two prior to death. 
Pathologic findings outside of the liver have been especially note- 
worthy. The reticuloendothelial system does not show evidence of 
destruction or lysis if drug doses are kept in the range indicated. The heart 
frequently shows an area of myocardial necrosis or calcification if the 
operation has not gone well, or if there has been severe hypotension. This 
is a common finding in dogs after long or shocking procedures. Pancreati- 
tis is a common complication of this operation. 
Pathologic findings in the liver are notable for two features: a lack of 
immunocytic response, and scattered areas of severe ischemic damage 
ranging from focal to mult~lobular. Both of these characteristics of the 
animal liver were noteworthy in the post-mortem examination of our single 
human case. Histologic find~ngs in this case are compared with those in 
canine hepatic replants and untreated homografts in Figures 1 through 4. 
Vascular injection studies showed changes in these animals best 
analyzed in two groups. 
i Post-mortem. Post-mortem injection studies have shown several 
types of change as noted in Figure 5. The t u o  most prominent were those 
of "hepatosis" and areas of absent artenal tilling. Hepatosis is defined 
clinically as a liber engorgement with a purplish dark or black color as 
~ i e u e d  in the living. Angiographicall). such l i ~ e r s  hou considerable spill 
minimal arteriosinusoidal shunts. 
Extensive lobar and focal ischemia; 
minimal arteriosinusoidal shunt- 
ing. 
Mlnimal focal ischemia and arterio- 
sinusoidal shunting 
Massive lobar and focal ischemia; 
extensive arteriosinusoidal shunt- 
ing. 
No  lobar ischemia but minimal focal 
ischemia; minimal arteriosinus- 
oidal shunts. 
Minimal focal ischemia and marked 
arteriosinusoidal shunts. 
Total main h e ~ a t i c  arterv occlusion. 
55 
380 
N o  lobar ischemia; moderate focal 
ischemia; moderate to marked ar- 
teriosinusoidal shunts. 
Severe diffuse focal ischemia; mini- 
mal arteriosinusoidal shunts. 
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Fig 3.- Dog X 69. Whole-liver homograft on the eighth post-transplant day. The portal area shown in the upper left portion of the field is densely 
infiltrated with large mononuclear cells. The portal vein is obscured by the cellular infiltration. The bile duct is dilated and the epithelium is flattened (see 
arrow). There is a striking reduction of hepatic cells wih a collapse of the architectural pattern. In the upper right portion of the field, a centrolobular area 
shows hepatocellular disarray and few sinusoids are recognizable between the portal and centrolobular areas. 
Fig. 4.- Dog X 64. Whole-liver replant on the 10th post-operative day. The portal area shows no alteration of portal vein, hepatic artery, or bile ducts. 
The cellularity of the portal area is slightly increased. The hepatic cells show the normal ratio of total cell size to nuclear size, and the architecture is well 
preserved. This Figure is introduced to show that the surgical procedure itself does not result in alterations seen in homografts. 
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Fig. 5.- Post-mortem hepatic arteriogram. Homotransplant, seven days. The arteriosinusoidal shunts appear as grape-like clusters around the arte- 
rial branches, especially noticeable in the lower portion of this photograph. Ischemia is not marked here. 
of the injection mass into parenchymatous tissue that might be termed 
"arteriosinusoidal" shunts. In some areas, the medium flows from the 
hepatic artery into the venous drainage channels. The defects in arterial 
filling are associated with hepatic necrosis recognizable grossly and 
microscopically. Serial sections have failed to identify the basis for 
impaired filling. There is slight perivascular cellular infiltration. The 
phenomenon may be vasospastic, hemodynamic, or immunologic in 
origin; it is our tentative interpretation that the coalescence of these areas 
of liver ischemia produces the extreme elevation in transaminase seen in 
the terminal animal. ' 
2. In vivo. Because of these findings, in vivo angiography was 
initiated about six months ago, employed the intravascular cannulae 
mentioned above. Such an angiograrn is shown in Figure 6. 
In these films, a slight narrowing of the hepatic artery at the area of 
anastomosis is repeatedly noted; in some instances, it may be a severe 
narrowing. In two such instances, hepatic arterial thrombosis was noted at 
this site, in one of which occlusion occurred and this was the principal 
cause of death. If the anastomosis is carried out obliquely and with extreme 
care to avoid narrowing, it is possible to have an hepatic arteriogram during 
life, that does not demonstrate the site of suture. 
The portal venous system has shown excellent patency and normal 
anatomic reconstruction with seemingly excellent blood flow. Thrombosis 
is rare. 
To date, we have been unable to demonstrate by antemortem in vivo 
angiography, the impaired filling of portions of the arterial tree noted in the 
post-mortem injections. This failure to demonstrate vascular insufficiency 
is due to a technical limitation of the method of in vivo arteriography since 
it frequently does not demonstrate the terminal branches whose failure to 
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Fig. 6.- In vivo hepatic arteriogram. Homotran 
peripheral lobular arteries are well filled. 
fill is noted at post-mortem examination. 
Heparin and a vasodilating agent (dibenzyline) have been injected 
regionally into the liver; this step has not altered the clinical, chemical, or 
histologic course of the transplant. 
Discussion 
The work reported herein has defined rather than answered a ques- 
tion. The liver at death is ischemic, as shown by histologic and angiogra- 
phic study. The Question of outstanding im~ortance in liver transulantation 
relates toihe interpretation of this ischemia. Is it to be considered an aspect 
of rejection, or merely a by-product of arterial anastomosis, involving a 
nther small nutrient artery, or a very large parenchymatous organ? 
The perfect control for this operation is a complete liver removal with 
reimplantation. This is very difficult to carry out because of the short length 
pf blood vessels involved, and the obvious problem of temperature control 
1" donor and recipient. The various types of autotransplantations and sham 
"plants carried out on immunosuppressive chemotherapy have failed to 
demonstrate ischemic lesions as widespread or severe as those seen in the 
@?splants. If the animal, in the course of the replantation, has a severe 
ePlsode of shock, he may show both cardiac and hepatic necrosis. This is 
not inevitable, however, and several long-term survivors have been ob- 
tained either with autotransplants or sham replants. It is thus clear that the 
ischemia is not an inevitable result of the surgical procedure itself. 
It, therefore, appears clear that the hepatic ischemia is, at least in part, 
of immunologic rejection. The nature of the operation and the 
arterial blood supply render the liver hemodynamically vulnerable 
'O an ischemic lesion after the surgical procedure itself; the very high 
Incldence of ischemic necrosis in the homotransplants and the lack of long 
Su"lvors suggest that the more widespread form of this disorder 1s 
splant, four days. The anastomosis is not visible. The 
associated with an immunologic process. 
The particularly unfavorable aspects of canine liver for these studies 
are evident. The dog liver easily becomes congested and turgid with 
manipulation or hypotension. The change, which we have termed hepato- 
sis, may be related to hepatic outflow obstmction," though the in vivo 
angiograms do not support the contention of outflow block. It is possible 
that long-term survival in experimental hepatic homotransplantation 
would be more easily achieved in some other species. 
It is further of interest that 6-mercaptopurine, azothioprine, and 
azaserine are all mildly hepatotoxic drugs. Azothioprine is given to the 
animal by mouth and the portal concentration is probably much higher than 
that obtained in a systemic circulation. One may, therefore, raise the 
possibility that a superior form of immunosuppression for hepatic homos- 
transplantation might be found with a drug that is given systemically, and 
is much less hepatotoxic. The combination of a parenteral immunosup- 
pressive agent with local radiotherapy is likewise an appealing combina- 
tion. 
Conclusions 
( I )  Immunosuppression, using azothioprine, azaserine, and predni- 
sone, readily abates or aborts the immunocytic rejection response in 
hepatic homotransplantation. 
(2) This favorable development is not associated with practical 
clinical survival, either in the dog or in man. 
(3) In both species, the terminal findings are those of extensive 
hepatic necrosis, spotty in some areas, and widespread in others; this is 
associated with non-filling of the terminal arterial branches in the involved 
areas. 
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(4) These findings are not as prominent in the autotransplanted or 
sham operated liver, even though the vascular anastomoses are the same. 
(5) It is, therefore, our tentative interpretation that this ischemic 
lesion is not wholly the result of hemodynamic alterations resulting from 
the operation of transplantation, but that the immune response of the host 
may be a contributing factor. 
(6) Further investigative bork must be devoted to the maintenance of 
an adequate arterial supply following homotransplantation of the liver, and 
the exploration of other modes of immunosuppression. 
A ~ ~ k n o r ~ l e d ~ g m e ~ ~ t ~  
The authors whlch to express their gratitude to Miss Joan Voorhees 
and Mr. Paul Vemaglla for their assistance in this work. 
Rqferences 
1. Moore, F. D., L. L. Smith. T. K.  Burnap, F. D. Dallenbach, G. J. 
Dammin, U. F. Gruber, W. C. Shoemaker, R. W. Steenburg. M. R. 
Ball & J. S. Belko. 1959. One-stage homotransplantation of the liver 
following total hepatectomy in dogs. Transplant. Bull. 6: 103-107. 
2. Moore, F. D., H. B. Wheeler, H. V. Demissianos, L. L. Smith, 0 .  
Balankura, K. Abel, J. B. Greenberg & G. J. Dammin. 1960. Experi- 
mental whole-organ transplantation of the liver and of the spleen. 
Ann. Surg. 152: 374-387. 
3. Goodrich, E. O., H. F. Welch. J .  A. Nelson, T. S. Beecher & C. S. 
Welch. 1956. Homotransplantation of the canine liver. Surgery 39: 
244-25 1. 
Starzl, T. E., H. A. Kaupp, Jr., D. R. Brock, R. E. Lazarus & R. L, 
Johnson. 1960. Reconstmctive problems in canine liver homotrans. 
plantation with special reference to the postoperative role of hepatic 
venous flow. Surg. Gynecol. Obstet. I 1  1: 733-743. 
Starzl. T. E.. H. A. Kaupp, Jr., D. R. Brock & J.  W. Linman. 1961. 
Studies on the rejection of the transplanted homologous dog liver. 
Surg. Gynecol. Obstet. 1 12: 135-144. 
McBride, R. A,, H. B. Wheeler. L. L. Smith, F. D. Moore & G. J. 
Dammin. 1962. Hornotransplantation of the canine liver as an 
orthotopic vascularired graft. Am. J.  Pathol. 41: 501-519. 
Murray. J. E.. J. P. Merrill, J. H. Harrison, R.  E. Wilson & G. J. 
Damrnin. 1963. Prolonged survi\al of human kidney homografts by 
immunosuppressive drug therapy. New Engl. J. Med. 268: 1315- 
1323. 
Starzl, T. E.. T. L. Marchioro. K.  N. von Kaulla, G. Hemann, R. S. 
Brittain & W. R. Waddell. 1963. Homotransplantation of the liver in 
humans. Surg. Gynecol. Obstet. 117: 659.675. 
Stanl, T. E. Personal communication. 
Sicular, A. S., F. Poronetto, A. E. Kark, D. A. Dreiling, L. Burrows 
& H. Popper. 1963. Rejection of the homotransplanted dog liver in 
the absence of hepatic insufficiency. Proc. Soc. Med. 112: 760-764. 
Neill, S. A,, W. D. Gaisford & G. D. Zuidema. 1963. A comparative 
anatomlc study of the hepatic veins in the dog, monkey, and human. 
Surg. Gynecol. Obstet. 116: 451-456. 
Eisernan, B. & F. C. Spencer. 1964. Man's best friend? Ann. Surg. 
159: 159-160. 
CLIO CHIRURGICA 
In this attempt to prevent liver rejection in dogs receiving azathioprine, the maximum survival in 
25 experiments was only 31 days. Ten of the 25 animals died perioperatively. Although some of the 
other 15 animals had preservation of liver function and hepatic graft architecture, there were few 
reasons for optimism except for an addendum describing the long-term survival in dogs in a series 
of new experiments. One of these dogs lived 11-213 years. 
At the time this paper was presented in 1964 at the American Surgical Association, five patients 
had been treated with liver replacement at the University of Colorado, all unsuccessfully. The 
repeated failures stimulated interest in the possible use of auxiliary liver hornografts. The "extra" 
livers underwent acute atrophy, and the suggestion was made in this article that the atrophy was 
caused by hepatic deprivation of specific substances in the portal venous blood. This was the 
beginning of the so-called hepatotrophic hypothesis (cf. Part IV). 
IMMUNOSUPPRESSION 
Immunosuppression after experimental and clinical 
homotransplantation of the liver 
Annals of Surgery, 160: 41 1-39, 1964 
T. E. Starzl, T. L. Marchioro, D. T. Rowlands, Jr., C. H. Kirkpatrick, W. E. C. Wilson 
D. Rifkind and W. R. Waddell 
The fate of whole organ liver homografts after transplantation to 
untreated canine recipients is well k n o ~ n . " ~ ' - " ' ~ " ' ~ * !  For several days after 
operation, the transferred tissue is life-sustaining. but after this there is 
rapid functional failure. The histologic abnormalities in the rejected liver 
consist of infiltrates of mononuclear cells which tend to be concentrated in 
the periportal areas, a necrotizing arteriolitis, and dissolution of hepatic 
parenchymal cells with retention of a relatively normal reticulum. 
In the present report. an attempt will be made to add an additional 
dimension by describing the behavior of canine and human hepatic 
homografts in recipients treated with immunosuppressive agents. Under 
these circumstances, a modlfied rejection wa? observed in many instances 
despite the absence of significant cellular invasion of the humograft. In 
addition. it was noted that severe hepatocyte injury often occurred in livers 
in which the duct system was selectively preserved or even hyperplastic. 
Finally. several previously unrecorded observations will be documented 
regarding more esoteric biochemical alterations in patients after hepatic 
homostransplantation. These include serial determinations of plasma or 
serum immunoglobulins, haptoglobins, amino acids, pyruvates, and lac- 
tates. 
Methods 
Tjpes  ofhomorrunspianration. Orthotopic homotransplantation was 
canied out in 25 dogs. after removal of the animal's own liver." The 
reconstructed blood suppl! to the revascularired homograft was essen- 
tially normal."'The time for transfer and complete revascularization of the 
cooled organ averaged 70 minutes. The effects of ischem~a were mini- 
mized by perfusion of the liver with cold (10-15" C.) lactated Ringer's 
solution prior to its remo~al: Internal b ~ l l a q  drainage was provided with 
a cholecystjejunostomj or c h o l e c y s t o d u o d e n o s t ~ .  Splenectomy was 
performed. Eleven animals died during or within three dabs following 
operation. These fa~lureb were considered to be technlcal:' and are not 
considered in the patholoe~c analysl\ (Table 1 ). 
In I5 dogs. an aux~liary li \er \*a\ placed In the right paravertebral 
gutter (Fig. I )  using a modificat~on-' of the method of Welch and his 
associates,"" re\asculariz~ng the portal vein from the ternilnal Inferior 
vena cava and the hepatic artery from the common iliac artery (Fig. I )  or 
aorta. The vascular supply to the graft was thus comparable to that of a 
portacaval transposition' in that systemic venous blood passed to the portal 
vein. Cold perfusion of the homografts was done with the same technic as 
with the orthotopic livers." The penod of ischemia averaged 32 minutes. 
Cholecystoduodenostom) was performed (Fig. I). The spleen was re- 
moved. Postoperatively. patency of the vascular anastomoses was checked 
with transfemoral venous and arterial angiograms (Fig. 3).  In four animals, 
the recipient dog's own liver was removed at a second-stage operation after 
27 to 28 days. leavmg the homograft as the only residual liver tissue. 
Five clinical hepatic homotransplantations were performed with 
previously described  technic^.'^"" The homograft was placed in normal 
anatomic position (Fig. 3) after removal of the recipient's diseased liver. 
Four of the patients (ages 29-67) had primar) malignancies of the liver. and 
the fifth was a three-year-old child with congenital bil~ary atresia. The 
livers were obtained from cadaver~c sources."" using an extracorporeal 
perfusion s) stem to provide interim circulation and cooling as the organ 
was removed.:' The times from donor death to revascularization in the 
recipient ranged from 163 to 320 minutes:' Splenectomy was performed 
in only one case (Patient 2). 
Inznzunos~rppress~on. Azathiopnne was used for the canine onho- 
topic experiments (Fig. 9) .  in quantities of 8- 15 mg./Kg. per da) for two to 
four days after operation and 2- I0  rng./Kg. per day thereafter. The highest 
dose possible was selected w hich d ~ d  not cause leukopenia. In three cases. 
this was supplemented after four to 12 days with a short cour\e of 
subcutaneous prednisolone, admin~\ ter~ng 20.100 mg./da) for four to ten 
days. 
Arathioprine wac u\ed in a comparable manner for canine auxiliary 
hornotransplantatlon studles (Fig. 4). In six of the I5 dogs. I00 mg./day 
subcutaneous prednisolone were also htarted on the dab of opemtion, with 
subsequent reductions In the dose every two d a s  to 50, 25, I0  and 0 mg. 
The use of azathiopr~ne wa\ similar In the clinical cases (Fig. I I .  12). 
Prednisone was used (100-200 mg./day within one-half to three and one- 
half days after operation in Patients 2 . 3  and 5.  and started before operation 
in Patient 3. This drug u a s  continued until death. Intravenous actlno-mycin 
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T A ~ L E  1 .  Pal/rologic l i i n d i n ~ s  i n  Auxiliary Canine Ilomograjis 
--- - 
'l'inic of 
Iliopsy or I'erivent~lar 
.\tctopsy General 1ntrahel)iltic Intrahcpatic Necrosis Immuno- Car~sc of 
NO. ((lays) Architecture Hcl~atic .\rtery Ijile Ducts Central V. cytes Death 
-- - - - -- . 
- - 
Only Hepatic Artery Open 
AHH 1 30 Cootl,central RIetlial anti in- \Yell pre- Xloderatr Periportal, Hepatic in- 
necrosis, motl- tirnal thick- ser\.eti tie- severe ficiency 
erate ening creaseti after re- 
number moval of 
own li\,er 
(28 clays) 
AHH 2 28 17air,central hletlial anti in- Well pre- Moderntc Periportal, 
necrosis, mod- tirnal thick- served severe 
erale; generally ening 
vacuolatetl 
1iep:itocytes 
72 Poor, only few 
hel)alocy tes 
remain 
Sc\.cre nietlinl 
anti intimal 
thickening 
Se\,crc I'eril)ortal, 
se\'erc ; 
gcncr:ll, 
moderate 
Sacrificed 
*AHH 7 28 Gootl, central 
necrosis, slight 
.\lctlinl thick- 
ening, Focal 
intirnai 
necrosis 
Coluninariza- 
tion, hyper- 
plasia, antl 
bile stasis 
65 I'air, central and 
scattercti necro- 
sis, motierate 
Tntinial and 
rnetlial thick- 
ening and 
focal necrosis 
Hyperl)lasia 
and bile stasis 
Motlerate Periportal, 
severe; 
general, 
slight 
Sacrificed 
Hepatic in- 
sufficiency 
after re- 
moval of 
own liver 
(27 days) 
*AHH 9 274 Cootl, some bncrr- 
olated hepato- 
cytes 
1:ocal intimal 
ant1 rnetlial 
necrosis 
Columnariza- 
tion 
None None 
Severe Periportal, 
moderate 
'AHH 10 19 Poor, diffuse loss 
of hepatocytes 
hieilial thick- 
ening, focal 
rnetlial and 
intimal 
necrosis 
Columnariza- 
tion, bile 
stasis 
Pneumonia 
Medial thick- 
ing and focal 
necrosis 
Columnariza- 
tion 
Severe Rare Not known n H H  14 33 Poor, central 
necrosis, severe 
Portal Vein ant1 Hepatic Artery Open 
AHH 3 26 Excellent, central hIetlial thick- Columnariza- hloderate Periportal, After angio- 
necrosis, slight ening tion, I i le  slight gram 
stasis 
I\HH 4 29 ]:air, central ne- Xfetli:il ant1 in- Kormal, tie- hfotlerate Periportal, Hepatic in- 
crosis, rnot1er- timnl thick- creaseti rnorlerate stcficiency 
:itc; gcnrr:~l c s r i i r l ~  n r ~ n ~ l ~ ~ r  alter re- 
iiq)%tocyle moval of 
v:icuoiizatio~i own li\,er (27 days) 
__.__ _ - .  
- -- . 
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- - 
Time  of 
I3iol)sy o r  I 'eri\ .c~iular 
A ~ ~ t o p s y  General In t  r;ihel);~ric Int  rahellatic Srcrosis  Jmmuno-  
S o .  ((lays) Architecture Hepatic Artery 13ile Ducts  Centra l  V. cytes  
AHH 5 29 Gooil, central ne- 3Icilial thick- Col t~mnariza-  Slight Peril)ortal, 
crosis, slight, ening tion moilerate 
focal periportal 
necrosis 
AHH G 27 Gootl, central ne- I.'oc:~l metlial Columnariza- Moderate  Periportal,  
crosis, mo~le r -  nccrrosis, in- tion slight 
a t e ;  focal tirnal thick- 
hcpatocytes ening. 
vacr~olization 
'AHH 8 13 Poor, central ne- In t ima;  thick- Columnariza- Severe None 
crosis, s e \ c re ;  en in^. focal t ion, hile 
perilmrtal ne- metlinl ne- stasis 
crosis, severe crosis 
'AHH 11 24 S o  sections 
AHH 12 20 Excellent, central Intinlal and  S o r m a l  Slight Per i l~nr ta l .  
necrosis, slight media! thick- slight 
ening;  focal 
mcilial ne- 
crosis 
*AHH 13 21 Poor, central ne- AIetlial thick- \Veil pre- Severe Periportal,  
crosis, severe ening ser\ ed, hile slig!lt 
stasis 
AHH 15 45 Gootl, central ne- hletlial thick- Hyperplasia Slight Peril)ortal, 
croqis, slight ; ening morlcrate 
motlerate peri- 
portal necrosis 
Cause of 
I lea  t h 
FIepatic in- 
sr~lhciency 
after re- 
mo\-al of 
own liver 
(28 days)  
After angio- 
gram 
Hepatitis 
own liver 
After angio- 
gram 
After angio- 
gram 
After open 
liver biopsy 
Sacrificed 
*Received eight day  course of pretlnisolone, s tar t ing on d a y  of operation. See tes t .  
C (200-400 micrograms/day) was administered every two to five days. In 
one case (Patient 2), 10 mg./day azasenne was given intravenously for two 
days after operation. 
Studies offunction. Numerous liver function s tud~es  were obtained. 
Analytic methods will be documented only for those determinations con- 
sidered in detail in the results. Bilirubin content of terum, urine, and T-tube 
drainage was measured by the method of Malloy and Evelqn," the one- 
minute reading being taken as the direct (conjugated glucuronide) frac- 
tion. and the 30-minute reading as the total bilirubin. Serial serum alkaline 
phosphatases were measured by the Bodansky method. Serum glutamic- 
oxalacetic acid trantarninase (SG-OT), serum plutamic-pymvic acid tran- 
saminase (SGPT), lactic acid dehqdrogenate (LDH). and isocitric acid 
dehydrogenate (ICD) followed similar postoperative patterns and, there- 
fore, only the results of the SCOT detem~inations will be described. 
Plasma sugars were analyted colorimetricall) on an autoanalyzer. 
Plasma pyruvates and lactate$ here  analyzed b> the metods of Friedman 
and Haupen. and Barker and Summerwn,'  respect~vely. Venous blood for 
lactate and pyruvate determination was collected without m s i s  in a tube 
containing 20 mg. potahslum oxalate and 15 mg. $odium fluoride. The tube 
was ~mmediatelq placed in an ice water slush at 0" C. and taken to the 
laboratory where the cellular elements here  removed by centrifugation at 
3,000 RPM for 10 minutes.,The plasma thus obta~ned was then frozen un t~ l  
the time of definitive anal!,i,. 
Plasma proteln fract~onat~on was detenn~ned h> paper electro- 
phoresis and fibrinogen a a ~  measured by the technic of Ratnoff and 
Menzie." Quick one-stage prothrombin times were obtained. Analysis of 
serum and urinary amino acids is referred to in the results section. A 
detailed account of changes in euglobul~n lysis times has been published 
elsewhere." 
Hapfofilohin t!pe.s. In Patient 5 of the clinical series. the serum 
haptoglobin genotypes of the donor and recipient were determined by 
vertical starch gel electrophores~s.*" The wells were charged with a 
solution cons~sting of 15 parts of undiluted serum and one pan of 10 per 
cent hemoglobin solution. After electrophoresis for I8 hours, the gel was 
divided into 7-3 mm, tlices and stained with 0 .  I C/r o-tolidine in acetic acid. 
The hemoglobin b~ndlng protelns appeared as blue bands. 
Srrunl in~muno~qiohulirrs. In addition. each of the three classes of 
~mmunoglobulins (gamma globulins) a a j  quantitatively estimated for Pa- 
tient 5 with a modif~cat~on '  of the immunochem~cal d ~ f f u s ~ o n  method of 
Huntley.Tommercially prepared*" goat anti-human earnma, globulin. 
anti-human gamma , globul~n and anti-human g a m m a ,  globulin were 
each incorporated Into separate volumes of Irk agar in 0.85C/r saline 
(buffered with veronal. pH 7.4. p 0.  IS) in a concentration of 7: 1. The agar, 
containing the heterologous ant~body was drawn into the lower portions of 
H!drolyzed starch was  the product of Connaught \ledlcdl Research Labora- 
torie\. Toronto. Canada. 
** Hlland Laboratone\. 4501 Colorado Blhd.. Lo\ Anzr.le\, Cal~fornla 
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Fig. 1.- Auxiliary liver homotransplantation in dogs. Note that the 
reconstituted portal blood supply is from the inferior vena cava. Chole- 
cystoduodenostomy is performed. 
Fig. 2.- Completed clinical homotransplantation. The reconstruc- 
tion is anatomically normal. The T-tube is placed through a stab wound in 
the recipient common duct, rather than through the anastomosis as shown. 
a series of silicone-coated capillary tubes, which were sealed and sup- 
ported vertically. An aliquot of the patient's serum was layered over the 
agar, and a precipitin band formed which migrated slowly through the agar. 
Tubes containing anti-gamma, globulin in the agar and overlaid with the 
patient's serum were allowed to stand for 24 hours. Tubes containing anti- 
gamma,, and anti-gamma,, stood for 72 hours. The distances traversed by 
the precipitin bands during these standard reaction times were measured. 
The level of each class of immunoglobulin in each serum sample was 
determined from standard curves. These curves were prepared simultane- 
ously using pooled normal human serum, to demonstrate the rel?tionship 
between distance traversed by the precipitin band and the log,, of the con- 
Fig. 3.- ~ ~ ~ i ~ ~ ~ ~ ~ h i ~  studies of auxiliary liver homograft (AHH 6 )  27 days after transplantation. A. Hepatic arterial supply B. venous supply. ~ o t e  
filling of small ramifications of both systems. 
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ALKALWE 
PHOSPHATASE IY) 
(Bodmskr Umlll m 
Fig. 4.- Course of dog with an auxiliary hepatic homograft. Azathi- 
oprine was the only immunosuppressive agent used. Note the irregular 
postoperative rises in alkaline phosphatase, SGOT and fibrinogen. The 
slight bilirubinemia depicted was uncommon. 
and connective tissue; periodic acid-Schiff (with and without previous 
diastase digestion of the sections) for identification of glycogen; 
phosphotungstic acid hematoxylin for study of connective tissue and 
definition of fibrinoid necrosis; trichrome stain for connective tissue, 
muscle and endothelium; Prussian blue iron stain; and bile stain. Sudan IV 
fat stains were applied to frozen sections from formalin-fixed tissues. A 
methyl-green-pyronin stain was used for Camoy-fixed paraffin-imbedded 
sections in order to demonstrate cells with high ribonucleic acid (RNA) 
content. 
Results 
Auxiliary Liver Homografts 
Clinical Course. Homotransplantation of an extra liver was well 
tolerated. There were only three spontaneous deaths, these occurring after 
13, 19, and 33 days (Table 1). The other 12 animals were sacrificed, died 
as a direct consequence of diagnostic instrumentation, or succumbed one- 
half to two days after removal of their own livers (four animals) of hepatic 
insufficiency. The dogs resumed alimentation quickly after operation and 
generally appeared to be quite normal. The period of postoperative study 
in the series ranged from 13 to 72 days. In six instances, the portal 
anastomosis was found to be occluded, an occurrence which did not 
influence the results in a distinctive way. Similarly, the use of steroid 
therapy did not demonstrably influence the biochemical or pathologic 
findings. 
When the anastomoses were patent, angiograms showed good filling 
of distal arborizations of both the portal and arterial systems (Fig. 3) 
without evidence of small vessel block. The reduced size of the ho- 
mografts, to be described below, was evident from these dye studies. 
Biochemical Studies. Although slight changes in serum bilirubin 
concentration regularly occurred (Fig. 4), clinically detectable jaundice 
developed in only two animals (maximum bilirubin 4.4 mg% and 5.8 mg 
centration of the respective immunoglobulin. %, respectively). 
Pathologic studies. Autopsies were performed as promplty as pos- Marked elevations in SGOT occurred in every animal. The mean 
sible after death. In most animal experiments, tissues were obtained imme- preoperative values were 27.8 f 2.3 (S.E.) S-F units. ~ostoperative, the 
diately or within a few hours. Delay between death and necropsy in the peak values were 293 f 56.9 (S.E.) S-F units after 12.7 f 2.1 (s.E.) days. 
human cases wasone-half, six, 12,12, and 16 hours. Specimens were fixed In instances* the rises occurred remittently (Fig. 4). 
in formalin and Camoy's solution. The most striking and sustained changes were in serum alkaline 
A variety of tissue stains were employed for study of the livers using phosphatase. From control levels of 2.2 + .1 (S.E.) ~ o d a n s k ~  units, the 
the technics summarized by [he ~~~d F~~~~~ ~~~i~~~~ ofpathology.~~ ne postoperative alkaline phosphatases rose to 203 * 36 (S.E.) after 18.3 f 2.4 
following histologic sections were prepared from formalin fixed and (S.E.) days. 
paraffin imbedded blocks: hematoxylin and eosin for general architecture; Preoperative plasma fibrinogens were 301 f 34 (S.E.) mg%. Postop- 
silver impregnation for reticulum; Verhoeff-van Gieson method for elastic eratively, these rose to 564 f 34 (S.E.) mg% after 7.6 f 2.6 (s.E.) days. The 
Fig. 5.- The auxiliary homograft (right) and the recipient dog's own liver (left) in experiment 
AHH 15. Note the well preserved but dimensionally reduced general structure of the homograft. The 
gallbladder did not shrink proportionately. The specimens were obtained 45 days after transplantation. 
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increases in fibrinogen occurred at an even earlier time than is apparent 
from the mean value, since the highest fibrinogen level in one dog occurred 
on the 34th day. Excluding this unusual animal (Fig. 4). the maximum rise 
occurred after an average of 5.6 days. 
Grosspathology. There was marked shrinkage of the homograft (Fig. 
5) in every animal which lived for more than 13 days. The homografts 
weighed from 120 to 265 Gm. in the animals autopsied from 19 to 72 days, 
as compared to 324 to 460 Gm. for the recipient's own liver. The gross 
architecture of the liver was extremely well preserved in each case. The 
lobar structure and relationships were quite identifiable (Fig. 5). The 
gallbladder and common duct were invariably intact, the latter structure 
often being even larger than normal. 
Microscopic studies. Preservation of general architecture ranged 
from excellent to poor. There was variable hepatocyte loss in every case 
(Table I), the principal areas of necrosis usually being around the central 
vein, although scattered focal necrosis was also sometimes present. The re- 
sidual hepatocytes were relatively normal (Fig. 6A) and stained PAS 
positive. In most specimens, there was considerable infiltration of 
mononuclear cells (Fig. 6) which were localized to the periportal area in all 
but two experiments (Table 1). In six animals (Table I), the degree of cel- 
lular infiltration was, however, very minimal or absent altogether, despite 
which other findings of rejection were present. 
There was a remarkable selective preservation of the duct system. 
The gallbladder was invariably an easily identifiable structure, which had 
excellent histologic preservation of general architecture (Fig. 7). Simi- 
larly, the common duct was minimally damaged. In many animals (Table 
I), the intrahepatic duct system had undergone columnarization of the 
lining cells, or actual hyperplasia (Fig. 6B). In 40 per cent of the specimens, 
there was evidence of bile stasis (Table 1) and frequently the ducts within 
the liver appeared to be dilated (Fig. 6B). 
The intrahepatic portal venous radicals were normal. The small 
arteries and arterioles had widespread changes, which were most 
prominent in the animals followed for the longest intervals. There was 
thickening of the intima and media, frequently leading to marked narrow- 
ing of the lumen (Fig. 6B). These changes usually appeared to be the result 
of intimal or medial proliferation, but focal areas of necrosis were also 
present in the intima and media of many vessels (Table 1). 
The hepatic reticulum was invariably preserved, but in an altered 
state. There was linear compression (Fig. 8) similar to that observed in one 
human case. In additon, there was some fragmentation and coarsening of 
Fig. 6A.- Biopsy of auxiliary hepatic transplant at 
28 days from dog AHH 7. There is increased cellularity 
in the portal area with good preservation of the ductal 
system. The adjacent hepatocytes are intact (from X 80). 
Fig. 6B.- Auxiliary hepatic transplant (AHH 7) 
after 65 days. The ductal system remains well preserved 
with columnarization and hyperplasia of the mucosal 
cells accompanied by moderate dilatation. The artery 
Shows marked intimal and medial hypertrophy and a 
perivascular inflammatory response. Diffuse loss of 
hepatocytes is seen in the neighboring area. H and E 
(from X 80). 
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the individual reticulum fibrils (Fig. 8). 
In two animals, serial histologic studies were obtained after one and 
two months, respectively (Table 1). In these dogs, the features of ho- 
mograft rejection were similar in both tissue specimens, although much 
more marked after the longer time. The progression of the changes in the 
inhahepatic ductal and arterial systems were particularly striking (Fig. 6). 
In one of these animals (AHH2), there was destruction of almost all of the 
parenchyma except for the ducts. 
Orthotopic Canine Homografts 
Clinical course. Eleven dogs died during the first three postoperative 
days, almost invariably as a consequence of outflow block and/or hemor- 
rhagic gastroenteritis. These have been reported before" and will not be 
considered further. Most of the other 14 animals made an uneventful recov- 
ery from pentobarbital anesthesia. They appeared to be healthy for the first 
few days after operation. Most resumed alimentation. Ultimately, all 14 
died, after three to 3 1.5 days. The gross causes of death were pneumonia, 
intussusception, pulmonary embolization, or gastro-intestinal perforation 
(Table 2). As will be described below, the extent to which homograft 
rejection contributed to the mortality was difficult to assess. 
Biochemical studies. It was oreviouslv established that untreated 
dogs developed progressive jaund;ce starting on the fourth or fifth day 
(Fig. 9) after hepatic hom~transplantat ion.~ Bilirubinemia was much less 
pronounced in the present treated series. The peak serum bilirubin concen- 
trations observed were 2.8 f 0.88 (S.E.) mg% after 9.8 f 2.2 (S.E.) days. 
The onset of jaundice was frequently a terminal event (Fig. 9). In half the 
experiments, elevations in bilirubin were never observed. A comparison of 
the course of an untreated dog with that of an animal receiving immuno- 
suppressive therapy is shown in Figure 9. 
Elevations of serum alkaline phosphatase also tended to occur late in 
the course, the maximum rise being 22 k 4.8 (S.E.) Bodansky units, after 
8.4 f 1.3 (S.E.) days. The very high values consistently demonstrated after 
auxiliary hepatic homotransplantation were not seen. 
In contrast to the alterations in bilirubin and serum alkaline 
phosphatase, rises in serum glutamic oxalacetic acid transaminase (SGOT) 
tended to occur earlier, the peak values being 207 f 21.9 (S.E.) S-F units 
after 5.4 f 1.3 (S.E.) days. The early rises in SGOT, which were thought 
to be the consequence of ischemic liver injury during operation, were 
reversible to a high degree. In the preterminal period when bilirubinemia 
and alkaline phosphatemia were prominent, SGOT's sometimes also 
exhibited a secondary rise (Fig. 9), but in other animals, the enzyme levels 
remained relatively low despite rapid deterioration of other biochemical 
parameters. 
Hypoglycemia, a common finding in the unheated animal" was 
never observed in dogs under treatment with immunosuppressive drugs. 
The lowest blood sugar ever recorded was 52 mg%. 
Gross pathology. The shrinkage so characteristic of the auxiliary 
homografts was not observed in the orthotopic specimens. Liver weights 
ranged from 330 to 740 Gm. In most dogs, there was gross homogeneous 
preservation of the specimen, although local intrahepatic abscesses were 
present in two. The tissue was usually more firm than normal. The vascular 
supply was intact in all 14 animals under consideration for pathologic 
analysis. The gallbladder and common duct were intact in all but one 
homograft, disruption of the cholecystenterostomy having occurred in the 
exceptional case. 
Microscopic studies. In all but one animal, there was some hepato- 
cyte loss (Table 2). the necrosis usually being concentrated around the 
central vein. 
There was a striking difference in the degree of round cell infiltration 
in the orthotopic as compared to the auxiliary hepatic homograft. Im- 
munocytes were completely absent in four of the orthotopic livers, and 
cellular invasion was not prominent in any (Table 2). The characteristic 
hepatocyte fallout was thus present, but without consistent evidence of 
classical cellular rejection (Fig. 10A). 
Fig. 7.- Low power scan of transplanted liver from dog AHH 7. The gallbladder is seen in the lower central 
portion of the figure. Note the good preservation of both the gallbladder and the intrahepatic portal tracts. The portal 
tracts appear to be hypertrophic and compressed. Mallory Trichrome Stain. 
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Fig. 8.- Reticulum stain of auxiliary homograft obtained after 29 days from AHH 4. The 
reticular scaffold is collapsed, coarsened, and diffusely fragmented (from X 80). 
The intrahepatic duct system was well preserved in every case; in 
four of the homografts there was either columnarization of the bile duct 
epithelium, or actual hyperplasia, the latter finding being most prominent 
in the animals living for the longest time. Ductular bile stasis was present 
in two specimens. Hepatic arterial and arteriolarchanges were present with 
medial and/or intimal thickening. In many instances, this appeared to be ; n. - 
due to medial or intimal proliferation, although the smudge lesions of focal ID' - 
necrosis were also present. The intrahepatic portal veins were normal. c *~ 
The hepatic reticulum was quite well preserved in every orthotopic m- D 
homograft, although there were areas of linear compression, and some - Y 
zones of fragmentation which were especially apparent around central ; .. 
veins in those grafts with marked hepatocyte loss (Fig. 10B). 2 a 
Human Liver Homografts 
Clinical course. The clinical courses of the five patients have been 
previously d e s ~ r i b e d ' ~ ~ ~ ~ ~  with particular emphasis on changes which oc- 
curred in the coagulation mechanism during and following ~urgery.~' The 
first patient succumbed from operative hemorrhage. The next four died 
after 22,7.5,6.5, and 23 days. The immediate causes of death in these last 
cases were pulmonary embb~ization; pulmonary embolization and gastro- 
intestinal hemorrhage: oulmonan, embolization and congestive heart 
failure; and bile peri&i;s due to common duct necrosis. ~ i G r  failure had 
an obvious role in the final outcome only in the last case, in which serious 
deterioration of hepatic function and a bleeding diathesis developed 
terminally. 
Biochemical studies. In all patients surviving operation, there was 
evidence of moderately severe ischemic injury to the homograft (Fig. 11, 
12). Serum levels of SGOT, SGPT, LDH, and ICD were markedly elevated 
for 24 to 48 hours. The highest SGOT's were 1,150,990,350, and 2,060 
S-F units, respectively, inthe last four cases. The serum enzyme abnor- 
malities were ra~idlv reversed. however. (Fig. 11, 12) and secondary rises 
. , . .  - 
did not subsequently occur evkn in Case 5. 
Preoperative jaundice was present in all but Patient 5. Postopera- 
Fig. 9.- Comparison of course of untreated animal (left with that of 
dog treated with azathioprine and prednisone (right). The treated dog died 
after 31 days with a perforated gastric ulcer. Note difference of bilirubin 
and alkaline phosphatase in the treated compared to the untreated animal. 
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tively, the jaundice initially deepened in all but Patient 3, the increased 
early bilirubinemia reaching a peak as long as eight days after operation 
(Fig. 12, 13). Bile which began to issue from the common duct in all the 
adult cases during the operation was later shown to have a bilirubin 
concentration as high as 250 mg% (Fig. 13). The reversibility of the biliru- 
binemia was similar to that of the SGOT, except that it occurred at a later 
time. The early rise in bilirubin was also thought to be due to acute ischemic 
injury, rather than to early rejection. 
Serum alkaline phosphatase was elevated preoperatively in all four 
of the adult cases, with a range of 12 to 35 Bodansky units. Postoperatively, 
these serum levels were persistently reduced to or toward normal in every 
instance (Fig. 11). The terminal alkaline phosphatases before death were 
5.3, 6.7, 10.4, and 8 Bodansky units in Patients 2 to 5. 
Prothrombin times which ranged from 40 to 100 per cent preopera- 
tively were maintained above 25 per cent in each case except the last one. 
In this patient, the prothrombin time was severely depressed from the time 
of surgery until death (Fig. 12). In all patients, there was a slow decline in 
total serum protein, but severe hypoproteinemia was present only in 
Patient 5 (Fig. 12). Specific changes occurred in plasma fibrinogen content 
which have been previously described in detail." These consisted of 
depressed fibrinogen content intraoperatively, with an almost immediate 
rebound which lasted for several days. In Patient 5 (Fig. 12), this sequence 
was seen but to a lesser degree than in any other case. 
As mentioned above, progressive liver failure was present only in the 
last patient. In this case, restoration of liver function toward normal was 
intempted on the 17th postoperative day after the patient developed acute 
abdominal pain. Hepatic function had been poor from the time of operation 
(Fig. 12), with persistently low prothrombin times, rapidly falling serum 
proteins, low plasma fibrinogen concentration, marked bilirubinemia, and 
low-voume T-tube drainage (50-150 ml../day). Although hypoglycemia 
did not occur, there was evidence of deranged carbohydrate metabolism. 
Progressive rises in serum pyruvate and lactate levels were observed (Fig. 
14). beginning on the fourth postoperative day and reaching peaks of 3.4 
mg% pyruvate and 73.4 mg% lactate. Excess lactate, calculated from 
Huckabee's formula," was as high as 31 millimoles per liter. 
Several factors which are known to influence lactate levels may have 
Fig. 10A.- Orthotopic canine homograft (HH 4) 
after 31 days. Note central loss of hepatocytes with good 
preservation around the portal tract. Immunocytes are 
absent. H and E stain (from X 80). 
Fig. 10B.- Same dog. Mote general preservation of 
reticulum, but with focal areas of collapse and fragmen- 
tation. Reticulum stain (from X 80). 
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Fig. 11.- Course of Patient 3, who had an intrahepatic cholangio- 
carcinoma. Skeletonization of all major structures entering and leaving the 
liver was canied out two weeks before defin~tive transplantation as shown. 
Note early rise in SGOT after transplantation. The sudden falls in serum 
bilirubin and alkaline phosphatase after each operation may have been a 
dilutional effect due to multiple transfusions uith fresh blood. 
been present including steroid therapy, pain, and hyperglycemia, although 
none of these lead to the production of calculated excess lactate." It is 
probable, however. that the lactic acldem~a is explicable by the mechanism 
defined by Ballinger' who demonstrated the inability of the hypofunction- 
ing liver to effectively metabolize normal or increased quantities of this 
substrate. Less striking elevations of serum pyruvate (higheqt 2 mg%) and 
lactate (highest 33 mg%) were documented in Cases 2. 3, and 3, but since 
all three patients had hypoxemia as the result of pulmonuy enlbolization, 
the significance of the findings is less clear than with Case 5 in which 
anoxic episodes were absent until terminally. 
In Patient 5 ,  the unconjugated plasma amino acids were studied 
serially by means of h ~ g h  voltage electrophoresis.* There was a general- 
lzed increase in the concentrations of I ~ s i n e ,  histidine. glycine. alanine. 
serine, \ d ine ,  glutamine. and taurine. 
Huproglohrr~ Srudie.~. The haptoglobins constitute a population of 
serum proteins characterized by the11 abilit) to fo rn~  a stable bond with 
hemoglobin.- The liver has been postulated to be a site of haptoglobin 
production.'The molecular heterogeneity of these henloglobin-binding 
proteins was demonstrated by Smithies \\ho obserked that serum protein 
fractions from nonnal subjects hod different mob i l~ t~es  when subjected to 
electrophoresis in a starch gel:' Smithies and Walker subsequently re- 
ported that the type of haptoglobin produced b) an lndi\ idual was under 
genetic control.'. Three major t ) p e  ae re  identified and designated 1-1.2- 
I and 2-2.,' 
In Case 5 ,  in uhich the donor and recipient were of dlffernt geno- 
types, haptoglobin studies were perfomled. Electrophore\~j of the donor 
serum, obtained or1 the day of  h ~ s  death. revealed the hapto_elobln genotype 
to be 2-2. The serum of the recipient in Case 5 wa\ examined prior to the 
surgical procedures, between the first-\tape operatlon and the transplanta- 
tion, and on several occasion\ after the 11ver transplant,ltion. The original 
haptoglobin type was 2- I 
* Amino acid dererm~nations performed by Thomas C. Wood. Jr.. medical 
Student Univers~t~ of Colorado School of Med~cine. Manu\cr~pt is In preparation. 
The first post transplant serum was obtained after two days. The 
haptoglobin genotype had changed to an unmixed 2-2. the genotype of the 
liver donor. The haptoglobin patterns of the donor and the rec~pient, before 
and after transplantation, are shoun in Figure 15. 
Later in the postoperative period. demonstrable haptoglobins disap- 
peared entirely. The 2-2 haptoglobin pattern was faint but probably present 
on the fourth postoperatlve day, but u a s  not detectable thereafter (Fig. 16). 
The 2-1 haptoglobin did not reappear. 
The biologic role of haptoglobins 1s not clear. although the11 possible 
functional significance and the wa) in w hich they are influenced by various 
disease states including trauma. liver disease and steroid therapy, have 
been the subject of a recent publication.' The observance of pure donor 
genotype in the reclplent 15 of interest for two reasons. It prov~des  evidence 
that the source of haptoglobin is hepatic. In  addition, it demonstrates a type 
of proteln synthesizing actlvlty of the neu li\er. The disappearance of  the 
new haptoglobin after four da)s cannot be conctrued, however. as being 
due to complete cessation of function of the homograft in vlew of  the sub- 
sequent survival of 19 dais. and because other factors are known to mask 
the presence of t h ~ s  ubstance.' 
Immur~o~lohuirr~s .  The seruni concentrations of ~mn~unoglobulins 
were serially determined In Patient 5 .  and compared to standard values de- 
rived from analqsis of pooled human sera.' 
When the recipient patient was first studied. before both the prelimi- 
nary and definitive surgical procedures. the values for gamma. globulin, 
gamma, ,  globulin, and gamma a globulin were withln the normal range 
(Table 3). The concentration of g a m m a  globulln fluctuated considerably 
during the first three weeks after li\er transplantation. Forty-eight hours 
before death it fell to significantly lower levels. The concentration of 
gamma \, globulin rose significantlj on the fourth postoperatlve day. The 
level subsequentlj fell and b) the end of the th~rd  postoperatlve week, it had 
returned to the presurger! \ d u e  (Table 3 ) .  Gamma,* globulin fell imme- 
diately after transplantat~on and then remained relatively constant until 48 
hours prior to death when the concentratlon fell still further. The changes 
in the concentratlon of the specific classes of antibody proteins are not as 
remarkable as the changes In prote~n fract~ons. as measured by electro- 
phoresis, reported by Hume ' and Kukral ' after human renal and canine 
hepatic transplantation respectively. The ~solated increase In gamma,, 
globul~ns is. however. of Interest. 
Gros.\ P u r h o l o , ~ ~ .  All organs nppelved to be essentially normal. The 
weight of the chlld I~ver  was 220 Gm. The weights of the four adult livers 
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were 1,700, 2,070, 1,720, and 1.760. Upon section. the livers seemed 
somewhat more pale and firm than nornial. In Patient 5 ,  there was a 2 cm. 
abscess in the right lobe. In the same case, there was necrosis of the distal 
1 cm. of the homograft common duct. 
Histologic Fitldings. There was extensive autolysis in the first 
homograft (Patient I ) ,  which was apparently due to an excessive period of 
ischemia. The other homografts were generally well preserved (Fig. 17- 
20) with from fair to excellent over-all architecture (Table 3). The reticu- 
lum was quite normal (Fig. 18B) in all but Case 5, in which focal areas of 
linear compression bere  present (Fig. 20B). In Cases 3-5, the intrahepatic 
arteries and arterioles had Inconstant intimal and medical thickening 
similar to that described above in dogs (Fig. 18A, 19). 
The intrahepatic ductal system was intact in each case. In one of the 
homografts (Case 2). there was columnariration and hyperplau~a. but this 
was in a liver provided by a sporadic drlnker. Trichronie stains revealed the 
presence of minimal periportal fibrosis in t h ~ s  specimen. There was 
evidence of moderate bile staqis (Fig. 17, 20A) in ti40 homograft?. The 
central veins were intact but there was slight to moderate perivenular 
necrosis in three of the four cases surviving operation. 
Immunocytes were found in the periportal area in s~gnificant num- 
bers only in Case 3 (Fig. 18), although a f e a  lymphoc) tes and plasma cells 
were present in Cases 2, 4, and 5 (Fig. 17, 19, 20). MGP stains were 
negative in all cases. 
The hepatocytes were PAS positive in Cases 2, 3, and 4, but no 
glycogen whatever was present in the liver cells of the homograft from 
Case 5. In Case 3,  there was a diffuse fatty metamorphosis (Fig. 18), and 
in Case 5 the individual hepatocytes were poorly preserved (Fig. 20). 
Intracellular bile pigment was present in Cases 4 and 5.  
The state of preservation of liver architecture was generally much 
better in the human cases than in either the canine auxiliary or orthotopic 
homograft series. 
Discussion 
From the foregoing data, there can be little doubt that the vigor of the 
rejection process was considerably attenuated by the immunosuppressive 
regimens which were employed. Prolongation of survival was obtained in 
the animals receiving orthotopic livers. The biochemical response was 
considerably different from that which invariably transpires after hepatic 
homotransplantation in the untreated animal.'"-' Finally, the state of 
histologic preservation of the homografts was far better In all three groups 
than could have been expected In untreated recipients. It is of interest that 
control of rejection in the human cases was more complete from a 
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Fig. 13.-Course of Patient 2. showing relationships of serum bilirubin. T-tube drainage volume 
and bilirubin content of T-tube bile. Note temporary uorsening of jaundice after transplantation. 
histologic point of view than in the orthotopic dogs at a comparable time 
after operation, suggesting that the magnitude of the problem may be less 
in man as has seemed to be the case with renal homografts. 
Despite these encouraging findings, evaluation of refinements in 
drug therapy has been difficult. Past efforts to potentiate hepatic homograft 
survival with total body irradiation have been completely unsuccessf~l. '~ 
In the present study the only agent shown to be of unequivocal value was 
azathioprine, and even this compound was incompletely effective. It ha s  
not possible in dogs to demonstrate with any objectivity a consistent 
improvement in results a i t h  the addition of prednisone to the basic 
azathiopnne regimen. If a beneficial steroid effect is present, as has been 
demonstrated after canine renal homotransplantation.', it is probably being 
obscured b) the many other pitfalls w h ~ c h  make difficult the consistent 
attainment of a useful liver preparation:' Alternatively, the possibilities 
must be conceded that the varlous drugs used are not so selective in 
preventing hepatic de,truction as they are in preventing renal homograft 
repudlat~on, that the 11ver i\ rnore highly antlgenlc and evokes a crushing 
immunologic response, as Greene's heterotransplantation s tud~es  would 
5eem to indicate." or that hepat~c tlssue is lnherentlq more vulnerable to 
rejection injury. 
Special attention should be directed to the intluencc of irnrnunosup- 
pression upon the pathologic feature, of reject~on. In the untreated recipi- 
ent, the most prom~nent findings arc those of classical cellular rejection, 
with earl? and extenrive invation of I)rnphocyte\ and plasma  cell^'^'^^^^ 
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Fig, 14,- Change\ in senlrn lactats ;ind ~ ! r u \ d t s  In C3\5 5 .  .A tran\lrnt eie\atlon occurred 
immediate]) poitoperativel~ u ~ t h  \ilb<equsnt dscl~ns  toward nornlal. The \sconiiar! n.e beginning 
on the fourth day was progres\l\e. Uots the iion?i,il lo ~ncrea\ed level> of plabma sugar. Normal 
ranges for serum Iricmle anti p j  rut Jir we ~ndlcatsd b? ths shaded bars. 
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Fig. 15.- Starch gel electrophoresis showing the haptoglobin geno- 
types of donor and recipient in Case 5. The genotype of the recipient prior 
to surgery was 2-1 (left) and the donor was 2-2 (center). The donor type 
haptoglobin was found in the serum of the recipient on the second 
postoperative day (right). 
which occurs coincidentally with or just before rapid disappearance of 
hepatocytes. Inflammatory changes in small hepatic arteries and arterioles 
have also been des~ribed.'.".~~.~~" It has been traditional to regard the 
cellular invasion as the primary event in the process with the small 
lymphocyte being the actual agent of de~truction.'~ 
With immunosuppression, the alterations are often strikinly differ- 
ent. The geographic distribution of hepatocyte dissolution is the same, 
being concentrated most heavily in areas around the central veins. The 
arteriolitic lesions are also found in various stages ranging from focal intra- 
mural necrosis to medial and intimal thickening and proliferation. But 
these changes may occur without significant invasion of immunocytes. 
The high incidence of non-cellular rejection in the orthotopic canine 
series necessitates a re-evaluation of the mechanisms of hepatic homograft 
rejection, just as has been the case for similar reasons in the field of renal 
hom~transplantation.'~.~'.~~ Physical contiguity of immunocytes to the par- 
enchymal cells is apparently not a req~isite.~' Instead, there is increasing 
reason to suspect that humoral antibodies may play a crucial role. Sicular 
and his associates" have obtained circumstantial evidence that gamma 
globulin is fixed in the macrophages, bile ducts, vessels, and hepatocytes 
of the transplanted liver. More recently, Popper3' reports that the greatest 
selectivity of antigen-antibody complexing is in the hepatocytes, a finding 
which could readily explain many of the pathologic findings in the 
presently reported series. 
Whether or not the non-cellular rejection seen during immunosup- 
pression is fundamentally different from the better known variety of tissue 
repudiation in untreated animals is open to question. It is possible that the 
primary mechanism in either case is served by humoral antibodies, and that 
the immunosuppressive treatment merely slows the process sufficiently to 
allow observational dissection of the serial events. In this concept, the 
Fig. 16.- Starch gel eletrophoresis of the recipient's serum on the 
second, fourth, sixth, tenth and 17th post-transplant days (left to right). No 
haptoglobins could be found after the fourth day. 
monocytic invasion of the classical cellular rejection could be viewed as 
a secondary phenomenon. It is also equally possible that humoral and 
cellular rejection are different and independent processes. 
The high incidence of arterial abnormalities in the livers is of special 
interest in view of the growing evidence that an ischemic vascular factor 
is of importance in the rejection of skin: cardiac" and kidney'5.1'," ho- 
mografts. The significance of these changes in hepatic transplants is not 
known. Moore2' in postmortem studies has demonstrated areas of poor 
filling in the hepatic arterial tree, and has suggested that similar devascu- 
larization may occur during life. Such changes could not be demonstrated 
in the present study with in vivo angiography, but the degree of small vessel 
definition was not so great as with his technic. Although acute vascular 
disease may contribute to the homograft failure, Popper's3' observations 
which were cited above as well as the frequent observation in the present 
study of selective liver cell injury cany the important implication that the 
hepatocyte rather than the vascular or duct systems may be the primary 
target. 
The auxiliary homograft preparation of Welch and Goodrich and 
their  associate^^.^' proved to be a useful tool in studying many aspects of 
hepatic homotransplantation. Delineation of the homograft vascularity 
could be conveniently accomplished. Consistent chronic survivals could 
be kept for late histologic examination. The selective preservation of the 
duct system was most evident in this group of animals. The hypertrophy 
and hyperplasia of the intrahepatic ducts, changes described by Mackay'' 
and Paronettom in liver diseases suggested to have an autoimmune basis, 
were most evident in this preparation. 
Nevertheless, the relative ineffectiveness of immunosuppression in 
the dogs with auxiliary livers is both noteworthy and discouraging in 
regard to clinical application of this technic. The degree of cellular 
invasion and hepatocyte loss was much greater than with the orthotopic 
livers. Furthermore, a very rapid diminution in size occurred after two 
weeks. 
Several ~ossible ex~lanations mav account for these findings. 
- 
Immunosuppressive therapy, which is partly dependent upon monitoring 
of function, was not delivered so incisively. The abnormal revasculariza- 
tion may have contributed although this is unlikely since dogs with 
portacaval transposition do not have loss of hepatic m a s 4  Competition 
with the dog's own liver for nutritional substrate may have been an unfa- 
vorable condition. Finally, the dog's own liver with its large reticuloendo- 
thelial mass may have contributed substantially to the immunologic 
reaction in the auxiliary homograft series, a factor which would be 
eliminated in the orthotopic preparation. 
CLIO CHIRURGICA 
h'ecrosis 
a t  Inlr~?l?rl~.ctic Cclrtr.11 
xo, Survivnl General .\rcllitccture Keticuh~nl Helmtic .\rlcry Rile 1)ricts Vein I m n , ~ ~ n t ~ y t e s  Kr~l!lTer Cells f l e ~ ~ a l o c ~ l e s  
. --.. .- 
. . 
P --. 
.. _. _~ 
Case I 4 I 1)ilTuse al~tolysis lntact 
Ca5e 2 22 Dn. Excellrnt Intact Normal 
Case .1 if 1)a. Gnorl; c?nIr:rl nnrl Intact Intinial thick- 
scatlrrc~l foc:il elring n ~ ~ r l  1x0- 
necrosis, nioclrrate liferation 
case 4 6f l )a .  Good; ccr~triil arirl Intact hle~lial :1rr11 % r r l , -  
scatlcrcrl focal inti~i~al tl~ick- 
necrosis, i~~iirin~nl eriin~ an11 
focal rircrr,sis 
None Peril)ort:~I, rnini- 
ma1 hI(;l1 
negnli! e 
Sornr:rl Slight Per~l~ortaf, 
slipht h l t i l '  
nc~a t i \  e 
Sc~rni:rl; morl- \\'ell l~rcser\erl 
erntc i rnn  r.\S+ 
corllerrt 
and <mall 
arnorlnl hile 
Case 5 25 Da. I.'nir; ceritrirl necrosis, local arr:rs i n  a i n -  Sorrr~nl; hlorlerate l'eril~~trtal, niini- Xr1rt11:rl; ri1011. I ' r~orly l tr~,sc~\c<l 
rnnclrratc; nricl- of linrnr tirnnl t l r i r k -  hile stacis, ninl Jl(;l' crate i r ~ r ~ ~  Pi\S- ; Cotit:xitr 
aonnl rivcrosis, co~ii~m"~iori ening, nlilli11t:tl nroclerate negati\ e corrtcrrt i ron  nnr l  liile 
morlerate l~ip,~rlri~t, lnrgr 
amounts 
- ..p---p--p----..-- ~~. - 
-- 
Summary 
The influence of immunosuppressive drugs upon rejection was 
evaluated in 40 dogs which received orthotopic or auxiliary hepatic ho- 
mografts. and in five clinical cases of orthotopic liver transplantation. The 
effectiveness of azathioprine and steroid therapy was judged upon serial 
measurements of function. upon duration of survival, and upon findings at 
~atholoczic examination. 
- 
Definite mitigation of rejection a as demonstrated in all three groups. 
From a histologic point of view. immunosuppression was most successful 
in the human-cases despite the ernploy&nt of badly ischerniat~zed 
cadaveric organs. Orthotopic canine homografts were lesh completely pro- 
tected, presumably because of a species d~fference in the vigor of rejection. 
The moqt severely damaged specimens were the c:tnine auxiliary livers 
which were placed in the right paravertebral gutter w~tholrt renloval of the 
recipient's own liver. 
In dogs treated with immunosuppressive agents, rejection was often 
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observed in the absence of mononuclear cell invasion. The homografts in 
such dogs commonly had central necrosis and diffuse vascular lesions, 
with selective preservation of the duct system, the general location of 
principal hepatocyte loss beins the bame as previously reported in non- 
treated animals. The pathophysiologic nlechanims in such non-cellular 
rejection are considered. It seerns pobsiblc that the hepatocyte is the 
primary target of attack by reclplent ant~hodie\.  Alternatively, the vascu- 
lar lesions may cause secondarq iichemic injury to the parenchyma, in 
spite of the fact that angiogram, i r i  t h ~ s  study talled to \upport this 
poss~bilit). 
In dogs, the use of optimall) prerened homografts makes possible 
the accurate ~den t~ f i ca t~on  of rejection wlth b~ochemical mea7urements. 
This diagnosi> wa\ made difficult II? the cl~nical cases because of the 
employernent ot cadaver~c organ\. which do not function normally as a 
consequence of ligonal and posmioriern i \chem~c II IJUS) .  Nevertheless, the 
results of serial liver te\t.; sugge\tsd that rejection was nut functionally 
present in an) hut Case 5 of the huma:i series during \un .~ ia I  periods of 6.5 
to 23 days. 
Several previousl> unrecorded ohsen~l t lvns  are tIt.\cnbed concern- 
ing more esoteric hiochernical change\ after hepatic horn,)rr,tnspIantation 
including alterations in \erurn or pla\ma irnrnunoglobul~n~. amino acids, 
pyruvates and lactates. In addir~on. ;i ca5e is documented In which the 
haptoglobin per lotpe  of the recipient con\srted to that of the donor. a 
finding which bupportz the concept that the liier 15 the o n l ~  \ource of this 
substance. 
Addendum 
A greatly increased iurvival after orthotopic canine homotransplan- 
tation has been achieved ui th  the comhination of daily azathioprine and 
intermittent intravenous doies of S" methionine which was alluded to in 
the discussion. Methionme was p ~ i e n  every 5 days in a dose of 1.8 mg. 
carrying approxinlatel) 90 n~icrocunes of S '. Eleven of 20 dogs so treated 
have had sunival of more than a month. The longe5t \ur\ i\ 31 obtained thus 
far has been 4-11-4 months. the aninla1 rt111 being all\? u ~ t h  normal hepatic 
function on Jul) 28 .  1961.1Vhethsr or not the i n ~ p r o ~ e d  re~ult.  are actually 
due to the add~tion of rsdloacti\i. rnethionine to !he rzglrnen or to some 
other unsuspected tactor ha< s t  to be detsrm~ned. 
Since the submi~l ion of th!.; n?:,nu,cript. Dr. Thoma5 \larchioro has 
produced Ttronp e\ idence that conipstlrion for a!!mentan nurritional sub- 
strate occurs ~31th the uie of th? s u \ i l ~ a n  li\':r 3nJ ihdt this 1, the cause for 
the rsrn,irLable diminution of hon~ogiaft .!re Ss5cribed in the bod) of the 
paper. b h e n  the hornoprdft rather th-n !he dog'< on  ri I I \  er I \  \ ascularized 
with >planchnic \enou, f lou.  the ;~ t l \ ! l ! , i~  honlograft retdinl its size and 
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Fig. 18A.- Homograft in Patient 3, after 7.5 days. 
A. The periportal infiltrate was greater than that seen in 
the other human cases, but the cells were MGP negative. 
Ducts are normal. Arterial medial and intimal thickening 
were seen. PAS stain (from X 80). 
Fig. 18B.- Homograft in Patient 3, after 7.5 days. 
Intact reticular structure. Note fat infiltration, which was 
proved with Sudan IV stains. Reticulum stain (from X 
80). 
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Fig. 19.- Homograft from Patient 4,6.5 days postoperatively. Liver is almost normal. Note thickening of artery in 
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Discussion 
Dr. Francis D. Moore (Boston): I would like to congratulate Dr. 
Reemtsma and Dr. Starzl for their interesting and very impressive efforts 
to discem the immunogenetic sequences in heterotransplantation and 
hepatic rejection. 
(Slide) This slide is from a paper that we presented here in 1961, and 
it shows the healthy liver cells and the immunocytes in the portal area of 
an untreated hepatic homograft with good liver cell function for many, and 
a later rejection sequence characteristic of cholangiolitic hepatitis with 
small bile duct obstruction. 
Under immunosuppressive chemotherapy the whole picture is 
changed. This shows a similar animal at about ten to twelve days. There is 
practically no immunocytic rejection whatsoever. 
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Fig. 20A.- Hepatic homograft from Patient 5. Note the poor staining quality of the 
liver plates and individual hepatocytes. Immunocytes are rare. H and E stain (from X 80). 
(Slide) However, the vascular lesion is most impressive. This is a 
postmortem hepatic arteriogram of a dog with a hepatic homotransplant 
under immunosuppressive chemotherapy, and it shows large areas of 
ischemia with closing off of terminal arterioles which, in serial section, do 
not show thrombosis. 
(Slide) This is an in vivo hepatic homotransplant arteriogram under 
immunosuppressive chemotherapy. This shows the arterial anastomosis. 
We can see the dye running into the liver well, but not filling it as well as 
we would like. 
(Slide) And here is the matching portal venogram. Here is the 
anastomosis here (indicating), filling the liver fairly well but evidently not 
enough to keep it alive. This is definitely a phase of rejection; it is not seen 
in the autografts. 
While the immunogenetic rejection response is easily abated in liver 
homotransplantation by the use of immunosuppressive chemotherapy, this 
has not resulted in the long-term maintenance of canine liver transplants 
after total hepatectomy. Dr. Starzl has had better results than we have had. 
We have never had a dog go longer than 14 days. He has had one at 30 days. 
In this rapidly growing field of homotransplantation it is important 
to recognize things that we have not achieved. The long-term laboratory 
survivor is needed, and we do not have any! 
In the case of liver we believe that the cause of this failure is vascular, 
probably a vasospastic or nonthrombotic vaso-occlusive feature of reJec- 
tion. Our single human experience corroborated this interpretation. 
Such long-term maintenance has likewise not been attained for heart, 
lung, adrenal, or pancreas, to name but a few organs with which members 
of this society are laboring. 
This point is an important one, because the first successful long-term 
kidney transplantation in man between individuals related more remotely 
than fraternal twins was preceded by long-term survival in the laboratory 
using a protocol very similar, if not identical, to that later used in man. 
Intra-order heterografts, such as chimp (or baboon) to man are 
likewise susceptible to careful laboratory preparation and study. Now that 
this area has been invaded by assault, it would seem wise to slow down and 
entrench our position by careful laboratory study of the rejection immunol- 
ogy in intra-order primate heterografts involving the several available 
primate species other than man, in the hope of obtaining laboratory 
verification before pressing the human patient, who has something to look 
forward to from a homograft. 
The ethical problem, in short, is that of science as a whole. Good 
science is ethical science, and in relation to Dr. Fior's talk, good biological 
science views the whole man and the whole problem with care and caution. 
Dr. C. Stuart Welch (Albany, New York): I rise to add my congratu- 
lations to Dr. Starzl and his group for the experimental work which they 
have been performing, and particularly that which has related to their 
studies on rejection reversal. 
My own interest in transplai~tation of the liver and in discussing this 
work is on a technical aspect rather than on the immunosuppression side 
of it. As Dr. Starzl said, we did our first transplants of the dog's whole liver 
in the lower abdomen. It is not necessary to place the liver transplants in 
the usual anatomic site in dogs, even though hepatectomy be done, and it 
is my belief that when the rejection phenomenon can be shown to be 
controlled, liver tranplants in the human being will then be justified. At the 
present time we have not attempted to do any. 
I also believe that liver transplants may have their greatest applica- 
tion in treating patients with cirrhosis of the liver, which is a particular 
interest of mine. In most instances of this diseases hepatectomy need never 
be done. 
Dr. Starzl also suggests here today that from the immunosuppressive 
aspect it may be important to do it, but if the latter is controlled, hepatec- 
tomy should not need to be done in cirrhosis of the liver. At most, perhaps, 
a pokacaval shunt would be necessary, leaving the old liver in pius 
a homotransplant of the liver, which could be done in the lower abdomen. 
This field of transplantation of the liver should be more rewarding than 
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Fig. 20B.- Hepatic homograft from Patient 5. Focal reticularcompression, seen in the central part of the field. Reticulum 
stain (from X 80). 
Fig. 20C.- Hepatic homograft from Patient 5. High power view of hepatocytes. Note variation in size and shape of 
hepatocytes and their nuclei. The liver cells contained no glycogen. PAS stain (from X 320). 
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hepatectomy and transplantallon for cancer of the liver. 
The size of the whole liver - and this is one of the technical aspects 
I wish to discuss -offers some obstacle to lower abdominal transplanta- 
tion. and we have been working on this subject. In recent experiments we 
have shown that only half of a l~ve r  (homotransplant) will sustain life in 
hepatectomized dogs and not only do some of these livers live but dogs will 
live hepactectomized when o n l ~  the arterial blood \upplj is reconstituted. 
Of 22 experiments of hepatectorny plu\ homotran\plantat~on of half 
the liver. six were successful. in that they wrvived over 24 hours, but four 
had rather longer survivals. Four homotransplants of the middle and left 
lobe in hepatectomiled dog5 survived from four to I2 days. These are only 
prel~minary experiments. but the sugge\tion I \  pre\ent that portions of the 
whole liver may ultimately \ur\,ive. which mean\ that a source of ho- 
motransplants from Ilve sources may be pojjible. 
I believe the tran\plantat~on Into the loucr abdomen 1s easier to do. 
and may well be the site of choice for tran\plant;ition In many d~\eases ,  and 
particularly in cirrliosi\. nlien it become\ feasihlt. to do these on a large 
scale. 
Dr. Joseph E. Mur ray  (Bojton).  I'djust like to a\l\ orie question of 
Dr. Starzl. and possibl) Dr. bloore. 
Is it a valid assuniptlon that immu~ie suppre\\ion I \  adequate because 
cellular infiltrate is lacking? In kldne) trnn\plant\ under irilrilune suppres- 
sion we see as many as five or 51s different m~cro\copic patterns of 
rejection only one of ahich i\  characterized b! cellular infiltrate. Dr. 
Moore has intmiated that the vascular Icsion whlch he descr~bed is on an 
immunological baus and I wonder if the li\er progran might better be 
directed toward testing some other drug\ unrelated to afathioprine. The 
vascular lesion which Dr. Star/l and Dr. Moore d e \ c r ~ k \  alrno\t certainly 
has an immunologic component to it. 
Dr. T. E. Starzl (closing): In answer to Dr. Murray's comments, it 
has not been our assumption that the absence of immunocytes means that 
the rejection process has been controlled. On the contrary. it is our view that 
noncellular rejection is t>plcal of the reaction u h ~ c h  we are going to see 
with Increa\lng frequent! in l~\ers . jus t  a5 has been observed a i th  kidneys. 
I think hi\ other coninients are cer). appropriate also. At the present 
time u e  are working with S- . iS-n?r th~on~ri  in the laboratory. using this 
radioactive ammo aciti a\  ari adju\ ant to Iniuran. The atudy is not complete, 
but the re\ult\ are encouraging. 
Concern~ng Dr. Welch'\ cornrnsnts. I think the reasoning behind his 
pioneer \tudie\ wa\ the \ame a \  our\. We had hoped that the patient 
recei\ lrig an organ a\ fiinct~ori;iIl) complex a\ the liver would ha\ e a k t t e r  
chance to i un lve  I E  d u r ~ n s  the rejection cr~sis  there \bere a funct~onal 
backstop from the nn~rnal ' \  or the patlent'> owti organ w h ~ c h  could k left 
in place. H o u e ~ e r .  the lriab~ltt! to C O I I ~ S O I  the rejection under these circum- 
stance\ h;i\ heen ;I d~\coiiraging orie. arid I t h ~ r ~ h  11 1, an 111 omen as far as 
an) u\e of t h ~ i  technic emplo!Inf ~ L I \ I I I ~ I I - )  ~rg;il i \ .  
The e.;plnn,~t~on for tt,e le,\ t a~orah le  heha:lvr of the auxiliary 
homograft is not clear. It rn,i) he that the injured li\er IS competing for sub- 
strate wlth the ,inimol'\ o\\il I~ \ e r :  that a e  are not t rnck~ns l i ~ e r  function 
so well. and rherctorc not treating rejzctlnn a \  effectl\el!: that d i \ ,erbl~nof  
the portal flow and \ e m u \  re\a\culari/ation from the \)\ternic r)\tem 
might be a factor. although Dr C h ~ l d ' \  t u d ~ s \  often !ears or more ago with 
tran\po\~tion are agairi\t ttii\: or that h? rerno\al of the xilrnal'a own liver 
there i5 a lo\\ ot the ret~c~iloendoltieilal In one versus the other 
s~ tua t~on .  
Dr. blciore'\ philo\ophic corilrilents arc certa~nl) appropriate and, as 
he know\. the) expre\\ our op~nion\  al\o. at least as far as the liver work 
is concerned. 
IMMUNOSUPPRESSION 
These experiments were carried out at the University of Colorado in 1963 and 1964 and 
presented to the Society of University Surgeons in February, 1965. Truly long-term survival was 
demonstrated repeatedly after transplantation between unrelated mongrel dogs under azathi- 
oprine. Ten dogs lived for at least four postoperative months at which time treatment was stopped. 
Several of the remaining dogs survived for years after stopping all treatment. This led to speculation 
that the liver was an immunologically privileged organ as originally suggested by Cannon'. (cf. 
Cannon's article, Part I) 
CLIO CHIRURGICA 
Factors determining short- and long-term survival after 
orthotopic liver homotransplantation in the dog 
Surgery, 58: 13 1-55, 1965 
Thomas E. Starzl, Thomas L. Marchioro, Ken A. Porter, Paul D. Taylor. Tanous D. Faris 
Thomas J .  Herrmann, Charles J. Hlad and William R. Waddell 
In an effort to answer many unresolved questions concerning ortho- 
topic homotransplantation of the canine liver, a complete reappraisal of 
this preparation was undertaken in early 1964 in both the untreated and 
modified host. A particular effort was made to (A) reduce the operative 
mortality; (B) interpret the significarice of pathologic changes in the 
homograft and in the recipient tissues: (C) define the presence or absence 
of a graft-host reaction: (D) study the effect of variations in therapy upon 
results: (E) assess the hepatotoxic propertiea of azathioprine: (F)  determine 
if and ui th  what regularit) hepatic rejection could be r e~e r sed  and chronic 
survival attained: and (G)  find if and when a state of relathe host-graft non- 
reactivit) developed some time after homotran5plantation. 
METHODS 
Mongrel dogs weiching 8.3 to 27.3 kilograms uere  ured. All animals 
had hematologic and liver function deremiinations before and at regular 
intervals after the experiments were begun. Red cell sun i \ a l  studies were 
performed w ith a Cr5 1 technique." Tetracycline and chloramphenicol were 
routinely administered Azathioprine* \%as employed in most experiments 
with a dose of 2 to 8 mg, per kilogram per dab. Intofar a possible. the 
induction ot letikopenia u a s  avoideti. .4rathioprine and anriblotic therapy 
was diwmtinued at 120 day\ in all surviving animals. Other xariations in 
therapj are described below. Tistue4 were examined uith light and 
electron microscop! 
For homotransplantation. l i ~ e r s  were obta~;ied from donors of dis- 
similar appearance. bur of approxi~natelg the same weight cis the recipients. 
Prior to removal, the donor li\er was cooled by perfu:,ion of chilled 
Ringer's lactate solution through the portal \em.  The technique of trans- 
plantation2-. resulted In an essentiallq nornmal blood suppi) (Fig. 1). The 
intenals of ischemia \\.eri. almost all less thail one hour. Cholec)stoduo- 
denostorny was established for ~nternal biliar) drainage. 
* lmuran suppl~ed by Burroughs and Company. Inc.,  Tuckhoe, N. Y 
Azathioprine toxicity study. In 18 nontransplanted dogs the effects 
of 30 days of azathioprine were studied. The animals were divided into 3 
groups of 6 each wh~ch  recel\cd: 
Group I. Dail) azathiopr~ne (2  to 4 mg, per kilogram). 
Grolip 11. D a ~ l )  a7athioprine plus 1 Gm. IntraLenous L-methion- 
ine.** The methionme powder u f i  d i5sol~ed in 100 ml. d i n e  and given 
in 30 minute,. 
GI-olrp :Il.  Dail) afc~thioprine plu, Intrabenous S '-niethionine every 
5 day" Since the specific actlLit) of the radio~sotope ~ a r i e d .  the amount of 
L-methionine ranged from 0 08 to 0.6 mg, t'vr the S ' do\e of 100pc. Based 
upon the measured biologic half-life ( I8 to 28 dais). and aisuming equal 
distr~bution of S ' to all metabol~z~ng cells. dail! total-hod? irradiation was 
estimated to begin at 0.2 or C.3 r per d3!, u ~ t h  equ~libration at I r per day 
after 18 to 28 days. 
Homotransplantation without azathioprine. Three groups of 
animals were studied nfrer orthotopic homotran\plantatlon: 
GI.OII;I '4. Supporti\e operati\e care oril): 7 dogs. 
GI-oup B. Dail? IPtraLenoui L-methionine i 1 Gm.) :  7 dogs. 
GI-ou;' C .  S '-merhionine e ier?  i d,~!s: Y dogs. 
Homotransplantation u i t h  afa thiopr inr .  A ~ ~ t h i o p r i n e  u a s  begun 
on the dab of tran\plantat~on in all except thow of Group 5. which 
recrixed pretreatment for 30 d;i!, t/io\r animal\ 1o)t during or 
shortl) after operation inlariabl) died from caukec other than failure to 
control rejection. a i  man) dog\ Liere ~ncluded in edch \erie> (except Group 
5 )  as were necsssar) to obtain I 1  iihich sun  i \ e J  one ueeL or longer. For 
stat~iticdl conipariwn of the effecti\ o f  Jifiering regimens. o n 1  these 
selected 1 I cmin~als u s re  included Eight wparare wrle.; u s re  studied in the 
follouin: chronoloz) 
* -  X X ~ )  , ~ ~ ~ r o g ~ , ~ p h ! c  .in.il!,!' h) Dr Fred Lea t s r  iDsni5r Veterans 
Adm~n~strarion Hosp!~dl) reiedled 3 slenlurn concentrdtion of approximately 150 
pg p a  gram methionine. 
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h t i c  anastomosis 
Fig. 1 .-Reconstruction after onhotopic liver homotransplantation. Internal biliary drain- 
age is with a cholecystoduodenostomy. Note that the aorta IS transplanted in continuity with the 
hepatic artery of the homograft. 
Group 1. Azathioprine, S"-methionine every 5 days, splenectomy: 
17 dogs. 
Gro~rp 2.  Azathioprlne, S,'-methlonlne every 5 days: 16 dogs. 
Group 3. Azathioprine, I Gm. per day L-methionine: 13 dogs. 
Group 4. Azathioprine only: 16 dogs. 
Group 5.  Azathloprine pretreatment: 12 dogs which survived the 40 
day azathioprine toxicity study and were subsequently provided with a 
homograft. (Postoperatively. 6 were treated as Group 2: 5 as Group 3; and 
1 as Group 4. Only 7 survived a week or more, an early postoperative 
mortality so great that the study wa\ d~scontlnued.) 
Group 6. Azathioprine. 2 nig. methionine every 5 days: 12 dogs. The 
dose schedule of methionine was cornparable to those of Groups 1, 2, and 
7, lacking only the radioisotope. 
Group 7. Azathioprine. I Gm. per day L-methionine, S"-methionine 
every 5 days. 10 mg. per kilogram choline per day: 17 dogs. 
Gt.orip 8. Atath~oprine onl?: I ?  dogs. This aeries was treatedexactly 
like Group 4. to determine ~f linrecognlzed variations in care had been 
introduced during the prolongcd ~nvestigat~on. 
RESULTS 
Azathioprine toxicity stud). 
Mortulir~ uriti c~lrti~c~i~l c.olrrse. Twelve of the I8 nontransplanted dogs 
lived through the toxiclty \tudy. 1 froru Group 1, 5 from Group 11. and 6 
from Group Ill. The other animals died after 18 to 33 days: 3 with bone 
marrow depression and pneumonitls. 2 from pneumonitis without leuko- 
penia, and I of unknown cause. All dogs lost welght during the first three 
weeks (Fig. 2). Decline\ in hernatocrit here  noted in all 18 dogs (Fig. 2), 
affecting the three experimental groups equally. 
B~oc.hrnl~ccrl chariges. Although none of the animals became jaun- 
d~ced ,  there was ev~dence of llver injury in all. Rises in SGPT, SGOT, and 
alkaline phosphatase (Fig. 2). were invariably observed within 2 to 7 days 
after beginning azathioprine. These changes were severe, usually peaking 
within 2 weeks and then decl~ning toward normal, despite continuation of 
therapy. However, return to completely normal values did not occur in any 
of the dogs. The addition of L-methionine or radioactive methionine did 
not alter the pattern of injury (Fig. 2). 
Parholo~ic. c'hun~c.t i ~ 7  th? liver. (Studies done hy K.A.P.) Twelve of 
the 18 livers were abnormal. In all 12, the centrizonal area was most 
affected (Fig. 3). with either frank necro\is (7 dogs) or pallor of the 
hepatocytes ( 5  dogs). Five of the 7 most severely damaged livers had other 
findings: 5 with h ~ l e  thromb~ In the central and mid~ona l  canaliculi, 2 with 
~ntracytoplasmic fat in the midzone. and 2 with scattered focal necrosis. 
The centrilobular changes were noted in all 6 11vers of Group I, 5 of the 6 
in Group 11, and only I of Group 111. Mononuclear cell infiltration was not 
observed. 
Four livers were examined electron microscop~cally. 3 of which had 
the centrizonal changes note above. In one, w h ~ c h  had appeared normal 
under light niicroscopy, the hepatocytes around the central veins had a 
decreased glycogen. a reduct~on In rough endoplaimic reticulum, and an 
increase in lipofuscin granules. In the other 3, these changes were more 
pronounced, extending in one liver to the midzonal area. In 2 of the livers 
there was d~latation of the bile canaliculi, with thinning and shortening of 
their rn~crovilli. 
Charlges in orhe!- orgut1.x. (Studies done by K. A. P.) Six animals had 
complete autopsy after 18 to 33 days of azathioprine therapy. Three that 
died of marrow aplasia had severe depletion of large and small lympho- 
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Fig. 2.- Toxicity of azathioprim-when used alone, with S-35- 
methionine, and with L-methionine. Six dogs were in each of the 3 test 
groups depicted. Despite the abnormalities of liver function, jaundice did 
not develop. 
cytes in the lymphoid tissue. Three others had moderate atrophy and 
hyperemia of the lymph nodes and spleen, with normal thymus and bone 
marrow. Pneumonitis and pulmonary congestion were present in 5 ani- 
mals. Megakaryocytes were often seen lodged in the alveolar capillaries. 
The other organs were unaffected. 
Homotransplantation without azathioprine. 
Operative mortality and survival. The only operative death resulted 
from hemorrhage. The remaining 22 animals survived for at least 2 days 
and 19 lived for 6 days or longer. All dogs were dead at 10 days. The mean 
survival was 7.1 + 2.2 (S.D.) days. Many animals had pathologic processes 
other than rejection which contributed to death: pneumonitis (12 cases), 
intussusception (6 cases), and multiple gastrointestinal ulcerations (2 
cases). The three subgroups were all comparable, animals receiving no 
therapy having no difference in survival than those treated with L- 
methionine or radioactive methionine (Table I). 
Clinical course. The clinical course and biochemical alterations were 
no different than those previously described in the pioneer studies of 
Moore and co-workersr6 and in our exper ien~e .~~ By the fourth day, all 
animals had marked increases in alkaline phosphatase, SGOT, and SGPT, 
and by the fifth day, 17 of 19 dogs had hyperbilirubinemia. 
Pathologic changes in the liver. (Studies done by K. A. P.) Interstitial 
edema, prominence of Kupffer cells, and necrosis of a few hepatocytes in 
areas of centrilobular congestion were present in the first 48 hours, changes 
which are nonspecific, since they have also been seen in liver autografts.') 
From the third day onward, the histologic features of rejection',".'"" were 
present in all but 2 homografts; these consisted of mononuclear cell 
infiltrations around and within the walls of small portal and central veins, 
centrilobular and midzonal hepatocyte necrosis, distortion of the centrally 
located sinusoids (often with mononuclear cells adhering to the endothe- 
lium), hypertrophy of bile- or hemosiderin-laden Kupffer cells, and 
intrahepatic bile stasis in association with destruction of bile duct epithe- 
lium. The severity of damage was related to duration of survival, and was 
not influenced by methionine therapjr. In 14 animals only a thin rim of 
hepatic cells remained around the portal tracts and some of the longest 
Survivors had reticulin collapse and early fibrosis around the central veins. 
With time, the character of the mononuclear cell infiltration changed. At 
first, approximately 40 percent of these cells possessed pyroninophilic 
cytoplasm, but few were typical mature plasma cells. The majority were 
difficult to classify and were the cells variously called "large lymphoid,"22 
"hemocytoblasts,'" and "immunoblasts."' After the sixth day the infiltrate 
was very dense in all the small portal tracts and contained a higher 
proportion of plasma cells. Fibrinoid necrosis in the walls of small hepatic 
arteries was seen in only 5 of the 23 dogs. 
Changes in other organs. (Studies done by K. A. P.) In the 19 animals 
dying after the third day the mesenteric lymph nodes were swollen, partly 
as a result of an intense proliferation of large cells with pyroninophilic 
cytoplasm. Macrophages containing hemosiderin and debris were present 
in larger numbers than normal. In those animals dying after the seventh 
day, the medullary cords were crammed with plasma cells. Similar changes 
were found in the spleens. Pulmonary congestion, hemorrhage, and bron- 
chopneumonia were common in these animals, while focal thickening of 
the alveolar septa and interstitial infiltration by mononuclear cells were 
seen in only a few dogs. Megakaryocytes were found trapped in the alveo- 
larcapillaries in all lungs. Myocardial and renal lesions were not seen, and 
fibrinoid necrotic lesions of arterial walls were not encountered in organs 
other than the liver. 
Homotransplantation with azathioprine. 
Operative mortality and survival. Thirty-two of the 116 recipients 
(27.5 percent) died at operation or during the first postoperative week 
(Table II), most commonly of pneumonitis (or atelectasis) and intussus- 
ception (Table 111). These 32 acute failures were considered operative 
deaths and were eliminated from analysis of the efficacy of immunosup- 
pression. 
In the 84 remaining dogs (72.5 percent) which lived for 7 days or 
longer, there was a high incidence of similar complications (Table IV), but 
there was usually also biochemical or histologic evidence that some degree 
of homograft rejection was present. Of the 84 dogs culled for definitive 
analysis, 44 lived for 25 days and 24 lived for 50 days or longer. Eight more 
died between days 50 and 120 of causes listed in Table V. Abnormal 
hepatic function was present in all 8, although other lethal complications 
were present in each. Another animal which died after discontinuance of 
azathioprine therapy is discussed below. Fifteen dogs are sfill alive, from 
62 to 324 days after operation (Table V). 
Hematologic changes. In virtually every animal a decline in hema- 
tocrit was observed, similar to that observed in nontransplant animals re- 
ceiving azathioprine. The 5 dogs surviving longest started with a mean 
preoperative hematocrit of 47.5 percent, which had fallen to 36.8 percent 
by the time azathioprine was discontinued on postoperative day 120. Forty 
days later the mean hematocrit had returned to 43.5 percent. The increase 
in hematocrit after discontinuance of azathioprine is strong evidence that 
Fig. 3.- Liver of a dog treated with azathioprine for 26 days. There 
is centrilobular necrosis of hepatocytes but no cellular infiltration. 
(Hematoxylin and eosin. Onginal magnification X 40.) 
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Table I. Surzqizal a f t e r  hepatic homotrarzspla~ztat io~~ to  recipic~lt  dogs treated 
u,ith azatilioprinc 
S u r r i ~ ' a 1  1 M e a n  surciz a1 
Group  
I ( n o  the rapy)  7 7 6 7.0 2-10 2.5 
I 1  fmethionine)  7 7 6 7.7 3-10 2.4 
111 (S.35-methionine) 9' 8 7 6 . 6  3-10 2.0 
2 3 22 19 7.1 2-10 2 . 2  
- 
"One dog did not  sur\.i\-e operation and  is therefore not includrd in thc statistical analysis 
Table 11. Survir,al after hepatic i lomotra~zsplantation to  recipient dogs treated 
wi th  azatlzioprine 
Survival 
-1 M e a n  r ~ ~ r v i i a l  of dogs S.D. 7 days 2 5  days 1 5 0  days iiuing 7 day, or more 1 (50 day 
or rnore ! or more , or more / (50 day /irnit)* 1 limit) 
1 'r 17 11  8 4 33.4 72.3 16.4 
2 t 16 11 7 5 31.7 68 .8  19.3 
3 t 13 11 7 3 29.5 63.1 15.0 
4 t  i 6 11 4 2 24.2 39.1 14.5 
5 12 7 2 1 19.7 28.6 15.6 
6 i 2 11 5 3 26.5 32.2 18.5 
7 17 11 7 3 28.9 37.1 15.6 
8 13  11 4 3 16.1 30.8 18.1 
116 8 4 44  2 4 27.9 47.3 16.5 
*The dogs s u ~ \ i \ i n g  longer than 30 days are  desclihed individually in Table V, the gleat is t  l onge~ i ty  now being 
3'24 days. Statirtical c\<iluation of  different legitncns take into account only :he filst 50 da)s. This  aboids introduc- 
tion of utrfair hiah in the e \ en t  of uriuiually p r o t ~ a c t e d  sru\ival. and  ailows cornpa~ i ion  of different \clies oi  animals 
underqoing operation i n  the ch~ono loqy  slioitn. I n  all oi  tile g loup i .  the actual inzari s u r b i ~ a l  i \ i t h r~u t  the attificial 
30 day lirnit has bcrn h ~ o u g h t  u p  t o  date  to  Feh. 10, 1963, and  is ju,t t o  the ~ i y h t  o f  the attifactually low \alurr. 
t I n  at  least one dog [lorn each group,  all t h e ~ a p y ,  includinq a ~ a t h i o p r i r ~ e ,  \,as discontinued af ter  120 days. 
Table 111. Homotransplantat ion ~ c i t h  
a:athioprine; nonirnmunologic conditions 
of death  of 32 arlimals t lurinq operation or 
i n  the  first postoperatice rreek. St ceral 
anirr~als liad more tllarz one corrlplicatio~l 
Pneumoriitis or  a te lec ta~ i s  
Intussiisception 
Hemorrhagic gastroenteritis 
Hepat ic  ~ r t e r i a l  occlusion 
Pulrnorisry emboli 
Operat i \ -e  hemorrhage 
Portal  vein occlusion 
Tota l  
this agent was primarily responsible for the chronic anemia. presumably 
from inhibition of erythropoiesis. 
In addition. a contnbutory early factor seemed to be increased red cell 
destruction, which may have been due to erythroplastic activity of the 
liver,' in view of the prominent hemosiderin deposits (to be described 
subsequently) in many of the homografts. Seven animals studied from 7 to 
27 days after homotransplantation had a red cell half-life of 6.7 k 3 (S.D.) 
days (normal for this laboratory. 14 days). After tile first month, the half- 
life graduall) returned toward nomial (Fig. 4). 
Clirricrrl( ortr-s~, hroc/~miii~c~l cha:~grr, and rc~,ersul oj'rqji~ction. The 
course after homotransplantation was extremely variable. In 24 (28.6 
percent) of the 84 definitive test animals rejection was uncontrollable. 
Inexorable jaundice developed (Fig. S), with anorexia and rapid weight 
loss. Rises in SGOT. SGPT. and alkaline phosphatase (Fig. 5 )  were similar 
to, but of generally greater ma~nitude. than those produced b) a~athioprine 
administration to the nontran\planted dog. Terminal con\ uls~ons or coma, 
intractable vomiting, and h1pogl)cemia bere common. All 24 animals 
died in less than 41 days. bith a mean \urvival of only IS days. 
A more benign rejection was obsenjed in 4 I of 8 1  experiments (48.3 
percent) despite the fact that hyperhil~rubine~ma and rises in SGOT, SGPT, 
and alkaline phsophatase were also present (Figs. 6 and 7). sometimes to 
the same degree a\ in the 21 an~rnals noted a h o ~ e .  Hobever. the biochemi- 
cal indices of hepatic injury were partially (Fig. 7). or even relatively 
completely, revers~ble (Fig. 6). At the peak of rejection. which lasted as 
long as 6 weeks in wme caws. these dogs often appeared to be In terminal 
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f i: i l i l i io!)~i~zc: complications otlzer thalz 
,, j,.ciio?? obrcrztcd in  dogs d ~ i t z g  7 OT more  
<inj.s nj t ( , r  lionzotranspla~z tat ion of t h e  liver. 
Sist?~-llitir of tllr 84 anin1al.r dicti at some 
i j r l ~ c .  n f t rr  t h r  fir it u ('el, aud  the  figurrs beloz" 
barcd 012 f 1 1 ~  n u t o f i ( ~ ~  findings: 15 alzimals 
O r r  still ali; c )  
p~ip:tnionitis o r  a t r l rc tas is  46 
l i > i l c .  m n r r o w  depression 11  
( ; r~ . c rn l i zcd  gast rointes t inal  hemor rhage  6 
I.i\.cr ahs r r s s  3 
( ; c ~ ~ e r a l i z r d  per i toni t i s  3 
Subdi iphl-apmat ic  abscess 3 
Intra-:ibdorninal h rmor rhage  3 
I'rrforated visctis 3 
Intussusception 3 
Rlreding duodena l  u lcer  3 
Pulmonary ernboii 2 
Hrpa t i c  a r t e r y  occlusion 2 
\ \  ourid d rh i scence  1 
P \  clonrplirit is 1 
Lcp g a t ~ r r e n e  1 
T ~ i e r ~ n n l  b u r n  of back 1 
- 
Total 9 :! 
condition, with clay-colored stools, dark urine, profound anorexia, and 
rapid weight loss. As liver chemistries subsequently improved, most of the 
animals had a return of appetite. A number of the dogs ultimately died from 
complications of chronic liver insufficiency. such as gastrointestinal hem- 
orrhage, or from pneurnonitls. but others continued to live for many weeks 
or months ~ i t h  gradually improving liver function. The longest survival of 
any animal u i th  this type of reversible rejection u a s  161 daqs (Fig. 7). 
Sixteen others lived for 50 d a  i or more. lndlcating that protracted survival 
under these unfavorable circumstances was not rare. 
In the other 19 dogs (22.6 percent). overt rejection d ~ d  not occur. 
Although there were rises in alkaline phosphatase. SGOT. and SGPT, the 
serum billrubin did not exceed 2.5 mg. percent at any time during 
postoperati\e azathioprine treatment (Fig. 8) .  Werght loss and anorexia 
were not pronounced. Sever dogs died from other causes than rejection 
before 25 days, so that failure to develop jaundlce may have k e n  more a 
function of the short survival than anything else. The other 12 all lived for 
more than 25 days. Five died after 28 to 35 days u ~ t h o u t  debeloping hyper- 
bilirubinemia. and the other 7 are still alive after 90. 1 16,201. 2 l8.228,and 
324 days (Table V). Five dogs from this favored group had a~athioprine 
discontinued at 116 to 123 days as described below. 
Chronic li\~erjuncrron. The last routine 11ber chemistry studtes done 
an all dogs living beyond 50 days are shown In Table V. In 6 of these 
animals other determinations were performed from 98 to 300 days postop- 
eratively. Bromsulfonphthalein retention at 45 minutes uaq 5 percent or 
less in 4 ,8 .2  percent in 1, and 34 percent In 1. Prothrombin tirnes were 52 
to 90 percent. Total proteins were 4.X to 5.8 Gm,  percent. 
Host-graft nor2rr~uc~ri1,it~. F v e  nonjaund~ccd anlmals had all therapy 
discontinued after 1 16- 123 days. All are still alive 63.8 1. 100. 109, and 204 
days later. One had a delayed rejectton, beginning 2 ueeks after stopping 
azathioprine, but the hyperbillmbtnemia aiid enrqme increa\es ultimately 
stabilized and reversed without treatment (Fig. 9 ) .  The other '1 have had no 
deterioration of homograft function in the ensuing 8 1 to 204 days (Fig. 8). 
In all cases, irregular Increases in the peripheral leukocyte count were 
observed during the first 2 months after cessation of therap). 
Fig, 4.- Red cell survival and hematocrit values in a dog that 1s still alive 321 da j  s after orthotopic 
transplantation. Note the sharp reduction in red cell half-life in the first postoperative month, with gradual 
return toward normal. Red cell survival was not altered b) u ~ t h d r a ~ a l  of azathioprine at the end of 4 months, 
but the depressed hematocrit rose charply during the succeeding months. 
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Table V. Homotransplantation zelith imn~unosupprcssion ( /ate  of 24 aniwzals living 
5 0  days or longer; the suruival figures for dogs still living is brought u p  to 
Feb. 10, 1965) 
1 Lnit nlka- 1 
line bhos- 
bilirubin phaiair SCOT 
G T O ~ S  cause of dea th  1 ( m g .  %) ( B . 5 . ' )  (5'-F.U.+) 
1 1 324 Alive$ 0.1 1 .9  2 3 
2 98 Pneurnoni t is ;  l iver failure 5.7 5 0 3  760  
3 116  Alive 0 . 3  5 8  6 2  
4 9 0  ;\live 0 . 3  1 7 2  9 4 
2 1 120  Gastrointes t inal  hemor rhage ;  l iver 3.7 296  8 7 0  
fa i lure  
2 5 8  Pneumoni t is  1 . 3  3 0 0  2 2 0  
3 228  ,\live$ 0 .1  7 3 4 7 0  
4 70 Gastrointes t inal  hemor rhage ;  liver 5 .9  5 1 6  1 6 6 0  
fa i lure  
5 181 Alive: 
.4live$ 
Pneumoni t i s ;  l iver failure 
.Alive$ 
Bleeding duodena l  u l ce r ;  l iver fail-  
ure$ 
Post biopsy hemor rhage ;  li\rer failure 
Pneumoni t is :  l iver fa i lure ;  gastroin- 
testinal hemor rhage  
Pneumoni t i s ;  l iver fa i lure  
Alive 
Alive 
Alive 
Alive 
8 1 7 2  Alive 
2 6 8  Alive 
3 6 2  .41ive 
*Bodansky units. 
+Sigma-Frankel units. 
iAzathioprine stopped after 116 to 1'23 days; subsequent course uithout immunosuppression. 
A sixth animal had serious liver malfunction while under azathi- 
oprine therapy (Fig. 7), a maximum bilirubin of I0  mg. percent being 
present on postoperative day 90. By day 120 this was decreasing and 
continued to decline after azathioprine therap) was stopped. The animal 
ultimately died of a bleeding duodenal ulcer 161 days posttransplant. 
Effect c fad j~wan t  therapy. Mean survival of the various test groups 
is shown in Table 11. For analytic purposes, no animal was credited with 
more than 50 days. Within this arbitrary tlme 11n11t. none of the regimens 
had a statistically significant superiority. In Groups I. 2 .  3. and 7 in which 
either S"-methionine andlor 1 Gm. per da j  L-methionine were admini- 
stered, mean sunrival exceeded that of Groups 3 and 8. In which these 
agents were not used. and was greater than Group 6. in which 2 mg. 
nonradioactive methionine was given every 5 days. However, even com- 
parison of the series combinations (Groups 1 .  2 ,  3. 7, versus 4. 6. 8: or I ,  
2, 3. 7 versus 4. 8 )  did not show a stati\ticallq significant advantage of the 
adjuvant therapy ( p  = 0.18 and 0.171. 
Group 5.  which differed from the other 7 serie\ in that 30 day, of 
azathiopnne pretreatment was employed, had the shortest mean survival. 
This seemed attributable to a heightened incidence of infection, a septic 
complicatton being the cause of death in 9 of the I1 fa~lures. Thus. 
azathioprine pretreatment had an adverse effect after hepatic homotrans- 
plantation in contrast to an apparent benefit pre\iouslj dewribed with 
renal homografts.' 
Pathologic changes after homotransplantation with azathioprine 
(Studies done by K.A.P.) 
Hnmogrufts in animals dying within one w e t .  Twenty-seven livers 
were examined and showed the central venular and sinusoidal congestion, 
variable centri~onal necrosis, interstitial edema, and Kupffer cell swelling 
already descnbed in the untreated dogs dying in the fir,t 2 postoperative 
days. In addition. centrilobular bile stasis was usual. Portal and central 
cellular infiltration was appreciable in only 7 and 2 of the homografts, 
respectively, consisting of mixed neutrophil~c and mononuclearcells, with 
pyroninophilic cjtoplasrn being rare in the latter. In several specimen,, the 
perivenular lymphatics were dilated. 
Electron microscopy exammation of a homograft at 6 days showed 
a few lymphoid cells around the small portal veins and adhermg to the 
sinusoidal endotheliurn. Some of these hati abundant free cytopla,mic 
ribo\omes arranged in rosetteh. The hepatocjtes adjacent to the central 
vein were necrotic: those cell5 just peripheral to thii Lone contained many 
fat droplets and ltpofuscin granule\, lacked glycogen and rough ergasto- 
plasm. and contained \wollen mitochondria. Hepatockte\ In the middle 
and penpheral zones were normal. 
Homo,qrilfir in uniniuls dying in 7 to 15 dajs .  Twenty-seven 
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Fig. 5.- An example of inexorable rejection de\pite ~niniunosuppres\ive therapy. 
Determination of the serum blllrubin bas  the mo\t useful meariirernent for following the 
course after homotransplantation since the other abnornictl~tie\ ot ii\el tuni t~on depicted 
can also be caused by dzath~oprine Group 6 series 
homografts were examined: central necrosls was present in 22. had 
extended to the midzone in 17 (Fig. 10). and was often associated with mild 
to moderate central congestion or sinusoidal di,tortion. With m e r e  
hepatocyte loss, central reticulin collapse had occurred. and in 5 the 
condensed reticulin bands connected adjacent central veins. Interstitla1 
edema. cholestasis, destruction of brle canalicular epithelium, and bile- or 
hemoslderin-containing Kupffer cell\ Here also present. In e \er> Ii\er the 
small, and often the large. portal tracts here  moderatel> (8 ca5esJ or 
extensivel) (19 cases) ~nfilrrated b) mononuclear cells (Fig. 10). 30 to 10 
percent of uhich possssed pyronlnophllic cytoplaim. As in the untreated 
animal\, many were the primitive "large 1)mphoid" cell\. other\ resembled 
plasma cells. A similar. but lesser infiltrate was noted in and around the 
walls of the central veins in I7 instance\. 
Preliminary ultrastructural a n a l > \ ~ s  of 3 hornograft\ at 8 to 10 d a ~ s  
revealed an exten\ion of the frndings noted abo\e  In the 6-da! 5pecimen. 
The lymphoid cells In the portal tracti and \inu\ords here  no\\ joined b> 
plasma cells and thelr precursor\ uith abundant rough endopla\mic 
reticulum. and the sinusoidal endothelium had dl\rntegrated In man! 
places. Dilatation and destruction of bile canal~culr uith niicro\illar 
and obstruct~on b) ma\se\ of bile plgrnent here  common. >Ian> intact 
hepatoc)te\ exhibited change, In the c)toplasmic 01-panelies a\ \\ell 3s In 
the nuclei. 
fforno,qr.c~fi, t r i  ur~inlcilv dvtriq it! I 6  to 25 r1ii1.r. In 14 of the 17 livers. 
mononuclear infiltr:ttlon arourid the portal and centlal \ e m \  was obsened. 
but in all but 3 the cell\ \\ere feuer than had been present after 7 to 15 days 
and had a decreawd percentage u ~ t h  pyroninophilic cytoplasm. The 
majorit) here  \;iid11 l ~ r n p h ~ t s ~  and plahma cell\ uith sorne hemosid- 
erin-laden rnacrvphagss. Cznrr~lohular hepcltoc)te lo\\  h a s  seen in 15 
homografts but 11 appeared to be recent onl) in the 3 ipecirnens with heavy 
cellular irit~lrrdtlon. The \ilniving Il\er cells :tround necrotlc areas often 
contamed f,it dropldts. h ~ l e  pryment partlileh. and rxcejs lipofuscin. 
Centr~zonal rerlculin soll:lp\e and depo\it~on in thew area, of collagen 
fiber\ \ \a \  coninion. arid in 3 l i ~ e r s .  h:ci:ti\ of c o n n r i t ~ \ s  t ~ \ \ u e  had linked 
adjacent centr~il \ t . ln\.  Pt.rrpon,tl ~ o n n s c t l \ e  ti\\ue \ \ a ,  not ~ricreased. Cen- 
trilobular brle ,ra\1\ .tnd herno\~derlri d e p o \ ~ t ~ o n  irere prornlnent. In one 
honiogr,ift there u'i, toial t lhr~ni~rd ni.iro\l\ of the ual l \  of small hepatic 
arter) hr;lnche\. (Thir \ \a \  the nnl! ekanlplr of t h ~ t  chdnge in the 101 
azathlopr~ne-treated hspat~c homograft\ e\,irnlned ni~~ru\copical ly . )  
Three horni~#r,~tt\ hers  e\arri~ned eIi . i . t ronniriro\c(~p~ially at 16, 17, 
and 25 dd)\ T \ \o  of the\?. i ihiih happened to  oms from the atlpical 
.;pecrrlien\ ulth he . i \  cellulcir ~nt'rltrdtron. \\err. \ lni~lar to tho\e In the 7 to 
I5 da? group. The third had oril) a feu number\ ot int~ltr;itrny cells which 
\\ere rnostl) I rnphoc) 1s.. and ni~tur t .  pla\m'i cell\ The other tindings alqo 
conflrnied tho\e ob iened  u ~ t h  irght rnlcro\cop!. .tnd rs\s,lleii that many 
cenrrrlohi~l;lr cCln,cllcuil had mliro\rliar lo\, dnci ue r s  pluzged urth bile 
pigment. Fat-lads11 hsp'ltoc) ti.\  dc'q~cerit o arsd. ot nsLro\l, Licked rough 
ergastoplasm. 
Hon~o?rafts iri uriinzals dxir~g in 26 to 50 du?.~. Four of the 18 livers 
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Fig. 6.- Virtually complete reversal of severe hepatic rejection. Note the severe jaundice which 
ultimately completely disappeared. The animal is still alive. Reversal u a s  accomplished wihout any al- 
teration in immunosuppressive therapy. The animal received adjuvant S-35-methionine, L-methionine, 
and choline (Group 7). 
were completely free of invasion, and in the others the quantity and char- 
acter of the cellular infiltrate was comparable to that of the previous group. 
The centrilobular hepatocyte loss was also similar. being present in 15 
homografts, but with recent necrosis in only 4. The central reticulin 
condensation was pre5ent in 17, and in 7. connective ti5sue bands had 
linked the central veins (Fig. 1 1 ). The portal reticulin and connective tissue 
were also increased in 4 livers. and In one of these there &as proliferat~on 
of small bile ductules. One homograft had small regeneration nodules 
lacking normal lobular architecture. The intrahepatic cholestasis and 
hemosiderin deposition described in the earher specimens were usuall) 
present. 
Homog~.ufrs in ur~imuls &ing in 51 ro 120 d q s .  Infiltration around 
the portal and central veins u a s  mild in 4 of the homografts and marked in 
the 3 others. In the fomler. the cells were almost all lymphocytes or plasma 
cells, but in the latter. many primitive cells with abundant free cytoplasmic 
ribosomes were also preient. Nonacute central hepatocyte loss with 
associated reticulin collapse and collagen deposition were similar to that 
described in the two preceding sections. In 6 of these. connective tissue 
linked in the central vein, and in 3.5everal central vein? were occluded with 
fibrous tlssue. Portal fibrosis h ld  occurred In all 7 homografts. and some 
fibrous and reticulin band, connected these areas to the central veins. 
Regeneration nodules were present In 2 homografts, and in all livers pe- 
ripheral hepatocytes shoued increased basophilia. occas!onal mitoses, and 
polyploidy. Centrilobular bile sta\in and Kupffer cell hemosideroiis were 
conspicuous in all the I~ re r s .  
Ef f t~ , i  qf ~,~thdrart.in,q ~herapy u,i)orl 11on10,qruft i~istolog>. In 3 dogs 
the homograft was biopsied ar 120 to 123 days when all immunosuppres- 
slve drugs were u~thdrawn.  A further biopsy was then obtained 77 to 84 
days later. One animal was biopsied for a third time 182 days after with- 
drawal of therapy. The animal whose liver was sampled on 3 occasions was 
unique in that all specimens appeared to be within normal lim~ts,  both with 
light (Fig. 12) and electron-microscopy. 
A second dog had an abnormal hepatic homograft at the time 
treatment was discontinued (Fig. 13. A) with moderate infiltration of 
mixed mononuclear cells (10 percent pyroninophilic) and neutrophiles in 
the portal areas, and a few mononuclear cells around the central veins. The 
lobular pattern was di\torted with fibrous and reticulin bands which linked 
portal tracts to each other and occasionally to central veins: by reticulin and 
collagen condensation around thickened central veins; and by pseudolob- 
ules of actively regenerating liver cells. The centrilobular hepatocytes had 
di~appeared and in some areas or were atrophic in others. Many remaining 
liver cells had decreased basophilia, increased lipofuscin, and pale, foamy 
cytoplasm; ~~ltrastmcturally they contained lipid droplets and lacked 
glycogen and rough ergastoplasrn. In the portal tracts, there was prolifera- 
tion of m a l l  ductules, accumulations of henlosiderin- and lipofuscin-con- 
paining macrophages. and occasional nonfibrotic intimal thickening of 
small hepatic arteries. B ~ l e  plugs were not seen. Seventy-seven days later 
(Fig. 13, B), the cellular infiltration was l~ghter and lacked neutrophiles, 
although the percentage of pyronine-positive cells was unchanged. Active 
proliferation of peripheral liver cells was continuing, but there were fewer 
regeneration nodules and the hepatocytes appeared to be more normal with 
both light and electron-microscopy. The fibrotic alterations persisted, but 
the over-all picturs was one of improvement. 
A homograft in a third dog had comparable abnormalities at the time 
therapy was withdrawn (Fig. 14, 4 )  differing only in that fibrosis was 
somewhat less and regeneration nodules were absent. E~ghty-four days 
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Fig. 7.- Reversal of rejection in an animal treated with azathioprine. Serum bil~rubin rose to more 
than 10 mg. percent and then declined. Note that the improvement in liver chem~stries cont~nued after 
discontinuance of azathioprine therapy at 116 days. Cause of death 45 dais later wah rnns5i~e hemorrhage 
from a large duodenal ulcer. Group 4 series. 
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oraft rejection. Fig. 8.- Course of an animal which ne\er exhibited an! clinical eLidsnce of honio, 
Note the weight gain following cessation of therap) at 4 months. The pronounced I~LLoc! tosis after 
withdrawal of immunosuppression was comrnonlq Leen. m i <  animal recslbed ad ju~an t  S-35-methionine. 
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Fig. 9.- Course of an animal which did not have clinically evident rejection during the first 4 postoperative months. 
After azathioprine was discontinued, there was deterioration of all liver chem~stries, despite which the animal appeared 
healthy and had little weight loss. The late rejection partially reversed without reinstitution of therapy. 
later (Fig. 14, B) there was further homograft damage in w h ~ c h  many cen- 
trally located hepatocytes contained fat droplets. Intrahepatic cholestasis 
was not present. Cellular infiltration was increased, chiefly due to an in- 
creased number of neutrophlles. The deterioration appeared to be due. at 
least in part, to the effects of cholangit~s. 
Effect of n~ethionine ripon homograft /iistolo,qy. Centrllobular necro- 
sis occurred in 40 percent of animals trpated with adjuvant methionine plus 
azathioprine compared to 64% when a~athioprine was used alone. The in- 
cidence of cellular infiltration in both groups a.as 85 percent. 
Changes rn host tissrtrs in 92 etperimenis. Changes in the recipient's 
lymph nodes and spleen roughly paralleled those in the hornograft. In 16 
experiments in which a h e a y  Infiltrate of pyroninophilic cells was found 
in the liver, "large lymphoid" and other smaller pyronme-positive cells 
were found actitel) proliferating around postcapillary benules in the 
lymph nodes and around small arteries of the spleen. as well as large 
numbers of plasma cells in the medullary cords and red pulp. The 
hyperemic lymph nodes had lost their normal folllcular arch~tecture. 
In 24 experiments in whlch moderate numbers of pyroninophilic 
cells were invading the homograft, the degree of proliferation of similar 
cells in host lymphoid tisiue wac variable. Fifty-two homograft\ had mild 
or no Infiltration of the liver, and here the recipient spleen and 1) mph nodes 
resembled those described earher In animals recei\ ing azathiopr~ne alone. 
in that "large lymphoid" cells and sniall lymphocytes were either norn~al 
or fewer in nuniber. 
Bone marrow changes u\ually seenied to be related to afathioprine 
administration. In several animals there was extreme myelold hypoplasia 
or even aplasia. There was some evidence of thymic hyperplasia in a few 
of the dogs that rejected the hepatic homograft after 24 days. The lungs 
often showed congestion, edema. and intra-alveolar h e m o ~ ~ h a g e .  Bron- 
chopneumonia was a frequent cornpllcatlon. A l~eo la r  ball  thickening and 
sequestration of megakan.ocytes were seen. A few of the kidneys showed 
either small a r e a  of chronic pyelonephritis or scars suggeitive of past in- 
fection with canine leptospirosis. Necrotic changes in the walls of arteries 
and arterioles In organs other than the liver were very rare. 
DISCUSSION 
The present canine studies provide increased hope that orthotopic 
hepatic homotransplantation may ultimately have use in the treatment of 
human liver disease. 'The overwhelming earl) mortality previously en- 
countered in dogs'4":'?'?' has been substantially reduced. Many long-term 
suwlvors were obtained, proving that control of hepatlc rejection is not 
uniquely difficult. and that results can be achieved which are similar to 
those previouslq reported for the kidney" 
Instead, the past discouraging expenences \eem ascr~bable to other 
factors which play an extremely prominent curnularive role. Technical 
failures are common unt~l  conjiderable experience 1s acquired. Hemor- 
rhaglc gastroententls, acute peptic ulceration. and intussusception are 
frequent. The susceptibility to pneumonitis appeared to be accentuated by 
the subdiaphragmatic presence of the large homogrnft. Finally. the hepa- 
totoxicity of azathioprine ha\ a special sipnlficance, slnce the target tissue 
of rejection is also injured by the drug used to pre\ent th15 process. 
Because elevations In SGOT. SGPT. and alkal~rie phoaphatase are 
caused both by azath~oprlne and bq rejection, the serum billrubin u a s  the 
most useful teat with which to ser~ally stud) hornograft function in the 
treated canine host. The regularity with which reversal of hepatic rejection 
could be documented b> thi\ mean.; is noteworthy, examples being seen in 
half of the technlcall! \uccessful experlrnent\. Of great Interest is the fact 
that reverial u a s  riot dependent upon inten\ification of Immunosuppres- 
sive therapy, since neither increased doses of azathioprine nor additional 
drugc \\ere used. and in one initance the phenomenon was noted in the 
ab\ence of all therap) (Fig. 9 ) .  It seems probable that rcjectlon of any tlssue 
is characterifed by a tendency to remls\lon. Although prednisone.' >'and 
lesi certainly actinomycin C '  or local irradi;ition."' rnay be of life-saving 
value In prornotlng the proceic after renal homotr;~n\pl;~ntation. the use of 
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Fig. 10.- Hepatic homograft which has been rejected by 15 days 
despite azathioprine treatment. There is widespread destruction of hepato- 
cytes in the central and middle zones of the lobules. Only a rim of liver cells 
remain around the small portal tract, which is heavily infiltrated with 
mononuclear cells. (Hematoxylin and eosin. Original magnification x 40.) 
such additional measures is ~robablv not reauisite in some instances 
regardless of the type of homograft ised. The spontaneity with which 
reversal may occur makes caution necessary in attributing this effect to any 
preceding variation in therapy. 
A related problem in evaluating treatment in mongrel animals or man 
is the extreme variability of host response to the foreign tissue. In the 
present study, this ranged from complete absence of rejection to uncontrol- 
lable repudiation of the liver homograft, a spectrum which undoubtedly 
conformed to the degree of chance antigen matching between donors and 
recipients. The presence in outbred populations of this powerful and unpre- 
dictable influence makes conclusions about minor therapeutic alterations 
meaningless unless hundreds or even thousands of experiments are per- 
formed. 
This criticism applies to the study of adjuvant lipotropic agents 
described in this communication. It would not be surprising if these 
substances were of value after hepatic homotransplantation, since they are 
said to prevent (or facilitate recovery from) lher  injury due to other 
cause~,J. '~ an effect which Schwarz, Stesney, and Foltz2' attribute in part to 
tracer quantities of selenium in the sulfur-containing amino acids. The ad- 
ditional factor of irradiation was introduced in those animals receiving S3'- 
methionine, although the calculated dose to the liver or whole body was far 
too small to be of predictable biologic importance. With testing, the 
lipotropic materials had no measureable influence on azathioprine hepato- 
toxicity, did not potentiate survival after homotransplantation to the 
otherwise untreated host, and did not cause a statistically significant 
prolongation of posttransplant survival when combined with azathioprine. 
Nevertheless, it is interesting that the longest average survival after 
homotransplantation to azathioprine treated recipients was in those 4 
groups which also received L-methionine or S3'-methionine, a finding 
which was uninterpretable because the range of results was so ?eat in 
every group. This may have been due to the system of testing, in which the 
variables of uncontrolled donor-recipient selection were of far greater 
importance in the individual experiment than the therapeutic variable 
being examined. 
Although the early recovery after liver homotransplantation has 
many hazards, chronic convalescence is no more difficult than after the 
transolantation of less com~licated organs. Indeed, the frequency and 
The consistency of this state of host-graft nonreactivity and the rapidity 
with which it seemed to develop exceeds that reported after canine renal 
hom~transplantation.~~~'~~~~~~ The explanation for this is not apparent, but 
conceivably the large antigenic mass could play a role or, alternatively, 
perhaps the liver with its enormous regenerative capacity is simply capable 
of sustained function in the face of continuing but minimal chronic rejec- 
tion. Findings in the serial biopsies obtained after discontinuance of 
therapy do not support the latter hypothesis, but the amount of histologic 
material available is still too scanty to warrant conclusions. It is also 
important to note that cessation of therapy was not followed by a graft-host 
reaction. None of the animals developed "secondary homologous disease" 
and the shortened red cell half-life noted in the early postoperative period 
did not recur. 
The correlation between liver chemistry determinations and the 
pathologic findings in the homografts was excellent. In the untreated ani- 
mal, the abnormalities of function and the anatomic injury were both 
progressive until death. Administration of azathioprine delayed the onset 
of rejection in virtually all animals but in most dogs dying within 7 to 15 
days the histologic and biochemical alterations were indistinguishable 
from those of the control experiments. From this time onward, most of the 
livers appeared to have survived the first assault and were settling down to 
repair and regeneration; delayed death was commonly due to pneumonitis 
or other nonhepatic causes. Phagocytic activity of Kupffer cells and 
macrophages was prominent for several months. The centrilobular local- 
ization of the original necrosis seemed responsible for the most conspicu- 
ous features of healing, including the centrizonal features of healing, 
including the centrizonal bile canalicular dilatation and cholestasis, the 
connective tissue bridges between the central veins, and the regenerating 
nodules which sometimes contributed to a pseudolobular 
- 
Histologic evidence indicting a vascular component of hepatic 
rejection was particularly sought in view of previous hypothesis that a 
reduction in blood flow was immunologically induced at either the 
sinusoidal l e ~ e l , ~ ~ ~ ~ '  or more proximally in the larger arteries of the portal 
tracts." The findings in the present study are compatible only with the 
former possiblity. There was evidence in some of the electron micrographs 
of damage to the sinusoidal endothelium followine contact with host 
" - 
lymphoid cells, a finding analogous to that reported in renal hom~grafts ," ,~ 
and one which could plausibly explain the centrilobular localization of the 
hepatocyte necrosis.-The possibility of occlusion of larger vessels is 
unsupported by the results reported here, since the degree of tissue injury 
to the hepatic artery or portal vein was relatively homogeneous, without 
areas of selection destruction. Furthermore, injury was not a prominent 
feature in the untreated series and was virtually never seen in the treated 
animals. 
rapidity with which dogs cduld be w i t h a w n  from immunosuppression 
without an ensuing fatal rejection is remarkable. Liver homografts m 5 of Fig. 11.- Hepatic homograft at 32 days from a dog treated with 
6 dogs which had therapy stopped after 1 16 to 123 days have provided llfe- azathioprine. The reticulin framework of the lobules has collapsed around 
sustaining function for 63 to 204 subsequent days and the cause of death the central veins and bands of reticulin now connect central veins to each 
of the sixth animal was from other causes than progressive hepatic failure. other and to the portal tracts. (Reticulin stain. Original magnification x 20.) 
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adherent mononuclear cells. The changing character of the mononuclear 
infiltration of the homograft was reflected by widespread proliferation of 
similar cells in the host lymphoid tissue. Specific changes in other host 
organs were not noted. 
Some of the biochemical and histologic alterations caused by un- 
modified rejection can also be produced by azathioprine. In 18 nontrans- 
planted dogs, acute rises in SGOT, SGPT, and alkaline phosphatase, un- 
accompanied by hyperbilirubinemia, were noted within a few days after 
beginning administration of this agent. Although these abnormalities 
tended to regress within the 40 day period of observation, more than two 
thirds of the livers showed histologic evidence of centrilobular hepatocyte 
damage or necrosis - often with intrahepatic cholestasis, but always 
without mononuclear cell infiltration. The hepatotoxicity was not pre- 
vented by methionine. Weight loss and progressive anemia also occurred. 
Lymphoid tissue was depleted. The mortality from the toxicity study was 
33 percent. 
The use of azathioprine to mitigate rejection increased the early 
mortality after homotransplantation, 32 to 116 dogs dying within the f i t  
week (28 percent), most commonly of pulmonary complications. The 84 
animals living longer than 7 days had a greatly potentiated homograft sur- 
vival, exceeding 25 days in 44 dogs, and 50 days in 24. Fifteen animals are 
still alive from 62 to 324 days postoperatively. Six dogs had all drugs 
stopped after 116 to 123 days. Only 1 has had a clinically evident late 
rejection and 5 are still alive from 63 to 204 days later. Three of these 
animals had repeat biopsies 77 to 182 days after cessation of therapy; one 
homograft which was normal at 4 months remained so 6 months later, 
another had an improved histologic appearance, and the third had deterio- 
rated. The longest mean survival was in those animals receiving adjuvant 
therapy with L-methionine or S3s-methionine, but the variability of the 
results was so great that a statistically significant advantage of these agents 
could not be demonstrated. Soon after operation red cell survival was 
decreased, but in chronic survivors there was no evidence of a graft-host 
reaction. 
There was great variability in the vigor of rejection, ranging from the 
uncontrollable (29 per cent) to the clinically undetectable (23 percent). 
Most of the animals (49 percent) had some biochemical evidence of 
rejection which proved to be spontaneously reversible, to a greater or lesser 
degree, since intensification of immunosuppressive therapy was not re- 
quired. These findings correlate well with the histologic studies. In 
virtually all animals, azathioprine delayed the onset of rejection but in 
those dying in the second and third postoperative weeks, the pathologic 
stigmas of rejection were very similar to the untreated controls. As in the 
untreated animals, the number of proliferating large pyroninophilic cells in 
the host's lymphoid tissues was roughly proportional to the number of 
mononuclear cells invading the homograft liver. After this time, the 
predominant histologic features in most animals were those of repair and 
regeneration, with either absent or relatively minor degrees of continuing 
destruction. Since the major rejection damage was centrizonal, the healing 
was most prominent in these areas with interconnecting fibrosis around the 
central veins, centrilobular bile canalicular dilatation and cholestasis, and 
pseudolobule formation. In some of the homografts, increased connective 
tissue was also present in the portal tracts, but in others including the 
longest survivor there were no residual abnormalities whatever. 
In azathioprine-treated animals, damage to the vessels in the ho- 
mograft portal tracts was found in only one liver. With electron microscopy 
there was some evidence of damage to the sinusoidal endothelium by 
adherent mononuclear cells, a finding which could be analogous to that 
described by Kountz and co-workers" in the peritubular capillaries of renal 
homografts. If immunologically mediated hemodynamic alterations play 
an important role in liver homograft rejection by interrupting the blood 
supply to the hepatocytes, it seems most likely that they occur at this 
intrasinusoidal capillary level rather than in the larger vessels. 
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DISCUSSION 
Dr. Francis D. Moore (Boston, Mass.). I apologize for getting up to 
discuss two papers in a row, but I think this work of Dr. Starzl and his co- 
workers is the most exciting work in the transplant field since the initial 
reports by Calne, and later by Zukoski, Murray, and Alexandre, showing 
the maintenance of intact renal histology with immunosuppression. Now, 
after a few years and a lot of work, we are beginning to get to the same place 
with the liver. 
Dr. Starzl and his team have furthermore shown a classic thing about 
transplant research in general. Namely, that they have made an experimen- 
tal plan, have perfected their own operative procedure, and then have stuck 
to it, running through a good series of animals with good controls and a 
careful effort to compare various immunosuppressive regimens. 
I rather tend to agree with Dr. Starzl that it is very difficult to make 
any statistical sense out of minor differences in immunosuppressive regi- 
mens because the dog is such a heterogeneous species and relationships are 
so peculiar. One finds unexpected prolonged acceptance of grafts in many 
different fields. Nonetheless, Drs. Starzl and Waddell and their group have 
accomplished more in the way of prolonged survival with liver transplan- 
tation than anyone else has, to my knowledge. 
As for our own work, we have perfoimed fewer operations and have 
fewer animals. We agree that early survival can now be attained pretty 
reliably. Our procedure is sl~ghtly different, since we use two end shunts 
and recently have been using the right renal artery to vascularize the 
hepatic artery - a nice device, since it avoids the aortic anastomosis and 
also keeps the pancreaticoduodenal branch intact. Whether this little thing 
will help us in the long run, I do not know. It is unnecessary in man. 
We have seen the very high alkaline phosphatase levels reported by 
Dr. Starzl in the written manuscript which go "through the roof'  with levels 
of 150 and 250, and may be related to the combination of Imuran and the 
transplant itself. 
We are sufficiently discouraged by the toxicity of Imuran in this 
particular setting to move over to a different combination, namely, thoracic 
duct fistula and local x-ray therapy, and I would hope that later in the 
morning Dr. Murray may show a slide on one of our first thoracic duct 
fistula kidney transplants, showing its efficacy in lowering the peripheral 
lymphocyte count. 
Finally. one could ask, "Is this problem ready to return to the clinic?" 
Drs. Starzl and Waddell made a very careful, cautious, and conservatively 
reported human trial, and we did with one patient. Now that we have 
learned so much more, are we ready to go back to the clinic yet? 
I am not sure of that answer and I will be interested to know what other 
members of the Society think, because the speed with which we go back 
to man with liver transplantation is going to have something to do with the 
public image of surgery in general. as it goes on with the problem of tissue 
transplantation. Maybe the time has come: maybe it needs another few 
months or a year, I am not sure. 
Again, I would like to congratulate the Denver group on a very 
outstanding piece of research. 
Dr. Richard C. 1,illehei (Minneapolis, Minn.). My compliments on 
Dr. Starzl's paper can only echo Dr. Moore's comments, so I will go on 
from there. 
There is, of course, an alternative to orthotopic homotransplantation 
of the liver in the animal or man. Some years ago Goodrich and Welch 
described a method of heterotopic transplantation of the liver in which the 
donor's liver is left in sttu temporarily or permanently. Dr. Karel Absolon 
of our Department has worked on a similar method in the laboratory for 
some years. and has written of the many advantages of such a technique. 
Certainly, it is simpler to place a second llver into the abdomen without 
removing the recipient's liver. This avoids many of the bleeding and 
clotting problems associated with hepatectomy, as well as greatly shorten- 
ing the duration of the operative procedure. These studles of Dr. Absolon 
culminated in a clinical attempt at heretoropic liver homotransplantation 
in a 13-month-old boy with proved biliary atresia in the fall of 1964 by Drs. 
Absolon, Ward 0 .  Griffen, and myself. 
The l~ve r  for transplantation was obtained from an infant undergoing 
open-heart surgery for complete transposition of the great vessels. Com- 
plete correctton by the method of Mustard was not successful and hence it 
was not possible to remove the cardiopulmonary bypass support despite 
repeated attempts during a 5 hour period of bypass. Permission was then 
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asked from the relatives of the infant if the liver could be removed for 
homotransplantation to the child with biliary atresia. This request was 
freely granted and the recipient was brought to the operating room and 
prepared for surgery while the donor was maintained on bypass and the 
liver removed. At the time of removal of the liver, bypass had continued 
beyond 8 hours. 
?'he liver was placed in the left lower quadrant of the recipient and 
circulation re-eqtablished by anastomosis of the hepatic artery and inferior 
yenacava of the transplant to the common ~ l i ac  vesqels of the recipient. The 
inferior vena cava above the transplant was tied off, while the portal vein 
of the transplant was anastomosed into its own inferior vena cava to allou 
decompression of the trunsplanted liver. The gallbladder of the transplant 
was anastomosed end-to-side to a loop of the recipient's jejunum. The 
common bileduct of the transplant was tied off d~sta l  to the cystic duct. The 
recipient's liver was not disturbed. Following this procedure. the 
recipient's jaundice virtuallq cleared. The child died on the thirteenth 
day from septicemia resulting from a bile fihtula due to 
slough of the common bile duct of the transplant where it was tied off. At 
autopsy, the transplanted liver appeared histologically normal. Thus we 
believe that such a technique deserves consideration in future liver trans- 
plantation in the human. 
Finally. the suitability of other organs for transplant taken from 
patients undergoing open-heart surgery who cannot be weaned from the 
support of cardiopulmonary bypass should be emphasized. We, Drs. Aust, 
Kelly, and mlself,  have on several occasions used kidneqs from such 
patients for successful homotransplantation after consent from the cardiac 
surgeon and the next of kin of the patient. In even  Instance the homotrans- 
planted li~dnebs have functioned immediate11 de\pite periods of cardio- 
pulnionar) bypas5 lasting up to 1 I hours before transplantation was 
performed. 
Dr. Starzl (clo\lng). I \\auld l ~ k r  to thnnh Dr. l loore  for his very 
graciouc comments. I ~ p p o i e  the dec~\ ion about the cl~nical application 
of this method all1 ha\e to rest hith the c~rcun?stance\ within any 
1ns:itution contemplating this and the conaclences of the people involved. 
I uould a lw  11k.e to thank Dr. L~llehel for h ~ \  comments. and because 
1 knob of the case 1 would l ~ k e  to point out one \er> lnterestlng feature of 
the Mlnneapoll\ tran\plant. That 1s. that the tran\ter \bas from a donor of 
A blood type to an 0 reclplent. a v~olation of the usual rules of tissue 
transfer, but this did not prevent good function of their homograft. 
IMMUNOSUPPRESSION 
Antilymphocyte serum (ALS) or globulin (ALG) permitted the prolonged survival of canlne renal 
and hepatic grafts. The results were better with livers than with kidneys. At the time of reporting, four 
canine hepatic recipients had lived for more than 50 days postoperatively, and although no further 
treatment was given after 20 postoperative days, two of these animals survived for six and 13 months. 
The report also described the first human trials of heterologous ALG. All five of the authors 
subsequently became division chiefs, departmental chairmen or both. 
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The use of heterologous antilymphoid agents 
in canine renal and liver homotransplantation and 
in human renal homotransplantation 
Surgery, Gynecology & Ohstetric~s, 124: 301 - 18, 1967 
Thomas E. Starzl, Thomas L. Marchioro, K. A. Porter, Yoji Iwasaki, G.  James Cerilli 
The potential value of heterologous antilymphoid serum as an 
immunosuppressive agent has been known for a number of years. How- 
ever, the first reference to testing of antiserums for homograft protection 
was by Woodruff, who later published with Anderson (20.2 1) detailed ob- 
servations of the effect of these agents used alone or in combination with 
thoracic duct drainage. Subsequent valuable studies have been contributed 
b) Waksman, Gray ( 2 ) .  Monaco (9. 10) and their respective associates and 
by Jeejeebhoy. Nagaya and Sieker. and Levey and Medawar (6. 7). The 
experimental model for the foregoing experi~nent\ cons~sted of skin 
grafting in rnlce, rats, or guinea pigs \shich were treated uith antiserums 
raised in rabbits. Except for our own brief report ( 1 1 )  and those of Abaza, 
and Mitchell and thelr colleagues there are no publ~shed accounts on the 
use of antil)niphoid \erum for the protection of \\tiole organ honiografts. 
The present 5tutiy is a further e\aluation of the irnportarice of this 
kind of irnmuno\uppres\ive therapy for the protectioli of \\hole organ 
homosrafts in dogs. a\  he![ as an account of it\ \ub\equent appl~cation in 
humans. Antiserums again\{ ths Iqmphoid ti\\ue of both specie\ here  
raised in hor\es. characteri~ed for tox~city and antibod) content, and 
rendered to glohiiliri as full! tiescribed else\silere (4 ) .  Thz tejt organs in the 
canine experiments \&ere thr kidneb and liver. Thf clmical patients had 
renal homotransplan!ation. 
METHODS 
Ctrr i r~le c . ~ [ ~ e r i r n u r ~ t ~ .  One hundred and thirty-four mongrel dogs 
weighing 10 to 25 kilograms were immunized against hepat~tis and 
distemper and used a hornograft recipients. Operations \sere perfomed 
under hodiurn pentobarbital anesthejia combined with the tranquillrer 
phencyclidine hydrochloride. Renal tran\plant\ \\ere accomplished b! 
tranjf'erring the donor I\ldnrj to the contralater;il reclp~ent ili;ic f m a .  hith 
anaStomohe\ of the renal artery to the proxlrn~il end 17f the cut common iliac 
"er). the renal vein to thc side ot the common i l~ac  \,em. and the ureter to 
the blatider. Bilateral recipient nephrzctorn! \ \a\  alMa!\ carried out. 
Onhotop~c hepat~c trn;l\pIant\ \&ere perfonnsd a\ pre \~vu\ l )  described 
(15). Before and after both kinds of homotransplantation, blood urea 
nitrogen, serum bilirubin, alkaline phosphatase, serum glutamic oxalacetic 
tranbaminase, serum glutamic pyruv~c transarninase, and complete hema- 
tologic ~tudies  were obtained at frequent intervals. The development of 
canine antibodies again51 hor\e 5erurn b a s  monitored by determination of 
preclpitin titers (4).  
.Animal\ \chlcti d ~ e d  after tranjplantation here  autopsied and the 
tissues exam~ned b j  light micro\cop). In a ~iuniher of experiments, biop- 
sie\ \sere taken at \ar)!ng ~nter \a l \  after tran\plnntation and examined 
both \sith light and electron niicro,cop!, 
Antiljnipho~d plarma - The 3 k ~ n d \  ot antrl>rnpho~d agents were 
obtained from iriimunized horse\ a \  de~cr ihed pre\ 1ou5l> (4) .  The flrst was 
unabsorbed antilbrnpho~d pla\m;i uith a Iei~hoagylut~nrn titer of ] : I 6  to 
l:256. The dose of l to 3 n?illilrtrr\ per L~loprarn \\as g i \en  mtraperltone- 
all! r \ery  1 to 3 da) \ for 5 to 30 (la)\ before renal honiotraniplantation and 
b) \irn~lar \chedule durrng the tint 20 or 30 pojtoperati\e dabs. After this 
tirnz. the rntenal\  b e t ~ e e n  ir!jeitionL Mere ~r.cre;iwd ro 1 ro 30 da j s  or 
therap! \&,is \topped. The pl;l,rnd \\a\  torrc. Of 36 dog\ entered Into the 
experlnient. I1 dred before operation. Tv.eI\s ot the renialning 25 defini- 
tive test an~mal \  had th!rn?ctom) 7 to 20 day\ before In,tlt;irion of plasma 
therap! 
An~ilqmphoid \ s r u m .  The \eco:id product teited \\as antilbm- 
phold herum \b~th a titer of 1 : 3 2  to I .  128. Thr\ obtai~led from 4 of the 
same horssa. hut ~t uz ,  prepared trom soagiil~itsd hloiid and partially 
abso rkd  apairi\t I O  per ~srit do: red cell pdck. S I X  do!\ recei\zd renal ho- 
rnotran\plantation \\ ~ t h  a comparable 1ntr.ipzritone~I docs xhedule as that 
described for plaima. In addrtion. 6 other arl~niali r z c r ~ \ s d  kidnehs Mith 
~nrraperitone~ii anti,erum thzrdpk \tartirls on the da) of transplantat~on. 
The bane anril>rnphoid yerum \ \a \  :i\tn ~ritraperitoneally to 9 
recrplent\ of orthotop~c I ~ \ e r  homo~ra i t \ .  kg inn~n :  1 to 26 da j s  before 
operatron. One o i  the pretreated dog, reizi\sti no further therap) after 
traniplant~ition. hut the other, had addrt~or;al po,toperatl\e rnjections. 
.Ant~l>rnphoid g1obulln.- The rhlrd Arn'l of antil~mphoid agent 
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tested was crude globulin which was precipitated from immune horse se- 
rum with ammonium sulfate afterbbsorption of the serum with dog red 
cells, and in some instances with dog serum. kidney. and liver. Many of the 
batches used were concentrated by lyophilization. The leukoagglutinating 
titer of the reconstituted injectate was 1 :5 12 to 1 : 1.024. The subcutaneous 
dose schedule was 0.2 to 0.5 milliliter per kilogram per day. The effective- 
ness of immunosuppression was evaluated both with renal and orthotopic 
liver homotransplantation. 
For 25 kidney tranbplantationr pretreatment of 7 to 13 days was 
provided for 12, and therapy was begun on the day of operation in the other 
13. In 4 of 9 dogs receiving liver grafts therapy was started on the day of 
transplantation, and the other 5 had 5 to 26 days of pretreatment. In the re- 
cipients of both kidney and liver hornografts. therap) u a  stopped from 35 
to 60 days after transplantat~on. 
Another 4 dogs received renal hornotransplantat~on after pretreat- 
ment for 60 days. No po5toperative therapy was given to these animals. 
Antilymphoid globulin and azathlopnne. - Crude globulin was 
given to 14 dogs. beginning on the day of operation. Postoperatively, I 
milligram per kilogram per day azathioprine was added. 
Control studies. - The su rv i~a l  of non-treated control animals 
previously reported from our laboratory u a s  1 1.3 i 4.6 standard deviation 
(SD) days after renal hori~otransplantation (14) and 7.1 i 2.2 (SD) days 
after orthotopic liver transplantation (15). New control animals were 
prepared for the present study with 7 renal and 10 orthotopic liver 
transplantations. The results were not d~fferent from those in the older 
series for which reason both old and neu groups were combined for 
statistical comparison with the results using antilymphold therapy. 
Four other control anlmals were treated for 30 days with crude 
globulin prepared from the serum of r~onimmunized horses. The dose of 
protein was the same. approximatel) 30 milligrams per kilogram per day, 
as with the globulin from immunized horses. Renal homotransplantation 
was then performed, and the subcutaneous globulin administration contin- 
ued daily until death. 
Renal homotransplantation was performed in 7 dogs treated only 
with 1 milligram per kilogram per day azathioprine. 
Data c o m p a r i s o n .  The various operations were performed over a 
period of almost 1-112 years uith ~a r i ab le  periods of available follow-up. 
In order to avoid bias in the event of unusually long survival and to allow 
comparison of senes studied at different times. credit for sumival of any 
animal was limited to 70 days. 
The variously tested antilymphoid substances differed in their titer, 
degree of purification. and extent of abrorption with tissues or red cells 
from the lymphoid donor species. Therefore, an effort u a s  made to relate 
the results b) means of a unlt system wh~ch  mas based upon leukoaggluti- 
nating titers of these different agents. If I milliliter of either horse plasma. 
horse serum, or crude horse globulin had a titer of 1: 128, it war said to 
contain 128 units. With a titer of 1: 1,024, 1 millilrter was considered to 
contain 1.024 units. It is recognized that such a unit nomenclature is arbi- 
trary and that the therapeutic efficacy may not be directly related to the titer 
as the system implies. 
Clinicul studrc.c. Twelve patlents have been given intramuscular 
antihuman lrnmune globulin which was prepared from the serum of horses 
imrnuniled with the lymph nodes, thymuses. and spleens of fresh cadavers 
(4). After absorption of the horse serum with hurnan red cells and ierum. 
precipitation ui th  ammonium sulfate. anti lyophilization. the reconstituted 
product had a leukoagglutinin titer of from 1 :8,192 to I : 16,384. The single 
doses of 4 milliliters provided 450 to 2,100 units per k~logram. The protein 
content was 7 to 9 gram.; per cent. The dekelopment of human antibodies 
against horse protein was monitored serially uith precipitin tests. The tit- 
ers of henlagglutinins against sheep red bloodcells uere  also followed, and 
Fig. I .- Course of a dog after renal homotr-anjplantatlon. eniplo) irig ;int~l!,rllphoid plasma (ALP) for ~mniunosuppression. 
Note the height los, and anemia cauwd b! both an earl!, and late courw of ther,lpy. Rejectron u a \  ,lo\ to occur after cessation 
of treatment. Kote the min~mal cliarlge In [he i)niptioc)te count uheri rlic pl,~inia u a r  gi\en iiur~rig the prevperatl\c period. 
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intradermal skin tests with 0.1 milliliters injectate were performed every 
2 weeks. The response to antilymphoid globulin of nontransplanted uremic 
individuals is described elsewhere (4). 
Eight patients with terminal renal failure were treated with immune 
elobulin. In 7, the horse globulin was glven for 5 or 6 days in advance of 
Fenal homotransplantation as well as postoperatively. In the eighth patient. 
pretreatment was for 35 days. After operation, injections were continued 
daily for 1 to 2 weeks, then every other day for 2 to 3 ueeks. and finally 
reduced to twice a week until the fourth month after which 1 injection per 
week was given. Two of these patients had transthoracic thyniectomy prior 
to transplantation. All 8 kidneys were obtained from blood relatives. There 
were 2 mothers and 6 siblings. The donor and recipient ages ranged from 
21 to 35 and from 16 to 36 years. respectikel). 
In contrast to the animal experiments. horse globulin was never used 
as the sole immunosuppressive agent. Azathioprine was htarted on the day 
of operation and continued thereafter in daily doses of 5 .2  to 0.5 milligram 
per kilogram per day. During the first month. prednisone was added if 
needed for control of rejection. After this time, when the antilymphoid 
globulin therapy was being reduced, prednisone u a s  5tarted in doses of 0.3 
to 0.67 milligram per kilogram per day for patients who had not had 
rejection. Actinomycln C in intravenous doses of 300 micrograms and 
local homograft irradiation were used irregularly if and when rejection 
occurred. 
To evaluate the effect of the globulin therapy, comparisons mere 
made with comparable patients treated in the past at the University of 
Colorado in whom survival of at least 63  days had been attained. The 
control patients of intrafamilial homotransplantations were divided into 3 
groups of 25. 13. and 22 each. The first series of recipients. treated in 1962 
and 1963. had rece~ved azathioprine only until the ons:t of rejection at 
which time prednisone was added. The second group received high dose 
steroid therapy from the day of operation onward In addltion to azathi- 
oprine. The third group differed in that smaller quantitie\ of prednisone. 
usually 0.5 milligram per kilogram per day. were started on the day of 
operation. This steroid dose was increased only a h e n  required to treat 
rejection. In all 3 groups. attempts uere  later made to reduce the prednisone 
dosage as rapidly a\ pos\ible. Since inclusion in the control groups was 
contingent upon survival for 63  day.. unfavorable patlent5 uere  automati- 
cally eliminated. Thus, 7 .  1. and 3 patients who were unsucce\\fully treated 
with the respective protocols for less than this period uere  excluded. An 
additonal patient in group 2 d ~ e d  on the last daq but is included. 
Lymphocyte antigens uere  analyzed by TeraaaLi and h ~ \  associates 
in the donors and recipients from the 3 control groups as well as the 
antilymphoid series. This information became available retrospectively in 
21 of the 25 patients of group 1 and 10 of the 13 patients in group 2. It was 
obtained prospectively for all patients of group 3 and of the antilymphoid 
series. In the last series, there were good. average. and poor matches in 3, 
3, and 2 patients respectively. Statistical comparison performed by 
Terasaki revealed no significant differences in the quality of antigen 
compatibilit) among the donor-recipient combinat~ons in 4 groups. 
For each of the 3 control groups and for the antilymphoid 5eries. the 
events in the first 63 postoperati\,e days mere compared bq determining the 
average dail) blood urea nitrogen, creatinine. creat~nine clearance. white 
blood count. Iymphoc>te differential. lyniphoc)te count, azathioprine 
dose, and predn~sone dose. From thi\ data it could be determined if the 
function in the antilymphold patlent, a a ?  as good a5 In the previou? series, 
if this function had been achieved u ith greater or smaller doses of standard 
immunosuppre\sive agent\, and if there were consistent d~fferences in the 
peripheral white cell differentla1 and total counts in the barlous groups. 
Late homograft rejection.- Three patienti had received maternal, 
cadaverlc, and maternal kidney\ respecrlvelq, 11. 7, and 5 months previ- 
ously. In each. there u a s  deterloration of renal function uhen  the predni- 
sone dose was reduced belou 1.3. 1.7. and I milligram per kilogram per 
day. In the first. second. and thlrd patlent\. In each In\tance. 4 milliliters of 
antiljmphoid globulin u ~ t h  a titer of 1:3.05)6 to 1:16,384 here  instituted 
eveO other dab or twice ~i ueek. and the predn~sone dose u a s  then 
attenuated. 
Secondar) cada~e r i c  h o m o t r a n \ p l a n t a t ~ o n . A  21 year old girl with 
removal of a failed homogratt 1 i month\ after rran\plnntat~on frorn a 
nonrelated living donor received 2 cadaveric kidnc)\ 5 and 8 meeks later 
while being treated u ~ t h  antilqmpho~d plobulln. azathiopr~ne, and predni- 
sone. The fir\t catia\,eric homograft which began to excrete urlne after a 
week u a s  remo\ed as anernerpenc) 2 da> \  later becau\e of acute renal vein 
thrombo\is. She had a cardlac arrest dusin: broncho\cop) and died 8 days 
after placement of the hecund cada \e r~c  hidne) uhich d ~ d  not function. 
Since evaluat~on of therapy u a \  ~niposs~ble  under the\c circumstances, this 
patlent v.111 not be discu\scd further. 
RESULTS 
Curirnc e.~perimenrs. Antilymphoid plasma.- The 25 dogs treated 
before and after renal homotransplantation uith dew of 64 to 512 units 
immune pla\ma had LI \ur\i\aI of 78.2 i 22 (SD)  days. a s~gn~ficant  ( p  < 
0.01) improvement over that of control\. The mean figures are somewhat 
Fig. 2.- A dog ullicll recei\ ed ail orthotopic li\er homograft after 6 intraperitoneal injections of antillmphoid serum 
(ALS). luo postoperati\s tlierap) \ \% ever y i \ rn .  4ote  that the I>mphoc)rt. count u.d\ l~t t l s  h a n ~ e d  The dog I \  at111 alive. 
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lower than those previously reported (14) because survival credit for any 
individual animal was limited to 70 daya. The 12 dogs with thymectomy 
lived for 26.4 + 22 (SD) days compared to 29.8 i 24 (SD) days for the other 
13. a difference which was not significant. Of the 25 an~mals ,  18, 1 1.9. and 
6 survived for at least 15, 20 30. and 50 days respectively. The 2 longest 
sunrivors lived for 95 and 144 d a ~ s .  
During the earl) postoperative period a h e n  injections were given 
every 1 to 3 days. the animals lost u e ~ g h t .  They usually became profoundly 
anemic, a corllplication apparentl? attributable at lea\t in part to the high 
hemagglutinin titers in the immune plasma (4). Later when therapy was 
either reduced or stopped, renal failure developed. u\uall) rather sloaly, 
in the longer surviving animals (F ig  1 ) .  
Antilymphoid serum. - We~ghr  loss and anemia a e r e  also observed 
with intrapeiitoneal antiljmphoid \erum administrations. but there were 
no preoperative deaths. The 6 dogs with renal honiotransplantation whrch 
received both preoperative and postopcrati\i: serunl in doses of 64 to 5 i 2  
units survived 27.2 i I 3  (SD) days. a statistically significant (p < 0.01) im- 
munosuppressive effect. Five. 4. and 2 animals lived at least 15,20. and 30 
days respectively. The longe$t survival was 49 days. 
In contrast. although I of the 6 animals treated beginning at the time 
of renal homotransplantat~on lived 38 days. the other5 all died in less than 
15 days. Mean survival was 12 .8k  12.5 ISD) day>, a \ d u e  which was not 
significantly better than nontreated controls. 
After orthotopic liver transplantation 5. 4. 3. and 2 of the 9 animals 
lived for more than 15.20.30. and 50 days respectively. The mean survival, 
with a limiiation of maximurri survival credit to 7 0  days for individual 
dogs, was 26.8 k 26 (SD) day.;, indicating a statistically significant (p  < 
0.05) prolongation of life. Moreover. 2 of the  animals are still alive and in 
good health after 5 and 6 months. 
Two important observations were made in these 2 long-surviving 
dogs. One animal received only 6 injections of antilymphocyte serum over 
a 26 day preoperative period. After liver transplantation, no further therapy 
was given. A definite lymphopenic effect was not produced (Fig. 2). The 
second animal, which had pretreatment for 1 month. received postopera- 
tive serum treatment for on14 20 days, After stopping therapy. there was a 
striking Iymphocytosis (Fig. 3). despite which overt rejection has not 
occurred. 
Antilymphoid g1obuiin.- The dogs received 100 to 500 units of 
globulin subcutaneously. Graduhl weight loas was not uncornnlon. A few 
batches of globulin caused anemia which developed slowly over a period 
of \everdl weeks. but this waq an unusual coniplicat~on. 
The 12 dogs treated both before and for 2 months after renal 
homotran\plar~tation had a postoperative survival of 22.9 i 23 (SD) days, 
a statisticallq significant ( p  < 0.02) prolongatlor; of survival. Five, 4 , 3 ,  and 
3 animals lived for more thz ,  15, 20, 30, and 50 daya respectively. In 
contrast, the 13 dog\ treated only after operlition had a reduced survival of 
14.3 i 7 (SD) days. a prolongation which was nevertheless statistically 
significant (p  < 0.05). This group had 4 .2 .  1 ,  znc! 0 living animals after 15, 
20.30. and 50 days. The slow but progressive late rejection in the animals 
treated with globulin (Fig. 4 )  was himilar to that described earlier in 
recipients treated a i th  immune pla,,ma or serum. 
The 4 dogs wt~lch received kidney\ after 60 days of pretreatment but 
which were not treated afrer operation all died after 9 lo 15 days. Surv~vai 
was 12 i 3 ISD) days, There was no itatist~call> significai~t difference from 
nontreated controls. 
The ~mmuilosuppressive effect after or:hotoprc iiver transplantation 
was more con\istent (p < 0.01 ). With iiniitaiion of credit to a maximum of 
70 days for any dog, the mean survival was 36 i 30  CSDI day\. Five, 5,4. 
and 4 dogs lived for mo1.e than 15, 70, 30 211d 50 d a ] ~ .  respectively. The 
Fig. 3.- A chronically \urvi\ Ing dog whch was treated before and for 20 days after orthotopic liver tiansplantation 
with intraperitoneal antilhmphoid serum (.L\LS). Note the pronounced lymphocytosis late in the postoperative period. The 
animal is in excellent health after almost 6 months. 
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longest survival, in an animal which is still alive, has been 120 days. The 
5 dogs which received therapy both before and after operation did not fare 
better than the 4 treated only afterward. 
As described earlier with immune plasma or serum. the production 
or maintenance of lymphopenia was not a prerequisite for potentiation of 
survival after either kidney or liver homotransplantation (Fig. 4). There 
was not an apparent correlatron between the presence or absence of post- 
operative lymphopenia and the success or failure of therapy. 
Antilymphoid globulin and azathioprine. - The 14 dogs which 
received combined therapy lived for 22.3 i 19 (SD) days. showing a sta- 
tistically significant immunosuppressive effect (p < 0.01). Eight, 5 , 2 ,  and 
2 animals survived for more than 15.20,30, and 50 days respectively. One 
of the 2 most chronic dogs died after 60 days and the other is still alive after 
100 days. In subsequent statistical comparisons. it should be recalled that 
globulin therapy was started just before or at the time of operation. 
Control studies.- The 7 untreated dogs with renal homotransplan- 
tation lived for9.4 f 3 (SD) days, witha range of 5 to 14 days. These results, 
combined with those from 16 comparable experiments performed at an 
earlier time, gave a mean survival of 10.7 k 3 (SD) days. After orthotopic 
liver transplantation in 10 dogs, survival was 6.8 i 3 (SD) days with a range 
of 2 to 11 days. The survival of these I0  fresh controls plus 22 more from 
earlier experiments was 7.0 t 3 (SD) days. 
The 4 animals treated preoperatively and postoperatively with globu- 
lin obtained from normal horse serum lived for 14.8 i 4 (SD) days, with a 
range of 9 to 18 days. This survival was not significantly better (p < 0.4) 
than that in control anima!s. 
The 7 dogs given 1 milligram per kilogram per daq azathioprine 
survived 20.1 i 18 (SD) days, Four, 2. 1, and I animals lived for at least 
15, 20. 30, and 50 days respectively. Thus the doses. ,llthough small. had 
a statistically significant immunosuppressive effect (p  < 0.05). 
Data comparison.- The foregoing data were used to ask several 
questions of potential clinical importance. To do this, smaller groups were 
TABLE I.-INCIDENCE O F  REJECTION DURING THE 
FIRST 63 DAYS IN PATIEhTS TREATED WITH 
ANTILY,\IPHOID GLOBULIN A S D  IN THE 3 RET- 
ROSPECTIVE C O S T R O L  GROCPS 
P6r cent 
,Vo. Rjeclion rcjeclion 
. . . . . . . . . . . . . . . . . . . . . .  Group I 23  2 3 92 
. . . . . . . . . . . . . . . . . . . .  Group 2 . .  13 7 54 
Group 3 .  . . . . . . . . . . . . . . . .  22  18  82  
. . . . . . .  Group 4 (antilymphoid). 8 4 50 
The  reduccd numberofrejections in Sroup2 was e i l d e n i l y  due to high 
dose p r u p h > l ~ c t ~ c  therapy s>ith precnlionc 
combined into larger series and the significance of differences in results 
were subjected to the Student t test. 
Is pretreatment valuable'? The 18 anlmals which received either 
antllyniphoid serum or globulin both before and after transplantation had 
a significantly (p  < 0.05) better sun,ival than those 19 dogs treated only 
after operation. 
Is cornb~nation therapy helpful or harmful'? The survival of the 14 
dogs treated postoperatively with 1 mill~grarn per kilogram per day 
a~athioprine plus iriirnune globulin was compared with that of the 7 dogs 
which received the wme course of ararhioprine alorie and with that of 13 
dogs which received only po\toperati\ e irrimune globulrn. Although the 
results with the two combined agents were k t t e r  than those obtained when 
antilymphold globulin wa\ used alone in a comparable dose schedule, the 
difference wa\ not statistically significant (p  < 0.2).  Similarly. the in- 
creased cur\ ival with the two combined agents in comparison with that 
using azathioprine alone was not stat~stically big~iificarit. 
Is success easier to attaln with liver than with kidney transplantation? 
S u r v i ~ a l  in the 18 liver experiment\ ~nbolking antllbrnphoid serum or 
~ i ~ .  4,- Potentidtion of canine renal honiograft iiin'ival with i rnniuno~~~ppre\$ion h! ~iii t idog-l~mphoid 
globulin ( A L G ~ .  ~ l t h ~ ~ g h  the ]>mphoc>te different~al fractlon u2s reduced. the total white count was increased and 
the absolute Iqnlphoc~ts  count \*as higher pojtoperativsl? than du r~ng  the coritro! penod. Ths e a r l  po\toperative 
was apparentl\ due to blood lo<s. Note the slow rejection after cessation of therapy. 
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" I 2  3 4 I 2 3 4 
GROUP 1 25 PATIENTS GROUP 3 2 2  PATIENTS 
1 GROUP 2 13 PATIENTS GROUP 4 8 PATIENTS / 
Fig. 5.- Variations in immunosuppression and renal function during the first 63 postoperative days in 4 successive 
groups of patients who received kidneys from blood relatives. Since the blood urea nitrogen and creatrnine clearance were 
not determined each day, these were compiled on a weekly basis. Those in series 3 received adjuvant therapy with 
antilymphoid globulin. Note the drastic reduction in average prednisone dose w h ~ c h  was achieved in these patients without 
significant loss of renal function. The progressive diminution of a~athiopnne dosage in the succeeding series is evident. 
globulin was significantly better (p < 0.05) than in 37 comparable experi- 
ments with renal homotransplantation. The comparison hac validity since 
approximately half of the recipients in each kind of transplantation 
received therapy both before and after operation. and the other half were 
only treated following operation. 
Pathologic s t u d i e s .  Ninety-nine of the renal homografts were 
examined histologically. In dogs treated wrth antilymphoid substances the 
features of rejection were not different from those dejcribed by Porter and 
his associates after immunohuppre\\ion uith other antirejection agents. 
These included inf~ltration a ~ t h  mononuclear cells of which 20 to 80 per 
cent had pyroninophilic cytoplasm. Platelet thrombi and intimal fibrous 
thickening of interlobular and arcuate arteries were common. Fibrinoid 
necrosis of arteriolar and arterial halls was prejent in half the specimens 
and glomerular capillary basement membrane thickening was found in 27 
per cent. Vascular and glomerular changes were rare in either the controls 
or treated dogs with short $us\ ival. The onl? clear difference in the various 
test groups h a \  a reduction in the degree of cellular infiltration. the number 
of cells possessing pyronrnophilic cqtopla\m. and the incidence of mitoses 
in those homograft\ frorn dogs treated w ~ t h  both low dose\ of arathioprine 
and antilymphord globulin. Two of the\e 13 kidnc)\ had no evidence of 
rejection. the onl) ones cornpletelq \pared in the entire \tudq. 
Similarly. in the 17 hepatic homograft\ studled either from autopsy 
or biopsy specimens. either froin autops! or h ~ o p \ >  \pecinienh. the findings 
were comparable to those pre\rou\ly reported in dog\ protected with 
azathioprine (15) .  Animal\ dyrrig before ? week\ had centrizonal and 
usually midronal necro$i\. ~nfiltratron of niononuclear cell\ around the 
portal tracts and central vein\, and centrilobular chole\tri\~\. The 6 ho- 
mograft\ exam~ned after 3 week\ had ~a r i ab le  centr~lobular hepatocyte 
atroph) or reticulin concieniat~on. or e \en later fibro\~a and proliferation 
of brle ductulej in the portal tracts. F ~ v e  ot these h li\erc contained 
mononuclear cell\ but in 7 of the\e the numbers v.cre lo\\ 
In all, p)roninophrllc cell\ \\ere \par\e. In \everal of these livers, 
active rejection appeared to ha\e  cea\ed In contra\t to the fiiidlngs in the 
homografts of the longe\t , un  i \  iris an~rnal\  aftcr renal hornotransplanta- 
tion when the histolog~c appearance \ugge\ted that none of rhcse kidnejs 
was be~ng  tolerated chron~call).  
The effect of the antil!mphord product\ on the I>rnpho~d tlssue, 
kidneys, and other rec~pient organ\ ha\ been de\crihed (1). This included 
myocardial necrosis and necrotizing coronav arter~tis which were also 
present but in lower incidence in the control animals. Dogs which had renal 
homotransplantation under antilymphoid therapy alone had hepatic 
cholestasis or centri/onal necrosis in an incidence of 10 and 4 per cent 
respectively. When azathioprine was aljo given. these figures rose to 77 
and 61 per cent. This latter finding was probably largely due to the 
azathioprine which 1s a known hepatotoxic agent ( 15). but conceivably the 
horse protein could habe contributed h! the synergibtic mechanism de- 
scribed by Paronetto and Popper. 
Clinital snrtltcs. New patients. - All 8 rec~pients are alrve w ~ t h  
excellent renal function from 0-112 to I5  \beel\$ after transplaiitatron. Their 
courses during the first 63 da) 5 of convale\cence are cornpared to those of 
the 3 earlier groups In Figure\ 5 and 8. 
Froni 1962 to 1966 a trend to consenatism with the use of a ~ a t h i -  
oprine \vaj noted. The rnean dally dose of 1.92 milligram\ per kilogram in 
the fourth \cries differed algnificanrl) from the mean\ of the first and 
second (p  < 0.01 but not of the third group. A rign~ficant l~nelir downward 
trend (p  < 0.01) wa\ present rn 311. 
In contrast, the aberage d a ~ l )  dose of s tcro~ds in the : 1:ontrol group< 
remained quite \table de\prte the effort to change the therapeutic protocol. 
However. the patient\ in the antil!rnphoid f lohu l~n  berre\ recelved greatl!, 
reduced quantit~e\ of prednl\one. The averape dally dohr \bas 0.71 mrlli- 
gram per krlograrn. a \tat~\tlcall! signlfrcant reduction (p < 0.05 I compared 
to 1.58 mril~grams per L~lograni rn tile pooled control ,cries. 
Renal function 111 ~ $ 1 1  5 group\ was anal)/ed to determine if the drug 
reduction described h ~ d  heen at the expen\e of ail rncrea\ed homograft 
injurq. When the pooled value\ of blood urea nltrogen. plasma creatinine, 
and creatinlrle clearance frorri the 3 cor~trol serle\ were co r~~pared  with 
those of the fourth. there h a \  rio ri@niflcant difference in any of the 3 rested 
variables. 
Ac \\auld be \u\pected from thi\ d,~t:l. difiicultle\ of the ,intrlym- 
phoid senes ~41th rejectloll were no! \errou\, Thl\ dlagno\ir &a \  not made 
during the fir\t 63 (Fig. 6 )  11; 1 of the X pitient\. In 3 other\. ,I rnild 
rejection c r ~ \ i \  *a\ ea\11! re\e~.eti Onl? 1 reciprent had a \econdsry rlse 
in blood urea nltrogen to o \ e r  100 rrl~ll~sr,inl\ per cent. rzqillrln: protracted 
high do% \rt.rord tht.r;ip i F ~ g .  7). Thc\e rc\ulr\ are cornparcd In Table I 
hlth those ohtalned In the 3 reuo\pectr\e iontrol \erle\ Onlh I I I  Froup 2. 
In u h ~ c h  ma\ \ i \e  , tero~d therap! \ \ , I \  u\ed fro111 the beg~nri~ng.  \ \a\  there 
a \in~ilar number of parlcnt\ u h o  cwapcii c,irl) po\topcratl\e rejection. 
The comparison uith group 3 is panicularl) important. The latter patients 
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Fig. 6.-Cour\e of a patlent treated heforc and after renal honiotr:~n\plant: i t~~?~i w t h  ,~ntil> mpholtl globulin. No 
rejection occurred. Kote the riw\ in prec~pitin arid lit.rnafglutin~n titer\. linding\ \bIi~cli prornptrd lnat~tution of 
prednisone therapy. These tlters subsequently fell. Thl, patient had a good antlgen match w ~ t h  hls s ib l~ng donor. 
F , ~ ,  7 ,  ~h~ cc,Llr\i. of the patler:t iihLi h d  .! rnnd~,r,i~e!! \z\t?rz r:jecrlc,n urnon2 rhi. X rrz,ited from the 
bepinning antll\mphvld g lohu l~~?  i L G i  The l o u n ?  iik~rll;i~?. u h o  hLid .I \ < r >  poor T s r ~ i \ ~ L 1  antiZen !n,ir~h with her 
fratemat donor, reqillrzd large doses of steroids which may have contributed to the relatlre lack of response in the 
preciptin and Icuhoagglut~nln tlters. 
IMMUNOSUPPRESSION 
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Fig. 8.-Effect of different immunosuppressive regimens upon peripheral white cells. The 4 series are 
in the same order as in Figure 5.  Group 4 received adjuvant therapy with antilymphoid globulin. The higher 
average total white cell count in the later series was apparently due to greater conservatism with the use of 
azathioprine. The differences in lymphocyte per cents and total counts were not significant. 
all had prospective antigen-typing studies and were treated from the 
beginning with 30 to 60 milligrams per kilogram per day prednisone, 
despite which early rejection occurred in 82 per cent, necessitating even 
higher steroid doses. 
Blood changes.- These are shown in Figure 8. With succeeding 
series there was a distinct linear rise in the average daily total white cell 
count, probably as the result of the increasingly cautlous use of azathi- 
oprine described earlier. Due to the variability of the \\bite cell counts, the 
differences between various pairs of groups were statistically nonsignifi- 
cant. The per cent of lymphocytes in the peripheral blood was approxi- 
mately the same in all 4 groups. The average total lymphocyte counts 
ranged from 1,380 to 1.606 per cubic millimeter. the highest values being 
from the patients receiving antilymphoid globulin (Fig. 8). but the differ- 
ences were not significant. 
Late homograft rejection.- The clinical courses in these 3 patients 
during the first 10 to 13 weeks of antilymphoid globulin therapy are 
summarized in Table 11. The 2 patients who had received kidneys from 
related donors had stabilization of renal function despite ver) drastic de- 
creases in steroid therap). In both instances, previouj dose adjustments of 
considerably lesser magnitude had resulted in deterioration of function 
(Fig. 9). The plasma creatinine and the creatinine clearance were not 
significantly altered in one patient, and In the other there was slight 
improvement. There were striking fall$ In the blood urea nitrogen, which 
were probably at least partially due to decreased protein catabolism 
secondary to the steroid withdrawal. 
The third patient, who had a hiling cadaveric homograft. also had a 
decline in blood urea nitrogen. Xevertheless. there h a \  a r~leasurable fur- 
ther loss of creatinine clearance with a rise in plasma creatlnine during the 
13 weeks of steroid withdrahal (Table 11). 
In all 3 patients. the institution of horse globulin reduced the lympho- 
cyte fraction of the differential count but. because the \ \ h ~ t e  count was 
allowed to increa\e with adju5tments of azathioprlne dote, the absolute 
lymphocyte counts were relatiiely unchanged. 
Evidence of serum toxicit).- Fever a well as tenderness at the 
injection site way seen in all patients. most severely after the first few in- 
jections. 
The antihorse-protein precipitin titers rose slightlg in all 11 patients. 
In 10 the maximum titer didnot exceed I : 16 and in the other it reached 1 :12. 
Five patients had a preclpitin titer h hich at fir\[ rose and then later declined 
despite continuation of injection5 (Fig. 7). 
Hemagglutinin tlters again\[ sheep red blood cells rose in 8 of 10 
patient, tested, in 6 instances to 1:32 or less. and in rhc other 2 to 1:255 and 
1:512. Secondary declines here  documented in 3 patientt. 
Skin tests. hhlch were obtalned in I0  patient\. sho\\ed an increased 
reaction in 7. This h a \  uauallg e\ident In both the 30 minutes and the 23 
hour reading and cons~sted not onl) of entheina but also of induration. 
Four of the I I patients had a systemic reaction other than fever. In 1, 
hives developed. Another became hypertensive for almost an hour. Imme- 
diately after injection. in the other 2 patients hypotension developed which 
lasted for 5 and 30 minutes and which was accompanied by air hunger. All 
3 patients recovered without specific therapy and each has subsequently 
received many more injections without incident. 
All patients had quantitative studes of urine protein excretion be- 
cause of recent demonstration in dogs that antilymphoid globulin can cause 
renal lesions (4). The 3 patients treated late already had proteinuria before 
instituting globulin therapy and could not therefore be accurately evalu- 
ated. None of the 8 patients treated with globulin from the outset has 
prote~nuria judged by standard laboratory urinalys~s. Quantitative analysis 
of 24 hour specimens revealed protein excretion of less than 400 milli- 
grams per day in each after a follow-up of 2 to 3 months. 
DISCUSSIOK 
Two general conclusions with immediate clinlcal implications seem 
justified from the information now available concerning antidog-lym- 
phoid products. First. there is an important difference in the response to 
injections of globulin prepared from the yerum of immunized as co~npared 
to non~inmunired horses. In the former, development of antibodies to the 
foreign protein 1s markedly retarded as measured by the simple and 
clinically practical precipitin test (4). presumably because of the immuno- 
suppressive qualities of the injectdte. The risk of serum sickness is 
undoubtedly thereb) reduced, as the ear l~er  odent \tudies of Gray and 
associates (3) and Lev! and Medahar predicted. It is not eliminated, 
ho\\ever, since 10% increase-. In prec~pitin titer were often seen in dogs, an 
observation which ma) explain the appearance of glomerular lesions after 
chronic therapy in a significant number of n ~ n t r a n s p l ~ t e d  animals as 
discussed elsewhere (4). 
Secondlq, although the capacitq of the prese~itly avallahle heterolo- 
gous anti1)rnphotd agents to niltigate rejection ofthe canlne kidney or liver 
tvas easil) and unequi\ocallg demonstrable in the present series of trans- 
plantarlons, its effect In an indiv~dual experiment h a s  unpredictable and 
weaker than that linobvn to be obtainable with optimal doses of n~a th i -  
oprine. Not only wai there a h~ghe r  incidence of i~ncontrolled early 
rejectlon but also. e \en after week\ or month\. the renal homografts all had 
evidence of a c t i ~ e  rejection. It 1s of interest that more conk ten t  early pro- 
tection of hepatic honiograft\ has  o b s e ~ e d .  and that in some examlned 
after se\eral months there h a s  lltrle histologic e \  idrnce of continuing 
in jun.  
The incornpletene55 of immunosuppre5s1on with antilgrnphoid se- 
rum wiis also e\ ]dent in the ttudie\ of Abaza and h ~ r  associates \\ ith ,canine 
renal homotransplantation. C\lng dallg Intra\enou\ therap), the! here  
able to prolong homograft function in 6 of 8 dog\. In 1 of ahich uremia 
e\enrually de\ eloped. ?Id\iinum \ u n  I \  a1 \+a< 79 dag .; nfrer transplanta- 
tion and 58 days after removal of the recipient's o\bn kidneys at a second 
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Fig. 0 .  Course of patient with a failing renal hornograft u h o  wah treated late with antilymphoid 
globulin. During tlie first 3 poktoperatl\,e months. there were \e\zraI potentially lethal po\toperative 
complications L\ hich were made more grab e by the need for h e a ~ y  \teroid therap). Eff'ort.. to reduce the 
prednisone tiosage resulted in deterioration of renal function. .After in\titutron of an:il\mphoid globulin 
therapy. renal function slightly improved de\pite a rapid decrea\e of  the \teroid tioies. 
stage operation. Using sheep antrdog-l~mphoid ~ e r u n i  inirn\enouslq. 
Mitchell and his colleagues reported only I of 8 dog\ \\it11 \LIT\ . . I \  dl of mure 
than 22 days. but that animal lived for 10 month, after \irnultaricoua 
homotranspiantation and bilateral neph~ectorn). I h e  ~cn\i\tenc!. of ~ u c -  
ct.\> has thus been less than t h ~ t  reported In iribrcd ro(icnr expcrirnenti by 
several previous investigarorh who ernpl,>qed a \ k ~ n  grnft te\i >)\teni. 
The foregoing infonn:~tion impcl\t.dccrtnli? re\triirioil, upor; the ira! 
In uiiich hor\e ai~tlhuman-l>i~iphoid siobulin coi~lti he :Iinical:! e\  a1t1- 
ated. It M i i i  clear that it h:!d to he uhsd a\ an a,?lii\;iiit rather :han a\  tll? 
primal-) imrnunocuppres~~w drug.  forth^\ redson. it became i r n j ~ ~ n a n r  to 
knot\ of the ph)\iolo@ic in:er:icrinn hei~lerri  tile ar~ril>mphold ~uba1aiices 
and the inore con\entional im~:iun:?\uppre.,ir\e dgent\. Thl\ u ,i\ J parricu- 
important que\tion \~ricz an earlier I~>pothe\i\  of Lex.e) mil \lr.daii.ar 
(6) .  \ubsequently tir\pro\c.d b! the \ame inve\t~gnroii (7). tieltl that [he 
lmniuno\uppre\\i\e propertie\ of antil!rnphoid \er-uir! bLere ilus 70 binding 
of the hrterologo~i\ antibodis\ to recrpisnt l>ri~~.hi~c!ts\  hereb? '.blind- 
folding" and functionall> ema\culatir~g thrrn. Such n po\\ibiIit: implied 
that the actioii of antil>niphoid $ub$ta~?ce\ &:I\ depcnilent upoi  a \tabile 
>~ei:r. i+ hicii c a u d  I! mphoid popillatioii. a t ~ d  t!i,~t rhs \uper~rnpo\ition r~ f  .,
3. rdpid turno\er of ,ten? cell$ rn~ghr cancel the effcc I. 
The canine e\perinlent\ u ith .iiitiI>~~iphoid ~lcihulin plu, ua th i -  
OPrine iiere therefore critical. I t  \<a \  fioanii that the iitri~tzd hut definite 
Prolon@ationofaur\ i ial .  ~ h i ~ h ~ o u l c l  hi. dcIiic\ed u !ih ~:ihoptiiliC+! therap) 
U\inp either agent. \ \ a \  \I!gtitl! insre,i\ed uhcri tlic \\<re zinplo!t.~i 
")?ether 4lthougt1 thi, impro\~nlent  i+,?\ n o t  \t.i~~\:icail! \igriit!~,int. thc 
"all) Iniportant ob\t.r\,i!ion u ~ .  thd! ~un11.11 ii, i \  n~l t  mLids \\or\?.  
l l o r e o ~ e r .  tile e x ~ e r ~ t  of !i~\tc)l~)gic ii~r~i~i:? U L I ,  I ? \ ,  111 thobe h o i i i o g r ~ f ~ ~  
from dog, proiided u ~ t h  iomhinatinn ther:ip!. 
There I \  ekidence rh,it ~ntil?rnphoid \ubstance\ can be used to 
complement !he ct!~cnc) of other irnmunoiuppressive measures. The 
studre\ ibhicl~ are r:?o,t rclc\ LII! to !he clinical protocol finally decided 
upori \sere 111;idc by Lt.\e> anLl \le:inuar (7:. They shoued a profoundly 
s!nergi\tic effect of ~tirc.i~,iI coitico\ieroid\ with .rntil>mpho~d serum. an 
ohwnation ria! iii\\irn:l.tr to that of Wr~c~driiff :ind .Ander\on (20) who 
cornhinz~i ~ i ; t i l >  ~nip/:oi:i \cru:ii u it11 t h~ rzc i c  ~ I I C I  :lrainvse in mice. Levey 
ilnd \ l<( la \ \ ,~r  1 7 )  li:~? 'ii,,, dei~~vti\rr:iteci ! i;it rc~!ai h ~ i !  irradiation and 
Irniliune \rrii:n trzatrnci~t ~ . o ~ l d  he u\ed togetiirr uith i*ti:efit. providing 
the roent~i.iii~i!!srap \ i i i \  gix.er? k f o r e  cspo\ute :i) the .int!gen. When ir- 
radiation *,I, ~ ~ i e i l  Ilitc. u 211 e-tahli\hcd \61r: hornofraft'. 111 \?rum-treated 
mice ue r s  re!ected ii:th~ri .I i?,\ !orlg heiorc !he expected time. 
The ~nf lu~r ic i .  o i rh!r:~e,t:iiii~ upon the :tCs<r~\rr;s\s of antillm- 
phoid herum or ~ l ~ h ~ i ~ i i  !lierap> 1. niori :oritroi sr,i.!i Zli~n,ii.o and hi$ as- 
hociates ! I O i  arid J~c.lccShi)>. u\ing rabnit a :~t i~cnin?\  In illice ;lnd rats 
rrsp..-iri\el). rsponsd i ~ i r  hztter ri.,ulti u heti :he ti!! IIIU. hdd  been exci\ed. 
This could ritrt!>r. ct~nt'inlied i!i our c:iriine \rudis\. iior 111 tt!o\e of Leveq and 
lled,iuar (7) \\ti(>\? nicou\c r.\perirner.t\ clc\el! resernbled those of 
Xlond~o and h ~ . ~  c,\i~cidtc\ .ind of Jeqeehho) . The performance of thlmec- 
torn> ~ i i  torn? of the ljatient. hereiri repoi-trd ni;l! not. rhsrefcre. ha\e  been 
ju\tilieli 
Inother derail uorth c~citli~iuiial comrnenr c o r i < ~ i ~ l \  ths proper timing 
for ,idn7irii\trarion ot the antil!iiipho~cI \ ub \ r .~ r i c s~ .  Careful i tudiri  by 
Leb~ . )  lIsd,i\\ar I 6 I ~ n l i ~ ~ a t e d  th'it I or 2 ~ i ~ r r ~ i p s r ~ t o r i e ~ i  injections were 
nioct e i f e ~ t ~ \ c  ~i giben 2 d,i:\ t)r rrior-;. ,jftsr ,kin graftjng and that 
pretr?,irnient u,i, o f ~ o n ~ i i i i . r c ~ b l ~  I:\\ L .ilur o r h ~ n s  ii ith a \irnilar mouse 
s!\tei~i but u ith rilerap! for longer ! ~ c r ~ o ~ l \ .  \Ioii,ico .ind hi\ collsaguea 19) 
found pretrs~ri~lent to he ~! i~t i~~ct i i i . I !  .id\ant,~;r.ou~. .I ci~ncluaion \up- 
ported h) our cdnine \tudie\. Therc i \  prohLtbI! rio real inconstiitenc) in 
rhesr r e ~ i i l t ~ .  \lnn,i,o'\ c ~ p e r i i i i e i ? ~ ~  ,!nil those herein reported were not 
IMMUNOSUPPRESSION 
, ,p,r F 11.-PATIENTS WITH FAILING RENAL H0510GRAFTS TREATED IVITH AKTILYSIPHOID GLOBULIN 
DURIKG STEROID \CITHDRA\VAL 
Ct~anqc d i~r ing 70 / n  7 3  ;/,erXr ?f therqt;, 
r :  ..:! o ~ / h  o r / ,  B. L'..V., Ctealininr, C~eai in i t i i  clrorarir, P ~ e d n i s o n ~ ,  
,\ .. I )o~ior  .4LG slorird n < ~ m .  per crn/ m ~ m .  per ern/ mi.  'min. m:m. / k p n . / d < y  
1 1 )  ".j l l o t h r r  11 80 -+ 45 2 .4  ---t 2.4 10 --t 12 1.3 -+ 0.67 
I [i l n ?  3 fo thr r  5 80 -+ 40 2 . 3 -  1.8 I 6  -3.34 1 .O -+ 0.35 
( 11 4 Cads\ er  7 115-3.75 3.2 -+ 7.0 5.5 -+ 3.0 1.7 --+ 0.23 
designed to determine the most important time to give a single or a limited 
number of injections, but instead to determine if treatment for a number of 
days before as well as after transplantation was superior to that started just 
before or at the time of operation. It is important to make this distinction, 
since pretreatment did appear to be of value in the canine experiments and 
was accordingly made part of the protocol used for patienti. 
There is evidence that the clincal regimen developed a\ a result of 
these various con\ider;~tion\ ha\ been at leait ot short term value. The 8 
recipients in the test \erie\ did not ha\e  unusually complete antigen 
matche\ with their donors and did not appear to enjoy other advantages 
over previousl) treated patients. The 8 patlent\ are well from 9.112 to 14 
weeks poitoperatively. In each of tlie preceding control series there was a 
15 to 28 per cent nionalit) rate during the \ame period. The quantities of 
azathioprine and predniwne were appreciably reduced in the globulin- 
treated patients during the crlt~cal first ? months w~thout the sacrifice of 
renal function. Thi\ wa\ particularly clear, with calculation of the steroid 
doses, slnce the total amount\ required in each preceding serie\ had been 
fixed at almost the jame lcvcl Thr  \ignificance of these ob,ervations is 
increased b) the fact that tlnta from tliow patient\ in tlie earlier \cries who 
died before 9 weeks were ehcluded from the comparative calculation, 
thereb) introducing a bias agctlnst the ant~lymphoid group. 
The influence of thz globulin therapy upor. the cour\e\ of the 3 
patients with late-tail~np t i o ~ i ~ o g ~ ~ I ' t \  I \  Ie\s clear. In 2 of thew 3 patients. 
the d o ~ e s  of prednijone Mere materially reduced without further evidence 
of kidney ~n ju r ) .  I t  I \  probahle that renal function in \uch patients can he 
improved little, if at all. by ~n \ t~ tu t ion  f antillrnphoid globiilin injections. 
but it is possible th;~t re\~dual function can be \u\tarned with conciderah11 
less prednijone. Bcriefit of t h ~ \  sort ~ l o u l d  not be unexpected r \ en  in these 
patient\ with late-failins gmtti  since XIonaco arid a\\ocinte\ ( 9 )  and Levey 
and Medauar  ( 7 )  \ho\-red that antilymphoid \i.runi can craw the immunol- 
ogic memory of presciisiti~ed aninial\. 
The rileans h> \+hich heterologou\ :intil>rnphoid \uh\tances mlrigate 
homograft rejection ha\ been di\cu\\ed el\e\bhere from the \ ~e\+point of 
the pathologic chLinge\ they c'luie in the I)mphoid ti\\ue\ ol'dogs ( 4 )  and 
in light of tlie ~ntoniiation re~:nll! pro\ ided h i  Le\e) and Ilet1,iwar (7). 
Although the imrnuiio\uppie\\i\ i. cffccr of thew ;igcnt\ ha\ riot been fully 
explained. the c\iiience I \  proiiing thdt it I \  contitigent upon neither 
lymphopenid nor 1)rnphviti depletion. The hone \erurn or l ohu l in  used 
for dog\ arid patient. of the pre\ent \tuti! caii\i.tl I)mpl~opi.nia under 
appropriate condition\ of  111 \ i \ o  tekting 14 ) .  ,I iact atiich I \  prohabl! of 
practical importance 111 di.cidi11g &herher or not n piltent piotl~ict i\ being 
used. iXe\ertheli.\>. thi\ \ i d >  often not ob\er\sd it1 ( i i~i rnal~ uhich i u r \ ~ \ e d  
for long per~ods  atter either hitJne! c>r Ii\er honiotranspl,int,~tioii. 
In the patients ibho  ere trcatrii u i th  7 o r  i!iore dnip iri addit~on to 
globulin. thi. \igntfic:irice ot ch ' in~e,  i i i  Ihmphoi! ti. count\ \ \a \  ? \en more 
diftlcult to interpiet. p ; i r ~ l ~ ~ i i ~ r l  wi;<~i coniparin; ri.,iilr\ in the test group 
ui th  thaw obtairlcil trorii e,irlitl \<tie\.  In  a p ~ \ t  c l~n i~ , i l  \ruii) whicli 
includeti marl) patisnt\ from tht retro\pscti\ c control group, I Ihi. i t  \\a, 
shown that I !nipho~.) tc~~i~ in the. po\1-t1.an\plarit period LoulJ not be 
correlated a i th  tlic pre\enct 0 1  ,ih\en;e rejcction Tliert \ \ , i \ ,  liowe\er. 
a direct correlcition het&c.cn the qudr!rii! ot \tsroid\ criipln!ed and the 
degree of I)niphupen~a, Tlli, ii!iporr.int ph,itniacolog~c \ ari;ible \ \a \  pres- 
ent in both our colitri~l ;inti t e , ~  ,erir., Cori~i.qui.t1tl!. niore c,irln:iot be \aid 
than that the patients treated with antilymphoid globulin had approxi- 
mately the same number of peripheral lymphocytes as previously treated 
patients who had received more than twice as much prednisone. 
Thus far, discussion has been largely confined to the considerable 
body of evidence supporting the concept that heterologous antilymphoid 
globulins may be useful agents in clinical honiotransplantation. It is 
important to emphasize that the extent to which this may be true will be 
strongly influenced by further atudiec of clinical toxicity. It was ment~oned 
earlier that glomerular lesions can be produced in normal dogs by chronic 
adminstration of these substances. Biopsy of the human homografts will be 
necessary at a relatively early time to determine if similar les~ons  are 
present. even though none of the patients now has proteinuria. Such 
histologic infomiation will guide a decision for or against further therapy 
in these or future patient,. 
Furthermore, other features of the patients' responses to horse 
protein are not yet clear. The modest and often reversihle increases in an- 
tihorse-precipitin titers have been cited. Moreover, the significance of rises 
in antisheep red cell agglutinins. which are apparent11 in response to a 
Forssman type antigen In the horse protein, is not yet known. Although life- 
threatening toxicity has not been ob\er\ed. [hi\ p ~ ' r s i b ~ l ~ t y  has not yet been 
excluded. It was principally txcau\e of this consi~ieration that 4 of the 8 
patients in the series of new patient5 were eventuall) treated with low dose 
steroid therapy even though the clin~cal diagno\i\ of homograft rejection 
had not been made. 
SUMMARY 
Plasma, serum, or globulin were prepared from the blood of horses 
which had been immunifed with canine lymphoid tissues. The respective 
agents which were rendered progressively less toxic by appropriate 
absorption and purification procedure5 were administered by the intraperi- 
toneal or subcutaneou\ route to dogs which recelved e~ the r  renal or 
orthotopic liver homotransplantation. The survival of anirnals after either 
kind of procedure was ignificantl) proloriged cori~pared to that of con- 
trols. although in virtually all clinical and pathologic evidence of rejection 
e\entuall) developed. The best r eu l t \  were obtained if treatment was 
started \e\eral da) before operation and continued thereafter. The degree 
of protection seemed to he greater for the li\er homograft\ than for the 
kidneys. Conibinat~on therap) of:inirl~rriphoid ~ l o h u l ~ n  and \mall doses of 
a7athioprine rebulted in \light arld itati\ticall) non\ipnificant increases in 
sur\ i \  al. but the degree of hi\tologic lnjur! seenied to he reduced. 
Although ea\ily detiion\trated. the imtnilno\uppre\\l\e effect of the 
antillmpho~d product\ ~ a \  1101 \tmng enough to warrant clinical use as 
other than an ad ju~an t  agent. Hor\e antihuniari-lbniphoid globulin has 
been u\ed for this purpme in I I patlent\ In combinatioii \\it11 azathioprine 
and predni\one. Eight of thew patients recei\i.d ~ntraniu\cular globulin 
starting before operation and continuing until the pre\ent time. Their need 
for therap! \-r ith the \tanciard iriirnuno~uppre\\i\ e drug\ h,i\ \eerned to be 
reduced u ithout a conbequent lo\\  of hotiiograft functlun. ,All are well after 
9-I/? to I4 \iet.i\. The ijrher -2 patient\ tiaii fa~lrng renal ho~i;ogmfts which 
had been placed froni 5 to 11  n ionth  pre\ iou\l>. . i t ter ~iistitution of 
globulin ther'ip! in the latter patient\. \ tero~d do\e \  Liere reduced. In 2 of 
the 3 patients. renal function \ tahi l i~ed Or improbed in the en\uing 10 to 13 
week\, but in the third there has been further deterioration. 
The sxpenniental nature of ths  clinlcal trial h.i\ k e n  itressed in light 
of the unknown risk of serious toxicity from the irijections of horse protein. 
CLlO CHIRURGICA 
This morbidity can be completely assessed only with further observation 
and by study of homograft biopsies in those patients now under treatment. 
Wider clinical trial is not recommended until this information has been 
obtained. 
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IMMUNOSUPPRESSION 
The kidney was the principal organ used by Calne et al in their first clinical trials of cyclosporine. 
However, two orthotopic liver transplant recipients also were included. This was one of the most 
important clinical papers on transplantation ever published. Almost two decades previously, Calne 
had been one of the most irnportant contributors to the development of baseline therapy with 6- 
mercaptopurine and azathioprineq 'OA description of the use of azathioprine-steroid therapy for liver 
recipients in England is reproduced in Part Ill. 
CLIO CHIRURGICA 
Cyclosporin A initially as the only immunosuppressant 
in 34 recipients of cadaveric organs: 32 kidneys, 
2 pancreases, and 2 livers 
Luncet, 2: 1033-36, 1979 
R.Y. Calne, K. Rolles, D.J.G. White, S. Thiru, D.B. Evans, P. McMaster, D.C. Dunn, 
G.N. Craddock. R.G. Henderson, S. A z i ~  and P. Lewis 
Summary 
34 patients treated with cyclosporin A received 36 cadaveric organ 
allografts (32 kidneys, 2 pancreases, and 2 livers). 26 kidneys are still 
supporting life, 3 after more than a year: the pancreases and livers are also 
functioning. 20 patients are not receiving steroids, and 15 of these have not 
had any additional immunosuppressive agents. In these patients infectious 
coinplications have not been severe. but a gastroduodenal lymphoma has 
developed in 1 patient. 6 patients \\ere given 'Cytimun' ( a  cyclophospha- 
niide derivative) and steroids in addition to cyclospor~n A: 5 of these died 
of infections and 1 also had a Iytnpliomn. I 1 patient\ received additional 
steroids: 1 of t!iese died frorn sep t i c~n i i a  nd 1)niphonia. Ncplirotoxicit) 
can be avoided by perioperative hydration ar~d forced diuresis. Cy- 
closporin A is effective on its o u n  and is a \er) potent imniunosupprcssi\e 
drug. Additional immunosupprzssi\,e agents ma) lead to severe coniplica- 
t i on~ .  
Introduction 
We report here our continuing experience of a pilot study of cy- 
clasporin A (C) A)  begun more than a year a g o .  32  patients in renal failure. 
all of whom had received previous blootf transfusions. \\ere treated. 31 
received first allografts and I a \econd allograft. I recelved a pancreas 
allograft from the kidney donor. The pancreac \\as transplanted in an iliac 
fossa b> nieans of a technique based on that of Dubemard et al . '? patient, 
"ere onhotopicall! transplanted u ~ r h  livers: 1 of thew, u h o  had juvenile- 
onset d~abetes,  receited a heterotopic pancreLiric nllograft. al<o by nieans 
of Dubernard's techilique. All patients and donor, itere rnisrnatched for A 
and B HLA antigena: most had t u o  01 more m~smatchz\ (see table). The 
DR matchirig IS nor !rr available. 
The itartins dose of CkX \ \a\  25 rngkgjda) in 7 patient\. 10 mgik&l 
d a ~  in 6. and 17 rng,kg/da> ~n 2 1 .  26 renal allograft\ are <till su\tainiiig life 
- of thern mori. than a ) e x  aftel. transplaiitation. The pnncri.ax\ and 
livers are also funzrio~ling 20 of the patlent< are off steroid,. ~ncludlng 15 
of 16 u h o  received no additional immunosuppress~ve agents at any time. 
There has been I acute rejection crisis with fever and a swollen kidney. 
Rejection episodes otherwise have presented as impaired renal function. 
No hidney has been lost through rejection. 
Nephrotoxicity 
In our first report of this study we were disturbed by the nephrotox- 
icity of C y A .  All the kidneys came from donors with brain death and intact 
circulations. There have heen 6 cares uith primary anuria and 9 cases of 
secondarb anuria. 9 of these 15 patients had insufficient histological 
changes on renal biopsy to explain the anuria. 4 had substantial rejection. 
We observed primnr) diurcsis a i t h  good continuing function in patients 
who had been deliberatelq hqdrated and given rnlmnltol. This is now our 
standard polic!. 19 patients were treated in this way and had primary 
diuresi\. 3 of thew developed recondarq anuria uith severe rejection on 
renal h iop~y ,  wh1c.h in each case responded to a course of steroids. 16 of 
these patients ha\e  renal allografts functioning uithout steroids and 11 
have not r ece i~ed  additional irnrii~~nosuppressi\e agent\. 
Infections and  Malignancj 
Of the 16 patients treated ui th  C>A onl?. 2 de~e loped  self-limiting 
viral infections - I herpes simplex and I herpe\ zoster and herpes 
simplex. I developed cyton~rpalovirus infection and ~nimunosuppression 
a a s  changed: C l A  \\as stopped and steroid, and 'C)tirnuni' (a  cyclo- 
phosphaalide d e r i ~ a t i ~ e )  \*ere started. 1 allograft from uhich repeated 
biopsy \peciniens had been taken became infected ui th  bacteria and was 
remo\ed. 1 patlent prtsented uith u e ~ g h t  lo\< and anlemia. A gastroduo- 
denal 1)niphonio \\a\  found at eridoscop) and resected. The patient has 
returned to work free of \)niptomz. 5 of 6 patient\ @\en zteroids and 
c!tornun d ~ e d  of sepsis: 1 of these hati a jejunal Ilrnphoma uhich was 
dicco\t.red 31 riecrop,!. I of 11 pdienti  gi\en additional steroids died of 
spesis arid pulnioiiar: 1)mphorna Of the rernalnlng 10. 1 had severe 
htrpsr-\~rnple\ ~nftction arid 1 perforated a signioid di\ertlculum which 
required a colostom) . Both of these patients recovered. 
IMMUNOSUPPRESSION 
DETAILS OF TRANSPLANT PATIENTS TREATED WITH CYA 
Case 
no. Outcome and present function 
June 26, 1 2 
1978 1 1 I Transplant nephrectomy day 28 P)elonephr~tls In graft. On dlalhsls 
I I I I 1 I 
3 2 5 12 No D ~ x h a r g e d d a y  22. June 28, 1979. serum urea 8 .9  mmol~l,  serum 
, ireatrnlne 119 mmolfl 
5 ) :2 July 14. / 2 1 25 1 . . I CM \ \ a n o n  dplas~a nd ssp t~crmla  D ~ e d  after 139 days 
1978 / Fred 
3 
4 
6 1 6  Aug. 4 I .M I 1978 '  i CM 1 S e p t r r m i a .  Died after 55 days Pred 
21 
,M 
27 
,M 
- 
CM 
Pred 
I / No lnlt~ai function. 1 l ~ t r e  day 24. Funct~on Improved wlth faliing 
dose of CyA. C.M stopped at 1 yr. Pred now 5 mgiday. Biopsy at 13 
mo: focal scarring and hypertensive changes. At 13 mo serum urea 
2 1.8 mmol,l, serum creatinine 41 8 mmolA 
July 1, 
1978 
July 14, 
1978 
Gcd function. B~opsy at 11 mo: focal scarring and hypertensive 
changes. At 11 mo serum urea 18.7 mmoiil, serum creatinine 359 
mmobl 
Fred 1 Oligurtc day 0. Diuresis day 9. Aug. 30, 1979: serum urea 29.9 
1978 
, 
I rnmolil, serum creatinlne 490 mmoM 
4 
3 
Jan. 25, 1 2 1 10 1 . . 1 CAM 1 D ~ u r e s ~ s  day 1. Oliguric dav 4. Good tunct~on u n t ~ l  death a t  8 mo 
1979 Pred from pneumcyst~s pneumonia 
Jan.  26, 2 10 7 Pred Dlures~s day 1, then ol~guria.  Good funct~on. Aug. 30, 1979: serum 
1979 1 urea 13.8 mmol,l, serum creatlnine 135 mmol,l. Prednow 5 mg/day 
- 
12 54 Feb. 28,  , . i Fred D ~ u r e s ~ s  day 14. Uled at 4 mo ofsept ic rm~a nd penumon~t~s .  i 1979 I L!mphoma found in lungs I 
- 
13 2 17 17 No Dlures~s day 1. Good function. Sept. 13, 1979: serum urea 10.6 
mmol,l, serum creatlnlne 256 mmob'l 
2 5 
25 
I , I I I I 
14 57 Liarch 19, 1 17 . . Anur~c .  No h n c t ~ o n  at any t ~ m e .  Died day 75 from sept~czmra na 1 F 1 1979 1 p u l m o n ~ t ~ s  Cand~dias~s  
May 19, 1 1 
1979 
.inurlc. Dluresis day 10. Good hncrlon.  Sept. 13, 1979: serum urea 
10.9 mmol,l, serum crearin~ne 136 mmoLl 
Vascular reiection day 7 Recovered function. Discharged day 53. 
Sept. 6, 1979: serum urea 13.3 mmoL1, serum creat~nine 287 
mmoM 
Cytomegalovirus infect~on and varicella. D ~ e d  of sepsis at 11 mo. 
Lymphoma found in jejunum 
1 
12.5 CM 
D~uresls day 16. Good flunctlon. S s p .  19, 1979. lymphoma resected 
from 1st part of duodenum and le\.cr curve oistomach. Serum urea 
6 . 5  mmol,l, serum creat~nlne 141 !.imol,l 
-1979: cover mmol/l, serum creatinlne 255 mmol/l serumurea 19.3 
asthma / for 2uk  1 
D~urssis day 1. Good funct~on. Sept. 27, 1979: serum urea 6 .9  
mmol,l, serum creatlnine 122 mmovl 
8.5 KO D ~ u r e s ~ s d a y  1. Goodfunctlon Sept. 13,1979: serumurea 18.2 
I mmol,l, serum creatlnine 163 mmol I 
. . 
-- 
~ \ . o ~ u ~ e s ~ ~  dab I G d  funitlon Sept 20, 19-9 berum urea 6 8 
mmol 1, serum creat~nine 102 mmo!, l 
C,M 
Pred 
21 37 July 10,' 2 7 KO D~uresisday 1 G o d  f u n c t ~ o n  Sept  13. 1 9 - 9  r r rumurea9 .9  1 F 1 1979 mmol,l, serum ireatinins 181 mrnol 1 
- 
22 I 5 2  I ~ u l y  10, 2 l  1 7 '  6 1 Sht D~uresls Jab 1. Gocdfuncrion. Sept. 21, 19-9. serumurea23.9 
3 x 1 g mmolfl ,  serum crear~nine 280 mmoiil .Lt 1979 
CLIO CHIRURGICA 
DETAILS OF TRANSPLANT PATIENTS TREATED WITH CYA-(continued) 
Age No. of Starting dose/ Present dose 
, 1 1 HLA-B 1 of CyA of CyA 1 Other 1 
m~smatches (mgkglday) (mg/kg/day) drugs 
Outcome and present function 
2 17 5 D ~ u r e s ~ s  day 1. Biopsy day 42: moderate cellular rejection. Sept. 12, 
1979: serum urea 14.7  mmoV1,serumcreatinine 182 mrnoM. 
Improving 
4 13 
2 5 ":l7i% 1 1 17 1 1 NO 1 D ~ u r r s ~ s  da\  1 Good function Serum urea 7 5 mmoV1, serum creatlnlne 9' mmol 1, plasma glucose 5 4 mmol'l &pancreas 
- 
24 
25 
15 
No I Dlures~s dd\ 1 l-unct~on now serum urea 26 8 mmoM, serum creatlnlne 285 mmol 1 Impro\lnp 
10 No Good funct~on 
Aug. 2, 
1979 
Aug. 5, 
1979 
50 
M 
17 
F 
28 
? 
30 
1 I I I 1 I 
I 
2. i 44 j Oct. 3, 3 NO D~uresis day 1 
'All patlenrs except nos 29 and 32 had renal allografts. 
CM=Cyt~mun, Pred=Predn~solone SM='Solu-medrone'. 
3 
M 1979 1 
l 7  I M 1979 1 creatin~ne 28" m m o l l  Improrlng 
29 
M 
50 
F 
68 
Other Side-effects 
All but 2 patlents had abnormalities of liver function early after 
operation. These consisted of raised serum bil~rubln and alkaline- 
phosphatase level\ and. in approximately half. ~ - a ~ \ e d  \eruni-trcinsaminase 
levels. The 2 reclplent\ of' l i ier  allograft\ h:i\e \~rnil:ir r n ~ l d  dcrangementi 
of liver functiori. The abnonnal~t i ra  of l i \ e r  Cunctlon (ended to resolve as  
the docs of C J A  u3\ rediiced \1,1~t patient\ hdd an Ini,re;!rc 11: g routh  of 
hair on the face arid boti). anti rnojr of the patlent\ I\ i t t i  rhe i~  own teeth 
developed fun1 hhpsnrophb. i\ hich tended to gcr hstizr u ~ t l i  rlms. Tremor 
n a s  con~iiion i l l  the earl: po\toper,~ti:r phn\e. u\il.ilI> 11 \ \ a \  niild and 
resolved with time; in 3 it was severe. 
12.5 17 
2 
2 
Renal Function 
None of the 26 patlent\ u ~ t h  11fe-\upporting renal allografts has 
entire[) normal kidriel func t~on.  The l o u e \ t  serum creatinlne is 97 mmol i  
1 and urea 3.1 rnmol/l. A \  a Froup. tho\e patient\ \till heing treated u i t h  
additional \ te ro~d,  h,iie the i \or\ t  function. rhc higlic\t ,erarn irratlnlne 
being 3 7 0  rn~iiol/l m i !  ursa 3 1 rnniol:'l 
\Ye ha \?  on \r\er;il occ,i ,~c~n\ n o t ~ c s d  ;in Irnpro\i.nient of renal 
function as the dose of CyA w a i  reduced. Most patients sumir ing  more 
D ~ u r e s ~ s  day 1 .  Blopsy day 2 1 : severe cellular relectlon. Pred now 
reduced to 15 mg'day. Serum urea 10 4 mmol'l, serum creatinine 
225 m m o l l  
5 
14 
17 
17 
Sept 4, 
1979 
Sept 10, 
19'9,11ve1 
than six months are receiving 10-12 rngkylday of C y A ,  although 1 is 
receiving only 1.6 mgikylday. 2 grafts showed evidence of rejection when 
the dose of C y A  was reduced. 
Discussion 
W e  are still ignorant of the phamacod)namics  of C y A  in man. A 
radioimmunoassa) for Ch.4 ic being de\elopcd. but aje do  not yet know if 
fluctuatiorls In ab\orption and \enin? concentrcit~on\ 'Ire related to nephro- 
toxrcrt> and Imniuno<uppre\\ l \e poti.nc). \ lo\t  C ) . i  I \  thought to be 
excreted in the bile. and \rnce ~t I \  t:~t-\oliihIs. abnorrncllitie, of lrver 
function probab!! ~nreriere u ~ i h  .ib\orpt~on ;irld cksret1c.n of the drug. 
Although an optlmum do\aps 1i.1, nor been i l a r ~ f i e d .  friiin our limited 
experlsncs i i s  iesl [hat 10 m s k g ' ~ i , i  rn'i) be too Iittlz a \  ,in initial dose and 
25 rnglg/d;i)  roo m u ~ h  1i.e arc Scrtrnp licttcr re\uli\ \ \ ~ h t  17 r n g ~ k d d a y  
stanlng do,? \Ye rcrid rc i  rcdiice thf L!C>\,I<~ ,liru I! hut h,ii i. been reluctant 
to i u t  I! belou I 0  rng:k:'tia!. ,tnii C'! .A h,i, I I ~ I I  heer: ,tilpped In an) of the 
currenrl! s u n  I \  lnf p:iiienr\. Ihl ,  p t j l~c)  :. t~c\i.ti o:! oiir e\pcrlsnce with 
rend  alIogr,itr, In do:, , ~ n d  ~ > t ~ h r ) i t l p ~ i  I l e ~ r t  tran\pl:int\ in p ~ g \ .  \ \here 
rejcitioil o c ~ ~ ~ r r e d  111 r i~o\t  iin~rlldl\ ii hei: C! i \r a, \toppe<i. although two 
pig\ treated \\ ith C'!.i Ti11 \ I \  inc~nili\ .ire \ L I P  : \  lrlg :i !cdr ,itt?r stopping the 
drug.' ' 
Pred 
Pred 
2 
Not 
done 
D ~ u r e s ~ s  day 1 .  B~opsy day 36: moderate cellular rejection. Pred now 
reduced to 25 mplda!. Serum urea 19.5 mmoV1, serum creatinine 
227 mmol I .  Improving 
D~uresls day 1 .  Biopsy day 18: severe cellular reject~on. Pred now 
reduced to 20 mg'da). Serum urea 2 1 mmol4, serum creatinine 329 
mmol.4. Improving 
\ept 17, 2 
17 
10 
17 
SM 
4 x  1 g 
Diuresis da\  1 Funct~on now serum urea 18 1 mmoM, serum 
Diures~s da\  1 Biopsb da\ 13 moderate cellular reject~on F u n c t ~ o n  
nou serum urea 54 4 mmol/l, serum creatlnine 664 mmoM 
Improrlng 
8 h o  Gaxi f u n ~ ~ ~ o n  
Powles et a1.' have used CyA to treat graft-versus-host disease in 
patients with bone-marrow grafts. They observed rapid recurrence of the 
cutaneous lesions after uithdrawal of CyA therapy. CyA shows striking 
species differences in its effects on organ allografts. In the rabbit the drug 
can sometimes be stopped quite early without subsequent rejection,' but 
slow rejection may eventually cause renal fatlure.' 
The mode of action of CyA ii not understood but it is the first partially 
selective immunosuppressive drug. It acts at an early stage in the differen- 
tiation of T cellsv 'and pobsibly on a siibpopulation of these.' Although the 
mechanism of nephrotoxicity of C)A is not known. it is reversible and not 
associated with morphological changes on light or electron microscopy. In 
view of the good results in patients who uere  deliberatel) hydrated and 
infused ui th  mannitol at the time of operation, u e  decided after the 
nineteenth case to hydrate and gi \e  mannitol to all patients and to withhold 
CyA until is was clear that there was a diuresis after 6 h. if the patient's own 
kidneys were present, a diethylene-triamine-penta-acetic-acid scan was 
done to determine that urine was coming from the transplanted kidney. If 
there was no diureiis we \rere planning to treat the patients with conven- 
tional i~nmunosuppression with azathioprine and steroids. This policy of 
selection has so far not been tested because all 13 patients iubsequently 
managed in this way have had adequate diuresis at 6 hand habe then started 
CyA treatment. It was also decided that if secondarq anuria occurred a 
percutaneous renal biopsy uould be done, and if this showed rejection one 
course of steroids would be given and then the steroids would be stopped. 
If rejection continued despite steroid treatment. we uould either abandon 
the kidney, stop immunosuppression and remove the allograft. or (if the 
patient's condition uas  satisfactory) irop the CyA and change to azathi- 
oprine and steroids. In 6 patients allograft function deteriorated and needle 
biopsies of the transplants showed rejection. All 6 patients responded sat- 
isfactorily to additional steroid; and in 3 the steroids have been >topped. 
We feel it is most important to avoid adding other immunosuppres- 
sive agents to CyA. if possible. A high incidence of infection and two lym- 
phomas wer found in patietns treated with additional drugs. The third 
lymphoma developed in a patient treated only uiih CyA. Xlalignant lym- 
phoma is a well-knoun complication of conventiot~ai inimunosuppres- 
sion.!! ' 18% of heart-grafted patient< uith ca~diurnypathy developed 
malignant lymphomata. ' The) here  treated uith high doses of azathi- 
oprine, steroids, and antithqmocyte globulin. In our trial of 34 cases 
extending over ony 15 months the occurrence of three lynlphomata is 
disturbing and makes us reluctant to make speculatiorls about the future of 
CyA. Our experience suggests that in man CyA is the most powerful im- 
munosuppressive agent jo far u ~ e d  in the nlanagernent of patients with 
cadaveric renal allografti. One of its moit attractive features is that is can 
be steroid-sparing. lt is also relativel) lion-toxic to the bone marrow. 
Patients do not have difficulry In taking :he drug and most are delighted 
with the lack of steroidal side-eff-cts. 
Safe and effective immunoiuppre\<ion remains an e l u s i ~ e  goal. The 
search for predictable, truly donor-specific immunosuppression has been 
disappointing. We expect that in the foreseeable future non-specific phar- 
macological immunosuppression with highly i e l e c t ~ ~ e  agents will be 
required in clinical organ grafting. CyA is a move in rhii direction in terms 
of its selectivit) against a >ubpopulation of l jn~phocytes. but its side- 
effects have been more serious than wouid have been expected from much 
experimental work in various species. Despite careful assessment in 
animals, when a drug is first used clinically the patient embarks on an 
uncertain and possibly hazardous journey. Every effort must be made not 
to repeat mistakes, and careful review of patients is essential before 
widespread use of the drug is advocated. 
We thank our medical, nursing. and technicai colleagues for their 
help with this study. 
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The third author on this paper was Goran B. Klintmalm. Klint- 
malm was a 29 year old surgeon in the late stages of h ~ s  training at 
the Karoinska lristtute. Stockholm. when he was sent by Dr. Carl 
Groth to the University of Coiorado in the summer of 1979 for a 
transplantation fellowship With h ~ s  great technical skills, intelli- 
gence, and organizational capabiiiries, he became an lrnportant 
force in the transition from the o ld "  to the m o d e r n  era of transplan- 
tation As much as anyone else, lie and his co-fellow Shunzaburo 
Iwatsuki, had one foot in the past and the other in the future. 
Klintmalm participated in all of the early t r a s  of cyclosporine- 
steroid therapy for renal and liver recpie~i ts in 1979 and 1980 at the 
University of Colorado Wher, this program was moved to Pittsburgh 
in the last days of 1980, Klintmalm b ~ c a r n e  one of the architects for 
the Pennsylvania program, a role which wac; repeated years later 
when he established the mutipie organ transpantation program at 
Baylor Univers~ty Hospital in Dallas. HIS liver transplantation pro- 
gram in Dallas is one of the biggest and best in the world. 
After acquiring experience with cyclosporine-steroid therapy in cadaveric renal recipients in 
1979 and early 1980, 14 liver recipients were entered into a clinical trial at the University of Colorado 
between March and September, 1980. Two of the patients died on the operating table and never 
received any immunosuppressive therapy The other 12 survived operation and 11 (91 %) of these 
lived for at least one year. The remarkable improvement in the outlook with cyclosporine became the 
single most important factor in the avalanche in clinical activities in liver transplantation that followed 
in the next 24 months. 
The International Transplantation Society met in Boston in 1980 during the 4th of July national 
holiday. The first results in Colorado with cyclosporine-steroid therapy for renal and hepatic 
transplant recipients were presented with acceptance by some of the audience and incredulity by 
most. The claims seemed too good to be true since the maximum follow-up for the liver recipients 
was only four months, but the optimistic views as well as the recommendations for polypharmaceu- 
tical therapy were vindicated in the ensuing months. 
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Liver transplantation, 1980, with particular reference 
to Cyclosporin-A 
Transplantation Proceedings, 13: 28 1-5, 198 1 
T. E. Starzl, S. Iwatsuki, G. Klintmalm, G. P. J. Schroter, R. Weil 111, L. J. Koep and K. A. Porter 
Thirteen years ago this month, liver replacement with extended 
patient survival was accomplished for the first time. That little recipient 
lived for more than a year before dying of metastases from the hepatoma 
for which she originally had been treated.' 
Results with conventional immunosuppression 
The demonstration of its feasibility did not make orthotopic liver 
transplantation a widely used clinical procedure, and in fact, only we' and 
Calne and Williams of England' have persisted in large scale trials. Two 
years ago in Rome, we summarized our experience and that of the British 
group using conventional ~mmunosuppreision with azathioprine and 
prednisone, to which in the Colorado series we had added lymphoid 
depletion with antilymphocyte globulin (ALG) or,  more recentlq, thoracic 
duct drainage. 
Our results have been so thoroughly reported that I will dwell on them 
in summary o n l ~ ,  and then mainly to emphasize how unsatisfactory they 
have been. By earl) summer of 1976, we had treated 11 l consecutive 
patients. Thirty-one ( 2 8 4 )  of these recipients had suniked for at least a 
year (Fig. I ) .  Now, with follou-ups of 4.5-10.5 years. I3  patlents are still 
living. The flatness of the late life survi\,al curve has been an important 
stimulus to persist in these efforts. and so has the very acceptable quality 
of life of these chronic sunivors.  Chronic graft rejection has been the 
single most common cause of late death.' 
A second Colorado series of 30 patients uas  compiled in the 
subsequent I8  months, ending in early 1978. Half (50%) of these patients 
survived for at lea51 1 year. and todaq. after 2.5 to almost 4 )ears. 13 (43%) 
are still living (Fig. 1). It was thought that improvementi in surgical 
technique (especially biliary tract reconstruction). better diagnosis of 
postoperative hepatic dysfunction. and refinements in immunosuppres- 
sion were responsible for the better results. 
It is distressing to report that we were unable to malntain these gains 
in a further series of 30 patients. of uhom the first 23 have been docu- 
survival isonly 33% (Fig. 1) .  Many of theearly deaths in the last series were 
attributable to technical or management errors, as in the past. These 
misadventures often were not intrinsically lethal but became so because of 
the need for high-dose steroid therapy. 
The preoperative use of thoracic duct drainage (TDD) as a steroid- 
sparing device which had been shown to be valuable in cadaveric kidney 
transplantation' proved impractical for conditioning of liver recipients.' 
The amount of thoracic duct lymph drained in patients with chronic liver 
disease was always large and sometimes it was prodigious. In Fig. 2 is 
shown a progressive increase in the volume of thoracic duct lymph, which 
rose to nearly a liter an hour during the 2 weeks preceding transplantation 
at the same time as the cell yield fell. After successful transplantation, the 
lymph volumes were halved (Fig. 2). This patient had agood result, but two 
patients died during preparation for transplantation because of our inability 
to manage fluid exchange of as much as 2 litershr. 
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mented elseuhere: ~nstead of using ALG, man) of these last 30 patients 
had lymphoid deplet~on with thoracic duct dramage' or 1)mphaphoresis. Fig. 1 .- Life survival curves of three successive series of patients 
who were given onhotopic liver homografts at the University of Colorado. All 30 were given azathioprine and prednisone. The projected I-year 
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Fig. 2.- Daily lymph volumes and lymphocytes obtalned by TDD 
in an orthotopic liver recipient whose original hepatic disease was primary 
biliary cirrhosis. 
The Justification for  Change 
By the end of 1979, we had concluded that no real movement of liver 
transplantation toward an acceptable risk was going to be possible without 
a drastic change in immunosuppressive techniques. Thus, when the possi- 
bility arose of using cyclosporin-A, we had no hesitation in proceeding. As 
everyone here knows, cyclosporin-A was the product of a Sandoz Corpo- 
ration research team. The powerful immunosuppressive qualities of cy- 
closporin-A were accurately delineated in rodents by Bore1 et aL6 Calne 
and hls associates of Cambridge, who were the first to use cyclosporin-A 
in larger animals and humans, reported these trials to this Society in Rome 
almost 2 years ago.. In Calne's most recent comprehensive pub l i ca t i~n ,~  
he described the administration of cyclospor~n-A to two liver recipients. of 
whom both were then alive with follow-ups of a few weeks. By personal 
com~nunication 2 weekr ago, the n u m k r  of cyclosporin-A liver cases in 
Cambridge had increased to five. Three were still alive (longest follow-up 
10 months), although one of the three had been switched to azathioprine- 
predrlisone because of nephrotoxicity. The deaths were due to rejection in 
one instance and an unexplained cardiac arrest 3 weeks postoperatively in 
the other. 
Cyclosporin-A and  Renal Transplantation in Colorado 
When cyclosporin-A became available for clinical trials in the 
United States in late 1979, we began its evaluation in the srmple kidney 
transplant model. From the beginning, it was obvious that unless some 
hidden problem surfaced, cyclosporin-A would change the face of trans- 
plantation. Between December 1979 and 1 month ago, we treated 36 
recipients of 37 cadaverlc kidneys with cyclosporin-A and prednisone. 
Eleven of the patients also had preoperative lymphoid depletion with 
thoracic duct drainage (10 examples) or lymphaphoresis (1  example).' 
After 1-6.5 months. 8 9 9  of the patients have been liberated from dialysis 
(Table 1 ). Two patients died with well functioning k~dneys ,  for a mortality 
of 5.6%. Two kidneys were lost to rejection, and a third organ was removed 
because of ureteral necrosis. Even though the follow-ups are still short, the 
early results (Table 1) have been supenor to those achieved bq us in the past 
wlth any other kind of immunosuppression. particularly corls~dering the 
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Fig. 3.- The developnlent of jaundice In the recipient of a cadaveric 
kidney who was being treated with cyclospor~n-A. Kote decline of the 
bilirubin after reduction of the cyclosporin-A dose. but with the penalty of 
renal homograft rejection. E\ entually, the combmation of prednisone plus 
an increased dose of cyclosporin-A allowed control of the rejection. 
fact that retransplantations were included in the rtatistics. 
Thus, we reinforce Calne's optimlst~c projections about the future 
role of cyclosporin-A in transplantation. However. our views about how to 
best use this valuable agent" are divergent from those of the Cambridge 
team, which has warned against combining cyclosporin-A w ~ t h  other 
agents. In contrast. we have concluded that cylcosporin-A alone, even in 
doses of 15-20 rngkgida). does not consistently prevent rejection, that it 
should be combined with steroid therapy for optimal use, and that the 
proper arnount of prednraone when cyclosporin-A is used 1s much smaller 
than when steroids are combined wlth azathioprine. Finally, cyclosporin- 
A has been safely combined with thoracic duct drainage. 
Conceptually. we have substituted cyclosporin-A for azathioprine in 
what is a modem-day versron of the time-honored double-drug immuno- 
suppression introduced in 1962 and 1963."' Having learned that rejection 
usually can be expected. we now start the sterords on the day of operation 
and reduce the prednisone in adults hy 20 or 40 mgiday until a maintenance 
dose of 20 mglday is reached (usually within 5 or 6 days). The amount of 
prednisone needed in the first 3 months has k e n  between one-fifth and 
one-tenth that uhich we used to gike when prednisone was combined with 
arathioprine. 
Besides learning from kidnev recioientc how to orovide immunosu~-  
, . 
pression, thls experience gave insight into the hepatotoxicity that has been 
seen with cyclosporin-A. We habe seen significant hepatotoxicity, includ- 
ing jaundice ~ ~ 1 5 %  of our k~dneg recipients, always with dally cy- 
closporin-A dose5 of about 17.5 mg/kg." This information in kidney graft 
recipients has been important in making dec~sions about hou, to give 
cyclosporin-A in liver transplant recipients. The patient whose course is 
shown in Fig. 3 developed jaundice 4 weeks after renal transplantation, 
while k i n g  given 17.5 mgkgida) of cqclosporin-A. The hepatic dysfunc- 
tion promptly reverred when the c)c ioqor in  was reduced to 7.3 mg/kg/ 
Table 1. Cadaveric Renal Transplantat ion a t  t he  Universi ty o f  Colorado Under Cyclosporin-A and Stero id  Therapy 
(Eleven o f  t he  3 6  Pat ients Also had Preoperat ive Lymphoid Deplet ion 
W i t h  Thoracic Duct Drainage or Lyrnphapheresis) 
P a t ~ e n t s  
K ~ d n e y s  Lost off 
P a r t e n t s  Grafrs D e a t h s '  Other T h a n  D e a t h  D l a l y s ~ s  
Pr~mary transplantation 3 0  3 0  2 I t 27  (90%) 
Retransplantat~on 6 7 0 2$  5 183%) 
Total 3 6  3 7 2 ( 5 . 6 % )  3 32 (89%) 
'One death from pneumonttls: one death from complication of coronary artery bypass. 
tLoss from rejection. 
t o n e  loss from ureteral necrosis, the other from rejection. 
IMMUNOSUPPRESSION 
Table 2. Onhotopic Liver Transplantation at the University of Colorado Under 
Cvclos~orin-A and Steroid T h e r a ~ v  
mgldl mg1kglOay mp/Dsy 
01 Age Lymphad Date of Blllrvbtn Cyclo-an-A Predn~son 
NO (Yews1 Dmgnosrs Oa~ ie t~on  C+%at~on Outcome 711180 7 1 /60  7 /1 /80  
171  2 9  Chronic aggesstve hepat~rtr 2 month TDD 310 8 0  Alwe 1 2  12 2 0  
172  24  Hecatma No 3 10  8 0  Alwe 4 0 10  2 5  
173  34 Ssconday bt1lat-y crrhos~s 1 5 month 
Lymphaphersrtr 3 2 1 /80  Altve 0 6 11 2 0  
174  2 0  Budd-Chw syndrome NO 3 / 2 5 / 8 0  Alive 0 6 8 10  
175  4 1 Prlmay bt1tat-y cmheslr No 4 13180 Alive 1 8  10  15 
176  33 Sclgos#np chorangft~s No 5 13 '80  Alwa 3 0 1 0  5 2 0  
177 26 Chronic aggesrlve hepatiter No 5 17180 Alwe 2 0 10  2 0  
178  3 7  Seconday blltay cfnhosls No 5 30180 Opwsr~ve death 
179  2 3  Bud6Ch91 syneome NO F15180 Al~ve nevolog~c damage 3 0 8 1 0  
day. At the new low dose of cyclosporin-A, the kidney graft began to reject, 
requiring an adjustment of steroids. After weeks of drug juggling, a good 
result was obtained. 
Cyclosporin-A a n d  Liver Transplantation 
The first liver transplantation under cyclosporin-A was not at- 
tempted until experience had been acquired with 22 cadaveric kidney 
graftings. Since then, nine orthotopic liver transplantations have been 
performed (Table 2). There was one operative death, when the abdominal 
incision could not be closed despite repeated attempts during a 48 hr 
period. Postoperative therapy with cyclosporin-A was not provided. Of the 
eight survivors, all are being :reated with cyclosporin-A. One has serious 
residual neurologic injury from a cardiac arrest. The others are well, 
although not all have perfect liver function. The eight survivors are being 
treated with 8-12 mg/kg/day of cyclosporin-A plus 10-25 mg/day of 
prednisone. 
We mentioned earlier our conclusions about the optimal way to use 
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cyclosporin-A in kidney graft recipients. It was not surprising that these 
conclusions seemed to apply in liver transplantation. Five of the eight 
patients who survived operation were suspected of having rejection within 
1-4 months postoperatively. In two cases there were increases in serum 
transaminases and alkaline phosphatase, but no jaundice. Three other 
patients also had increases in serum bilirubin. 
One to five liver biopsies were obtained in these five patients. In 
every case the grafts contained mononuclear cells and other findings com- 
patible with cellular rejection. Eosinophiles were more prominent than in 
rejecting livers under conventional immunosuppression. The liver func- 
tion abnormalities were promptly amelio1,ated with steroid therapy, thus 
reinforcing the histopathologic impression of rejection. 
The high incidence of rejection in liver recipients treated with 
cyclosporin-A but not initially given prednisone has caused us to adopt the 
same policy of prophylactic steroid immunosuppression (Fig. 4) described 
earlier for adult renal graft recipients, namely, 200 mg prednisone on the 
first postoperative day, reduction by decrements of 40 mglday until 40 mg 
is reached. On the next day, the maintenance dose of 20 mg is reached from 
RELIEF OF BlLlARY 
OBSTRUCTION 
+ 
ALKALINE PHOSPHATASE 
( I .U.1 
BILIRUBIN 
l10101, ma%] 
CYCLOSPORIN-A 
(rnp/kq/dayl 
" I 1 
0 I 2 3 4 5 6  
WEEKS POST -TRANSPLANT 
Fig. 4.- The development of uremia in an orthotopic liver recipient treated with cyclosporin-A. Kidney function 
returned to normal after a reduction in cyclosporin-A dose. Note that prednisone was given from the beginning, but in rapidly 
decreasing amounts. Later (not shown), the penalty of decreasing immunosuppression was liver homograft rejection as 
judged by liver biopsy. An increase of the cyclosporin-A dose plus steroid therapy seemed to control the rejection, but 
subsequently it was found that the liver homograft was partly constructed. The cholecystojejunostomy was converted to a 
choledochojejunostomy, with amelioration of the low-grade jaundice. 
CLIO CHIRURGICA 
which further slow reductions (or increases) are individualized (Fig. 4). 
n e  development of rejection in spite of such treatment signals a need for 
more steroids. We do not respond by drastically increasing doses of 
cyclosporin-A, since we have learned from kidney graft recipients that the 
hepatotoxicity range is entered with daily doses of 15-20 mg/kg. Funher- 
more. nephrotoxicity could be the price of such adjustments. Three of our 
eight liver recipients under cyclosporin-A have developed renal dysfunc- 
tion, which promplty improved after a dose reduction (Fig. 3). 
Summary 
The field of liver transplantation, which had reached a state of 
tantalizing but incompletely fulfilled promise, has been rev~talized by ex- 
perience with the new immunosuppressive drug, cyclosporin-A. For 
optimal value, cyclosporine-A in both kidney and liver recipients has re- 
pired steroid therapy. but the amounts of prednisone have been a small 
fraction of thoqe used in the past. It seems to us that the cyclosporin-A- 
prednisone combinat~on should permit a new chapter to be opened in trans- 
plantation. 
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Part I11 
The Human Trials: 
The First Cases 
THE HUMAN TRIALS 
Part Ill 
The Human Trials 
The first cases. By 1 March 1963 when the first clinical attempt at orthotopic liver 
transplantation was made, the technical problems with the operation were reasonably well 
understood although not completely resolved. The recipient was a 3 year-old boy with biliary atresia 
who had had multiple previous operations. The transplantation could not be completed because of 
hemorrhage from venous collaterals and because of a coagulopathy. Even for a team that had been 
fully prepared for technical vicissitudes by hundreds of animal operations, the experience was a 
shock. Two more liver transplantations were carried out in the next four months. In both the 
operations seemed satisfactory although the recipients died after 22 and 7-112 days. 
These first three cases were reported in November of 1963.' In July and October, 1963, two more 
attempts were made at the Universty of color ad^.^ Isolated trials of liver transplantation also were 
made at the Peter Bent Brigham Hospital in Boston3 and in F r a ~ c e . ~  These first seven liver 
transplantations and the causes of failure are summarized irl Table I .  Pessimism settled in worldwide 
for more than three years. The operation seemed too difficult to ailow practical application. The 
methods of preservation were inadequate for an organ so seemingly sensitive to ischemic damage. 
Finally, the quality of immunosuppression available was too primitive to permit success. 
1-ABLE 1 : THE FIRST TRIALS OF ORTHOTOPIC LIVER TRANSPLANTATION 
~~~~~ 
No. Location Age Survival Main Cause 
(Ref.) ( ~ r . 1  D~sease (Days) of Death 
1 Denver (1) 3 Extrahepatic biliary atresia 0 
2 Denver ( I )  48 Hepatocellular cancer, 22 
cirrhosis 
3 Denver ( I )  68 Duct cell carcinoma 7-112 
4 Denver (2) 52 Hepatocellular cancer, 6- 112 
cirrhosis 
5 Boston (3) 58 Metastatic colon carcinoma 11 
6 Denver (2) 29 Hepatocellular cancer, 23 
cirrhosis 
7 Paris (4) 75 Metastatic colon carcinoma 0 
Hemorrhage 
Pulmonary emboli, 
sepsis 
Sepsis, pulmonary emboli, 
gastrointestinal bleeding 
Pulmonary emboli, ? 
hepatic failure, 
pulmonary edema 
Pneumonitis, liver 
abscesses, hepatic failure 
Sepsis, bile peritonitis, 
hepatic failure 
Hemorrhage 
By the summer of 1967, these deficiencies had been rectified at least partially, and many long- 
term survivors had been obtained in the laboratory, some dogs having passed the four year 
postoperative mark by this time. Better immunosuppression with the so-called triple-drug therapy 
was available (cf. Part 11). 
On 23 July 1967, a 1-112 year old child with a huge hepatoma was given a new liver and was 
restored almost immediately from a morbid state to seemingly good health. More cases followed5 
in what were the f~rst examples of successful transplantation of an organ other than the kidney. The 
lessons learned were generic and within six months the first attempts were made at transplantation 
of the heart,6 pancreas7 and lung.s 
By the spring of 1969, 25 patients had received orthotopic liver homografts at the University of 
Colorado, and one more recipient had undergone an orthotopic heterotransplantation from a 
chimpanzee. These cases and a summary of all previous work were published in a text in late 1969.9 
Meanwhile, Professor Roy Calne at Cambridge University (England) began his first clinical trials in 
CLIO CHIRURGICA 
1968,1°and a few months later he formed a collaboration with the hepatologist, Professor Roger 
Williams at King's College Hospital in London that has endured for two decades. The Colorado and 
Cambridge teams continued their clinical efforts throughout the years, in spite of frequent disap- 
pointments and many tragic failures. Although life was prolonged in a number of patients treated in 
the 1960's, the longest survival of any recipient through 1969 was flve years and 11 months. The 
longest survivor in the world today received her new liver on 22 January, 1970. That little girl, three 
years old at the time of operation. just has completed her 18th postoperative year, is married to a 
United States Marine and lives in Okinawa, 
Technical Principles. In principle, liver transplantation is exceptionally straightforward. It 
involves the removal of the diseased native liver and its replacement with the liver of a cadaveric 
donor in as anatomically a normal way as possible. All of the essentia steps were described in the 
first report' including a new technique for intrauminal suturing of vessels that had to be recon- 
structed without redundancy i r l  ciose quarters. The technique used by Calne essentially was the 
same.1° More complete details of the operation were summarized in the 1969 text.3 However, great 
difficulties with some aspects of the operation continued for years. 
Bile duct reconstruction. In most of the first human cases, the homograft common bile duct 
was anastornosed to the recipient common duct over a T-tube stent. Unfortunately, this approach 
was abandoned in favor of cholecystoduodenostomy, an operation that was somewhat easier 
technically and one that had worked well in canine experiments. The first inkling that unrecognized 
biliary obstruction was common came in a report by Martineau et al." Subsequently, the incidence 
of bile duct complications including obstruction, fistula and cholangitis was shown to be more than 
30%.12 l3 Eventually, these problems were minimized with biliary reconstruction by choledo- 
chocholedochostomy with a T-tube stent or, if this was not feasible, choledochojejunostomy to a 
ROUX limb.I3 
In England, Calne had encountered the same problems with biliary obstruction and fistula,l5and 
he adapted for reconstruction an operation developed by Waddell et all6 at the University of 
Colorado. With the so-called Waddell-Calne procedure, the common duct of the homograft is 
anastomosed to the homograft gallbladder that then serves as an extension conduit to the recipient 
common duct or bowel. The Waddell-Calne operation is not used very often in most centers, but it 
is a sound procedure that can be useful or even lifesaving in some complicated cases in which an 
extra length of the homograft common duct is needed. 
Veno-venous bypasses. There were reasons why veno-venous bypasses were not used 
systematically for orthotopic liver transplantation until recently ' 4  However persuasive the argu- 
ments, the result was that an operation was repetitively performed in humans under conditions that 
limited its usefulness, increased its perioperative risk and made training of the next generation of 
hepatic surgeons difficult, The mistake was made of believing that a fundamental principle of 
surgical physiology worked out in animals, namely, that veno-venous bypass was essential for 
effective liver transplantation," 16was not truly relevant in humans. The articles defining this principle 
are reproduced in Part I .  
How this error was rectified cannot be traced easily from the articles describing the work. The 
stimulus for reassessment was a persistent 5.10% intraoperative mortality that was due almost 
entirely to poor patient tolerance during the venous occlusions of the anhepatic phase. However, 
nothing decisive was done to rectify the situation until a tragedy occurred in Pittsburgh on 13 May, 
1982 that utterly demoralized the transplant team. A teenage hemophiliac male with chronic active 
hepatitis died on the operating table from the combination of bleeding, third space fluid sequestra- 
tion and cardiovascular instability that was then common during hepatectomy and the sewing-in of 
the new liver. 
The dimensions of the mother's grief were beyond description and could not be relieved during 
the long night which members of the transplant team spent with her The vigil was not made easier 
by the thought that we might have been hardened by our own repeated failures to the point of no 
longer making improvements, The program was closed for more than a month until 15 June. 1982 
when in the mid-afternoon one of us (TES) went to the office of Dr. Henry T. Bahnson. Chairman of 
the Department of Surgery at the University of Pittsburgh, for aconversatlon in which the physiologic 
THE HUMAN TRIALS 
requirements for the veno-venous bypass were discussed. Dr. Bahnson was requested to set up a 
pump-driven bypass for the next case. Bahnson grasped the essence of the problem instinctively, 
and he agreed immediately. That night, a liver replacement was carried out under veno-venous 
bypass in a 6 year old child with biliary atresia. The bypass was performed under 3 mglkg heparin 
with a roller pump and other conventional equipment used for open-heart surgery. This technique 
of a pump-driven bypass had been described in dogs 10 years earlier by Cutropia et aI,lg but their 
article was unknown to us at the time. There was little trouble in reversing the heparin effect 
afterwards. All those who were there that night were ecstatic about the ease and non-stressful nature 
of the transplantation under bypass conditions. 
The way in which liver transplantation was facilitated by veno-venous bypass was verified in a 
number of other cases. By 1 July, 1982 abstracts describing the technique were submitted under 
the authorship of Bahnson and Starzl to the Southern Surgical Association and to the American 
Association for the Study of Liver Diseases. Both were rejected. Meanwnile, problems tiad been 
encountered with reversal of the heparin effect in several of the adult recipients. Veno-venous 
bypass under systemic heparinization had worked marvelously in those patients with relatively 
"simple" diseases such as primary biliary cirrhosis and in recipients who had never had any previous 
operations. The same was not true in patients with difficult pathology or exceptionally advanced 
disease and especially in those who had undergone multiple procedures previously. Here, the 
bleeding from the raw surfaces was so great and the heparin effect was reversed with such difficulty 
that the value of bypass technique was vitiated. In fact, two patients with veno-venous bypass under 
heparin died of hemorrhage when clotting could not be restored. 
The possibility of reducing or eliminating the systemic heparinization was discussed. From a 
lifetime of experience with cardiopulmonary bypass techniques, Bahnson was convinced that this 
would not be safe. However, one of Bahnson's young associates, Dr. Bartley Griffith, thought 
differently and approached one of us (TES) early in September, 1982 about omitting the systemic 
heparin. Griffith and Dr. Robert Hardesty, another of Bahnson's associates, had avoided systemic 
heparin in patients with pulmonary insufficiency who had been supported with extracorporeal 
membrane oxygenators. Griffith and Hardesty just had purchased an atraumatic centrifugal pump 
that they thought would permit the pumping of venous blood without anticoagulation. The rest of the 
bypass equipment, including the cannulas and tubing, was not much different than in the first trials 
under heparin. 
On 30 September 1982, work began on dogs in the laboratory. The project was assigned to Dr. 
Scot Denmark, the resident on cardiac surgical research. Griffith and Denmark provided the bypass 
capability. The liver transplantations were performed by members of the transplantation service 
including the senior fellow, Dr. Byers Shaw, Jr. By the end of 1982, most of the work that was reported 
by Denmark at the Surgical Forum of the American College of Surgeons in October, 1983 already 
had been completed.20 However. clinical trials of the non-heparin bypass were not started, in part 
because it was difficult to predict which patients really needed bypass. In addition, there still was 
uneasiness about the possibility of clot formation in bypass tubing and consequent pulmonary 
emboli. Finally, Shaw, who later became an enthusiastic proponent of the t e ~ h n i q u e , ~ ?  was opposed 
to its use at this time. 
During the Christmas season of 1982 and in January of 1983, three more deaths occurred on 
the operating table in much the same way as with the earlier hemophiliac patient. As a consequence, 
a decision was made by Starzl at the end of January, 1983 that veno-venous bypasses must be used 
for all adult recipients of liver transplants from that time onward. In view of Bahnson's previous 
trepidation about using ion-heparin bypass, Griffith, as an additional safety precaution, added the 
hepar~n-bonded (Gott) cannulas for both the outflow and inflow sides of the s y ~ t e m , ~ ~ e v e n  though 
this was not an integral part of the animal technique The problems with bleeding that had been 
aggravated by systemic heparinization were greatly ameliorated. It was obvious that from that 
moment onward liver transplantation could be a far more reasonable procedure that would be within 
the capability of many general and vascular surgeons and which henceforth could be taught to 
surgeons in training in a systematic way. 
The sequence of articles from this work was orderly, but the actual publication schedule was not. 
CLIO CHIRURGICA 
The rejection of Bahnson's two abstracts expunged those beginnings from the record with the 
exception of a brief notation in a review article.'lThe animal work on non-heparin bypasses by 
Denmarkzo appeared promptly in the literature. However, the descriptions by Griffith et alZzof the 
first clinical application of the new method as well as details of technique were delayed. These were 
sent to Surgery, Gynecology& Obstetricson 29 July 1983. However, the article was not published 
until more than 1-112 years later.zz In the meantime. an account of the advantages of veno-venous 
bypasses in liver transplant recipients was given by Shaw at the American Surgical Association in 
the spring of 1984 and published the following October in Annals of Surgery." Shaw acknowledged 
Griffith's contribution, but the result of the publication delay was that Griffith's article had become 
almost permanently "In press." 
The generous nature of all those who worked on the project made the question of such detail 
unimportant for purposes of attributing credit or priority. However, it is worth noting howthe collegial 
interactions between the cardiac and transplant surgeons at the University of Pittsburgh made 
possible a pooling of ideas and resources. The resolution of the bypass problem began with a 
personal friendship between Bahnson and one of the editors (TES) that was conducive to the sharing 
of thoughts and objectives to an extent that might not otherwise have been possible. Griffith's entry 
into the problem and his advocacy of a non-heparin system was central to eventual success; it 
required an initiative on his part without which the matter of veno-venous bypass might have been 
dropped. Not the least factor in the story was Bahnson's encouragement of Griffith to pursue an idea 
that he, Griffith's Chief, initially did not believe to be sound. 
Not all liver transplant surgeons believe that veno-venous bypasses are of overriding impor- 
tance. Calne and his associates have described the use of veno-arterial bypass, sometimes with an 
intervening oxygenator. They contend that strain on the heart is relieved t h e r e b ~ . ~ ~ T h o s e  who have 
trained with Calne, including Wall et have emphasized that liver transplantation can be 
performed without this extra step, a position also held by the Denver-Pittsburgh team for many years. 
However, the practicality of liver transplantation with veno-venous bypass is so much greater 
compared to that in previous times that the principle of bypass is widely accepted. 
Coagulation problems. The presence of the coagulation expert, Dr. Kurt von Kaulla, at the 
University of Colorado i f  the 1960's was a key element in the development of the transplantation 
programs there. Von Kaulla studied the renalp5 and hepaticz6 recipients and characterized the 
clotting defects in both classes of patients. In the first three liver recipients,'he demonstrated clotting 
factor defects, showed the seriousness of fibrinolysis as well as how to treat this problem and 
recommended the thromboelastogram to follow the minute-to-minute clotting changes in the 
operating room in much the same way as is recommended and practiced currently. Other studies 
showing consumption of clotting factors including platelets within the graft itself2728 and the 
development in some patients of a hypercoagulable state postoperatively completed the picture. 
Flute et a1290f Cambridge provided confirmatory data. Although this information was available, it was 
not acted upon systematically for therapeutic correction until the anesthesiologists at the University 
of Pittsburgh did so in the early 1980's under the direction of Dr. Yoo Goo Kang. Now cautious 
correction of coagulation defects is an Integral part of liver transplantation, greatly diminishing the 
hemorrhages of nightmare proportions that were common. The other factor that has greatly 
ameliorated the intraoperative bleeding problems has been the systematic use of veno-venous 
bypasses. 
Refinement in multiple-organ procurement. The techniques of organ procurement and 
preservation used clinically came from the laboratory procedures (cf. Part I). However, much further 
development was required for the procurement of multiple organs from human cadaveric donors that 
were expected to provide kidneys, hearts, pancreases and other tissues as well as livers. The 
stimulus for improvement came from the hepatic preservation methods introduced clinically in 1976 
and 1977 which made liver storage safe for six or e~ght  hours (cf. Part I ) .  Teams from the Un~versity 
of Colorado began to fly to distant cities, particularly Los Angeles on the West Coast, and as far east 
as New Haven, Connecticut. Calne began to recruit donors in continental Europe. 
At first, the individual organs were skeletonized, and after all of the dissection was completed, 
the kidneys were removed and cold perfused on the back table. The liver and heart then were 
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removed simultaneously. The removal of all four organs was a rare event, and the first time the 
kidneys, liver and heart were removed from a single donor was on 17 April, 1978 during a visit by 
the University of Colorado team to the University of Minnesota. 
It quickly became obvious that in situ cooling of organs was going to be necessary if extrarenal 
organ transplantation were to flourish. During the times when the numbers of liver or heart transplants 
were small, the annoyance caused for renal transplant surgeons by multiple-organ procurement was 
relatively minor. As multiple-organ procurement became routine, a major educational effort was 
required to recruit the cooperation of kidney transplanters. The procedures developed in Denver and 
Pittsburgh were demonstrated throughout the eastern two-thirds of the United States. At the request 
of the Surgeon General of the United States, Dr. C. E. Koop, a description of the new operation of 
multiple-organ procurement was p~blished.~~Modifications f this procedure have been made for 
unstable donors or even for donors whose hearts have ceased to beat. In the space of less than five 
years, multiple-organ procurement, using techniques that are interchangeable not only from city to 
city but from country to country had become the norm in all parts of the world. 
Infection control. Bacterial and fungal contamination from the liver was a special and poorly 
understood problem in the first clinical trials of liver tran~plantation.~' A basis for management was 
laid by laboratory  experiment^,^^ and by 1969 the principles of therapy were well delineated.33 
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In this account of the first three clinical attempts at orthotopic liver transplantation, the recipient 
operation was described rather completely, the donor operation and preservation were described 
in principle in the era before brain-death was accepted or even understood, a relatively complete 
profile of the clotting changes was provided by  von Kaulla and a convincing argument was made 
for further clinical trials in spite of the deaths of all three recipients. 
Efforts at liver replacement had originated in the Northwestern University laboratories five years 
previously under the sponsorship of the Department Chairman, Dr. Loyal Davis. Davis also was 
Editor-in-Chief of Surgery, Gynecology& Obstetrics. The association helps explain why the report 
of the first human liver transplants was sent to Surgery, Gynecology & Obstetrics. In retrospect, it 
might have been difficult to find another editor who would publish a paper that was so potentially 
controversial. 
When Loyal Davis died in 1982, one of the editors (TES) attempted to show the Davis influence 
on the origins of both renal and hepatic transplantation. Excerpts of these reminiscences, from an 
article published in Surgery, Gynecology & Obstetrics, * follow: 
In the developments in organ transplantation and hepatic surgical treatment of the 
last quarter century, Loyal Davis played a peripheral, but by no means insignificant or 
passive, role. During the first part of this period, Doctor Davis was chairman of the 
Department of Surgery at Northwestern University, and throughout almost all of it, he was 
Editor-in-Chief ofsurgery, Gynecology and Obstetrics. The fact that he functioned in these 
two powerful administrative positions in an intelligent and creative way was part of the 
explanation for his long tenure in both offices. 
[ I 
Compared with today, grantsmanship in 1958 was a primitive and ingenuous art form. 
During that year, while still a thoracic surgical resideni under Doctor F. John Lewis, I sent a 
four page grant application to the National Institutes of Health requesting funds of about 
$30,000 a year for five years. The objectives were to investigate if insulin had different effects 
if it was given by the portal versus the systemic venous system, to study the effect of 
endogenous insulin upon the liver and its metabolism and to look at the possibility of 
ameliorating disorders of insulin and carbohydrate metabolism by portal diversion proce- 
dures. The money was awarded. 
In retrospect, it was surprising that support was prov~ded. The rationale for the 
proposal was countercurrent to the prevailing opinion which held that portal venous blood 
contained no specific substances that distinguished it in any important way from other kinds 
of venous blood. Complications, such as encephalopathy, were well known to occur after 
portacaval shunt in dogs or in humans, but these were thought to be the consequences of 
loss of volume of hepatic blood flow after portal diversion rather than the loss of special portal 
constituents. The underlying assumption in the grant request was radically different. It 
suggested that splanchnic venous blood returning from the nonhepatic splanchnic viscera 
was capable in a special way of influencing hepatic structure and function In later years, this 
concept became known as the hepatotrophic hypothesis. 
No support could be found in the Northwestern laboratories for the hepatotrophic 
hypothesis for the simple reason that appropriate exper~mental models had not yet been 
developed with which to test the theory. Yet Doctor Davis always remembered the original 
question. As the pieces fit into place showing, first, that portal venous blood had specific liver 
supporting quailties and second, that these qualities were due to hormones (especially 
insulin) coming from the nonhepatic splanchnic organs, he published the evidence in 
Surgery, Gynecoiogyand Obstetrics. He lived long enough to see hepatotrophic physiology 
*Star21 TE: Loyal Davis, Surgery of the liver and transplantation of the kidney. SGO, 157: 160-3, 1983 
CLIO CHIRURGICA 
Loyal Davis at the age of 65 years. (1 896-1 982) 
become a defined field of research with numerous applications in clincial medicine ( I )  
[ ] In order to pursue some of the inquiries which were on my mind in 1958, it was 
necessary to have a reproducible experimental preparation of total hepatectomy I devel- 
oped a method for use in dogs that differed from any previously reported technique in that 
the retrohepatic vena cava was left intact The portal system was connected by vascular 
anastomosis to the vena cava The procedure has become widely used in laboratory 
experimentation In addition rt was realized as a direct consequence of these efforts that it 
might be possible to replace the ext~rpated liver with a hepatic homograft Many of the tech- 
nical details of total hepatectomy and transplantation were similar including the use of a 
venovenous bypass from the lower to the upper half of the body of tkie animal which allowed 
temporary decompression of the surgically connected portal and systemic venous beds 
In the summer of 1958 the first efforts at orthotopic hepatic transplantation (hepatic 
replacement) were made in dogs The project would have discouraged a more experienced 
or intelligent investigator since the first 27 procedures resulted in operative deaths of the 
recipients However the two p~inciples essential for success were finally worked out One 
was protection of the venous beds of the intestine kidneys and hindquarters during the 
period of venous occlusion as the new liver was inserted this was accomplished by more 
efficient veno-venous bypasses The other principle effective graft preservation was met by 
core-cooling the liver with cold lactated Ringer s solution This simple preservation technique 
became standara for laboratory transplantation research with other organs and in clinical 
renal transplantation 
Once the technical principles essential for success had been defined (2) the 
operation of hepatic replacement could be studied in detail Methods could be tested for the 
preventton of the rejection process which was the next great barrier to be surmounted In the 
Chicago series of untreated canine liver recipients the maximum survival period before 
death from rejection was 20 and a half days 
Efforts to prevent rejection with total body irradiation of the recipient (or of the graft) 
were completely unsuccessful It was not until 1963 after I had moved to the University of 
Colorado that prolonged survival seriods were achieved using drug therapy with azathi- 
oprine In 1964 and 1965 animals which were treated with this drug or later with antilympho- 
cyte globulin began postoperative lives that lasted more than a decade and were terminated 
by old age 
At Doctor Davis suggestion the results of experimental studies on transplantation of 
the liver from the Northwestern laboratories were published in Surgery Gynecology and 
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Obstetrics (2). It could not have been too surprising to him in the autumn of 1963 to receive 
a report of the first clinical trials with this procedure; he accepted the article for publication 
by return mail (3) Replacement of the liver has become an increasingly successful way of 
treating end stage hepatic disease (4, 5). 
r 1 
1 J 
When Doctor Davis died I had known him for 35 years After I left Chicago I wrote 
or called him several times a year and until the last two or three years I always made it a 
point to meet him at the party given by W B Saunders Company at the American College of 
Surgeons for what for me was an important critique of the past year As he became old his 
attendance there became irregular but when he did not come he always wrote and 
apologized I did the same I made no major decision in my profess~onal life without 
consulting him first During a11 this time I never called him ~y his first name It was a patter 
of respect To some people who did not know Doctor Davis well he was a hard and unyielding 
person I did not see him that way 
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Fig. 1.- Liver tissue in Patient 1. A, left, Patient's own liver, showing advanced biliary cirrhosis. This 3 
year old child had congenital atresia of the bile ducts. B, right, Appearance of homotransplanted liver at autopsy, 
12 hours after death. The patient exsanguinated on the operating table, 4 hours after revascularization of the 
homograft. Note extensive autolysis. Hematoxylin and eosin, X19. 
tively. The first patient died on the operating table during attempted 
removal of a third ventricular brain tumor. The second donor died after a 
protracted terminal illness caused by a cerebral astrocytoma. The third 
donor died 2 days after massive cerebral hemorrhage. 
The circumstances immediately preceding death were different in 
the first compared with the last 2 cases. The donor for Patient 1 had a 
cardiac arrest for which open cardiac massage was carried our for 45 
minutes before death was acknowledged to have occurred. An additional 
15 minutes was required for insertion of the extracorporeal perfusion 
apparatus. In Donors 2 and 3, respiratory arrest preceded the disappear- 
ance of heart action by several minutes. The latter 2 patients maintained 
blood pressures of 100 millimeters of mercury until a few moments before 
death. The exhacorporeal perfusion was begun 5 and 6 minutes after pro- 
nouncement of death. 
Donors were selected of the same major blood groups as the recipient 
patients. In Patients 1 and 2, the blood groups were A+. In the third case; 
the donor was 0 -  and the recipient O+. Evaluation of liver function in the 
first donor was not possible. In Donors 2 and 3, complete liver chemistry 
levels were obtained and found to be essentially normal. The donor liver 
for Patient 2 was used despite a history of episodic alcoholic excess. 
In the last 2 cases, it was possible to maintain a very close vigil on the 
donors for the 24 to 48 hours preceding their death. Two measures were 
followed with particular interest, the blood pressure and the hourly urine 
output. In both cases the maintenance of an effective blood pressure and the 
continued excretion of urine were considered to be evidence that good 
tissue perfusion was present until just before death. 
Donor operation. Insertion of the catheters and institution of 
extracorporeal perfusion were accomplished in 15 minutes, 5 minutes, and 
6 minutes after pronouncement of death in the donors used for Patients 1, 
2, and 3, respectively. The delay in the first case was caused by the 
necessity to position and prepare the donor's groin. In the 2 subsequent 
cases, the operative field was prepared and draped prior to death, after 
approval had been given by the family. 
After certification of death, a longitudinal incision was made over the 
femoral mangle. The femoral artery and vein were cannulated, and the 
catheters advanced into inferior vena cava and abdominal aorta (Fig. 4). 
Exhacorporeal perfusion was provided with a circuit consisting of a 
glucose-primed bubble oxygenator, a single DeRakey pump, and a heat 
exchanger. The priming solution was 2,000 milliliters of 5 per cent 
dexhose in water, precooled to 15 degrees C. by passage through the heat 
exchanger. Each liter of perfusate contained 1 gram of procaine hydrochlo- 
ride, 10,000,000 units of aqueous penicillin, and the amount of heparin 
calculated to be 1.5 milligrams per kilogram of the donor patient's weight. 
In Donor 3,200 milligrams of prednisolone were also added. 
Initial flow rates of 30 to 50 milliliters per kilogram per minute were 
obtained in all 3 cadavers. Cooling proceeded evenly so that body tempera- 
tures reached 15 degrees C. 45 to 104 minutes after the onset of perfusion. 
Flow rates were adjusted to 10 to 20 milliliters per kilogram per minute 
when the temperature reached 20 degrees C. and flow was continued at this 
rate thereafter. In Donor 1, venous return began to decline after 2 hours and 
during the next 110 minutes perfusion ceased altogether. In Donors 2 and 
3, reduction in venous return was anticipated and successfully prevented 
by the addition of whole blood, plasma, and 5 per cent dexhose in water to 
the oxygenator reservoir. Donor 2 required 4 units of whole blood, 500 
milliliters of plasma, and 2 liters of additional priming solution. In Donor 
3,4 units of whole blood, 750 milliliters of plasma, and 6 liters of additional 
dextrose solution were required to maintain adequate venous return. As 
will be subsequently described, the low thoracic aorta was clamped in 
order to concentrate perfusion to the lower half of the corpse. 
As soon as it was ascertained that perfusion was adequate, the 
previously prepared chest and abdomen were entered through a generous 
right thoracoabdominal incision (Fig. 5A). An incision was immediately 
made in the fundus of the gallbladder at a site which would be suitable for 
subsequent cholecystoenterostomy, should this type of biliary anasto- 
mosis prove to be desirable. All bile was aspirated to prevent autolysis of 
the extrahepatic biliary structures. The diaphragm was then incised back 
to the vertebral column. A vascular clamp was placed on the low thoracic 
aorta (Fig. 4) to provide selective perfusion of the infradiaphragmatic 
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Fig. 2.- Specimens in Patient 2. A, left, Patient's own liver, showing hepatoma. B, right, Liver homograft obtained 
at autopsy 22 days after operation. Note good preservation of architecture. There was slight periportal fibrosis which is 
thought to have antedated transplantation. Note mild cholestasis and fatty metamorphosis. A few aggregates of mononu- 
clear cells were present in the periportal areas. Hematoxylin and eosin, X19. 
Fig. 3.- Specimens in Patient 3. A, left, Intrahepatic duct cell carcinoma which necessitated operation. B, right, Hepatic 
homograft 7-112 days after transplantation. Note good state of preservation of parenchyma. Periportal accumulations of cells 
are principally neutrophiles. Hematoxylin and eosin, X19. 
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Fig. 4.- Extracorporeal perfusion of the cadaver donor. The venous 
drainage is from the inferior vena cava and the arterial inflow is through the 
aorta, both catheters being ~nserted through the femoral vessels. Note 
clamp on thoracic aorta to perfuse the lower half of the corpse selectively. 
A glucose primed pump oxygenator is used with a heat exchanger. 
portion of the body. The portal structures were dissected (Fig. 6A), care 
being taken to obtain suitable lengths of common duct, portal vein and 
hepatic artery. All extraneous tissue was ligated in continuity before 
division, including the lesser omentum (Fig. 6A). 
Following isolation of the portal structures, the infrahepatic inferior 
vena cava was cleaned off as far inferiorly as the renal veins. Next the 
hepatic ligaments were divided (Fig. 5B). The liver was then gently 
retracted to the left and the right adrenal gland carefully dissected from the 
posterior surface of the right lobe (Fig. 5C). The adrenal veins entering the 
cava were ligated and divided (Fig. 5C). At the conclusion of these meas- 
ures it was possible to pass the finger behind the cava from diaphragm to 
renal veins without encountering any obstruction. 
Finally, the short segment of suprahepatic inferior vena cava u a s  
dissected free. After cutting of the fibrous union of the vessel with the 
diaphragm. it was possible to provide more length by entering an areolar 
plane and bluntly dissecting the tendinous diaphragm superiorly. A site for 
eventual transection u a s  selected above the point of entry of the hepatic 
veins. 
After this preparation of the liver for removal, extracorporeal perfu- 
sion was discontinued. The portal vein has  cannulated as far inferiorly as 
possible and infusion begun with lactated Ringer's solution cooled to 15 
degrees C. The liver was then removed by transection of the previously 
isolated structures as the infusion continued (Fig. 7). 
Recpientoperaiiori. In Patient 1 .  the entire procedure to be described 
was performed at one operation. In Patients 2 and 3, the surgical steps were 
carried oui in two stages. The time interval betueen the first and second 
operations was 22 hours in Patient 2 and 14 days in Patient 3. The long 
delay in the last patient u a s  d ~ ~ e  to the unexpected recoverq of the patient 
initial11 proposed for organ donation. Thoracoabdominal incisions uere  
employed in Patients 1 and 2. and a right paramedian abdominal incision 
in Patient 3. 
The first stags operation consisted of preparation for recipient 
hepatectom) with dissection and skeletonization of those structures to be 
subsequentl) anastomosed to the homograft. Consequentl). the steps 
followed were identical to those described in the donor operation (Figs, 5 
and 6A). At the conclusion of this stage. the liver was attached inferiorly 
only by the three constituents of the portal triad and the inferior vena cava 
(Fig. 6A) and superiorly by the suprahepatic inferior vena cava. The 
incision was then closed and the patient returned to the recovery room, with 
provisions for return to the operatirig room on a moment's notice. 
When it was learned that the donor had died, the recipient patient was 
taken back to the operating room and anesthetized, prepared, and draped. 
The previous incision was opened. A siliconized plastic tube was inserted 
into the inferior vena cava, via the femoral vein, and its upper end inserted 
into the external or internal jugular vein (Fig. 8A). When anival of the 
donor liver was imminent. vascular clamps were placed across the supra- 
hepatic and infrahepatic vena cava. the portal vein, and the hepatic artery. 
The external bypass was then opened, the residual connecting structures 
transected (Fig. 6B), and the liver removed. In Patient 2, a second external 
bypass from the splenic to the extemal jugular veins was used for portal 
decompression (Fig. 8A), but this clotted after a few minutes. 
Reconstitution of the vena cava at the diaphragm was peformed first 
with continuous No. 4-0 silk, after lateral fixation with stay sutures. A 2 
layer anastomosis was performed posteriorly, with eversion of both layers 
(Fig. 8B). Next the vena caval anastomosis below the liver was constructed 
in 1 layer with No. 4-0 continuous silk. again with an intraluminal everting 
technique for the posterior row. After completion of these anastomoses, 
normal flow was restored through the vena cava and the external bypass 
was removed. The hepatic artery and portal vein were then reconstructed 
with No. 6-0 silk, and thereby first arterial and then portal venous flow was 
established (Fig. 8C). In Patient 1, biliary drainage was provided by a loop 
cholecystojejunostomy, after distal ligation of the common duct, this 
simple method being selected because of the moribund state of the patient. 
In Patients 2 and 3, a 2 layer choledochocholedochostomy was performed 
with fine catgut and silk. A T  tube was placed in the recipient portion of the 
common duct, with one limb passing through the anastomotic site (Fig. 
8C). Both subphrenic spaces were extensively drained. 
Because of the fatal multiple pulmonary emboli in Patient 2,  a vena 
caval plication was inserted in the last patient, midway between the renal 
veins and the caval bifurcation Three mattress sutures were used to create 
4 small channels. 
Coagularion studies. The over-all clotting process was monitored by 
serial thromboelastograms. as described by von Kaulla (13). These provide 
continuous mechano-optical recordings of the onset and progress of fibrin 
formation and fibrinolysis, insight into speed and kinetics of coagulation 
being afforded thereby as well as information on the final firmness of the 
clot. The thromboelastograms were supplemented by Quick one stage 
determinations of the prothrombin complex. plasnla fibrinogen analyses 
by the method of Ratnoff. and measures of the thrombin time by the method 
of von Kaulla (14). 
Fibrinolytic activity was serially measured by the euglobulin lysis 
time of von Kaulla (15). This method has the advantages of speed and sim- 
plicity. Iri addition. the results are affectzd neither by heparin nor by the 
antifibrinolytic drug epsilon-amir~ocaproic acid (EACA) which was 
administered to all 3 patients. The technique nleasures primarily plasmino- 
gen activator rather than plasmin (fibrinolj sin). K o m ~ a l  ysis times are 120 
minutes or longer. 
T h r r a n ~  ro orevenf rejection. The general scheme of treatment was 
' ,  . .. 
similar to that previously used for renal homografts ( 1 I ,  12).  In Patient 1, 
thymectomy was performed 16 day: before transplantation, In addition, 5 
to 6 milligrams of azathioprine per kilogram were glven daily for 13 days 
preoperatively. 
In Patient 2. 4.5 milligram5 of azathioprine per kilogram and 30 
milligrams of prednisone were given the day preceding definitive trans- 
plantation. Splenectomy was performed at the time of the first stage 
operation. Postoperati\.elj, 1.5 to 6 n~illigrams of azathioprine per kilo- 
gram uere  given dail). either intravenously or orally. Intermittently 
actinomycin C h a s  administered intravenously (Fig. 9). Azaserine. 10 
milligrams per day. \\as gi;'en intra\enousiy for the first 2 da j s  after 
operation. A similar regimen was follohed for Patient 3, except that neither 
splenectomy nor thqmectom) uas  performed and azaserine h a s  not used. 
RESULTS 
Tinlesfioni n'ec~ri: ir: r.c~iisciriarirarion o f t h ~  iionioqrufir. The total 
intervals from donor death to ri.\aicularization of the hornograft in the new 
bed were 465, 152, and 192 minutes. Fifteen, 5, and 6 rrilnutes elapsed. 
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Fig. 5.- Preparation for extirpation of the liver. The steps followed are essentially the same for the donor 
and recipient operations. A, Line of incision used for all the cadavers and in Patient 2. B. Mobilization of the 
falcifonn. triangular. and coronary ligaments. C. Dissection of the right lateral and posterior surfaces of the 
inferior vena cava: ligation of the adrenal velns. After completiori of this maneuver, it is possible to sweep the 
finger from the diaphragm to the renal veins hithout rneetlng resistance. 
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Fig. 7.- Donor liver after removal from cadaver. The blood is 
washed from the donor organ by gravity perfusion through the portal vein. 
Note the incision in the gallbladder, employed to prevent autolysis b y .  
entrapped bile during harvesting. 
Fig. 6.- Final steps in removal of the liver. A,  Dissection of the 
structures of the portal triad and division of the lesser omentum. B, The third patient had normal respiration for the first 72 postoperative 
Operative field after recipient hepatectomy. hours. Acute d v s ~ n e a  then develo~ed.  necessitating tracheostomv and 
respectively, from pronouncement of death to the institution of extracor- 
poreal perfusion. The 3 perfusions, including the brief final infusions. 
lasted 375,98, and 126 minutes. The time lapses from removal of the donor 
liver to rearterialization were 75, 49, and 60 minutes, an additional 10 to 
26 minutes being required for the subsequent reconstruction of the portal 
vein. 
Sumival. The first patient bled to death on the operating table, 4 hours 
after revascularization of the homograft. The second and third patients 
lived for 22 and 7-112 days. rerpectively. 
Clinical course. Respiratory insufficiency was the most prominent 
feature of the postoperative course in the last 2 patients. With Patient 2. air 
hunger was evident immediately after recoverq from anesthesia. At this 
time, blood sugar was 350 milligrams per cent; serum lactic acid 33 
milligrams per cent, normal 6 to I6 milligrams per cent: serum pyruvates 
2 milligrams per cent. normal 0.7 to 1.2 milligrams per cent; arterial 
oxygen tension 51  millimeters of mercurq: arterial carbon dioxide tension 
25 millimeters of mercury: and plasma pH 7.28. Spontaneous ventilation 
was 25 liters per minute. The data were interpreted as being consistent with 
an alveolar-capillary diffusion defect. Eighteen hours postoperatively. 
tracheostomy was performed. and the patient was maintained on a closed 
system respirator for the next 30 hours. After \+irhdrawal from the 
respirator. mild dyspnea persisted. but this was not progressive until the 
last 48 hours when respirator support again became necessarq. Four days 
after operation. e \~dence  of extensive thrombophlebitis debeloped in the 
right lower extremitj. Intravenous and intramuicular heparin therap) wab 
provided from the eleventh to the fifteenth postoperative days with 
decrease in the swelling of the leg. Oral d ~ e t  was taken from the fourth to 
the nineteenth postoperative days. Terminall>. h ~ g h  fever de~eloped.  The 
roentgenogram of the chest. which had previously been clear. showed the 
appearance of extens~ve consolidation in the left lung during the last 3 da) i 
of life, 
, . - 
mechanical ventilation for the rest of his life. One day later, radiographic 
evidence was noted of extensive consolidation of both lower lung fields. 
Despite the previous performance of a vena caval plication, pulmonary 
emboli from the lower extremities were iuspected because of the appear- 
ance of edema in the leg amputation stumps. Intravenous heparin therapy 
was instituted from the third to fifth postoperative days and then discontin- 
ued because of gastrointestinal hemorrhage. His condition progressively 
deteriorated. with ~ncreasingly d~fficult ventilation and with continuing 
gastrointestinal hemorrhage, until his death 7-112 days after transplanta- 
tion. Oral dietary intake could never be resumed. 
Alrerarions in the cougulat~otz nzrc.izutiisnis. Esie?tially normal 
preoperative thromboelastograms were obtained in Patient I .  despite a 
moderate reduction of the prothrombin complex - prothrombin time 53 
per cent. After implantation of the liver there was an extreme activation of 
the fibrinolytic system as demonstrated by almost immediate dissolution 
of the clot on the thrombelastogram (Fig. 10) and bq aeuglobulin lysis time 
of 5 minutes. Intra\enous infusion of 0.1 gram of E.AC.4 per kilogram 
abolished completelq the fibrinolytic activit! (Fig. 10). The clot obtained 
after EACA administration wac. however. structurallj poor (Fig. 10) 
because of the low plasma fibrinogen content of 95 milligrams per cent, 
and the hemorrhagic diathesis proceeded to a fatal termination. After ad- 
ministration of EACA. the euglobulin ly s~s  tlme remained unaltered, 
which indicated that the mechanism causing excessibe levels ofplasmino- 
gen acti\ator iub\tance had not been corrected. 
Patient 2 had a norn~al preoperative prothrombin complex and 
thromboelasrogram. Plasma fibrinogen a\eraged 300 milligrams per cent, 
and the eugiobulln lqslh rime u a \  3 hour\. .At the fir51 srdge operation, 
mob~l~rat ion of the liber eioked a marked Incredqe of fibrinolytic activity 
(Fig. I I ). This change returned to normal near the end of the procedure at 
a time when therapeutic infus~ons of fibrinogen and fresh blood had been 
started. Sone of the other clotting parameter\ \\ere markedl) affected (Fig. 
1 1). During the actual licer transplantation at a becond stage the fibrinolytic 
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Fig. 8.- Anastornotic procedures in hepatic transplantation. A. External bypasses for decompression of the inferior vena caval and 
splanchnic venous beds. Both bypasses were inserted into the cenlcal  jugular skstem. The ~planchnic kenous catheter used in Patlent 2 
was inserted after removal of the spleen. Portal decompression \bas found to be unnecessarl, pro\iding the caval bypass functions 
satisfactorily and is of suffic~entl! large caliber. B. Anastomosis of suprahepat~c ~nferior kena cava. Note that the cuff of the homograft 
is actuall! a contluenie of the hepdt~c ie111, dnd the ken8 L L I ~  The pnrrrrior row I,  pertonned in 2 i . \ert~nf ld>er\. If con\lderat~ons of 
time are not prejrinp. the ~ritcrior oii I,  al\n douhl) \uturril C. Subhi.pLit~i operdtlie t~elil  ,it complet~on o i  all ana\ tornoei .  So te  that 
gallbladder h ~ r  been remoied , I I ? ~  that the T tube I \  iii\c.rti.d thrnu:h d \tab iiound In the rsclplelir portlor1 of the cnrnporltt. common duct, 
with the upper l ~ m b  passing throucgh the anastomosis. 
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Fig. 9. - Pharmacologic therapy provided to prevent rejection in 
Patient 2. Avoidance of leukopenia was attempted by careful selection of 
doses of azathioprine (imuran). ACTI-C, Each arrow is 200 micrograms of 
intravenously administered actinomycin C. I, First stage operation; I I ,  
Second stage operation. 
activity increased drastically. Occlusion of the hepatic circulation as the 
last preparatory step for hepatectomy was followed by a very pronounced 
shortening of the euglobulin lysis time despite the preceding prophylactic 
infusion of fresh blood and fibrinogen (Fig. 12). The thromboelastogram 
showed progressive di\solution of the clot obtained at this time. Twenty- 
eight minutes after beginning recipient hepatectomy, 0.1 gram of EACA 
per kilogram was administered intravenously, abolishing the fibrinolytic 
activity as measured with the thromboelastogram. The euglobulin lysis 
time was again unaffected and remained pathologically short for more than 
2 hours (Fig. 12), which indicated that high levels of plasrninogen activator 
persisted during this period. During the latter pan of this interval. the new 
liver was not immediately corrected a ith the pro\ ision of the homograft. 
Approximately 1 hour after revascularization of the homograft, the euglob- 
ulin lvsis time had returned to normal values. There were no clinical siens 
- 
of bleeding during the operative and the postoperative period at either stage 
of the procedure. Other clotting measures remained within normal limits 
except-for a moderate rise of thethrombin time during the actual transplan- 
tation. 
For several days after operation, the thromboelastograms indicated 
a progressive tendency to hypercoagulability. There was shortening of the 
"r" values of the thromboelastogram aild a concomitant shortening of 
prothrombin time. Starting on the fifth postopsrative day, a progressive fall 
of plasma fibrinogen level was noted. The euglobulin ljsis time was 
frequently unusually long - many hours. Retrospectively, these later 
observations are best interpreted as indications of intra! ascular clotting. 
The changes in coagulation in Patient 3 ?ere comparable to those of 
Patient 2, both quantitatively and qualitatively, except that the shortening 
of euglobulin lysis time persisted for se\eral houri longer. Therapy with 
fresh blood, EACA, and fibrinogen was similar to that employed in Patient 
2. 
Liver function. Serial postoperatl\e li\er functions were obtained in 
the last 2 patients. The presence of hepatic function was evident from the 
facts that blood sugars could be mamtained at normal levels uithout 
intravenous gluco\e, that b ~ l e  in quantities of I50 to 600 cubic centimeters 
per day u a s  collected from the T tube the billrubin content of which wah 
65 per cent or more conjugated. that no e\ idence of hepatic coma was ob- 
served, and that secondar~ bleeding did not occur except when heparin 
therapy was being administered. 
There wai  evidence that moderately \evere parenchlmal injury 
occurred at the time of transplantation. The serum glutamic-oxalacetic acid 
transaminase balues rose to 1,150 and 990 un~ t s  within a feu hours in 
Patients 2 and 3, respectivel~. but these were returning toward normal In 
24 hours (Fig. 13). Lactic acid dehdrogena5e and serum glutam~c plruvic 
acid transaminase values followed similar curves. Bilirubin rose to 12.8 
Fig. 10.- Thromboelastograms of Patient 1. A, B, Two hours after 
revascularization of homograft. Bleeding diathesis was evident clinically. 
Note onset of clot formation occurs at normal time, since "r" value - time 
from start of record to clot deposition - is normal. However, the clot is tiny 
and is lysed as fast as it is formed. C ,  D. Fifty and 20 per cent of normal fresh 
blood added to specimen A delays but does not prevent clot lysis. E, 
Recordings after 0.1 gram per kilogram intravenous EACA. Fibrinolytic 
activity is abolished. The abnormally small thromboelastogram is due to 
low fibrinogen. Hemostasis could never be obtained. 
milligrams per cent after 9 days in Patient 2 and then progressively 
improved (Fig. 14). In Patient 3, the bilirubin dropped from 20.4 milli- 
grams per cent preoperatively to 7.2 milligrams per cent after transplanta- 
tion. During the last 3 days of life, concomitant with the gastrointestinal 
bleeding, bilirubin again rose, to 15.4 milligrams per cent. 
Alkaline phosphatase began to fall immediately afler operation in 
both the second and third patients. The lowest postoperative prothrombin 
time in Patient 2 was 43 per cent and in Patient 3, 26 per cent. The latter 
value was obtained just before death. Total proteins were maintained at 5 
grams per cent or more, although terminally the albumin dropped to 1.6 
grams per cent in Patient 2. 
The improvement in hepatic function of Patient 2 continued for the 
entire course. In Patient 3, there was a secondary deterioration of liver 
function terminally, coincident with gastrointestinal bleeding. 
Autopsj$ndings. The anastomoses in Patient I were all patent. The 
liver weighed 220 grams, and on cut surface had a prominent lobular pat- 
tern. Histologically, the lobules of the transplanted liver were preserved in 
general outline only. A few scattered clusters of liver cells were partially 
preserved. but the remainder were severely autolyzed (Fig. 1B). The 
cytoplasm was smudged and many nuclei were absent. Portal triads were 
intact. The sinusoids and central veins were dilated. 
The homograft in Patlent 2 weighed 1,700 grams. Al vascular 
anastomoses were intact, although there was a thin layer of circumferential 
adherent thrombus at the portal vein anastomosis. The right iliac vein and 
terminal inferior vena cava were occluded with old and fresh clot, above 
which was a 4 bq 1.5 centimeter free-floating, nonocclusive thrombus. 
Multiple large and small emboli occupied both pulmonary arteries. There 
was massibe infarction of the left lung as well as the right lower lobe. 
H~itologic iections of the liver revealed good preservation of lobular archi- 
tecture (Fig. 2B). There was considerable bile statsis and a mild degree of 
fatty metamorphoii~ and periportal fibrosis. A few aggregates of mixed 
neutrophiles and mononuclear cells were in the periportal areas (Fig. 2B). 
Some hepatic cells had finely granular cytoplasm with shrunken nuclei. 
The transplanted liver in Patient 3 weighed 2,070 grams. The 
vascular and common duct anastomoses were patent. No thrombi were 
found anywhere except for 2 small adherent clots just above the site of the 
vena caval plication. Two pulmonary emboli were found in each lung, 6 to 
9 mi1limetel.s in diameter. Necrosis of lung had not occurred. There was 
extensi\.e pulmonary edema. Microscopically. the liber cells were well 
presened, although moderate fatty metamorphosis was present (Fig. 3B). 
Aggregates of periportal cells (Fig. 3B) were chieily neutrophils. 
DISCUSSION 
Few experimental studies are available concerning whole organ liver 
homotraniplantation, and all of these involve the use of dogs. Goodrich and 
his colleagues published the first extensive experiments on hepatic trans- 
plantation in 1956. The \ d u e  of these investigations was llmited by the fact 
that the organs here  transplanred to the pel\ is. without removal of the 
dog's own li\er.  Since then. Moors (3. 5) and Srarrl (9. 10) and their 
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Fig. 11.- Changes in coagulation during first stage operation in Patient 2, when liver was prepared 
for subsequent removal. Note striking decrease in euglobulin lysis time during mobilization of liver. 
colleagues have reported successful hepatlc transplantation in dog3 wlth 
anatomically normal placement of the homograft after removal of the 
recipient's own liver. These ~tudies  clarified the physiological and bio- 
chemical events ahich transpire dunng rejection of hepatic grafts. In nd- 
dition. the investigations defined the specific difficulties \\hich must be 
surmounted if operatibe failure 1s to be aboided. 
The pro\ision of a biable and min~mally darnaged horiiogrnft i \  
undoubtedly the most Imponant single factor in the detemiinat~ori of 
yuccess. It is necessary to obtain the donated tissue from a cadaver. Yet the 
extraordinar) iensitivit? of the tissue to arioxia requ~rea thdt an adequate 
hepatic circulatiori be present before death and that \ome form of hepatic 
Preienarion be inst~tuted lmrned~atel) after death before the on\et of 
lrre\er\ible cellular iri,jur). For the lattcr purpose. the h)pothenri~c prrfu- 
>Ion technique reccntl) developed b! Xlarchioro arid h ~ \  colleague, 
bed. I t  i, posible uith this method \irnultaneou\l> to cool and perfuse the 
h e r  within a feu iiilnute\ after death. before begir'ning it, operatlie 
remobal. The most eftectrve mean\ of po\tmonen? pre\enation are futile. 
however. if the moribund state has been protracted. In Patient 1, the 
selection of a donor after prolonged cardiac masaage was unwise. In 
contrast, the circumstance of death ofthe donors for Patients 2 and 3 were 
highly favorable. 
Although the technique of hgpothennic perfusion has made liver 
twn\plantation fea\ible. the method has definite limltatlons in extending 
the postrnorteni viabilit) of hepatic !)\sue. Marchioro and his associates 
habe \houri that stbere liepatocellular irijur! alnioit ilivar~ahl) occurs with 
perfus~ons orniore than ? hours. The pol~c: of \tagin? the operation in the 
recipiei?i\. which \ la \  followed in the last 2 patient,, allo\\s reduction of 
this time to a mlnimuni. After prelimmar! niobili/ation of the diseased 
li\er .mil prepdratlon of the structure\ for aub\equent anastomoses. the 
definiti\e second opzratlon can be perfornied after rhr lnci\ion has been 
quickl! reoperred uith a minimum of tediouj time-con\uming dissection. 
The jurgical detail\ of implantation involke. for the most part, 
utili~ation of  ell \tanciardized \urgical method\. The ia\cular anasto- 
moses frequenti! must he pzrfornird i \~ t l i  short cuff, and with limited 
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Fig. 12.- Changes in coagulation during definitive transplantation at second stage in Patient 2.  Note drastic 
decrease in euglobulin lysis time and moderate delayed fall in fibrinogen level. EACA, 0.1 gram per kilogram, was 
given intravenously at 8:47 p.m. 
exposure, necessitating ~ntraluminal sutunng techn~ques (Fig 8B) The 
greatest hazard is In performance of the inferlor vena caval anastomosis at 
the dlaphrdgm Both the donor and recipient segments of the \ens cava 
often habe orifices of m a l l  posterior phren~c tributaries u h ~ c h  are un- 
knowingl> s e ~ e r e d  uhen the respectlxe l ~ ~ e r ,  are r e m o ~ e d  Such open 
or~fices are located d short dlhtdnie from the cut edge of and can on]) be 
seen from the inqide of the Lessel Failure to \utLre the openings dunng the 
cakal-ca\al ana\tomosls results in later hemorrhage at d time *hen the 
presence of the homogratt make\ ieiondar! expo5ure of thi, drea almost 
~mposs~b le  The double suture method de~e loped  in dog$ for t h ~ c  anasto- 
mosis has virtually eliminated this problem (Fig. 8). 
Reconstitution of internal biliary drainage in infants will probably be 
most effectively accomplished hi th  a Roux-en-Y cholecystojejunostomy. 
In the 2 adults. choledochocholedochosrom~ h a s  simple to perform by the 
stenting of the anastomosis u i th  a T tube inserted through the recipient 
portion of the common duct (Fig. 8C). Although the prinicipal arterial 
supply to the common duct comes from retroduodenal sources. Parke. 
Michels, and Ghosh ha\e  demonstrated that \ascular contr~butions, upon 
which \ iab~l i t>  of the donor common duct depend\, aljo come from the 
hepatic arteriej in the hilum of the l i ~ e r .  
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Fig. 13.- Graphic depiction of m u m  enlyrne alterationr following 
hepatic transplantation in Patient 2. Note immediate rise in SGOT with 
subsequent decllne. LDH and SGPT were slmilarlq affected. 
One unique technical requirernent is for decompreskion of the venour 
system5 which must be temporar~l) occluded during the tr':nsplantation. In 
the dog. failure to oh ta~n  \at~sfactory drainage from these venous pools 
results in certain failure, particularly when an) degree of venouj hyperten- 
<ion i\ allowed to develop in the splanchnlc bed. In man. the necessity for 
providing drainage from at least the porral system is probably not so 
itnportant as in the dog. Child has denionstrated that acute occlusion of the 
portal vein in nionke)\ and man i\ usually \\ell tolerated. pre,umablq 
beca~lse collateral channels are more abundant In pr1rnate5 than in iotcer 
form\. Indeed. it was dernonstrated in the pre~entl) reported 3 cases that 
drainage of the portal <)stem was not necesrary. In 2 of the 3 patients, 
external bypasses were not used. and In the third, t lc~w ieaiccl after a feu. 
minutes. The conclu\ion 5eems jujtified that a single el tec t~\  e bypas\ from 
the inferlor vena cats to the superlor vena cava 15 ; r i l  th;:? I ,  ~cquireti for 
adequate venous retum to the heart from both tkic inf;.ri:ir- ,. t ri:i ca\al and 
portal systems. 
Exper~ence with the\e 3 patient\ \ tre\\r\  thc rii.c.il f .-(  ;,.,<. torit!~)l of 
the coagulation proces\e\ during and after trn~i\pi~ritatr,jii :'i~iroiind clot- 
ting defects were demon\trated In all at the t~rnc of trar~,planra!l,~n resuitine 
in fatal hemorrhage in the fir5t patient. The h e n l o ~ ~ h ~ ! ~ i ~  t~nti ricq d i ~ l  rloi 
rewlt from an acute de f~c~enc )  of thme clotting firctor\ uhich .ire s)nthe 
w e d  in the liver. Anal) \ i \  ofpla\riia fibr~nogen dtirlng the 11;-crless phase 
In Patients 2 and 3 dld not reveal a c l~n~ca l ly  sig~iific;rnt irop. a finding in 
accord with man) exper~rnental itudie\ \\hich \ho\b thar a \ubstantial 
decrease In clotting factors after tutal hepatectorng requir+ <?\era1 hours 
to develop Instead. the important t~nding appeared to be an exploiibe 
lncreaie in the pla,ma fihrinolbtii ac!~\~tb  u h ~ c t ~  de\i.loyed \\ (thin min- 
ute\. both during man~pulation of the 11vi.r- (Fig, I I i and litter removal 
(Fig. 12).  The emct  cclii\e of thih change i\ open to iome \peculation. As 
a  orki king h)pothe\~\ .  ~t rn~ght be a \ j ~ ~ ~ i l e i i  that the I ~ \ s r  nonnall) elabo- 
rate\ ;I auhrtance ~ h i c l i  inhibits con\el\ion oi pla\rntnogen to plasmin 
Ifibrlnol! sin, pre\umabl) b) a tieter-rent action on ;I pia\riilnogen act~vator. 
Ah\ence of the liver or (evere hepatic Injurg durlng o p e r a t ~ ~ e  nian~pulation 
could conceivabl! pemilt uncontrolled conver\inn of plasm~nogen to 
pla jm~n b) relilo\al of such a re\tralnlng lnfluerlce on the acti\ator syctem. 
LVhateber the explanat~on for the 111creaii.d f i b r i i ~ o l ~ r ~ c  a c t l \ ~ t > .  it is 
lmperat~ve to antlclpate r h ~ \  tenticnc> anii to pro\tde proph)last~c treat- 
ment before a frank hemorrhagic dlnthe\~\ de\slop\ In the recond and 
third patient>. EACA \ \a\  admint\tered proph~Iacricnll>. \ ~ i t h ~ n  a feu 
minute\ after rsmo\al of the r e c ~ p ~ e n t ' \  Itver. Thl\ drug. uhich pre\ents 
actl\atlon of pl,l\mlnogen to pl;i\ni~n b) lnhthittng pln\minogen activa- 
[or\. ;ipp,irenti> pre\erited the f i t i r~ r~u l ) t~c  crl\l\ ~n ths \ t  Idst 7 patients 
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Fig. 1 4 . G r a p h  showing rise in serum bilirubin to 12.8 milligrams 
per cent in Patient 2 nine day\ after tranrplantation. After transient 
deepening of jaundice there was progressive Improvement. 
despite profound decreases in euglobulin ly\i\ time. The administration of 
fibrinogen and fresh blood at the time of tran\plantation are probably also 
of sisnificant value in reduclng the danger of a hemorrhagic diathesis. 
In view of the effort expended to define and prevent the hemorrhagic 
diathe\i, which led to the death of the first patient. it is ironic that Patients 
2 and 3 should have died becau\e of the late consequences of intravarcular 
clottinp. In both the latter patlent\, the immediate cause of death was 
mult~ple pulrnonar). ernboli. In both. the characteri5tic clotting deficiency 
which \bas ob \ened  at the time of operation \ca\ succeeded by a hyperco- 
agulahle state ieveral day\ later. which may ha \ e  been an important 
contrlhuting factor in the formation and propagation of the emboli. 
The source of the pulmonary emboli in Patient\ 2 and 3 is a matter of 
intcrcir. It is encouraging that the vascular \uture lines of the transplant 
itself d ~ i l  not h a i r  :i \elect~ve tendency to develop thron~bosis. Rather, the 
perlphcra! tnroiiihoii\ in Patient 2 was in the right iliac cein and the 
ternirn;~! iiifer~or \end iava,  uhich led to the belief that protection from this 
complication v,oulti he afforded by the use of Spencer', vena caval 
pl~caiic:~: pro~e,iurs. In I'a!lent 3 ,  however. rn which vena caval pllcation 
wai pt:rk)niiec!, a peripheral focus of thrombu\ could not be found at 
autop\y. It I \  po&,\ible 111 this patlent and in the second one as well that 
semifluid cloti \\ere orlginall> fornled in and passed through the external 
b>pa\s syite~ii  iron1 tht. inferior to the superior \en;\ ca \ a  during the 
tran\plnntation. The early development of respiratoq d ~ s t r e ~ s  In both pa- 
tlenr, i \  cc~r i~pat~hie  uith such a \equence of events. In future attempts at 
hepat~c hornotran\planration. 11 i\ probable that the\e embolic complica- 
t1on5 can be prebented uith \\ell tirned and accuratel) controlled heparin 
therap). either at the tirne when the external bypass is in use or in the 
po\toperati\e period. 
T h ~ s  experience \\ith humans ha\ contimied many previous experi- 
mental impre\\ion\ of the funct~oric~l behav~or ofthe hepatic homograft. In 
dogs recel\ inp 11\er hi)rl~ograft\ under opt~nial c~rcu~iistance\ of cooling 
and rnlnlnial dotior organ ~xhe rn la .  there i \  a pronipt resumption of hepatic 
metabolism uith mrnrmal irnrned~ate derangement of tunct~on.  Blochemi- 
cal e\idence of graft repudiation h q ~ n s  on the fourth or fifth dab in the 
untreated animal. but t h ~ s  can be rnit~gated or p re~en ted  b) the use of a 
therapturic reglllien s~rnllarto that en1plo)ed in [he cl~nical cases. The most 
useful rnearurernenti to folloi\ the course of the rejection process are 
serum bilirubin. serilrn alkallne phmphatais. and serum glutamic ox- 
alacet~c acid transarnin~~se. Under more ad\erse experimental conditions, 
simulating tho\e nece,\ar) In a clln~cal \ettinp. Slarchioro and his col- 
league\ h;i\e kiinun that there 1, a nioderatel) ss \  ere ~hchemic rnjur) to the 
carilne l ~ \ e r .  nidntfe~ted h> \harp r1,i.s In b~lirubin. alkaline phjosphatase 
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and SGOT within the first 24 hours. Differentiation of the latter nonspe- 
cific changes from those due to rejection is an important aspect of the 
postoperative care. 
Both of the patients who survived the operative procedure exhbited 
a functional pattern of acute parenchymal injury. Rises in SGOT to 950 to 
1150 S F  units occurred within the first day and then rapidly receded. 
Jaundice temporarily deepened. The subsequent curves of various function 
tests were in the direction of improvement until immediately before death, 
demonstrating the reversibility of these early changes. 
The experiences in these cases have demonstrated that the immediate 
problems of clinical hepatic homotransplantation are subject to practical 
solution. They provide little information, however. concerning the feasi- 
bility of long term maintenance of liver homografts, although the progres- 
sive improvement of liver function and the degree of histologic preserva- 
tion of the transplants after 7-112 and 22 days are encouraging notations. 
In unpublished observations from our laboratories. it has been found 
possible to obtain prolongation of survival of pharmacologically altered 
dogs with liver homografts, which has been comparable to that obtained in 
treated animals receiving renal homografts. Cltimately, it may be neces- 
sary to conclude that the treatment required to prevent rejection is signifi- 
cantly different with livers than with kidneys. At present, however, there 
is no evidence to support such a belief, and the further acquisition of 
experience in the treatment of these otherwise doomed patients appears to 
be justified. 
SUMMARY 
A number of problems are described which must be surmounted for 
the clinical use of liver homotransplantation, based upon experience with 
3 patients. The first patient died of hemorrhage during conclusion of the 
operation. The second and third patients liver for 22 and 7-112 days, 
respectively. both ultimately dying from multiple pulmonary emboli. 
The operative requirements for successful liver transplantation 
appear to be subject to practical solution. Of the utmost importance is the 
procurement of a viable and relatively undamaged donor organ. This has 
been accomplished with the use of an extracorporeal circuit which perfuses 
and cools the liver immediately after death. In addition, the time interval 
between death of the donor and restoration of a hepatic blood supply in the 
transplanted site has been shortened by operating on the recipient patient 
in 2 stages. At the preliminary operation, all structures are skeletonized 
above and below the liver with facilitation of the recipient hepatectomy and 
multiple anastomoses which are performed at the second and definitive 
procedure. While the transplantation is being performed. the venous return 
from the splanchnic and inferior vena caval systems is temporarily oc- 
cluded. It has been found necessary to decompress only the inferior vena 
cava during this time uith an external bypass from the inferior to the 
superior vena caval systems. 
Changes in the coagulation mechanisms constitute a serious deter- 
rent to success. During operation, a bleeding diathesis is regularly detect- 
able by laboratory examination. Postoperatively, a state of hypercoagula- 
bility has developed, which probably contributed to the lethal complication 
of multiple pulmonary embolization in 2 patients. It is also possible that the 
use of the external bypass contributed to the formation of the emboli. 
After operation. hepatic functions were immediately deranged, 
probably as the result of injury incurred during the transpiantation, with 
progressive improvement thereafter. Later, biochemical evidence of 
homograft rejection was not observed, and at autopsy in the last 2 patients 
there was surprisingly good gross and histologic preservation of graft 
structure. It is thought that the therapy with azathioprine, prednisone, and 
actinomycin C had forestalled the rejection process. 
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CLIO CHIRURGICA 
In April, 1968 at the Amercian Surgical Association, the first public report was given of the 
prolonged survival of several patients after liver replacement. The discussion by Frances D. Moore 
was particularly supportive and has been reproduced. 
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Orthotopic homotransplantation of the human liver 
Annals of Surgery, 168: 392-4 15, 1968 
Thomas E. Starzl, Carl G. Groth, Lawrence Brettschneider, Israel Penn, Vincent A. Fulginiti, 
John B. Moon, Herve Blanchard, Alfred J. Martin, Jr. and Ken A. Porter 
Until last year, the kidney was the only organ which had been 
transplanted with subsequent significant prolongation of life. There had 
been nine reported attempts at orthotopic liver transplantation; seven in 
DenverIY '?" and one each in Bostonh and Paris.' Two of these patients had 
succumbed within a few hours after operation,'?' and none had lived for 
longer than 23 days. 
This dismal picture has changed within the last 9 months, inasmuch 
as seven consecutive patient5 treated with orthotopic liver transplantation 
from July 23, 1967 to March 17, 1968 all passed through this previously 
lethal operative and postoperative period. Three of the recipients are still 
alive after 9, 2-113. and 1 months: the others died after 2, 3-112,4-113, and 
6 months. 
Methods  
The  Recipients. Summary information for the seven patients is 
given in Table 1. Their ages were 13 months to 16 years. Six were females. 
The indications for transplantation, which had been established by earlier 
explorations at other hospitals, were extrahepatic biliary atresia in five 
cases and liver cell carcinoma in the other two. The clinical condition of the 
recipients ranged from fair to moribund. The sickest was Patient 5 who had 
required repeated paracenteses for several weeks before admission and 
who, as a complication of this procedure. had developed a continuously 
draining lower abdominal per~toneal fistula that did not close until a week 
after transplantation. When the patient arrived in Denver. examination 
revealed renal failure with ol~guria,  proteinuria. and a blood urea nltrogen 
(BUN) of 70 mg.1100 ml. A few hours before operation massive gastroin- 
testinal hemorrhage developed. probablj from esophageal varices. The 
bleeding continued until aftzr the transplantation had been completed. 
This child and the other four \ s ~ t h  extrahepatic biliaq atresia had 
preoperative serum billrubln concentration of 16.1 to 30.9 mg.1100 ml, and 
alkaline phosphatase levels of 88 to 632 international units (normal 50 to 
150). Other biochemical meaburei of hepatic metabolism were tqpical of 
this disease- ' with retention of moderatel) good synthetic function. For 
example, the prothrombin ~ a l u e s  ranged from 50 to 100% of normal and 
the total serum proteins \sere 6.5 to 7.9 gm./100 ml. The patients had ascites 
and all 5 had some evidence of pulmonary arteriovenous shunting as 
described in a previous p u b l i ~ a t i o n . ~ ~  None had other congenital anoma- 
lies. 
In Cases 1 and 7 ,  hepatic cell carcinoma was diagnosed 6 months 
before transplantation. Although both patients were given liver irradiation 
(975 and 3,200 R,  respectively) and chemotherapy, the tumors had contin- 
ued to enlarge (Fig. 1). When first seen at our institutions, both children had 
leukopenia (2,000 and 3,500 WBC/mm.'). They had no evidence of extra- 
hepatic metastases. Liver function was normal. 
The  Donors. The cadaveric donors were pronounced dead on the 
basis of cardiac arrest, by members of the service in charge of their care. 
Previously, all had irreversible central nervous system injury, with no 
spontaneous respirations and with isoelectric electroencephalograms. In 
each, life had been maintained for days or weeks with mechanical venti- 
lators and in all but one there had been repeated previous cardiac arrests. 
After death. ventilatory support and cardiac massage were continued 
insofar as possible in Cases 1-6 until the organ could be cooled as described 
below. In Case 7, the adult donor was placed on cardiac pulmonary bypass 
10 minutes after death. This technic" accomplishes both perfusion and 
cooling of the cadaver at the same time as hepatectomy is being canied out. 
The donors and recipients had variable discrepancies of age, size, and 
weight. The lingering terminal course of the donors made it possible to 
chose recipients on the basis of histocompatibility analysis in addition to 
compatibility of red blood cell types (Table 1). In each case the donor 
lymphocqte antigens were determined both in our laboratories and by Dr. 
Paul Terasaki of Los Angeles. The histocompatibility profile was used to 
select the best of several previously studied prospective recipients. The 
matches eventually accepted are shown in Table 1. Sone were perfect, 
although in Case I there were no breeches of 7 major groups of the recently 
classified human histocompatibility (HLA) system"" one or 2 group 
incompatibil~ries were present in each of the other donor-recipient combi- 
nat ion~.  
Donor Hepatectomy. W m  ischemia time was minimized by the 
postmortem resuscitative efforts described above. In addition the livers 
were core cooled either by the technlc of extracorporeal hypothermic 
perfusion mentioned earlier (Case 7 )  o rb )  the immed~ate infusion (Cases 
1-6) of cold (2' C.) balanced electrolyte solut~on containing heparin, 
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Fig. 1 .- Growth of a hepatoma in Patient 1. A - Liver scan In F e b r u q .  1967, using Au". The child a a s  then 13 
months old. Most of the tumor was in the left lobe hut smaller growths in the right l o k  precluded re5ection. B - A  repeat 
study 3 months later showlng only a small remnant of functional liver tissue. The excised liver we~ghed 1.185 grams. 
procaine, and low molecular weight dextran. through a cannula inserted 
into the superior mesenteric vein (Fig. 2). With the latter method, egress for 
the fluid was provided by incising the inferor vena cava. In order to prevent 
autolysis the gallbladder was opened at its dome and irrigated with saline 
to remove all bile. 
The aorta was rernobed in continuit) with the hepatic artery (or 
arteries). It was rapidly exposed and rnobilrzed by lifting the spleen and left 
transverse colon into the wound (Fig. 31, opening the plane between the 
pancreas and left kidney, dividing the left renal veln. Incisrng the crura of 
the diaphragm. and ligating and d~viding all hranche\ except the wperior 
mesenteric artery and the celiac axis. The superior mesenteric arterj was 
spared until it could he proved that ~t did not give rise to pan of the hepatic 
arterial supply. 
The rest of the procedure was essentiall! the same as the originally 
described" except that the cannulated superior mesenteric vein was re- 
tained with the specimen: this nece\sitated ligat~on of the splenic vein and 
several other tributaries beneath the neck of the pancreas. In 2 cases with 
anomalies, a small right hepatic artery was found directly pmterior to the 
portal vein and traced back to us origrn from the superior mesenteric artery. 
The latter vessel a a s  ligated distal to this point (Fig. SC). 
During the final ytages of exclsron, a cannula was Inserted into the 
distal aorta and used to flush the arterial tree with balanced electrolyte so- 
lution. In all but Case 2. the hotnografts were then imerted into a 
preservatlon unlt for one to several hours. The preservatlon was with the 
combined technics of hypothermia. hyperbaric oxygenation. and low flow 
perfusion of both portal and arterlal systems with diluted homologous 
blood of a compatible red cell type. The total flow rates (6 ml./Gm. liver1 
hour). temperature (4' C.). trrnes of charriber decompression. and other 
methodolog~c deta~ls were exactl) the \ame as reported carlier in dog 
experiments.' When the \pecimrn, were sub\equentlj removed from the 
chamber. the vessels were recut according to the requirernerits for their 
anastornoses 
Recipient Operation. In i i \  of the e l e n  patrents. the operation was 
not begun until the homograft a a s  in the chamher arid had been checked 
for defects under corid~tion\ of perSu\~on. A large tran\berse abdominal 
incision was uied. The niost difficult step a n >  exclslon of the recipients' 
diseased livers slnce exrensi~e lipper adborn~nnl adhejions and portal 
hypertension were present In the patlents u it11 b~liar! dtresra, the removed 
organs a e ~ g h e d  665 to 88.7 gr;inij. The I ~ \ e r  frorn the 19-month-old child 
a ith hepntonia rserehed 1. I85 Gm.: the I:\er and hepatonla in the 16-year- 
old girl aeighed 2.575 grams. In all but Ca\e 7. the enlarged apleens were 
remo\ ed after the hornozraf \ had been placed. 
The transplantar~on.: ae re  perfomied \kith the prr\iou\l) described 
technic.:' w ~ t h  the exception of mnie rrnportant dct,~il,. Rr11ai.y dralnage 
was provrded b! cholec> ,toduodeno\tvni) i F I ~ .  I r  in\read of choledo- 
chocholedochosto~n>. 4nother exrrcn~el) sigriificrint ~.hange. ;is recently 
 reported.'^ as the ornl\\ron oi  b>par\e\ to decornprej\ the \pl:inchn~c and 
S)sten?ic venouz i!cten~s durrng the ;inhepatic phaje. In the w e n  patients. 
the portal vein and irifer~or L sna cti\ a \\ere ~ r ~ ~ i u l t a n e o u ~ l ~  occluded for 50 
to 90 minutes. The maximuni resulting fall in arterial blood pressure b a s  
20 mm. Hg. The intestines became slightly dusky in several cases, but this 
change was immediately rebersed hith the restoration of venous return. 
The order of the anastonloses &as suprahepatic vena caval. infrahepatic 
vena caval, hepatic arterial. and port;ll venous. In Case I .  the caval clamps 
were released after the first 2 anastornoses a e r e  completed. In the others, 
no \ ascular channels were reopened until at least three. or In two cases, all 
four vessels had been reconstructcd. 
In five patients. the homografts hepatic nner! or celiac axis was 
anastomosed to the recipicrit proper or common hepatic a r t eq  (Fig. 4A). 
In the other tho.  a separate branch to the right lohe ro\e frorii the superior 
mesenteric ar ten.  The first time the anornal) was encountered (Case 2 ) ,  the 
two vessels were indiv~dually connected to the right and left branches of 
the recipient proper hepatic artery (Fig. 4B). The next time (Case S ) ,  the 
Fig. 2.- Core cooling of cadaveric liver used for infant donors. 
Immediately after entering the abdomen. the cannula I \  placed into the 
readily access~ble superior rne\entenc \ e ~ n .  This \e\sel 15 fdr enough away 
from the portal triad so that the portal veln. u h i ~ h  \ b i l l  ult~rnately be used 
for anastomosis. is not in danger of i n j u ~ .  Egress of the perfujion fluid is 
p ro \~ded  b> the \snotom) in thr supratiepatrc inferior \en:\ ca \a .  Rrle is 
washed from the gallbladder through the cholec)\totom!. For the adult 
donor (Case 7 r .  the l i ~ e r  uac  cooled b) total bod! extracorporeal perfusion, 
and the tlushrng c a n e d  out atter completion of the hepatectomy. 
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\ 
Donor  .2orta 
\ 
I I Fig. 4.- Recipient operations. Cholecystoduodenostomy was per- 
~ i ~ ,  3,- ~ ~ b i l i ~ ~ ~ i ~ ~  of [he aorta during donor hepatectomy, formed in all 7 cases. A - The kind of arterial anastomosis used in Cases 
identification and ligation of the branches is facilitated if variable traction ' 9  3 3  4, and 7. The horngraft axis Or common hepatic artery was 
is applied to the distal aona. During the initial dissection. all of the aortic attached lhe proper Or common hepatic Arterial anasto- 
branches except the coeliac axis and superior mesenteric artery are ligated moses in Case 2. The right hepatic originated from the superior mesenteric 
and divided; the latter vessel is cut only after it has been shown not to give m e V .  C- Anastomosis of the homograft aorta to the recipient a o n a ( ~ a s e  
rise to an anomalous hepatic arterial branch. 5). This technic was used because of the double arterial supply. 
distal donor aorta was end-to-side to the abdominal against gram negative organisms; these included ampicillin. cephalothin, 
aorta of [he recipient ( ~ i ~ ,  4 ~ ) .  ~ i b ~ ~ ~ ~ i ~ ~  of sufficient recipient aorta kanamycin. chloramphenicol. and polymyxin. The choice of antibiotics 
above the celiac axis required incision of the  diaphragmatic crus, was made on the basis of prior cultures from the recipients' skin, trachea, 
me anterior aortic was isolated a pan,al occlusion clamp during urine, and feces. Additional cultures were taken during operation from the 
the period of suturing, r h e  end of [he homograft was ligated donor and recipient duodenum and from the donor gallbladder bile. In the 
a few millimeters beyond the origin of the celiac axis (Fig. 4C). event of growth from these locations, an adjustment in therapy based upon 
be mentioned later, patients 1.3 had temporarq. paralysis of sensitivity data u a s  made within 2 1  hours. In two cases, there was enough 
,he right diaphragm, r h i s  uas thought to have resulted from crushing of the time to attempt preoperative sterilization of the recipient gastrointestinal 
right phrenic nerve by the vascular clamp uhich uas applied to the tract u i th  a 6 and 48-hour course, respectively, of orai Neomycin, 
suprahepatic inferior vena cava. In Cases 4-7, a longer cuff u a s  developed Polym).xin. C'oxacillin and h'ycostatin. 
and care &as taken not to include an! diaphragm in the bite. The compli- Postoperatively. cultures uere  taken at least twice a week from the 
cation was avoided. wounds. nose, throat, urine, and feces In order to have a continuous record 
~~~~~~~~~~~i~~ and postoperative M ~ ~ ~ ~ ~ ~ ~ ~ ~ .  Monitoring of of the endogenous bacterial flora. In addition. blood cultures were obtained 
metabolic changes facilitated during operation by use of a 3 or more times a week since it was soon learned that peripheral bacteremia 
sampling catheter in the radial artec, A continuous intravenous infusion could be the first sign of l i ~ e r  sepsis. Frequent changes in antibiotics were 
of glucose solution given at 0.5 to I G ~ , / K ~ ,  per hour during the made according to the sensitiv~ty of the bacteria in these various locations. 
anhepatic phase. Glucose administration u a s  continued postoperatively. In addition, ueekly or biweekly suabs  from the nasophar)nx, throat, 
when  it was inadvertently stopped in one for a p p r o x i m a t e l y  20 rectum, and urine uere  obtained for virus isolation. The swabs were 
minutes after to [he reco\er) room, hypoglycemic immersed in ~ e a l  infusion broth containing 0.5% bovine serum albumin; 
resulted, wi thin  2 or 3 days W a s  no longer need for continuous 0.1 ml. u a s  moculated into monolayer cultures of human diploid fibrob- 
glucose. By this time. all the patients had started eating. lasts (WI-38). primar) rhesus monke! kidneq cells. and H-EpL cells. The 
Rapidly developing metabolic acidosls a lwa) \  seen during the cultureswere obsened dail) for cqtopathic effect and tested weekly for 
anhepatic interval. Data on the,e changes 1" the first four cases has been hemadsorption with guinea pig evthrocytes. o n e  blind pasqage was 
published" and the findings in the next three uere  similar. The extent of the performed for each 'pecimen in  each s)stem, 
acidosis could not be completely characterired since it \&as intermittentlq The general plan of immunosuppressive therapy i i  shown in Figures 
corrected, I,, [he six infants, sod;um bicarbonate uas !"fused during the 5 to 9. Arath~oprine, prednisone and heterologous antilymphocyte globu- 
in total doses of 27 to 78 m ~ q , ,  a> guided bq frequent determi. lin" uere  started during the operation. The maintenance doses of azathi- 
nations of arterial p ~ ,  ~ 0 2 ,  and bicarbonate, ~h~ ~ b . ~ ~ ~ ~ - ~ ~ d  girl who oprlne uere  usuallq less than I mg./Kg, per day. In Cases 1-4 the quantities 
weighed 39 Kg. recei\ed 290 milliequivalents. of prednisone were rapidlj reduced during the first f e ~  postoperative 
~ ~ f ~ ~ ~ ,  during, and for ,e\eral hours after transplantation, blood weeks ( F I ~ s .  5-7) but in Cases 5-7 the steroid ui thdraaal  uah at a much 
coagulation was folloWed %irh 1 1 different rests,  ~h~~~ provided a meas- loner rate ( F ~ g s .  8 . 9 ) .  The .ALG was gi\en daily for the first one or 2 weeks 
ureof fibrinolqsini. piatelets. six ciott~ng factor, produced b! the ~ ~ \ ~ ~ ~ ~ d  h e n  eker> second or third da!. ALG \sa$ stopped before the end of the 
Factor VIII (antihemaphilic globulin) which is extrahepatic in plmned 1-month course of therap! in Pat~ents 2 and 4 because of the 
~h~~~ results are being reponed In  derail,. ~ ~ ~ i l ~ ~  amino de\elopment of high titers of precip~tating antibodiel againht equine horse 
caproic acid (EACA, g i v e n  just after r e \ a b c u l a r l r a t i o n  of the l i b e r  i n  protein. .4ctinom)cin C (40 o r60  yg.1 was ~ntermit tent l~  given to Patients 
Patient 2 ,  but thrombogenic agents were nor gl\en to the others. 2-5 (Figs. 6. 8) .  The homografts of Patients 1-5 were irradiated with 2 or 
~ ~ ~ h i ~ i l l ~ ~  or one of the spectrum anristaphylococcal 3 doses of I00 or I50 R at depth on alternate dab5 beg~nning 3 to 13 weeks 
drugs were started j n t r a \ e n o u s ~ q  before or dur ing and po't-tramplantation (Figs. 5 - X i .  The indication for e~rher  local x-ray 
a f t e r~a rds .  In add~tion: agent\ were gl\en u h ~ c h  are usuall> effectl\e t h e r a p  Or Actlnom!cln W a s  reJzctlOn. 
The function of the transplanted livers was followed with a battery of 
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Tinic 1)cath to  
l%lootl 0rg;ln l'crasaki XTisniatches 
Case No.  Age Sex \\'eight (Kg.)  Croul) 1)ise;lsc Rrvasciilarizatiori l f a j o r  Groups  No. Sera 
1. Donor 18 m t h  hl 
1iecil)icnt I 0  nith 1: 
2. 1)olior 48 nith 1; 
l<cc.il~ient 20; nith 1.' 
4 .  I )onor 20 nith I '  
Iiccil)ic.nt 14 mth  1.' 
1ieci~)irrit 16 nith 1: 
6. T)onor 33 nith \I  
1iccil)icnt 25 mih  ;\I 
7 .  ~ i r  2 i  !.r ;\I 
1iecil)icnt 16 j.r I: 
-~ 
* I<\trahel);lt ic. 
l l i c r o c r ~ ~ h a l y  ; 311 min 0 4/60 
: ~ s ~ ~ i r a t i o ~ i  
1)nrumonitis 
I{c{)atolna 
I)ro\vrii~ig 282 niin 2 (hlac)  14/(A) 
1j i I i :~r~.  atrvsia* 
. \cute  ('IS 2 i l  min 5, i 8/60 
l<iliary a t  resi:i* 
E;r:ll~l)e's tliscnsc 212 min 2 (>'lac) y/m 
Hiliary :rtrcsia* 
\\'crtI1iic-I4olFti1an's 242 min 5, 7 23/($) 
(lis:xsv 
I{ili;lry ;~t rcs ia* 
standard hepatic function tests. In addition. the same clotting studies 
performed during operation were repeated at one to 4 week intervals. Liver 
scans using a technetium sulfide technrc"were obta~ned every one to 3 
week\ or more often ~f ind~cated. 
Pathological Studies. Paraffin hections were routinely prepared 
from all t i s~ues .  In some instances add~tional rnaterial \\as fixed in Palade's 
buffered osrniurn tetroxide for jubsequent electronniicro,copy and in 
liquid nitrogen for later examination bq fluorescent antibody methods. The 
thin sections for electrornicroscop) uere  stained with lead hydroxide and 
examined in a Phillip? EM 300. Section\ of the f r o ~ e n  ttssue were tested 
by Drs. Andres. Hsu, and Seegal of Columbia University, with antisera 
prepared against human immunoglobulins G, M, and A, BIC/BIA globu- 
lins. C'lq and fibrinogen. Appropriate controls were also used. 
Results 
Survival. Patients 2 .3 .4  and 5 dled 133, 186,60. and 105 days post- 
transplantation. The three others are still alive with excellent liver function 
after 269, 68, and 33 days. 
Two of the death\ (Cases 4 and 5) occurred within a few days after 
and were caused by the septic hepatic infarctions to be described below 
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Fig. 5.- Course in Case 1.  The patient is still alive 9 months after orthotopic l i ~ e r  transplantation. The indication for operation was 
hepatoma. Note the high rises in SGOT and SGPT, and the hacterern~a w hich occurred at the tlme of the initial liver infarction. The later sep- 
ticemia developed when the patient became leukopenic during treatment w ~ t h  ~ incn i t i ne  for tumor metastases. The thoracotomy was for 
removal of an unexpanded right upper lung lobe. The fir>[ two laparotomiss uere  for excision of tumor recurrences. Liver function has been 
stable for 8 months. 100 R d e p t h  dose of local homograft Irradiation. The temperatures are the highest for each day. 
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Fig. 6.- Case 2. The original disease was extrahepatic biliary atresia. A double arterial supply was connected as shown in Figure 
4B. The right artery thrombosed within 2 days necessitating hepatic resection. and subsequent drainage of a subhepatic abscess. 
Eventually hepatic and renal failure developed, the latter leading to hyperkalemia and cardiac arrest. Bacteremia and later fungemia were 
intermittently demonstrated until eventual death from massive intestinal necrosis. Survival was 4-112 months. Acti C-Intravenous 
actinomycin C in micrograms. 150 R-depth dose of homograft irradiation. The temperatures are the maximums for each day. 
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Fig. 7.-Course in Case 3 after orthotopic liver transplantation for extrahepatic biliarj atresia. Hepatic function was excellent during 
the first 3 months despite infarctions of large portions of the central and right liver which were treated with debridement. Thereafter, liver 
failure was progressive. Note the late parallel increases in alkaline phosphatase and bilirubin. The immediate cause of death was 
intraperitoneal rupture of an undrained residual abscess. Survival has  6 months. Liver irradiation Mas with l50R depth dose at each arrow. 
The temperatures are the dailq maximums. 
(Fig. 8). rile delayed consequences of the same complication were largely operative in juv  to the right phrenic nerve in Cases 4-7 was mentionedear- 
responsible for the unfavorable outcome in Cases 2 and 3. lier. 
Technical Complications. The iatrogenic right diaphragmatic pa- In performing recipient hepatectomy, the small bowel in one case and 
ralysis in patients 1.3 for 10, 7 ,  and 2 ln case 1, failure the right transverse colon in another were perforated during mobilization 
of the right upper pu]monq lobe to expand prompted its removal during of intestinal loops that had been caught at the site of previous hilar 
the fourth postoperative week ( ~ i ~ ,  5 ) .  ne subsequent prevention of dissections. The rents, which were closed in 2 layers, healed without 
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Fig. 8.- Course in Case 5 after orthotopic liver transplantation for extrahepatic hiliar) atresla. A vigorous and protracted rejection 
began within a few days postoperatively which was not reversed for 10 weeks. Function was improving when persistent gram negative 
septicemia presaged liver sepsis. Complete right lobar infarction finally occurred causing death withln 48 hours. At autopsy the right 
hepatic artery was thrombosed. Acti C-intravenous actinomycin C in micrograms 150 R- homograft irradiation. 
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F I ~  9 -Course in Cdse 6 The operatton u a i  tor extrahepatic b111ary 
atresia The homograft was immob~lized b\ suturing 11s Iigdments Jaun- 
dice has not re~urred although rejeit~on M A ,  didgno\ed from the third to 
seventh postoperatlke weeks becau\e of the rise\ In allial~ne phosphatase. 
SGOT and SGPT these chdnge\ h , ~ \ e  receded B\  4 week\ all antibiotic 
therap\ n a s  stopped The child hd\ since k e n  atehriie The temperatures 
are the maximums tor edih da\ An equdll\ k n i g n  cource has been 
observed m Case 7 
incident. 
Earlier attempts at liver transplantation were complicated by fibri- 
nolycis, hypofibrinogenemia, thrombocytopenia and hemorrhage."2227 
The same clotting abnornialities here  seen in the more recent cases as well 
as depression of a number of discrete clotting factors produced within or 
outside the liver: these findings are being reported in detail elsewhere.' 
Nevertheless. bleeding was not a difficult problem. In the infants, the 
estimated blood 1055 ranged from 160  to 1,200 ml. (average 790 ml.). The 
16-year-old girl rece~ved 4.000 ml. transfusion, almost all as the result of 
hemorrhage during hepatectomy. 
Homograft Sepsis. T u o  to I04 day, after transplantation. five of the 
seven patients developed gram negative septicemia with a variety of 
microorganisms including Aci-ohat lei--Klebsi~~llu.  Esc.her.ic.hia to l i ,  and 
Bacteroides. Bilirubin, alkal~ne phosphatases, serum proteins, and 
prothrombin times were little affected if at all. but there he re  high rises in 
the SGOT and SGPT (Figs. 5 - 8 ) .  Liver scans showed large defects, 
involving principally the right lobe (Figs. 10. I I ) .  Each of the patients had 
developed a septic hepatic infarct. 
This complication nos  not eaailq controlled in spite of specific 
antibiotic therapy and excisions, extraperitoneal debridements (Fig. 12). 
and drainage. Two of the five patients died w~thin  a fen days. The other 
three, who initially sunjived the complication of regional hepatic gan- 
grene, had a protracted subsequent morbidity. The tract5 running to the 
subphrenic space (Case 2 )  or within the li\er (Cases 1 and 3) were irrigated 
and probed ever) day. They could not be kept sterile in spite of local and 
systemic antibiotics. The same organisms cultured from the draining 
wounds appeared from tnne to time in the blood stream necessitating 
reoperation and more ex tens i~e  debridements (Figs. 5-7) .  At these times it 
was noticed that plugs of dead tissue radiated from the main tracts. often 
surrounding thrombosed intrnhepatic portal t r~ads .  Betueen debridements 
there was variable e \  idence from the scan\ that f i l i~ng in of the defects was 
occumng as the consequence of hepatic repeneratlon (Fie\.  10, 11) .  
Neverthele\s, the open hounds ne\er conipletel) healed. eken after more 
than 8 month> in Case 1. 
Earl!: Liver Function. During the first feu postoperatlke days, all 
seven of the patients had moderate but rap~dl?  reverc~ble rise\ in SGOT and 
SGPT. In spite of th15 e ~ i d e n c e  of ~\cheniic lnjur). the I~ker,  prob~ded life 
sustaining funct~on from the be!inning. The t u o  rsclpients uith normal 
bilirubin ~ a l u e s  before operation d ~ d  not beconie jaundrced n i t h ~ n  the first 
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10.- Radioisotope liver scans in Case 1 obtained with 99M-technetium. A - Seventeen days after transplantation. The isotope uptake is 
d but there are no defects. B -Large non-opacifying areas are demonstrable (arrows) 29 days after bansplantation in the posterior part of the right 
patient had septicemia. C- Three days later. The necrotic liver tissue had been debrided. D - The defects are no longer seen 252 days after 
. Note that the liver has progressively increased in size. 
Fig. 
diminishe 
lobe. The 
operation
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Fig. 11 .-Radioisotope liver scans in Case 3. A - Normal scan 10 days post-transplantation. B - Non-opacifying areas in the right and central parts 
of the liver 27 days postoperatively. Septicemia had developed. C - The necrotic areas were debrided. There was evidence of regeneration 84 days post- 
transplantation. Liver function was still excellent. D - Liver shrinkage and diminished isotope uptake 176 days after transplantation. The child died 10 days 
later when an abscess in the left lobe ruptured into the peritoneal cavity. 
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Oprn ~ n c ~ , ~ o n  through 
10 th tnl.rrpar. 
for dra~noge of  
abrresr 
Fig. 12. -Operative approach to septic liver infarctions through the 
loth intercostal space. Neither the pleural or peritoneal cavities were 
entered. 
postoperative week and the five patients with biliary atresia had rapid 
partial or complete disappearance of hyperbilimbinemia (Figs. 6-9). 
Alkaline phosphatases decreased from 140-632 to 27-165 units during the 
first week. 
All the recipients had a transient fall in total serum proteins (Figs. 5- 
9), the lowest value in the first postoperative week being 3.4 Gm.1100 ml. 
in Case 3. The three children with the most severe acute hypoproteinemia 
developed transient peripheral edema which resolved as the serum proteins 
began to rise. 
The serum protein depression appeared to be due at least partly to an 
increased protein loss or heightened catabolism. rather than to a failure of 
synthesis. The plasma levels of Factors I (fibrinogen). I1 (prothrombin). V 
(Accelerator globulin), VII (proconvertin), IX (Christmas) and X (Stuart) 
which are manufactured by the liver were maintained above 50 to 70% of 
normal in all seven oatients from the first to the seventh davs.' In addition. 
Kashiwagi et a1 ' have shown that the ~dent~f iable  protein genotypes hap- 
toglobin and group spec~fic omponent, whlch are s ~ n t h e c ~ z e d  only in the 
liver, changed wiihin hours to that of the donor.   heir studies suggested 
that there was a considerably accelerated protein turnover. 
Subsequent Liver Function. Evaluation of later function was diffi- 
cult in all the patients (Cases 1-5) who developed septic hepatic infarctions. 
A course analogous to that seen after canine homotransplantation to 
immunosuppressed recipients:'?' was seen only in Cases 6 and 7 in which 
the complication of regional hepatic gangrene has thus far been avoided. 
Both of the latter two patients apparently had a rejection episode. The 
first had moderate and reversible increases in SGOT, SGPT, and alkaline 
phosphatase but without the recurrence of hyperbilirubinemia (Fig. 9). 
Very similar enzyme changes were seen in Case 7 beginning in the second 
postoperative week but in this patient the serum bilirubin concomitantly 
rose to 6 mg.1100 ml. and then began to fall again as the SGOT. SGPT, and 
alkaline phosphatases returned toward normal. At these times, there was 
little or no depression in either patient in the concentrations of plasma 
proteins or of 6 measured clotting factors which are s~nthesized by the 
liver. 
Changes in SGOT and SGPT had a different significance in the five 
patients who developed regional hepatic gangrene. With this complica- 
tion, the transaminase rises were h~ghe r  and more abrupt (Figs. 5-8) than 
those associated with rejection and they were usuall) accompanied b) 
minimal acute alterations in other measures of l ~ ~ e r  function. In Cases 1- 
3 there was little other ebidence to support the diagnosij of rejection at that 
time (Figs. 5-7). Difficult rejections had alread) occurred In Cases 4 and 
5 but these appeared to have long since been reversed at least in terms of 
resolution of jaundice (Fig. 8). 
In the three patients who did not die as the immediate consequence 
of septic liver infarction, it was difficult to differentiate the subsequent 
adverse effects of this complication from those of chronic rejection. The 
child whose preoperative diagnosis was hepatoma (Fig. 5) has had stable 
excretory and synthetic hepatic function (including normal levels of all six 
of the analyzed liver-based clotting factors) in the 8 months since debride- 
ment procedures. In contrast, progressive liver failure developed about 2 
months after the septic hepatic infarctions in Cases 2 and 3 (Figs. 6 and 7), 
with jaundice, alkaline phosphatemia and eventual depression of all stud- 
ied plasma proteins. The latter two children redeveloped the extensive 
venous collaterals on the abdomen which had been present preoperatively 
and in one of them ascites recurred; eventually. homograft shrinkage was 
demonstrated with liver scans (Fig. 11). 
Extrahepatic Infections. Five of the seven patients had evanescent 
parahilar or lower lobar infiltrations during the early course, for which a 
bacterial or viral etiology could not then be established. Subsequently, 
Patient 5 persistently had cytomegalovirus (CMV) in tracheal excretions 
from postoperative days 75 to 105 at the same time as diffuse pneumonitis 
and Aerobacter-Klebsiella bacteremia developed (Fig. 8). At autopsy, 
there was extensive bilateral pneumonia and histologic evidence of lung 
infestation with bacteria, cytomegalovirus. and Pneumoc~ysfis carinii. In 
another patient (Case 3) chronic pneumonitis was evident radiographically 
for the last 3 months of life. Fungal and viral studies of the autopsy 
specimens have thus far been inconclusive. Finally the second infant in the 
series had CMV in tracheal secretions on two occasions but never devel- 
oped symptoms or abnormalities of her chest x-ray. At autopsy, there was 
no histologic evidence of CMV in the lungs but there was moderately 
severe infestation with Pneumocystis curinii. 
Transient fungemia was detected in Cases 1 ,2 ,  and 4 during the sixth, 
fourth, and first postoperative months. Patients 1 and 2 were infected with 
Candida alhicans and were given intravenous Amphotericin B and an 
investigational drug 5-fluorocytosine,* respectively; the latter agent 
which is less nephrotoxic than Amphotericin was used because the patient 
had azotemia. Patient 4, who had an unidentified yeast, was treated with 
Amphotericin B. In all three cases the fungemia ceased after the beginning 
of therapy. Two of the children subsequently died. In one, a fungal infec- 
tion could not be found at autopsy. Multiple fungal brain abscesses were 
present in the other. 
Asymptomatic Herpes simplex virus excretion was demonstrated in 
the 16-year-old recipient. beginning 3 weeks after transplantation. This 
girl has a past history of recurrent Herpes simplex mucocutaneous lesions. 
O the r  Complications. Concomitant with progressive liver failure, 
and shortly after she had been treated wtih both kanamycin and Polymyxin, 
Patient 2 developed a series of renal complications including azotemia, 
oliguria, secondary electrolyte disequilibrium, and cardiac arrest caused 
by hyperkalemia. She was resuscitated with cardiac massage and then 
treated with peritoneal massage for 48 hours. She lived for another 4 weeks 
until necrosis developed of the entire small intestine. At exploration the 
involved bowel was resected. Almost all of the intestinal veins and many 
of the small arteries were thrombosed. She died 24 hours later. 
The child treated for hepatoma (Case 1) developed multiple metas- 
tases in the lungs and abdomen during the fourth postoperative month. Two 
of the intra-abdominal recurrences were excised 3 and 7-112 months after 
transplantation. The first which weighed 28 Gm. was superior to the right 
transverse colon. The second, which partially obstructed the sigmoid colon 
and left ureter at the pelvic brim, weighed 164 Gm.: one month later 
adhesiolysis was necessary because of intestinal obstruction. A course of 
0.02 to 0.1 mg./Kg. of intravenous vincristin sulfate ( ~ n c o v i n q  for 7 
weeks, started in the fourth postoperative month. did not halt the growth. 
Gastrointestinal bleeding has previously been noted after orthotopic 
liver transplantation in dogs.'' " p igs , '  and man."" Serious postoperative 
hemorrhage from the gastrointestinal tract was not observed in any of the 
seven patients although occult melena was often seen. Antacid therapy was 
routinel provided. 
Pathologic Studies. As a result of the debridement procedures, 
homograft tissue became available from 8 to 54 days after transplantation 
* Roche Company. Professional Service Department, 212 Oxford, New York, N.Y. 
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Fig. 13.- Hepatic homograft from Patient 4 two months after transplantation. A large infarct (inn in the right lobe 
is separated from the viable liver by arim of fibroblasts and small lymphocytes. There is excess fibrous tissue and several 
small bile ductules in the portal tract (pt). H & E (X 180.) 
in Cases 1-4. A biopsy was obtained after 100 days from the liver of Patient 
1. The homografts of Patient 2, 3,4, and 5 were removed at autopsy. 
The pieces of liver removed from Patients 1-5 at debridement of the 
right hepatic lobe all contained multiple infarcts. In the necrotic centers of 
many of these there were large numbers of gram negative bacilli. The 
infarcts were rimmed by abundant neutrophile polymorphonuclear leuko- 
cytes, many eosinophiles and some lymphoid cells. Multiple infarcts were 
also present in the hepatic homografts removed from Patients 2-5 at 
autopsy. The areas of dead tissue were predominantly in the right lobe and 
were surrounded by a zone of proliferating fibroblasts and by small 
lymphocytes (Fig. 13). Several of the infarcts contained gram negative 
bacteria. In Patients 2,3, and 4 thrombosis of the right hepatic artery could 
be seen with the naked eye; in Patient 5 microscopy showed obliteration of 
this part of the arterial tree by organized thrombus. 
The pathological changes in the noninfarcted parts of the liver varied 
in degree in the five cases. The biopsy obtained from Patient 1, 100 days 
after hepatic transplantation, was the least abnormal (Fig. 14). In the portal 
tracts there was a moderately dense focal cellular infiltration. The majority 
of these cells were small lymphocytes, but about 5% were plasma cells with 
IgM in their cytoplasm. Several were neutrophile polymorphs; a few were 
eosinophiles. There was a slight increase in the amount of portal reticulin 
and collagen and new bile ductules were present in the portal tracts. The 
Kupffer cells were prominent but not increased in number. A few of the 
centrilobular bile canaliculi contained small bile "thrombi."There were no 
alterations in the fine stmcture of the hepatocytes and the blood vessels 
were normal. The lack of important pathological changes in this liver 
correlated well with the good match of donor and recipient shown by 
lymphocyte typing. 
Similar, but slightly more pronounced changes, were present in the 
liver homografts removed from Patients 4 and 5 at 2 and 3-112 months, 
respectively, after transplantation (Fig. 15). Although the portal fibrosis 
was marked there was no linking of adjacent tracts. There were many 
proliferating small bile ductules and in Patient 5 the bile ducts were dilated 
and filled with casts that were composed of inspissated bile, surrounded by 
neutrophile polymorphs. Cellular infiltration in these livers was slight. 
The most severely damaged homografts were those from the long 
surviving Patients 2 and 3. In Patient 2 the portal fibrosis had progressed 
to cirrhosis. There was linking of portal tract to portal tract and portal tract 
to central vein by bands of fibrous tissue. The normal lobular architecture 
of the liver had been lost and there were small regeneration nodules. Areas 
of liver cell necrosis were present (Fig. 16). Some hepatic artery branches 
showed slight to moderate degrees of fibrous intimal thickening. In Patient 
3 there was portal fibrosis but not cirrhosis. Many of the small branches of 
the hepatic artery were greatly narrowed or obliterated by intimal thicken- 
ing. The thickened intima contained collagen and large fat-laden cells. In 
some of the affected vessels the internal elastic lamina was ruptured. 
Cellular infiltration was slight, there being only a few foci of small 
lymphocytes in the portal tracts. This was in contrast to the dense lymphoid 
cell infiltration seen in the hepatic tissue removed from this same patient 
27 days after transplantation. 
Discussion 
Survival in all 7 of the presently reported cases exceeded that 
obtained previouly in human trials.5~'6,'9,22~23 The results have established that 
the actual operative procedure can be done in man with relative safety and 
that subsequent survival is possible for at least as long as 9 months. The 
course after transplantation of these children was markedly different than 
that of earlier recipients of orthotopic liver homografts inasmuch as all but 
one of the patients had a very satisfactory early postoperative convales- 
cence. As discussed elsewhere," the difference was probably due princi- 
pally to several improvements in care including more discriminating donor 
selection, the employment of an efficient method of interim organ preser- 
vation, and improved immunosuppressive agents. 
Three of the seven patients are still alive 9 months, 2-113 months, and 
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Fig. 15.- Patient 5. Hepatic homograft removed at autopsy 3-112 months after transplantation. The portal 
fibrosis is more marked than in Patient 1. The Kupffer cells are prominent. (H & E X 180.) 
Fig. 16.- Patient 2. Liver graft removed at autopsy 4-112 months after transplantation. The normal lobular 
architecture is interrupted by bands of connective tissue. Part of the liver is necrotic (nec.) (H & E X  180.) 
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Fig. 17.- An anatomical explanation of the predisposition of the 
liver to bacterial sepsis. Presumably the invading microorganisms enter via 
the portal vein or through the reconstructed biliary tract. 
dangerous situation could be further aggravated in the post-transplantation 
period either by the diminutions in blood flow or by the organ swelling 
which occurs with rejection. The constellation of circumstances might be 
especially hazardous in infant livers with their fine caliber thin-walled 
arterial branches. 
Because of the possible contributor) role of such mechanical factors 
in the production of right lobar infarction. the homograft u a s  fixed in the 
desired position in the last two cases by firmly reattaching its falciform 
ligament to the same ligament in the recipient. Thus far. these two patients 
have not had an) evidence of acute liver necrosis during the follow up 
studies of one and 2.113 months, respectively. 
Compared to the septic liver infarctions. the other complications seen 
in the patients seemed relatively trivial. The mild intraoperative bleeding 
diathesis required no therapy. The acute acidosis uhich occurred at about 
the same time:' was easily managed. The right hemidiaphragmatic paralj-  
sis which was probably caused by crushing the right phrenic nerve in 
Patients 1-3. was transient (10 to 50days): furthermore it was prevented in 
the next four cases. 
Certain other complications uhich plagued earlier attempts at onho- 
topic liver transplantation were eliminated in the present series. Postopera- 
tive gastrointestinal hemorrhage did not develop in an) of the patients. 
Pulmonary embolization. which was either the primar) or an important 
contributory cause of death in three of the first five recipients of orthotopic 
liver homo graft^,'^?^ did not occur at all. In the earlier cases, the clots 
originated at or near the lower venotomy sites used for insertion of plastic 
bypasses.?':. At that time. such prostheses were thought necessary during 
the anhepatic phase for decompression of the blocked portal and vena caval 
systems. It is tragic to realize from the experience in the presently reported 
series that such external bypasses are not necessary. 
Most importantl), the toxicity from immunosuppressive agents so 
often seen in our earlier e~perience"::~'  was avoided. There were no 
examples of bone marrow depression, probably because the azathioprine 
doses were generally kept at less than one mg.iKg. perda).  Prednisone was 
initially given in large quantities but reduced thereafter as rapidly as 
possible. Heterologous antilymphocyte globulin (ALG) which in many 
dogs can delay or prevent liver homograft rejection when used as the only 
therapy,:' was employed as an adjuvant agent in the same general way as 
has been reported after clinical renal homotransplantation.?' 
Patients 6 and 7 in this series have had only minor and easily 
reversible signs of rejection during their one and 2-112 month periods of 
follow-up study. Evaluation of the effectivenesi of the foregoing immuno- 
suppressive regimen was complicated in the other five cases by the devel- 
opment of extensive liver necrosis which. as discussed earlier, was not 
necessarily caused by rejection but which could be expected to adversely 
effect both hepatic function and structure. In one of the latter three patients 
who survived this complication at 23 days (Case I),  a liver biopsy 77 days 
later had only minimal abnormalities. The donor-recipient histocompati- 
bility match in this case was the best one in the entire series; good liver 
function has been maintained during the entire 9 months after transplanta- 
tion. The other two children who were saved by liver debridement or 
excision, only to die of hepatic failure 4 and 5-112 months later, had 
shrunken homografts at autopcy. Histologically, these organs had the kind 
of fibrosis seen in many long survivors after comparable canine liver trans- 
plantation." However, there were no mononuclear cells or other stigmata 
of active rejection in the specimens. 
Similarly, the principal abnormalities in the homografts from the two 
children who died after 2 and 3-112 months. within a few days after right 
hepatic artery thrombosis, were those of repair and to a lesser degree, 
regeneration. In each, the extent of fibrosis was moderate. Both of these 
patients had passed through difficult early rejections but had good liver 
function prior to the vascular accidents in the transplants: serum bilirubins 
were 2 and 2.3 mg.1100 ml., respectively, just before death. 
Reasonable conclusions from these combined clinical and pathologi- 
cal observations would seem to be that the immunosuppressive regimen 
used did not uniformly prevent the onset of rejection; that it permitted 
eventual control of the acute phase of this process: and that the degree of 
ultimate organ damage was a reflection of the severity of earlier rejection 
injury and in turn of the extent of donor-recipient histocompatibility. 
Efforts to improve the histocompatibility matches in future trials will 
depend upon character~zation of the ahi te  cell antigen profile of a large 
number of prospective recipients from whom the appropriate choice could 
be made. In order to have a large enough recipient pool to permit fine 
selectivity, an inter-cit) network of collaborating physicians will be 
necessary huch as that which is nou being developed through our institu- 
tlons. 
Summar?- 
Seven patients aged 13 months to 16 years were treated with 
orthotopic homotransplantation of cadaveric livers between July, 1967 and 
March, 1968. The indication for operation was congenital extrahepatic 
biliary atresia in five cases and carcinoma of the liver in the other two. The 
histocompatibility match between the donors and recipients ranged from 
poor to excellent. After donor death, the homografts received interim 
preservation with a technic that included hypothennia. hyperbaric oxy- 
genation and perfusion with diluted blood. Postoperative immunosuppres- 
sive therapy was provided a i th  azathioprine, prednisone, and heterolo- 
gous antilymphocyte globulin (ALG). Four of the recipients died after 60, 
105. 133, and 186days. The other three are still alive after 9,2-113, andone 
months. The improved results in the present series compared with those 
obtained in earlier human trials. seem to be a consequence of improved 
donor selection. the application of an effective organ preservation system 
and the use of an improved immunosuppressive regimen. 
All seven of the recipients had good early liver function. In five of the 
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Fig. 18.- Angiographic studies performed in a 5-year-old child immediately after her death from head injuries. Dye was 
injected into the common hepatic artery (CHA) proximal to the gastroduodenal artery (GDA). Left - Initial injection. Note the 
smooth course of the right hepatic artery (RHA). Right - The restraining ligaments of the liver have been incised, a chole- 
cystoduodenostomy performed, and the head of the x-ray table elevated to 60". The right lobe of the liver has rotated down and 
medially. The course of the left hepatic artery is undisturbed. However, the right hepatic artery (RHA) is now severely kinked 
where it passes beneath the common duct (see discussion). 
seven cases all or part of the right liver lobe underwent necrosis from 2 to 
104 days after operation. Thrombosis of the right hepatic artery was proved 
in four of these homografts either at operation or autopsy; additional 
angiographic studies in cadavers suggested that the regional de-arteriali- 
zation had an at least partially mechanical etiology. With invasion of the 
necrotic liver tissue by gram negative bacteria, the patients became 
profoundly toxic. Two of the recipients died within a few days, and two 
others died of progressive liver failure 4 and 5-112 months later. 
In the 5 livers studied pathologically from 60 days to more than 6 
months after transplantation, there was portal fibrosis, a slight infiltration 
by small lymphocytes around the portal vein branches, proliferation of 
small bile ductules and some central cholestasis. One of the two longer 
surviving homografts had progressed to cirrhosis and in both many of the 
small hepatic artery branches were narrowed by intimal thickening. These 
various changes are thought to be the result of rejections; they were least 
severe in the homograft which was shown by lymphocyte typing to be most 
compatible with its recipient. 
Addendum 
July 13, 1968 -The 3 patients surviving at the time the manuscript 
was submitted are still alive. The first patient will be one year post- 
hansplantation in 10 days. The other 2 have now been followed for 5 and 
4 postoperative months respectively. Three other recipients treated 3 
months, 6 weeks, and 3-112 weeks ago are well. There have been no septic 
hepatic infarctions in the last 5 cases. 
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Discussion 
Dr. Francis D. Moore (Boston): Dr. Starzl's work in this field is 
absolutely outstanding and for those of us interested in liver transplanta- 
tion, this is a banner day when we can contemplate four patients alive and 
well with lethal liver disease removed and a new liver in place. This is a 
magnificent achievement and liver surgery as of this day has an entirely 
new look from hither forward. But I would like to use this opportunity to 
discuss another aspect of Dr. Starzl's work. 
Four years ago, at the Society of University Surgeons, when Dr. 
Starzl's initial clinical experience and ours l i k e ~ i s e  had ended with 
fatality, it was clear (and so stated at the meeting) that more progress was 
needed before it would be ethically, morally. surgically and scientifically 
acceptable to move ahead again with clinical liver transplantation. 
Immunosuppression without hepatotoxicity was essential. as hell as 
improved perfusion-storage. S o a  these things have come to pass, espe- 
cially by the development of anti-lymphocyte globulin, and it is appropri- 
ate again to move ahead. If this forward motion is undertaken by persons 
or departments that have practical capability in transplant immunology and 
histocompatibility matching, as well as surgical experience with transplan- 
tation and the postoperative care of patients on immunosuppression, there 
is no need for consultant boards to declare the patient operable or a team 
from another institution to decide that the donor is dead. 
The time-temperature curves for liver donation, the permissible 
normothermic dead-time, and the prior state of death are the same for liver 
donation as for heart, with the heart somewhat less vulnerable to normoth- 
ermic ischemia. 
There has recently been a statement issued by a committee in 
Washington that attempts to deal with these matters as applied to the heart. 
As nearly as I can see, none of the authors of this document has busied 
himself with the transplant problem over these last 15 years; the document 
makes no reference whatsoever to the long work of many Departments in 
this country who have labored through the difficult years of transplanta- 
tion, nor does it acknowledge the obvious fact that actual experience in 
immunogenetics, immunosuppression and surgical transplantation are the 
essential normal prerequisites to moving ahead with any newly trans- 
plantable organ. 
Nor does it make reference to the fact that the moral security of the 
next 25 years of American surgery, in exploring this new field, will rest 
secure just where it has in the past 20 years: in giving free and untram- 
melled opportunity for development to those Departments and individuals 
that are willing to take the time and trouble to develop both the immunol- 
ogical and surgical aspects of organ transplantation, as Dr. Starzl has 
demonstrated today with a project that was held in abeyance until the 
fundamentally ethical nature of science itself indicated that it was time 
again to move ahead. 
Dr. Eric W. Fonkalsrud (Los Angeles): I would like to congratulate 
Dr. Starzl and his associates for their very excellent contributions to 
furthering the knowledge of both liver preservation and transplantation, 
and for their remarkably good clinical results, shown in this study. 
We have followed Dr. Starzl's work with very great interest, however 
have used a slightly different technic in the laboratory and in one patient. 
The emphasis in our studies has been on the use of hepatic cell 
stabilizing drugs, such as chlorpromazine and cortisone administered to 
the donor after death followed by external hypothermia to the graft after 
excision. A siliconized internal vascular shunt has been used to decom- 
press the inferior vena cava and portal vein to the right atrium in the 
recipient. 
This slide [slide] shows the liver of a 2-112-year-old boy with biliary 
atresis who underwent orthotopic liver transplantation. The total time of 
liver ischemia was 91 minutes. 
This photograph shows how pink and uncongested the graft appeared 
30 minutes after revascularization. The falciform ligament and suspensory 
ligaments of the grate were attached to the diaphragm in this patient, not 
so much to prevent arterial kinking as to provide support to the vena caval 
anastomosis. 
The patient recovered from the operation rapidly and experienced a 
drop in bilirubin from 33 to 4.5 mg.1100 ml. and alkaline phosphatase from 
115 to 15 KA units within 24 hours. There was prompt good bile excretion 
which was drained externally. Immunosuppression was started on the day 
of operation and continued as in Dr. Starzl's study. 
The patient was ambulatory and taking a regular diet when, on the 
fourteenth day, he promptly became septic -and developed air under the 
right diaphragm as is shown on this abdominal roentgenogram. Explora- 
tion showed a large area of necrosis in the dome of the right lobe of the liver, 
as is shown on this slide. Postmortem showed thrombosis of the small 
branches of the right hepatic artery, as is seen in this photograph, and which 
is very similar to those described in Dr. Starzl's paper today. All of the 
major vascular anastomoses were patent. 
This photomicrograph shows an area of relatively normal liver tissue 
with ductal proliferation in an area that a a s  not infarcted. The area of 
transition between the infarct and the normal liver tissue is clearly seen. I 
would like to ask Dr. Starzl if he has an explanation for why arterial 
thrombosis occurs so late after grafting and if he believes there may be 
additional causative factors such as a manifestation of rejection? Do you 
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believe that adding arterial blood to the portal vein may be of any benefit 
in these patients? Would short- or long-term anticoagulation be of any 
help? 
Dr. Thomas E. Starzl (Closing): I would like to thank Dr. Moore not 
only for the thoughts he expressed, but for the kindness he has displayed 
to us this afternoon and at all times in the past, which has made it possible 
for our two institutions to exchange data long before it was published. 
The approach to preservation described by Dr. Fonkalsrud is a 
different one than we used in our cases. We were anxious to obtain longer 
tern  preservation than we have ever found possible with such simple 
perfusion methods. With our recently used technic we have been able to see 
the liver within the chamber and to evaluate it under circumstances of 
perfusion before anything was done to the recipient. 
As to the cause for the late thrombosis, I think one can only speculate. 
It seems likely to us that the mechanical defect which I demonstrated ear- 
lier may not be completely occlusive and that there may be added factors, 
as Dr. Fonkalsrud suggested. Possibilities might include the swelling that 
occurs in liver homografts at the time of active rejection, or alternatively 
the diminished blood flow that is very often seen in the canine liver at the 
time of a potentially reversible rejection. With a combination of any of 
these circumstances, infant livers with their fragile arteries might be 
subject to a special risk of dearterialization. 
THE HUMAN TRIALS 
On 2 May, 1968, Professor Roy Calne of Cambridge performed the first human liver transplan- 
tation after a preceding period of investigation of this operation in pigs (cf. Part I). Subsequent 
contributions of Calne and his associates at Cambridge and at King's College Hospital (London) are 
evident throughout this book. 
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Liver transplantation in man 
I. Observations on technique and organization in five cases 
British Medical Journal, 4: 535-40, 1968 
R. Y. Calne and Roger Williams 
Summary: In view of the extreme sensitivity of the human liver to 
ischaemic damage, the organization of clinical transplantation is of neces- 
sity complicated. From our preliminary experience of five human liver 
allografts we feel that active collaboration between hospitals is essential in 
order to practise human liver transplantation. It is unnecessary and unde- 
sirable to interfere in any way with potential liver donors. Nevertheless, the 
nature of the surgical technique requires that the liver is cooled within 15 
minutes of death if satisfactory function is to result in the grafted organ. 
This report describes technical difficulties that were encountered 
which can limit successful liver transplantation. The first patient was in 
severe liver failure and had an accessory liver graft in the splenic fossa after 
splenectomy. This liver suffered irreversible ischaemic damage, which led 
to an uncontrollable haemorrhagic state with exsanguination that resulted 
in death the day after operation. The second patient, a 10-month-old infant 
with biliary atresia and liver failure, died from cardiac arrest shortly after 
the operation. 
The remaining three transplants developedgood initial function. One 
patient survived 11 weeks, and one has returned to work. 
Introduction 
The liver can be transplanted to the normal anatomical position 
(orthotopic) or to an abnormal situation (heterotopic). A variety of hetero- 
topic techniques have been described (Starzl et al., 1966), but none is ideal. 
It is difficult to accommodate an extra liver in the abdomen in such a way 
that it receives arterial and portal blood and drains hepatic venous blood 
and bile. There is a danger that the multiple anastomoses will be kinked or 
otherwise compromised. Orthotopic liver transplantation requires prelimi- 
nary hepatectomy of the recipient (Moore et 01.. 1960: Starzl er 01.. 1960). 
This provides the liver with normal anatomical surroundings, and revascu- 
larization and biliary drainage are straightforward. 
Renal function can be replaced artificially by dialysis. which is used 
to support the patient before and if necessary after renal rransplantation. 
n e r e  is no comparable method of replacing liver function. The two 
categories of fatal liver disease for which transplantation may be indicated 
are progressive liver failure with cirrhosis and primaq malignant tumours 
of the liver. If the liver is malignant then hepatectomy is an obvious 
prerequisite, but with non-malignant progressive liver disease there are 
theoretical advantages in leaving the residual function of the patient's own 
liver and avoiding a dangerous and difficut hepatectomy. The unsatisfac- 
tory surgical features of heterotopic liver transplantation may, however, 
make this an unwise choice. 
If the liver is left at 37" C. without a blood supply for more than 15 
minutes serious damage is likely to occur. The liver cell necrosis results in 
impairment of function and also appears to be responsible for the uncon- 
trollable haemorrhagic syndrome that occurred in our first case. Toprevent 
this damage it is therefore essential to cool the liver within 15 minutes of 
death, by infusion of a chilled innocuous fluid through the portal vein. If 
this is followed by a cold plasma/bicarbonate/dextrose solution the liver 
can be kept at 4' C. with little deterioration for two hours (Schalm, 1968). 
Slow deterioration does, however, occur, and, since hepatectomy of the 
recipient can be an extremely difficult and time-consuming operation, 
longer preservation is desirable. The most satisfactory method so far 
described by Brettschneider et al. (1968) utilizes hyperbaric oxygen, 
hypothermia, and continuous perfusion with diluted blood. With this 
technique excellent preservation of canine livers for eight hours has been 
achieved, and an identical method has been used to preserve human livers 
fortransplantation by Starzl etal.  (1968a). Before laparotomy of thedonor, 
while the preservation apparatus is being prepared, it may be helpful to cool 
the cadaver by means of a heart-lung machine with a refrigeration unit 
(Marchioro et ai.. 1963). 
Organization 
It follows from the above remarks that the requirements for a clinical 
liver transplantation are as follows: a recipient with fatal liver disease at a 
terminal stage, but who is nevertheless fit enough to withstand a major and 
prolonged operation, and a donor whose liver can be cooled within 15 
minutes of death. It is not surprising that clinical liver transplantation has 
been slow in developing. Of five heterotopic liver transplants in man the 
longest survival was 35 days (Starzl er al., 1967). Previous to July 1967 
nine orthotopic liver transplants were performed in man and the longest 
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survival was 23 days. Since that time the clinical liver transplantation pro- 
gramme at Denver has had more sucess (Starzl et al.. 1968a, 1968b). Of 17 
transplants in 16 patients the longest survivor was more than a year, the 
patient eventually dying from secondary deposits of his original primary 
hepatoma. Of the seven patients sunjiving at the present time, one has 
received a second liver transplant after the first had been rejected and 
removed (Starzl. Rrettschneider, and Porter. personal communication). 
In view of the major organizational requirements for a successful 
liver transfer it is necessary for there to be a period of waming during which 
arrangements can be made. The recipient ihould therefore have sufficient 
residual liver function to pemlit him tc wait for the availability of a 
transplant. The most suitable donors are cases in which resuscitation has 
been performed, but nhere  irreversible brain damage has occurred and a 
decision has been made. quite irrespective of any transplantation consid- 
erations, tu cease resuscitation. When recovery is impossible it is custom- 
ary to cease artificial ventilation and support of the circulation. This was 
true before the deveioprnent of organ transplantation. and we feel it is 
unnecessary to modify the procedure in any way for the purposes of 
transplantation. ?'he medical staff caring for the patient should not be 
involved in thc transplantation operation. After resuscitation has been 
abandoned no procedures are started on the donor until it is clear that there 
is no spontaneous respiration or heart beat, and death has been confirmed 
by independent medical staff. Liver transplantation can then be performed 
entirely within the confines of long-established ethical medical treatment. 
All that is necessary is for the doctors who have decided to stop rescusci- 
tation to inform the transplantation team, who will then be prepared. 
Since the availability of suitable donors in any one institution is 
limited, it is felt that if clinical liver transplantation is to be developed in 
the United Kingdom it will be rlecessary for hospitals to collaborate. We 
do not feel justified in moving a potential donor from one hospital to 
another for the purposes of organ transplantation. Instead, we move the 
transplant team artd the recipient to the same hospital as the donor. A close 
liaison has been established between Addenbrooke's Hospital, Cambr- 
idge, and King's College Hospital, London, where there are complemen- 
tary interests in liver transplantation and liver disease. It is proposed to 
undertake a definitive programme of liver transplantation, collaborating 
with other hospitals where this is possible. 
This report summarizes certain technical aspects of our first five 
cases. The full clinical details of Cases 3 and 4 are given in an accompa- 
nying article at p. 541 (Calne et al., 1968). Reports of the anaesthesia and 
tissue typing are in preparation. 
Case 1 
A 47-year-old man was admitted to Addenbrooke's Hospital on 23 
May 1967 with gastrointestinal bleeding. He had a past history of alcohol- 
ism which had led to liver failure, with ascites and periods of coma. 
Fig. 1.- Diagram of operative procedure in Case 1, showing 
heterotopic liver allograft in the splenic bed. 
On examination he was pale, jaundiced, and ill-looking. The liver 
was not palpable, but the spleen could be felt below the left costal margin. 
There was marked ascites. Haemoglobin was 11.3 g.1100 ml., white blood 
cell count 5,400/cu.mm.. platelets 60,000/cu.mm., prothrombin ratio 17- 
13. and bilirubin 2 mg.1100 ml. (1.6 mg.1100 ml. conjugated). Spleno- 
portogram showed large gastro-oesophageal varices. Serum albumin 
varied between 1.9 and 2.3 g.1100 ml. The patient had had two previous 
attacks of haematemesis and melaena requiring transfusion and had been 
comatose for one week. He recovered from coma and became fully alert. 
In view of his continued gastrointestinal bleeding, low albumin, clinical 
jaundice. and a previous history of coma, it was felt that any surgical 
procedure aimed at reducing portal venous pressure would result in 
irreversible coma. His liver disease was considered to be beyond conven- 
tional therapy. The possibility of hepatic transplantation was discussed 
with the patient. who was anxious that this should be tried. 
The donor was a 50-year-old woman who died from a head injury. 
She was brought into hospital dead and attempts at resuscitation were made 
for half an hour. There was 110 response to the resuscitative efforts. 
Via a midline abdominal incision the superior me5enteric vein was 
cannulated and perfused with 1 litre of chilled balanced salt solution. An 
incision was made in the right common iliac vein to allow egress of 
perfusate. While perfusion was in progress the liver was removed and put 
into a plastic bag surrounded by cold perfusion fluid. The hepatic artery 
was similarly perfused and the plastic bag was surrounded with ice. This 
procedure was used in the four subsequent cases. 
Before the start of perfusion there had been a period of one hour in 
whch the liver at 37' C. had been unperfused. 
Recipient Operation 
Under light general anaesthesia a left subcostal incision was made 
and extended across the midline. Ascitic fluid was aspirated. The spleen, 
which was extremely large, was removed. The liver was taken out of the 
p!zstic bag at 11.30 a.m., three hours after the death of the donor. It was 
rotated so that the hilus faced towards the midline and it was placed in the 
splenic fossa, the shrunken cirrhotic liver allowing room for the transplant. 
The gall bladder faced anteriorly and the suprahepatic inferior vena cava 
faced towards the renal vein. The anastomoses were performed as shown 
in Fig. 1. The coeliac artery was anastomosed end-to-end to the splenic; the 
superior mesenteric vein was anastomosed end-to-end to the splenic vein, 
and the splenic vein of the transplant was anastomoaed to an accessory 
splenic vein, which lay in the tail of the pancreas. Clamps were removed 
from the splenic vessels and blood was allowed to perfuse the liver. The 
infrahepatic inferor vena cava was ligated. The suprahepatic inferior vena 
cava was anastomosed end-to-side to the left renal vein. The liver appeared 
to perfuse satisfactorily. The common bile duct was ligated and the gall 
bladder was anastomosed to the end of a Roux loop of jejunum. The 
anastomoses took an hour. so that the total ischaemia time was four hours. 
The wound was closed in layers with drainage. Though no heparin had 
been given after operation there was a continuous steady loss of blood from 
the drains. Two hours after the operation bleeding became more profuse; 
blood oozed from the wound and around the intravenous infusion. The 
blood clotted and then underwent complete fibrinolysis after about 20 
minutes. The patient did not recover consciousness. 
The wound was reopened and bleeding was seen to be coming from 
the whole operative site and particularly from the caval anastomosis. 
where additional sutures were inserted. Haemorrahge continued in spite of 
the administration of aminocaproic acid, intravenous fibrinogen, and fresh 
blood. In all, 23 litres of blood were transfused. The patient died at 5.30 
next morning. 
The biopsy taken shortly after transplantation of the liver showed 
marked degenerative changes in many of the liver cells (Special Plate, Fig. 
2). Necropsy revealed the typical changes of severe portal cirrhosis of the 
patient's own liver with large gastro-oesophageal varices. The trans- 
planted liver was severely congested. The anastomoses were all patent. 
though the inferior venacaval anastomosis was narrowed by the additional 
sutures. Histology of the transplant showed congestion, haemorrhage, and 
areas of liver necrosis. Some liver cells were reasonably well preserved. 
There was no regular zonal distribution of these changes. 
Comment.- This liver was removed from a cadaver after 
irreversible ischaemic damage had occurred, and this led to an uncontrol- 
lable haemorrhagic state. The heterotopic situation of the liver was not 
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abdominal wall, and gross ascites. The liver was markedly enlarged. The 
spleen was just palpable. An umbilical hernia was present. 
It was felt that the prognosis was hopeless. and the parents requested 
that an attempt should be made to perform a liver transplant. 
The donor was a child of 2 who had died as a result of upper 
respiratory tract infection which led to cardiac and respiratory arrest. The 
time of death was 4.35 p.m. Cardiac massage and artificial ventilation were 
attempted without any result. At 4.57 p.m. a transverse upper abdominal 
incision was made, a cannula was inserted into the superior mesenteric 
vein, and the liver was perfused with 1 l ~ t e r  of cold Hartmann's solution 
containing 2,000 i.u. of heparin and then with 500 ml. of plasma/bicarbon- 
ate/glucose solution' (Schalm, 1968). An incision was made into the 
inferor vena cava to allow the perfusate to escape. An accessory right 
hepatic artery was found to be arising from the superior mesenteric artery; 
this was preserved together with the other vessels and the bile ducts. 
Recipient Operation 
A bilateral subcostal incision was made. Dilated anastornotic veins 
in the anterior abdominal wall were individually ligated and divided. 
Ascitic fluid was aspirated. Dense adhesions between the bowel, the 
parietes, and the liver were divided. The liver was huge, green, and 
embossed with bile cysts; there were large lymph nodes at the hilus. 
Removal of the diseased liver was time-consuming. The liver was skele- 
tonized until it was attached only by its vascular connexions. The portal 
vein and inferior vena cava were temporarily occluded, and since this 
produced no deterioration in the general condition of the patient no 
vascular shunts were used. Hepatectomy was completed at 7.35 p.m., when Fig. 2.- Biopsy of liver allograft in Case 1, showing degenera- 
tion of liver cells and intrahepatic haemorrhage. (x 335.) the donor liver was removed from ice. The vena cava was anastomosed to the vena cava above the liver, and 
satisfactory and congestion of the liver at necropsy indicated poor venous 
drainage. 
Case 2 
A child of 10 months was admitted to Addenbrooke's Hospital on 1 1 
June 1968 with jaundice which had developed shortly after birth. Lapa- 
rotomy at the age of 2 months confirmed the diagnosis of biliary atresia. 
During the two months preceding admission the child had developed 
biliary cirrhosis with ascites and was considered to be unsuitable for any 
further treatment. 
Haemoglobin was 8.61100 ml.. bilirubin 8.2 mg.1100 ml. (5.7 mg. 
conjugated), total protein 6.2 g.1100 ml. with a moderate increase in alpha2 
- and gamma-globulin. 
On examination he was extremely jaundiced, with enormous ab- 
dominal distension, dilated superficial veins coursing over the anterior 
Fig. 3.- Diagram of operative procedure in Case 2. 
the portal vein was anastomosed to the portal vein end-to-end. The clamp 
was removed from the portal vein at 7.55 p.m. and blood was allowed to 
perfuse the liver. After 10 ml. of blood had been discharged from the 
inferior vena cava below the liver this vessel was clamped and the vascular 
clamp was removed from the inferior vena cava above the liver. The aorta 
was mobilized and cross-clamped, a Carrel patch with the coeliac artery of 
' Preservation fluid containing 100 ml. of reconst~ruted human plasma, 10 ml. 
of 2% procaine, 8 ml. of 5% glucose. and 20 ml, of 1.4% sodium bicarbonate. 
Fig. 4.- Diagram of the operation at the stage of hepatectomy in 
Case 3, showing the hepatic veins clamped and the inferior vena cava 
intact. A direct shunt emerges from the portal vein and drains into the right 
internal jugular vein. 
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dilatation of lymphatics. There was a slight neutrophil infiltrate of the 
hepatic capsule. Most of the liver parenchyma was well preserved. 
Comment.- It was felt that the extensive operative procedure in an 
exceedingly ill child was too great for it to withstand, but the liver 
preservation appeared to be adequate. 
Case 3 
A 46-year-old woman was admitted to Addenbrooke's Hospital on 
7 February 1968 with a primary cholangiocarcinoma which had caused 
obstructive jaundice and gastrointestinal haemorrhage. Chlorambucil 
treatment for her tumour resulted in marrow depression and septicaemia. 
Full details are reported elsewhere (Calne er al.. 1968). 
Though in an extremely ill state, the patient was most anxious to have 
a liver transplant, and in spite of persisting marrow damage liver transplan- 
tation was performed. 
The donor was a 5-year-old child who had died as a result of mumps 
encephalitis. Death occurred at 4.50 p.m. A transverse abdominal incision 
was made and the superior mesenteric vein was perfused with cold 
heparinized Ringer's solution at 5.05 p.m. An incision was made in the 
right common iliac vein to allow egress of perfusate. The perfusate was 
changed to plasma bicarbonate dextrose solution. Similar perfusate was 
used in the hepatic artery. 
Recipient Operation 
A bilateral subcostal incision was made. The liver was found to be 
huge, with deposits of growth palpable in both lobes but no ascites and no 
Fig. 5.- Diagram of operative procedure in Case 3, showing evidence of growth outside the liver. There were dense vascular adhesions 
anastomosis of the suprahepatic inferiorvenacava to the hepatic veins. The between the porta hepatis, omentum, and duodenum. The liver was skele- 
infrahepatic vena cava is ligated. tonized until it was attached only by its vascular connexions. During the 
dissection the patient's blood pressure tended to fall, probably owing to 
the donor was anastomosed end-to-side to the aorta of the recipient. The 
superior mesenteric artery of the donor was anastomosed end-to-end to the 
recipient's hepatic artery and the inferior vena cava was anastomosed end- 
to-end to the inferior vena cava below the liver. All anastomoses were 
completed by 8.50 p.m. The bile duct was ligated and the gall bladder was 
anastomosed to a Roux loop of jejunum (Fig. 3). The liver was rather pale 
and blotchy and did not appear to be perfusing well. but all anastomoses 
looked satisfactory. The falciform ligament of the transplant was sutured 
to that of the recipient. No heparin was used, 4 mg. of fibrinogen was given 
intravenously, haemostasis was achieved, and the wound was closed in 
layers. Intravenous dextrose and bicarbonate were given. 
The child's condition improved at the end of the operation: he was 
breathing spontaneously and regained consciousness. Half an hour after 
the end of the operation there was a sudden cardiac and respiratory arrest. 
the cause of which wac not determined. Attempts at rescuscitation failed. 
At necropsy no cause of death could be found. All anastomoses of the 
transplant were patent. Microscopy of the transplant showed slight cen- 
trilobular necrosis of many lobules and oedema of the portal tracts with 
manipulation of the liver causing embarrassment of respiration and cariiac 
action and intermittent obstruction of the vena cava. The patient was 
systematically heparinized with 10.000 units of heparin. The portal vein 
was clamped at 6.08 p.m. and portal venous blood was shunted to the right 
internal jugular vein (Fig. 4). It was felt that the inferior vena cava of the 
recipient was much too large to be anastomosed to the vena cava of the 
small donor liver; therefore the liver was filleted off the vena cava, 
clamping the main hepatic vein and ligating all other branches. The 
malignant liver was removed at 6.20 p.m. and the donor liver was removed 
from the ice at 6.40 p.m. 
The suprahepatic inferior vena cava was anastomosed end-to-end to 
the main hepatic vein. The portal vein was anastomosed end-to-end to the 
portal. There was considerable discrepancy in size, and plication was 
necessary in order to complete the anastomosis. The clamp was removed 
from the portal vein at 7.1 1 p.m. and blood was allowed to perfuse the liver. 
After 30 ml. of blood had been dixharged from the inferior vena cava 
below the liver this vessel was ligated and the clamp on the hepatic vein was 
removed. The coeliac artery with a rim of aorta was anastomosed end-to- 
end to the divided hepatic artery of the reci~ient  (Fie. 5 ) .  This anastomosis 
was completed at 7.23 p.m., and on release of the arterial clamp an 
excellent pulse was felt throughtout the length of the hepatic artery of the 
donor and the liver changed from a dark red colour to bright salmon pink 
4 0  Ibo with a normal consistency. The diameter of the common bile duct of the 
recipient was 0.7 cm., while that of the donor was 0.3 cm. An end-to-end 
- ! 4 0  , 
F 
anastomosis was felt to be surgicallj unsatisfactor). The alternative of 6 1 2 0  ; anastomosing the gall bladder to the bowel was felt to be undesirable 
-7 n 
F 
because of the danger of ascending cholangitis. Accordingly the gall 
- IC00, bladder was mobilized from its bed. 
C .  0 
5 2 0  80 % The distal two-thirds were freed from the liver and turned down- 
L 
.- -
9 wards. There was no acute kink and the fundu5 of the gall bladder was anas- 
I K l :  
E 
tomosed to the open end of the common bile duct with continuous 410 
4 I 0  > chromic catgut. The anastomosis lay in a iatisfacton position, and bile was 4 0  :.
- seen to be produced from the 11ver at this stage. The common bile duct was 
2 0  then ligated. The falciform ligament uas  sutured to the diaphragm, and a 
I 0 
minute liver biopsy was taken. Yates drains were brought out of the lateral 
10 IZ 14 I b  18 20 22 24 2 6  28 X) 4 8 10 12 14 extremities of the wound. which wai closed in lagers. E ~ e r ) ,  attempt was 
A p r ~ l  Ma7 made to secure haemoqtasis. but the whole of the operation clte was oozing 
blood at the end of the operation and the patient felt cold. The heparin was 
~ i ~ ,  6,-chanofalkaline phosphatase in  ~ i ~ ~ . , i ~ ~ ~ ~ ~ ~ ~  unitsand r e~e r sed  with protarnine. Fibrinogen wa\ gl\en, and the patient \+as 
total bilirubin in mg,llOO of blood (case 3 ) .  ~ l ~ ~ d  lekels of both fell warmed with blanket>. Significant bleeding from the uound ceased in the 
very rapidly after liver allografting on 2 May 1968. subsequent two hours. During the operation the patient received 7 litres of 
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Fig. 7.- Operative procedure in Case 4. The long arm of the T tube 
emerges through the recipient's common bile duct. 
blood, 100 ml. of 20% mannitol, and intravenous dextrose and bicarbon- 
ate solutions. 
Biopsy of the transplanted liver shortly after revascularization 
showed well-preserved liver cells. Initial function of the liver was consid- 
ered to be good (Fig. 6). The patient rapidly regained consciousness. Full 
operative details are recorded elsewhere (Calne era[ . ,  1968). 
The patient died 1 1 weeks after operation following partial infarction 
of the liver. This appeared to be caused by a clot arising in the recipient 
hepatic artery, where it had been clamped during the operation. 
The donor was a 13-year-old child who had died as a result of a head 
injury. Death occurred at 11.27 p.m. A bilateral subcostal incision was 
made. and the superior mesenteric vein was perfused with 2 liters of cold 
heparinized Hartmann's solution followed by 200 ml. of plasma bicarbon- 
ate dextrose solution. The cold infusion began at 11.40 p.m. An incision 
was made in the right common iliac vein to allow egress of perfusate. An 
accessory right hepatic artery was found to be arising from the superior 
mesenteric artery. This was preserved together with the other vessels and 
the bile ducts. The liver was immersed in cold saline in a bowl surrounded 
with ice at 12.35 a.m. 
Recipient Operation 
A bilateral subcostal incision was made. The liver was grossly 
enlarged, and there were numerous vascular adhesions between the liver, 
parietes, and surrounding viscera. These were ligated and divided. Huge 
veins were coursing over the surface of the liver, which bled on touch. 
During mobilization of the liver bleeding occurred whenever the venous 
outflow was obstructed. There was no evidence of extrahepatic spread of 
tumour, but the whole of the left lobe of the liver was replaced by tumour 
and multiple small tumour deposits were scattered through the right lobe. 
During the final stages of the skeletonization of the liver the infrahepatic 
vena cava was divided; both ends were controlled and ligated. The 
patient's systolic blood pressure fell to 60 mm. Hg, but gradually rose with 
replacement of blood. The hepatectomy was completed at 1 .OO a.m., when 
the donor liver was removed from the ice. The vena cava was anastomosed 
to the vena cava above the liver; the portal vein was anastomosed to the 
portal vein end-to-end. The clamp was removed from the portal vein at 1.26 
a.m., and blood was allowed to perfuse the liver. After 30 ml. of blood had 
been discharged from the inferior vena cava below the liver this vessel was 
clamped and the suprahepatic caval clamp was removed. The liver rapidly 
assumed a satisfactory colour of pale pink and normal consistency. The 
coeliac artery was anastomosed end-to-side to the proximal hepatic artery 
of the recipient, a Carrel patch being used. The donor superior mesenteric 
artery was anastomosed end-to-endio the cut dlstal hepatlc artery (Flg. 7). 
Case 4 The clamp was removed from the hepat~c artery dt 1 55 a m ,  and the 
A 4l-~ear-old man was admltted to Klng's College Hospital on 23 lnfrahepatlc vena caval anastomosis was made end-to-end September 1968 wlth a prlmary 11ver cell cancer Full detalls are reported The common b ~ l e  duct was anastomosed wlth 410 Interrupted catgut 
elsewhere (Calne et a1 , 1968) There was massive enlargement of the liver, Sutures end-to-end over the upper llmb of a rubber T-tube, which was but Ihe patlent was nOt~aundlced and was In "Iew the brought out through the reclp~ent's common duct below the anastomosis. 
prognosis he was anxlous to have a llver transplant Bile was seen to be produced by the liver at thls stage The T-tube was 
brought out through a stab lnclsion Haemostas~s was achieved, the 
* - . S T  falc~form l~gament was sutured to the diaphragm, and a mlnute llver blopsy 
was taken Two grammes of amplclll~n dissolved m 50 ml of sallne was 
F I ~  8 - Operative b~opsq of 11\er allograft of Case 4 at the 
time of transplantation. shouing \\ell-presened h e r  parenchyma. (H. I 
and E. x 335.) Fig. 9.- D~agram of operatlve procedure m Case 5. 
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introduced under the diaphragm and in the subhepatic space. Yates drains 
were brought out by stab incisions through both flanks from both subdia- 
phragmatic areas and from the subhepatic space of the right side. The 
wound was closed in layers. 
The patient's general condition at the end of the operation was good 
and he woke immediately from the anaesthetic, but continuous haemor- 
rhage occurred from the drainage site on the right side, and after 12 hours 
the abdomen was re-explored. One litre of clotted blood was found in the 
peritoneal cavity; this was removed. No bleeding could be found at any 
point in relation to the liver or elsewhere. The wound was closed, and 
haemorrhage was then seen to be coming from the drain site in the right 
flank. This wound was opened further, and an artery in the subcutaneous 
tissue was found to be bleeding; this was oversewn, and other small vessels 
nearby were clamped. Bleeding then ceased, and the patient's general con- 
dition became excellent. He had received mannitol, bicarbonate, dextrose, 
and 22 litres of blood. The transplant biopsy taken shortly after revasculari- 
zation showed well-preserved liver parenchyma (Special Plate, Fig. 8). 
The subsequent postoperative course is recorded elsewhere (Calne et 
al., 1968). At the time of writing the patient is clinically well and has 
returned to work, having been discharged from hospital on the seventeenth 
postoperative day. 
Case  5 
A 46-year-old man was admitted to King's College Hospital on 27 
October 1968 with a primary cholangiocarcinoma which had caused ob- 
structive jaundice. In view of the hopeless prognosis he was anxious to 
have a liver transplanted. 
The donor was a 64-year-old man who had died as a result of a head 
injury. Death occurred at 10.26 p.m. A bilateral subcostal incision was 
made, and the superior mesenteric vein was perfused with 2 litres of cold 
heparinized Hartmann's solution followed by 200 ml. of plasmahicarbon- 
ateldextrose solution. Cold infusion began at 10.30 p.m. An incision was 
made in the right common iliac vein to allow egress of perfusate. The liver 
was removed and placed in cold saline at 11.15 p.m. 
Recipient Operation 
A bilateral subcostal incision was made. The liver was grossly 
enlarged, but there was no evidence of growth on the surface of the liver 
or elsewhere in the peritoneal cavity. There were dense adhesions in the 
region of the aditus. The common bile duct was extremely fibrotic, and it 
was felt that it would be unsuitable for anastomosis. It was therefore 
divided and ligated just above the duodenum. Some purulent material 
discharged form the hilus of the liver; this was cultured. Hepatectomy was 
completed at 11.15 p.m., when the donor liver was removed from the ice. 
The vena cava was anastomosed to the vena cava above the liver, and 
the portal vein was anastomosed to the portal vein end-to-end and blood 
was allowed to perfuse the liver. After 30 ml. of blood had been discharged 
from the inferior vena cava below the liver the vessel was clamped and the 
suprahepatic vena caval clamp was removed. The liver rapidly assumed a 
satisfactory colour of pale pink and normal consistency. The coeliac artery 
of the donor was anastomosed to the hepatic artery of the recipient end-to- 
end. The clamp was removed from the hepatic artery at 12.15 a.m., and 
there was an excellent arterial pulse up to the hilus of the liver, with no 
evidence of kinking or obstruction (Fig. 9). The infrahepatic vena caval 
anastomosis to a Roux loop of jejunum which was brought up through the 
mesocolon. There was considerable bleeding from the jejunal wall in spite 
of the fact that diathermy had been used to open it, but it appeared that the 
all-coats catgut layer had stopped the bleeding. Two grammes of ampi- 
cillin dissolved in 50 ml, of saline was introduced under the diaphragm and 
in the subhepatic space. A Yates drain was brought out through the right 
extremity of the main wound. which was closed in layers. 
The patient's condition at the end of the operation was good, and he 
rapidly regained consciousness. The following day there was severe 
gastrointestinal haemorrhage. which continued in spite of normal clotting 
factors and transfusion of fresh b!ood. Laparotomy was therefore per- 
formed, and the bleeding was found to be coming from the jejunal side of 
the cholecystduodenostom~ The bleeding points were individually li- 
gated and the anastomosis was redone. The transplant biops) taken shortly 
after revascularization showed a well-presened l i ~ e r .  He received. in all, 
7 litres of blood. 4 g ,  of fibrinogen. and 200 mg. of hydrocortisone in 
addition of mannitoi, bicarbonate, and dextrose. No heparin or protamine 
was given. The postoperative course was complicated by further gastroin- 
testinal haemorrhage, jaundice, and peritonitis. Death from sepsis oc- 
curred after three weeks. 
Discussion 
These five cases allow several conclusions to bc made. The 
irreversible ischaemic damage in Case 1 leading to an uncontrollable 
haemonhagic syndrome reinforces the importance of reducing the warm 
ischaemic time to a minimum of 15 minutes between death of the donor and 
cooling of the liver. In the subsequent four cases the donor liver was cooled 
within 15 minutes of death, and in Cases 3-5 with total ischaemic times 
(from death of donor until revascularization with portal blood) of 141, 106, 
and 94 minutes, excellent preservation was achieved by the simple cooling 
that was used (Schalm, 1968). 
The extremely serious liver failure in Case 1 by the time the 
transplantation was performed made the likelihood of success unlikely 
even with a well-preserved and satisfactorily transplanted heterotopic 
liver. Though the splenic fossa provided room for the liver transplant, and 
the anastomoses appeared satisfactory at the time of the operation, the 
venous drainage was inadequate, and the other anastomoses might have 
been compromised if the patient had adopted an upright posture. We feel 
that the orthotopic site is preferable. 
In Case 1, 2, and 5 biliary drainage was to a Roux loop of jejunum. 
This was felt to be preferable to cholecystciuodenostomy, though less de- 
sirable than biliary drainage, which retains the patient's own sphincter of 
Oddi, as in Cases 3 and 4. 
The cause of death in Case 2 was not apparent; however, the child was 
extremely frail and ill, and athe recent rapid development of ascites 
indicated terminal liver failure. 
In Case 3 there were technical difficulties in fitting a small child's 
liver into an adult. The infarction of the transplant, however, was not due 
to the discrepancy in size, since the arterial thrombus arose on the recipient 
hepatic artery where the vascular clamp had been applied. The cholecysto- 
choledochostomy appeared satisfactory and well vascularized at the time 
of operation. 
One patient (Case 4) was less ill than the orhers. The hepatectomy 
was particularly difficult, but he withstood the operation extremely well. 
We are in full agreement with Starzl et al. (1968b) that in humans it 
is unnecessary to shunt blood from the inferior caval and portal systems 
when the patient is anhepatic. It is, however, desirable to have two 
intravenous infusions set up in the superior vena caval system before 
clamping the inferior vena cava, so that the return of blood to the heart can 
be augmented should there be a precipitous fall in blood pressure. 
At present we believe the most suitable cases for liver transplantation 
are patients with primary hepatic or biliary tract carcinoma and biliary 
atresia. Some idea of the number of such cases present in this country was 
obtained by Terblanche and Riddell (1967) from an analysis of the 
Registrar General's Statistical Review of England and Wales for the year 
1964. There were 429 deaths from primary hepatic carcinoma and 1,070 
deaths from primary biliary carcinoma (gall bladder and bile duct) for all 
age groups, with corresponding figurzs for those dying between 0 and 60 
years of 145 and 195. Orthotopic transplantation of the liver is a major 
surgical procedure, and it is unlikely that patients over the age of 60 will 
often be considered, in view of the high incidence of associated disease, 
particularly of the cardiovascular system. About 30% of primarq hepatic 
tumours may have distant metastases by the time of diagnosis. and perhaps 
another third of such patients are treatable by hepatic lobectonly. Carcino- 
mas of the hepatic and common bile duct are often slowly growing and 
metastasize late, so that about 130 to 160 patients from these two groups 
may be suitable for hepatic transplantation each year. 
Biliary atresia. though rare. is another condition with an almost 
uniformly poor prognosis, in which the defect can rarely be corrected sur- 
gically. In the same year in th 0-60 age group there were 490 deaths from 
cirrhosis, 106 from acute viral hepatitis, and 54 from acute hepatic failure 
due to other causes, including drugs. All these are potential recipients. but 
the metabolic derangements of hepatic coma, the portal h)pertension, and 
the frequently attendant renal impairment usuallq present in these patients 
are likely to increase the operative and immediate postoperative mortality 
considerabl>. Operating on patienta with acute ~ i r a l  hepatitis ma) also 
can? grave dangers to the surgical and nursing teams. 
With regard to the avallabillty of donors in 1964 there were 1,135 
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deaths from subarachnoid haemorrhage and primary brain tumour and 
2,478 from motor-vehicle accidents with a fractured skull or head injury in 
the 0-45 age group (Terblanche and Riddell, 1967). In both these groups 
some of the patients are likely to be maintained on respirators until the final 
demise. The patients dying in the older age groups cany a higher risk of 
their livers containing an occult secondary carcinoma. Despite an apparent 
adequate supply of donors, there will be major problems in organization for 
the individual patient, as already outlined. These problems will persist until 
organ preservation techniques have been developed, which will enable the 
donor liver to be preserved for periods of more than two to three hours. 
Though the indications for liver transplantation will be widened in 
the future, at the present time the most suitable cases are adults with fatal 
hepatic disease who are too ill for an independent existence outside 
hospital, but have not yet reached a moribund stage. 
We wish to thank our medical, nursing, and technical colleagues who 
have helped to initate this transplantation programme. We have had most 
generous assistance from so many people that it would be invidious to 
mention individual names. We are particularly indebted to the anaesthet- 
ics, bacteriological, biochemical, pathological, haematological. radiologi- 
cal, and medical illustration departments of Addenbrooke's Hospital and 
King's College Hospital. We thank Mrs. M. Allen for preparing the 
drawings. 
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THE HUMAN TRIALS 
Dr. Gerard Martineau 
Until the publication of this article, there was virtually no mention of biliary complications after 
liver transplantation. The four reported cases were tragic since the obstructions had been neglected 
until irreversible inspissated bile concretions formed. Diagnosis of such complications by tran- 
shepatic cholangiography was not attempted commonly because of the dangers and deficiencies 
of this technique, but this all was to change shortly with the development in Japan of the so-called 
Chiba ("skinny") needle. From this time onward, biliaryobstruction or other complications of bile duct 
obstruction were high on the list of diagnostic possibilities if postoperative hepatic dysfunction 
developed. The flawed procedure of cholecystoduodenostomy was not yet abandoned, but this 
step soon was to follow. 
Martineau is a French Canadian who was afellow at the University of Colorado from 1970 to 1972. 
His present position is Professor of Surgery, Universite Laval, Quebec, Canada. He was unable to 
continue his work in liver transplantation but he has retained a special interest in other kinds of 
hepatic surgery. He is 51 years old. 
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Delayed biliary duct obstruction after orthotopic 
liver transplantation 
Surgery, 72: 604-10, 1972 
G. Martineau, K. A. Porter, J. Corman, B. Launois, G. T. Schroter, W. Palmer, C. W. Putnam, C. G. Groth, 
C. G. Halgrimson, I. Penn and T. E. Starzl 
After orthotopic liver transplantation and bilary reconstruction h j  
cholecystoduodenosromy, four of 40 patients developed delayed ohstruc- 
tion of the cjstic duct. The recipients had the clinical syndrome of 
fulminating cholangitis with jaundice, fever, leukocytosis, toxemia, and 
hacteremia. Allfour patients died: of the four, moparients dieddespite late 
oenteros- reoperation and re-establishment of bile drainage b j  choledo-,h 
tomy. In all four cases, a fac,tor cotltrihutin~ to the biliary obstruction may 
have heen infection of the e,xtrahepatic hiliarj ducts utirh or without 
ulceration, and in three of the li1,ers. there was evidence of infection of the 
ducts u i th  CMV.  If c~holecystoduodenostomy I S  used in future cases, 
prompt re-exploration and conversion to c~holedochoenterostoml. should 
he considered if the diagnosis of duct obstruction, cholan,qitis, and 
persistent hacterenzia are made. 
In our institution biliarv duct reconstruction after orthotovic liver 
transplantation has usually been employed with cholecystoduodenostomy 
after ligation of the graft distal common duct.-After this tqpe of reconstmc- 
tion, chronic survival of both experimental animals and man has been 
achieved. Hoaever,  the present communication uill prerent four ex- 
amples of failure of cholecystoduodenostom) resulting from delayed ob- 
struction of the cystic duct near its junction with the common duct. In each 
instance, the result was death. Evidence will be presented that cytomega- 
lovirus (CMVI infection of the extrahepatic blliarq duct system may have 
contributed to these complications. 
METHODS 
The four patlents underwent the l~ve r  eplacement operation depicted 
In Flg 1. 4 including cholecjstoduodenostomj The) were all treated 
U ~ t h  triple-drug reglrnen that included horse antllj rnphoc! te globulin 
(ALG) and prednlsone The third agent for Pat~ents 1 and 2 uas  
azathlopnne and Pat~ents 3 and 4 uere  treated Instead with cjclophospha- 
mlde 
The patlents u h o  de~e loped  c k i t ~ c  duct obstruction uere aged 16 
months, 14 years, 16 years, and 11 years. Their primary diagnoses were 
biliary atresia (Patients 1 and 3) and chronic aggressive hepatitis (Patients 
2 and 4). 
RESULTS 
Incidence of the complication. The four cystic duct obstructions 
occurred in the first 44 consecutive liver transplantations. Since chole- 
cystoduodenostomy had been performed in only 40 of the 44 recipients, the 
corrected incidence was 10 per cent. 
The  clinical syndrome. At the time of the original transplantation, 
all four homografts secreted bile which welled up in the gallbladder 
through the cystic duct. Good hepatic function with clearing of pre- 
existing jaundice continued during the early convalescence. (Fig. 2) 
After 3 to 22 days. hyperbilimbinemia recurred. preceded by major 
increases in the alkaline phosphatase and accompanied by minor rises in 
the transaminases (Fig. 2). In each of the four cases, rejection was thought 
to be present and has  treated with increased doses of prednisone (Fig. 2). 
In three of the four instances, there u a s  some remission of the secondary 
jaundice (Fig 2 ) .  This u a s  initially interpreted as support for the diagno- 
sis of rejection. 
All of the patients became remittently febrile with the onset of liver 
function aberrations. Shortly after, bacteremia was detected in multiple 
blood cultures (Fig. 2). The microorganisms a e r e  those indigenous to the 
gastrointestinal tract, being predominantlk gram-negati~e pathogens 
(Table I) .  Once the bacteria appeared in the bloodstream, blood cultures 
remained positive until death in spite of antimicrobial therapy. The patients 
appeared toxic uith marked tachycardia accompanying the fever spikes. 
Leukocytosis (as high as 50.000 per cubic millimeter) and thrombocy- 
topenia (as I O N  as 5,000 per cubic millimeter) uere  invariably noted (Fig. 
LJ. 
Each patient had seLeral l i ~ e r  scans. In Patient I. partial gangrene of 
the right hepatic lobe occurred after thrombosis of the right hepatic artery; 
the necrotic area d ~ d  not pick up the technetium isotope. The other three 
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Fig. 1.- Biliary duct reconstruction with cholecystoduodenostomy. A, Surgical technique. B, 
Operative cholangiogram in a patient who developed jaundice almost three months after orthotopic 
transplantation. In this case, obstruction was ruled out. 
Wit I .  Clinical features of four patients wi th  posttransplantation biliar). obstruction 
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homografts had minor abnormalities but not in any distinctive pattern. 
Efforts a t  surgical correction. In Patients 1 and 3, a re-exploratory 
operation was performed. By insertion of a ballon catheter into the 
gallbladder (Fig. 3, A and B ), the duct system was re-evaluated. Although 
the gallbladder and cystic duct were collapsed, the common duct and the 
intrahepatic ducts were dilated (Fig. 3, C ). The liver had multiple soft areas 
which proved upon aspiration to contain a bacteria-laden thin fluid. The 
gallbladder was removed and choledochoduodenostomy was performed. 
After operation, there were falls in the bilirubin (Fig. 2). but both patients 
died of uncontrolled sepsis. 
Pathologic observations. At autopsy from 31 to 105 days after 
transplantation, there was a chalklike, c ~ m b l y  debris which formed casts 
in some of the dilated intrahepatic ducts of all four livers (Table 11). The 
cystic ducts were small in Patients 1 and 4, similar to the findings previ- 
ously demonstrated at reoperation in Patients 2 and 3. 
Patient 1 had a complete thrombosis of the right hepatic artery with 
consequent gangrene of the right lobe of the liver (Table 11). In Patient 4, 
an abscess of the right hepatic lobe, which was in free communication with 
the dilated right main hepatic duct, had ruptured through the liver into the 
subphrenic space. 
At the time of reoperation or at autopsy, bits of gallbladder were 
obtained. Histopathological evidence of chronic cholecystitis was found in 
three of the four gallbladders (Table 11). There was widespread ulceration 
of the lining epithelium in Patients 1 and 4 and focal ulceration in Patient 
- - - -- - - - - 
3. These three gallbladders also showed infiltration of the submucosa by 
mononuclear cells and polymorphonuclear leukocytes and replacement of 
the muscle by fibrous tissue. Intranuclear inclusions resembling those 
produced by cytomegalovirus (CMV) were present in many of the mucosal 
eoithelial. submucosal eoithelial. and connective tissue cells of the cystic 
Postopcratir e I 
jound~cc recur- I Maximum 
rtnce (days  I srcondar) bili- 
af ter  trans- , rubln rise 
ducts andgallbladders frbm Patients 2,3,  and 4 (Fig. 4). Groups of enlarged 
virus-infected cells that had been shred were present on the gallbladder and 
duct mucosal surfaces and in the lumens. 
The liver homografts from Patients 1.3, and 4 showed clear evidence 
of large biliary duct obstruction. The portal tracts were enlarged and were 
lightly infiltrated with mononuclear cells and polymorphonuclear leuko- 
cytes. There was proliferation of small bile ducts and ductules. The ducts 
were dilated and some contained inspissated bile. Bile lakes were present 
in Patients 1 and 3. Centrilobular cholestasis was marked in Patient 1 and 
slight in Patients 2 and 3. There was marked chronic cholangitis in Patients 
3 and 4. Cells with CMV-like intranuclear inclusions were present in the 
hepatic homografts of Patients 2,3,  and 4. None of the homografts showed 
clear evidence of past or active rejection, although IgM and Clq were 
present in some of the vein walls of the graft in Patient 1. 
Many cytomegalic inclusion cells were present in the alveolar 
epithelium of the lungs of Patients 2,3,  and 4 at autopsy, and in some of 
the hepatocytes and bile duct epithelialcells of the liver removed at the time 
of hepatic transplantation from Patient 2. 
Viral studies. CMV was isolated from the liver homografts, and 
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Fig. 2.- The course of a 16-year-old recipient of a hepatic homograft (Patient 3). Although liver 
function was satisfactory initially, hyperbilirubinemia developed 15 days after operation, but receded 
slightly with intensification of immunosuppression. Systemic iepsis prompted re-exploration, at which 
time a cholangiogram (Fig. 3, C) was obtained and biliary diversion was converted to choledochoduo- 
denostomy. However. the child died of uncontrolled sepsis 16 days after transplantaion. 
several other tissues obtained at autopsy from Patients 2.3, and 4. In Patient 
2, the virus was also cultured from the patient's o a n  liver which had been 
removed two months previously. Typical intranuclear and intracytoplas- 
mic virus particles were found on electron microscopic study of the 
cytomegalic cells from some of these tissues. 
DISCUSSION 
Extrahepatic biliary obstruction after orthotopic liver transplantation 
has been noted before, but it usuallq resulted from technical errors or from 
the recurrence of ma1ignancy:Delayed cystic duct obstruction of the kind 
herein reported has been decsribed' in only one patient, the same child (OT 
12) as Patient 1 .  Three more examples habe nou been encountered, giving 
an incidence of 10 percent In our serles for this lethal complication. 
In each of the four instances. bile drainage seemed satisfactory at the 
time of operation, and. furthermore. it was free enough to permit clearing 
of pre-existing hyperbilirubinemia during the initial convalescence. Then, 
3 to 22 days postoperatively, jaundice deepened. Rejection was diagnosed 
and treated with increased doses of prednisone. 
The diagnosis of rejection seemed supported in three of the four cases 
by the partial re\ersal of the secondaq hyperbilirubinemia. Nevertheless. 
even these three patients continued to have lob-grade jaundice. All four 
recipients became febrile and developed bacteremia and leukocytosis. The 
clinical picture of life-threatening cholangitis a a s  noa  complete. All of the 
recipients e\entuall! died from intrahepatic and systemic sepsis; two 
patients died in splte of reoperation and secondar) construction of chole- 
dochoduodenostom). In the latter t u o  patients. the provision of adequate 
biliarq drainage \+as too late since multiple foci of infection within the liver 
here  dread) ae l l  established. At either autopsy or reoperation, the 
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Fig. 3.- Cholangiography of hepatic homograft. A and B, Technique of dye injection through a 
duodenotomy and the anastomosis. C, Obstructed duct system in Patient 3. 
11. Pathological f ~ a t u r e ~  of foirr obstrz lc t~d Ire.pn~ic Izo~,~ogra/ts* 
intrahepatic ducts and common ducts of the four homografts had become 
remarkably dilated and filled with bile and a soft chalklike debris. There 
was collapse of the cystic duct and gallbladder. 
The etiology of the biliary obstruction probably involved other 
factors than simple positional distortion at or near the junction of the 
common and cystic ducts, since the mechanical arrangement in each case 
was initially satisfactory for bile drainage. It is possible that acute rejection 
played a precipitating role with swelling and consequent occlusion of the 
cystic duct lumen particularly very early in convalescence. With partial 
reversal of the process, as seemed to have been achieved in three of the four 
patients by intensified immunosuppression, bile flow through the chole- 
cystoduodenostomy could have resumed, although suboptimally. How- 
ever, in the specimens examined at reoperation or autopsy, there was no 
real evidence to indict present or past rejection in etiology of the delayed 
obstruction. 
In contrast, the development of cholecystitis or viral inclusion 
disease in the homograft gallbladder could have been a factor particularly 
after the first few weeks. One or both lesions were present in the gallblad- 
ders of each of the four cases. In one patient, there was evidence that the 
cytomegalic disease was established before hepatic transplantation. The 
viral infection might have been particularly significant because, recently, 
it has been shown that infection with a Papovavirus of the epithelial cells 
lining a homograft ureter can produce obsuucti~n.~ The obstruction in 
Liver 
Hepat ic  I Intra-  / Cyton:eg -  j . 
cases of either renal or hepatic homografts could presumably be secondary 
to the kind of ulceration with or without healing that CMV can produce in 
the urinary or gastrointestinal tracts'or by the shedding of swollen cells 
containing intranuclear viral inclusions which could contribute to the 
obstructing debris. Whatever the exact mechanism, the small cystic duct 
would be preferentially susceptible to the mechanical consequences of all 
events. 
One way to minimize biliary obstruction of the kind documented in 
this report would be to abandon cholecystoduodenostomy as the primary 
means of biliary reconstruction and, instead, to employ one of the standard 
techniques of common duct anastomosis combined with cholecystectomy. 
Unfortunately, the methods employing the common duct have also carried 
a high risk after liver transplantation, mainly because of anastomotic 
leak.'.4 Moreover, a secondary operation to correct such a leak provides 
limited options, since the prior removal of the gallbladder eliminates the 
possibility of delayed cholecystenterostomy. Finally, the use of the com- 
mon duct for anastomosis would not preclude obstruction secondary to 
infestation by CMV. If this virus proved to have an important causal 
relationship to duct obstruction, amore sensible approach would be to con- 
sider antiviral treatment as, for example, with cytosine arabinoside. Under 
immunosuppression, it is known that a very high percentage of whole 
organ recipients are chronic carriers of CMV although until recently there 
has been little evidence that this virus causes important sequelae. 
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Fig. 4.- Obstructed cystic ducts of hepatic allografts in Patients 2 (A) and 4 (B). The wall 
(W) of each duct is lined by swollen epithelial cells which contain cytomegaloviral inclusions. 
Some similar cells lie free in the lumen (L) of each duct. (Hematoxylin and eosin. X900.) 
It is our present view that cholecystoduodenostomy is still the safest 
way to reconstruct the biliary system initially after liver transplantation, 
since the procedure can be done without internal stents or drainage and 
because it bums no anatomic bridges if reoperation becomes necessary. 
However. with cholecvstoduodenostomv. there must be a firm commit- ,, 
ment to perform a re-e;ploratory operation for very specific indications. 
These indications consist essentially of the clinical features of cholangitis, 
including evidence of obstruction, a septic course, and, above all, p&sis- 
tent bacteremia. The first two of these findings can be seen with simple 
rejection, but continuous bacteremia should raise the highest suspicion of 
a surgically correctible complication. At operation, the cholecystoduo- 
denostomy could then be converted to choledochoenterostomy if war- 
ranted by the findings of transduodenal cholangiography. In two of the 
presently reported cases, the significance of the bacteremia was not 
appreciated until autopsy, and in the other two corrective surgery was 
delayed so long that all hope of succes was lost. 
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THE HUMAN TRIALS 
This article was presented at a tribute to David Hume in Richmond, Virginia, almost one year 
after Hume's death in an airplane accident. New information was given including: recognition that 
biliary tract complications were occurring from inappropriate techniques of biliary reconstruction; 
a description of the resistance of the liver to hyperacute rejection from pre-formed antibody states; 
a description of a third chimpanzee-to-human heterograft; and a discussion of the effect of native 
liver disease on the outcome of transplantation. All of these lines of inquiry were followed in the 
succeeding years. 
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Progress in and deterrents to orthotopic liver transplantation, 
with special reference to survival, resistance to hyperacute 
rejection, and biliary duct reconstruction 
Transplantation Proceedings, 6: 129-39, 1974 
T. E. Starzl, M. Ishikawa, C. W. Putnam, K. A. Porter, R. Picache, B. S. Husberg, C. G. Halgrimson and G. Schroter 
Before I begin, I want to add my own personal reminiscence. I knew 
Dave Hume for almost 14 years, slightly for the first 4 and well for the last 
10. I first talked to him at an elevator entrance at the Greenbrier Hotel in 
West Virginia, in April, 1959, and for the last time in April, 1973, in the 
lower lobby of the Century Plaza Hotel in Los Angeles. In May, 1973, I was 
in the railroad station in Albuquerque, New Mexico, when I learned from 
my grief-stricken youngest son that Dave was dead. It is strange how the 
exact details of these and some other memories in between. of the time I 
spent with Dave Hume, stand out with the same clarity as what I was doing 
when I learned of the bombing of Pearl Harbor, the assassination of John 
Kennedy, but very few other things. The most eloquent tribute to Dave 
Hume I have heard was the briefest, coming from anon-medical friend who 
told me sadly," He really was a dynamite guy!" 
There is almost no aspect of clinical organ transplantation into which 
Dave Hume did not breathe life. Liver transplantation was no exception. 
It will surprise no one that his contribut~ons were important and concisely 
stated. although never published. He gave his obsewations to one of us 
(T.E.S.) as personal communications throughout the years and granted 
permission for their use in a book published 5 years ago. They should be 
listed briefly. 
Hume performed one of the earliest auxiliary hepatic transplanta- 
tions, to the splenic fossa of a recipient whose abdomen could not 
accommodate the extra organ plus the host liver. Undaunted. he proceeded 
to remove the total native liver. In another trial. this time \\ith orthotopic 
transplantation, Hume described hyperacute rejection. which if it was a 
valid diagnosis was the first on11 documented example of this complica- 
tion des t ro~ing a liver homograft. Finall), one of Hume's recipients who 
had a hepatoma plus cirrhosis l i ~ e d  for about a year postoperatively after 
liver replacement. eventually dqing v, ith v, ~despread metastases similar to 
those we have recorded after hepatic transplantation for the indication of 
ma l ignan~y .~  
There is no point in sa!, ing more about these experiences of Hume, 
since, important as they were, they were really peripheral to his main 
interests. Instead, I would like to discuss three aspects of orthotopic liver 
transplantation that might introduce either new data or new ideas. These 
concern our survival statistics, hyperacute rejection in livers, and the 
problem of biliary duct reconstruction. 
Survival Statistics 
According to the April 1974 report on liver transplantation being 
prepared by Dr. Carl G. Groth for the American College of Surgeons Reg- 
istry, about 200 patients have had liver replacement.: Since 1963 we have 
contributed 82 to this total, at a rate since 1967 ranging from 6 to 13 per year 
(Table 1). We have had 18 and 9 recipients, respectively, who have lived 
formore than 1 and 2 years. Thirteen recipients are still alive from 2 weeks 
to almost 5 years postoperatively. The 3 longest survivors are 4 years, 10 
Table 1 .  Cuus of or tho top^ Liver Transplantation 
T r w t d  in Denver 
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Table 2. C w n t  Status o f  18 One-Year S u n i r o n  
after Orthotopic Liver Tmnsplantation. Eight A n  
Still Al ive from 14 to 58 Months. The Other 10 
Even?uolly Died from the C o u u s  Listed Below 
OT T8me 01 5wtk 
Humbr !months Cause of Dwth 
15 12 Recurrent cancer 
29 12 Serum hepotitus and liver failure 
8 13 Recurrent cancer 
58 13 'C1 ?Chronic reject~on 
?Recurrent hepotitus 
16 13% Rejedion and liver failure 
14 14 Recurrent cancer 
54 19 Multiple liver abscesses neces. 
sitotlng retransplantotion 
36 20 Systemic Nwardro infection dnd 
chronic oggresslve hepotitls 
13 30 Releetion and l ~ r e r  failure tollow. 
ing retransplantotion 
19 41 Hemoph;lvs wpticemio and =on. 
dory liver and renal failure 
months; 4 years, 4 months; 3 years, 10 months; and 3 years, 2 months. 
There have been 10 late deaths, from 12 to 41 months postopera- 
tively, and for the reasons listed in Table 2. The latest mortality was at 3 
years, 5 months, following a bout of Hemophilus septicemia (OT 19). The 
homograft arteries contained the same kind of occlusive lesions that have 
been seen in renal transplants.' 
The causes for the high acute failure rate have been discussed 
elsewhere.' The single most important factor has been a multiplicity of 
technical misadventures of which complications of biliary duct recon- 
struction lead the list (see next section). Poor control of rejection and 
systemic infection are the next leading causes of death. 
The Strategy of Bile Duct Reconstruction 
As was just mentioned, the Achilles' heel of liver transplantation has 
been biliary duct reconstruction. The different techniques we have used to 
restore bile drainaee include choledochocholedochostomv with or without 
'2 
a T tube (not applicable with biliary atresia), cholecystoduodenostomy 
after ligation of the graft common duct, and choledochoduodenostomy. 
~ e c a u s e  of continuing dissatisfaction with all of the aforementioned 
techniques of duct recontruction, we have recently embarked on a trial of 
Roux-en-Y cholecystojejunostomy (see later under Possible Solutions). 
The lethal complications with most or all of these procedures were of two 
general kinds, one obvious and proved and the other subtle and still 
speculative. 
Table 3. K ind  of Primary Bile Duct Ruconstwctian Used in 
82 Consecutive Cases of Orthotopic L i v o  1 mnsplontotion 
Rev. e r - Y  Cholccysto 
Chokcytoduo- Chokdochocho. Cholccjstole- Choledochoduo- Loop 
dmostorn~ kdochostomy lunortorny de-ortomy klvnostomy Tota! 
Number 59 9 8 4 2 82 
Obsiruction 15 0 2 0 0 17' 
Fistub 2 5 0 1 0 8' 
'In these 25 caws, reoperotions were performed in 13 pattents with o?iempt at duct reconstruct~on. A satisfactory r e  
ccvery fdowed in only 4 of the ruipierits Two loter died aher 6 and 13b months port.tronsplontat~on survival. The other 
ore olive after 3 months and 2 yeors, respea~vely. Both survivors now hove the Cnol biliory dud reconstruction shown in 
g 2C. 
Yomograft l~lrer 
Fig. 1.-Two kinds of biliary duct obstruction aftercholecystoduodenostomy. (A) The anatomic basis for a technical error that cost the life of 3 patients. 
Distal ligation of the double-barreled extrahepatic duct system resulted in total biliary obstruction. This recurrent accident has caused us to perform 
cholangiography on all liver homografts before transplantation. (B) The kind of biliary obstruction caused by stenosis of the cystic duct. Martineau reported 
that cytomegalovirus infection of the duct could be responsible for this development." 
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Fig. 2.- Schematic representation of the bacterial contamination or lack thereof in three different kinds of biliary reconstruction. (A) Cholecystoduo- 
denostomy. This extremely simple operation probably carries the greatest risk of graft infection. (B) Roux-en-Y cholcystojejunostomy. This operation 
protects from hepatic sepsis by placing the new liver outside the main gastrointestinal stredrn. The isoperistaltic limb is made at least 18 in, long. (C) Roux- 
en-Y choledochojejunostomy. The end-to-end duct-to-bowel anastomosis is s~mple  ~f the duct is dilated, as would be the case if a conversion became 
necessary from B to C. 
Starenlent of the Problem 
Mechanicalprohlems. The obvious biliary duct problems have been 
obstruction and biliary fistula from anastomotic leaks. In our 82 cases of 
orthotopic liver transplantation the initial biliary reconstruction was even- 
tually shown to be unsatisfactory. leading either to death or early reopera- 
tion in 25 cases (Table 3), for the staggering incidence of 30%; the true 
frequency h a s  undoubtedly even higher, since many patient\ died so early 
postoperativel) that an incipient duct problem would not )et have been 
manifested. In 13 of the 25 recipients an effort h a s  made at secondary 
repair. Even in these I3  reoperated cases the b~liarq duct problem was an 
important contributor?, or the main cause of death in at least 9. 
None of the comnionl! u\ed methods of biliar) duct reconstruction 
h a s  trouble-free (Table 3). LVlth cholec!stoduodeno~torn!. fistulae were 
uncommon. but ob\truction occurred In 2.iC> of cases. The obstructions 
ranged from accidental acute ligation of the c!\tic duct before performing 
cholec)stoduodenostom (Fig. 1.A) to delaled obstruction (Fig. IB) of the 
c)stic duct in borne cases, apparent15 due to c!tornegaloilrus (CMV) 
infection ueeks or months postoperati\el!.- %lost cornmonl!. no obvious 
etiologic cau\e ha5 s\ident. accounting for the partla1 c ~ s t ~ c  du t obstruc- 
tion. With choledochochoiedochostoi~i~ or cholsdochoduodenostomy the 
leading complication bar b~llar! fistula fomiation. 
There were two obstructions with Roux-en-Y cholecystojejunos- 
torny. In one, the kind of cystic duct ligation shown in Fig. IA had not been 
recognized and was not diagnosed until autopsy. In the other case, there 
was partial obstruction (Fig. 3B) of the cystic duct necessitating conver- 
sion of the ultimate hookup shoan in Fig. 2C). 
Special bacteriologic i~ompl~c~utionr. With the well-defined techni- 
cal complications cited above. clinical evidence of cholangltis (including 
bacteremia) 1s easily understandable and is often accompanied by histopa- 
thologic findings of cholangitis. In addition. a subtle and as yet hypotheti- 
cal complication ma) occur in spite of an apparently satisfactor). biliary 
duct reconstruction. It has been reported by us that systemic infection and 
even as!mptomatic bacterem~a are common prohlems In liver recipients.' 
For )ears there has been 5trong ju\tificatlon to believe that the transplanted 
liver Itself mas the portal of entrq b) uhich microorganismi of all kinds 
gained access to the bloodstream. The variety of bacteria that were cultured 
from peripheral \ein\ of patients, both early and man! months after 
operation. has  5triklnglk s~miiar to that found in dogs and pigs subjected 
to li\er injur! or hepatic transplantation.' In the human liver rec~pients with 
bacteremia the failure to flnd an! other focus of infection necessitated 
indictment of the homograft (a5 a \Ite of entr) ) by the procejb of exclusion. 
The t h o  router ofentr) could be the portal ~ e i n  or the duct \)stem. but the 
former possibilit! seems less and less ~ n ~ p o n a n t .  
The exposed relation of the duct \?item of the orthotopic liver to 
gastrointestinal flora is probably the first step in bacterial "leak" through 
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Fig. 3.- Post-transplantation cholangiographic studies. (A) Intravenous cholangiogram in a 47-year-old recipient of a hepatic homograft, the biliary 
drainage for which was with Roux-en-Y cholecystojejunostomy (Fig. 2B). The patient's liver function studies were normal at the time of the examination. 
However, the findings of a very slightly dilated common duct and air in the biliary system (arrows) are suspicious for low-grade obstruction. (B) A 
percutaneous transhepatic cholangiogram performed 4 weeks post-transplantation because of persistent elevations of the serum bilirubin (8- 10 mg1100 ml). 
At the time of transplantation, biliary drainage had been established with a Roux-en-Y cholecystojejunostomy (Fig. 2B). After obtaining this study, the patient 
was re-explored, the gallbladder removed, and the Roux limb anastomosed to the dilated common duct (large arrow), as shown in Fig. 2C. The patient's 
jaundice rapidly cleared, and he now has normal liver function 3 months post-transplantation. GB, gallbladder; CD, common bile duct; C, cystic duct. 
the homograft, which may well be bacteriologically porous without the 
presence of histopathologically significant cholangitis. This situation after 
cholecystoduodenostomy is depicted in Fig. 2A. If bacteria enter the 
circulation through the duct system of hepatic homografts, the logical 
solution would be to cany out liver transplantation as far removed from the 
mainstream of the gastrointestinal tract as is possible, as has been illus- 
trated in Figs. 2B and 2C. 
Practical Solutions 
The five guiding principles we are now attempting to follow are: (1) 
avoidance of stents or drains; (2) preservation of maximum extrahepatic 
biliary duct tissue; (3) intensification of diagnostic efforts to differentiate 
between duct obstruction and rejection, including performance of 
cholangiography in all homografts prior to transplantation; (4) early 
reoperation for suspicion of obstruction; (5) placement of the liver in a 
relatively bacteria-free relation to the mainstream gastrointestinal continu- 
ity. None of the presently available operations completely meets all of 
these objectives, so that considerable individualization of care is neces- 
sary. 
A Roux-en-Y cholecystojejunostomy (Fig. 2B), our present proce- 
dure of choice, permits all the above listed objectives to be partly met. If 
postoperative biliary obstruction later develops, the Roux limb can be 
detached, the gallbladder removed, and an anastomosis performed to the 
now dilated common duct (Fig. 2C). 
The most important objection to this approach is that a Roux-en-Y 
cholecystojejunostomy can be an extremely difficult added procedure at 
the end of a long and arduous liver transplantation. The typical adult liver 
recipient is dying of hepatic failure and has massive collaterals in the small- 
bowel mesentery. In addition, the mesentery is usually thickened and wa- 
terlogged with edema fluid. Construction of a Roux-en-Y isolated limb 
under these conditions may require 3 to 6 additional hours of operating 
time in a patient who has already sustained thousands of milliliters of blood 
loss. Under these adverse conditions, it may be the better part of valor to 
perform a simple cholecystoduodenostomy with the objective of returning 
later. 
If at the time of transplantation the gallbladder were found to be 
defective, we would then make a selection between choledochocholedo- 
chostomy with T-tube stenting, and a Roux-en-Y choledochojejunostomy. 
No matter what the initial procedure, an intense suspicion about the 
cause for postoperative jaundice is a necessary condition of postoperative 
management. The simplest precaution is to perform routine intravenous 
cholangiography in the early postoperative period (Fig. 3A). In almost all 
of our patients who develop jaundice, transhepatic cholangiography (Fig. 
3B) and percutaneous needle biopsy are now performed. Cholangiography 
has been greatly expedited by our use of the Chiba needle introduced in 
Japan6.' and now being used in several American centers. These thin- 
walled small-caliber needles have great flexibility that permits the diag- 
nostic studies to be done with an improvement in safety (Fig. 3B). 
It is not yet established that these changes in policy will improve the 
results after liver transplantation. Our approach is fundamentally different 
from that proposed by Calne, who believes that duct-to-duct reconstruction 
over a T-tube and preservation of the sphincter of Oddi will be the better 
so lu t i~n .~  The fact that different methods are being tried to solve a 
generally recognized set of problems should be of advantage in evolving 
solutions that can eventually be agreed upon. 
Hyperacute Rejection 
The pathophysiology of hyperacute rejection has been well worked 
out in recent years. Fixation of antibody to the transplant is apparently the 
initiating event, as was first noted in kidney homografts after breaches of 
red-blood-type b a n i e r ~ . ~  In later years the predominant cause of hyper- 
acute rejection has been the presence in the recipient of antigraft cytotoxic 
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Table 4 .  T h r n  Cows of Orthotopic Tronsplontotion of ABO-incompatible L iven 
59 11/12 & I ~ o v  atreslo AB - A 1 4 (ontl-B' 173 Septlcemlo (from (Arte-iol and arteriolar 
llrcr7) norrowlng (port repct~on) 
60 46 Primary blllory AB4 A 1 32 (on,) B) 61 Septlcem~o (from Mild cyiomegolonrol In- 
c~rrhos~s I~ver?; fect~on 
P u l m o n o ~  emboli No rejectton 
61 42 Postnecrot~c A 4 0  1 5 1 2  41 Dissem noted herper Cytomegolonrur ~nfectton 
cirrhos~s (ant1.A) ond cytomegolo No  relect~on 
vlrur 
Pulmonory emboll 
Brain ~nforct~on 
antibodies, as was first described by Terasakil0 and confirmed by Kiss- 
meyer-Nielsenl' and others.12 " 
In experimental animals of widely disparate relationship, an experi- 
ment of nature with hyperacute rejection may be constructed, as for 
example in transplanting organs from pigs to dogs."The serum of dogs 
contains heterospecific antiporcine cytotoxic antibodies. 
With either homografts or heterografts transplanted to recipients that 
possess preformed antigraft antibodies. the actual destruction of the 
homograft or heterograft is a complex process in which formed blood 
elements and clotting factors are entrapped by the graft." '' The resulting 
occlusion of the major vessels causes ischemic necrosis and a characteris- 
tic purple or mottled appearance. 
It is probable that the kidneys. because of the special filtering 
properties of the renal microvasculature, are unusually prone to the 
irreversible consequences of hyperacute rejection. In contrast, the liver 
may be unusually resistant, as the abilit) of pig livers to perform rudimen- 
tary functions for a number of hours while being perfused with human 
blood might have predicted. 'Tven in the difficult pig-to-dog heterograft 
model in which kidneys are grossly rejected in a few seconds the liver often 
does not suffer this fate for more than an hour." 
The resistance of the liver to hyperacute rejection may prove to be 
Table 5 .  &rial Antigraft Isoagglirtinin T i ten in the 
T h m  Recipients of ABO-incompatible L iven 
D e ~ r i b d  in  Table 4 
sufficiently great to permit transplantation under conditions that would be 
categorically unacceptable for kidneys. If so, an important stricture on the 
practicality of the procedure will be eased. Patients dying of liver disease 
usually cannot wait for an ideal homograft. If transplantation could be 
conducted in spite of preformed antibody states, patients deprived in the 
past of a trial at treatment would no longer be arbitrarily excluded. In this 
connection. our previously unreported experience is of potential interest. 
ABO incon~patihiiir?. In 1972, 3 patients with ABO-mismatched 
livers were transplanted to recipients whose conditions were considered 
sufficiently grave that the) could not wait (Table 4). Hyperacute rejection 
did not occur. and no obvious adverse consequence5 uere  seen. The titers 
of antigraft isoagglutinins were highly var~able. and at least in one Case 
reached prodigious levels (Table 5 ) .  Eventually the three patients all died, 
but the pathologic findings were remarkabl) minor. The homograft of 1 of 
the patients (OT 60) became partially obstructed by the mechanism of 
cystic duct stenosis shown in Fig. 2B: following biliary reconstruction, the 
recipient died of pulmonar) sepsis. The other 2 patients had almost no 
abnormalities in their livers when they died of infectious complications. 
C?..totoxic anrihodies. This ability of the liver to remain healthy under 
conditions that would be predictabl! harmful to most kidneyr is a notewor- 
thy feature that has been seen in xhe r  preformed antibody situations. 
During the last 2 years. 3 patients with antidonor cytotoxic antibodies have 
been given livers. In all 3 cases cytotoxins were also present against most 
of the donors of an indifferent lymphocyte screening panel. Thus the 
prospects of finding a liver without a positive cytotoxic antibody cross- 
match were considered nil. As a consequence. a decision was made to 
proceed despite the potentially adverse prognostic implications. 
None of the 3 patients developed hyperacute rejection, although they 
all eventually died from 3 - ID  weeks to 13-112 months later (Table 6), in 
2 cases with relatively good livers. In OT 7 I .  the homograft ieemed to have 
been severely damaged b j  ischemia, as well as cellular rejection, although 
its poor initial function could ha\e  been a manifestation of acute antibody- 
mediated injur).. After 10 d a ~ s  the organ was remobed and replaced by a 
chimpanzee heterograft. against which the recipient c)totoxins also re- 
acted. The chimpanzee liver functioned for most of the I? subsequent days 
of the patient's life. Upon pathologlc examination the initial homograft had 
many focal areas of necrosis compatible ki th  the diagnosis of ischemic 
injury. In contrast, the heterograft u a s  hel l  preserved. Centr~!obular 
cholestasis was a prominent feature. Other~bise, there a a s  little evidence 
of rejection. This uas  our third trial of chimpanzee-to-man heterotrans- 
plantation, the other t h o  havlng been previousl> reported. ' -  
It goes without sallng that preform:d antibod) states should be 
avoided if at all possible. Hohever,  the experience cited both w ith the ABO 
red cell and cytotoxic antibodies makes it possible that thls kind of positive 
cross-match is not an absolute but only a relative contralndicat~on for liver 
transplantation. 
Summary 
An account of 82 conse:utive pnhotopic liver transplantations car- 
ried out in Colorado is given. ':ighteen patients have lived for 1 year post- 
operatively, and the longest survival is almost 5 years. 
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vegetable whose systemic support was eventually discontinued. The 
second case was a child with biliary atresia who had a perfect result and 
who died some 7 months later from the kind of complication that appar- 
ently killed Roy Calne's long-surviving patient last week, and which killed 
one of our longest survivors, namely septicemia. The third combination 
was an AB to A death that occurred about 2 months or so postoperatively, 
and followed an attempt to correct a biliaq duct obstruction. I think these 
cases had no evidence of antibody damage. As to the 3 with cytotoxins, 
only case 3 might have had antibody damage. In that liver there are findings 
that could be explained by immunologic or ischemic damage. I am 
fascinated by Calne's case with the high-titer cytotoxins, and although one 
might become incontinent at the moment of revascularization I think I 
might try confronting a cytotoxic cross-match again if I really had to do it. 
Dr. Wolf: Just two more general questions. One, what is your current 
feeling on transplanting for malignant disease? And secondly. how about 
your current immunosuppression for these patients? 
Dr. Starzl: I think the patient with malignant disease is a bad risk, but 
it's obviously a matter of judgment as a clinician when you are confronted 
with a case; in spite of all kinds of resolutions about not wanting to do  more 
tumor cases you end up treating the patient. Not long ago I had such a 
patient with a duct-cell carcinoma. I was skiing in Aspen at about the time 
the patient arrived, and when a donor became available I did him because 
there was a donor and because it obviously was his only chance. As a matter 
of fact. I have thought for a long time that this kind of neoplasm might be 
a good indication because the tumor itself is so small. At the time of the 
liver replacement in the case I just mentioned, I never had a positive tissue 
diagnosis until the case was all finished. Even then the pathologist had to 
go on a detective hunt to find the tumor. It was very small and partly 
necrotic. The cases that we have had difficulty with have been the 
hepatomas that %ere already big. Even then we knon that it is possible to 
effect a cure. Roy's case has demonstrated this. We have a child at 4 years, 
4 months who obviously represents a cure of a hepatoma, and there are 
some others around. A few. So I think that under properly defined 
circumstances it would be reasonable to do a few of these, and so I don't 
have a closed mind about it. 
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Wlllam R Waddell 
William R. Waddell was Chairman of the Department of Surgery at the University of Colorado, 
and he witnessed the many complications from biliary tract reconstruction in liver recipients. He 
proposed a technique that subsequently was used routinely by Calne in Cambridge. Ironically, it was 
not tried by the Colorado-Pittsburgh surgeons until much later. In 1972, Waddell left the chairman- 
ship at the University of Colorado, and, in 1985, he retired from university life to a busy private 
practice in Silver City, New Mexico. 
Today Grover is Professor of Surgery at the University of Texas Health Sciences Center at San 
Antonio and Chief of the Cardiothoracic Service at the Audie Murphy Memorial Veterans Administra- 
tion Hospital. From 1 July, 1966 through 30 June, 1970 he was a resident in surgery at the University 
of Colorado. 
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The gallbladder as a conduit between the liver and intestine 
Surgery, 74: 525-9, 1973 
William R. Waddell and Frederick L. Grover 
The use of the  gallbladder as a connecting conduit bewteen the pro 
imal bile duct system and the intestine has been described and illustrated 
by patients with traumatic injury of the bile ducts and inoperable carci- 
noma ofrhe pancreas in whom this method njas utilized. It is suggested that 
some of the problems of bile duct reconstruction after orrhotopic liver 
transplantation might be amenable to solution by this technique. 
The gallbladder is commonly used to allow biliary drainage into the 
intestine. Its accessibility is advantageous. However, there are sometimes 
difficulties.The cystic duct may be very narrow or actually stenotic from 
previous inflammation. The valves of Heister are a potential source of 
obstmction. Tumor may encroach upon the cystic duct or be so near as to 
make it unacceptable when attempting palliation. Trauma or infection may 
have destroyed the segment of the common bile duct from which the cystic 
duct arises. Also for the special needs of hepatic transplantation and 
reconstruction after Whipple operations, a low entry of the cystic duct may 
preclude use of the gallbladder if the cystic duct is to be used as a 
connecting conduit between the common bile duct and the gallbladder.' ' 
Even if bile and contrast material drain into the intestine ia the cystic duct 
and gallbladder, there may be back pressure. 
Methods 
To circumvent these and other difficulties. the infundibulum of the 
gallbladder has been anastomosed to the right hepatic duct on one occasion 
and the common hepatic duct in three cases (Fig. 1 ). These procedures were 
straightforward and the functional effect seems to be excellent. Recent 
reports from transplant surgeons' ' indicate that there may be a wider use 
for this approach to the problem of bile duct reconstruction and other 
possible applications are suggested by the following four cases which 
illustrate the actual and potential utility of this procedure. A description of 
the previous use of this exact procedure has not been found. but a recent 
report by Javara and associates'describes creation of a tube from the 
gallbladder. The presently described technique is less complicated and 
appears to be the same functionall). 
Case  Reports  
Case 1 (C.G.H. No. 333643). A 16-year-old female was admitted to 
Colorado General Hospital in December, 1968, shortly after an automobile 
accident in which she was thrown against the dashboard. Because of mild 
shock and signs of peritoneal irritation a laparotomy was performed and a 
ruptured spleen was removed. The only other abnormality was a retroperi- 
toneal hematoma involving the tissues about the duodenum. A Kocher 
maneuver and careful inspection of the area failed to reveal the source of 
bleeding that had caused the hematoma. A drain was placed into the 
dissected area. 
Twenty-four hours later bile began to drain to the exterior. Radiol- 
ogic studies failed to clarify this situation and accordingly the patient was 
returned to the operating room for a second 
exploratory operation. The bifurcation of the common hepatic duct was 
avulsed from the right and left hepatic ducts. This area was reconstructed 
over a No. 12 latex rubber Y tube (Fig. 2). From this time on, the 
convalescence period was normal. After preliminary clamping and radiol- 
ogic evaluation. the Y-tube was removed approximately two months after 
the original injury. 
A month later. jaundice, chills, fever, and right abdominal pain led to 
readmission and another laparotomy for repair of a stricture involving the 
proximal portions of both the right and left hepatic duct and 3 cm. of the 
upper part of the common hepatic duct. The solution to this problem was 
first to mobilize the distal common duct and carry out an end-to-end suture 
of this to the dilated left hepatic duct over a T tube (Fig. 3). The original 
intention in this case u a s  to rejoin the ducts in the normal fashion. 
However, that plan had to be abandoned when it was found that the right 
and left ducts could not be brought together because of tissue loss, scarring, 
and infection. The right hepatic duct was anastomosed to the gallbladder 
(Fig. 4). The second alteration in the course came when it was found that 
contrast material could not be forced from the gallbladder into the common 
bile duct (Fig. 4): therefore the cholecystoduodenostomy was constructed. 
These various anastomoses were all made ui th  inner robs of catgut and the 
outer rows of fine silk (exterior layers only). A straight catheter u a s  passed 
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I C A S E  1 CASE 2 I 
Cu 
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CASE 3 LIVER TRANSPLANT 
Fig. 1 .-Diagrammatic illustration of the anatomic arrangement of structures and the bile drainage systems in three 
cases described and a suggested method of bile drainage for orthotopic liver transplant. 
through the gallbladder into the right hepatic duct system. Fig. 1 shows the 
anatomical arrangement after reconstruction. Convalescence was un- 
eventful. The tubes were removed after three months. The patient has 
remained well until the present, which has been for 3 112 years. 
Case 2 (C.G.H. No. 455652). A 52-year-old electrician developed 
jaundice and vague upper abdominal symptoms in January, 1972. Lapa- 
rotomy disclosed a large adenocarcinoma of the head and body of the 
pancreas. It was inoperable because of local extension into the retroperi- 
toneum and about the superlor mesenteric vessels. A Roux-en-Y loop of 
jejunum was anastomosed to the gallbladder. The jaundice cleared rapidly, 
and the patient was given weekly intravenous injections of 5-fluorouracil. 
He had mild upper abdominal pain and discomfort but was generally hell  
for the next nine months when jaundice reappeared and rapidly deepened. 
Liver function as determined in serum samples a a s  consistent with 
extrahepatic biliary obstruction. 
In October. 1972, another laparotomy showed a contracted hard 
pancreas with no evidence of hepatic or lymph node metastases. The distal 
common bile duct and the origin of the clstic duct were surrounded by 
tumor and probably scar tissue as judged by the contracted and shrunken 
mass in the vicinit). The common bile duct was 2 cm. in diameter. The 
gallbladder lay adjacent to it. The cholecystojejunostomy was widely 
patent. A large anastomosis between the gallbladder and the common 
hepatic duct was constructed (Fig. 1). The patient's jaundice cleared 
rapidly, and after a short time he recovered and aaa  discharged to resume 
chemotherapy in the outpatient clmic. He has remained ae l l  to date. 
Case 3 (C.G.H. No. 413991). A 44-year-old houseulfe dereloped 
obstructive jaundice for a hich laparotom) uas  performed in June. 197 1. 
A lesion compatible with carcinoma of the head of the pancreas inbolr ing 
the distal common bile duct and portal bein a a s  found. A choledochoduo- 
denostomy and cholecystostomy were performed. In August, 1971, an- 
other laparotomy was performed to obtain a histological diagnosis, and at 
the same time, a gastroenterostomy was established to relieve partial 
duodenal obstruction caused by encroachment by a large carcinoma of the 
pancreas which appeared to replace the entire pancreas. Only the midpor- 
tion was biopsied, and it showed adenocarcinoma. 
Shortly after this operation, the patient was begun on 5-fluorouracil 
and testololactone. This has been continued to date. Her principal difficul- 
ties have been due to attacks of cholecystitis and possibly cholangitis as 
long as the cholecystostomy tube remained in the gallbladder. It finally fell 
out. After one jear of aeekly administration of 500 mg. of 5-fluorouracil, 
the dosage was reduced to 450 mg. per week. 
In October. 1972, during a flu epidemic that severely affected the 
patient and her family, she developed diabetes mellitus. The insulin re- 
quirement a a s  50 U. per day. Fluorouracil and testololacto~~e were 
continued after a brief trial of aldactone ahich was tolerated poorly. In late 
December. 1972. she became deeply jaundiced until the previous chole- 
cystostomy site opened and drained large quantities of bile. After re- 
evaluation of gastrointestinal and biliary tracts b) radiologic examination, 
it a a s  apparent that the duodenum, the distal common bile duct, and the 
choledochoduodenostomy were obstructed. At laparotom) in January, 
1973. the pancreas a a s  represented by a 3 b> 3 cm mrsi.  the right-hand 
extremit? of ahich encroached upon the common duct and the first part of 
the duodenum. The mass a a s  very much smaller than 18 months previ- 
ousl). and most of the pancreas seemed to hare disappeared. leaving the 
duodenal loop collapsed with the second portion o\erlying the spine and 
aorta. An anastomosis betaeen the gallbladder and proximal common he- 
patic duct and then a side-to-side cholec~stoduodenostomy here  made 
(Fig. 2. Case 3 ) .  Her convalescence u a s  uneventful. and she had resumed 
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Fig. 2.- Cholangiogram in Case 1 showing Y tube in place and the 
damaged bifurcation and hepatic duct. 
her usual state of health while receiving 5-fluorouracil, testololactone, 
insulin, and pancreatic enzyme replacement. 
Case 4 (C.G.H. No. 468033). A 40-year-old engineer became 
jaundiced in January, 1972. He had no symptoms. He had taken large 
quantities of alcohol daily for years, but he had not been ill as a result and 
was not considered to be addicted to alcohol. A month later, a laparotomy 
was camed out at which time a distended gallbladder, obstructed common 
bile duct, and nodular hard pancreas were found. The duodenum was 
opened and biopsies of the ampulla of Vater and pancreas were obtained. 
No tumor was identified in these specimens. A loop cholecystojejunos- 
tomy was constructed and below this the two limbs of jejunum were joined 
with a jejunojeunostomy. 
During the subsequent nine months, the patient continued to he 
without symptoms and the jaundice cleared. In November, 1972, he began 
to have upper abdominal pain, anorexia, nausea, vomiting, and weight loss. 
A variety of laboratory tests and radiologic examinations failed to reveal 
the cause of severe and worsening symptoms. Gastric hypersecretion to the 
extent of 2 L. a day and high acid content (80 to 90 mEq. per liter) were the 
only significant additional data. The patient was transferred to the Univer- 
sity of Colorado Medical Center where a short while later another lapa- 
rotomy was performed. The patient had carcinoma of the pancreas almost 
completely obstructing the second part of the duodenum. There was 
implantation of tumor in the previous duodenostomy site, and the porta 
hepatis was involved to some extent. Although the cystic duct was not 
obstructed, its origin was at the upper margin of the main tumor mass. 
There was a 5 cm. cyst in the midportion of the pancreas. Vagotomy and 
gastrojejunostomy, pancreatic cystgastrostomy, and cholecystocholedo- 
chostomy were canied out. The latter anastomosis was between the 
gallbladder and the common bile duct immediately below the junction of 
the main ducts from the right and left lobes (as in Case 2, Fig. 1). 
Fig. 3.- Cholangiogram in Case 1 showing reconstructed left 
hepatic duct anastomosed to common hepatic duct over a T tube. 
Convalescence from this operation was uneventful. The patient's 
symptoms, mainly caused by duodenal obstruction, were relieved. He has 
been maintained on chemotherapy for two months and has returned to 
work. He is improving steadily and a long period of control of cancer is an- 
ticipated. 
Discussion 
As illustrated above, palliation of inoperable carcinoma of the 
pancreas, bile duct reconstruction after trauma and perhaps hepatic trans- 
plantation are possible uses to which this procedure might be put. The 
procedure has certain advantages that can be mentioned. Both of the anas- 
tomoses are relatively easy because they can be made large and there is no 
tension. Contrary to many illustrations, the infundibulum of the gallblad- 
der is usually alongside or very near the common hepatic duct. The 
inaccurate portrayal of the exact anatomy of the region probably has 
resulted from spreading things out too much to avoid overlap. There is 
naturally some variation but generally the right hepatic duct and the upper 
common hepatic duct are in juxtaposition to the gallbladder. 
In connecting a normal-sized common bile duct or common hepatic 
duct to the gallbladder, as in reconstruction after orthotopic liver transplan- 
tation, a duct with a long beveled end opening or a linear side opening will 
allow the creation of an anastomosis which is considerably larger than the 
actual and functional diameter of the duct. In anastomosing a distended 
common hepatic duct to the gallbladder, a simple side-to-side connection 
has been used as illustrated. Another anatomical consideration is that the 
common hepatic duct immediately below the bifurcation is about as far 
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Fig. 4.- Operative cholangiogram in Case 1 showing left hepatic duct anastomosed to the common 
hepatic duct over a T tube and the right hepatic duct anastomosed to the gallbladder with a straight catheter 
through the anastomosis. Note that despite distention of the gallbladder, no contrast material enters the common 
bile duct. Subsequent to and because of this demonstration, the gallbladder was anastomosed to the duodenum. 
from tumor in the head of the pancreas as one can place an anastomosis. It 
is believed that this might prolong the interval between operation and 
extension of tumor to cause recurrent biliary obstruction (Fig. 1, Cases 2, 
3, and 4). 
Finally, if this type of reconstruction were adopted for hepatic 
transplantation, it would have the following advantages. First, the catastro- 
phe of utilization of a cholecystoduodenostomy when a low entering cystic 
duct has been ligated, divided, or otherwise obstructed can be avoided. 
There have been several such cases. Second, the avoidance of reverse flow 
through the cystic duct will eliminate extrahepatic obstruction at the cystic 
duct level from rejection and bacterial or viral infection. Third, no tubes or 
drains are necessary in this type of reconstruction; because the anasto- 
moses are large and accessible, they can be made watertight and do not 
require stinting or temporary decompression of the proximal or distal 
structures. Fourth, this procedure is advantageous in allowing the proximal 
anastomosis to be made with two openings the same size with tissues of 
approximately the same thickness. Similarly, the gallbladder-to-intestine 
anastomosis can connect two openings of the same diameter. This in 
contrast to methods in which a small bile duct is anastomosed to the 
intestine. 
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This was a relatively complete account given at the American Surgical Association of the first 
nine years of the Cambridge-King's College liver transplant program. Immunosuppression was with 
azathioprine and prednisone. Calne had adapted the procedure for biliary reconstruction originally 
developed by Waddell for routine use in his liver transplant recipients. Thereafter biliary tract com- 
plications were reduced greatly in the Cambridge experience. 
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Observations on preservation, bile drainage and rejection 
in 64 human orthotopic liver allografts 
Annals of Surgety, 186: 282-90, 1977 
R. Y. Calne, P. McMaster, B. Portmann, W. J. Wall and Roger Williams 
The combined CambridgelKing's College Hospital series of 64 
orthotopic liver grafts' experience dates back to 1968. Man)-patients were 
referred for liver grafting late in the course of their diseases and were 
operated on when they were too ill or died before suitable li\.ers c,ould he 
found. Complications of hiliar! d r a i n a ~ e  were the most frequent causes of 
death. In the past two years we ha1.e acquired esperience of a method of 
liverpreseriation n,hich permits up to 8 hours of sufe storape without an! 
complicuted machines and w,e h0i.e heen uhle to transport 22 lliers b! air 
and roadfrom other institutions to our ou.n unit. This has enlarped the pool 
of potential donors and therefore reduc.ed the ui,eruge waitinp time for a 
liver transplant. A N P M .  method of hiliar) clruinu,qe has been employed in 
24 patients usiti,q the vasc~ulurizeri gull hlucldcr us u conduit hetween the 
donor and recipient comnlon duc,t.s. Tiiis has resulted it? a marked reduc- 
tion in early postoperati1~e c,oniplic uriot7s of hiliur) fisrirla and ohstrucred 
bile drainaxe. R'ow that suriri,ul iius improt ed. it iius hec.onie clear that un- 
controllable rejection of the alioyr~ujred 11i.cr in niun is much less severe 
than that e-tperienced ~ . i t h  kidne) trunsplunt~. The resulrs of 1ii.er qrafting 
in our unit dirriny rhepasr!earure better than those ohtained with kidnejs 
from cadoi,er donors. 
We have recently published overall r e~u l t \  on the first 60 patients 
receiving or thot~pic  liver allografts in the CambridgeKing's College 
Hospital series.' There has been a steady impro~ement  and many errors 
previouslj made have been recognised and are now akoided. It is the 
purpose of this paper to describe the current changes in management of 
patients, to discuss liver preservation. biliary drainage and the low inci- 
dence of rejection of liver allografts. 
Indications a n d  Otera l l  Results 
In theory. anbone dbing from di\ed\e pr~maril) conflned to the l ~ v e r  
would be a potential candidate tor I~kcr  trdnsplantdrion The ruo  d~sease  
categones that need considerarion dre non-neopld\ric parench~matous 
llver d~sease  in panlcular most form\ of c l r rho\~\  and primar) malignancy 
of the l ~ c e r  The results ot Il\er grafting for metastarlc tumor habe k e n  
poor due to early tumor recurrence Preoperdti~e assessment 1s seldom 
straightforward. The prognosis of parenchymatous liver disease is notori- 
ously variable and the timing of the operation is of great importance. Liver 
grafting should be considered the first day it is clear that the patient will not 
be discharged from hospital. It is useless to wait until the patient is 
moribund with hypostatic pneumonia, since there is no adequate artificial 
substitute for liver function that can improve the patient's condition. 
Primarb malignant!, of the liver should be treated by partial hepatic resec- 
tion when this is possible. If, however. both lobes are involved liver 
transplantation may be considered. Australia antigenemia is not a contra- 
indication to transplantation. although rigorouc precautions are required to 
prevent disseminating infection. One of our patients with Australia anti- 
genemia and a hepatoma received hyperimmune gamma-globulin follow- 
TABLE. 1. Indic,ntionr .for Orthotopic  Li1,er Grqf t ing 
p, i ~ ? d r l  cance r  of liver and bile duc t \  34 
~ ~ ~ a t o c e l l u l a r  c r c inoma  20 
~ l a n g i o c a r c i n o m a  I?  
,.!ipffer cell s a rcoma  1 
Haemangioendothel ioma 1 
xietastatic cance r  of t he  liver 4 
Cirrhosis 22 
Crqptogenic 7 
Primary b ~ l i a r y  4 
Alcoholic 3 
Post hepatitis 2 
Secondary biliary 2 
Subacute  hepat ic  necrosis  1 
k,:leros~ng cholangitis 1 
m a c h ~ o m a t o s i s  1 
i,ictosaemia 1 
t-. id-Chiar i  syndrome  2 
E \ r r a h e p a t ~ c  biliary a t res ia  2 
64 patients t rea ted 2nd May 1968-7th March  1977. 
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TABLE 2. Surr, i~,al  of 64 Recipients of Orthotoplc Liver Allografts 
Died B e t e ~ e n  Died Be tween  Survived 
Total  Died Within Firs t  Week Six M o n t h s  More  T h a n  Alive a n d  D a t e  
Performed First  Week  and  Six Months  and  O n e  Y e a r  O n e  Yea r  of Allograft 
I%b I974 3 5 I I 19 2 2 1 (19 F e b  74) 
(5 y r  3 mth)  
(2 y r  1 mth )  
1975- March 1977 29 0 10 4 1 14 (24 Dec  75) 
( 1  yr  1 mth )  (30 D e c  75) 
(12 A p r  76) 
(20 A p r  76) 
(3  0 c t  76) 
(8 N o v  76) 
(10 N o v  76) 
(19 N o v  76) 
(17 Dec  76) 
(29 D e c  76) 
(3 F e b  77) 
(20 F e b  77) 
(20 F e b  77) 
- - - - - - (7 Mar 77) 
Total 64 11 29 6 3 15 
ing removal of the diseased liver, before the graft was revascularised. His 
blood is now free from Australia antigen more than a year after  pera at ion.^ 
The prognosis of acute liver failure is difficult to predict. Fatal downhill 
progress is usually rapid and liver grafting is therefore unlikely to be 
suitable treatment. Infection is contraindication to liver transplantation. 
Most patients who have received liver grafts, when there has been estab- 
lished infection in any part of the body prior to surgery. have died from 
progressive, uncontrollable sepsis. 
Thirty-eight of our patients suffered from malignancy of the liver, 
four of these had metastatic liver tumor. Twenty-six patients had non-ma- 
lignant liver disease, cirrhotic processes consituting the majority (Table 1). 
The median age of the patients was 43 years, the oldest 65. Only five 
patients were aged 17 or under. One was aged under 11 years, an infant of 
ten months with biliary atresia. Of the 35 patients operated on before 1975, 
1 1 died within the first week after operation but there were no deaths within 
this period in the 29 cases operated on from 1975 and 14 of these 29 patients 
are alive. Six patients lived more than a year. Of the 15 patients currently 
alive, one has survived more than three years after operation. The longest 
survivor in the series lived five years and three months (Table 2). Although 
a variety of complications may in each individual case contribute to a fatal 
outcome, the primary cause of death as shown in Table 3 was most 
frequently due to complicatioris of biliary drainage. Recurrent tumor and 
sepsis in the presence of satisfactory biliary drainage were next in the 
frequency. Unmanageable rejection was responsible for death in only four 
patients. The improved peri-operative survival since 1975 is believed to be 
due to increased experience in the anesthetic management of the patients 
during operation and better quality donor organs. During the operation 
great care is taken uhen the vena cava is clamped above the liver to ensure 
that there is sufficient infusion of blood to the superior vena ca \ a  since the 
return of blood to the heart may be reduced by more than 50%. Prior to 
revascularisation of the liver. the organ is flushed through the portal vein 
with 400 ml of plasma protein fraction at room temperature to remove po- 
tassium ions and acid metabolites. It is important that there should be a 
continuous dialogue between the surgeon and the anaesthetist so thatmajor 
cardiovascular and metabolic changes are anticipated and corrected before 
serious abnormalitiei occur. All blood transfubed to the patient is filtered. 
General anesthecia is supplemented by an epidural block. ~bhich is contin- 
ued postoperat~vel>. This enables the patient to sit up. inspire deeply and 
cough during the early postoperative period. We b e l i e ~ e  this has reduced 
the incidence of postoperative pulmonary complications. 
Liver Preservation 
Removal of the l~ve r  from a "heart beating cadaver" provides the 
most perfectly preserved organ for transplantation. Until recently in the 
United Kingdom, where the concept of brain death had not been accepted, 
organ removal was started when circulatory arrest had occurred following 
cessation of mechanical ventilation. The liver suffered a severe handicap 
imposed by the ischaemic damage occurring while the heartbeat continued 
perfusing the organ with increasingly deoxygenated and acidic blood. In 
the past two years it has been possible to commence liver removal, either 
immediately after cessation of mechanical ventilation or while ventilation 
continued. Fifteen of the last 21 livers transplanted have been removed 
form "heart-beating cadavers." The initial cooling of the liver is performed 
in situ through the portal vein with gravity drainage of Hartmann's solution 
at 4". After infusion of 1.5-2 litres of this solution the flush is changed to 
TABLE 3. Pr i rnup Cultsex of Derith und 
Orher Seriorr~ Cornplicc~tions 
Deaths  in first postoperat ive  w e e k  1 1  
Hemorrhage 6 
Cardiac  arres t  3 
Pneumonia  1 
Acu te  Rejection 1 
Deaths  f rom complicat ions  o f  biliary 13 
drainage 
Deaths  f rom recurrent t u m o r  9 
Deaths  f rom sepsis in t he  p re sence  o f  8 
satlhfactory biliary dra inage 
Deaths  f rom chronic rejection 3 
Other  causes  of death:  5 
Thrombosis  of IVC a n d  por ta l  vein 2* 
Hepat ic  artery thrombosis  1 
Spontaneous  colonic perforat ion 1 
Myocardial infarction 1 
O the r  ser ious  complications: 
Reticulum cell s a rcoma  In  patient dying af ier  6 
months  f rom sepsis 
Operat ive  cardiac  a r r e s t  succes s -  In patient surviving more  
fully resuscitated than  3 years  
Development  of adenoca rc inoma  of In  patient dying after o n e  
rectum year  from recurrent 
cholangiocarcinoma 
-- 
' O n e  of these  patlents had  suffered f rom the  Budd-Ch la r~  syn-  
d rome  a n d  was  not antrcoagulated pos tope ra t~ve ly .  
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an ice-cold protein fraction with additives.* Seven hundred milliliters of 
this solution are infused through the portal vein and another 300 ml via the 
hepatic artery. The liver is then stored in ice-cold saline in a sterile 
container surrounded by ice." Since 1973.22 livers have been preserved 
by this method and transported to Cambridge or King's College Hospital 
from institutions between 28 and 200 miles away. The ischemia times have 
ranged from two hours to seven hours 50 minutes. All the recipients had 
good or excellent postoperative function of their liver grafts. With such a 
simple and satisfactory short-term preservation technique we doubt 
whether there is a need for complicated perfusion apparatus. The shortage 
of liver donors has necessitated the use of extremely poorly matched 
donors. This does not seem to have affected adversely the results of clinical 
liver grafting. Indeed, grafts have functioned well in the presence of strong 
specific anti-donor cytotoxic antibodies and when A, B, 0 incompatible 
donor livers have been transplanted." To transplant kidneys with similar, 
apparently overwhelming, immunological disadvantages would be court- 
ing disaster. 
Bile Drainage 
This is the technical Achilles' heel of liver transplantation. Approxi- 
mately 50% of our patients and those in the Denver series have developed 
serious biliary tract complications and this figure would probably be higher 
if patients succumbig in the earlier postoperative phase had survived 
longer. Direct duct-to-duct drainage may fail because of a poor supply to 
* To each 800 ml of PPF is added: 2000 IU Heparin, 250 mg 
Hydrocortisone, 500 mg Ampicillin, 6 ml 0.1 N HC1, 5 ml. of 10% 
Magnesium Sulphate, 250 mg Dextrose, 15 mEq Potassium Phosphate. 
the lower end of the donor common duct and tension on the anastomosis. 
The protective defence of the sphincter of Oddi against infection is 
however retained. In experimental animals if the sphincter of Oddi is 
bypassed cholangitis is an almost invariable sequel. This complication has 
been common in man when bile drainage has been into the duodenum 
bypassing the sphincter. Techniques utilising the gall bladder have had the 
disadvantages of the narrow cystic duct which may become blocked and 
the blind sump end of the common duct distal to the entrance of the cystic 
duct, in which bile sludge may accumulate. 
Since November 1973 Starzl has favoured using a long Roux loop to 
avoid ascending infection and anastomosing this to the gall bladder or the 
common bile duct." We feel that the objective of biliary drainage should 
be to preserve the sphincter of Oddi, to provide a wide anastomosis with 
a good blood supply, to have no sump for the accumulation of biliary sludge 
and to have ready access to the biliary ducts for irrigation and diagnostic 
radiography. These objectives are obtained with a new gall bladder conduit 
technique that we have used in 24 of the last 29 cases.' In two patients the 
conduit was constructed as a secondary procedure after breakdown of duct- 
to-duct anastomoses. The remaining 22 conduits were the primary method 
of drainage. The gall bladder is mobilised leaving its blood supply intact. 
The donor common duct is trimmed back and cut obliquely to provide a 
wide anastomosis and a good blood supply. Hamnann's pouch of the donor 
gall bladder is anastomosed to the donor common duct. The fundus of the 
gall bladder is anastomosed to the obliquely cut recipient common duct. 
The anastomoses are splinted with a specially constructed T-tube with a 
narrow gauge irrigating arm, threaded through the proximal anastomosis 
(Fig. 1). One to two litres of heparinised normal saline are infused by a drip 
set through the irrigating tube each day for the first ten days after operation. 
If cholangiography (Fig. 2) is then satisfactory, further flushing is stopped 
and the T-tube is spigotted. It had been our policy to leave the T-tube in 
Fig. 1.- Pedicle graft conduit with donor gall bladder. Hartmann's 
pouch is anastomosed to donor common duct and fundus anastomosed to 
recipient common duct. Irrigating T-tube is inserted with irrigating arm 
through upper anastomosis. Blood supply to gall bladder is carefully 
preserved. (By courtesy of the Br. Med. J.) 
Fig. 2.- T-tube cholangiogram of patient with orthotopic allografts 
with gall bladder usedas pedicle graft conduit. (By courtesy of the Br. Med. 
J.) 
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T A B L E  4 .  Complicutions of Bili(lp Drtrinnge in 53 Patients Slrn,it,ing thr Firsr Post-oprrc~ri~~e Wrek 
Technique 
Number  of Cases  Numher  With Biliary Blockage 
a t  Risk Complications Fistula by Sludge Deaths 
Duct-to-duct 
Gallbladder to c o m m o n  duc t  
Gallbladder to intestine 
New gallbladder condui t  technique 
Conduit t o  Roux loop 
Totals  53 
- 
* T w o  fistulds closed by c o n d u ~ t  echnique. 
place without disturbance provided there were no complications. In two 
patients the tubes fell out after a month. One tube has been in place for more 
than a year. 
In view of the danger of infection and obstruction of drainage by the 
tube we now believe that the T-tube should be removed after three months 
if cholangiography shows adequate drainage. Although the follow-up is 
short. in each patient bilialy drainage has been initially satisfactory and the 
incidence of biliary leakage and obstruction of bile flow has been markedly 
reduced (Table 4). In two patients with secondary biliary c~rrhosis in whom 
the recipient's common duct could not be used. the technique was modified 
by anatomosing the fundui of the gall bladder conduit to a long Roux loop 
of jejunum (Fig. 3). Of the seven duct-to-duct anastomoses in the last 28 
cases. two were successfully converted to conduits following fistula 
formation, one became blocked with sludge, the remaining four drained 
satisfactorily. Two recent cases had duct-to-duct anastomoses because of 
gall-stones in the donor gall bladder. In one case the gall bladder had been 
removed a year previously and in the other, stones were found when the 
liver was removed and a cholecystectomy was therefore performed. Our 
longest surviving patient had satisfactory duct-to-duct drainage for three 
years, but the T-tube required changing at operation after 16 months. In 
view of the high complication rate of other methods of biliary drainage, we 
would favor the conduit technique if this is possible, with a duct-to-duct as 
the next best biliary drainage available. 
Techniques involving anattomosis of the common bile duct can be 
difficult. since there are marked variations in calibre of normal human 
common bile ducts: in adults we have seen ducts of 2 mm in diameter which 
accommodate only a small probe and in order to perform a satisfactory 
anastomosis the surgeon ma) require loop magnifying glatses. At the other 
extreme ducts may be as large as 1 cm in diameter. 
Biliary Sludge 
If bile drainage is interfered with in any way, there is a likelihood of 
cholangitis and precipitation of biliary constituerits forming sludge. This 
secondar) sludge formation has been observed frequently in recipients of 
liver allografts with impaired biliary drainage.'' There is another form of 
biliary sludge which usually presents in the first or iecond postoperative 
ueeks as the on11 demonstrable cause of obstructed bile drainage. A major 
constituent of these cases is collagen (Fig. 4). Cholesterol and bilirubin are 
present in relatively small amounts.' The incidence of this primary sludge 
IS not known since it has only recently been recognlsed. It produced biliary 
obstruction in at least six patients. The shedding of collagen from the lining 
of lntra- and extrahepatic ducti probably follous iichemic necrosis. This 
damage may be incurred in the transplant operation. but could also be the 
result of rejection. In the pig the b i l i a ~  duct epithelium does not appear to 
be more aggressi\el) rejected than the rest of the l i ~ e r  parenchyma, but 
primaq biliar) sludge has not been observed In porcine l i ~ e r  allografts and 
u e  have little information on the susceptibilit) of blle duct epithelium to 
rejection compared ulrh the re<t of the li\er parench>ma in man (vide 
lnfra). Primaq sludge can also occur late when there has been occlusion 
of the arterlal suppl) to the liver. It u a s  observed after five years in one of 
T r a n s v e r s e  
Fig. 3.- Gall bladder conduit technique used *hen the recipient 
common bile duct is unsuitable. The fundus of the gall bladder is anasto- 
mosed to a long Roux loop ofjejunum. (By courtesy of the World J. Surg.) 
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Fig. 4.- Morphology of primary biliary sludge. (Top) shows gross appearance. (Bottom) shows the main constituents to 
be collagen from bile duct wall, the architecture of which is in part preserved (hematoxylin and eosin X 160). 
our patients and after a year in another. Once collagen has been liberated 
into the biliary duct system it cannot be dissolved, but the irrigation in the 
fust two weeks is aimed at preventing its accumulation into obturating 
casts, and certainly hiliary sludge has been far less common since imgation 
has been used. We now also inigate duct-to-duct anastomosis. Primary 
sludge has not occurred in any of the 15 transplants where the livers have 
been taken from heart-beating cadavers, nor has it been present in the four 
patients who had uncontrollable rejection. We therefore feel that the most 
likely culprit in the pathogenesis of primary biliary sludge is non-immu- 
nological ischaemic change. Bile secretion was investigated in three of our 
patients. Supersaturation of bile with cholesterol was found in two cases 
immediately after surgery and during episodes of acute rejection. The bile 
was never lithogenic in the third case. Subsequent studies suggested that 
changes in bile composition do not influence sludge formation. We agree 
with the Denver group that secondary bile sludge formation is usually due 
to anastomotic stenosis and infection. 
Immunosuppression 
The standard immunosuppressive treatment has been Azathioprine 
and Prednisone in doses comparable to those used in renal transplant 
patients. In view of the ischaemic damage in many livers transplanted in 
our series Cyclophosphamide is now given for the first three days instead 
of Azathioprine. Two patients were weaned completely off Prednisone and 
maintenance therapy of immunosuppression in most patients has required 
less drug dosage than patients with kidney grafts. In contrast to the Denver 
practice, we do not now use antilymphocyte globulin. 
Occurrence of Rejection 
Rejection can be difficult to diagnose. Needle biopsies have been 
performed but have been of less practical value than biopsies of renal 
allografts. A positive leukocyte migration test' in the presence of deterio- 
rating liver function and a normal T-tube cholangiogram is assumed to 
indicate rejection and a short course of increased steroid dosage is 
commenced. This is usually followed in a few days by an improvement in 
liver function. 
Most of the patients have shown a rise in serum bilirubin starting 
seven to ten days after the operation. Often there has been no other evidence 
of rejection at the time and the jaundice has subsided without change in im- 
munosuppressive therapy. Although it is possible that the early rise in 
serum bilirubin level is related to ischemic damage, it does not appear to 
have become more severe or frequent since the use of livers removed at 
other hospitals and transported over long distances. There is no evidence 
that these episodes are related to azathioprine toxicity since they still 
occurred in cases in which cyclophosphamide was substituted for azathi- 
oprine during the first two post-operative weeks. 
In four patients severe rejection was considered to have been a major 
cause of death. Included in these was one patient in whom immunosuppres- 
sive drugs had been withheld because it was thought at the time (1968) that 
the hepatitis virus, presumed to be the cause of his subacute hepatic 
necrosis, might be reactivated. The other three patients became deeply 
jaundiced with high serum alkaline phosphatase and moderately raised 
serum transaminase levels, these continuing until their deaths. 
The final morphological changes in the allografts were mononuclear 
cell infiltration of the portal tracts and the presence of foamy lipid laden 
histiocytes in the walls of the hepatic arterioles and throughout the 
sinusoides. A feature that has not been previously described occurred in 
one of our patients, namely virtual absence of small bile ducts (Fig. 5) in 
the portal tracts. This may explain the relentless progressive intrahepatic 
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Fig. 5.- Interlobular portal tract, showing a mild mononuclear cell 
infiltrate and absence of identifiable duct. Post mortem liver tissue stained 
with hematoxylin and eosin; X 160. 
obstructive jaundice that was observed with relatively good hepatic 
parenchymal function until just before death. His original disease was 
hepatoma in an alcoholic cirrhotic liver. 
Discussion 
Patients referred for new and dangerous surgical procedures are 
usually considered for operation too late in the course of their diseases. 
Even if the decision to transplant a liver is made when the patient is fit for 
surgery, his condition may deteriorate so as to constitute an unacceptable 
operative risk by the time a donor liver becomes available. Sepsis, tumour 
recurrence and above all, complications of biliary tract drainage have been 
responsible for the poor overall survival rate of recipients of liver grafts. 
Nevertheless, patients who have been discharged from hospital have often 
done extremely well. They frequently require less steroids than renal 
transplant patients and therefore do not have such severe cushingoid 
features. One hundred and three of the patients in Starzl's series were 
transplanted a year or more ago? Thirty of them or 29% have survived for 
at least one year after liver replacement. The one-year survival figures have 
been improving, fluctuating in the 25-45% range. Pumam and colleagues 
have pointed out that if the very heavy early mortality were to continue 
after the first year, there would be significant cause to question the validity 
of the procedure. Fortunately, most of the patients who reach the one year 
mark continue to do well thereafter. Thus, half of all the Denver one-year 
survivors are still alive. 15 patients have reached the two year mark, eight 
have reached three years, and there have been four five-year survivors. The 
longest survivor in their series and in the world is now more than seven 
years post-transplantation. She is living at home, attending school and has 
normal liver function. Two other five-year survivors are also entirely well, 
but the fourth one died a few days short of the six year mark of chronic 
rejection and partial biliary obstruction. 
Although tumor recurrence is common, palliation can be achieved 
and there is no difference in principle between treating a patient with liver 
cancer by grafting and giving similar palliative treatment to a patient with 
cancer of the lung, stomach or colon by resection of the growth. It is, 
however, likely that parenchymatous liver disease rather than primary 
malignancy will be the main indication for liver transplantation in the 
future. 
The simple method of short term liver preservation referred to above 
has increased the catchment area of donor livers and therefore shortened 
the waiting time for patients accepted for liver grafting. The new technique 
of biliary drainage using the gall bladder as a conduit has produced 
gratifying early results, relatively free from the previous common compli- 
cations. 
The most remarkable aspect of liver transplantation has been the low 
incidence of progressive uncontrollable rejection.I0 In this respect the 
human experience is similar to observations made in experimental ani- 
mals. Studies in the Cambridge University Department of Surgery have 
shown in the pig that liver cells possess less MHC surface antigenic 
specificities than kidney cells3 and hepatocytes are more resistant to killing 
by allogeneic lymphocytes in tissue culture than are kidney cells. The 
difference in expression of surface antigens on liver cells could be an 
important factor in the relatively privileged immunological status of the 
liver. Hepatic metabolism and contributions of Kupffer cells could also be 
relevant though definitive data on these two speculations are lacking. It had 
been shown that six months after grafting Kupffer cells are of host origin.'.' 
It is likely that many patients have been overtreated with immuno- 
suppressive drugs and this has been responsible for some of the infective 
complications and may in theory have impaired the development of active 
immunosuppressive mechanisms. We now attempt to give the minimum 
necessary dosage of immunosuppressive drugs. Between June 1975 and 
May 1976 our results for liver grafting have been better than those obtained 
with cadaveric renal transplants. Study of the mechanisms responsible for 
the low incidence of rejection of human liver allografts might help in an 
overall understanding of the renal and cardiac grafts, and it is possible that 
earlier operation on patients with non-malignant liver disease could shift 
the liver from third to first place in the "therapeutic batting order" of organ 
grafting. 
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Discussion 
Dr. Joseph G. Fortner  (Kew York, Kew York): This is really a 
major contribution, one of many of Professor Calne's and as you know, he 
and Dr. Starzl have been the pioneers in the liver transplantation field. 
I think it's reall) very impressive that he has 15 patients alive for 
variable periods of time. In the evaluation of the 64 patients that he has 
transplanted, the vast majority of failures are due to factors that are 
controllable and correctable: and I think this is the most encouraging pan 
of this whole presentation. 
Hemorrhage, intraoperative cardiac arrest, and problems with biliary 
drainage are all things that we can fix: and in liver transplantation the 
problem is not one of some problem with rejection that we can't control, 
but, really, something that we can. 
I must confess. however. to not being able to accept 100% the use of 
the gallbladder as a conduit. It sort of goes against my general surgical 
background to do this, and I think in a complicated setting such as a liver 
transplant we should use a technique that's been proven to have minimal 
complications in a general surgical setting. 
Of the 14 liver transplants that we've done at Memorial Sloan- 
Kettering Cancer Center. we have found in this limited experience that an 
end-to-side choledochojejunostomy really is, in our hands. at least, the best 
way to have biliarj  drainage, and thus cope with one of the big problems. 
We are, as you may know, investigating the heterotopic or auxiliary 
liver graft as an alternative to the orthotopic graft in patients who have end- 
stage noncancerous liver disease. We have done seven of these now. One 
patient is living and well more than four years after transplantation, a little 
boy with biliary atresia. One patient lived eight months, and one lived three 
and one half months. 
Dr. Paul  S. Russell (Boston. Massachusetts): I think all of us 
recognize that there are three principal problem areas that we have to face 
with any organ which we are trying to transplant. One is the technical, and 
in liver transplantation there are a number of such technical difficulties 
which have been called to our attention tonight. 
The problem of organ availability is the second, and that is still far 
from solved, particularly in the case of liver transplantation. Dr. Calne and 
others have done quite a lot in order to improve preservation techniques, 
but you will note that they are still rather limited, and still far from what we 
can do with kidney transplantation. Thus. much more can and should be 
done about liver presen ation. 
I'd like to call special attention hoaever.  to what I think is the most 
interesting thing that a e  have heard from Dr. Calne. and that is the special 
quality of the liver in respect to rejection. the third problem area. I think it's 
true that the liver is rejected a ith less vigor than are many other organs, and 
we're gradually beginning to contruct a kind of an electromotive series of 
rejectability of organs, in hhich it may be suggested that the liver is less re- 
jectable than is the kidney, which is less rejectable than is the heart, ahich 
is much less rejectable than is skin. 
'Illere is evidence to support this from animal systems. where a e  
have control of immunogenetic differences and can try different organ 
transplants in ver). strictly regulated circumstances. It's interesting that this 
difference does not pertain with equal force a h e n  one implants just a piece 
of an organ as a free graft. It has to be vascularized organ. which releases 
its antigens into the circulat~on of the rec~pient.  
Some years ago a e  \sere able to show that the liver has enzymes 
which will degrade antigens deri\ed from other tissues. Whether such a 
mechanism is ac tual l~  operati\e in the vascularized liker transplant or not 
I don't know, but I'd be very much interested to know from Dr. Calne 
whether he has any idea at all as to what the mechanism for the striking dif- 
ference in behavior of livers on transplantation as compared to other organs 
might be. 
Dr. Joseph E. M u r r a y  (Boston. Massachusetts): I will just make 
four points. I think, historically. we must give credit to Drs. Starzl and 
Calne for bringing clinical liver transplantation into actuality, but I believe 
both of the authors will recognize the experimental prototype which Dr. 
Francis D. Moore established in the late fifties in the laboratory at the 
H m a r d  Medical School: and I believe it was there that Dr. Calne received 
some of his first stimulus in the field of liver transplantation. 
The hierarchy of rejection of organs. which Dr. Russell mentioned, 
is a definite one, and I recall, again in the mid-fifties, at a conference in New 
York when Professor Medawar, on reviewing some work that we had 
presented on the differential rejection of skin versus kidney. commented, 
in his own picturesque way, that the transplanters had freed the biologists 
from the "tyranny of the skin graft"; because in the early fifties all 
transplantation was using skin as the indicator organ. and. of course, the 
rejection of the skin is by far the most severe and the most abrupt of any of 
the other organs. 
Interestingly enough, there is a differential rejection of kidneys from 
the same animal under different circumstances when it's placed into the 
same recipient. 
I would like to make an additional comment which is not truly 
pertinent to Calne's report. I have never liked the use of the term "brain 
death". The Harvard Committe under Dr. Beecher's chairmainship which 
defined it didn't really use the term "brain death." They were defining 
death of a human being as defined by cessation of function of the brain; and 
I've always felt that the term "brain death" was a false one, suggesting that 
we surgeons were trying somehow to overlook the fact that the patient 
might still be alive when the orans are taken. 
It's a small point, but I think we should say death of an individual, as 
defined by cessation of function of the brain. 
And finally, we talk about long-term follow-up, and we certainly 
have beautiful follow-up in Dr. Calne's and Dr. Starzl's patients. In thepre- 
vious paper on the ambiguous genitalia they're still looking for final 
results, although they have been working in the field for 20 or 30 years. I 
think that it behooves all of us in surgery. when we have a problem, to 
establish some son of a communication system, a registry, if you wish, so 
that we can get good documentation which can be translated across the 
decades, rather than waiting for that future twenty years which always 
seems to be ahead of us. 
Professor R. Y. Calne (Closing discussion): I take Dr. Fortner's 
point that the actual reason for looking for a new technique was because all 
the old techniques were unsatisfactory. And I'm not saying that the 
gallbladder conduit technique is the final answer. but in our hands it has 
produced much better results. I think it must wait time to be proven, but 
every other technique that's been used in any large series has been 
unsatisfactory. 
I wish I would answer Paul Russell's question on the mechanism of 
acceptance of the liver. It's by far the most interesting aspect of liver 
grafting and we have been studying this in the pig for many years. We have 
some information. but not an answer to his question. 
Liver cells, hepatocltes, have less transplantation antigens than 
kidney cells. They have SD-antigens, but not LD-antigens. The liver has 
a unique lining of the endothelium with Kupffer cells, which changed to 
recipient type after six months in two human cases that have been studied. 
This could be relevant. 
We don't know if the liver has a major influence on the recipient's 
immune system, or whether the liver itself is less susceptible to rejection, 
possiblj it's a combination of both these factors. 
As far as Dr. Murray's comments are concerned. I'm delighted to 
have the opportunitj to pay homage to Dr. Moore for having worked in his 
department, and getting m) first interest in liver grafting at the Brigham, 
and being associated a i th  Dr. Murray for many years in experimental and 
clinical transplantation. I accept also his point that brain death is the 
diagnosis of death of the indi\  dual. 
CLIO CHIRURGICA 
In May, 1975, one of the editors [TES] took a sabbatical in London and with Professor K.A. Porter 
made a clinico-pathological assessment of 93 consecutive liver transplantations. In each case an 
attempt was made to find reasons for success or failure. A number of changes in management 
resulted including more frequent cholangiography, more frequent biopsy and an assessment of 
causes of hepatic dysfunction other than rejection. At the time it was not appreciated, but the stage 
had been set by Calne's 1977 article and by this one for the effective testing of cyclosporine when 
it became available several years later. 
THE HUMAN mIALS 
Orthotopic liver transplantation in ninety-three patients 
Surgely, Gynecology & Obstetrics, 142: 487-505, 1976 
T. E. Starzl, K. A. Porter, C. W. Putnam, G. P. J. Schroter, C. G. Halgrimson, 
R. Weil 111, M. Hoelscher and H. A. S. Reid 
Liver replacement with a homograft was first attempted in a human 
on 1 March 1963 (29). Between then and Thanksgiving Day 1974,92 more 
patients were similarly treated at our center. In this review, it will be 
emphasized that 27 of the 93  recipients achieved survival of at least one 
year after transplantation with a maximum of six years and that many of 
these patients have been able to return to a full and useful life. At the same 
time, attention will be focused upon the causes for the heavy mortality that 
has retarded the acceptance of this new procedure and upon means by 
which the record might be improved. 
Methods 
Material. 
Pediatricpatients. Fiftl-six of the 93 recipients were 18 years of age 
or younger at the time of operation (Table I). Forty of these 56 pediatric 
recipients had biliary atresia. In the 36 youngest of the 40 patients with 
atresia, the mean age at operation h a s  31.3515.7  (S.D.) months, range 3 
to 67. The four oldest children in the atresia group were seben, 11, 11 and 
15 years of age. Because of their long survival. they were thought. on 
clinical grounds, to have intrahepatic biliary atresia, and this diagnosis was 
compatible with the histopathologic findings of micronodular biliary 
cirrhosis in their native livers. Two of these latter four livers contained 
incidental liver cell carcinomas. Only one such malignant condition was 
found in the diseased livers of the other 36 patients with extrahepatic 
biliary atresia in whom transplantations were canied out at a younger age. 
The 16 pediatric patients with diagnoses other than biliary atresia 
(Table I) had a mean age of 12.9+4.6 (S.D.) years. range 1 to 18. Nine had 
some variant of chronic aggressive hepatitis without HBrAG antigenemia. 
Three had hepatomas which could not be removed with conventional 
partial hepatectomy. Two had Wilson's disease. There was one example 
each of congenital biliary cirrhoiis and cirrhosis associated with alpha-l- 
antitrypsin deficiency of the homozygous PiZZ phenotype. 
Adult patients. The 37 adult patients treated during the same time 
averaged 39.0+1 I .  1 (S.D.) years, range 21 to 68. Their most frequent di- 
agnoses were primary hepatic malignant tumor, chronic aggressive hepa- 
titis and alcoholic c i r rho~is  (Table 11). All of the patients with non- 
neoplastic disease were profoundly ill before they were considered for 
transplantation. Five had a diagnosis of the hepatorenal syndrome; several 
were unconscious: almost all were wasted from the chronic disease. 
For specific patients of either the adult or pediatric subgroup. 
orthotopic liver transplant or OT code numbers have been given, so that the 
TABLE I.-PEDIATRIC PATIENTS 
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Common 
duct Clamp on 
h e p a t ~ c  a 
Fig. 1.- Technique of retrograde removal of liver. A, Incisions. AA, Subcostal incision used for all ortho- 
topic liver transplantations. BB, CC and DD, Frequently used extensions from the AA incision. B, Beginning 
retrograde removal after transection of inferior vena cava and hilar structures. All posterior tissue that is cut 
should be ligated, although the named vessels encountered, such as the right adrenal vein, are few in number. 
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Fig. 2.- A, Operative field after retrograde liver mobilization. The last remaining structure, the 
suprahepatic inferior vena cava, has been clamped above the liver. B,  Technique for mobilizing a suitable 
length of suprahepatic vena cava after placement of clamp. In adults, this usually involves cutting away 
cirrhotic liver tissue over the frequently distorted and foreshortened right and left hepatic veins. 
reader may follow given recipients through different publications from our 
center. This method of patient identification has been used for most of our 
past publications, beginning with a major review of our experience in 1969 
(31). 
Management. The operative care and postoperative care of patients 
with liver transplantation have been described before (25, 31). but some 
details deserve emphasis. Since 1968 when the concept of brain death 
became widely accepted in the United States, cadavers usually have not 
been considered for liver donation unless there is some effective circula- 
tion and unless aortography can be performed to delineate the hepatic 
arterial supply in advance. Complicated presenation devices are no longer 
used. 'The livers of infants and children are usually perfused with I to 3 
liters of a chilled electrolyte solution through the ponal Lein just before and 
after organ removal (31).  Sometimes, the livers of adults and large 
adolescents may be more effectively cooled by connecting these cadaveric 
donors to a cardiopulmonary bypass into which a temperature reducing 
heat exchanger has been placed (31).  E ~ e n  after such preliminary total 
body chilling by means of a heart-lung machine. a final intraponal infusion 
of cold electrolyte solution is used. Incidentally, the technique of hypoth- 
ermic cardiopulmonar~ bypass 1s excellent to rescue cadaveric donors who 
become unstable in the hours preced~ng the transplantation or in the course 
of removing the l i ~ e r .  
The HL-A match was not used as a criterion of donor-recipient selec- 
tion, but these data were obtained in all instances since 1964. Major incom- 
patibilities were present in all but a handful of patients (Table 111). The 
quality of HL-A matching has not seemed to influence the outcome, 
although the scarcity of good matches has reduced the meaning of such a 
correlation. 
Preformed antired cell isoagglutinins that react against donor tissues 
and cytotoxins, which can be detected by their lysi? of donor lymphocytes, 
immediately destroy many renal homografts that are transplanted in 
violation of such positive crossmatches. The liver is resistant to this so- 
called hyperacute rejection (26).  In our series. three liver transplantations 
were carried out in spite of red cell group incompatibility and three more 
were performed in confrontat~on of cytotoxic antibodies (Table 111). There 
were no unequivocal hyperacute rejections. An account of this 
experience is being published separately. 
Other modifications of technique or changes inour past policy should 
be mentioned. Originall), splenectomy was performed at the time of trans- 
plantation if this procedure had nor already been carried out at an earlier 
time and if it u a s  considered to be safe. Of the first 80 patients, four had 
prior and 57 concomitant splenectomq. In the last 13 patients of this report, 
splenectom) h a s  omitted. 
Host hepatectom) is usually still performed by individually dissect- 
ing the hilar structures and the vena cava above and belou the liver and by 
then cross clamping and dividing the vessels just as the liver is removed 
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Fig. 3.- Techniques of biliary duct reconstruction used for most of the transplantation recipients. A, 
Cholecystoduodenostomy. B, Cholecystojejunostomy. C, Choledochojejunostomy after removal of gallbladder. 
D, Choledochocholedochostomy. Note that the T-tube is placed, if possible, in recipient common duct. 
(29,31). However, in some adults, a safer way has been to transect first the 
hilar structures and, subsequently, the infrahepatic inferior vena cava when 
all else is in readiness (Fig. 1). Then, by pulling on clamps which are placed 
on the hepatic side of these structures, the liver is dissected free from below 
to above, ligating all cut tissue on the way (Figs. 1 and 2). The suprahepatic 
inferior vena cava remains intact as the stalk of the specimen until it is 
clamped just before the liver is removed. The variation in operation has 
been particularly useful in developing a reasonably long suprahepatic cuff 
of the inferior vena cava in adults. The vena cava or main hepatic veins may 
be dissected free from within the cirrhotic liver in a bloodlesi field (Fig. 
2B). 
In several of our first recipients who did not have biliaq atresia, bile 
duct reconstruction was with choledochocholedochostomy over a T-tube 
stent (Fig. 3D). The method lost favor because of a high incidence of bile 
fistula, and cholecystoduodenostomy after ligation of the common duct 
(Fig. 3A) became our first choice for a number of gears. However, since 
November 1973, the preferred technique has been cho~ecystojejunostomy 
with a Roux-en-Y loop (Fig. 3B).thus r e m o ~ i n g  the homograft from the 
mainstream of the gastrointestinal tract and draining it through a defunc- 
tionalized jejunal limb. Altemativel!. Rou-en-Y choledochojejunostomy 
(Fig. 3C) or choledochocholedochostomy (Fig. 3D) has been used for 
recently treated patients. In a number of patients, it has been necessary to 
convert from cholecystojejunostomy to choledochojejunostomy (Fig. 3B 
and C) because of obstruction at the cystic duct ( i7) .  
The first five patients were treated with azathioprine and prednisone. 
The next 88 recipients were given triple drug immunosuppression, which 
usually consisted of azathioprine and prednisone. to which a two weeks to 
four months' course of horse antilymphocjte globulin was added (31). If 
hepatotoxicity of azathioprine was suspected, cyclophosphamide was 
substituted. since it has an immunosuppressive effect comparable with that 
of azathioprine (32). In a number of later patients. cyclophosphamide was 
used at the beginning with a switch later to azathioprine. 
Histopathoiogic stirdies and ciinic.al correlations. During the 12 I/  
2 years of study, samples were accumulated from the diseasednative livers, 
homografts and selected other tissues and fixed in 10 per cent buffered 
Formalin (aqueous solution of formaldehyde). Frozen sections he re  
stained hith Sudan IV for fat. and then. the remainder was processed and 
the paraffin sections were stained with hematoxqlin and eosin. Gordon and 
Sweet's silver impregnation method for reticulin fibers. Perls' Prussian 
blue method for iron. Weigen's for elastic counter-stained with hematox- 
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a b 
Fig. 4.- Acute rejection. Hepatic homograft, OT 31, nine days after transplantation. Large 
numbers of lymphoid cells are present in the portal tracts and between the damaged hepatocytes. 
Hematoxylin and eosin, a, X300; b, X500. 
Fig. 5.- Chronic rejection. a, A small hepatic artery branch in a graft, OT 16b, 339 days after re- 
transplantation is almost occluded by intimal thickening. Elastic stain, X60. b, Residual scamng after re- 
jection. Same graft, OT 16b. There is increased portal fibrous tissue and connective tissue septums extend 
into the lobules. Reticulin, X60. c, Centrilobular cholestasis with bile "thrombi" in dilated canaliculi in 
graft, OT 14a, one year and 16 days after transplantation. BIle stain, X200. d, Collapse of reticulin fiber 
framework around central veins in graft, OT 10, 186 days after transplantation. Reticulin, X60. 
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Frequently, additional small hepatic samples were initially fixed in 
glutaraldehyde solution, and then postfixed in osmic acid and embedded 
in Epon, a synthetic embedding medium. Half micron and ultrathin 
sections were cut. The former were stained with azure I1 for examination 
in the light microscope, while the latter were stained with lead citrate and 
examined in a Phillips 300 electron microscope. 
Many of the findings in the liver grafts have been reported before 
(21). In preparing this survey, the old specimens were re-examined, and 
new ones were analyzed. Clinicopathologic correlations were made in 
each about the reasons for failure. The most important element in the final 
decision was the state of the homograft and the evidence in it of injury from 
an old or a new rejection. The clinical course and the findings of the autopsy 
also were taken into consideration. 
An effort to assign a single, most important cause of failure inevitably 
required oversimplification, since the terminal events were always com- 
plex. Thus, although infection almost invariably played an important role 
at the end, as has been emphasized before (17,25,31), infections are not 
mentioned hereinafter unless they seemed to play a triggering and primary 
role. The all important role of infection in these sample patients is to be 
described in a detailed separate publication. 
The effects of hepatic homograft rejection and other postoperative 
events upon liver function tests have been exhaustively described by us 
(17,25,29,31) and by Williams and his associates (35). The abnormalities 
of function with rejection are not diagnostic, since the profile of tests may 
range from a pattern of obstruction to one of parenchymal necrosis. The 
single most important test in observing the patients has proved to be serum 
bilirubin concentration, which frequently will be referred to in the clinico- 
pathologic correlations. 
Results 
Pediatric patients. 
Other than biliary atresia. Nine of the 16 patients lived for at least 
one year after transplantation. The seven others who received a total of 
eight grafts died after one to 188 days. Acute rejection (Fig. 4) was directly 
responsible for one of these seven deaths (Table IV). Late rejection (Fig. 
Fig. 6.-Large bile duct obstruction. a, Biliary cast syndrome 
in graft, OT55, two years and two months after transplantation. The 
wall of the distended bile duct is fibrous, and the lumen is blocked 
by inspissated bile and debris. Hematoxylin and eosin, X60. b, 
Biliary cast syndrome in graft, OT43,47 days after transplantation. 
A portal tract is greatly expanded and an intrahepatic bile duct is 
blocked by inspissated bile. Hematoxylin and eosin, X50. c, 
Chronic large duct biliary obstruction. Enlarged fibrous portal tract 
with proliferated bile ductules containing bile casts. Hematoxylin 
and eosin, X70. 
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Fig. 7.-Presumeddrug toxcity. Biopsy of a graft in apatient, 
OT 74, who was deeply jaundiced at one year and five months after 
transplantation. The liver functions returned to normal after azathi- 
oprine was replaced with cyclophosphamide and after the predni- 
sone dosage was lowered to less than half of its previous level. a, 
Centrilobular hepatocytes are swollen and show abnormal vari- 
ation in nuclear size. Hematoxylin and eosin, X200. b, Centrilobu- 
lar cholestasis with bile thrombi in dilated canaliculi. Bile stain, 
X200. c, Normal portal tract. Hematoxylin and eosin, X200. 
5) of a primary graft indirectly led to another death, inasmuch as a retrans- 
plantation became necessary and was not successful in spite of the fact that 
the second organ was not rejected (Table IV). The non-immunologic 
factors of biliary obstruction, tumor recurrence, perforation of a colonic 
diverticulum and ischemic liver necrosis were responsible for the other 
fatalities that occurred within the first year (Table IV). 
Shortly after one year (Table IV), two more patients died with 
recurrences of the hepatomas for which transplantations had been per- 
formed. In one of these livers, biliary obstruction developed as a result of 
a metastasis, and the other one contained evidence of chronic rejection, for 
which retransplantation was attempted. A third child died 26 months after 
liver replacement for chronic aggressive hepatitis. At autopsy, a stricture 
was found at the choledochocholedochostomy site, with dilatation of the 
duct system which was packed with inspissaied bile and debris (Fig. 6). 
There was no evidence of rejection. The mechanical problem probably 
could have been corrected if it had been diagnosed. Transhepatic cholangi- 
ography had been attempted four times in the six months before death, but 
the duct system was not entereil. 
The last late death occurred six years after transplantation. The 
original diagnosis in this patient was Wilson's disease. After liver replace- 
ment, the homograft had no tendency to accumulate copper (30). About 
four years postoperatively, the patient was thought to have discontinued 
the immunosuppressive therapy for several months. Liver function, which 
had been perfect, deteriorated, and he became jaundiced. Resumption of 
treatment did not reverse the process in spite of the fact that the liver biovsv 
. . 
now had relatively minor abnormalities. Because a transhepatic cholangi- 
ogram showed a partial biliary obstruction, bile duct reconstruction was 
revised with conversion of cholecystoduodenostomy to choledochojejun- 
ostomy; jaundice persisted. At autopsy, almost two years later, the main 
finding in the liver homograft was cholestasis, similar to that seen in Figure 
6, suggestive of chronic bile duct obstruction. 
Five of the 16 recipients in this nonatresia pediatric subgroup are still 
alive after 13 months to almost five years (Table I). Each attends junior 
high school, high school or a university. They all have normal, or nearly 
normal, liver function, with serum bilirubin concentrations ranging from 
0.5 to 1.5 milligrams per cent. 
One of these patients who is now well became deeply jaundiced and 
profoundly ill almost a year and a half after transplantation. A liver biopsy 
was interpreted as showing drug toxicity (Fig. 7). Cyclophosphamide was 
substituted for azathioprine with subsequent slow improvement of liver 
function during the next few months (Fig. 8). 
Biliary arresia. The 40 recipients were given a total of 45 livers. One 
of the second grafts was from a chimpanzee (26,30). The other four organs 
for retransplantation were from cadavers as were all the 40 primary grafts. 
The one year survival figure was 11 of 40 patients or 28 per cent. 
In a recent publication, clinical or pathologic analyses were given for 
each of the 40 individual patients (30). Our interpretations from that raw 
data of the main reasons for graft losses and deaths are summarized in 
Table V. The complications came in progressive waves, to which specific 
etiologic factors selectively contributed at successive times. 
Acute problems of surgical technique or management were the most 
common causes of failure and resulted in the deaths of 11 children in 
5.7k6.6 (S.D.) days, range zero to 20. Graft vascular thrombosis, bleeding 
and the use of necrotic livers headed the list (Table V). The deaths occurred 
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Fig. 8. The first two post-transplantation years of patient, O T  74. The second liver biopsy, which is shown in Figure 7, 
suggested drug toxicity. Substitution of cyclophosphamide for azathioprine and reductions in steroid dosage were followed by 
gradual resolution of the profound hyperbilirubinemia. 
too soon to permit an effect upon the pre-existing jaundice, except in achild 
in whom the hepatic artery clotted but who had the longest survival time 
of 20 days. The serum bilirubin fell promptly and was 1.5 milligrams per 
cent just before death, which resulted from infection in multiple areas of 
liver necrosis. Birtch and Moore (4) have reported a similar experience of 
survival of 45 days by a patient who had a deanerialized and partly necrotic 
but functioning homograft. The recipient of the chimpanzee heterograft 
had a serum bilirubin concentration of 14 milligrams per cent after 14 days 
when he died from pulmonary insufficiency that had been present since the 
time of retransplantation. 
Another seven children died after 60.9k22.9 (S.D.) days after addi- 
tional mechanical complications which usually involbed the reconstructed 
biliary duct system in one of the ways shown in Figure 9 and which were 
not immediately lethal (Table V). Infection was the usual final event in the 
downhill course. The last serum bilirubin concentrations in these patients 
were 9.9k6.1 (S.D.) milligrams per cent, range 3 to 22. There was no 
histopathologic evidence of rejection in any of the grafts. nor was 
cholangitis aprominent feature. Virus infestation of the cells lining the bile 
ductules or of the hepatocytes was diagnosed in three of these seven livers 
(Fig. 10). It has been suggested by Martineau and his associates ( I  7) that 
such virus infestation of the biliary tree can cause swelling. necrosis and 
shedding of the infected cells to form obstructing casts. 
The foregoing pooled I8 examples of predominantly technical or 
mechanical difficulties accounted for 55 per cent of all the deaths in the 
atresia experience. The staggering total actuallq may have understated the 
true contribution of surgical technical complications to the failures, since 
it excluded the four examples of septic hepatic infarction (Table V) in 
which portions of the liver became dearterialized and necrotic with 
invasion b) bacteria from the intestinal tract. The latter complication has 
been suggested to be due to a combination of insufficient immunosuppres- 
sion plus technical or mechanical factors u hich tuist or otherwise jeopard- 
ize the hepatic arterial patency (25. 3 1). 
Rejection played a surprisingly minor role In causing graft loss or 
death, at least insofar as this could be detected by histopathologic exami- 
nation. Four patients acutely rejected the primary graft (Fig. 4) after 
17.3i11.0 (S.D.) days. The last serum bilirubin concentrations were 
17.8k7.5 (S.D.) milligrams per cent, range 13 to 29. 
Three grafts were designated as being lost primarily from chronic 
rejection because of the severe arterial narrowing. lymphoid cell infiltra- 
tion and other findings that are characteristic of this process (Fig. 5). These 
transplants had been in place for two months to two and one-half years and 
were supporting serum bilirubin concentrations of 19, 10 and 20 miligrams 
per cent. Three of the four livers that were lost primarily because of septic 
hepatic infarction had chronic rejection as well. 
Systemic infections or else infestations of the homografts were 
thought to be the main causes of failure in eight patients. generally at an 
intermediate time. Concomitant chronic rejection had damaged two of the 
homografts of the five patients who had lethal systemic infection (Table 
V).  Serum bilirubin concentrations uere  variable in these instances, 
ranging from 1 to 52, with a mean of 16.0+16.4 (S.D.) milligrams per cent. 
The three patlents uith infected livers had bilirubin levels of 52. 15 and 10 
milligrams per cent. 
One liver uhich was obtained from an anencephalic monster never 
cleared bilirubin. Ironically, it had the histopathologic findings of intra- 
hepatic biliary atresia when ~t was removed 85 days later. An attempt at 
retransplantation failed uhen  the hepatic artery of the second transplant 
clotted. 
Eleven or 28 per cent of the 40 patients survived for at least one year 
after operation. and seven are still alive with good or perfect function from 
their original hepatic homografts after 13, 15.26. 34.46.53 and 71 months 
(Table I) .  All are living essentiallj normal lives. Their return visits to 
Colorado range from ekery three to 12 monthi. None are jaundiced. In two 
of these patients. serial biopsies were obtained. Some of the early speci- 
mens showed classical cell mediated rejection (30) which was readily 
controlled as judged b j  the final clinical outcome. As already recounted, 
the late deaths occurred I2 112. 13 112, 30 and 41 months after transplant. 
THE HUMAN TRIALS 
Fig. 9.- Examples revealed by transhepatic cholangiography of homograft cystic duct 
obstruction after biliary reconstruction with cholecystoenterostomy. a, Original procedure was 
cholecystoduodenostomy. After this transhepatic cholangiogram, conversion was made to chole- 
dochoduodenostomy. At operation, the filling defect near the exit of the cystic duct was found to 
consist of a chalk-like sludge. There was not complete relief of jaundice. When the patient died 13 
months after transplantation, the homograft still had intrahepatic evidence of large duct obstruction. 
b, The original reconstruction was with cholecysto-Roux-en-Y-jejunostomy. This was converted 
to a choledochojejunostomy. The patient is well a year later. c, The original reconstruction was with 
cholecysto-Roux-en-Y-jejunostomy. This was converted to a choledochojejunostomy. The patient 
is well about two years later. CD, Common bile duct; CyD, cystic duct; GB, gallbladder, and J, 
Roux-en-Y limb of jejunum. 
Adult Patients. Only seven or 19 per cent of the 37 adult recipients 
lived for as long as one year postoperatively. The results were not satisfac- 
tory after transplantation for any of the main indications for liver transplan- 
tation (Table 11). Only one of nine alcoholics survived for as long as one 
year. Three of nine patients with chronic aggressive hepatitis lived for this 
long, as well as two of 12 patients with primary tumors of the liver. Two 
patients in the malignant category are still alive 15 and 22 months after liver 
replacement for the small intrahepatic duct cell carcinoma described by 
Klatskin (15) that obstruct the confluence of the right and left hepatic ducts 
and cause early jaundice. The recipient with the longer follow-up period 
has multiple recurrences in the transplanted liver. The patient (Table 11) 
who had the Budd-Chiari syndrome is the only one with this diagnosis 
known to have been treated by liver transplantation. 
In Table VI, a single principal reason was identified for the loss of 
each of the 35 homografts that were transplanted to the 33 adult recipients 
who eventually died. Seventeen of the recipients or 59 per cent of the 29 
who died in the first postoperative year had lethal complications which had 
their genesis intraoperatively or just afterward (Table VI). 
Eleven of these 17 early accidents were classed as technical and led 
to death in 19.8 f 11.4 (S.D.) days. Only one of these 11 patients was not 
jaundiced before death. The other ten had final serum bilirubin concentra- 
tions that ranged from 7 to 46 miligrams per cent, with a mean of 26.8 + 12.7 
(S.D.). Three of the patients were given livers that were irreparably 
damaged by ischemia in operations that were long and bloody. The grafts 
of the three more recipients were mined by tying off an anomalous double 
barreled channel of cystic and common duct preparatory to performance of 
cholecystoenterostomy (31). The complication was not recognized or 
treated in two patients. An attempt to relieve the consequent total biliary 
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obstruction in the third patient resulted in a bile fistula and lethal peritoni- 
tis. In five more patients, bile fistulas developed with peritonitis, and they 
died after 13 to 34 days. The leaks were at the site of choledochocholedo- 
chostomy or at the T-tube insertion site in four instances. The fifth fistula 
was caused by necrosis of the gallbladder after cholecystoenterostomy. 
Cerebrovascular accidents accounted for six other intraoperative or 
puzzling early postoperative complications. Two of the patients were in 
Stage IV hepatic coma at the time of operation, but the other four were more 
or less alert. After operation, five or six recipients, including one in 
~ rev ious  coma. had a lucid interval that lasted from a few hours to three 
hays before the; were crippled by neurologic disabilities that were sugges- 
tive of major brain stem damage. The transplant operations in each instance 
had been iong and difficult, with many blood transfusions which further 
reduced thrombocyte counts that had already been low. The neurologic 
damage was so profound in each instance that death followed within a few 
days, or else a decision was later made to stop active treatment. The six 
patients died after 21.7k14.8 (S.D.) days, range 3 to 41. By then, two 
patients had serum bilirubin concentrations of 28 and 7 miligrams per cent, 
respectively, but the other four had bilirubin values which ranged from 0.7 
to 2.7 milligrams per cent. All the liver grafts were free of rejection, and 
two were completely normal. The brains had areas of myelinolysis in the 
brain stem. In addition, there were other cortical and subcortical abnor- 
malities in some of the brains. These latter included small hemorrhages, 
infarcts and edema. 
There were seven deaths 17.329.8 (S.D.) days after transplantation 
from systemic infections which usually reflected the poor preoperative 
state of the patients. Two were receiving second grafts, one patient had 
candidemia at the time of transplantation, one was a fragile end-stage 
alcoholic and three were patients who were treated early in our experience 
before infectious disease care under conditions of immunosuppression had 
been standardized. Two of these last three patients had also had pulmonary 
embolization from clots which had formed in a venovenous bypass tube 
which is no longer used (29). The final serum bilirubin concentrations were 
variable, ranging from 1.5 to22 milligramspercent, withameanof 9.9k7.6 
(S.D.). 
At an intermediate time of 2 0 9 ~ 2 2 1  (S.D.) days, ranging from 47 to 
564 days, six grafts were retrieved by death or retransplantation that had 
histopathologic findings of extrahepatic biliary obstruction. The original 
biliary duct reconstruction was with'cholecystoduodenostomy or Roux- 
en-Y cholecystojejunostomy. There was clinical evidence of adequate bile 
excretion initially. Hone\er ,  it was either proved later in four patients or 
assumed in retrospect that the site of obstruction was at the cystic duct, as 
shoun in Figure 9. Reoperation Bas performed in four patients, and a 
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secondary choledochoenterostomy was attempted with what was thought 
to be success. However, histopathologic findings persisted within the liver 
of large bile duct obstruction weeks or months later. Furthermore, jaundice 
was not permanently relieved. The final mean serum bilirubin concentra- 
tion reflecting the function of these grafts was 18.4k8.4 (S.D.) milligrams 
per cent. range 5 to 28. Two of these apparently obstructed hepatic 
homografts were removed after 564 and 11 1 days and replaced under the 
probably erroneous assumption that they had been rejected. The patients 
died 1 l and 22 days later. 
The most surprising observation was that only one of the 35 livers 
transplanted to adult recipients contained the classical findings of acute 
cell mediated rejection. Four other grafts contained residual changes of 
acute rejection or evidence of repair following this process, but rejection 
was not considered to be the main cause of failure. Furthermore. there were 
no examples of chronic rejection. 
However, only three of the remaining 30 livers were structurally 
normal. The majority of the others contained such diverse and nonspecific 
findings (Fig. 11) as fatty infiltration, venous congestion. centrilobular 
cholestatsis. atrophy or necrosis of the centrilobular hepatocytes and focal 
necrosis or infarction that were thought to be secondar). to ischemia or 
sepsis. One liver had severe centrilobular atrophy and reticulin coilapse at 
the time of death from hepatic failure after 161 days. A convincing final 
diagnosis u as not made. Several l i ~  ers were infested n ith c j  tomegalovirus 
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Fig. 10.- Virus infestation of cells lining bile ducts. a, Several bile ducts obstructed by swollen virus infected 
cells in an expanded portal tract in a liver graft, OT 30.37 days after transplantation. Hematoxylin and eosin. X50. 
b, Detail of similar obstructed duct in another infected graft, OT 44, shows enlarged lining epithelial cells containing 
nuclear inclusions. Cytomegalovirus was identified in this liver. Hematoxylin and eosin, X700. 
particles (Fig. 10) which were in hepatocytes and in the cells lining ducts. 
Two hepatic grafts were invaded with recurrent malignant tumors of 
the same kind that had destroyed the native liver, leading to death after 349 
and 87 days. One was a hepatoma and the other was a hemangioendothelial 
sarcoma. 
Four of the seven patients who survived for one year are still alive 
with follow-up periods of 13 to 22 months. They have perfect liver 
function. All four live at home and work full time or attend school. The 
patient with the longest follow-up period has recurrences of intrahepatic 
duct cell carcinoma. 
The three deaths after one year were at 13 112, 19 112, and 20 112 
months. All were patients whose original diagnosis was chronic aggressive 
hepatitis. However, recurrence of the aggressive hepatitis was observed 
only in the recipient who was an HB,Ag virus canier (Fig. 12). Candidiasis 
and nocardiosis contributed to her death as Corman and his associates have 
reported (7). In the other two recipients, the grafts were destroyed by the 
biliary obstruction already cited, which was not recognized in one instance 
leading to an ill-advised retransplantation and which was apparently not 
effectively treated in the other. 
Discussion 
In a positive sense, the most important conclusion that has emerged 
from this experience with liver replacement was that prolonged survival 
repeatedly was possible. A total of 27 patients lived for at least a year 
following operation, and 16 of this group are still alive after more than one 
to almost six years. The outlook has slowly improved, although not to a 
satisfactory state. The first 25 recipients who formed the basis of a 
monograph on liver transplantation (31) included only five one year 
survivors. The next group of 25 contained six, and the group after that had 
eight. There have already been eight one year survivors among the 18 
patients beginning with No. 76. 
The chronic survivors, particularly those in recent times, have had 
remarkably stable liver function, and usually, they have achieved complete 
social rehabilitation. Survival of more than a year after orthotopic liver 
transplantation has been recorded from other centers by Williams (35). 
Waldram and Calne and their associates (34) in England, by Daloze and his 
colleagues (8)' in Canada and by Hume and his associates ( 1  2) in the United 
States. 
One reason the results were not better was the great technical 
1.  The patient described in this report is alive one and one-half years after 
transplantation. The other two one year survivors in the Montreal series of six patients 
died after two and threequarters and three and three-quarters years as learned from 
personal communication on 3 December, 1975. 
difficulty of performing orthotopic liver transplantation under the trying 
conditions of end-stage hepatic disease with consequent portal hyperten- 
sion and multiple coagulation and metabolic defects. Even excluding the 
biliary duct complications, about a fourth of the patients who died left the 
operating room with situations that were incompatible with survival, such 
as ischemic liver necrosis, graft vascular thrombosis and uncontrolled 
hemorrhage. The mortality from technical accidents involving vessels was 
particularly high in infants with biliary atresia, partly because of the small 
size of the structures for anastomosis. The recent use of microsurgical 
techniques has almost completely eliminated such losses. In future trials, 
children with a wide range of diseases, including biliary atresia, undoub!- 
edly will be the most favorable group of recipients. 
More critical questions must be asked about the six crippling cere- 
brovascular accidents which constituted the single most lethal complica- 
tion intraoperatively, and early postoperatively among the 37 adults. The 
most consistent, although not the only, damage was found in the brain stem 
and consisted of the kind of myelinolysis that is associated with end-stage 
liver disease. Williams and his associates (35) also may have encountered 
cerebrovascular accidents, inasmuch as two of their 26 recipients failed to 
awaken from anesthesia. Lampe and his co-workers (16) have reported a 
serious, but partly reversible, diffuse brain injury in an 1 1 year old recipient 
of an orthotopic liver. They ascribed the complication to intraoperative 
hyperosmolarity that had been caused by excessive glucose administra- 
tion. Hyperglycemia was not a regular feature of our patients, although it 
was present in some of them. Intraoperative thrombocytopenia and hy- 
pocoagulability may have led to small hemorrhages into areas of pre- 
existing brain disease. Air embolus as the causation has not been ruled out. 
The neuropathologic findings in these autopsies are being restudied, so that 
preventive measures may be developed for future patients. In the mean- 
while, the high risk of brain damage in adult patients who had a wide 
variety of diagnoses suggests that as a general policy candidacy for trans- 
plantation was being considered too late in the terminal course of the 
disease. 
In the livers that were eventually retrieved for study by death of the 
recipient or removal at retransplantation, a potentially encouraging but 
perplexing observation was the paucity of unequivocal findings of either 
acute or chronic rejection. Early biopsies from a few of those grafts 
contained the unmistakable lymphoid infiltrations of acute cell mediated 
rejection (30,3 l), but this process usually had been controlled at least by 
histopathologic criteria by the time the whole organ was examined. 
Moreover, the kind of chronic rejection that has been so well described in 
dogs (21, 28) and which is characterized by obliterative vascular lesions 
with or without lymphoid infiltration and fibrosis was not common either. 
About one in four of all the grafts studied had strong histopathologic 
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Fig. 11.- Pattems of liver injury not thought to be rejection or obstruction. a, Focal areas of necrosis, OT 69. 
Hematoxylin and eosin, X60. b, Acute venous congestion, OT 17. Hematoxylin and eosin, X60. c, Centrilobular cholestasis 
with bile thrombi, OT 97. There was no evidence of large duct obstruction, drug toxicity or rejection in this patient. Hema- 
toxylin and eosin, X200. d, Diffuse fatty infiltration of hepatocytes, OT 94. Frozen section stained with Sudan IV, X60. 
evidence of large bile duct obstruction, and in most of these instances, there 
was confirmation that such mechanical problems had been present from 
premortem clinical studies or from postmortem gross examination. Some 
of the livers had demonstrable infestation and injury by bacteria, fungi or 
viruses. However, the majority of the livers contained changes that might 
be considered nonspecific under other circumstances. Examples were fatty 
infiltration, venous congestion, centrilobular cholestasis, centrilobular 
atrophy or necrosis and focal necrosis or infarction. 
The interpretation from these findings may prove to be that liver 
recipients are being systematically overimmunosuppressed, particularly 
since, as a final event, almost all liver recipients who die have significant 
extrahepatic infections (31). If overtreatment is the problem, a change in 
management policy will be called for, whereby lightening instead of 
intensification of immunosuppression would usually be an appropriate 
response to deterioration of postoperative liver function. 
This kind of radical approach can hardly be justified yet since many 
patients with a graft that is failing early after transplantation respond to 
increased doses of prednisone. It may be that some of the structural 
abnormalities that are presently thought to be nonspecific are actually 
subtle manifestations of hepatic rejection or recovery from this process. 
Such an interpretation would fit with observations in dogs that start to 
recover from rejection, either spontaneously or as a result of treatment with 
immunosuppressive drugs (11, 21, 28, 31). Characteristically, the ho- 
mografts of such animals lose the lymphoid cell infiltration and develop 
prominent centrilobular bile stasis, atrophy of the centrilobular hepato- 
cytes, collapse and condensation of the centrilobular reticulin and in- 
creased amounts of reticulin and collagen in the portal tracts. Besides any, 
or all, of these findings, fat deposition is not uncommon. 
Similiar observations, including centrilobular bile stasis, have been 
made in the homografts of unheated, but long surviving, pigs by Hunt (13) 
and Battersby and his colleagues (2) and in treated baboons by Myburgh 
and his associates (19). Autografts of dog livers reported by us (31), Alican 
and Hardy (1) and McBride and his associates (18) did not have the 
cholestatic or other findings. The same absence of these findings in pig and 
baboon hepatic autografts has been described by Battersby (2) and 
Myburgh (19) and their colleagues. 
The critical and, as yet, unanswered questions are whether or not the 
foregoing changes in homografts and particularly the finding of intra- 
hepatic cholestasis could represent ongoing rejection and, if so, how? 
Myburgh and his associates (19) have suggested the possible dynamic and 
immunologic nature of the cholestatic lesion on the basis of their own 
observations as well as a more general hypothesis of Schafher and Popper 
(22). In essence, their argument holds that a continuous and often sublethal 
injury to the hepatocytes is mediated by humoral antibody or by small 
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Fig. 12.- Recurrence of viral hepatitis. a, Hepatitis affecting graft, OT 36. Hematoxylin and eosin, X250. b, 
Same graft stained with orcein. Granular material is present in the hepatocyte cytoplasm. This usually indicates the 
presence of hepatitis B viral antigen. Shikata stain, X300. 
numbers of leftover lymphoid cells. The hypothesis continues that hepa- 
tocyte organelles, including the smooth endoplasmic reticulum, are dam- 
aged, causing perturbations in the secretion and relative concentrations of 
bile salts, cholesterol, phospholipids and bilirubin with the consequent 
formation of intrahepatic sludge and the establishment then of a reinforc- 
ing cycle of sludging and obstruction. Studies will need to be designed to 
test this potentially important theory, an extension of which Waldram and 
his colleagues (34) have applied to partially explain sludge formation in the 
large bile ducts. 
Unfortunately, similar histopathologic abnormalities can be caused 
by many agents. Fahrliinder and his co-workers (9) reported that, in eight 
patients, severe bacterial infection of organs other than the liver caused 
intrahepatic cholestasis with minimum hepatocellular injury or inflamma- 
tion. Electron micrographs revealed dilatation of the canaliculi and rough 
endoplasmic reticulum. A clinical syndrome of liver failure associated 
with infection recently reported by Norton and his colleagues (20) may 
well represent a more severe version of the same process. 
It is self evident that intrahepatic cholestasis or the other manifesta- 
tions of liver injury could also be caused by drugs, particularly those used 
for immunosuppression. The possibility that either azathioprine or predni- 
sone can harm animal or human livers was already well known a decade 
ago (27.3 1) from experience in kidney transplantation, although there was, 
at that time, no good way of separating out the instances of serum hepatitis. 
With the development of the HBsAg screening tests by Blumberg and his 
co-authors ( 3 ,  Torisu and his associates (33) were able to survey the 
serums of 83 of our renal recipients. Because serial serum samples had 
been systematically stored, it was possible to develop a longitudinal profile 
of the HBsAg state going back as long as five or six years. The serum of 
nearly 20 per cent of the patients had become HBsAg positive, but the 
ultimate incidence of severe liver disease in this group was not substan- 
tially different from that in the kidney recipients who had been consistently 
HB,Ag negative. Because of these observations incriminating factors other 
than serum hepatitis in the cause of post-transplantation hepatic dysfunc- 
tion, a number of our renal recipients with serious postoperative liver im- 
pairment have been switched to cyclophosphamide (32). The improve- 
ment that may follow in the hepatic state without deterioration of renal 
homograft function has been confirmed by Beme and his associates (3) and 
in at least one of the liver recipients herein reported. A similar program of 
drug change in liver recipients with hepatic malfunction is likely to be 
important in future patients, notwithstanding the belief of Briggs (6) and 
Ireland (14) and their associates that azathioprine is totally devoid of hepa- 
totoxicity. 
Because the definition of the cause for postoperative hepatic mal- 
function is emerging as the most critical element in the care of liver recipi- 
ents, other active diagnostic steps will need to be taken, of which repeated 
needle biopsies and cholangiography are probably the most important. 
Even if unequivocal diagnosis of conditions like hepatitis, drug hepatotox- 
icity, rejection and inmahepatic infection is not possible, repeated tissue 
study findings could give a better insight into the evolution of recovery or 
failure of the transplants which will be applicable in future patients. 
Clearly, radical decisions about therapy, such as one for retransplantation, 
should not be made without prior biopsies and without multiple efforts at 
transhepatic cholangiography to rule out large duct obstruction. 
The greatest dividend from improved diagnosis may be better man- 
agement of the biliary duct complications that have so beset liver transplan- 
tation in our hands (17, 26, 31) and as reported by Williams and his 
associates (35) in the King's College-Cambridge series in England. Bile 
fistulas usually require wide drainage. With duct obstruction, reoperation 
is mandatory before there is incurable infection of the homograft. 
In our series of obstructions, the most common reoperation has been 
conversion from cholecystojejunostomy to choledochojejunostorny (Fig. 
3B and C). In the series herein reported, there were about 20 livers in which 
the ducts were certainly, or probably, obstructed. Only a few were 
successfully corrected, virtually all within our recent experience, includ- 
ing five of the 16 patients who are still alive. 
With such a high incidence of biliary tract complications, continuous 
reassessment of the initial choice of reconstructive procedure will be 
necessary. Although our usual first choice is a Roux-en-Y cholecystojejun- 
ostomy, choledochocholedochostomy with a T-tube stent has been used 
frequently, taking pains to provide broad wound drainage. The former 
operation has had a high incidence of obstruction, and the latter has carried 
a high risk of fistula (26). With either complication, we (17) and Waldram 
and his group (34) have noted a remarkable tendency for the ducts to 
become filled with a chalk-like debris, leading to what has been called the 
inspissated bile syndrome. 
Periodic reassessment also will be necessary of the influence of the 
original host disease upon the outcome insofar as this factor influences fu- 
ture patient selection. None of the diseases for which liver transplantation 
has been used so far can be categorically precluded as an indication for 
further mals, especially in children. The brightest chapter in liver trans- 
plantation has been in the treatment of inborn errors of metabolism in 
children, including our two patients with Wilson's disease, our patient with 
alpha-1-antitrypsin deficiency and the child of Daloze (8) with Niemann- 
Pick disease. 
Although the experience with adults with cirrhosis in general and 
with alcoholic cirrhotics in particular has been dismal, this has often been 
because of their appalling condition at the time of treatment. Earlier 
decisions need to be made about treatment with transplantation. Even 
continued efforts to treat recipients with chronic HB,Ag antigenemia are 
probably warranted, especially if hyperimmune specific gamma globulin 
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large experience with hepatic trisegmentectomy, a partial liver resection in 
which approximately 85 per cent of the liver is removed (24). A number of 
the patients in that series who, as it turned out, could be treated by 
conventional means had k e n  referred to us for consideration of liver 
transplantation after an erroneous decision of nonresectability had been 
made at earlier operations. The same point has been made by Smith (23). 
Summary 
During the 1 1 112 year period ending 13 months ago, 93  consecutive 
patients were treated with orthotopic liver transplantation. Fifty-six of the 
recipients were 18 years old or younger, and the other 37 were adults. The 
most common indications for operation were biliary atresia. primary 
hepatic malignant tumor. chronic aggressive hepatitis and alcoholic cir- 
rhosis. 
There has been a gradual Improvement in results throughout the 
period of study, although not to a satisfactory level. Twenty-seven of the 
93  patients survived for at least one year after liver replacement with a 
maximum of six years. and 16 are still alive after 13 to 71 months. The 11 
late deaths after one to six years were caused by chronic rejection, biliary 
obstruction. recurrence of hepatoma. systemic infection or hepatitis of the 
homograft. 
Rejection of the liver as judged by classical histopathologic criteria 
played a surprisingly small role in the heavy over-all mortality. account- 
ing for less that 10 per cent of the deaths. Technical or mechanical 
problems, especially those of biliary duct reconstruction. were a far greater 
cause of failure. as were systemic infections. Six of the 37 adult recipients 
had lethal cerebrovascular accidents during, or just after, operation. When 
abnormalities of liver function developed in the postoperative period, the 
nearly automatic diagnosis of homograft rejection, in retrospect, proved to 
have been wrong in most instances. 
Further development of liver transplantation depends upon two kinds 
of progress. There must be reduction of operative and early postoperative 
- 
a, Prirnar) graft In patient who undrrwent rctransplnntation; b, second accidents and complications by more discriminating patient selection, 
graft. purely technical improvement and better standardization of bilia.ry duct 
*Rcopcratlon was atternptcd in  three of thcse patients, one w ~ t h  obstruc- 
tion and ~ H O  with fistula reconstruction. The second area hill  k in sharpening the criteria for the 
t.41tcrnpts wrre madc to opcraic sccondaril? upon four of thcse patients. differential diagnosis of postoperative hepatic malfunction, including the 
:Four other grafri con:alned resld~ial changes or rcpair following acutc 
mjcct~on, but t h l s  w a s  not considered to be thc maln causc of failurc. liberal use of transhepatic cholangiography and needle biopsy. Only then $Bactcr>al or fungal or both can better decisions k made about changes in medication or about the need 
for secondary corrective surgical procedures. 
therapy can be offered. 
The treatment of hepatic malignant tumors with liver replacement 
remains a controversial issue. One of our patients is cured of a hepatoma 
after almost six years, but that neoplasm u a s  small and was an incidental 
finding in a liver that had biliary atresia. Five other patients with hepatomas 
who lived long enough for observations to be made had recurrences as did 
a sixth patient uhose native liver and, later, uhose liver graft were 
destroyed by a hemangioendothelial sarcoma. Two of our three patients 
with intrahepatic duct cell carcinomas are alive one and one-quarter and 
one and three-quarter gears postoperatively. Lnfortunatelg. the patient 
with the long survival period has massive recurrences which are predomi- 
nantly in the homograft. 
Although details have varied, the over-all message from Williams 
and his associates (35) has been the same, although somewhat more op- 
timistically expressed. In their series of transplantations for four hepato- 
mas, five duct cell carcinomas. t h o  metastatic malignant lesions and one 
cholangiocarcinoma, eight of the I2 patients were afflicted u ~ t h  recurrent 
neoplasm. In four of their fi \e patients ~ i t h  duct cell carcinoma, obvious 
metastases developed, the exception being a recipient u h o  died after three 
weeks. On the other hand. hepatoma recurred once in four inutances. but 
on]! one of these recipienrs li\ed as long as one year. That exceptional 
patient u h o  died of biliarj obstruction after more than fibe gears was free 
of metastases at autops!. H o u e ~ e r .  rhe orig~nal tumor uas  apparentlj slow 
growing. since she had been auare of an abdominal m a v  for more than six 
years preceding transplantation. 
Recurrences after l i ~ e r  transplantation for primarg hepatic malignant 
tumors also ha\e  been recorded bq Hume i 12) and Fortner (10) and their 
associates. It 1s axiomatic that the outcome In an! given patient will depend 
on the extent of the neoplasm at the time of transplantation. In this 
connection. a precaut ionq note about uhdt constitutes genuine candi- 
dacy for liver replacement may be Introduced on the baas  of our unusually 
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J. C. Cutropia 
Passive veno-venous. bypasses were described in Part I. In 1972, Cutropia of Mendoza, 
Argentina published the first description of pump-driven veno-venous bypass without heparin. Dr. 
Cutropia was then 31 years old. He is now Chief of Surgery and Director at Hospital Espariol of 
Mendoza, Argentina. Dr. Cutropia's work was not known at the time a similar technique was applied 
clinically in Pittsburgh. 
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Transplante hepatic0 ortotopico experimental 
Experimental orthotopic liver transplantation 
Revista exspariola de las enfermedades del aparato digestivo, 38: 553-70, 1972 
J. C. Cutropia, F. Coratolo, A. Spinetta, J. Kei, A. Ribas, L. Assini, G. Delle Donne, M. Bianchi, 
A. Guiiiazu and J. A. Verdaguer 
The study was conducted at the Department of Surgical Research of 
the Third Chair of Clinical Surgery, Mendoza University School of 
Medicine and the Espafiol Hospital of Mendoza, Argentina. 
Orthotopic liver transplantation was carried out in the following 
stages: harvesting of the donor liver, recipient hepatectomy without inter- 
ruption of the posterior vena cava and the orthotopic placement of the 
donor liver. 
Prior to this series, 38 experimental transplantations were conducted 
in order to perfect the surgical technique as well as postoperative manage- 
ment. 
Materials a n d  methods. 
This series was comprised of 40 healthy mongrel dogs of either sex 
with weights ranging from 15 to 27 kg: 20 animals were donors and an 
equal number were recipients. 
Prior to surgery they were given liquids exclusively. 
No immunosuppression was administered. 
Anesrhesla. Anesthetic agents were adminsitered by venotomy in the 
donors and by cephalic vein cutdown in the recipients. Respiration with 
oxygen was maintained by mechanical ventilation. The induction of 
anesthesia was achieved with droperidol-fentanyl. 2cclIO kg. diacepinone 
chlorobenzene. Img/kg; the second stage of anesthesia was sustained with 
sodium thiopental. 5mgy'kg. and galamine. 2 mg/kg. 
Reversal was obtained with atropine sulfate. 0.5 mg/lO kg, niketam- 
ine, 0.15 m g k g  and neostigmine. 0.5 mg/lO kg. 
Surgical rechniqire regard in^ the donor. 
- Midline incis~on from the xyphoid to the pubis. 
- Division of falciform ligament, triangular ligaments and of the gas- 
trohepatic omentum. 
- Dissection of the common hepat~c arteq as far as the celiac axis, 
ligation and div~sion of the pyloric and gastroduodenal arteries. 
- Identification and d i ~ ~ s i o n  of the common bile duct below the 
confluence with the cystic duct. 
- Dissection of the portal vein as far as the gastrosplenic vein, ligation 
and division of the pyloric and gastroduodenal veins. 
- Dissection of the posterior vena cava from the diaphragm as  far as the 
right supradrenal vein. 
- Division of the suprahepatic posterior vena cava by means of a 
pericaval phrenicotomy. 
Fig. 1.- Gravity perfusion of the donor liver. v.C.C., caudate vena 
cava; a.H.c., common hepatic artery; v.P., portal vein; c. common bile duct; 
v.B., gallbladder. 
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Fig. 2.- Recipient hepatectomy sparing the caudate vena cava. 
v.Sh., suprahepatic veins; v.C.C., caudate vena cava; v.P., portal vein. 
- Division of the common hepatic artery in continuity with the celiac 
axis with the introduction of a thin catheter permitting perfusion. 
- Division of the portal vein with the introduction of a catheter 
permitting perfusion. 
- Puncture of the base of the gallbladder with lavage and the creation 
of a cholecystostomy with a Pezzer tube. 
The perfused organ (Fig. 1) is camed to the operating table on a tray. 
For perfusion at 4-8°C 500cc of lactated Ringer's solution was mixed with 
procvaine, 1 g, heparin, 5000 units, protease inhibitor, 100,000 units, 
sodium bicarbonate, 40 meq. 
Perfusion was accomplsihed by gravity with a 140 cm column for the 
arterial line and a 30 cm cloumn for the venous line. The ratio between flow 
Fig. 3.-Decompression of the caudate vena cava and the portal vein 
in the recipient while these vessels is accomplished by means of a roller 
pump or a simple tube. v.C.C., craniad vena cava; v.P., portal vein; v.C.C., 
caudate vena cava. 
to the hepatic artery and portal vein was maintained at 1:2, i.e., 1000 cc  
perfused through the arterial side for 500 cc perfused through the venous 
side. 
The donor was exsanguinated by means of aortic puncture. In this 
way 200-400 cc of blood was obtained. 
rative technique regarding the recipient. 
Midline incision from the xyphoid to the pubis. 
Division of the falciform ligament, the triangular ligaments and the 
gastrohepatic omentum with meticulous hemostasis. 
Visualization of the common hepatic artery through the gas- 
trohepatic space. The hepatic arteries are identified and dissected. 
Identification of the common bile duct proximal to the duodenum. 
Dissection of the portal vein from the hilum of the liver as far as the 
duodenal vein. 
Dissection of the infrahepatic vena cava as far as the renal veins. 
Wide side-to-side portacaval anastomosis* with 5-0 silicone-treated 
silk with a continuous everting suture. 
Ligation and division of the hepatic arteries. 
Ligation and division of the common bile duct. 
Division of the portal vein between vascular clamps proximal to the 
hepatic hilum. 
Placement of two sutures in the diaphragm on either side of the vena 
cava; these are used to pull the liver and diaphragm caudally. 
Individual dissection and division of all hepatic veins; thus, an 
anhepatic animal is obtained and the posterior vena cava remains 
intact (Fig. 2). 
Construction of an external right femoro-jugular bypass with sili- 
cone-treated plastic tubes. The tubes are silicone-treated for 30 
minutes with water-soluble silicone diluted 1:20 in distilled water 
and then sterilized in an autoclave. 
In the first ten animals a roller perfusion pump was used for veno- 
venous bypass: in the remaining ten animals the bypass was passive 
with a simple tube (Fig. 3). 
Division of the posterior vena cava between vascular clamps leaving 
a venous cuff of sufficient length to permit anastomosis. 
End-to-end anastomosis of the recipient's subdiaphragmatic vena 
cava with the donor liver's suprahepatic vena cava using 5-0 silicone- 
Fig. 4.- Vascular reconstmction in the recipient. The portacaval 
shunt is occluded with a clip. v.C.C.. caudate vena cava; v.P., portal vein; 
v.B.,  gallbladder. *Actually mesocaval. 
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treated silk in a continuous everting suture. 
- End-to-end anastomosis of the donor liver's infrahepatic vena cava 
with the recipient's suprarenal vena cava with the same material and 
in the same manner as in the previous anastomosis. 
- Removal of the vascular clamus from the uosterior vena cava and the 
retention sutures from the diaphragm. After placing the liver properly 
in the right subdiaphragmatic space, the pericaval diaphragmatic cuff 
is fixed~to the muscle of the right hemidiaphragm. 
- Retrograde drainage of as much as 100 cc of blood from the donor's 
portal vein. End-to-end anastomosis of the donor portal vein with the 
recipients portal vein with 5-0 silicone-treated silk in a continuous 
everting suture. The vascular clamps are removed. 
- End-to-side anastomosis of the donor's common hepatic artery to the 
arch of the recipient's common hepatic artery with 6-0 silicone- 
treated silk. 
- Closure of the portacaval anastomosis with a plastic clip(Fig. 4). 
- Exteriorization of the cholecystostomy drain. 
- Closure in individual layers of the abdominal wound. 
- Removal of the shunt tubes. 
Intraoperati~e care of the recipient. 
During hepatectomy 500 cc of lactated Ringer's solution was ad- 
ministered, and from the onset of the anhepatic state to completion of the 
procedure 500 cc of lactated Ringer's solution with glucose, 0.5 g k g h r ,  
and sodium bicarbonate, 2 meqkghr ,  was administered. At the conclusion 
of the vascular anastomoses. 500 cc of blood 100,000 units of proteinase 
inhibitor and 4 g of E.A.C.A. ( epsilon-aminocaproic acid) was infused. 
For every unit of blood infused (300 cc) sodium bicarbonate, 10 
meq., and calcium gluconate , 200 mg, are injected. 
Also, during each hour of the procedure the recipient was admini- 
stered 50 cc of 15% mannitol and the diuretic response was observed. 
Postoperative care of the recrprmt 
Cannulation of the vein was maintained for 72 hours and 50 cc/kg/ 
hr of 5% glucose in physiological saline was infused. Every eight hours 
chloramphenicol, 1 g, and analgesics were adminstered by venoclysis. 
After the third day this was done intramuscularly. Oral alimentation, first 
liquids and then solids, was initiated as soon as possible. 
Studies in recipients. 
- In all animals the bi l iaq  secretion was measured every 24 hours. 
-Total bilirubin and the direct and indirect fractions, SGPT and 
alkaline phosphatase were determined daily in all recipents by spec- 
trophotocolorimetry. 
- Angiography, fluoroscopically and with images, was performed 
using sodium diatrizoate. During the immediate postoperative period 
in recipient 13 selective arteriography of the liver was performed via 
the left femoral artery. On the second day, in recipient 14, venogra- 
phy of the vena cava by means of the left femoral vein and, in recipent 
15, splenoportography by pubcture of the spleen were performed. 
- Cholecystography with sodium diatrizoate venography of the vena 
cava in recipient 14 on the same day. 
- Autopsy in all animals. 
- Microscopic examination of all transplanted livers after fixation in 
10% formol with paraffin and staining with hematoxylin-eosin. 
Results. 
The average length of the operation was 270 minutes. 
The average time of hepatic perfusion was 20 minutes, the average 
time for completion of the hepatectomy was 170 minutes and the average 
time for the vascular anastomoses was 80 minutes. 
The shortest survival (Fig. 5) was a few minutes and the longest was 
six days. 
Clinical observations. 
A short time after the cesat ion of respiratory assistance in recipient 
3 the animal became cyanotic and died without ever resuming adequate 
spontaneous respiration. 
Fig. 5.- Survival of 20 orthotopic liver transplants. 
e i ~ i s  cCva h.  
Fig. 6.- Bile drainage via cholecystostomy in 20 orthotopic liver transplants 
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Fig. 7.- Total serum bilirubin determined in 20 animals with orthotopic livers transplants. 
Fig. 8. 4 l u t a m i n e  pyruvate transaminase levels in 20 dogs with onhotopic liver transplants. 
L 
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Fig. 9.- Alkaline phosphatase levels in 20 homogeneic orthotopic liver transplants. 
Recipents 2 and 11 died 20 and 10 minutes after the operation, 
respectiveiy. 
Recipients 1, 5, 12 and 16 bled copiously from their laparotomy Immediately following the operation, the values of SGPT (Fig. 8) 
wounds. and alkaline phosphatase were elevated, and they attained their highest 
After recovering from anesthesia. recipients 1. 4, 5, 7 and 12 had levels in recipients 7, l 8  and 20. 
dyspnea, pallor of the mucosa and conjunctiva, cyanosis and some vom- 
iting that continued until the dogs died. Radiologic findings. 
Recipients 13, 16 and 19 had unremarkable postoperative courses Selective arteriography of recipient 13 demonstrated (Fig. 10) that 
until the third day; then they became tremulous. vomited. had convulsions the anastomisis was intact and perfusion of lhe liver was good. 
and died. Venography of the cava in recipient 14 (Fig. 1 1) revealed a stenosis 
on the sixth postoperative day after emesese, weakness at the level of the infra- and suprahepatic posterior vena cavae caused by 
and prostration, recipient 6 became  unconscious^ icteric and bilirubinuric, the unequal diameters of the two vessels with retrograde filling of the 
After unremarkable postoperatibe courses and adequate voluntary suprahepatic cava. 
oral feedings, recipients 8 and 10 died without any obvious signs or Splenoportography in recipient 15 (Fig. 12) demonstrated an ob- 
symptoms. struction to flow at the portal vein anastomosis casued by stenosis and 
thrombosis. 
Laborarorj resulrs. Cholecystocholangiography (Fig. 13) in recipient 14 demonstrated 
~~~i~~ the days before the death ofrecipent 18, the majority of the the point of ligation and dikis~on of the common bile duct as well as the 
total bilirubin was comprised of the conjugated fraction. intrahepatic flow of bile. 
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Fig. 10. -Selective hepatic arteriography in recipient 13. The arrow 
indicated the anastomosis of the donor and recipient hepatic arteries. a ,  
donor common hepatic artery and hepatic artery; b, recipient gastroduo- 
denal aretry; c,  craniad portion of recipient pancreaticoduodenal artery; d ,  
recipient right gastroepiploic artery; e, recipient common hepatic artery. 
Autopsy findings. 
In recipients l ,2,5,11 and 12 autopsy revealed 200-700 cc of blood 
in the abdominal cavity, and in the remaining animals there was 50-600 cc 
of anthochromic fluid. 
In all of the animals the liver was tense and congested. 
In recipients 4,6,7,9,17 and 20 the gallbladders contained 18-22 cc 
of bile; in the remaining animals there was 5-10 cc. 
Recipients 18 and 19 had hepatic abscesses. 
Rupture of the hepatic parenchyma was observed in recipients 1,5  
and 12. 
Anastomoses involving the portal vein were narrowed in recipients 
4,5,7,  15 and 17, involving the subdiaphragmatic vena cava in recipients 
8, 14 and 17 and involving arteries in recipients 4,6 ,7 ,  12 and 20. 
Fig. 12. - Splenoportography of recipient 15. The arrow demon- 
strates the narrowed anastomosis between the donor and recipient portal 
veins. a,  dilated recipient left gastric vein; b, dilated recipient portal vein. 
Fig. 1 1 .  - Venacavography of recipient 14. The arrows indicate the 
narrowed anastomosis of the donor and recipient vena cavae. a, supra- 
hepatic veins that are visualized because of the poor drainage of the 
posterior vena cava. 
In recipients 2 and 1 1  the suprahepatic cavocaval anastomoses were 
intact dorsally. 
Thrombosis of the portal anastomosis was noted in recipient 15 and 
in the arterial anastomoses in recipients 7, 12, and 20. 
Splanchnic venous congestion was observed in recipients 4,7,9,14, 
15 and 17, and in recipients 9, 14, 15 and 17 there was a large amount of 
blood in the intestines. 
Recipient 6 had massive atelectasis of the right lung and in recipient 
10 the lungs were markedly congested. 
In recipient 6 there was an extensive area of necrosis of the epicar- 
dium of the left ventricle. 
Microscopic findings in transplanted livers. 
- Congestion with sinusoidal distension and rupture of the centrilobu- 
lar veins as seen in the classic blue livers in recipients 1,4,5,6,7,8,  
9, 10, 14 and 17 (Fig. 14). 
Fig. 13. - Cholecystangiography. The arrow indicates the point 
where the donor common bile duct is ligated and divided. 
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Fig. 14. - Photomicrograph, 42. Areas of collapse and distension 
of the sinusoids. Rupture of the central vein of the lobule. Diffuse mononu- 
clear cell infiltration. 
- Congestion with moderate infiltration of lymphocytes and plasma- 
cytes of the periportal and centrilobular spaces in recipients 8,13,18 
and 19 (Figs. 15 and 16). 
- Loss of hepatic architecture and the presence of mononuclear cells in 
recipients 12, 13, 15, 16, 18, 19 and 20 (Fig. 17). 
- Zones of autolysis with polymorphonuclear cells and bacteria in 
recipients 13, 16, 18 and 19. 
- In recipients 2 , 3  and 11 no lesions were observed. 
Conclusions. 
No problems were encountered regarding the harvesting and perfu- 
sion of the donor livers with regard to the techniques employed. 
The size and weight of thd donor and recipidnt must be similar. The 
use of smaller animals as donors led to strictures of the anastomoses due 
to the difference in the diameters of the vessels. 
. 
Features regarding technique in the recipient. 
- Because of the difficulty working in the right subphrenic space, two 
linen sutures were placed in the diaphragmatic muscle lateral to the 
posterior vena cava. When tied to the parallel arms of an abdominal 
retractor, these can be used for caudal traction. Thus, the right 
hemidiaphragm, the subphrenic vena cava and the liver can be 
immobilized and displaced inferiorly thereby facilitating work on 
these structures. 
- Once the hepatectomy and caval division are complete the supra- 
hepatic anastomosis is difficult to suture due to the short cuff of the 
vena cava at the dia~hragm.~In order to overcome this problem, the 
hepatectomy was performed leaving the vena cava intact requiring 
slow, meticulous dissection that prolonged the operation 
considerably? However, if prior to the hepatectomy with caval 
division the two or three anterior hepatic veins are ligated and divided 
an adequate caval cuff can be obtained thereby decreasing the 
operative time. 
- With the use of a roller pump in the femoro-jugular bypass, it was 
possible to control adequately drainage from the inferior vena cava 
and portal vein into the superior portion of the vena cava. The simple 
tube in the passive shunt must have an internal diameter of least 4.5 
mm in order to function properly. 
- The end-to-side anastomosis between the common hepatic artery of 
Fig. 15. -Photomicrograph, 260. Portal space with mononuclear 
cell infiltration. 
the donor liver and the common hepatic artery of the recipient was 
employed because ligation of the gastroduodenal artery, required for 
an end-to-end anastomosis, risks serious devascularization of the 
duodenum and pancreas.' 
- The task of taking down the side-to-side portacaval anastomosis 
draining the splanchnic system and cava requires a great deal of time.6 
This is overcome by the temporary occlusion of this anastomosis 
with a plastic clip that can be applied easily and quickly. 
- Determination of bile production and secretion, one of the hepatocel- 
lular functions, is accomplished by means of cholecystostomy. In 
several animals the biliary drainage was diminished due to the 
reduced caliber of the tubes and technical errors. 
The exact cause of death in the recipients, usually due to intraopera- 
tive and postoperative complications, is difficult to determine (Table I). 
Intraperitoneal hemorrhage was a manifestation of deficient operative 
technique such as anastomotic defects and rupture of the hepatic paren- 
chyma. 
TABLE I 
Probable Causes of Death in 20 Orthotopic Liver Transplant Recipients 
Recivient Probable cause of death 
intraperitoneal hemorrhage 
intraperitoneal hemorrhage 
respiratory insufficiency 
splanchnic sequestration 
intraperitoneal hemorrhage 
right pulmonary atelectasis 
splanchnic sequestration, arterial thrombosis 
undetermined 
gastrointestinal hemorrhage 
myocardial infarct, pulmonary edema 
intraperitoneal hemorrhage 
intraperitoneal hemorrhage 
hepatic insufficiency 
gastrointestinal hemorrhage 
gastrointestinal hemorrhage 
hepatic insufficiency 
gastrointestinal hemorrhage 
hepatic insufficiency, rejection 
hepatic insufficiency 
arterial thrombosis 
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Fig. 17.- Photomicrograph, 260. Loss of architecture and peripor- 
tal hepatocytes. Fig. 16.- Photomicrograph, 260. Centrilobular vein, mononuclear 
cell infiltration. 
ischemia? The animals that died after the fourth postoperative day dem- 
onstrated histologic evidence of rejection, i.e., mononuclear cell infiltra- 
tion and destruction of the hepatic parenchyma. 
Vomiting and convulsions were observed in those recipients that 
died between the third and fourth postoperative days; in these, laboratory 
results indicated progressive hepatic damage. The pathogenesis of this 
hepatic insufficiency is obscure. 
During the fourth and fifth postoperative days7recipient 18 became 
prostrate and did not eat; transaminase, alkaline phosphatase and bilirubin 
were elevated and, at the same time, bile formation decreased (Fig. 18). 
The syndrome of rejection in recipient 18 is an immunologic phe- 
nomenon that injures and ultimately destroys the hepatocyte and results in 
intrahepatic cholestasis. 
With auxiliary liver transplantation2 survival was better than that 
achieved in our study. The explanation can be found in the fact that the 
recipient of an auxiliary liver does not endure an anhepatic period, the 
period of hepatic anoxia is diminshed because the duration of the procedure 
decreased so that insufficiency of the auxiliary liver does not cause death 
of the recipient. 
Consumptive hypocoagulation with hyperfibrinolysis, as a result of 
cardiovascular insufficiency and the anhepatic period in addition to 
physico-chemical injury to the donor live;, could be responsible for 
capillary hemorrhage in the incision.' 
Arterial thrombosis caused hepatic dearterialization demonstrated 
by elevated plasma enzymes. Thrombosis was due to strictures at the 
anastomoses. 
Early deaths were caused by hepatic outflow obstruction manifested 
clincially by bluish discoloration of the liver and gastrointestinal hemor- 
rhage, at autopsy by firm hepatomegaly and splanchnic congestion and 
histopathologically by distension and collapse of the sinusoids6 
The degree of outflow ob~truction,'.~ in the context of a patent 
subphrenic anastomosis, directly limits the time of hepatic anoxia. From 
the first postoperative day, all of the animals had elevated enzymes, a 
manifestation of hepatocellular damage due to a moderate period of 
Summary. 
The surgical technique employed in performing 20 canine orthotopic 
liver transplantations is described. 
The animals were evaluated by clinical observation, by laboratory 
and radiologic examination and by autopsy. 
The surgical technique is comple and was responsible for several 
failures. 
Hepatic venous outflow obstruction, in conjunction with hepatic 
anoxia, was one of the main causes of early death in the dogs. 
The syndrome of rejection was observed in one dog. 
In three dogs, the pathologic anatomy revealed lesions compatible 
with rejection. 
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Scot Denmark 
Scot Denmark, the senior author of this experimental study, was a General Surgical Resident on 
a one-year rotation in the laboratory. He since has become a cardiac surgeon and is in private 
practice in Dayton, Ohio. Although there were not many animals in this investigation, the work had 
a profound influence in clinical practice. 
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Veno-venous bypass without systemic anticoagulation 
in canine and human liver transplantation 
Surgical Forum, 34: 380-82, 1983 
Scot W. Denmark, Byers W. Shaw, Jr., Thomas E. Starzl and Bartley P. Griffith 
Previous attempts to perform liver transplantation during veno- 
venous bypass with systemic anticoagulation (heparin) in 12 patients at 
this medical center resulted in excessive blood loss in six and at least one 
fatality. The purpose of this study was to test the plausibility and conse- 
quences of using a veno-venous circuit without systemic anticoagulation 
during liver transplantation. 
MATERIALS AND METHODS 
Orthotopic liver transplantation was performed in ten mongrel dogs 
(20 to 25 kg) while using the bypass circuit without systemic heparin. 
Results of hematologic profiles, hemodynamic measurements, and 
postmortem examination were compared with those in three dogs in which 
no bypass was used. These three control transplants employed the "cuff' 
technique described by Cooperman et al.' Bypass was initiated with 
drainage from the divided portal vein and proximally occluded infra- 
hepatic vena cava with return to an external jugular vein. The circuit 
consistedof acentrifugal pump and flow probe with 318-inch Tygon tubing 
coated with 5% albumin and primed with a physiologic electrolyte solu- 
tion. Appropriately sized Bahnson caval cannulas were used for the jugular 
vein and cava. uhile a fenestrated stainless-steel ventricular vent with 11 
4-inch Silastic tubing drained the portal vein. Bgpass continued for two to 
four hours at rates of flow betueen 400 and 1.500 mlimin.  In the clinical 
trial. Caval drainage was obtained a i th  7 mm-Gott tubing introduced via 
the right common femoral vein advanced to the iliac vein: the same size 
was used for the portal vein. and a 9 rnm-piece provided venous return to 
the patient's left axillary vein. The remainder of the circuit was unchanged. 
RESCLTS 
The use of bgpass a ~ o l d e d  lo\\ cardiac output and portal benous 
congestion usuallj associated a ~ t h  c a ~ a l  and portal \ e m  occlus~on 
Hematologic profiles were not significantly different between groups and 
indicated a slight decrease in RBCs (5.67 to 5.16 x IOb/mm'), WBCs (13.8 
to 9.8 10'/mm2), platelets (145 to 117.5 x 10'/mm3), and fibrinogen (145 
to 80 mg%/dL) associated with the bypass. Fibrin split products and mono- 
mers were moderately elevated (staph clumping 1 to 128, ethanol gel 1 to 
4+). Fibrin threads were seen on the support struts of the pump housing in 
two studies in which the flow rate decreased below 800 mL/min. Gross and 
microscopic examination of the lungs failed to show intravascular throm- 
bus. In the clinical trial. PT. FTT, and fibrin monomers increased slightly 
during bypass. whereas fibrin split products remained unchanged and 
fibrinogen levels decreased. The patient developed a fatal aspiration 
pneumonia during the first postoperative week. At postmortem examina- 
tion, no intravascular thrombus was found at the cannulation sites or in the 
lung. 
DISCUSSION 
The use of a bypass circuit in liver transplantation provides several 
advantages by avoiding severe cardiovascular derangements, particularly 
hypotension. often associated a i th  caval clamping prior to hepatectomy. 
At completion of the infrahepatic vena caval and portal anastomoses, 
blood rich in potassium and hydrogen ions is returned to the systemic 
circulation from the previously stagnant capillary beds of the lower body 
and splanchnic circulations. A bypass circuit that decompresses the portal 
vein and the cava below the liver could prevent the accumulation of 
potassium and acid which might cause cardiac arrhythmias. Azpeitia et al 
used several different shunts (without a pump) during liver transplantation 
in dogs.'Partial cardiopulmonarq bypass provided hernodjnamic stability 
during human libel rransplantat~ons performed by Calne et al.'All of these 
investigators used heparin systemicall>. In this experiment. veno-venous 
bypass aithout sjstemlc anticoagulation preserved the physiologic state 
during liver transplantat~on aithout imposing significant coagulopathy or 
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thromboembolism and served to stimulate a clinical trial in which bypass 
cannulas were heparin bonded. The use of this system in one patient was 
associated a i th  normal cardiac output, portal decompression, and no 
significant change in coagulation factors. platelet count, fibrin split prod- 
ucts and monomers, or thromboelastogram. The study has demonstrated 
the fea5ibility of veno-venous bypass without systemic anticoagulation. 
The experimental and early clinical success has prompted plans for routine 
clinical use in human liver transplantat~on. 
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The role of Bartley Griffith, then an Assistant Professor of Cardiac Surgery, in the development 
of veno-venous bypasses is described in the introduction ot this section. Dr. Griffith has become the 
head of an internationally known and respected thoracic transplant program at the University of 
Pittsburgh and is now Associate Professor of Surgery at the age of 39 years. 
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Veno-venous bypass without systemic anticoagulation for 
transplantation of the human liver 
Surgery, Gynecology & Obstetrics, 160: 270-2, 1985 
Bartley P. Griffith, Byers W. Shaw, Jr.. Robert L. Hardesty, Shunzaburo Iwatsuki, 
Henry T. Bahnson and Thomas E. Starzl 
A crucial intraoperative period during onhotopic liver transplanta- 
tion occurs during mobilization of the diseased recipient liver prior to 
hepatectomy and during the subsequent anhepatic phase of the hepatec- 
tomy and implantation of the new liver. During this time, obstruction of the 
portal vein and inferior vena cava can result in a fall in cardiac output and 
arterial pressure, consequent hypoperfusion of critical organs, damage to 
the engorged subdiaphragmatic capillary beds and extensive bleeding 
from high pressure venous collaterals. These nonph)s~ologic conditions 
have been responsible for intraoperative or delayed deaths and have 
contributed to the lack of n ide  application of replacement of the liver.' 
When orthotopic liver transp!antation was developed in dogs, bypass 
techniques were used to \hunt blood from the Ioaer to the upper half of the 
body without pumps and a)steniic heparini7atlon. 'The clinical applica- 
tion of the pas\i\e bqpass resulted in the forniatlon of clots in the tubing 
with consequent passage of multiple "emboli" to the lungs.'The use of a 
pump driven bypa\\ under 5) stemic heparinization &a \  discouraged by 
major difficulties in reversing the heparin effect in patients a i t h  endstage 
hepatic disease and multiple pre-ex15ting coagulatiori defects.'"We report 
herein upon a pump driven nonheparin b>pass sjstem that was tested in 
dogs and was subsequently applied in 23 patients who underwent replace- 
ment of the liver. 
Technlqi(e. 
The unique components of the clrcult include modified heparin 
bonded Gott aneurqini shunt tubing (arglle Di\ islon. Sheraood Medical) 
for drainage and return cannulae. plu, a cen~rifugal blood pump (Bio- 
Medicus. Inc.). The cannula to drain blood from the inferlor \ena  cava is 
advanced through the saphenofernoral ~ e n o u s  junctlon to near the conflu- 
ence of the comrnon iliac veins (Fig. I ) .  The cannula ahich removes 
splanchnic blood 1s placed end-on into the tr;in\ected portal \ s in  (Fig. 1 ) .  
The fus~form Gott shunts ah1c.h are 60 centimeter.; long \bith an extra side 
hole at one end. are Ideal for drainage. After intra\aacular insertion. thehe 
cannulae are cur ahere  the~r  diameter is large and joined together a l t h  a 
three-eighths inch polished stainless steel Y type connector (Fig. 1). The 
blood is drained to a centrifugal pump which returns the effluent to the 
ipsilateral axillasy vein (Fig. 1 )  through a 7 or 9 millimeter Gott cannula 
without a side hole. Connections of the cannulae to the blood pump and a 
flow meter are made with short segments of uncoated three-eighths inch 
polyvinyl chloride tubing. 
The entire curcuit may be primed an debubbled on the operative field. 
After connecting the sterilized components. the drainage cannulae are 
submerged in a basin of saline solution. A regulated wall suction is then 
applied to the tip of the return cannula so that priming IS completed as the 
saline solution is drawn through the circuit components. The disposable 
blood pump head Inaq then be passed off the the field and connected to its 
motor console. Alternativel). the cannulae ma) be individuall) primed by 
a bulb tqpe s ~ n n g e  and connected to the remainder of the circuit which has 
been primed by the extracorporeal perfusion team in a clo5ed loop manner. 
While the former method does not require input from a perfusionist, the 
latter has caused the least operative ~nterruption and i \  currently preferred. 
The rotation of the centnfugal blood pump 1s adjusted to deliver the 
maximum blood return at the mmrmal re\olutions per minute. In adults, 
total flow has averaged 1liters per minute and has ranged between I .5 and 
6.0 liters. In man) patient\. the portal circulation has contributed rnore than 
one-half of the total flow. The veno-\ enous hqpass has often been inrtiated 
prior to extensi\e retrohepatlc reiectlon. and its a e r a g e  duration of 100 
minutes (a  range of 70 to 158) has, therefore, included the tlme required for 
the completion of recipient hepatectorn) plus implantation of the donor 
graft. 
Venou\ re\enoirs are not needed in t h ~ s  \)stern. All circuit tubing is 
shortened as much as possible to rninirn~ze exposure to fore~gn surfaces. 
Except for the rare formation of fine fibnn htrands on the rim\ of the 
connectors and on the pump cone support.;. there ha\ been no e\ ldence of 
ex 1 r )  o thronibo.;~.;. In one patlent. a \oft iliac \ em thrornbosl\ a a a  removed 
a i th  the drainage cannula. but there has been no clinical or autopsy 
ekldence in any patient of \ enoui smbolih~n. Component blood replace- 
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Fig. 1.- Anhepatic stage of transplantation of the liver with cavoportal to axillary bypass circuit. 
ment during the period of bypass has actually improved the pre-existing 
coagulopathy during the bypass in spite of a tendency for the platelet 
counts to fall during this time. 
So far, this system has been used only in adults. Children have been 
found to tolerate the combined portal and venacaval occlusion far better 
than adults, and it is possible that the system should be used in younger liver 
recipients only when indicated by vasomotor instability during test cross 
clamping. In adults, the advantages of bypass are sogreat that it has become 
a routine part of transplantation of the liver. 
Summarj. 
A technique of veno-venous bypass without heparin has been devel- 
oped for use during the anhepatic phase of transplantation of the liver. With 
this method, the ability to compress the temporarily obstructed vena caval 
and portal venous systems has made hepatic transplantation an easier pro- 
cedure. 
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THE HUMAN TRIALS 
Byers W. Shaw. Jr. Henry T Bahnson - Hank Bahnson 
was Chairman of the Department of Sur- 
gery at the University of Pittsburgh for 25 
years and retired in September 1987 He 
was one of the ploneer heart surgeons at 
the John Hopkins Hospital nearly 40 years 
ago His contributions to the veno-venous 
bypass technology are descr~bed In the 
~ntroduction to this section 
Byers Shaw was the Fellow on the Pittsburgh Transplantation Service at the time the veno- 
venous bypass technique was worked out and applied clinically. His important role in this technical 
advance was described in the introduction to this section. Dr. Shaw has become one of the most 
experienced and best liver transplant surgeons in the world. He is now Professor of Surgery and 
Chief of Transplantation at the University of Nebraska, Omaha. 
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Venous bypass in clinical liver transplantation 
Annals of Surgery, 200: 524-34,1984 
Byers W. Shaw, Jr., Douglas J. Martin, Jose M. Marquez, Y. G. Kang, Alan C. Bugbee, Jr., Shunzaburo Iwatsuki, 
Bartley P. Griffith, Robert L. Hardesty, Henry T. Bahnson, Thomas E. Starzl 
A venous bypass technique (BPI that does not require the use of 
systemic anticoagulation is used routinely at our institution in all adult 
patients during the anhepatic phase of liver transplantation ILT). Corn- 
plete cardiopulmonary profiles n.ere obtained in a subset of28 consecutive 
cases. During the anhepatic phase whrle on bypass, mean arterial pres- 
sure, central r,enous pressure, and pulmonary arterial wedge pressure 
were maintained at preheparectom! levels. Oxygen consun~prion fell sec- 
ondary to a decrease in temperature and the remoi,al of the lir,er. Conse- 
quently, cardiac index fell without an increase in arterial-venous 0 2  
content difference, reflect~ng adequate tissue oxygenation. Compared n,itk 
63patients in aprer'ious series gir,en LT n.irhour b~pa.ss INBPI, the 57 total 
BP patients experienced better postoperarii'e renal fiinction (p<0.001), 
required less blood use durtng surgerx lp < 0.01 I ,  and had better survival 
30 days after LT. The equii,alenc~ of 90-do! survii,al tn these groupa 
results from the lack of effect of BP on the long term suri,ti~aI of patients 
considered at high risk for metuhol~c reasons. BP patients at high rtsk for 
technical considerations, liower~er. .suri,ived LT n,hereas IVBP patients did 
not. BP offers other advantages important in estuhlishitig LT us a service- 
oriented procedure. 
The dramatic impact of cqclosporine on su r~ iva l  follouing liver 
transplantation has been widely reported. 'Yet despite extensive experi- 
ence w ith the operation during the preceding 17 years, onlj  a few important 
technical improvements here  reported to have significantl) enhanced 
survival.' "In fact. during the first 3 years in which cyclosporine was used. 
mortality related to a difficult intraoperative course remained a disturbing 
problem. For the most part. these difficulties centered around the anhepatic 
phase and repeatedly underscored the need for an effective method of 
venous bypass. The need for the dekelopment of new methodologj u a s  
clearly demonstrated by the severe penalt) ~mposed by the requirement for 
systemic heparinization during a trial of kenous bypass using conventional 
techniques in 12 patients dur~ncg the summer of 1982. The dekelopment in 
the laboratory of a heparin-less bypass s) stem u a s  reported hq Denmark 
et al.' and the initial clinical trial using these techniques pre5ented by 
Griffith et al. T h e  effect~keness of thic method of venous b>pass is the 
subject of the current study. 
Methods 
Between February 15, 1983 and March 22, 1984, a total of 57 adults 
were treated with orthotopic hepatic transplantation at the University of 
Pittsburgh using venous bypass without the use of systemic anticoagula- 
tion. The technique used is essentially that described by Griffith with only 
minor changes. In particular, the use of a 9-mm Gott (Argyle Division, 
Sherwood Medical, St. Louis, MO) shunt for cannulation of the portal vein 
and a 7-mm shunt for the axillary vein has proven to be a more satisfactory 
alternative to the reverse situation described in the previous paper."The 
femoral vein is cannulated with a 7-mm Gott shunt via a cut-down on the 
saphenous vein. 
The femoral and portal vein cannulae come together at a metal Y- 
connector, which is in turn attached to 318-inch polyvinyl chloride tubing 
(Tygon. Norton Industrial Plastics. Akron, OH), which leads to a conical, 
centripetal force pump head (Bio-Medicus, Inc.. Minnetonka, MN). The 
return flow is to the axillaq vein. The system is a completely closed one 
that does not require a reservoir in the circuit. An electromagnetic flow 
meter (Bio-Medicus, Inc.. Minnetonka. M S )  is attached to the outflow of 
the pump head. Flows are maintained at 1000 mllmin or more, a rate that 
was defined in the laboratory as that below uhich formation of clots and 
platelet aggregates were more likelj to occur. Once bypass flow has been 
established at a satisfactory rate, the vena cava belou and above the native 
liver is clamped and the liver excised. Hemostasis in the liver bed can then 
be obtained. if necessary. The portal venous and lower caval systems are 
decompressed so that, in general, venous hypertension does not exacerbate 
the bleeding at this point. 
The revascularization of the neu i i ~ e r  then occurs in a routine 
manner.'The usual sequence involkes seu ing the upper vena cava anasto- 
mosis followed b) the loher caval anastomosis. The l~ve r  is then flushed 
out uith 300 to 500 ml of cold saline kia the portal \ em cannula. This step 
flushes the preservation fluid. high in potassium, out of the liver. It also fills 
and evacuates air from the \ens cava. The patient is placed In a Trendelen- 
berg position and the fluid a l l o ~ e d  to escape through the anterior part of 
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the lower caval anastomosis. Whether the portal vein or arterial anasto- 
mosis is completed next is dependent upon a number of variables. In 
general, 60 to 80 minutes are allowed for ther anastomoses before some 
flow is returned to the liver. In those situations where clamping the portal 
vein slde of the bypass circuit (in order to perfomi the portal vein 
anastomosis) results in dropoff of the flon below 1000 ml.min, the bypass 
should be discont~nued to minimize the chance of thrornbus formation. If 
the arterial anastomosis has been completed b) t h i ~  time, the anenal and 
caval clamps can be released prior to decannulating the portal vein and 
coming off bbpass. The proper choice for sequencing these steps must be 
determined by the surgeon for each situation. 
Inrraopcrur~rr Moriiroririg. 
Cardiopulmonar) data uere  obtalned wing a multiple lumen pulmo- 
nary artery catheter. In the subset of patients for whom complete profiles 
were obtained, a four-lumen catheter emplo) ing an oximeter at the distal 
tip (Ox~metnx.  Inc., Mountain Viev.. CA) h a s  employed. Complete car- 
diopulrnonary proflles were obtained prior to the induction of anesthesia. 
after anesthesia had been established but before significant tluid los5es had 
occurred, just before initiating the bypass, during the bypass. and shonly 
after revascularization of the 11ver. Oxygen consun~ption was calculated 
using the Fick equation. Coagulation data were obtained routinely on all 
patients using a thrornboelastogram. 
Renu1 Function. 
The mean serum creatinine of all patients was determined immedi- 
ately prior to undergoing liver transplantation and then after surgery. Com- 
parisons were made between the preoperatibe values and the highest post- 
operative value with 7 2  hours of transplantation. The means were com- 
pared using the paired and unpaired Student's t-tests. The number of 
patients in the bypass and non-bypass groups who were not on dialysis 
prior to surgery but who required dialysis within the first 7  days of 
transplantation were determined and cornpared using the c h ~  square test. 
Patients with preoperative renal failure or preoperative requirements for 
dialysis were eliminated from this latter comparison. A subset of 30 con- 
secutive patients here  monitored for urine output during sul-ger). 
TABLE 2. Cardiopulmonary Profiles 
Pre-bypass B Y P ~  
Variable Mean S D  Mean S D  P 
T("C) 
H R  (bpm) 
M A P  (mmHg)  
P A 0  (torr) 
CVP (mmHg)  
PC02 (tom) 
PO, ( t o r )  
SaO, 
PvO, ( t o n )  
S v 0 2  (torr) 
Hgb (g/dl) 
P H ~  
CI (Llmin.  m2) 
SI 
RVSWI 
LVSWI 
SVRI 
PVRI 
a-vDO, 
V O d m 2  
0, transport 
HR-heart rate: MAP-mean arterial pressure; P.L\O-pulmonary arterial 
wedge pressure; CVP-central venous pressure: 60:-par t ia l  pressure 
carbon dioxide: p02-partial pressure oxygen; Sa02-arterial oxygen sat- 
uration: Pv02-mixed venous ox)gen pressure: Sv02-oxygen saturation 
pulmonary artery; Hgb-hemoglobin: pHa-arterial p ~ ;  CI-cardiac index; 
SI-saturation index; RVSWI-right ventricular stroke work index; 
LVSWI-left ventricular stroke work index: SVRI-systemic vascular re- 
sistance: PVRI-pulmonary vascular resistance; a-vDO,-arterial-venous 
Blood Use. oxygen content difference; VOz/m2-oxygen consumption. 
Figures regarding the number of units of blood components used 
during transplantation were kept by the central ~ l ~ ~ d  ~~~k of plantdtion uslng a conventional bypass system that neceaaitated systemic 
pittsbureh, M~~~ blood use has cornoared uaine the unDaired antocoagulation a i th  heparin. These are the subject of a brief comparison - G 
test and the median values b) the rank-sum test. with the current system. 
Mortalif\ arid Sur~.ii.ul. 
Life-table analysis was used to determine survival of the various 
groups and these value\ compared by the method of Greenhood using the 
standard errors of the sur\.ival possibilities for each interval. Minimum 
follow-up on all patients was 35 days. A total of 63 and 57 patients in the 
non-bypass and bypass groups, re\pecti\elb. here  used for survival 
calculations. 
Heparini:eri B?pass,ti.onr Jilnrz 15-Sr~prrnihr~r 6 ,  1982. 
Twelve patients. nine of whom uere  adults, underwent liver trans- 
TABLE 1. Indicuiions for Liver Truns~lunration 
No 
B Y P ~  Bypass 
Postnecrotic cirrhosis 
Primary biliary cirrhosis 
Sclerosing cholangitis 
Malignancy 
Budd-Chiari syndrome 
Secondaq  biiiary cirrhosis 
Alpha-I-antitnpsin deficiency 
Wilson's disease 
Miscellaneous 
Total 63 57 
Results 
From March 9. 1980 to March 22. 1984, a total of 129 adult patients, 
12 at the University of Colorado and 117 at the University of Pittsburgh, 
underwent onhotopic hepatic transplantation. Sixty-three of these patients 
were treated without the use of any venous bypass technique, nine with 
bypass technique utilizing systemic anticoagulation, and 57 utilizing 
venous bypass w~thout qyitemic anticoagulation. The indications for 
transplantation are shown in Table 1. 
Carriro~~ulnior~ar~ D a. 
Flow in the bypass system ranged from 1 to 13 liters per minute, with 
a mean of 2.77 ( 5 0 . 8 2 7 )  Llmin. Average bypass time was 91.2 (519 .7 )  
minutes. Complete cardiopulmonary data were obtained in 28 consecutive 
cases between March 30 and August 16, 1983. These data are presented in 
Table 2.  The pre-bjpass values are the means 
(LSD) of those obtamed after induction of anesthesia but before devascu- 
larization of the native liver. The bypass data are the means (LSD) of the 
data obtained during the actual anhepatic state w hile patients were under- 
going venous bypass. These data show that the oxygen consumption (VOJ 
M.) fell secondarb to a decrease in temperature (T) and remobal of the liver. 
~6nsequent ly .  cardiac Index (C1) fell without an increase in arterial- 
venous oxygen content difference (a-vDO,). reflecting adequate tissue 
oxygenation. In addition. s) stemlc vascular resistance (SVRI) fell signifi- 
cantly hhlle mean arter~al pressure (hlAP) ,  central venous pressure 
(CVP). and pulmonary arterlal wedge pressures (PA01 did not change. 
Renul Fllnc,florz. 
Table 3 reveals that renal function changed to a significant degree in 
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TABLE 3. Comparisons ofPostoperative Renal Function 
No Bypass Bypass 
(N  = 38) (N = 48) P 
preoperative mean 
serum creatinine 1.65 i 1.85 1.23 k 1.43 
p < 0.005 p < 0.05 
Postoperative mean 
serum creatinine* 3.00 ? 2.70 1.5 1 ? 1.27 
Mean change +1.29 & 1.95 +0.35 r 0.90 p < 0.001 
Patients requiring 
dialysis during 
first postoperative 
week 6 0 p < 0.01 
* Maximum value in first 3 postoperative days. 
both the patients with bypass and those without. Of note is that the increase 
in creatinine in the non-bypass group (+1.29 ~ 1 . 9 5  mgjdl) is significantly 
greater (p<0.001) than that seen in the bypass group (+0.35 5 0 . 9 0  @dl). 
Complete anuria or marked oliguria was not an infrequent occurrence 
during the anhepatic phase in the previous e perience with liver 
tran~plantation.~ Urine output during the anhepatic phase is maintained 
quite well in patients on bypass, with a mean urine flow of 187 (+ 249) ml/ 
hour (range 0-1360 ml/hour). Complete anuria or marked oliguria was not 
an infrequent occurrence during the anhepatic phase in the previous 
experience with liver transplantation.' Urine output during the anhepatic 
phase is maintained quite well in patients on bypass, with a mean urine flow 
of 187 (+ 249) mlhour (range 0- 136 mlhour).  Complete anuria was expe- 
rienced in only one patient in the bypass group. In addition, marked 
hematuria, a postoperative occurrence in 10% to 15% of non-bypass 
adults, has been absent in the bypass group. 
Blood Use. 
Data were compared for the total blood use during the transplant 
operation of 36 patients using venous bypass and a total of 43 without 
bypass. These data are presented in Table 4. The range in blood use of the 
non-bypass group was 3 to 25 1 units of packed red blood cells (PRBC) and 
was 5 to 157 units PRBC for the bypass group. The median blood use was 
27 for the non-bypass group versus 16 for the bypass group (p<0.05). Mean 
blood use was calculated by eliminating 10 cases from each group. The five 
lowest and five highest numbers were withdrawn from the comparison 
because of the wide standard deviations, which did not allow for a repre- 
sentative comparison. The mean loss in the non-bypass group (32.7 5 2 5 . 1  
unitsPRBC) was higher (p<0.01) than in the bypass group (18.9 +8.0units 
PRBC). An examination of Table 5 reveals that the mean blood loss with 
the heparinized bypass sytem was 53.1533 units PRBC with a range of 10 
to 94 units, significantly higher than the non-heparin bypass group 
(p<0.001) or the non-bypass group (p<0.05). 
Hospital Staj.  
The number of days that patients remained in the hospital from the 
date of transplantation to the date of discharge are compared for the two 
groups in Table 6. The mean length of stay for the non-bypass group was 
56.4 (535.1)  days versus 5 1.1 (528.9)  days for those bypassed (p>0.50). 
If all patients whose prolonged hospital stay was secondary to retransplan- 
tation were eliminated, the length of stay is still not different between these 
groups (p>0.05). 
TABLE 4. Packed Red Blood Cell Reauirement lL'nits/ 
No B ~ p a s s  ' B)pass 
(N = 43) (N = 36) P 
Range 3-25 1 5- 157 
Median 27 16 p < 0.05 
Mean 32.? k 25.1 18.9 ? 8.0 p < 0.01 
TABLE 5. Experience with Venous Bypass using Systemic 
Anticoagulation. June 25. 1982 to Seprember 6 ,  1982 
(.Vine Adulr Patients Undergoing 11 Operations) 
Operative deaths 319 (33%) 
Mean blood loss (units PRBC)t 53.1 I 33.0. * SD 
Range 10-94 
30-day survival 519 (55.6%) 
90-day survival 219 (22.2%)$ 
p < 0.05 compared to  no bypass; p c 0.01 compared to  non- 
heparinized bypass. 
t PRBC-packed red blood cells. 
$ Each living, 22 months after surgery. 
Bypass and Retransplantation. 
The requirements for retransplantation are similar between the by- 
pass and non-bypass groups, with 14 patients in the former and 12 in the 
latter group requiring retransplantation. The survival following retrans- 
plantation is not significantly different at either 1 month or 3 months after 
surgery. 
M o r t a l i ~  and Sur~,ival.  
The actuarial survival curves for the non-bypass and bypass gorups 
are shown in Figure 1. All patients in each group were followed for a 
minimum of 30 days after surgery and included 57 bypass and 63 non- 
bypass patients. Survival at 30 days was 91.1% for the bypass group 
compared to 73% for the non-bypass group (p<0.004). At 90 days, how- 
ever, survival in the bypass group (73.2%) was not significantly different 
from that in the group without bypass (68.3%) (p>0.05). Six of the patients 
in whom bypass was not used died on the operating table. The one operative 
death occuning in the bypass group was the result of an irreparable injury 
to the donor liver. That patient experienced no cardiodynamic instability 
during the hepatic revascularization. Table 5 reveals that three of nine 
patients bypassed using anticoagulation died in the operating room, and a 
fourth expired before 30 days. Only two of the nine patients survived 
beyond 90 days and both were living 22 months after surgery at the 
conclusion of the study. 
An examination of the causes of death in both groups reveals that they 
are quite similar. Sepsis, accompanied by multiple organ failure and, in 
particular, liver failure, was universal. In an attempt to understand why the 
significant difference in survival at 30 days was no longer present by 90 
days, patients were classified into three groups. Status 1 patients are stable, 
relatively low-risk candidates. including those who are primarily outpa- 
tient care-dependent with only infrequent hospitalization. Sutritional 
status is good to excellent. A history of significant esophageal variceal 
bleeding but with rapid recovery would not exclude a patient from this 
group. Status 2 patients are those who require frequent hospitalization, 
who have advanced cirrhosis with moderate to severe ascites, occasional 
episodes of grade 3 to 4 encephalopathy, recurrent episodes 
of variceal bleeding with attendant worsening of encephalopathy, and 
those whose life-style has been significantly altered by their disease. Status 
3 patients were the very high-risk group. The criteria for which patients 
would be placed into this group are either metabolic or technical. All of the 
metabolic group patients require hospitalization, most in the intensive care 
unit. All have frequent bouts of grade 3 to 4 encephalopathy. Malnutrition 
is severely advanced: ascites and hypoalbuminemia are extreme. Some 
patients with acute hepatic decompensation secondaq to toxic agents were 
TABLE 6. Posroperatlve Hospiial S tay  
(Paiients Discharged in Pitisburgh) 
NO B k ~ a s s  Bypass 
(N  = 30) (N = 37) 
Range 16-145 days 21-165 days 
Median 51 days 42 d a y  p s 0.05 
Mean 56.4 I 35.1 51.1 I 28.9 p > 0.50 
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placed under this category by virtue of their emergent situation. In the 
current study, nine of the 26 Status 3 patients (four in the non-bypass, five 
in the bypass group) were in stage 4 coma in an intensive care unit setting 
with severe renal dysfunction and requiring ventilatory support. Technical 
considerations that would require a Status 3 classification include a 
previous portacaval shunt, thrombosed portal vein, or multiple previous 
abdominal surgeries involving the liver or bile ducts. Four patients in the 
non-bypass and two in the bqpass group were so classified. 
A breakdown of the sunjival curves based on this assignment of 
status is deplcted In Figures 2. 3, and 4. In Status 1 patients, elght of nine 
non-b)pass and all six bypass patients remain alive at the end of the study. 
Among 41 Status 2 patients without bypass. 30-day and 90-day survival is 
88% and 76%, re5pectively. compared to 97.2% and 85.2% for the sarne 
intervals among 38 Status 2 patients treated with bypass. Thirteen patients 
were classified as Status 3 in both non-bypass and bypass groups. Survival 
at 30 days was 31% for the non-bypass group compared to 61 3% of the 
bypass group (p<0.01). Howe\er, mortality in the bypass group between 
30 and 90 days was significantly higher (p<0.05) than in the non-bypass 
group, so that survival b) 90 days was 31% and nine per cent In the non- 
bypass and bypass groups, respectively (<0.05). Among the four patients 
classified as Status 3 in the non-bypass group because of technical 
considerations, three were operative deaths and the fourth died in less than 
48 hours after surgery. Both of the technical Status 3 by-pass patients are 
alive 2 and 6 months after surgery. 
Discussion 
Despite the landmark improvenients in survival rates among liver 
transplant recipients provided by the introduction of cyclospodne,"early 
mortality and morbidity related to a difficult intraoperative course re- 
mained a significant problem. Approximately 50% of all patients who died 
within 1 year following transplantation a e r e  lost by the end of the first 30 
days. In addition. operative mortality among the first 63 adult patients 
treated with cyclosporine was 9.5%. 
Hisrorlcal Buc,kgound. 
Physiologically and sometimes technically, the most difficult period 
of the actual transplant operation is the anhepatic phase, when the native 
liver has been removed. Cross-clamping the portal vein and the abdominal 
portion of the inferior vena cava causes severe problems. The first results 
from the loss of return to the central venous system of the large volume of 
caval flow from the abdomen. The second stem5 from the hypertension that 
develops in the obstructed portal and systemic venous beds. The third 
occurs at the time of liver revascularitation when stagnant blood from the 
obstructed venous beds, sometimes rich in a c ~ d  and potassiurn, is suddenly 
returned into the systemic circulation. 
Previous studies revealed that the t )p~ca l  response to the anhepatic 
phase is a 50% reduction In cardiac output accompanied by a marked 
increase in systemic vascular resistance." More recent experience has 
shown that the response can be quite variab!~. In \oullg. otherwise healthy 
individuals it is slmilar to what occurs in severe acute hypovolemia. 
Although arterial blood pressure is fnirl) well maintained. cardiac output 
is reduced to a5 much as one-fifth of the preocclusion levels while systemic 
vascular resistance increase5 three to four fold. Patient, with preexisting 
cardiac dyifunction. or older patients. do not tolerate the los, in central 
venous volume and marked increaw In bascular re5istance well and can 
develop cardiac failure, marked h>potenslon. cardlac arrhythmias, and 
even cardiac Prrest. E\en patients w ith more resil~ent cardlac function will 
sometimes require the infurlon of large volume\ of fluid (or  blood 
products) into the central venous skstem in order to compensate for the 
marked fall in preload. The penalt) for this I \  severe tluid o ~ e r l o a d  at the 
time of liver re\ascularirution when non~lal  \enou\ return i5 restored.' 
The occius~on of portal ~ e n o u s  outflo\\ ii, tolerated to quxe variable 
degrees as well. Clamping the portal veln in the nornlal dog rejults in the 
death of the animal wi th~n 2 0  to 30 nilnutes." Cirrhotic dog\. however. 
can tolerate portal \ein c lamp~ng for o\ er 1 hour. -Clamp~ng the portal Lein 
in nomial man cau,es fewer problem\. either becau,e of a riiore extensive 
collateral network or because of the nornlsl lack of hacrerinl flora In human 
portal blood. ' 'Even so. the prewncz of pott,~l h> penenslon ,lnd extensive 
collateral clrculat~on In hurnan, with cirrho\is probabl) provides an 
advantage similar to that In the canine cirrhosis model.'This has been par- 
ticularly evident when long periods (greater than 1 hour) of portal occlu- 
sion have been necessary in patients without portal hypertension, such as 
those with primary malignancies. The degree of gut swelling and petechial 
hemorrhage in the bowel wall has been much more severe than that seen 
in cirrhotics. Frank gastrointestinal hemorrhage has not been an infrequent 
occurrence in this setting. 
In the normal dog model. various methods are used to keep portal 
occlusion times as brief as possible. These Include the classic method of 
end-to-side portacaval shunt combined with a femoral-to-jugular venous 
bypass cannula- ) , o r  the u,e of the "cuff '  technique for vascular anasto- 
moses originally used by Kamada 'in rats and employed for the normal dog 
model by Monden." 
The original human trials at Denver lnvolved the use of venous 
bypasses in anticipation of problems sirnilar to those seen in dogs.'But the 
inordinate incidence of embolic phenomena accompanying the use of 
passive shunts led to the11 abandonment when certainty evolved that 
humans tolerated the anhepatic phase without venous decompression 
much better than dogs . '  T a l n e  has selectively used partial cardiopulmon- 
a~ bypass in an attempt to support patients during the anhepatic phase, 
with vlvying degrees of success."' 
A trial of venous bypass using a con\entional cardiac bypass appa- 
ratus was undertaken in Pittsburgh in the summer of 1982. Although 
physiologic advantages during the anhepatic phase were quite evident. 
these were outweighed by the severe penally imposed by the need for anti- 
coagulation. This is graphicall\ demonstrated in Table 5.  Attempts at 
minimizing the use of heparin provided no improvements and the tech- 
nique was soon abandoned. 
But the need for some sort of hqpass technique remained all too 
evident by the recurring nightmares of the anhepatic phase in a number of 
patients. Hence, a trial of a method that wc~uld not require the use of 
systemic anticoagulation was undertaken in the laboratory using the 
nonilal dog model. The success of these experiments, as mentioned earlier, 
was reported by Denrnarkvand the ~nltial clinical experience presented by 
Griffith."' 
Hernodynamic Arli~ar~ta,qes. 
The data presented in the current study demonstrate the degree to 
which normal physiology is restored by the use of venous bypass system. 
Cardiac filling pressures (as measured b> a pulmonary artery catheter) are 
supported. and although the cardiac index falls. it does so to a much lesser 
degree than it does without bypass and apparently as an appropriate 
response to decrea\ed demand. This latter  ont tent ion is supported by the 
obsewation that at the same time that cardiac output has fallen. oxygen 
consumption also decreases while the rnixed venous oxygen content does 
not change significantly. One poss~ble explanation for this is the removal 
of the liver, a large metabolic machine, from the sqstem Eut in addition, 
the patient's core temperature falls significantly. further !owering meta- 
bolic demand. This fall in temperature has been reported before. 'I t  was 
attributed to a varlet) of causes in the previous repolt. including long 
operating times, the prewncc of the cold (4-10' C i  donor li \er in the 
abdomen while the ~ascu ln r  anastomows were completed. and the revas- 
cularization of the donor liver M hen cold presen ation mlution ia flushed 
out ofthe liver and into the \qktemic circulation b\ the restored blood tlow. 
The technique of venous blpass used currently is a clo5ed s) stem w ithout 
a heat exchanger in the circuit. Addit~onal cooling of hlood undoubtedly 
occurs as it passes through the h>pas\ clrcutt. Patlent core temperature falls 
continuousl) during the hkpa5i pha\e and reaches a nadir just after l ~ \ e r r e -  
vascularizatiori. 
The high bolume of blood returned to the heart from the benous beds 
that otherwise uould be ob\tructed is further e\ idenced b) the high flow 
rate\ obtained in the h>pas\ clrcult\. The mean tlow for all patients of 2.77 
( 5 0 . 8 2 7 )  Llrnin represent\ 5 5 ' ;  of the mean cardiac output obtained for 
these patients during the h>pa\ \  phase. 
Reriul Furrc.fiori 
The irnaller increase In serum creatinlne le\el and the virtual elimi- 
nation of the requirement for henlodial i i h  during the earl! recovery phase 
in the b)-pas\ group i i  rncouragln:. Pre\ I O U \  difficultiei. evident in the 
current btud) b> the nie'in postoperatl\r .;erum crearinine in the non- 
b ) p a n  group nf 3.0 ( ~ 2 . 7 1  rngtdl and b) the requirement among six 
patients (without overt renal dysfunction before surge7 ) for hemodialysis 
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P e r c e n t  s u r v i v a l  
With  b y p a s s  
I57 p a t i e n t s l  
-9- 
No bypass  
163 p a t i e n t s ]  
---a--- 
Days  
p c 0 . 0 1  a t  7 days  
p < 0 . 0 1  a t  30 days  
Fig. 1.- Ninety-day actuarial survival for liver transplants performed with and without venous bypass. 
cent  survival 
1 0 0 X ~ 3 ~  w n 3 
WITH BYPASS 
6 P A T I E N T S  
-0- 
NO BYPASS 
9 PAT IENTS 
---+J--- 
Days 
Fig. 2.- Actuarial survival of Status 1 patients with and without venous bypass. 
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P e r c e n t  s u r v i v a l  
lo"% n n WITH BYPASS 
u V : D-n-El., 38 PATIENTS 9 0 
- -4- 
D a y s  
Fig. 3.- Actuarial survival of Status 2 patients with and without venous bypass. 
P e r c e n t  s u r v i v a l  
WITH BYPASS 
13  PATIENTS 
--4- 
NO BYPASS 
1 3  PATIENTS 
---+J--- 
- - - - -___  
---_ 
--- 
- - - -_ 
2 0  - ---  - - - - -__ - - 
--- 
---  
- -  _ 
1 0  - a 
Days  
p < 0 . 0 1  a t  30 d a y s  
p < 0 .05  a t  90 d a y s  Fig. 4.- Actuarial survival of Status 3 patients with and without venous bypass. 
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during the first week following transplantation, are undoubtedly related to 
renal damage occumng primarily during the anhepatic phase when the 
suprarenal vena cava is completely occluded. 
Blood Use. 
The lower blood use documented since routine venous bypass was 
instituted is explained by several factors. The most important results from 
the complete lack of venous hypertension in the systemic and splanchnic 
beds during the anhepatic phase. Without bypass, this hypertension contin- 
ues to increase and hemorrhage can accelerate markedly during the 
anhepatic phase. The bypass also allows for a certain period of time (15- 
60 minutes) of meticulous effort at hemostasis in the hepatic bed after the 
liver is out of the way. 
Length of Postoperative R e c o ~ e r j .  
The use of bypass had no effect on the length of hospital stay. This 
is true even if one eliminates from consideration all patients whose 
recovery was complicated by the necessity for a second or third transplant. 
A bias may be present in these figures since the routine monitoring of daily 
cyclosporine blood levels was instituted after the introduction of venous 
bypass for all adult recipients. These blood levels demonstrated surpris- 
ingly variable cyclosporine absorption, which necessitated prolonged 
hospital stays for a number of patients who might otherwise have been 
discharged earlier in the pre-bypass era. 
Mortality and S ~ m i v a l .  
An examination of Figure 1 reveals that although intraoperative 
mortality and the postoperative mortality up through the first 30 days is 
markedly less in the bypass group, by 90 days this difference is no longer 
significant. The reason for this apparent parado is revealed by Figures 2, 
3, and 4. Four of 13 patients in the high risk group (Status 3) who were not 
bypassed died in the operating room in contrast to no operative deaths in 
the bypass Status 3 group. At 30 days, the improved survival continued but 
was overshadowed by a markedly increased mortality in the bypass group 
during the next 60 days when compared to the non-bypass group. Seven of 
these 13 bypass patients required retransplantation. two in whom rejection 
followed periods of satisfactory liver function. the other five without every 
[sic] obtaining satisfactory hepatic graft function. Two of these patients 
died before 30 days. the other five between 30 and 90 days. In the non- 
bypass group, two patients required retransplantation, both of whom 
subsequently died. More importantly, only two of the bypass patients were 
classified Status 3 because of extreme technical considerations and these 
are the only two survivors from this category. In contrat. four of the 13 non- 
bypass Status 3 patients were so categorized for technical concerns. Three 
died during surgery and the fourth 2 days later. 
The causes of death among those in both groups who survived 
beyond the first 2 weeks after surgerq are virtually indistinguishable. All 
had severe hepatic dysfunction and developed sepsis with subsequent 
multiple organ failure. Overall, this is an extremely high-risk group in 
whom the application of venous bypass results in improvements in early 
survival but appears to have little impact on long-term results. An ex- 
tremely important exception to this conclusion must be made in the case of 
those patients determined to be high risk for technical reasons. Both 
surviving patients in the bypass group uould almost certainly have been 
operative mortalities without the use of bypass. In fact. in the pre-bypass 
era. one of these patlents would have been excluded from candidacy for 
liver transplantation b j  virtue of ha\ ing a knoan  portal vein thrombosis. 
Complications. 
No pulmonary emboli or deep venous thromboses related to the 
bypass procedure have occurred. Wound seromas or hematomas in the 
groin or axilla have developed in six patients. All of these collections 
resolved spontaneouslq, two following drainage. During surgery, no 
changes in blood coagulation profiles attributable to b)pass have been 
seen. 
Recent experience r e ~ e a l i  [hat patients uith acute Budd-Chiari 
syndrome are probabl) nor candidates for venous blpass. In two recent 
cases, attempts at thrombecrom) of the clotted portal and vena caval 
systems folloaed b! ectablishrnent of b!pass resulted in suboptimal f lous  
in the bjpass circuit. In add~rion, rhe risk for embolizing preformed 
thrombus material was recognized to be quite high. Attempts at bypass 
were abandoned in both of these cases and the anhepatic phase proceeded 
without incidence. 
Other Considerations. 
Some of the most important advantages of the venous bypass, how- 
ever, are not demonstrable by the strict analysis of physiological and 
survival data. Many situations arise in which portal and caval venous 
occlusion times must be extended beyond the normal 60 to 90 minutes 
usually felt acceptable without bypass techniques. This includes any 
patient in whom the normal, careful, meticulous dissection during the 
recipient hepatectomy is impossible, and removal of the liver can be ac- 
complished safely only by immediate and complete devascularization of 
the organ, followed by rapid resection. Hemostasis in the bed is then 
obtained during the anhepatic phase. and may require an hour or more of 
intense effort which, if accompanied by increasing portal andcaval venous 
hypertension. may prove fruitless, even dangerous. The bypass system in 
this situation allows for a period of careful and deliberate hemostasis while 
keeping the venous beds decompressed and maintaining central venous 
pressures. It also allows time for careful preparation of vessels for anasto- 
moses. including dissecting out a usable recipient hepatic artery and portal 
vein if this were not possible before complete hepatectomy. Finally, the 
bypass removes a great deal of pressure from the surgeon performing the 
vascular anastomoses since the onus of completing them quickly and yet 
accurately is somewhat lessened. This offers particular advantages in a 
training situation. 
Future Outlook. 
In general, pediatric patients have fared much better than have adults 
during the anhepatic phase of orthotopic liver grafting. Nevertheless, a 
method of venous bypass for the small patient would offer distinct 
advantages in a number of high-risk situations. Application of the appara- 
tus currently in use is hindered by the lower limit of bypass flow (1000 ml/ 
min) required to eliminate the possibility of thrombus formation. In certain 
situations. the disadvantages of systemic heparinization of the recipient 
may be overshadowed by the life-sustaining support of a venous bypass. 
In addition, the laboratory experience that defined the safety of the lower 
limit of bypass flow was all obtained without the use of heparin-bonded 
cannulae, tubing, or pump heads. Work is in progress that may redefine the 
lower limit of safe bypass flow and thus make venous bypass available in 
pediatric patients. 
Last. although the final impact of venous bypass alone has yet to be 
determined, its routine use has significantly lowered the early mortality 
which. in the past, has often been associated with a difficult intraoperative 
course. The fact that its overall impact is not greater underscores the 
continuing need for better immunosuppression and better definition of the 
overwhelming risk factors in recipients. 
References 
Starzl TE, Klintmalm GBG. Weil R 111. et al. Liver transplantation 
with use of cyclosporin-A and prednisone. N Engl J Med 1981; 
305:266-269. 
Calne RY, Williams R, Lindop M, et al. Improved survival after 
orthotopic liver grafting. Br Med J 198 1: 283: 1 15-1 18. 
Starzl TE. Iuatsuki S, Van Thiel DH. et al. Evolution of liver 
transplantation. Hepatolog? 1982: 2:614-636. 
Malatack JJ. Zitelli BJ. Gartner JC et al. Pediatric liber transplanta- 
tion under therapq uith cyclosporin-A and steroids. Transplant Proc 
1983: 15: 1292- 1296. 
Starzl TE. Groth CG. Brettschneider L. An eberting technique for 
intraluminal vascular suturing. Surg Gynecol Obstet 1968: 127: 125- 
126. 
Starzl TE. Groth CG. Brettschneider L. et al. Orthotopic transplan- 
tation of the human l i ~ e r .  Ann Surg 1968; 168:392-315. 
Starzl TE. Schneck SA. Mazzoni G. et al. Acute neurological 
complications after Iiber transplantation with part~cular reference to 
intraoperative cerebral air embolus. Ann Surg 1978: 187:236-240. 
Calne RY. A nea  technique for biliar) drainage in orthotopic liver 
transplantation ut~lizing the gall-bladder as a pedicle graft conduit 
THE HUMAN TRIALS 
between the donor and recipient common bile ducts. Ann Surg 1976; 
184:605-609. 
9. Denmark SW, Shaw BW Jr, Griffith BP, Starzl TE. Venous-venous 
bypass without systemic anticoagulation in canine and human liver 
transplantation. Surg Forum 1983: 34:380-382. 
10. Griffith BP. Shaw BW Jr, Hardesty RL, et al. Veno-venous bypass 
without systemic anticoagulation for human liver transplantation. 
Surg Gynecol Obstet. in press. 
11. Greenwood M. The errors of sampling survivorship tables. In 
Appendix 1, Reports on Public Healih and Statistical Subjects, No. 
33. London: His Majesty's Stationer) Office. 1926. 
12. Pappas G. Palmer WM, Ma~tineau GL, et al. Hemodynamic altera- 
tions caused during orthotopic liver transplantation in humans. 
Surgery 1971; 70:872-875. 
13. Moore FD. Wheeler HB. Demis~annos HV. et al. Experimental 
whole organ transplantation of the liver and spleen. Ann Surg 1960; 
152:374-387. 
14. Starzl TE, Kaupp HA. Brock DR. et al. Reconstructive problems in 
canine liver hornotransplantation with special reference to the post- 
operative role of hepatic venous flow. Surg Gynecol Obstet 1960; 
11 1: 733-743. 
15. Starrl TE, Marchioro TL, Huntley R,  et al. Experimental and clinical 
homotransplantation of the liver. Ann h'Y Acad Sci 1964; 120:739- 
765. 
16. Starzl TE. Groth CG, Brettschneider L, et al. Extended survival in 3 
cases of orthotopic homotransplantation of the human liver. Surgery 
1968; 63:549-563. 
17. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. 
Transplant 1979; 28:47-50. 
18. Monden M. Barters RH. Fonner JG. A simple method of orthotopic 
liver transplantation in dogs. Ann Surg 1982; 195: 110-1 13. 
19. Starzl TE. March~oro TL, von Kaulla K, et al. Homotransplantation 
of the liver in humans. Surg Gynecol Obstet 1963; 117:659-676. 
20. Calne RY. McMaster P. Smith DP. et al. Use of partial cardiopulmon- 
ary bypass during the anhepatic phase of orthotopic liver grafting. 
Lancet 1979; 2:612-614. 
21. Aldrete J .  Clapp HW. Starzl TE. Body temperature changes during 
organ transplantation. Anesth Analg 1970; 49384-388. 
CLIO CHIRURGICA 
The multiple-organ procurement procedure was evolved over a period of several years and in 
its final form was published at the request of the Surgeon General of the United States in the hope 
of creating a standard approach for excision of many organs from the same donor. This objective 
has been realized worldwide and has greatly facilitated the transplantation of organs other than the 
liver. 
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A flexible procedure for multiple cadaveric organ procurement 
Surgery, Gynecology & Obstetrics, 158: 223-30, 1984 
Thomas E. Starzl. Thomas R. Hakala. Bqers W Shdu,  Jr , Robert L. Hardesty. Thomas J. Rosenthal, 
Bartleq P Gnffith. Shun7aburo Imatcuki and Henry T Bdhnson 
Wlth the Improvements In rmmunosuppresiion thdt have occurred In 
the last few years, a great Increase can be expected In the demand for 
cadavenc kldneqs and other vltal organs Doctor Koop Surgeon General 
of the L n ~ t e d  States has conkened conferences 'tnd s \ m p o \ ~ d  to examine 
questions of cadaver~c org'in t o l ~ c ~ t a t ~ o n .  removal pretendtion and de- 
plojment In such disiuss~ons 11 has been oh\lous that a uniform 
procedure should be de~e loped  u h i ~ h  15 flexible enough to dllou the 
exciuon of \arious organ iolnblnatlon\ u ~ t h o u t  leopard\ to an j  of the 
lnd~b~dun l  graft\ T h ~ s  \tud\ % a \  done to repon the method u h l i h  u e  ha\e  
used u ~ t h  \ a t ~ s t d ~ t ~ o n  t r ie\eral \ear\  
THE .APPROPRIATE DOhOR 
In the Un~ted  States. it has become common to remove organs from 
so-called hean-beatlng c;idaier.; ir. :th pronounced brain death. W ~ t h  some 
leisure. studies car1 be obta~ned in \uch donors uf the function of individual 
organs. Ca rd~o~ascu la r - r e \p~ra to r  in\t , lb~l~t) inn) be reflected in the 
necessit) for va\oprcssor suppon. poor blood ga\ \slue\ or other adverse 
findings familiar to Intenslie care ph>\lcims. I T  \u ih  donor\ are unstable. 
kidne) rerno\al rnn) be ;dl that I S  po\\ible. Houe \e r .  mo\t brain dead 
donors can be maintained and rniprobed \ \ ~ t h  con\snt~orial Intensive 
therap) and then an ~Itternpt can tx rliade to co-ordinate the needs of 
>urgeon\ u h o  perfom trati\plantdtio~is in different part\ cot the countn in 
lisht ot the a\ailabil~t) ot potential extrarenal graft\ 
THE PRINCIP1.E OF  COXE C 0 0 L I \ G  
The intraoperati\e infus~on of cold t l u~d ,  I \  common to all preserva- 
tion techniques. The rno,t irnponant objectlie I \  the aioid;ince of warm 15- 
chemia. Coolin? of an or;;iii ;raft b) intraiasc~ilar ~ntu\ ion of chilled 
lactated R~nger ' ,  wlution dt the tirne oi c i r c u l ~ t o r ~  ame\t \ids introduced 
into the laboraton for e\perirnenral tran>plant;it~o~i of the Iiier almost a 
quarter of a centur) ago 1 1  I ,ind \ \a \  prornptl) dpplied cIinic:ill! for the 
presenatlon ot h~dne! \ I 7 I and ,111 other organ\ Such cool~np expands 
man) fold the dur,ltion of oragan \ i ~ b i I ~ t ] r  a id allon, the unhurried 
appllcdt~on. if dek~red. of other more \ophi,ticated preker\ .irlnn rnea\urei. 
Lactated R~n:er', \olutiori ha. ,i lo\\ poiasslurn iontent dnd is near11 
isotonic. Chillled \pscliil soiution~ tilth dn electrol!te cornpo,it!on \irnilxr 
to that in cell\ irere \ho\in In a ~ t u d )  done in 1969 I ! tci  <\:end the per- 
missable limit of cold renal ischemia hejond that achievable uith isotonic 
solutions. The same effect has been shoun wlth livers (4). Cardiac 
surgeons have cooled the h e m  ui th  barious cardioplegic solutions that 
have potassium concentrations of about 20 milliequiralents per liter. 
The simplest and probably the best u a )  to achieve immediate 
internal coolinp of an) organ is b j  in situ infusion uith lactated Ringer's 
solution. Then. the ~ n d i ~ i d u a l  organ\ ma) be Infused u ~ t h  ipecified 
amounts of ipecial solutions after t h e ~ r  emo~ea i  . The transplantation 
surgeon\ in the northeastern pan of the United State\ prefer thls approach 
since 11 avoids the uncontrolled- infui~on of large amount, of the potas- 
sium-nch Collin\ tjpe solution\. H o u c ~ e r .  the use ot'Coll~ns solut~on for 
the in \ ~ t u  infusion of the donor procedure I \  \o uide\pread that re- 
education a u a j  from t h ~ \  practlce h,i\ been dlff~cult.  Furthermore, the 
establishment of a unifomi code for ~nfu\lon I \  not obligntop slnce the 
various io lut~on\  can be u\ed \o e a s i l  tor the in \itu cooling of different 
organ\ In the same donor :I\ v.111 be made clear here~n.  
THE I\CISIOU 
A cornpiete m~dl lne  incl\lon I \  made frorrl the \upra\ternal notch to 
just abobe the i)rnph)bi, pubis (Fig .  1 1. The sternurn splitting component 
of the Incision ha\ replaced the cruciate ,~hdoniin,~l lnci,lon u h ~ c h  u a  
commonlj u,ed pre\ ~ o u \ l ) .  \lost ho\p~tal \  ha\e  J bone cutt~rig \ au  for the 
stenium. but the Pitt\biirgh procurement teani 31ua)s can.~e\  a Lebtche 
knife and nialler pluk a \temuni \preaiier ibhich ha\e been u\sful uhen 
\rslting \mall hospit,ila that do not h a ~ e  cardiothilrai~c equipment The 
long incl\lon prco\~de\ good c.xpo\ure tor renio\dl ot the hean. both 
kidneks. the I ~ \ e r  and other thoracoahdoniinal \ I\cera. 
GRAFT \EPHRECTOMY 
All of the multiple organ remo\ dl \  can br en\ isloned as modifica- 
tions of the e \  i\cer;it~on technique, for cads\ er liidne) remob a1 uhich 
ha\e  been de\cnbed in other repon\ 15.  61. 
The extraper~toneal \ p ,~ i e  I \  entered b! lnil\lnS the per~ronsal 
reflect~on of the a\ceridrng cnion. cecum and ti~\tal part of the \mall 
inte\tlne (Fig. 2 1 .  The m~ll and 1a1ye iiitekt!ne ,ire \iiept up and the right 
ureter I \  ident~tieti. d i r \ ~ i t e d  i\tall> .end iu t  airo,\ nedr the bladder t F ~ g .  
2).  its tip I \  ued uith d Ion: \ilk ,uture. drid aboie [hi\. an Incl\ion ir made 
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Fig. I .-Total midline incision used for multiple organ procurement. 
I 
d;cend~nq colon and  
cr~urn reflected / 1  i 
bar o and v 5 
c o l o n  
Fig. 2.- Nephrectomy: preliminary steps for in situ infusion of 
kidneys in a cadaveric donor with an effective circulation who has been 
so that urine can e ~ a p t e .  A urine culture may be obtained. The left ureter pronounced dead as a result of neurologic criteria. 
is treated in the same way either now (Fig. 2)  or. if this is inconvenient 
because of the intact inferior mesenteric vessels, at a later time. 
The distal part of the aorta and inferior vena cava are dissected free, 
encircled and d~vided (Fig. 2 ) .  Both great vessels are mobi l i~ed superiorly, 
ligating and dividing the inferior mesenteric artery and two or three sets of 
lumbar branches (Fig. 2). Upward di\section of the anterior \urface of the 
aorta is continued until the left renal vein is encountered crossing the aorta 
from left to right (Fig. 2). Just superior to ths, the superior mesenteric artery 
can be felt as a taut strand passing almost directly anteriorly providing the 
intestines are retracted anteriorly and super~orly. The superlor mesenteric 
artery 1s encircled and ligated (Fig. 2). The vlscera are returned to their 
natural location and attention i\  directed to a higher level. 
The aorta 1s encircled either just above orjust below the diaphragm. 
The easiest way to have perfect access to the aorta at the more \uperior level 
is to deepen the midline ~ncision where the central tendon of the diaphragm 
fuses with the inferlor surface of the pericartiium. The fu\ion is opened up 
by separating the left part of the tendinous d~aphragrn from the pericar- 
dium. avo~ding entry into the pericaridal ca\ it) if possible (Fig. 3). A\ the 
dissection proceeds leftward. the left side of the thoracic cavil) is encoun- 
tered immediatel) and encircled (Fig. 3 ) .  
Alternati\eIq. the left triangular ligament of the liber may be inclsed 
and the upper part of the abdominal aorta can be enc~rcled just above the 
origin of the celiac axi5 (Fig. 3 A ) .  This can be done safel!, after cuttlng the 
arcuate ligament and aortic hiatus (Fig. 3 ) .  When only the kidneys are to 
be removed. the celiac axi5 also 5hould be enc~rcled (Fig. 3A), l~gated and 
divided. 
The patlent is now gi\en i milligrams per kilogram of heparin. 
Cannulas are placed in the di\tal part ofthe aortaand the inferior venacava 
(Fig. 3 ) .  The clamped aor t~c cannula is attached to an airfree infusion 
system through which chilled prc\er\atlon \elutions can later be infused 
(Fig. 3) .  The clamped Leila cava cannula I, 'lttached to tubing that leads to 
a bleeding bag on the floor. Ail a!pha-block~ng agent can be glven at this 
time, and it is a common practlce lo give drugs, such as chlorpromarine, 
which are said to stabillre microsomal membranes. 
If the kidneys are to be removed, no further dissection is necessary 
or desirable since infusion of the chilled preservation fluid will be done in 
situ. Either lactated Ringer's ~olut ion or one of the potassium-rich Collins 
solutions may be used. The aorta is cross clamped just above or below the 
diaphragm after making sure that the celiac axis and the superior mesen- 
teric artery are ligated or clamped (Fig. 4). The chilled electrolyte solution 
passe7 predominantly into the renal arterial supply. The effluent is drained 
out through the ~nferior vena caval cannula to the bag on the floor. When 
in situ infusion of a liter or more in adults has been completed, the aorta is 
transected at one or the other level previously defined near the diaphragm, 
and the vena cava i, transected above the entrance of the renal veins (Fig. 
SA).  
The washed out kidneys are now removed from below. The cannulas 
In the inferior vena cava and aorta as well as the ureters marked with 
ligaturer are gentlq retracted anteriorly by on assistant who is asked to keep 
track of these four structures (Fig. S B ) .  In the meanwh~le, the surgeon 
retracts one of the k~dneys  anteriorly with a hand placed behind Gerota's 
fascia and the nurse or another assistant performs the same task on the other 
side (Fig. SB) .  Neither the kidney5 nor the four retracted structures are 
allowed to fall poster~orl) at any time. All tissues passing posteriorly are 
cut. staying close to the l~gaments and muscles covering the vertebral 
bodies (Fig. 5 8 )  and continuing superiorlq until the previousl) transected 
aorta and inferior vena cava are reached. Once the posterior dissection is 
completed. the flimsy residual tissues between the gastromtestinal tract 
and the anter~or surface of the specimen are disconnected. The k~dneys  are 
taken from the body en bloc and placed in an ice basin on a back table (Fig. 
6A).  The! can be prepared for machine perfusion of the entire specimen if 
thii technique 1s preferred or the kidneys can be separated for either 
perfusion of the individual k ~ d n e j s  or preservation in \lush. If the kidneys 
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Fig. 3.- A and B, Nephrectomy: preparation for in situ infusion by 
encircling the aorta just above or alternatively just below the diaphragm. 
are to be separated, the left renal vein is transected flush at its entranc into 
the inferior venacava (Fig. 6B). If slush preservation is planned for kidneys 
that were cooled by initial in situ infusion with lactated Ringer's solution, 
a final flush with one of the Collins type solutions is necessary. 
For division of the kidneys for slush preservation, it is safest and most 
convenient to turn the specimen over (Fig. 6B). With one blade of a scissors 
inserted into its lumen, the posterior wall of the aorta is incised. A perfect 
guide to the line of aortic incision is the row of ligated or clipped lumbar 
arteries (Fig. 6B). Then, with a perfect internal view of the renal arterial 
branches passing laterally, the anterior wall of the aorta is incised longitu- 
dinally from the inside (Fig. 6B). If a perfusion is planned, aortic flaps are 
fashioned during separation and used for closure so that cannulas need not 
be placed directly into the renal arteries. If the left renal vein was detached 
from the vena cava as described earlier, it is perfectly safe to divide quickly 
the remaining structures connecting the right and left kidneys. 
After the kidneys or other organs, or both. have been cooled and 
excised, segments of the iliac arteries and veins are routinely removed (Fig. 
7) and placed in a cold tissue culture solution for refrigeration. The thoracic 
aorta and pulmonary artery may also be taken. Such grafts can be life- 
saving in the event of unexpected technical problems in the recipient (7). 
TOTAL HEPATECTOMY 
Removal of the liver requires only minor modifications of the 
foregoing basic technique. As soon as the midline incision is made, the 
liver is inspected to be sure that its color and texture are normal. Anonlalies 
are looked for. of uhich arteries to the left lobe from the left gastric artery 
or to the right lobe from-the superior mesenteric artery are the most 
frequent. Ways of dealing with such anomalies have been described 
e l ~ e ~ h e r e  (8, 9) and will not be considered herein. 
If the anatomy is normal. the splenic and left gastric arteries are 
dissected. ligated and d~vided (Fig. 8). and the celiac axis is dissected as far 
back touard the aorta as is convenient. The aorta is encircled at one of the 
locations above the celiac axis as uas  described in the section on graft 
nephrectomy (Figs. 3 and 8).  
Turning more didiillj, the gastroduodenal artery and, uhen  present, 
Common ~ l i o c  
o ond v 
Bleeding b o g  \\ 'I 
Fig. 4.- Nephrectomy: in situ infusion of kidneys with cold preser- 
vation fluid through the distal part of the aorta, with a venous bleed-off 
from the distal inferior vena cava. The aorta is clamped proximaly at one 
of the sites shown in Figure 3. 
the right gastric artery are ligated and divided. Beneath the gastroduodenal 
artery is found the portal vein (Fig. 8). The common bile duct is mobilized 
to as low as level as possible and transected (Fig. 8). At the same time, the 
gallbladder is incised and bile is washed out in order to prevent autolysis 
of the mucosa of the biliary tract. The portal vein is cleaned inferiorly to 
the junction of the splenic vein and the superior mesenteric vein. The 
splenic vein is ligated, and through its central end, a cannula is placed 
through which a slou infusion of lactated Ringer's solution at 5 degrees C.  
is begun (Fig. 8 ) .  The superior mesenteric vein is encircled If necessary for 
exposure. the neck of the pancrease should be divided. 
Next, the distal part of the abdominal aorta and inferior vena cava are 
freed and ligated as described in the section on graft nephrectomy (Figs. 2 
and 4). but the superior mesenteric aner). is not yet tied. Aortic and vena 
caval cannulas are placed after systemic heparinization. The infusion rate 
of the cold lactated Ringer's solution through the splenic vein is increased. 
In adults, the liver can be felt tocool after 1 or 2 liters of infusion at the 5ame 
time as the bod) temperature falls. In children. smaller\olumes of lactated 
Ringer's solution are needed for an o b ~ i o u s  effect. At this time, the 
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Fig. 5.- A and B, Nephrectomj: removal of perfused kidneys en 
bloc. The kidneys and great vessels are held anterlor to the plane of scissors 
dissection. 
Fig. 6.- A. placement of kidneys In an ice bas~n.  B. Division of 
kidneys uslng a posterior approach to split the aorta. 
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previously encircled superior mesentetic artery (Fig. 8)  is tied, followed 
immediately by ligature of the superior mesenteric vein (Fig. 9). Over 
infusion is prevented by intermittent bleeding off through the inferior vena 
cava cannula. The circulation of the donor still intact and the progressively 
cooling liver still has an hepatic arterial supply. This has been termed the 
"pre-cooling' phase (9). 
Procurement is terminated as with graft nephrectomy by cross 
clamping the aorta near the diaphragm at one of the sites of its previous 
encirclement (Fig. 9).  Cold solution through the aortic cannula is immedi- 
ately infused as a i t h  graft nephrectomy, and blood from the inferior vena 
cava is drained onto the floor bag. The right atrium is also opened as an 
extra precaution against overdistention of the liver. Anesthesiologic sup- 
port is stopped. Portal infusion with lactated Ringer's solution is discon- 
tinued shortly after aortic cross clamping. After 1 to 2 liters of lactated 
Ringer's or Collins solution have passed in through the aortic cannula, the 
kidneys as well as the liver are bloodless and cold. The celiac axis is 
detached from the aorta with an aortic patch or taken in continuity with the 
full aortic circumference. If further renal cooling is desired, the donor aorta 
can be clamped just below the celiac axis. 
Until this time, dissection of the suprahepatic vena cava has been 
avoided. Now, the suprahepatic vena cava is dissected free along with the 
surrounding cuff of diaphragm. The liver is peeled inferiorly cutting 
posterior attachments, including the right adrenal veins (Figs. 8 and 9). No 
unusual effort is made to tie individual tributaries to the vena cava at any 
level since this can be done later at leisure in an ice basin in the recipient 
operating room after the specimen has been returned to the parent hospital. 
Since the celiac axis has already been cut free in continuity with a circum- 
ferential piece of aorta or an aortic patch, the liver is ready for removal. 
The freed liver is taken to a back table, given a final flush in adults 
with 500 or 600 milliliters of cold Collins type solution and placed in a bag 
which is filled with the same kind of solution. The bag is sealed and covered 
with crushed ice in a picnic cooler. The ten or 15 minutes required to 
remove the liver is not harmful to the kidneys which are not subjected to 
any warm ischemia whatsoever. With the liver out, removal of the kidneys 
en bloc is canied out as described in the section on graft nephrectomy. The 
excision is greatly facilitated by the absence of the liver. Vascular grafts are Fig. 7.-Removal of segments of iliac arteries and veins and thoracic 
removed as described previously. aorta. The vascular grafts are refrigerated and kept in case of an emergency. 
d ~ c w e .  ' r o r o c  c o o r l o  t n c  rc lcs  7 2  'or e . e n 4 u a  c r o s s  c1arr.c 
Fig. 8.- Hepatectom) : hilar dissection and transection of the common bile duct as 
an initial step in multiple organ harvesting. Note that the splenic vein (or alternatively the 
superior mesenteric vein) is cannulated for eventual delivery of preservation fluid. 
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Fig. 9.- In situe infusion technique used when the kidneys and liver 
are removed from the same donor. R.y.a. ,  Right gastric artery; G.d.a., gas- 
troduodenal artery; S.U.. splenic artery: S.i,., splenic vein; P.v., portal vein, 
and S.m.r.. Superior mesenteric vein. 
REMOVAL OF THE HEART 
With k i d n e ~ s .  The simple preparatory steps described previously are 
completed. The cardiac tearn no\\ assumes command. The principle that 
is followed is to disconnect the thoracic and abdominal aclrtlc circulation 
by aortic cross clamping at one of the encirclement le\els just above or 
below the diaphragm (F IE .  10) at the precise moment of cessation of heart 
beat. with immediate graft coollng of both abdominal and thoracic viscera. 
The preparation for thi, technical \tep I \  the aortic dissectton previously 
described in the qection on graft nephrectorny (Fig. 1 ) .  
Before this final itep i b  taker\. the pericardium 15 inclsed. and the 
aortic root is separted from the main pulmonarq aner) . The superior vena 
cava is stapled 2 centimeters proximal to ~tsjunctlon u:ht the right atrium, 
the inferior \ens cava is c!an?pled or incised t Flg. 101 and the beating heart 
is allowed to enipt). .At the \ame tlirie as the ;ions 15 crois clamped at the 
diaphragm. the thoracic aortic arch 15 clarnped at the orlgin of the innomi- 
nate arterq. Chilled electrol! te solution i j  infuwd into both the aortic root 
Sup veno cova 
S ~ t e  o f  c r o s s  
c l o r r p i n g  o f  _ 
t h o r o c ~ c  a o r i o  ; 
I v c  ~ n c i s e d  
A l l  s i t e  of c r o s s  c l o r n p r , ~  , 
a b d o r n ~ n o  o o r t o  
Preservat ion 
, '  
Fig. 10.- Final steps if the heart is to be removed'in combination 
with nephrectomies or hepatectomy, or both. See text for details. 
(Fig. 10) and into the distal part of the aorta and renal arterial bed (Fig. 4). 
The heart is removed first (Fig. 10). Sequentially. the inferior vena 
cava, left-hided pulmonary veins. pulmonary artery. superior vena cava 
and right-s~ded pulmonary veins are d~vided.  The aortic clamp at the level 
of the innominate artery is removed and the aorta stapled at this level prior 
to its transection in order to facil~tate infusion of the cold cardioplegic 
solution during implantation of the donor heart. The excised heart is 
immersed in chilled electrol>te solution during transplantation. After the 
heart is out. the kidneys are removed a\ described earlier. 
With 11i.cr cmd ktdt ic~s .  The thoracoabdominal di\connection prin- 
ciple is the same a\ just described. While the circulation is \till intact, the 
intraportal fusion of cold lactated Ringer's solution is begun into the 
splenic vein. Should ventricular fibrillation occur as a consequence of 
infusion the chilled solution. the aorta could be clampled, cardioplegia 
infused and the heart harve\ted an) iirne. This foreshortening of the 
procedure should not be necessar).. and w lth a jingle exception. the heart 
alwra)s has been removed in our experience under the optimal coriditions 
of liver and kidney cooling. The incidental coolirig of the heart b) cold 
blood and fluid coming out of the l i ~ e r  ma) contribute to \mooth cardiac 
cooling. Care is taken not to rtrnu\e much of the irirrapencardial inferior 
vena cava since it is not Important for the cardiac graft but ma) be needed 
b) the surgeons performing hepatic operations. .After the heart is excised, 
the Ii\er and kidne)\ are removed in that order. 
EXPENDABILITY F'ACTROS AND CRAFTS QUALITY 
The \\a) in uhich the organs are renio\ed u ~ t h  multiple graft 
procurement defines an explicit prlorlt) list of heart. 11~i . r  and kidneys in 
that order. The heart mujt function ~mrnedlatel) and the l l ~ e r  nithin a few 
hours. uhereab immediate function of renal graft, i \  not a prerequisite for 
recipient s u n  ikal. 
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Nevertheless, the rate of acute tubular necrosis requiring hemodialy- 
sis in patients in whom kidneys were obtained at multiple organ harvests 
has been only one-fifth of the lowest incidence reported after the harvest 
of kidneys alone (10-12). The exceedingly low rate could reflect the 
acceptance of only very good donors for hearts and livers or the fact that 
there is a high intensity of skilled surgical and anesthesiologic input in such 
instances. However. the most important factor probably is the systematic 
use of a superior method of nephrectomy which totally precludes any 
period of warm Ischemia for the kidneys and which eliminates the 
manipulation that can unknowingly damage kidneys if renal vascular 
skeletonization techniques are used. 
OTHER ORGAN COMBINATIONS 
The general principles herein described can be applied to graft 
pancreatectomy or intestinal graft removal. If the whole pancreas is trans- 
planted as we recommend. the combination of liver and pancreas removal 
is incompatible. 
SUMMARY 
Techniques have been developed which permit removal of the 
kidneys, liver, heart and other organs from the same donor without 
jeopardy to any of the individual grafts. The guiding principle is avoidance 
with all organs of warm ischemia. This is achieved by carefully timed and 
controlled infusion of cold solutions into anatomic regions. the limits of 
which are defined by preliminary dissection. 
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Part IV 
Auxiliary Liver Transplantation and Hepatotrophic Physiology 
By the time of Welch's first experiments,lthe concept of transplanting an extra kidney into a 
heterotopic pelvic site was well accepted. This background in renal transplantation may have 
influenced those interested in auxiliary liver transplantation. However, this is speculative. 
Welch's first mention of auxiliary liver transplantation was a brief note in the Transplantation 
Bulletin,' at that time an appendage to the Journal of Plastic and Reconstructive Surgery. The 
following year, Ned Goodrich and Harold Welch (C. Stuart's nephew), two of Welch's residents at 
Albany Medical College, New York, provided more complete information.' 
The operation, as originally described by Goodrich and the Welches or slightly modified by later 
authors, involved the transplantation of an extra canine liver in the right paravertebral gutter or pelvis 
of a non-related mongrel recipient. The hepatic arterial supply was derived from the aorta or iliac 
artery. Venous inflow was reconstituted by anastomosing the distal iliac vein or inferior vena cava 
of the recipient to the homograft portal vein. Welch and Goodrich, and subsequently others, proved 
that such livers produced bile for several days after transplantation and then ceased to function. The 
organs had histopathological evidence of rejection, a not unexpected finding since immunosup- 
pressive therapy was not employed. 
It was ten years more before auxiliary transplantation was attempted in immunosuppressed 
canine recipients. A disquieting observation soon was made.34The auxiliary homografts, inserted 
by a modification of Welch's techniques into dogs treated with azathioprine, were much more 
severely damaged than were orthotopically placed livers. The extra organs underwent rapid 
shrinkage which was easily discernible within two weeks. There was hepatocyte atrophy and fallout 
with consequent crowding of the intrahepatic portal tracts. These atrophied transplants were 
incapable of sustaining life. One of the explanations suggested3was that the portal venous blood 
contained some unspecified substance or substances that was important for maintenance of liver 
integrity. 
Marchioro et aI5 provided support for the latter hypothesis in experiments that were designed 
to divert splanchnic venous flow through the auxiliary liver and away from the recipient's own liver. 
Now the atrophy affected the native livers but not the homografts. Marchioro remarked: 
Apparently, there is a competition between co-existing iivers for some metabolite or 
other substance in the portal venous blood. That organ which has first access to the portal 
flow retains its initial functional and morphologic integrity. The other organ, whether it be the 
homograft or autologous liver, undergoes atrophy predominantly affecting the centrizonular 
area. 
The validity of this general point of view was confirmed by Marchioro in non-transplant  experiment^,^ 
but the nature of the so-called portal hepatotrophic substances remained obscure for several more 
years. 
In 1973, strong circumstantial evidence was uncovered that the most important of the portal 
hepatrophic substances was insulin,'and three years later the hypothesis was tested directly with 
insulin infusion experiments in dogs submitted to portacaval s h u ~ t . ~  It has become accepted 
universally that substances, especially insulin, in the splanchnic venous blood are important for the 
anatomic and metabolic integrity of the liver.g In addition, it is clear that splanchnic venous blood 
modulates hepatic regeneration but by mechanisms and to an extent that have not been defined.1° 
Attempts to define the ideal physiologic conditions for aux~liary liver transplantation clarified an 
important biologic principle and at the same time delineated the requirements for cl~nical trials with 
this procedure. The first attempt at auxiliary liver transplantation was made by Absolon et al"at the 
University of Minnesota on 3 November 1964. That child, who suffered from biiary atresia, received 
the extra liver in the splenic fossa after splenectomy and lived for 13 days before dying of bile 
peritonitis and sepsis. By early 1968, eight more attempts had been made, all with a fatal outcome 
(cf. Table I). 
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The first auxiliary liver transplantation with unquestionable prolongation of life was performed by 
Fortner et all2 at the New York Memorial Hospital on 13 December 1972. The recipient, who had 
biliary atresia, still is alive with a follow-up of 15 years. 
At the meeting of the International Transplantation Society in Rome in September. 1978, Fortner 
was able to collect information on 50 attempts at auxiliary liver transplantation, undoubtedly a 
minority of the actual number of cases attempted. Fortner's child was the only example of an 
unqualified success. Subsequently, Houssin et all4 in France reported 29 months' survival in an adult 
who was given an extra liver. 
With the increased success of orthotopic liver transplantation, interest in the alternative (and as 
it has turned out, high risk) procedure of providing an extra liver has waned, and very few further 
efforts have been reported since 1980. The importance of auxiliary liver transplantation's place in 
history may depend in the the long run on its role in clarifying hepatotrophic physiology. 
TABLE 1: AUXILIARY LIVER TRANSPLANTATIONS THROUGH JUNE 1968 
Investigator Date Disease Age Survival Cause of Death 
(Yrs.) (Days) 
Absolon (1 1) 11/3/64 Extrahepatic biliary atresia 1111 2 13 
Starzl (15,16) 2120165 Alcoholic cirrhosis 50 22 
Starzl (1 5,16) 7/05/65 Alcoholic cirrhosis 47 34 
Starzl (15,16) 11/3/65 Extrahepatic biliary atresia 1-4/12 0 
Cree (1 7) 10/27/66 Subacute hepatitis 17 2 
Fonkalsrud (1 8) 3/02/67 Hepatoma 46 12 
Calne (19) Summer '67 Alcoholic cirrhosis 47 11.2 
Sheil (20) 411 2/68 Cirrhos~s 45 3 
Starzl (15,16) 6120168 Alcoholic cirrhosis 48 24 
Bile peritonitis, sepsis 
Sepsis, hepatic failure 
Sepsis, hepatic failure, 
GI bleed 
Cardiac arrest 
H e ~ a t i c  failure 
Thrombosis hepatic artery, 
homograft necrosis 
Hemorrhage 
Hepatic failure 
Sepsis, hepatic & 
renal failure 
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Although Welch previously had published a brief note on auxiliary liver transplantation, this more 
complete account by the Albany team was a landmark paper in the history of liver transplantation. 
Goodrich went into private practice in Santa Fe, New Mexico but suffered a stroke at age 50 and 
retrained in pathology. We were unable to locate him. Harold Welch is Chief of Surgery at Albany VA 
and Professor of Surgery at Albany Medical College. 
C. Stuart Welch died of a myocardial infarction in1980 on his birthday. He was 71 years old. 
Nelson, then Chief of Surgery at the Albany VA, died of burnsfrom an explosion in his apartment while 
refinishing furnitwe. The VA pathologist, Beecher, is retired and is in good health. 
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Homotransplantation of the canine liver 
Surgery, 39: 244-5 1, 1956 
Edward 0. Goodrich, Jr., Harold F. Welch, John A. Nelson, Theodore S. Beecher and C. Stuart Welch 
In this communication we shall report our experience with ho- 
motransplantation of the dog's liver. Our purpose in attempting this trans- 
plantation was, first, to find out whether the operation was technically 
possible with survival of the liver, and, second, to determine the longevity 
of such transplants and their effect upon the host. The dual blood supply of 
the liver presents a unique technical problem for which we developed 
several types of anastomoses. A greater difficulty, however, is the sensi- 
tivity of this organ to anoxia.' This obstacle is compounded in the dog by 
the presence of intrahepatic saprophytic cloatridia which proliferate rap- 
idly under anaerobic conditions. These organisms cannot be uniformly 
eliminated although Raffucci and Wangensteen' have demonstrated an 
increased tolerance to interruption of hepatic arterial flow in dogs prepared 
with wide-spectrum antibiotics. 
In the experiments being reported, we attempted to ameliorate the 
effects of hepatic anoxia during the period of complete interruption of liver 
blood flow while transplanting the organ by two methods. We first used 
long-term preparation of the donor with wide-spectrum antibiotics, in an 
attempt to eliminate the intrahepatic saprophytes. Later, we inserted a 
polyethylene shunt between the recipient dog's aorta and the hepatic 
arterial tree of the donor liver while performing the afferent anastomoses. 
This latter technique proved more satisfactor). and will be described in 
detail. 
Experimental Method 
Technique of Liver Transplanraiion L'siny un Arierial Shunt.- 
Donor and recipient dogs ue re  prepared simultaneouslq by two surgical 
teams, and the entire liver of the donor was transplanted with the accom- 
panying vascular trunks into the lower adbomen of the recipient. The 
recipient's liver was not disturbed Donor animals were selected so that 
they weighed 5 to 10 kilograms less than the recipients. Intravenous 
Nembutal anesthesia was used and the donor b a s  canied on endotracheal 
intermittent positive pressure. 
By careful dissection the donor's portal vein. ~nfrahepatic and 
suprahepatic vena cava. and the hepatic artery and its proximal tree were 
isolated via a thoracoabdominal incision. Slnce the hepatic artery was 
usually too small for reliable patenc) of the anastomosis. ~t was usually 
necessary to use the celiac axis or a segment of aorta. With the other 
branches ligated, the aortic segment provided a readily anastomosed 
extension of the donor's hepatic artery. Before removing the liver, the 
donor was heparinized. 
At the same time, the recipient's vessels were prepared through a 
lower right rectus abdominal incision. The infrarenal inferior vena cava, 
the distal aorta. and external iliac arteries were isolated. The vena cava was 
transected and fixed over a Blakemore-Lord cuff,' in preparation for 
nonsuture anastomosis to the subcardiac vena cava of the donor. The site 
of transection of the aorta was then elected, and a polyethylene tube was 
inserted into this vessel in a position proximal to the level of transection. 
When the recipient had been prepared, the donor's vessels were 
transected as rapidly as possible, in the following order: the infrahepatic 
vena cava which was ligated, the portal vein, the aorta below and above the 
celiac axis, and the subcardiac vena cava. The liver was then placed in the 
lower abdomen of the recipient and the hepatic outflow was first estab- 
lished by completing the vena cava anastomosis over the previously placed 
Blakemore-Lord cuff. The polyethylene shunt was then connected to 
another tube placed in a branch of the hepatic arterial tree of the donor liver. 
When using the aortic segment preparation. the superior mesenteric artery 
proved to be the most suitable location for the shunt. With the shunt in 
operation, it was then possible to perform both proximal and distal aortic 
anastomoses accurately and less hurried]), meanwhile being assured of 
adequate oxygenation of the transplanted liver. When the arterial anasto- 
moses were completed. the shunt was discontinued and the portal vein of 
the donor was connected to the recipient's distal vena cava over a second 
Blakemore-Lord cuff. To prevent motion of the transplant and kinking of 
the suprahepatic vena cava. the diaphragmatic tags on the suprahepatic 
vena cava were tacked to the right psoas fascia Hith one or two sutures. 
Finall), a plastic cho lec~s tos tom~ cannula* was inserted and brought out 
through the hound. uhich u a s  then closed in laqers. Flg. 1 is a diagram- 
matic representation of the liver transplant with anastomoses. 
Liver biopsies bere  obtained before and after transplantation and at 
dail) intervals after operation. Bile output was recorded and in some 
animals daily Bronmsulphalein extraction curves were obtained. The 
* Manufactured b) Mr. L. W. Carson, Wheaton, Ill. 
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Fig. 1.- A, Demonstrates the temporary shunt between the recipient dog's aorta and the donor liver. The course of arterial blood flow from the 
recipent's aorta is via the polyethylene shunt to the superior mesenteric artery and aortic qegment of the transplant. R, Demonstrates the completed liver 
transplant and shows the afferent and efferent anastomoses as described in the text. 
clinical condition of the animals was closely followed and antibiotics. needle biopsy on the first postoperative day, In five of the animals having 
fluids, and blood were given as indicated. Upon death or sacrifice post- successful transplants, removal of the liver was on 
mortem examinations were perfomled. one of the days followine transplant. None of the recipients survived this 
Other. Tec.hnrr/lre~ fir- Llvrr. Tt-crt~.~plorrtc~tior~. The technique de- 
scribed here was developed after a number of other methods had proved 
less satisfactory. Arteriali~ation of the donor's portal vein by the 
recipient's external lilac artery. after the method of Schilling. was first 
used.' In these experiments the hepatic arterial tree was not used. Later. 
end-to-end anastomosis of the recipient's external iliac artery to the 
donor's hepatic artery or celiac axis was co~nbined wlth anastomoses o f a  
recipient common iliac vein to the donor portal vein. All of the animals in 
the earlier experiment5 were prepared with oral wide-spectrum antiblot- 
icst for penods ranging between four and twenty-one day\, in an attempt 
to prolong the hepatic tolerance to anoxia. No shunt was used in these ex- 
periments. Animals in this group were followed postoperatively in the 
manner outlined previou,ly. 
Results 
Sl ir~. i~ ,al  of Trtrnspltrnrs - Homotransplantation of the canine liver 
has been performed successfullj twenty-one times in forty-nlne attempts. 
In all successful cases the animal\ lived ;t least f i \e  days. and in no 
unsuccessful experiment did the recipient suwive over thirty-six hours. In 
all successful experiment\, blle was produced for from one to seven days 
with one exception, in uhich \iable hepatic tlssue was demonstrated by 
f The chlonerrac)clene and tctrdcqclene uhed In ihe\e experiments were 
suppl~ed by Lcdzrle Lahor~tons, .  D I \ I \ I ~ I I  of Amencan C)dnirn~d Cornpan) 
procedure. The shunt technique as described was used in thirteen pairs of 
animals with 69 per cent ~uccessful transplantations, while in thirty-six 
pairs of animals prepared with wide-spectrum antibiotics and having 
various types of afferent anastomoses there was 33 per cent survival. 
Typically, in a successful transplant experiment, bile began to rise in 
the cannula as the mound was being closed. The animals recovered from 
the anesthesia within one to four hours. but remained lethargic for from 
twelve to twent) -four hours. During the first day bile was produced at a rate 
of 2 c.c. per kilogram of donor body weight. Solid food was occasionally 
taken at this time. but more frequently the diet was \~oluntarilq limited to 
liquids. The temperature and pulse rate were normal or slightly elevated, 
but no local signs of peritoneal irritation were manifested when omentum 
was draped over the liver prior to closure. By the end of the second day, bile 
output increased. and the animal appeared to be approaching a more nearly 
normal state. During the third twenty-four-hour period, bile secretion by 
the transplant was usuallq maximum and amounted to 4 to 5 c.c. per 
kllogram of donor \+eight. During this period the bile ivas very dark, 
mucoid. and rather tlpical of gall-bladder bile. In the subsequent two days, 
the bile output fell off and the bile became less inteniel) colored and more 
water). About the fifth day secretion ceased and was followed in oneor  two 
daqs by a serosanguineous. then a foul sanguino-purulent discharge via the 
cholecystostom) cannula. After the fifth daq sun.ivors exhibited varying 
degrees of toxemia uhich were frequently fatal. and exploration after 
cessation of the bile floa revealed a completely necrotic liver. usually 
infected. in the process of degeneration and sloughing. 
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Microscopic Studies ofLiver Biopsies.- The microscopic picture of 
the transplanted liver usually correlated well with the bile output, although 
occasional inconsistencies were found. These were thought to be due to 
failure of some portions of the transplant to receive an adequate blood 
supply while other portions of the organ were functioning. Liver biopsy 
taken immediately after transplantation showed morphologic changes of 
varying intensity. In practically every instance there was some sinusoidal 
congestion which seemed to extend peripherally from the region of the 
central vein, and in extreme cases this congestion caused disruption of the 
hepatic cords. Where frank necrosis of individual hepatic cells occurred, 
it was usually centrolobular and was accompanied by a polymorphonu- 
clear leukocytic infiltrate. When the experiment terminated within thirty- 
six hours, a wide range of microscopic changes were found, ranging from 
a slight progression of these changes to massive necrosis with bacterial 
invasion and intense acute inflammatory exudate. Both needle biopsies 
and sections of successful transplants taken at exploration or autopsy 
showed a patchy distribution of lesions. Serial biopsies, therefore, some- 
times exhibited rather marked differences, with relatively badly damaged 
tissue being followed the next day by a specimen exhibiting relatively 
minor change. When viewed as a group, however, the pattern of change 
was fairly constant. In some of the surviving animals slight recovery from 
the congestion and cellular changes seen immediately postoperatively was 
found. In no instance, however, did the liver ever regain its control status. 
In a few instances focal anemic necrosis associated with congestion and 
hemorrhages with acute inflammation progressed rapidly so that the liver 
was more or less totally destroyed by the second or third day. 
Usually, however, beginning on the fourth day, there was more or 
less general increase in cellularity of the portal spaces. The exudate con- 
sisted of numbers of small round cells of the chronic inflammatory type and 
larger mononuclear cells, presumably fibroblasts. This reaction continued 
in a progressive fashion. At about the same time, rather extensive necrosis 
of the remaining hepatic tissue occurred. This was usually patchy in 
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distribution but eventually became generalized. In the end, the liver was 
totally necrotic and all anatomic features were lost. In only one animal was 
any viable tissue seen after the sixth postoperative day. In this particular 
instance, moderate amounts of apparently viable tissue were found about 
the periphery of the lobules, whereas the central portion showed extensive 
anemic necrosis, congestion, and acute inflammatory infiltrate. This 
animal died of distemper on the seventh day. 
Bromsulphalein Ex-traction.- Bromsulphalein extraction curves 
obtained on five survivors also correlated with bile production and the 
microscopic picture, indicating maximal transplant function on the third 
day. In Fig. 2, extraction curves for Bromsulphalein taken in one experi- 
ment are shown. 
Cotnp1ications.- Occlusion of the venous return from the hindquar- 
ters in the early experiments caused edema in several animals, and the 
development of abdominal collaterals increased the hazard of needle 
biopsy. Therefore, direction of the venous return from the legs through a 
portal vein of the donor liver was effected in perfecting the transplantation 
technique. A few cases of right hindlimb paralysis were precipitated by 
interruption of the right external iliac artery, but this complication did not 
develop in those animals in which the distal circulation was re-established. 
Employment of the shunt technique doubled our survival rate and 
reduced the necessity for completing the arterial anastomosis hurriedly, 
thereby reducing the incidence of thrombosis. It also obviated the labor and 
expense of prolonged preoperative preparation of the donor in an uncertain 
attempt to render the liver bacteriologically inactive.' The shunt was found 
to require constant attention during anastomosis. On several occasions the 
vessels of the transplant became twisted about the end of the relatively rigid 
shunt, causing premature thrombosis within the tube, and quite possibly 
within the artery, also. 
Of the twenty-eight transplantations which were failures, eight were 
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Fig. 2.- The values for Bromsulphalain retention in the serum of a dog in whom a liver transplant is functioning are shown above. 
Five milligrams per kilogram of the combined weights of both dogs (recipient and donor) was given. The curve designated 1 d. preop. is 
the control. Curves on the second and third postoperative days show that a more rapid extraction of the dye occurred, the result of the 
additive function of the liver transplant. On the fifth day dye extraction was less than normal. At this time the transplant was nonfunctioning. 
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due to what can be called, for lack of a better term, " to~emia."~.  In six of 
these the liver was completely anoxic for over thirty minutes, and in three 
gross gas bubbles were encountered in the liver at post mortem. In no case 
did the recipient survive when the donor liver was anoxic for over thirty- 
three minutes. Afferent arterial anastomosis thrombosis caused eight 
failures when arteries smaller than the aorta here  used. although one liver 
secreted 15 c.c. of bile for six hours before death. Intraperitoneal hemor- 
rhage caused four deaths. In two instances the efferent vena caval anasto- 
mosis was tuisted, causing multiple fractures in the dome of the liver, 
while In one case a dehiscence occurred at the portal iliac veln cuff anas- 
tomosis. No source of hemorrhage was established In the other animal. 
Aspiration of gastric contents caused one death, and in one experiment the 
animal died of a massive pulmonary embolism after release of the vena 
caval clamp. The occluding clamp had been placed about 3 cm. below the 
highest point of dissection on the vena cava, contrary to our usual practice, 
and had thereby allowed a thrombus to form between the clamp and the 
renal vein. No cause of death could be determined in five cases. 
Discussion 
Homotransplants of kidneys In an~mals  have been shown to survlve 
for from one to eighteen days. with the majority of investigators reporting 
an average of four day, of transplant function.' These organs are then 
destroyed by the inevitable host reactlon nhlch is thought to be an immu- 
nologic phenomenon.' We have k e n  able to demonstrate that the liver can 
be transplanted with maintenance of viability for varying periods up to one 
week. It would appear. therefore, that the canine liver is subject to the same 
forces which govern the course of renal homotransplants in this species. Of 
great significance is the finding of Hume and associatesQhat homotrans- 
plants of kidney may survive much longer penods in the human being than 
in the dog. 
It is quite improbable that human livers could be transplanted with 
survival of the transplants. not so much because of the technical difficulties 
but more so because of the difficulty of obtaining a suitable donor liver. 
There is no question but that a temporary functioning liver transplant 
would have a place In the treatment of patients n ~ t h  chronic liver disease 
and especially those in acute failure or coma. In the latter condition 
recovery of the liver is possible in many instances and a temporarily 
functionning transplant would tlde the patient over. It is our present interest 
to determine how effective liver tran,plants can be in animals with hepatic 
failure and deficiency states. Short of actual transplantation of the liver is 
the technique of viviperfusion using animals in l i ~ e r  failure and donor 
livers. This technique is being investigated currently in our laboratory. The 
subject of heterotransplants In the case of the liver is also of interest in that 
short-term function of donor livers would hake calue. 
The peculiar bacterial flora of the dog's liver " and its uncertain and 
difficult eradication' caused a significant number of failures in the group 
prepared a l th  antibiotics, since there was no way to predetermine the 
efficacy of our preparation. This factor was controlled in the present 
experiment by reducing the period of complete hepatic anoxla to a few 
minutes, through the use of an arterial shunt. Since the human liver is 
usually cterile. u e  belleve that ~t is of importance to in~estigate the 
reactions which occur after transplantation of normally \terile livers in 
other species. We have transplanted livers in monkeys (.l.fac~ac~us rhesus) 
but, so far. the technical difficultie, habe not been overcome and we have 
had no survivals. 
Another difficult) encountered in this \tud) in whlch dogs have been 
used, namel). central lobular conge\tion, ma) be due to the activity of the 
hepatic vein  sphincter^.'^ 
At the present writing we have Ler! l~ttle data on the cornposition of 
the bile excreted by the I i ~ e r  tran5plnnta. The actlie formation and 
excretion of bile is incontrovertible and the cgross appearance and texture 
of this bile is quite normal. We have noted that during periods of greatest 
transplant activity, as indicated by BromsuJphalein retention curves, 
definite blue discoloration of the bile occurred for one to two hours after 
injection of the dye. 
Liver transplants may prove useful in the study of hepatic physiol- 
ogy. Although technicall) difficult and time-consuming, the procedure 
may also provide a useful technique for mvestigations in such varied fields 
as shock. homeostasis, irnmur~ity. and hormone metabolism. 
Summary  a n d  Conclusions 
A description of several techniques used for the transplantation of the 
liver in dogs has been given. together with observations on forty-nine 
experiments. 
The entire h e r  of the dog can be transplanted intact to another dog 
with presenratlon of function in so far as the excretion of bile is concerned 
for penods up to five days. 
The liver seems to be subject to the same type of homotransplantation 
reaction as is the kidney when transplanted in the dog. Microscopically, the 
changes first seen in the liver are small round cell and mononuclear 
infiltration of the periportal spaces which occur about the fourth day. 
Thereafter, necrosis begins and progresses rapidly. being complete usually 
by the end of the fifth day. 
Bile production and Bromsulphalein extraction are maximum on the 
third day after transplantation of the liver. 
None of the canine livers In this experiment tolerated complete 
anoxia for a period over thirty-three minutes. in spite of preparation with 
antibiotics. 
References 
Markowitz, J., and Rappaport, A. M.: The Hepatic Artery, Physiol. 
Rev. 31: 188-204, 1951. 
Raffucci, F.L., and Wangensteen, 0 .  H.: The Tolerance of Dogs to 
Occlusion of Entire Afferent Vascular Inflow to the Liver, Proc. 
Surg. Forum. Clin. Congress Am. Coll. Surgeons. Philadelphia, 
1951. W. B. Saunders Company. pp. 19 1-195. 
Blakemore, A. H.. and Lord, J. W.: Techniques of Vitallium Tube 
Prostheses in Portacaval Shunts. Ann. Surg. 122: 476-489, 1945. 
Schilling, J. A,,  McKee, S. W.. arid Wilt, W.: Experimental Hepatic 
Portal Arteriovenous Fistula. Surg.. Gynec. Br Obst. 90: 473-480, 
1950. 
Lewis. F. J.. and Wangensteen. 0 .  H.: Penicillin in the Treatment of 
Peritonitis Due to Liver Autolysis in Dog\. Proc. Soc. Exper. Bioi. & 
Med. 73: 533-535. 1950. 
Mason. E. D.. and Davidson. E. C.:  Studq of Tissue (Liver) Autolysis 
in Vivo: I. Blood Changes: Physical and Chemical. J. Lab. & Clin. 
Med. 10: 622-630. 1924- 1925. 
Ellis. J. C.. and Dragstedt. L. R.: Liver Autolqsis In Vivo. Arch. Surg. 
20: 8-16, 1930. 
Hume. B. M.. klerril, J. P.. Miller. B. F., and Thorn, G. W.: 
Experiences With Renal Homostransplantation in the Human: Re- 
port of Nine Cases. J. Clln. Invest. 34: 327-382. 1955. 
Simonsen, M.: The Acquired Immunlty Concept in Kidney Ho- 
motransplantation. Ann. New York Acad. Scl.. ~ o l ,  59. art. 3, 1955, 
pp. 348-452. 
Wolbach, S. B.. and Salkl. T.: Spore-bearlng Bacteria Present in the 
Norniai Dog's Liver. J. Med. Res. 21: 267-278. 1009. 
Fine, J.: Personal cornmunicat~on. 
Maegrnith. B. G.: Microanatomy of Hepat~c Vascular System. Liver 
Injur). Hoffbauer. F. W.. Edltor. Trans. Tenth Conference, New 
York, Josiah Macq, Jr. Foundation, 195 1, p. 181. 
AUXILIARY LIVER TRANSPLANTATION AND HEPATOTROPHIC PHYSIOLOGY 
As soon as immunosuppression was used to prolong the viability of auxiliary liver grafts, it was 
noted that the extra organs underwent profound atrophy and were damaged far more than livers 
placed orthotopically (cf. Part I, Starzl, T.E. et al, Ann Surg, 1964). The experiments by Marchioro 
provided evidence that there were specific substances in the portal venous blood without which an 
optimum environment for a liver graft could not be provided. 
Marchioro is Professor of Surgery at the University of Washington, Seattle. In this and other 
studies establishing the hepatotrophic concept, the impeccable work of Porter, the pathologist, 
always provided the principal evidence. Porter is Professor in the Department of Pathology, St. 
Mary's Hospital and Medical School, London. 
CLIO CHIRURGICA 
Physiologic requirements for auxiliary liver homotransplantation 
Surgery, Gynecology & Obstetrics, 121 : 17-3 1, 1965 
T. L. Marchioro, K. A. Porter, T. C. Dickinson, T. D. Fans and T. E. Starzl 
For hepatic homotransplantation, two general types of operative 
procedures are available. One, which would be applicable for the treatment 
of malignant disease of the liver, consists of removal of the recipient's own 
organ and replacement with a hepatic homograft. The other variety of 
operation, which was first described in principle by Welch and Goodrich 
and their associates (Fig. IA), is designed for the treatment of patients with 
hepatic failure due to benign disease, such as cirrhosis, and does not 
involve recipient hepatectomy. 
There would be important advantages in performing hepatic ho- 
motransplantation without recipient hepatectomy. The formidable task of 
extirpation of a liver would be avoided. In addition. a n j  remaining function 
of the diseased host liver would be retained so that immediate total 
dependence upon the homograft would not be necessary. In spite of these 
appealing features, the disconcerting observation was recently made1"' 
that there was very marked and rapid reduction of the sire of auxiliary 
homografts which were placed b] Welch's technique into dogs receiving 
inimunosuppressive agent<. the diminution of homograft mass beginning 
within 2 weeks. Different explanations for this phenomenon were sug- 
gested, including the possibility that there was competition for nutritional 
substrate by the two livers u i th  the result that the dog's own organ, which 
received the alimentary venous flow first. was operating at a physiological 
advantage in comparison to the ectopically placed hornograft. 
In the present stud), the role of portal ~ e n o u i  tlow in affecting the 
well-being of the homograft and the host'< own 111er was ctudied by a \eriei 
of experiments designed to a l l o ~  one or the other libel to ha\e  primary 
access to the splanchnic Lenous tlow. The consquence of the stud! has 
been to clarify those phy\~ologic factors uhich appear to be requisite for 
the successful employment of auxiliiry liver honiografts. 
Methods. 
Twent)-six mongrel dogs. ueighing 1 1.3 to 23.1 kilograms, were 
used for recipients. The experiment \*.a\ carried to completion in 15 of 
these animals, and the group constitutes the basis for the present report. 
Liver homografts were obtained from health) animals \&sighing from 0.5 
to 5 kilograms less than the recipient. All operati\e procedure$ were 
performed under pentobarbital anesthesia. 
Each recipient anlmal was treated with azathioprine. 2 to 8 milli- 
grams per kilogram per day, as the sole immunosuppressive agent. This 
drug was administered orally except during the immediate postoperative 
periods, at which time the intravenous route was used. As soon as possible 
the animals were returned to standard kennel feedings. In 3 of the dogs, 
removal of their own livers was canied out 61 to 77 days after homotrans- 
plantation, by a method which preserves the intrahepatic inferior vena 
cava.': For these dogs, azathioprine was continued; and, in addition, 
radioactive sulfur methionine was administered intravenously to one dog 
every 5 days after hepatectomy, each dose containing 88 microcuries of 
radioactive sulfur in approximately 1.8 milligrams of methionine. No con- 
tinuous infusions of glucose were used after hepatectomy and the pre- 
exiating high protein diet was resumed as quickly as possible. 
Postoperative hematologic studies were obtained daily in order to 
determine the safe dose of arathioprine. Biochenlical determinations were 
performed twice a week. These consisted of the measurement of serum 
bilirubin by the Mallo)-Evelyn technique, alkaline phosphatase by the 
Bodanshy method, serum glutamic oxalacetic tmnsaminase and serum 
glutamic pyru\ic transaminase in Sigma-Frankel units. and fibrinogen 
analysis using Ratnoff's method. In addition. blood sugar, blood urea 
nitrogen. stool color, fluid intake and output, and daily weights and tem- 
peratures were recorded. 
At karying inten~als postoperatively the animals were re-explored. 
Biops) specimens Mere obtained from the host likers and from the ho- 
mografts. and estimates here  made concerning the relative sizeb of the 2 
livers. In addition. operati\e angiograms were performed in the majority 
of animals in order to demonstrate the patencq of the anastornose? and to 
obtain general information about the direct~on and magnitude of venous 
blood flow. The latter studies s e r e  performed ui th  50 per cent hypaque, 
by injection into the appropriate portions of the artenal and venous 
systems. In addition to the pathologic studies made by open biopsies, 
complete autopsies ue r r  obtained In edch in\tance as qulclly as possible 
after death. All extraneous tissue was dis\ected free from both livers, and 
comparative weights of the homograft and the dog's own liver were 
obtained. The patency of each anastornosir w a> specificall! noted. Tissues 
here  fixed in formol-saline and Camoy's solution for histologic studies. 
Sections were routinel) stained with hematox) lin and eosin: Gordon and 
Sweet's silver Impregnation for reticulin: Verhoeff and van Gieson's 
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Fig. 1.- Experimental protocols for auxiliary hepatic homotransplantation. A, Previously reported rnodifi- 
cation of Welch-Goodrich hepatic homotransplatnation. Homograft undergoes rapid atrophy and diminution in 
size. Portal blood flow is from the systemic venous system. B. Preparation of group 1 dogs in present study. Yon- 
hepatic splanchnic flow is diverted through the hornograft. With this preparation, the homograft retains its size and 
the animal's o*n liver undergoes shrinkage. It is usually more convenient to bring the hepatic artery behind, rather 
than in front of, the portal vein as depicted. C. Superior mesenteric vein is ligated belou the splenic vein, 
partitioning nonhepatic splanchnic flow between the autologous liver and the hornograft. Homograft shrinkage 
occurs but more variablj (group 2). D. Auxiliary homotransplantation in group 3. The host liver vascularized as 
with the portacaval transposition of Child. 
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Fig. 2.- Operative venous angiogram of dog 5 showing retrograde 
passage of nonhepatic splanchnic flow through the homotransplanted liver 
(lower). The ligature around the portal vein is evident (arrow). The dog's 
own portal system has also filled with dye from collaterals. Note the large 
size of th homograft compared to the small dimensions of the dog's own 
liver. 
method for elastic and connective tissue; periodic acid Schiff; Perl's 
Prussian blue method for iron; and Kutlik's bile stain. Other special stains 
were used if appropriate. 
Three different types of auxiliary homotransplantation were per- 
formed: 
Group I .  Six homografts were placed in the right paravertebral 
guner. The donor vena cava was interposed into the recipient terminal 
inferior vena cava (Fig. 1B). The hepatic artery was revascularized by 
means of an end-to-end anastomosis with the right common iliac artery. 
The end of the homograft portal vein was anastomosed to the side of the 
recipient's superior mesenteric vein (Fig lB), using No. 6-0 silk. The 
recipient's own portal vein was ligated above the most cephalad tributary, 
the pancreaticoduodenal vein (Fig. 1B). The splanchnic blood flow was 
thus directed in 
a retrograde fashion into the homograft, so that the dog's own liver was 
supplied only by the hepatic artery. 
Group 2 .  In 6 dogs, a similar operative procedure was carried out 
except that the ligature was placed on the superior mesenteric vein just 
below its junction with the splenic vein (Fig. 1C). The venous return from 
the small intestine was thus diverted through the homograft and the venous 
flow from the splenic and pancreaticoduodenal areas passed through the 
recipient animal's own liver. There was consequently a division of the 
nonhepatic splanchnic flow, both livers receiving a fraction. 
Group 3. In 3 animals portacaval transposition was performed from 
3 to 9 months before definitive transplantation. After complete recovery 
from this preliminary operation, an auxiliary homograft was placed in the 
same location as in groups 1 and 2 (Fig. ID). The portal vein was then 
ligated above the entrance of its highest tributary. This modification was 
designed to give both livers a complete arterial and venous blood supply. 
The nonhepatic splanchnic venous flow first passed through the homograft 
and then via the cavaportal anastomosis to the recipient's own liver. 
Results in group 1. 
Survival. Six of the 10 animals survived operation. In 3 dogs both 
livers were in place for 25, 28, and 52 days, after which the dogs died of 
pneumonia, hemorrhage from a cecal ulcer, and from homograft necrosis, 
respectively. In the first 2 instances, all vascular channels were found to be 
patent at autopsy. In the third, the vessels were proved to be patent at 
angiography 30 days after homotransplantation, but in the subsequent 22 
day interval the portal-mesenteric anastomosis cloned. The other 3 dogs 
were subjected to second stage complete removal of their own livers. 
Survival after recipient hepatectomy. Three dogs underwent re- 
moval of their own livers (Table I) after 77.61, and 73 days. At the time 
of hepatectomy an estimate was made of relative masses of the 2 livers, and 
in each instance the homograft was defmitely larger than the animal's own 
liver, which had undergone striking shrinkage. The first of these, dog 5, 
resumed a full diet within 2 days and was in excellent clinical condition for 
the remainder of his life. He was re-explored for open hepatic biopsy 43 
days later, and 6 days after this procedure was found dead in his cage from 
a complete evisceration that had occurred during the night. 
The second, dog 8, also recovered promptly from pentobarbital 
anesthesia but died 8 days later from the consequences of wound dihis- 
cence, peritonitis, and massive gastrointestinal hemorrhage from an acute 
duodenal ulcer. 
The third, dog 10, alsorecovered promptly from hepatectomy, but his 
subsequent course was complicated by massive ascites. Twenty-seven 
days after hepatectomy, he was re-explored for biopsy and died the 
following day. 
After hepatectomy, it was noted that the appetite and nutritional re- 
quirements for the 2 longest surviving dogs were markedly increased, as 
much as 5 or 6 times the ordinary diet being consumed daily, despite which 
a weight gain did not occur. 
" " 
Angiographic studies. In 3 animals, dogs 5,8, and 9, the blood supply 
to the host's own liver and the homograft was investigated by injection of 
a contrast medium into the terminal aorta and the splenic vein. In each, a 
major portion of the nonhepatic splanchnic venous flow appeared to pass 
through the homograft, although dye was noted to enter the host liver 
through collaterals (Fig. 2). All arterial anastomoses investigated were 
found to be open. In 1 animal in which the portal-mesenteric venous 
anastomosis was found to be patent at angiography, subsequent thrombo- 
sis was found at autopsy 22 days later. 
Biochemical studies. Following placement of the auxiliary ho- 
mograft there was a prompt rise in alkaline phosphatase, beginning within 
a few days after operation (Fig. 3). The serum glutamic oxalacetic 
transaminase and serum glutamic pyruvic transaminase followed a similar 
but variable pattern. Chemical jaundice was observed in only 1 dog, the 
highest value being 1.9 milligrams per cent. Fibrinogen tended to rise early 
in the postoperative course as has been previously de~cribed'~ with the 
Welch-Goodrich preparation. 
Following removal of the animal's own liver, sharp increase in 
bilirubin was noted in all 3 dogs during the first few days of total 
dependence upon the homograft, to levels as high as 14.5 milligrams per 
cent (Fig. 3). The stools became temporarily clay-colored and the urine 
deepened in color. Despite this, these animals appeared to be in good 
general condition, and within 1 week the jaundice began to recede in all 
(Fig. 3), stabilizing between 4 and 7.6 milligrams per cent at the same time 
that bile reappeared in the stools. Hypoglycemia was not observed. Rises 
of alkaline phosphatase, serum glutamic oxalacetic transaminase and 
serum glutamic pyruvic transaminase occurred after autologous hepatec- 
tomy with subsequent partial return toward, but never to, normal (Fig. 3). 
The stools of these animals frequently were observed to contain poorly di- 
gested focd, the excreta resembling the dog food which had been recently 
ingested. Stools wre voluminous. Analysis of the diet and stool for fat dem- 
onstrated almost complete lack of fat absorption in the 2 longest survivors. 
AUXILIARY LIVER TRANSPLANTATION AND HEPATOTROPHIC PHYSIOLOGY 
PRE &/ST OP TIME IN DAYS 
Fig. 3.- Clinical course of dog 5 of group 1 series. Note the abrupt bilirubinemia which followed 
removal of the dog's own liver, autohepatectomy. After autologous hepatectomy, the dog lived for 49 days 
with sole dependence upon the homograft, ultimately dying as the result of a wound dehiscence and 
evisceration which followed repeat biopsy. 
Fig. 4.- Auxiliary liver homograft, left, compared to the animal's own liver, right, in dog 8 of group 1 series. The 
homograft was obtained at autopsy, and the animal's own liver was removed 8 days earlier. The weight of the homograft 
was more than twice that of the autologous hepatic tissue. 
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TABLE I.-RESULTS IN GROUP 1 
Dog 
No. 
2 
4 
5 
8 
9 
10 
Weight 
donor kgm. 
14.1 
14.5 
15.4 
18.6 
18.2 
20.0 
F&ght of 
recipient, 
kgm. 
15.2 
19.5 
18.2 
20.5 
18.6 
22.9 
Total Removal 
survical, host 
days liucr 
28 No 
25 No 
126 Yes 
69 Yes 
52 No 
101 Yes 
Gross pathologic observations. The weights of the animal's own 
liver and those of the homograft are listed in Table I. In each instance, the 
homograft weighed more than the host liver, despite the fact that the donor 
animals were all smaller than the recipients. In 3 animals, dogs 5,8, and 10, 
the comparative weights of the autologous liver and the homograft were 
not obtained simultaneously, the interval from hepatectomy to death being 
8 to 49 days. In the other 3, both weights were obtained at autopsy. 
The animal's own liver in each instance was grossly normal except 
for it's small size (Fig. 4). The homografts in 5 instances appeared to be 
relatively normal (Fig. 4) except for some increased firmness. In the one 
dog in which thrombosis of the portal system occurred following angiogra- 
phy, the homograft was nodular and appeared cirrhotic and partially 
necrotic at autopsy. 
Microscopic findings in host liver. Samples of host liver were 
examinedmicroscopically 25,26,28,30,35,51,52,61,63,73, and 77 days 
following high ligation of the portal vein and hepatic homotransplantation. 
Five of the 11 specimens were obtained either at open biopsy or at the time 
of removal of the host liver, while the others were collected at autopsy. 
In the earlier samples there was necrosis of a variable number of the 
cells in the central zones of the hepatic lobules (Fig. 5A). In a few of the 
specimens this was associated with fat droplets in the cytoplasm of the liver 
cells in the other zones. The small branches of the portal vein were dis- 
tended with blood. Large amounts of hemosiderin were present in the 
Kupffer cells and within macrophages which lay in the portal tracts. 
Survival after 
hepaleclomy, 
days 
Not done 
Not done 
49 
8 
Not done 
28 
rvaght 
homografi at 
autopsy, gm. 
325 
380 
656 
478 
440 
492 
Itiight of horf 
Iic,n at aulopg 
heparectomv, ,om. 
322 
306 
225 
211 
300 
310 
In the samples collected after the thirty-fifth postoperative day there 
was centrizonal atrophy of the hepatic cells with collapse of the reticulin 
network immediately adjacent to the central vein (Fig. 5B). The bile ducts 
and hepatic arteries were normal. There were no infiltrating lymphoid 
cells. Iron pigment was still present. 
Microscopic findings in the auxiliary homograji. Samples of the 
homografts were examined microscopically 25 to 126 days following 
transplantation, either at open biopsy, at the time of removal of the host's 
own liver, or at autopsy. Only autopsy tissues were available from dogs 2 
and4.28 and 25 days respectively after transplantation. Dog 9 had a biopsy 
30 days after homotransplantation; the portal venous anastomosis subse- 
quently thrombosed, and the dog died 52 days after the original operation. 
Serial specimens were available for the other 3 dogs before and after 
removal of the host's own liver and at subsequent autopsy. These were 
obtained from dog 5 after 35,63, 120, and 126 days. In dog 8 the tissues 
were taken after 26.61, and 69 days. In dog 10 the specimens were obtained 
after 51,73,100, and 101 days. In dog 9 in which thrombosis of the portal 
system occurred after angiography, there was widespread centrizonal 
necrosis accompanied in several areas by necrosis of whole lobules and 
collapse of the reticulin framework. 
In 4 of the other 5 liver transplants, there was cellular infiltration (Fig. 
6A). In dog 2, which lived for 28 days, this affected only the small portal 
tracts, but in the others the adventitia of the central hepatic veins was also 
involved. The infiltrate consisted of small and medium-sized lympho- 
Fig. 5.- Biopsies of their own livers from 2 dogs in group 1: A, left, 35 days after operation (dog 5). There 
is cenmzonal necrosis of the liver cells; P, portal tract. Hematoxylin and eosin, X65. B, right, 5 1 days after operation 
(dog 10). The centrilobular reticulin has collapsed (arrow). Reticulin, X90. 
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Fig. 6.- Biopsies of hepatic homografts from 2 dogs of group 1: A, left, 35 days after transplantation (dog 5). 
The portal tracts contain many infltrating cells. The wall of the central hepatic vein is thickened and lightly infiltrated 
with cells. Hematoxylin and eosin, X65. B, right, 61 days after transplantation (dog 8). There is a dense accumulation 
of reticulin and collagen fibers around and within the wall of the central hepatic vein; P, portal tract. Reticulin, X65. 
Fig. 7.- Two canine hepatic homografts: A, left, 120 days after transplantation (dog 5 group 1). A band of reticulin 
fibers links 2 central veins. Reticulin, X65. B, right, 52 days after transplantation (dog 18 group 2). Centrizonal liver cell 
necrosis and hemorrhage is combined with cellular infiltration of the portal tracts (P). Compare with Figure 6A. 
Hematoxylin and eosin, X65. 
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Do: Il*righf of 
No. donor, kgm. 
14 14.7 
15 15.6 
16 15.0 
18 10.9 
19 11.7 
20 15.4 
'Sacrificed 
TABLE 11.-RESULTS IN GROUP 2 
Tl'eighf o j  Total s:irr.iual, l lb tqhf  of  homqqrnf, at 
recipient, kgm. d a y  a,i:op?v or sacrijce, gm. 
19.0 46 285 
18.6 41 400 
24.1 57* 118 
15 9 52* 150 
15.0 50* 158 
19 58* 346 
cytes, plasma cells, and larger cells with scanty pyroninophilic cytoplasm, 
large nuclei, and prominent nucleoli. The only unaffected liver was that of 
dog 4 which lived for 25 days. There was a tendency as time went by for 
the cellular infiltration to diminish in intensity and for plasma cells to 
predominate. For example, in dog 5 in which the infiltrate was very heavy 
at 35 days, there was a slight diminution by 63  days, but by 120 days 
invading cells were far less frequent and were then mostly plasma cells. A 
similar striking decrease was seen in dog 8 in which the biopsy taken at 61 
days showed much less cellular infiltration than was present at 26 days. 
When cellular infiltratron involved the central hepatic veins, there 
was swelling of the endothelial cells and, in 2 of the dogs. fibrinoid necrosis 
of the venous wall was present. In biopsies, these vein5 uere  the site of 
fibrous intimal thickening and accumulation of reticulin and collagen 
fibers around the adventitia of the affected vessels (Fig. 6B). Fibrous 
occlusion of some central veins uas  found in dogs 5 and 8. 
A few foci of acute fibrinoid necrosis were seen in the walls of small 
hepatic arteries in dog 2: in the other dogs these vessels uere  normal. The 
sinusoids were distorted in the central {ones of the liver frorn dog 2. and 
in this same animal the Kupffer cells were loaded with hemosiderin. In the 
other 4 homografts the sinusoids were normal and the Kupffer cells 
contained very little iron pigment. The portal veins and lymphatics were 
normal in all the honiografts. 
In the 1 animal. dog 2. which died from massive gastrointestinal 
hemorrhage there was necrosis of liver cells in the central zones of the 
lobules. In the other homotransplants, the liver cells appeared normal. 
In the biopsies from dogs 5 and 10 at 120 and 100 days, respectively, 
fibrous and reticulin bands linked adjacent areas of centrilobular 
perivenous fibrosis (Fig. 7A). There was also slight periportal fibrosis. The 
lobular architecture was normal ill the other three hepatic homotransplants. 
Small bile ducts hecame increasingly difficult to identify in dogs 5 
and 10 after 63 and 73 days. respect~vely, and this fact was associated with 
the appearance of inspissated bile in the centrilobular canaliculi. In the 
earlier biopsies from these dogs and in the other homotransplants, bile 
ducts and canaliculi were normal. 
Results in group 2. 
S u ~ ~ i v a l .  Six of the 10 dogs wrbived the immediate postoperative 
period. Two of the 6 reniaining dogs died spontaneously. The first lived for 
41 days and died 4 days after biopsy and direct inspection of the arterial 
anastomosis. At operation. a needle wa\ inserted into the hepatic artery for 
pressure determination. At postmortem exarriinstion the vessel was found 
to have a fresh thrombosis. Pneunionia was also pre\ent. The other animal 
died at 46 days of bilateral pneumonia. 
The other 3 animals were sacrificed from 50 to 58 days after ho- 
motransplantation, usually following biops! and angiography. 
Angioq.ra[~hic. \nrdir.\ Four of the 6 dogi had angiograms. In these 
4 ,  the vascular ariastomoses arere patent and hlood flow a h m e  the mesen- 
teric ligature u a s  demonstrated to the animal's own li\er (Fig 8A). Flow 
below the ligature passed to the hornograft (Fig. XB). 
B~oc~l:emic~u/ sr~idii~s. These were eshenttall!, the same as in group 1 
(Fig. 9) .  In none of thc dogs did jaundice de\elop. No iecond stage host 
hepatectomies were carried out. 
Grosc puri:o/o,yit nhscr-i,crrioris In dog 14 the portal \ein was found 
at autops!, to be thronibosed. In this experiment. the dog's own liver 
weighed 390 grams. and the homograft meighed 285 grams. 
In the other5 animals. In \\hich the portal branche.; were patent, there 
was variation in the \ire, of the hornograft and the animal's own liver 
(Table 11). In dog 20. the hornograft \\as distinctl) larger, helng 346 grams 
compared to 262 grams for the host liver. In the other 4. the host liver was 
larger, but in one of these, dog 15, the difference was slight, the homograft 
weighing 400 grams compared to 475 grams for the autologous organ. In 
the other 3, the disparity was greater, the homografts weighing 158, 150, 
and 118 grams compared to autologous liver weights of 265,358, and 485 
grams. respectively (Table 11). 
Microsc~u[~ic srurlies in host li~ler. Samples of host liver were 
examined microscopically 37, 39. 41, 46. 49, 50, 52, 55, 57, and 58 days 
following ligation of the superior tnesenteric vein and hepatic homotrans- 
piantation. Six of the 12 specimens were obtained at open biopsy, while the 
others were collected at autopsy. 
Four of the livers were normal. The liver from dog 18, which had 
suffered a serious b!ood transfusion reaction, showed congestion of the 
sinusoids in the centers of the lobules and necrosis of the liver cells adjacent 
to the central veins which were congested. Inspissated bile was present in 
some of the centrilobular canaliculi. In the greatly atrophied liver from dog 
20 there were the same changes of centrizonal atrophy of the hepatic cells 
with collapse of the reticulin network adjacent to the central vein as were 
seen in the host livers of group I .  
Mic.rosc,oprc finiilngs in the o~r,~.ilirrr-). hon~og~.afr.s. Samples of the 
homografted livers were examined at the same time after transplantation 
as were specimens from the dogs own livers. In 2 of the livers large vessels 
were thrombosed. The biopsy at 39 days from dog 14 showed inspissated 
bile in the centrilobular canaliculi and large deposits of hemosiderin in the 
Kupffer cells. but no other abnormalities. Seven days later, after portal vein 
thron~bosis, there was extensive centrizonal hemorrhage and necrosis of 
liver cells. In dog 15, hepatic artery thrombosis produced widespread hem- 
orrhagic necrosrs of the liver. 
Of the other4 homotransplants. the 3 livers which underwent atrophy 
all showed centrizonal necrosis of liver cells (Fig. 70) .  In dog 16 this was 
present in the first biops) taken at 37 days and at the time the liver cells in 
the middle and peripheral zone5 contained many fat deposits in their 
cytoplasm. By 55 days the necrotic process had spread so that in many areas 
only the periportal liver cells remained. In dogs 18 and 19 the process was 
not so severe. The liver from dog 20 showed no centrilobular necrosis of 
liver cells. 
Infiltration with lymphoid cells was present around the smaller 
branches of the portal vein and around the central veins in these 4 hepatic 
homotransplants. In dog 16 the number of infiltrating cells was at first 
large. but in the biopsy taken at 57 days this infiltration was greatly dimin- 
ished. Slightly fewer cells were present in dogs 18 and 19. and very few 
were present in dog 20. 
As in group I ,  cellular infiltration around the central veins was 
accompanied by swelling of endothelial cells and in 2 iwtances by focal fi- 
brinoid necrosis of the vein uall .  Perivenous fibrosia and occlusion of the 
lurnina of the centra! velns subsequently occurred in dogs 16 and 19. 
Portal veins were nom?al. There were foci of acute fibrinoid necrosis 
in the wall of a small hepatic arten. (Fig. 101 and eccentric intimal fibrous 
thickening in another in 1 homografted li \er at 50 days. dog 19. The 
sinusoids were ~nterrupted in the liver lobules of the 3 animals showing 
centrilobular necrosis. Hemosidenn was present in large amounts in both 
Kupffer cells and in macrophage, lying in the portal tracts in the livers from 
dogs 16 and 18. The Ijmphatics \bere normal in all the honiografts. 
There was collapse of the reticulin network of the lobule\ adjacent to 
the central Xein in the 3 dogs which bhowed centr~lobular lo55 of l ~ ~ e r c e l l s .  
In the specimens from dog\ 18 and 19 at 52 and 50 days respectively, 
fibrous and reticulin bands l~nhed adjacznt a r e a  of fibrosis around central 
\sins.  In dog 16 there wai complete collapse of the reticulin franiework 
w herever necro\ib of all the l i~e rce l l \  in ;I i ~ b u l e  had occurred. The lobular 
architecture was undisturbed in dog 20. 
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Fig. 8.- Operative angiograms on dog 20 of group 2. A, left, Contrast medium injected into the splenic vein 
passes through the animal's own liver. B, right, Contrast material injected through a distal mesenteric vein tributary 
passes through the homografted liver. Note the relatively large size of the homograft compared to the animal's own 
liver. This impression was confirmed at autopsy at which the homograft weighed 346 grams and the autologous 
liver, 262 grams. 
In the homograft from dog 16, many of the small bile ducts were 
severely damaged, and this was accompanied by accumulations of bile 
pigment in the surviving liver cells. Proliferation of the smaller bile ducts 
was present in the homgraft from dog 19. In the other 2 animals, the bile 
ducts and canaliculi appeared normal. 
Results in group 3. 
Survival. A completely satisfactory technical result was not obtained 
in any of the 6 experiments. Three dogs died immediately after operation. 
Late thrombosis of the homograft vena cava was observed in 2 of the 
remaining dogs, and late thrombosis of the portal vein in the third animal. 
Discussion. 
Since the description of auxiliary hepatic homotransplantation by 
Welch and Goodrich and their associates, anumber of studies of this prepa- 
ration have been ~ublished. The assum~tion has been eenerallv made that 
in behavior in the two types of homografts is not solely of immunologic 
etiology. Rather, the auxiliary homograft shrinkage appears to be due to 
deprivation of nonhepatic splanchnic flow in the presence of the recipient 
animal's own liver. When, as in the present study, the situation is reversed 
so that the nonhepatic splanchnic flow is directed initially through the 
homograft, a similar shrinkage is observed in the dog's own liver. These 
experiments have made clear at least one physiologic requirement which 
must be observed in revascularization of the auxiliary liver homograft. Be- 
cause of the apparent competition for nutritional substrate which occurs in 
the presence of 2 livers, the homografted organ must receive its portal 
supply directly from the alimentary venous return. 
The histologic changes in the recipient's own liver are of great 
interest in the dogs of group 1. During the entire course of these animals, 
serial biochemical changes were described, but it was, of course, impos- 
sible to be sure if these resulted from homograft injury or from damage to 
the autoloeous liver. The small size of the host livers in these animals. in v 'd 
the changes observed in the grafted tissue were solely due to immunologic which the splanchnic flow was diverted completely through the homograft, 
rejection. Virtually all of this earlier work was carried out in canine was apparently due to centrizonal necrosis with collapse and condensation 
recipients which were treated with immunosuppressive agents, including 
Welch's original studies and those subsequently reported by Sicular and 
Mehrez and their associates. Under these circumstances, the influence of 
physiologic factors upon the outcome was difficult to delineate because the 
full vigor of homograft rejection destroyed the transplanted tissue within 
a few days. 
The only reports in the literature of auxiliary homotransplantation to 
recipients which were receiving immunosuppressive drug therapy were 
published from this lab~ratory. '~~"In dogs, it was found that the behavior 
of such secondarily placed homografts was significantly different from 
that of orthotopic homografts in similarly treated animals in that the 
auxiliary homograft markedly diminished in size within a few weeks after 
operation. The present study provides strong evidence that this difference 
of retjculin in-the center of the lobule. These changes are similar to those 
described by Mann and his associates more than 30 years ago, after the 
performance of Eck fistula in dogs, an experiment in which immunologic 
factors were absent. In the host livers of the present study, there was 
nothing to suggest that they had been damaged by a graft versus host 
reaction: lymphoid cell infiltration and arterial lesions were not seen. Also, 
although it is known that azathioprine can cause hepatic damage, the 
normal state of the majority of the dogs' own livers in group 2 makes it 
improbable that chronic drug toxicity was an important factor. It is 
interesting that the only host liver in group 2 which showed more severe 
centrilobular lesions and general atrophy came from dog 20 in which the 
homograft had retained its full size. 
The same substrate starvation, which appeared to have caused this 
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Fig. 9.- Clinical course of dog 20 of group 2. The animal is the same one as shown in Figure 8. 
damage to the host liver, seemed to have an even more adverse effect upon 
the homograft, particularly when judged by the gross characteristic[sic] 
and weight of the competing livers. In the animals of group 2, in which the 
2 livers shared the nonhepatic splanchnic flow, 5 of 6 homografts were 
smaller than the respective host livers and in the 3 most severely atrophied 
transplants, in this series, the same centrizonal necrosis was very promi- 
nent. Because the homograft is subject to the injury of rejection, the 
resultant histological alterations cannot be so clearly assigned a metabolic 
etiology, however, especially since centrizonal necrosis has also been 
described as characteristic in the rejecting orthotopic hepatic homograft, 
either with or without use of immunosuppresive drugs."." 
Long survival of some of the animals in the present study permitted 
analysis of the pathologic findings at a much later time than has previously 
been possible and allowed a serial view of the histological changes. In the 
first 2 experimental groups, the majority of the homotransplanted livers 
showed evidence of a cellular homoeraft reaction with lvm~hoid cell 
Fig. 10.- Homografted liver 50 days after transplantation (dog 19 
group 2). In the portal tract a branch of the hepatic artery shows fibrinoid 
necrosis of its wall. The surrounding connective tissue is infiltrated with 
cells. At the right of the photomicrograph there is centrizonal necrosis of 
liver cells. Hematoxylin and eosin, X50. 
infiltration around the small branches of the portal vein and around the 
central hepatic veins. In all of these homotransplants that were sequentially 
biopsied, the infiltration tended to decrease with time, a process which was 
not appreciably hastened following removal of the host's own liver. 
Late in the course, centrilobular fibrosis and phlebosclerosis and, to 
a much lesser extent, periportal fibrosis were seen. In the longest survivors, 
these changes had progressed to the development of fibrous bands which 
linked some of the affected central zones. In many ways, the evolution of 
these structural alterations resembled that of veno-occlusive disease such 
as that described by Bras and his associates. Another late finding was the 
loss of small bile ducts with consequent accumulation of inspissated bile 
in the centrilobular canaliculi. Fibrinoid necrosis of branches of the hepatic 
artery was rare. It is probable that these late changes occurred as the result 
of the action of circulating and cell-bound antibodies produced by the host, 
but at present it is still difficult to distinguish immunologically mediated 
lesions from those which result from mechanical or other factors. The 
central phlebosclerosis and surrounding fibrosis could, for example, have 
been the result of a mild chronic degree of early postoperative outflow 
block. As more long term survivors from canine hepatic homotransplan- 
tation are studied, these questions concerning the late pathologic findings 
in the homografts should be resolved. 
Summary. 
Auxiliary hepatic homotransplants were performed in dogs, the 
second liver being placed in the pelvis of the recipient. In each instance, the 
hepatic artery was revascularized from the external iliac artery. In 6 dogs, 
the portal vein of the homograft was anastomosed to the superior mesen- 
teric vein and the proximal portal vein then ligated; the splanchnic blood 
flow was directed in a retrograde fashion through the homograft, and the 
dog's own liver was left supplied solely by the hepatic artery. In another 
6 dogs, a similar operation was performed and venous revascularization 
canied out so that the non-hepatic splanchnic flow of the recipient was 
shared by both the host liver and the homograft. 
In those animals in which the nonhepatic splanchnic flow was 
diverted through the auxiliary liver (group I), the homograft retained its 
full size and there was marked shrinkage of the host's own liver. Histologi- 
cally, the loss of size observed in the host liver appeared to be due to 
cenmzonal necrosis with collapse of the reticulin which was most pro- 
nounced around the central vein. 
In those animals in which the host liver and the homograft shared the 
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nonhepatic splanchnic flow, there was variable shrinkage of the homograft 
with retention of normal size in all but 1 of the host livers. These findings 
appear to have defined an important physiologic requirement for auxiliary 
homotransplantation. Because of the apparent competition for nutritional 
substrate, which seems to occur in the presence of 2 livers, the homografted 
organ must receive its venous inflow directly from the alimentary venous 
return. 
Of even greater importance than the preservation of homograft 
morphologic integrity is the retention by the optimally vascularized aux- 
iliary liver of the ability to sustain life. as demonstrated by the ultimate test 
imposed by removal of the host's own liver. Despite the fact that 5 of the 
6 homografts in the first group of animals had histologic evidence of 
cellular rejection, autologous hepatectomy in 3 of these dogs was followed 
by survival of 8, 28, and 49 days with total posttransplant survival of 69, 
101, and 126 days. 
Survival in these experimental animals was greater than any previ- 
ously reported hepatic homotransplantation and permitted observations of 
late pathologic changes. These included phlebosclerosis of the central 
veins, perivenous fibrosis of the portal and central veins, the development 
in the 2 longest survivors of fibrous bands joining some of the affected 
central zones one to another, and the disappearance in the same 2 dogs of 
the small intrahepatic bile ducts with the development of intrahepatic 
cholestasis. In the dogs in which serial biopsies were carried out, the 
findings of cellular rejection were demonstrated in every instance to 
diminish with the passage of time, the first histologic demonstration of the 
reversibility of rejection in hepatic homografts. 
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Antonio Francavilla 
The nature of hepatotrophic substances was unknown until 1973 when strong circumstantial 
evidence that they were hormones, especially insulin, was provided from so-called splanchnic 
division experiments. The principle of the experiments was to divide the liver into fragments with 
differing splanchnic venous input from various intraabdominal organs. The liver fragment exposed 
to the venous effluent from the pancreas always was healthier than the other fragments suggesting 
that pancreatic hormones (especially insulin) were the critical hepatotrophic substances. The 
biochemical studies were provided by the brilliant Italian physician, Professor J. Antonio Francavilla, 
Chairman of the Department of Hepatology, University of Bari, Italy. The way in which Dr. 
Francavilla's biochemical studies supported and extended the histopathologic observations of Dr. 
Porter was a classic demonstration of the power of interdisciplinary research. Dr. Francavilla's work 
in this field has continued to the present time and currently is concerned with the biochemical events 
and control of hepatic regeneration. 
AUXILIARY LIVER TRANSPLANTATION AND HEPATOTROPHIC PHYSIOLOGY 
The origin, hormonal nature, and action of hepatotrophic 
substances in portal venous blood 
Surgery, Gynecology & Obstetrics, 137: 179-99, 1973 
T. E. Starzl, A. Francavilla, C. G. Halgrimson, F. R. Francavilla, K. A. Porter, T. H. Brown and C. W. Putnam 
Long ago, Rous and Larimore(39)were intrigued with the possibility 
that portal venous blood contained hepatotrophic factors and that the 
extrahepatic diversion of these factors by portacaval shunt was responsible 
for the poor health of dogs with Eck fistula. However, the observations of 
Mann(27) did not support the hepatotrophic hypothesis, and the work in 
1953 of Child and his associates(1 I )  using portacaval transposition was 
generally interpreted as crucial evidence against it. By replacing the 
diverted splanchnic venous blood with an inflow to the portal vein from the 
inferior venacava, Child avoided most of the adverse effects of Eck fistula. 
The concept became rooted from these studies and those of Fisher and his 
associates(l5-17) and a number of subsequent authors that the quality of 
portal venous inflow was not a prime determinant of good hepatic struc- 
ture, function. or capacity for regeneration. Instead, it became accepted 
that the quantity of total hepatic blood flow was the main consideration. In 
spite of the demonstration that canine livers submitted to transposition 
underwent major deglycogenation and were. thus. not actually nor- 
ma1(43,52), the flow oriented view held sway until it was definitively 
challenged by investigations that had their origin in studies of experimental 
liver transplantation as has been thoroughly reviewed in a recent mono- 
graph(50). 
First. it was noted that auxiliary hepatic homografts underwent 
remarkable atroph) if these extra I ~ i e r s  were revascularized in an ectopic 
location with a double s) stemic blood supply analgous to that with Child 
preparation(51). One possible explanation that u a s  advanced was that the 
organ which was perfused first by splanchnic venous blood extracted a dis- 
proportionate share of unspecified substances and that the other organ 
atrophied because of its disadvantaged competitive situation. The hy- 
pothesis was supported by Marchioro and his associates(29) who showed 
that the transplant atroph! could be preiented bq diverting the nonhepatic 
splanchnic benous blood away from the host liver and through the graft. By 
so doing. the atrophq now afflicted the natibe organ. Confirmatory obser- 
vations were reported by ThomfordiS6). Halgrimson(?O), and Tretbar(57) 
and their associates. Thomford(56) shoued that the atrophy in Welch 
auxiliaq homografts could be prevented in recipients wh~ch  had under- 
gone immunosuppression if the host livers were removed within afew days 
after transplantation, and Tretbar(57) and Halgrimson(20) and their col- 
leagues demonstrated that the shrinkage could be reduced by the diversion 
of portal blood away from the host liver even though it was not directly 
rechanneled through the transplant. Observations by Sigel and his associ- 
ates(47,49) with hepatic autografts implanted to intestinal pedicles or 
directly revascularized in the neck could be interpreted in the same general 
way. 
The transplant preparations which made apparent the foregoing 
physiologic effects had two serious flaws which prevented definitive con- 
clusions about the pathogenesis of the atrophy. First, the total flows 
delivered to the two coexisting livers were often different. Second, there 
was by definition an additional inherent inequality of the two organs since 
the homograft was usually under immunologic attack despite host im- 
munosuppression whereas the animal's own liver was not. Consequently, 
other experiments were undertaken which were designed to circumvent 
one or both deficiencies. 
One preparation not involving transplantation was u5ed by 
Marchioro and h ~ s  associates(28.30) and termed a split transposition. 
Splanchnic venous blood was provided for one portal vein branch of the 
liver whereas the other portal branch was supplied with blood from the 
inferior vena cava. Later. Price(36), Lee(25), and Chandler(9) and their 
associates performed analogous experiments. with either canine partial 
hepatic autografts or isografts of inbred rat livers. All these experiments 
showed hypertrophy in the hepatic tissue which was perfused with splan- 
chnic blood and atroph) of the other hepatic fragments. In addition to 
hypertrophy. Marchioro and his associates(28) shohed that the advan- 
taged hepatic portion had binucleate and trinucleate hepatic cells. mitosis, 
and proliferating bile ducts, all indications of hyperplasia. With quantita- 
tive studies of deoxyribonucleic acid sqnthesis. Lee(25). Chandler(9) and 
Fisher(l8) and their associates proved that the hepatotrophic effects of 
splanchnic blood upon the liver include hyperplasia as well as hypertro- 
phy, It has become ~ncreasingl! accepted that the portal hepatotrophic 
factors are probably not just artifacts of transplantation and other experi- 
mental maneuvers but are prime determinants of the initiation and control 
of the liver hypertrophy and hyperplasia in many circumstances. 
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control studies and liver lobe weights. and the remaining 95 dogs had one 
of the following operative procedures. 
Group 1 .  Parrialpor-tuc cii,ul rru~rsposirio~i, a. Split transposition. - Ln 
15 dogs, the left (Fig. l a )  and in 18 dogs the nght (Fig. I b) portal vein was 
detached from the main portal trunk and revasculanzed by an end-to-end 
anastomosis to the supra-adrenal inferior vena cava b) thernethod of 
Marchioro and h ~ s  assoclatesi28). The procedure divldes the liver into two 
compartments which are dissimilar In that one receives portal blood from 
the total splanchn~c ~ e n o u s  bed and the other obtain$ its portal ruppl) from 
systemic sources. including the effluent from the k~tineys. adrenals, and 
hindquarters. 
b b, Split tranyposltlon rnlnus adrenal anti renal inflow.-The procedure 
was identical to that just described except that the kystemlc venous blood 
was derived from the infrarenal inferior \ens cnva thereb) excluding the 
renal and adrenal effluent. This blood %a \  transmitted to the appropriate 
branch of the portal vein b) waq of an Internal juglarveln graft. In six dogs, 
the systemic venous input h a s  to the left portal branch (Fig. Ic) and in two 
dogs, to the right portal beln (Fig. Id). 
Grorcp 2. splar~c~l i r l ic~f lo~ dii.r\ior~. The two portal branches were 
isolated. One was left undisturbed: the other was detached and anastomo- 
e by e n s  of an i x  vein grafi to the common mesentem vein MOW 
the level of the splenic and pancreatic Lenous input. Proximall). the mes- 
enteric trunk u a s  I~gatedjuar below the splen~c vein (Fig. 2).  Thus. one side 
of the liver received portal blood of an intestinal source. and the other side 
received venous blood returning from the pancreatic, splenic. and gastro- 
duodenal beds. Twent) experiment\ each were performed to the rlght and 
c d left sides. 
Fig. 1 .  Partial portacaval transposition. a and b, Entire vena caval In the dog. the pancreas has two distinct lobes. Earl) in the series, it 
flow is directed i n t o  either the left or [he right portal venous branch, and wasdiscovered that the tall of the inferior pancreatic lobe almost ~nvariably 
d, ~ h j ,  differs from a and b in  [hat [he vena ca, flo\+ excludes the adrenal drains into the rnebenteric venous circulation (Flg. 2. insets). Thereafter, 
and renal blood. A venous graft is always required to bridge the gap. thls portion of the pancreas was always rehected at the time of the 
splanchnic division procedure. Three dog\ operated upon before this 
observation was rnade had d e l a ~ e d  nartial oarlcreatcctornv at the time of 
. . 
the first biopsy one month after the original operation. 
This article was undertaken to report ;~natornic and biochemical Grolcp 3. tort11 porrcrc.u\,al rrun.sposition.s, a. Standard transposition.. 
studies of the source and mechanism of the hepatotrophic factors in the Kine  dog, underwent ponacabal transposltlon by of 
splanchnic venous blood. The results have lndlcated that these originate method(l l )  and as shown In Figure 3a, An open 
from the pancreas and are hormonal in nature. before the transoosition. 
b. Total transpositior~ m i n u  adrenal and renal ~nflo\b.-F1i.e doys had 
Methods 
a modified portacavaltrmsposit~on (Flg. 3b) w ith a revasculanzation of the POI-tul D i ~ e n r o n  Pr-oc.c~tlures portal vein by means of a venous graft from the infrarenal inferior vena One hundred and one mongrel dogs. welghlng 12.4 to 24.1 kilo- 
grams. were used. Six normal dogs were sacrificed to obtain tissues for 
Fig. 2.- Technique of d ~ ~ i s l o n  of \planchnlc \enous flow into a pancreat~co-gastroduodenal-splenic 
compartment and an intestinal compartment. Blood from these respectl\e sources is d~rected into the right or left 
lobes. The tail of the inferior lobe of the pancreas a a s  resected slnce it drains separatel) Into the mesenteric vein. 
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Fig. 3.- Techniques of transposition for the dogs in group 3. a, 
Standard portacaval transposition of Child. b, Modified transposition 
which eliminates adrenal and renal venous blood from the portal blood 
samples. A venous graft is always required. 
Posroperative Srudies 
The dogs were maintained on a standard kennel diet. Bilirubin, 
alkaline phosphatase, and serum glutamic oxalacetic transaminase values 
were checked twice a week. These values were never abnormal. 
Vesselparency. Prior to liver biopsy, the patency of the anastomoses 
was determined either by angiography or at exploratory laparotomy. At 
angiography of the dogs in groups 1 and 2, an effort was made to see if dye 
injected in one venous pool spilled into the other bed. Complete gross 
separation was always demonstrated. 
Liwr  biopsies. In all dogs found to have patency of the two portal 
branches. biopsy specimens uere  taken from both sides. To minimize any 
effects due to the anesthetic agents. the specimens were removed under 
normothermia as soon as possible after induction of anesthesia with phen- 
cyclidine hydrochloride ( ~ e r n y l a n q ,  atropine, and pentobarbital sodium. 
The liver was first carefully examined for gross ev~dence of hypertrophy 
or atrophy. Blood flow to the area of the biopsy was not interfered with in 
any way until the specimen had been removed. In all experiments except 
those of group 3. both sides of the liver were biopsied and the specimens 
processed separately. Two grams of liver tissue were excised. One and one- 
half grams of tissue were snap frozen within five seconds and stored in 
liquid nitrogen at -158 degrees C.  until the biomedical studies were 
performed. The rest of the biopsy specimen was used for pathological 
studies. A portion was fixed with formalin, and the remaining tissue was 
frozen in dry ice. 
Autopsy proc ed~cres. Most of the dogs were sacrificed after the last 
biopsy. In the dogs in group 1 and 2. the liver was excised and extraneous 
tissue, including the gallbladder, trimmed from it. After ueighing the 
entire liver. the two portal branches uere  carefully dissected out and a 
decision made as to the exact portal venous distribution to each of the lobes 
and sublobes of the liver. When the entire liver had been thus subdivided 
into the right and left components, it was cut along the axis and the right 
and left portions weighed separately. The normal weight ratio for the right 
lobes versus the left lobes had been shown b) C h ~ l d (  1 I ). Marchioro(28), 
and Pouyet(34) and their associates to be about 30:70. Of the six normal 
control dogs which uere  sacrificed, these same proportions uere  verified 
as will be noted later. 
In dogs dying prior to biopsy. the same morpholog~c evaluation for 
atrophy and hypenrophy was performed, and specimens uere  taken for 
histologic studies. but no arrangements uere  made for biochemical deter- 
minations. 
Crireria for- h ~ p e r r r o p h ~  On histopathologic stud!. relative atrophy 
or hypertrophy of the different li\er portions was usuall! evident, and 
differences of a lobule size. fat content, reticulin pattern. and glycogen 
content could be detected filth the appropriate \rains. 
To obtain a quantitati~e estimat~on of the hepatocyte size. a tracing 
device was attached to the light microscope. and large numbers of hepato- 
cytes In each experiment uere  draun on a standard thickness paper. Forty 
representati~e traced hepatoc) tes uere  then cut out. and the pieces of paper 
they occupied were ueighed (Fig. 1). The u e ~ g h t  in grams uas  used to 
Fig. 4.- Hepatocyte shadows traced during histopathologic exami- 
nation. These were later cut out on standard paper and weighed as an index 
of hepatocyte size. The specimens depicted were from the experimental 
group 2 (see Fig. 2a). The right lobes with the large hepatic cells received 
venous blood from the pancreas. stomach, duodenum, and spleen. The 
relativly shrunken left lobes with the small hepatocytes received intestinal 
blood. 
denote size units. We have shown this to be an accurate method for 
comparing cell sizes by confirmatory planimetry and by studies of unicel- 
lular organisms. the size of which could be directly determined. 
~Lireria for hyperplosia. The following hallmarks of hyperplasia 
were looked for: increased numbers of mitoses, the presence of binucleate 
and trinucleate hepatocytes, increased numbers bf bile ductules, and 
increased thickness of the hepatic cell plates. 
Biochemical Derern~inattons 
Hepatic. glxc,ogen. The method of Bloom and his associates(4 ) was 
used to separate the trichloroacetic acid soluble glycogen fraction from the 
insoluble one. Both fractions were quantitated with the anthrone method 
of Seifter and his colleagues(42). and the results were expressed in 
milligrams of glycogen per gram wet weight of liver. 
Acri1.e and rota1 phosphorl\.lase. The active form of hepatic 
phosphorylase, Enzyme Commission Number 2.1.11 .. u a s  measured by 
the method of Shimazu and Fukada(45). wherein additional activation 
during the assay of phosphorylase. Enzyme Commission Number 
2.7.1.38,. is prevented by inhibiting dephosphophosphorylase kinase and 
phosphorylase phosphatase. Enzyme Commisssion Number 3.1.3.17, 
with ethylenediaminetetra-acetate and sodium flouride, respectively. The 
assay for the phosphorqlase determination contained 50 millimoles of 
glucose-I-phosphate and 1 per cent glycogen. to which a glycerol extract 
of liver was added. Incubation u a s  for ten minutes at 37 degrees C., 
following uhich the Inorganic phosphate released was measured by the 
methodof Takahashi(S5). The activit) of the phosphorylase was expressed 
as millimicromoles of phosphate liberated in one minute b) 1 milligram of 
protein of liver extract. 
Total phospho~ylase activity was assayed in the same way except that 
inactive phosphorylase u a s  first rendered active with adenosine 
triphosphate according to the method described b) Shimazu and 
Amakawa;'. 
Hepat~c c ~ c . / t c  3'. 5'-adetlosine mor~ophosphare (c?.c,lic AMP ). The 
method for extracting the liver sequentially ui th  trichloroacetic acid and 
cold water-saturated dieth) l ether has been described by Wastila and his as- 
sociates(60). The extract u a s  directl) a sabed  for cbclic 3'. 5' -adenosine 
monophosphate by the protein binding method of Gilman( 19). The kalues 
obtained represent the means of four determinations of each sample and are 
expressed as picomoles per gram wet weight of liver. 
Protein concerir~.orion. The protein of a ueighed liver specimen was 
extracted uith I0 per cent trichloracetic acid and digested uith 3 per cent 
desox)cholic acid in sodium hkdroxide. The protein concentration h a s  
then measured with the b~uret  method of Henr) and h ~ s  colleagues(21). 
Prorei~i ~ ~ n r h r s i s  Tuent)-four hours before biopi). the dogs were 
given an inrra~enous ~njestion of 60 mill~curiec of -C-leuc~ne uhich had a 
speclfic ac t i~i tb  of 28.1 mill~curies per mill~mole. 470 to 100 milligram 
portion of the biops! specimen u a s  processed by the method of Schneider 
and Hogeboom(1 I )  aa modified b) S i e k e ~  1tz(46), and the resulting protein 
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Fig. 5.-Changes in peripheral and portal venous insulin and hepatic 
cyclic 3', 5'-adenosine monophosphate, cyclic AMP, occurring in a normal 
dog infused with tolbutamide. Note that the peak insulin response in the 
portal blood occurred 25 to 40 minutes after infusion and that no significant 
alterations in hepatic cyclic 3', 5'-adenos~ne monophosphate were caused 
acutely by the tolbutamide itself. 
powder was collected on a millipore filter. The filters were introduced into 
counting vials contaming 20 milliliter\ of Albano and Francavilla's 
standard scintillation solution(l) and counted on a Picker ~ i q u i r n a t q ~ h e  
results were expressed as counts per minute per gram wet weight of liver. 
Tofu1 lipids U I Z ~  t ~ - i , ~ l ~ ~ ~ t ~ t - i d e ~ .  Tutal lipid5 were measured by a 
modification of the method of MacKenzle and hi5 colleage5(26), by which 
a tissue sample is ho~nogenired in and extracted a i th  a cold 1:l  ethyl 
a1cohol:ethyl ether solution, washed, dried. and weighed. 
The triglyceride fraction was extrlicted and weighed by a modifica- 
tion of MacKenz~e's micromethod as deriked froni Barron and Ha- 
nahan(?), using kilicic aciticolurnn chromatography to separate the triglyc- 
eride from the other lipid component\. The colurnri \ \a\  first washed with 
5 grams of X5:IS he4ane:benzene. Then, rhe first two fraction5 of 4 grams 
each were eluted uith a mixture of 97:3 hexane:ethyl cthcr and collected 
for triglyceride determinar~ons The total lipids and triglyceride fractions 
were expre i ed  as milllgram\ per gram wet ueight of l i irr .  
GlircoXit7a.tc Glucose pho\phorylation b) giuc:;kin,iir, Enzyme 
Commiivon tiumber 2.7. !  2.. \ \a\  a\sa>ed by the giuci:,--t, phosphate 
dehydrogen:isr \pectrophotometric method of Sala5 and his col- 
league;(4O). The results weri. expressed as rnlcrornole~ of glucose 
phosphoryiated per minute per gram wet weight of liver at room tempera- 
ture. 
Kinetic Studies i f C u  lit. . j ' ,  5' -udenocinr .Wot~o[~horpi!~~rc (C?i.lic' AIMP) 
Arni~io~p/~?ilirir r e f .  To determine the rate of fomiation of liver cyclic 
3', 5' - adenosine monophosphate. 13 dog\ of group\ 1 or 2 were submit- 
ted to an aminoph>lline infurion t h o  months after their operation As 
described h) Rohison and hi\ roup(38) .  the rnetii!, lxanthines In appropri- 
ate dosage5 are essentiall> complete inhibitor\ of c)clic 3' 5' -adenosine 
monopho5phate phoiphodi?\teraas. Since Btitchi.; arid Sutheriand (8) and 
Cheurig ( 10) ha\e  s!icjwn tiiii pho\phodieitrra\r to bc t!ie principal enzyme 
invol\ed in the cataboli~rri of ~ y c l i c  3'. 5 -adznosine nionophosphate. 
inhibit~on of the enL>nle uith ainlnoph\llint. aiio\\sd the qusntitation of 
cycl~c 3'. 5 -adenosine nlo:iopho\ph,~ts forni~tiori A iarge dosage of 
aminoph~l i inr  a a i  uwd. Thi< fi\eri rapidl? ti? pernil1 pronipt comple- 
tion of the itudieb tiefore the oi;\et ot iicl,~!eti phi io iogic  sflects. such as 
aminophllline induced change\ in ~n\ul in  le\i.l\ \\tiich niight by them- 
selves affect the metabolism of cyclic 3', 5' -adenosine monophosphate. 
The dogs were anesthetized, and open biopsy specimens of the right 
and left lobes were taken for baseline levels. Then, 3 grams of aminophyl- 
line in 300 miliiliters of 5 per cent dextrose in normal saline solution were 
infused by way of a periphera: vein at a constant rate during a six minute 
interval. Biopsy specimens of 100 to 200  mill~grams in weight were 
removed from both sides of the liver at iwo, four. and six minutes after the 
infusion was begun. taking care to minimize blood loss These were 
immediately frozen in liquid nltrogen and assayed for cyclic 3'. 5' - 
adenosine monophosphate a5 described previously. 
Tolhutunl~de-~l~ccugo~i  t e ~ t .  As revieued b} Exton and Park(l3),  the 
level of hepatic cyclic 3'. 5' -adenosine monophosphate is, at least in part, 
under the control of endogenous i n d i n .  To determine whether o i  not the 
livers of dogs remained responsive to change, in insulin level after a portal 
diversion procedure. a test was developed in which the cyclic 3 ' ,  5' - 
adenosine monophosphate re5ponie tu 2 ~neasiired du'>kige "f .zndopenous 
insulin was measured. 
To generate a standard endogenous ~nsulin respcinse, a 40 n~illigram 
per kilogram dose of tolbutamide was given to normai dogs as a one minute 
infusion by way of a peripheral vein. With the insulin ancibody method of 
Morgan and La~aroh(32) .  it w a  found that the peak insulin increase in the 
portal blood occurs 25 to 40 minute\ after the infusion of toibutamide (Fig. 
5) 
The tolbutamide itself did not cauae major chnngca in hepatic cyclic 
3', 5' -adenosine monophosphate (Fig. 5 ) .  Ncver.rIie!ess. the levels of portal 
blood insulin eenerated by the test are kriowli frorn other studies of Robison 
and his colieagues(38) to produce a reduction Iri the hepatic cyclic 3'. 5 '  - 
adenosine monophosphate, even though !h:se ,ire so sligh: ?ha: they are 
difficult to measure by direct techniques. tiohi.ve;, :he effcct of the insulin 
can be demonstrated bJ giving gluiagon s~m~lraneousiy  as was demon- 
strated in the three control experiments (Fig. 6). Cil~cagoii iormally pro- 
duces a many fold increare in iiver cyclic: 3'. 5' -adenosine rnonophcsphate 
when given by aysten~ic vein, but when the livrr rccrrvci! both en:icipenous 
insulin and exogenous glucagon sin?ult;~r~eolisly, the net eftect was a more 
modest rlse In cyclic 3', 5 '  -adenosine ~ndncipIio!~phate !Fig 6 )  In these 
control dogs. the right lobes of the Ilver had a norliial blood supply whereas 
the left portal branch was occlutied so that the left iiuiic: did r!ot directly 
receive any venou5 efflueni from the pdncreaz 
The conditions of the tesis in the I :i dciin;r:\,e dopi of groups I or 2 
were as f o l l o ~ i :  the aneathetired dog\ wrri. rnaii:!s:!!ei! oi! lactated 
Ringer's soiutio!; w hile biopsy y e ;  inieiii c;i t.,!::!i .,idr of :he liver were 
taken. Tolbu:a:nide. 40 miiligrarns per i\ilugrnni body .r,tight. was given 
intravenously tor one niiiiutr. follo~liiig +iliich an infuiiu:~ of  5 g-ams per 
kilogram ot dextrose was given over 25 ni1;ii;tes. ?'hell, i .40 g a n i ~ ~ s  per 
kilogram body u,eigh: of glucsgon wr rc  Zicei: in 300 n:~llli~;ers a t  5 per 
cent dextrose du r~ng  eight ir?iilutcs. Biopsy \peciniefis n r r e  tzkei; at two, 
four, six and eight niiliutea after ;!I? gl~,cajiori intcicior-i .+-:is k g u n ,  frozen 
in liquid nitrogen. and assaled fur the cyclic 3'. 5 -adenosine mono- 
phmphate, as described previously. 
Results 
Part;ul Porrui.i:;.cil 71-ari~porrtron 
hforpholo~ic fi~rili t~pi.  t ignteen of the 33 experiments with unmodi- 
fied split trkinaposition ucre  cdrried t:i compli-t~on G. lth the proof of the 
patencj uf the venous channtlr ditzr apprcixirriiitci, rz&c) n;onth.;. In i I of 
t h e e  suczessful experiment>. the 1nie:ior beria cava \*:a anastornosed to 
the left portal branch (Fig. !a).  a ~ i d  in t h ~  other i i ic :p ,  Ihc vrna r~ival  
anastornosis a a s  to the right br;mcl! (Fig. Ibj.  
The result, ahich ;Ire partiall) \urnrndri/ed I!; Fig~,rc 7 confirmed 
and extended the ob,erv,stion, prevlou\ly repo;teii frnn: our laborsto- 
ries(lX.30). The liver lob's recei\ iny ,>?i?i:~hqii bt;noii,. 1nf13u p i n e d  
weight after 7 %  O 5 tatand;iid de\ iatci:il: i?:c?r,:h\ :,n,'. S,a:rl \ir~k.iiig hqpeltro- 
phy of the indi~,idual hepri.?c;ii.\. \.htre,l\ :.ir .~'!x\ beiris pcrh5ed with 
venal ca\ai blood khrank ~ r t h  ;1 dir-iiriaiion 9:' tiit 1; er crli s i ~ r .  Cood 
histopatholosic stuclici ac re  obts:::eJ tion; 17 .,f tfme !?I Ii:r:\. The Lver 
lobules here lsiger ori the ~planchriii in dii of ;tie 1'1 rkperirnenis, and 
lipid Mat. le\i  prominent in 12 of 17 d i d  abijut ri;:ral i:' the o;hci five. 
GI!,cogen. asjudged with period~c a c ~ d  S ~ h i C l ~ t ; i i : ~ ~ d  :ccrio!!i. often seem 
more promr~ieiit iii the lokee upplic,d v\~tii  ipiai;chrlzc \enc,ua blood 
although thl-. i,nding \ia< inioii,tnct. Conssqlirntiy. ht-a\> reliance was 
placed on the quantitative glycogen assays which will be described. 
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Fig. 6.- Results with the tolbutamide-glucagon test in three dogs from groups l a  or Ic  in which there was clotting 
of the venous grafts. Consequently, the left branch of the portal vein transmitted no blood at all while the right lobes had 
a full splanchnic inflow. Note that the hepatic cyclic 3', 5'-adenosine monophosphate response to exogenous glucagon 
was considerably less in the lobes having a portal inflow compared wih the lobes suffering from portal devascularization. 
The relatively lower cyclic 3', 5'-adenosine monophosphate presumably represented a restraining insulin effect. 
L E F T  
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There was also evidence of hyperplasia on the side receiving splan- 
chnic blood. This consisted of the presence of hepatic cell plates two or 
more cells thick, binucleate and trinucleate hepatocytes, increased num- 
bers of bile ductules, and slightly increased mitosis count. 
Of the eight attempts at split transposition with exclusion of the 
adrenal and renal blood, only one experiment was completely successful, 
that with vena caval flow to the right lobes (Fig. Id). The morphologic 
effects of this procedure at nine weeks (Fig. 7) were comparable but 
slightly less extreme than with regular split transposition. 
Biochenlicul concenrrarions. Beginning within four weeks and 
continuing until two months there were marked biochemical differences 
between the lobes according to the source of portal venous inflow (Table 
I). Hepatic tissue receiving splanchnic blood. whether this be on the right 
or left side, had significantly higher concentrations of glycogen and 
glucokinase relative to the lobes supplied by the vena caval blood. In 
contrast, the lobes supplied bq the vena caval blood had significantly 
higher cyclic 3' ,  5' -adenosine monophosphate and active phosphorylase 
concentrations. The hepat~c triglycende concentration seemed to be in- 
creased by splanchnic venous inflow, but the observations here  too few to 
permit statislical significance. The comparisons of proteln concentration 
and protein synthesis here  not strikingly different (Table I). 
In the one successful experlmeht of group Ib ( Fig. Id) in which 
adrenal and renal venous blood was excluded from the vena caval supply 
to the right lobes, the chemical pattern h a s  altered after nlne weeks in a 
different wa) than in the dogs of group la.  In the right and left lobes respec- 
tively. glycogen h a s  5.7 and 5.25 m~lligrams. glucoklnase was 1.0 and 1.5 
micromoles. actibe phosphor)lase mas 17.4  and 15.3 millimicromoles, 
and cyclic 3'. 5 '  -adenos~ne monophosphate h a i  974 and 1.225 picomoles. 
I' 
RIGHT 
Splunt hnlc Floit Dii icion 
Fort) experiments were attempted. and I2 here  carried to comple- 
tlon In SIX successful expenmenti, the pancreatic, ip len~c,  and gastroduo- 
denal blood passed to the right lobes (Fig. 2a). and in the other six the blood 
passed to the left lobes (Fig. 2b). 
Morphologicfindings. The effects of these alterations on the liver 
tissues after one to five and one-half months, 73 f 53 (S. D.) days, are 
summarized in figure 8 and compared with the liver tissue from six normal 
dogs. The lobes which received the pancreatic, gastroduodenal, and 
splenic blood retained or increased their expected weight compared with 
the other lobes supplied by intestinal venous blood, and the individual 
hepatocytes in the favored lobes increased in size (Fig. 8). The latter 
hepatocyte and lobe size increases occurred whether the pancreatic, 
gastroduodenal. and splenic flow was to the left or right lobes. In addition 
to the hepatocyte size, complete histopathologic analysis was performed 
on all 12 livers. In nine of these 12 experiments, the liver lobules were 
obviously larger on the side supplied by the pancreatic-gastroduodenal- 
splenic venous effluent (Fig. 9). The degree of lipid deposition was less on 
this side in one experiment but about the same in the other 11. 
There was also evidence of hyperplasia in the liver tissue supplied by 
blood from the pancreas, stomach, duodenum, and spleen (Fig. 9). This 
consisted of hepatic cell plates two or more cells thick. binucleate and 
trinucleate hepatocytes, and increased numbers of bile ductules. A slightly 
raised mitos~s count was also found in those livers biopsied less than three 
months after splanchnic floh division. 
Bioc.hemica1 to~7c~erirr-arion After 10.1 i 7.6 (S. D.) heeks, range one 
to five and one-half months, the h e r  tlssue prov~ded with pancreatic- 
gastroduodenal-splenic blood contained hlgher concentrations of glyco- 
gen in spite of the fact that alimentar) glucose was passing primaril) to the 
contralateral hepatic lobes. These findings were statisticall! significant in 
the experiments of group ?b  In uhich the pancreatic-gastroduodenal- 
splenic blood hent  to the left lobes (Table 11). When this blood h a s  directed 
to the right side in the dogs in group Za, the right lobes behaved sim~larly. 
but the changes here  short of statistical s~gnificance. Under both condi- 
tions, the glucokinase ~ a i  elevated in parallel with the g l ~ c o g e n  but not to 
CLIO CHIRURGICA 
LIVER/BODY WEIGHT (%) 
1 
1 
NO. OF EXPERIMENTS 
Fig. 7.-The morphologic consequences, after ?i 0.5 (S. D.) months in the dogs of group I, of supplying parts of the liver 
with nonhepatic splanchnic venous blood. shaded areas. as compared with vena caval blood. Results are also given for six normal 
dogs. Note the gross weight gain and hepatocyte hypertrophy on the aide perfused with splanchnic blood. Although the relative 
sizes of the lobes were altered according to the murce of portal venous l n f l o ~ .  note that the rotio of the liver we~ght  o total body 
weight was relatively unchanged. One standard devlatlon is depicted in the bar graphs and written out for the weight percentages. 
TABLE I -THE EFFEC T I N  S P L I T  T R A S S P O S I T I O S  E S P E R I \ I E S T S  O F  G R O C P  1 OF P O R T 4 L  VENOUS INFI.O\V FRO\! 
T H E  S P L A N C H S I C  VERSLTS T H E  I N F E R I O R  L.ES.4 CA\'AL BEDS 
S,$lanchnrc,flo~~ to right lobes Yplanchnic/?ou lo le f t  lobes 
- O n e  month--- TLLO months-- _ O n e  month__-_ - - T u o  mor!:hr 
.Vo. Rtghi  Lej6 p .ah. Ktght Lpjt p d V ~ .  R ~ g h t  Lef t  /i hb. Right L I ~ I  p 
Glycoqen, mgm./gm.  
of liver 
Total  . . . . . . . . . . . .  7 5.15 3.79 <0.02 11  3.74 2.26 <0.001 3 2.92 3.74 NS 7 2.45 4.66 <0.001 
i 1.00 k 0 . 4 3  f 1.16 i l . 0 8  i 1 . 6 3  i 2 . 6 9  i 0 . 7 0  i 0  -6 
Trichloroacetic acid 
soluble . . . . . . . . . .  7 4.65 2.81 <0.02 11 3.00 1.59 <0.001 
k l . 1 1  i 0 . 8 1  - + 1.03 1 0 . 8 8  
Cyclic adenosine 
monophosphate. pico- 
m o l e s ~ g m , o f l i v e r . .  7 1,050 1,638 <0.001 11 1,162 1,695 <0.001 3 1,276 906 <0.1 6 1,718 1,363 <0,05 
i l 5 9  i 2 8 4  1 8 6  1 2 5 6  f 185 k 211 i 9 6  i 2 6 7  
Phosphorvlase, milli- 
micromoles ,m in . l  
mqm. of liver protein 
Total . . . . . . . . . . . 
Active . . . . . . . . . . . 
Glucokinase, micro- 
moles 'gm. lmin . . 
Protein concentration, 
mem. qm. of liver. 
Protein synthesis, 
counts 'min.!gm. 
of l iver . .  . . . . . . . . . 1 2,175 2,558 6 1,758 1,866 NS 2 2,016 2,021 XS 
i l l 7  i 2 4 6  k 3 7 8  k 2 4 3  
Triqlvcerides, mgm./ 
gm ,  of liver. . . . . . . 3 16.8 11.6 <0.1 
f 3.0 i l . 6  
Means numbers of dererminatlons. and standard deviations are given 
- \ I1 p vhlues cornp.ire the two I ~ v c r  sides 
'il'jthln the lirnltq of the dndlvt~c method used,  the measurements of rota! phosphon lase actitit? were constant in a gi \en experiment, no matter what the 
slte of rhe Iiber blaps\. For this reason, rhese determinations are  pl \en onl) for the s ~ d e  of the liver recei\lng splanchnic blood. 
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TABLE 11.-THE EFFECT IN SPLAYCHNIC DIVISION EXPERIMEhTS O F  G R O U P  2 O F  PERFUSING THE LIVER WITH 
PANCREATIC D L O D E S A L  SPLENIC VERSUS INTESTINAL BLOOD 
- - -Sp lanchn: r  j?oio to ri,oht l o b e s -  S p l a n c h n i i f l o w  to lejl lobes-- 
__-One month--- 7 1 1 . 0  m o n l h s  O n e  m o n l h  -TWO months 
No. R~ght Lejl p JVO. R : ~ h l  Lejt p ,Vn. R~ghl Lej! p No. Rzght h f t  p 
Glycoqen, mqm./gm. 
of liver 
T o t a l  . . . . . . . . . . . .  5 5.28 5.26 NS 4 3.64 3.13 NS 4 3.31 4.51 <0.02 6 2.83 4.07 <0.01 
1 1 . 2 6  k 1 . 4 7  k 1.63 k 1.67 1 1 . 9 0  k 1 . 9 1  k 1 . 8 7  k1 .64  
Trichloroacetic acid 
soluble . . . . . . . . . . .  5 4.11 4 . 0 3 N S  4 3.35 2.35 NS 4 2.93 3.70 <0.1 6 2.00 3.23 <0.001 
k l . 0 5  k l . 0 5  - +0.40 k 1.55 k 1 . 9 0  5 2 . 0 5  
Cyclic adenosine 
monophosphate 
picomoles/p;m. of 
l i v e r . .  . . . . . . . . . . . 5 1,276 1,258 NS 4 1,215 1,123 NS 4 725 1,052 NS 6 1,077 1,164 <0.1 
k 1 0 2  1 7 6  1 1 9 1  k 1 7 5  
Phosphorvlase, 
mill imicromole~/min./  
m e m ,  of liver protein 
T o t a l .  . . . . . . . . . . . 
Active.  . . 
Glucokinase, micro- 
moles:gm./min.. . . 
Protein concentration, 
mgm./gm.  of liver. 
Protein synthesis, 
counts/min./qm. 
of liver . . . . . . . . 
hfcanc, numbcr of det~rminations, and standard deviations are given. 
Ail p values compare thr two sides. 
*\Cithin the limits of the analytic method used, the measurements oftotal phosphorylase acti\.ity wcrc constant in a given cxperimcnt, no mnttcr what the 
site of the li\.er biopsy. For this reason, these determinations are given only for the side of the liver receiving splanchnic blood. 
TABLE 111 --THE EFFECT O F  PORTACAVAL TRANSPOSITION (LEFT) AND PORTACAVAL TRANSPOSITION h4IA'US 
T H E  RENAL. A S D  ADRENAL BLOOD (RIGHT)  UPON GLYCOGEN CONCENTRATION AND CYCLIC 3', 5'-ADESO- 
S I S E  hIONOPHOSPHATE 
Transposi!ion_- - -Trat irpori t ion minus renal, adrenalp 
"Vo. Preoperative Postoperalive P NO. Preoptralicr Posloperalive 1 
Glycoeen, mgm./gm. 
of liver 
Tota l  . . . . . . . . . . . . . .  5 3 .82k0.53 2.10k1.04 <0.02 2 4 .08k 1.12 2 . 2 7 1  0.40 NS 
Trichloroace tic acid 
soluble . . . . . . . . . . . .  5 3.13k0.42 1.70f 0.83 <0.001 2 2.9950.55 1.89f0.31 NS 
Cyclic adenosine 
monophosphate, pico- 
moles/em. of liver.. . 5 (1107)* 1 ,7291215 <0.01 2 (1 107)* 1,701 k 4 6  /C.Oi 
- 
The experiments are group 3a and 3b. 
All p vdlur? compare the preoprr.~tive and postoperative determinations. 
I h ~ s  "normal"for cyclic 3', 5'-adenosine monophosphate was derived by taking the mean of a series ofcyclic 3', 5'-adenosine monophosphatc determina- 
tions in biopsy specimens tdhen from canine livers having a normal portal blood supply. 
a statistically significant degree (Table 11). 
Cyclic 3', 5' -adenosine monophosphate, active phosphorylase, pro- 
tein concentration, and protein synthesis did not conform to a consistent 
pattern. 
Total Porracni'al Transposition 
The five dogs with successful conventional transposition (Fig. 3a) 
underwent follow-up study for 10.2 t 2.0  (S. D.) weeks, and the dogs with 
transposition minus adrenal and renal blood were each studied for two 
months. At autopsy, the per cent of total liver to total body weight was 1.8 
and 1.9 per cent in the respective groups. 
The dogs a i th  standard as well as those with modified portacaval 
transposition had hepatic deglycogenation and striking elevations in cyclic 
3', 5' -adenosine monophus?hate (Table 111). 
Kinetic Studies 
Partial porracaval transposition. In four of five dogs of group l a  
(Fig. la orb) ,  the rate of cyclic 3', 5'-adenosine monophosphate formation, 
as unmasked by the aminophylline test, was greater in the liver tissue 
receiving vena caval blood than in the contralateral lobes receiving 
splanchnic venous blood (Fig. 10). 
In the single successful experiment in which partial transposition was 
with vena caval blood minus adrenal and renal inflow (Fig. Id),  the cyclic 
3', 5 '  -adenosine monophosphate response showed a different pattern in 
that the side of the liver supplied with vena caval blood had a much slower 
rate of cyclic 3', 5' -adenosine monophosphate accumulation than the lobes 
receiving splanchnic blood (Fig. 1 I ) .  These results were similar to those in 
three control experiments in which one side of the liver did not have portal 
vein inf1o.w at all due to clotting. This side accumulated cyclic 3', 5' - 
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Fig. 8.- The morphologic consequences of splanchmc venous flow division in the dogs in group 2 
compared with normal dogs after 28 to 173 days, average 73. The liver fractions which were perfused with venous 
blood from the pancreatic, gastroduodenal, and splenic areas are shaded. Note that these portions gained weight 
and underwent an increase in hepatocyte size relative to the other side while the total liver weight to body weight 
ratios were little altered. One standard deviation is depicted graphically on the bar graphs and written out for the 
weight percentages. 
adenosine monophosphate much more slowly than in the fully vascular- 
ized lobes (Fig. 12). 
With the tolbutamide-glucagon test, the lobes receiving nonhepatic 
splanchnic blood showed a response similar to that of the control dogs, 
whereas the contralateral lobes supplied with the supra-adrenal vena caval 
blood showed a rapid accumulation of cyclic 3', 5' -adenosine mono- 
phosphate (Fig. 13). 
Splanchnic flow division. With the aminophylline infusion test, it 
was found in four experiments that the lobes receiving splenic-gastroduo- 
denal-pancreatic blood had a more rapid rate of cyclic 3'. 5' -adenosine 
monophosphate synthesis than the contralateral lobes supplied with intes- 
tinal blood (Fig. 14). 
However, the lobes with splenic-gastroduodenal-pancreatic venous 
inflow were found by the tolbutamide test to be under insulin control in that 
three of five experiments showed a much slower rate of cyclic 3', 5' - 
adenosine monophosphate accumulation in response to exogenous 
glucagon than in the lobes receiving mesenteric blood (Fig. 15). 
Discussion 
Little dofibt remains that there are substaices in splanchnic venous 
as opposed to systemic venous blood that are important for the mainte- 
nance of hepatic structure and function. The first steps by which this 
concept was developed and validated have alreadj been mentioned. The 
extent of present day acceptance of the concept can k appreciated by the 
fact that Fisher and Lee and their associates( 15-17.24). who until recently 
were the most outspoken cntlcs of the hepatotrophic hypothesis, have 
lately supported the idea. By adapting the double liver fragment principle 
introduced during investigation of auxiliary liver transplantation in our 
laboratory(28. 30, 51). they and thew colleagues have added convincing 
evidence of their own supporting the hepatotrophic theory(9, 18. 25). 
The advantage of the various double or split liver preparations forthe 
investigation of hepatotrophic mechanisms is that the hepatotrophic fac- 
tors are apparently exhausted by exposure to one hepatic fragment and, 
therefore, are unavailable to other competing l~ve r  tissue if the latter is 
endowed with a blood supply deficient in such substances. With a single 
liver, as historically was used in the 
studies of Eck fistula or portacaval transposition. the unmasking and 
precise study of splanchnic hepatotrophic effects has  difficult or impos- 
sible after the portal by-pass procedures since biologically active sub- 
stances in the diverted spanchnic venous effluent were presumably re- 
turned to the liver by way of the systemic blood although in diluted 
concentrations. Parenthetically, a recirculation effect could account for the 
superior liver state of dogs with Child's transposition compared with 
animals with Eck fistula since the quantity of diluted hepatotrophic 
substances reaching the liver would be proportional to the total hepatic 
blood flow which is more than twice as great with transposition than with 
Eck fistula. Then, the classical error in interpretation followed, namely to 
assume the quantity of blood flow was infinitely more important than the 
quality of the blood in maintaining hepatic structure and function. 
Conceding the qualitative specialness of portal venous blood, the 
experiments in this study were designed to answer two sets of additional 
questions The first concerned the source and the nature of hepatotrophic 
factors in splanchnic venous blood. The second was involved with the 
mechanism of action of this factor or complex of factors. 
The origin of the hepatotroph~c factors was deterniined from studies 
of the morphologic and biochemical changes induced in the liver by modi- 
fications of the portal venous inflow. These were of three types: total 
portacaval transposition, partial portacaval transposition. and splanchnic 
flow division. 
The observations of March~oro and h ~ s  associates(28, 30) were first 
confirmed in experiments with partial transposition. Within four to eight 
weeks, liver lobes supplied with aplanchnic venous inflow had hypertro- 
phic glycogen-rich hepatocytes which in addition often had findings of 
hyperplasia. In contrast, the other lobes of the liver supplied by vena caval 
blood underwent involution changes. The hepatocytes became smaller, 
and the glycogen concentratlon decreased. 
Next. surgical techniques here  used that partitioned the splanchnic 
flow. The mr?jor part of the hepatotrophic influence as manifested both by 
morphologic and biochemical criteria a a s  unequivocally sho~bn to be in 
the blood returning from the pancreas. proximal part of the duodenum, 
stomach. and spleen. In contrast. the other hepatic lobes fed by nutrition- 
ally rich venous blood from the small intestme underhent in\olutional 
changes. including a t roph  (Fig. 16) and deglycogenation nearly as 
profound as if a bena caval supplq had been used. 
For several years, there has been good reason to suspect that the upper 
splanchnic organ complex and specifically the pancreas a a s  the source of 
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Fig. 9.- Photomicrographs of sections from a liver which had been subjected to splanchnic flow division. 
The part of the liver supplied by the pancreaticogastroduodenal-splenic blood, panels on left, shows enlargements 
of the liver lobules, abundant glycogen, and hypertrophy and hyperplasia of hepatocytes when compared with the 
part supplied by intestinal blood, panels on right. Upper, Reticulin stain, X 10. Middle, Periodic acid-Schiff, X 87. 
- -. 
iower; Hematbxylin and eosin, x 87. 
the hepatotrophic factors. In the studies of the blood flow requirements for 
auxiliary hepatic transplantation by Marchioro and his colleagues (29), 
atrophy of the native liver could be minimized by provision of pancreatic- 
gastroduodenal-splenic blood even though all the rest of the splanchnic 
venous blood went to a co-existing liver homograft. Pouyet and his 
associates (34) came to the same general conclusion with carefully 
documented splanchnic division experiments similar to those in group 2 of 
this studv. The correctness of these observations was later confirmed in a 
beagle homotransplantation model used by Ranson and his associates (37). 
In all these studies as well as in those reported herein, a contribution to the 
hepatotrophic support of the liver could hypothetically have been made 
from the stomach, duodenum, or spleen although some of Pouyet's 
experiments essentially ruled out the spleen and stomach. Nevertheless, it 
was logical as Price and his associates (35) have suggested to look for a 
hormonal explanation. This was done in the present study with a series of 
biochemical evaluations. 
The first step was to analyze the hepatic changes caused by the 
classical portacaval transposition of Child and his associates (1 I), a proce- 
dure which profoundly deglycogenates the liver (43,52) as was confirmed 
in the present study, deprives it of access to pancreatic hormones until after 
recirculation by way of the hepatic artery or systemic venous blood, and 
subjects the whole organ more or less continuously to endogenous epi- 
nephrine. Since Sutherland and Rall(53) and Murad and his associates (33) 
have shown that epinephrine works by the activation of adenyl cyclase and 
the consequent formation of cyclic 3'. 5'-adenosine monophosphate, the 
finding of elevated concentrations of cyclic 3', 5'-adenosine mono- 
phosphate in the total transposition livers of the dogs in group 3a was 
consistent with the concept that epinephrine was being excreted in large 
enough quantities to play a significant role in the deglycogenation. Never- 
theless, proof that direct hepatic perfusion by endogenous epinephrine was 
not the only factor promoting these changes was provided by the experi- 
ments of group 3b in which transposition minus the adrenal and renal blood 
was successfully carried out in two dogs. Falls in hepatic glycogen 
concentration and rises in cyclic 3', 5'-adenosine monophosphate occurred 
of almost the same magnitude as in the standard transoosition. Here. it 
. 
might be suggested that adrenal secretions which by-passed the liver were 
recirculated to the organ after passing through the cardiac mixing chamber 
and even the capillary beds. obvious atrophy was notproduced 
in these transposition livers with or without direct provision of adrenal 
venous blood. 
In the split transposition experiments of group la, increases in cyclic 
3'. 5'-adenosine monophosphate similar to those caused by a standard 
transposition were found in the deglycogenated and atrophic lobes of the 
liver receiving supra-adrenal vena caval blood as compared with the lobes 
supplied with splanchnic venous blood. In these experiments, the increases 
of activated glycogen phosphorylase and the decreases in triglyceride 
concentration in the lobes perfused with vena caval blood were consistent 
with the metabolic conseauences of eoineohrine infusion and increased 
. a 
cyclic 3'. 5'-adenosine monophosphate, as summarized by Himms-Hagen 
(22). The fact that the concentration of endogenous epinephrine was 
physiologically significant was also suggested by some of the portal 
angiograms in the split transposition experiments which showed relative 
vasoconstriction in the lobes being perfused by supra-adrenal vena caval 
blood. Thus, it was not surprising in the one successful split transposition 
experiment in group Ib that exclusion of the adrenal and renal venous 
blood from the lobes supplied by the inferior vena cava curtailed both the 
rise in cyclic 3', 5'-adenosine monophosphate and the fall of glycogen 
concentration although atrophy was not thereby prevented. These last 
findings were in contrast to the observations discussed in the preceding 
paragraph in the livers of two dogs that had total transposition minus the 
CLlO CHIRURGICA 
LOBES W l T H  S P L A N C H N I C  L O B E S  WlTH V E N A  
V E N O U S  I N F L O W  CAVAL INFLOW 
LOBES W l T H  S P L A N C H N I C  LOBES W I T H  INFLOW F R O M  
VENOUS INFLOW INFRARENAL V E N A  CAVA 
1 
0 2 4 6 0 2 4 6  
T l M E  A F T E R  BEGINNING AMINOPHYLLINE INFUSION 
(rn1n.1 
b g 
Fig. 10.- Aminophylline infusion tests in five dogs with partial 
portacaval transposition. In all but one, the rate of formation of cyclic 3', 
5'-adenosine monophosphate was greater in the lobes deriving their portal 
inflow from the inferior vena cava although these differences were usually 
not obvious until several minutes had gone by. 
adrenal and renal blood. The apparent disparities indicated once more that 
influences other than the adrenal secretions were of importance in regulat- 
ing cyclic 3', 5'-adenosine monophosphate levels and in determining 
atrophy or hypertrophy. They focused attention upon the crucial role of the 
pancreas. 
Such a pancreatic role may be a,sumed to be due to the interactions 
of glucagon and insulin for wh~ch  cycllc 3'.  5'-adenosine monophosphate 
also reprewts a secondary messenger system. Like epinephrine. pancreatic 
glucagon increases cyclic 3'. 5'-adenosine monopho\phate as demon- 
strated by the classical s tud~es  of Sutherland and Rall (53).  setting in 
motion multiple chemical processes. Bergen (3)  and Weintraub (61) and 
their associates deacrlbed the re\ulr~ng glycogenolysis. Gluconeogenesis 
has been documented by Exton and Park (14). lipolyriq by Butcher and his 
associate$ (6). and ketogeneiis by Menahan and Wieland (3 I ) as well as by 
Exton and his group ( I?). 
As reviewed b j  Exton and Park ( 1  3). Sutherland and Robison (54), 
and Robison and his colleagues (38). insulin promotes many converse 
metabolic event, by deprejrion ofthe basal Iebel of cyclic 3' .  5'-adenosine 
monopho\phate, thus qualifiying as an anabolic hornlone. Besides aiding 
glycogen synthe,i~ b) the cyclic 3'. 5'-adenosine monopho\phate mecha- 
nlsm, Sala\ and h15 co authors (10) ha\e  shown that insulin supports 
glycogen metabolism by increasmg hepatic glucokina\e. and Lamer (23) 
has demonstrated activation of glucose transferase. Consequently, in the 
liver partition experiments of group5 1 atid 2. it \ \a\  not surprising that 
glucokinase level\ were elevated on the side of pancreai Inflow and 
reduced on the ,ide receiving either vena cabal or inte\tinal flow. Butcher 
(7) and Robison (38)  and their col league have \honn that ~n\ulin regulates 
lipld s \n the \~s  b j  inacti~ating lipoljtic enL!nle\ through a lowering of 
cyclic 3'. 5'-adenosine monophosphate levcls. Insulin also controls protein 
synthes~s b) a niechanivn that I \  not understood. 
The fact that glucagon and insuli~i have partiall) cancellmg effect? 
helps explain why the c ) c l ~ c  3'. 5'-adeno\ine rnonophojphate levels in liver 
lobes with an inflov of pancre,ltic \ e n o ~ i \  blood te~ideil neither to be ver); 
high nor v e q  Ion. In turn. i t  help\ expla~n wh] In the expzriinents of group 
? significant difference\ could not be demonstrated betireen the cyclic 3', 
5'-adenmine rnonopho\phate Ie\el\ of Il\er lobe\ recei\i~ig pancreatic 
venous blood ver\u\ tho\e recelvlng the hornlone-poor effluent from the 
small inte\rine. 
The atorementioned blochem~cal studles prov~ded Insight about how 
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Fig. 1 I .- Rate of cyclic 3' ,  5'-adenosine monophohphate formation, 
as measured by the aminophylline infusion test, in the single successful 
experiment of group Id. 
various hormones could affect the liver. However, since cyclic 3', 5'- 
adenosine monophosphate is destroyed so rapidly, mainly by the enzyme 
cyc l~c  3'.  5'-adenosine monophosphate phosphodiesterase, accurate evalu- 
ation of the rate of its production by the simple measures of its tissue 
concentration was not possible. Consequently, In several special experi- 
ments on the dogs of group I ,  aminophylline was used to block the 
phosphodiesterase. The considerable extent to which the rate of cyclic 3', 
5'-adenosine monophosphate product~on was increased in the hepatic 
tissue exposed to adrenal venous blood could then k determined. 
The same kind of information was obta~ned in the livers of group 2 
dogs in which neither hepatic side received adrenal venous blood directly. 
The aminophylline test uncovered a striking difference between the two 
set, of liver lobes. The rate of cyclic 3'. 5'-adenosine monophosphate pro- 
duction was retarded in the liver lobes receiving blood from the intestine 
but was essentially normal in the lobes rece~ving pancreatic-gastroduode- 
nal-splen~c blood. It might be suggested that the l o k s  receiving blood from 
the intestines in quch experiments should have higher cyc l~c  3', 5'- 
adenos~ne monophosphate levels if there were an unopposed presence of 
intestinal glucagon. However, Unger (58) and Valverde (59) and their 
associates have shown that t h ~ s  substance which has some physiologic 
qualities similar to pancreatic glucagon and which in addition cross reacts 
with antiglucagon ant~bodies does not affect the level of hepatic cyclic 3', 
5'-adenos~ne monophosphate when injected into the portal circulation of 
the dog or into the pelfusate nourijhing an isolated rat liver. 
The role of ~nsu lm in controlling the level of cyclic 3', 5'-adenosine 
monophosphate was further documented by the tolbutamide-glucagon 
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Fig. 1 2 .  Am~nophylline infusion tests in three dogs taken from 
groups l a  or lc  in which the left portal branch clotted. leaving these lobes 
supplied only with anenal blood. whereas the right lobes received both 
arter~al and splanchn~c venous blood. Yote that the rate of synthes~s of 
hepatic cqclic 3'. 5-adenosine monophosphate u a s  greater in the right 
lobes having a portal mflou than In the left lobes suffering from total portal 
de\asculari~ation. The time units are in minuteb. 
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LOBES WITH SPLANCHNIC LOBES W l T H  VENA CAVAL 
VENOUS INFLOW INFLOW 
TIME AFTER BEGINNING GLUCAGON INFUSION 
(min.) 
LEFT RIGHT 
Fig. 13.- Results of tolbutamide-glucagon tests in eight dogs with partial portacaval trans- 
position, demonstrating the effect of endogenous insulin in the lobes receiving splanchnic venous 
blood. These insulin-controlled lobes had a restrained cyclic 3', 5'-adenosine monophosphate 
response to the exogenous glucagon whereas the response in the other lobes was uninhibited. 
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infusion test. In this experiment, measurable increases in endogenous 
portal insulin were caused by an injection of tolbutamide. This was 
followed by the intravenous administration of exogenous glucagon. In all 
the experiments performed, there was a striking difference in the produc- 
tion of cyclic 3', 5'-adenosine monophosphate between the liver sides 
according to the type of blood supply, indicating once again a profound 
metabolic dissociation. Hepatic lobes perfused with pancreatic blood and, 
thus, under insulin influence had modest or no rises in cyclic 3', 5'- 
adenosine monophosphate in spite of the exogenous glucagon whereas the 
other lobes had uninhibited increases. 
The data accumulated in this study leave little doubt that the previ- 
ously nebulous hepatotrophic factors in splanchnlc venous blood are 
hormones and that the major anabolic hormone is insulin counterbalanced 
to an unknown degree by the opposing effects of glucagon and possibly 
epinephrine as well. The interrelationship of these hormones determines 
the chemical znvironment of the liver thereby influencing its function and 
structure. In most of the experiments herein reported, the competing liver 
fragment preparation developed during research on auxiliary hepatic 
transplantation was the expefimental tool whereby the metabolic dissocia- 
tion and morphologic changes caused b) different hormone exposure 
easily could be exposed and examined. But the findings in this special 
experimental model have major implications in normal as bell  as abnormal 
hepatic physiology. 
For example, the reason for the l i ~ e r  atrophy caused in animals by the 
performance of Eck fistula obviousl) ~nvol\,es hormone deprivation. 
Explanations of a similar kind can be easil) formulated for other portopri- 
val states, including those caused in man b portacaval anastomosis of a 
ponal veln uhich has significant resldual hepatopetal f lou.  Why ponal 
diversion procedures have been of such great value for children with 
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certain of the glycogen storage diseases (52) becomes evident. Even in 
attempts at liver preservation, it may be suggested that long term conser- 
vation by perfusion is not apt to be successful unless the chemical and 
hormonal constituency of the perfusate is made to simulate at least some 
of the features of portal blood. 
Although numerous other examples could be cited of the potential 
importance of hormonal mechanisms affecting the liver, attention will be 
focused only upon the virtual certainty that such hormonal factors are 
central to an understanding of hepatic regeneration. The way in which the 
portal hormone constituents can direct liver regeneration will require 
further detailed study from which clarification of some confusing past 
claims should emerge. A number of authorities on hepatic regeneration, 
including Sigel(48). Fisher (18). and Price (35) and their colleagues, have 
suggested that hypertrophy and h)perplasia are dissociated phenomena 
during regeneration. Price and his associates (35) have stated that there 
actually is a reciprocal relationship betueen hypertroph) and hlperplasia. 
The latter authors believe that hypertrophy is controlled by endogenous 
glucagon, and that hyperplasia is determined b> some factor released by 
the liver itself. 
Almost all the experiments purporting to show a dissociation be- 
tween hepatocyte hypertroph) and hyperplasia have involved studies of 
deoxyribonucleic acid or ribonucleic acid s!ntheils or cell mitosis counts 
within a few hours or daks after a major traumatic procedure. In our own 
studies which permitted chronic obsenationh, hjpenroph) and h~perpla-  
sia occurred together, although not necessarll) in ab,olute parallel, in 
hepatic fragments supplied b) elther rota1 spimchnic blood or blood from 
organs in the upper pan of the abdomen \s hereas atroph) and the absence 
of hbperplasia uere  found in li\er tissue deprived of the appropriate 
splanchnic influence. These obsenations indicate that hbpertrophy and 
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Fig. 14.- Aminophylline infusion testa two months after splanchnic 
flow division in four dogs. Cyclic 3'. 5'-adenosine monophosphate synthe- 
sis was much more rapid in the hepatic lobes receiv~ng pancreatic- 
gastroduodenal-splenic blood than in the contralateral lobes supplied with 
intestinal venous effluent. 
hyperplasia are associated rather than dissociated, a point of view more in 
accord with the majority of regeneration studies which were recently 
reviewed by Bucher (5). 
The findings are also consistent with the hypothesis that the h o m o -  
nal hepatotrophic substances which have been the subject of this article are, 
in fact, the essential control factors of or at least play a vital role in hepatic 
regeneration. 
Summary 
The origin of hepatotrophic factors in splanchnic venous blood was 
investigated by modifying the portal venous inflow to different parts of the 
canine liver while leaving the arterial blood supply and biliary drainage 
intact. 
In one variety of experiment, termed partial transposition, the liver 
portion perfused w ~ t h  the total splanchnic venous blood underwent weight 
gain and hepatocyte hypertrophy, hyperplasia, and glycogenation com- 
pared with the portion perfused with venous blood from the hindquarters, 
kidneys, and adrenal glands. but the combined weight of the total liver 
remained constant in spite of the rapidly evolving regional disproportions. 
The lobar changes were well developed within one to two months. At this 
time, the hepatic lobes supplied with splanchnic venous blood had higher 
concentrations of glucokinase and lower concentrations of cyclic 3', 5'- 
adenosine monophosphate and active phosphorylase than the lobes receiv- 
ing hindlimb and adrenorenal venous blood, indicating that the biochemi- 
cal environment of the different liver regions was drastically different by 
virtue of being under specific hormonal control. 
The dissociation was even more dramatically illustrated by dynamic 
studies in which the destruction of cyclic 3', 5'-adenosine monophosphate 
by phosphodiesterase was blocked with aminophylline thereby permitting 
estimation of the rate of formation of cyclic 3'. 5'-adenosine mono- 
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Fig. 15.- Tolbutamide-glucagon infuaion tests In f i ie  dog\ t u o  months after splanchn~c flow division. In the 
two experiments in which pancreat~c-gasrroduodenal splenic blood pa\ied to the left lobes. group 2b. there were no 
significant d~fferences In the hepatic c)ciic 3 ' .  5'-adenos~ns rnonopho\phate concentration\ on the two \Ides ofthe liver. 
However, in the three dogs of group Za. top. there \\a\  ;i runawa) retponje In the lobe\ recel\ Ins lntestlnal venous blood 
compared with a restrained re\pon\e In the. lobes nour~\hsd b) pancreatic-;a\troduodenal-\plen~c \ rnou\  blood. 
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AUXILIARY LIVER TRANSPLANTATION AND HEPATOTROPHIC PHYSIOLOGY 
TOTAL NUMBER OF OBSERVATIONS 
Fig. 16.- Summary from the different experiments depicted in 
Figures 1 and 2 shows the influence of the type of portal inflow upon hepa- 
tocyte size. The data are taken from Figures 7 and 8 and are compared with 
values obtained from the livers of normal dogs. Note that the presence of 
hypertrophy or atrophy was almost exclusively under the control of 
pancreatic-gastroduodenal-splenic blood and that the addition or subtrac- 
tion of blood from other sources was of little further consequence. 
phosphate. In addition, the modifying effect of tolbutamide-induced 
endogenous insulin upon exogenously administered glucagon was evalu- 
ated bv serial determinations of cvclic 3'. 5'-adenosine m o n o ~ h o s ~ h a t e .  
. . 
These investigations with the aminophylline and tolbutamide-glucagon 
tests demonstrated the anabolic role of insulin and the opposing roles of 
both glucagon and epinephrine in contributing to liver h&eos&sis. Epi- 
nephrine and glucagon caused striking increases in cyclic 3', 5'-adenosine 
monophosphate, and i n d i n  had the converse effect. 
Another type of preparation involving partition of the splanchnic 
venous blood between the liver portions was termed bplanchnic flow divi- 
sion. The substances responsible for the hepatic hypertrophy. hyperplasia, 
glycogenation, and weight gain were shown to emanate mainly, if not 
virtually exclusively, from the pancreatic-gastroduodenal-splenic venous 
drainage. In contrast, intestinal nutritional substrate and hormones from 
the intestine or adrenal gland were not profoundly influential in either pro- 
moting or preventing the morphologic or glycogen concentration changes. 
The concentrations of cyclic 3', 5-adenosine monophosphate. phosphory- 
lase, and glucokinase in the two sides of the liver did not follow as 
distinctive a pattern as in the partial transposit~on experiments. However, 
the aminophylline and tolbutamide-glucagon tests revealed the same type 
of major dissoc~ation of cyclic 3'. 5 '-adenos~ne monophosphate as with the 
. . 
partial transpositions. Particularly impressive was the way in which trace 
doses of tolbutamide-induced endogenous insulin on the side nourished by 
pancreatic venous blood restrained the cyclic 3'. 5'-adenosine mono- 
phosphate response to exogenoui glucagon. ahereab the other liver frag- 
ment which was not so covered by insulin had completely uninhibited rises 
in cyclic 3', 5'-adenosine monophosphate. 
The conclusion from these experiments is that the hepatotrophic 
factors previously reported from our laboratories and b) other investiga- 
tors to be in splanchnic venous blood are pancreatic hormones and 
specifically insulin and glucagon. Of these, insulin is anabolic and 
glucagon is mainly catabolic but not exclusivel) so. since glucagon also 
has the anabolic effect of stimulating gluconeogenesis. The insulin- 
glucagon relationship and the interrelationship of these hormones to 
others, such as epinephrine. in the moment to moment regulation of 
nutrient and hepatic homeostasis is a central fact of liver physiology that 
should reconcile a number of previousl) di\ ergent opinions about por- 
toprival sqndromes, mechanisms of hepatic atroph) and hyperplasia, and 
the control of liver regeneration. 
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AUXILIARY LIVER TRAKSPLAXTATION AND HEPATOTROPHIC PHYSIOLOGY 
These experiments directly tested the hypothesis that insulin was the principal hepatotrophic 
substance by evaluating the effect of insulin infusion into one of the main portal branches in the hilum 
after complete portacaval shunt. The liver fraction infused for four days with insulin retained cell size 
and morphologic integrity compared to the contralateral insulinoprival fragment which atrophied. 
Remarkable differences also were noted in hepatocyte proliferation. 
Dr Charles Putnam was a student at Hamilton College, New 
York, when he began yearly summer visits to the University of 
Colorado in 1964, working as a volunteer in the transplantation 
laboratory He continued this practice throughout his medlcal 
school years and while a junior at Northwestern Unlversty School 
of Medicine he helped TES wrlte the text Experience in Hepat~c 
Transplantation W B Saunders Co 1969 His name appears as a 
secondary author in many of the important Colorado papers in the 
late 1960 s and early 1970 s Much of this work was done while he 
was a house officer in training Putnam joined the University of 
Arizona School of Medicine faculty in 1977 His present rank IS 
Professor of Surgery and Pharmacology 
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Effects of insulin, glucagon, and insulin/glucagon infusions 
on liver morphology and cell division after complete 
portacaval shunt in dogs 
Lancet, I: 82 1-5, 1976 
T. E. Starzl, K. Watanabe, K. A. Porter and C. W. Putnam 
Summary 
Insulin, glucagon, and insulin/glucagon mixtures have been infused 
for four days into the left portal vein of dogs after portacaval shunt. In the 
left but not the right liver lobes, insulin alone reduced atrophy, preserved 
hepatocyte ultrastructure, and trebled cell renewal. Glucagon alone had no 
effect. In small doses glucagon alone did not potentiate the action of insulin 
and in large doses it may have reduced the insulin benefit. These studies 
explain the development of the previous mysterious Eck fistula syndrome, 
provide clues about in-vivo cell growth control by hormones, and suggest 
new lines of inquiry about the pathogenesis and/or treatment of several 
human disease processes. 
Introduction 
A completely diverting portacaval shunt (Eck's fistula) profoundly 
alters the structure and function of the liver in several species.  Until 
recently, theze changes were thought'qn what has been termed the "flow 
hypothesis" to be caused by and be proportionate to the reduction in total 
hepatic blood-flow whlch the procedure causes: We have suggested 
instead that disruption of nomlal endogenous insulin delivery to the liver 
was mainly respon~ible" and in prel~minar): communication we showed 
that infusion of commercial inaulin into the t~ed-off central portal vein of 
dogs prevented most of the  acute atrnph~c hanges that are ordlnaril) very 
advanced by light microscopy within four da)s after ponacaval shunt.'" 
In this investigation, more complete srud~ez were performed in dogs 
of hormone infusions after Eck's fistula. Insulin, glucason. and combina- 
tions of these two agents in variou, dosei Mere tested for their effect upon 
the morphologj and dik iaion-rates of the hepatocytei. 
%lethods 
Anresthesia for operation and later killing u ~ t h  sod~urn pentobar- 
bitone supplemented u ~ t h  phencyclidine hhdrochloride ( 'Semylan') and 
succ~nylcholine chloride ('Anectine'). Large s~de-to-side portacaval 
shunts were constructed with excision of ellipses from both portal vein 
and the inferior vena cava. The shunts were made completely diverting by 
individually ligating the main right and left portal trunks. Frequent mom- 
ing blood-sugars were determined during the period of study by means of 
an 'AutoAnalyrer'. 
The expe~imental groups of mongrel dogs are shown in table I. In 
groups 2-9, the tip of a fine infusion catheter was placed into the tied-off 
left portal branch and led through the body wall and through a long 
Experimental arrangement in groups 2-9. 
I.V.C. = inferior vena cava. P.V.= portal vein. R. V. =renal vein. 
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No treatment 
Hcpannivd ssltne 
Large dose rnsulrn 
Small dose insulin 
Purified insulin 
Small dose glucsgon 
Large dose glucagon 
2/1 inaulin/glucsgon 
UlOO in~ulidglucagon 
TABLE I-EXPERIMENTAL GROUPS A N D  HORMONE DOSES 
p-pp - - 
.All tnsul~n was commencd regular msuhn, accpt  in p u p  5 tComparrrons were by Student's r test 
subcutaneous tunnel to a small calibrated finger pump that was incorpo- 
rated into a light body cast (see accompanying figure). The infusion 
volumes never exceeded 25 ml per day. Regular commercial insulin from 
beef and pork pancreas was used for much of the work. To rule out artefacts 
from contaminants, research-quality bovine insulin prepared by the Eli 
Lilly Company (Indianapolis) was used in group 5 (lot no. 24C-3 130). The 
glucagon which was pure (Lilly lot no. 95C-03 14) came from beef and pork 
pancreas. The small and large glucagon infusion doses in the glucagon- 
alone groups 6 and 7 respectively would have provided approximately a 
211 or 21100 insulin/glucagon molar ratio had insulin been given in the 
amounts used in groups 3 and 5. A 211 ratio is in the physiologic range." 
Biopsy specimens were obtained from a left lobe at the time of 
portacaval shunt (LO), and from left and right lobes (L4 and R4) at the time 
of killing. About two hours before killing, 63  of the 70 dogs were given 4.5 
mC of (CH,-'H) thymidine by the intravenous route. The specific activity 
of the thymidine was 6.4 C per mmol. Because the same dose was always 
used without regard to animal size, the dose spectrum per kilogrammme 
per body weight was broad, ranging from 0.16 to 0.48 mC. Shunt patency 
and catheter position were always verified at necropsy. 
After fixation in formalin, frozen sections were cut from the samples 
of liver tissue and stained with sudan-4 for fat. The remaining tissue was 
then processed and the paraffin sections were stained by a variety of 
methods which have been described p rev iou~ ly . '~  Autoradiography was 
carried out on paraffin sections using Kodak NTB2 liquid emulsion and an 
exposure time of 28-35 days. Small cubes of each hepatic sample were used 
for electron microscopy. Initial fixation was glutaraldehyde was followed 
by osmic acid. After embedding in 'Epon'. ultrathin sections were cut, 
stained with lead citrate, and examined [sic] in a Philips 300 electron 
microscope. The size of the hepatocytes was determined by tracing out 
large numbers of midzonal liver cells on standard-thickness paper, cutting 
out the silhouettes, and weighing them. The weights were referred to as size 
units. We have shown this to be an accurate method for comparing cell 
sizes by confirmatory planimetry and by studies of unicellular organisms, 
the size of which could be directly determined. Midzonal hepatocytes were 
P vdunt 
L4 us R4 
also used for measuring on electron micrographs the length of rough endo- 
plasmic reticulum per area of cytoplasm by Loud's method." 
I 
I h g  weights 
(;NUP NO. of 
no. exwriments Tya of pons1 infusion' 
Results 
Conrrols and placebo infusions. 
Four days after portacaval shunt, the liver cell size units in both the 
left and right lobes of the animals of group 1 decreased by about half (table 
I). In addition to the hepatocyte shrinkage. light-microscopic examination 
showed that the hepatocytes were irregular in shape and were depleted of 
glycogen. The lobules were smaller than normal and the reticulin frame- 
work was condensed around the central veins. The Kupffer cells were 
enlarged and filled with material which included ceroid and lipofuscin and 
in three animals hzmosiderin. A little fat was visible in the hepatocytes in 
5 of 1 1  dogs. The number of hepatocyte mitoses was greater than normal. 
The ultrastructural changes caused by Eck fistula within the fourdays 
were the same in the left and right lobes. The most prominent effects were 
decreases in the amount of rough endoplasmic reticulum with disruption 
and dialation of the cistemre. hforphometric analysis showed that the area 
of rough endoplasmic reticulum per volume of cytoplasm was reduced to 
c;lucdpn dux 
, iwi/J(gIJd~! 
IllCdn2S.D ! 
lmulin d m  
(uniuhg/day) ( m e p n + s . ~ . ,  
between half and a third the quantity found in the preoperative biopsy and 
the number of membrane-bound ribosomes was reduced. The quantity of 
smooth endoplasmic reticulum was increased. Some of the mitochondria 
were enlarged and showed distortion of their cristz. 
The autoradiographic studies gave quantitative confirmation of the 
impression of an increased mitosis-rate (table 11). The number of hepato- 
cytes undergoing D.N.A. synthesis in both left and right liver lobes was 
nearly 5 per 1000 (table 11). The rate in 17 normal dogs including 6 that 
were subjected to sham dissections of the portal tract was recently 
established in our laboratories as 1 .6i0 .4  (S.D.) per 1000 cells in the left 
lobes and 1.6+0.5 (S.D.) in the right lobes.' 
All the foregoing findings were almost precisely the same in the dogs 
of group 2 whose left lobes were infused with a heparin saline infusion for 
four days after Eck fistula (tables I and 11). 
G U  aizc umts 
( m a n + s . o . )  
LO I L4 R4 
Insulin infusion. 
The infusion of 0.43 units per kgtday of commercial insulin into the 
left portal vein for four days after Eck fistula in group-3 dogs rnarkedly 
reduced the hepatocyte shrinkage in the left lobes without affecting at all 
the acute atrophy of the right lobar hepatocytes. The amount of glycogen 
in th cytoplasm of the hepatocytes in the left lobe was still less than normal, 
but much more than in the atrophic right lobar hepatocytes. The Kupffer 
cells in both lobes were enlarged and full of ceroid and lipofuscin. 
Ultrastructurally, comparisons of the left and right lobar hepatocytes 
showed that the liver cells exposed to insulin infusion were almost normal. 
The area of rough endoplasmic reticulum per volume of cytoplasm and the 
number of membrane-bound ribosomes were only slightly reduced; dila- 
tation and disruption of the cistemae were minimal. Glycogen granules 
were frequent, but the number of small fat vacuoles was increased. The 
changes in the hepatocytes in the right lobe did not differ from those seen 
in the controls. 
Autoradiography showed that in the insulin-infused left lobes the 
number of cells undergoing D.N.A. synthesis had nearly trebled whereas 
TABLE !]--CELL DIVISION B Y  AL'TORADIOGRAPHI I N  THF  L I V E R S  OF 63  
DOGS 
No of labclled hepa~ocytes 
per 1000 hcpatocytcs 
(meant s.D.I 
P values. 
L4 cs R4 
I 1 I 
. ( . ~ > I I I / > ~ ~ ~ L ~ L ~ I ~ S  uerc b i  Studcnl's i rest 
: I l l  I '  undllcred or sham-oprrated Jogs the left and ngh! lobar value. respcc- 
i ~ ~ c l !  ucr? I 6 t 0 . 4  and 1 . 6 i 0  5 Thc lncreag caused b) E i k  fistula I S  slgnifi- 
i J i l !  veil ( X I 1  
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TABLE Ill-MORNING BLOOD-SUGARS DURING FOUR-DAY EXPERIMENTAL 
PERIOD 
D.N.A.-synthesizing cells in the right lobes of the group-? dogs were not 
different in numbers from those in the untreated Eck fistula animals of 
groups 1 and 2. 
The results in all the end-points measured were almost exactly the 
same in the dogs of group 5 when purified insulin was used instead of the 
commercial insulin (tables I and 11). A pronounced but slightly reduced 
protective effect of the left lobes was still evident even when the insul~n 
dose was reduced in group 4 to about a third of that used in groups 3 and 
5 (tables I and 11). 
In all the groups morning blood-sugars on frequent occasions did not 
deviate significantly from normals in our laboratory (table 111). 
(rruup 
no 
?.,>r~~~,il dogs 
I and 2 
3 
4 
s 
6 
7 
K 
Y 
Glucagon infus~on. 
The administration of small (group 6) and large (group 7)  doses of 
glucagon into the left portal vein for four days did not appreciably 
influence any of the changes caused by Eck fistula (tables I and 11). 
Insulinlglucagon ~nfusron. 
When glucagon was added to proven effecttve doses of insulin to 
make an isulin/glucagon molar ratio of 211 (group 8). the effect was no 
different than with insulin alone (tables I and 11). 
The animals of group 9 receive 100 times as much glucagon. Now the 
protection from hepatocyte atrophy in the left lobes afforded by insulin 
seemed partly lost. By one-way analysis of variance using Duncan's 
multiple range test with 95% confidence limits, the L1 hepatocytes were 
not in the same subset as the protected groups 3, 5 ,  and 8, but neither did 
they fit with the control and pure glucagon groups 1 .2 .6 .  and 7. The badly 
affected left lobar liver cells were ctill significantly less shrunken than 
those on the right (table I).  The autoradiographic observationc w ith D.N A. 
incorporation showed the same threefold increase in the left lobes as u i th  
insulin alone or as with 211 insulin/glucagon ratio (table 11). 
The light and electron-microscopic analyqis did not show why the 
insulin protection had been partly lost in group 9. The amount of glycogen 
in the left lobar hepatocytes seemed almost norn~al.  but the ~ o l u m e  of 
rough endoplasmic reticulum u a s  less than in the hepatoc!tes in the left 
lobes of dogs infused with insulin alone or insulin combined uith louer 
doses of glucagon. Some mitochondria! abnormalities were also present. 
N o  of 
dcterm~nat~ons 
10 
20 
38 
13 
2 1 
24 
12 
24 
24 
Discussion 
Eck thought ' that a completely diverting portacaval shunt (Eck's 
fistula) in dogs was compatible u i th  prolonged good health. This conclu- 
sion was refuted In 1893 by Hahn, Massen. Renckiisic], and Pawlou1 '  
whose dogs with Eck fistula developed anorexia. ueight lo,s, liver 
atrophy, and hepatic encephalopath). The inabilit) to explaln these conse- 
quences caused Bollman ' t o  write in 1961" "In the 83 years since 11 was 
first reported. the Eck fictula has been reawnably successful In h~ding Ira 
secrets as well as in gibing rise to man) addltlonal questlonq fundamental 
to an understanding of the functions of the inteitrne. li\er. and brain." B) 
then it had been widel! accepted that the Eck fistuia slndrorne u a \  cau5ed 
by a suboptimal volume as opposed to qualitq of hepatic blood-tlou. Thia 
conclusion had apparent support from the fact that the portopribal compli- 
cations could be minimised if the central tied off portal ~ e i n  h a \  revaicu- 
larized with sy\temic \enous blood (Chlld's portacaval transpo5ition ) or 
u ith arterial blood. 
The flou concept \*a$ undermined b! a irrtes of inLestlgations In 
which two canine liver\ or fragment\ of the aame l i ~ e r  Sere  given different 
kinds of portal inflow.'""'"The hepatocytes perfused with total portal flow 
Blood-wgar (rng/dl 
(meants D ) 
61: 9 
63i 8 
65t13 
71r 8 
71111 
65112 
652 10 
631 9 
68113 
or its pancreaticogastroduodenosplenic fraction became glycogen-rich, 
hypertrophic, and more active in cell renewal than the hepatocytes in the 
disadvantaged liver tissue which developed the histopathological features 
caused by Eck fistula despite apparentlq adequate replacement flow. 
Collectively. the enrich~ng constituents thus demonstrated to be in portal 
blood were called hepatotrophic substances. It became obvious from 
biochemical'" [sic] and pancreatectomy or allo an-diabetes s t u d i e ~ ~ ~ ~ ~ [ s i c ]  
that insulin was the most important of these substances and that the well- 
known efficiency of insulin's removal during a first pass through hepatic 
tissue" :'made it relatively unabailable for a second liver or liver fragment. 
At the same time the benefit after portal d~version from flow augmentation 
procedures such as Child's portacaval transposit~on was explained. If 
insulin and other hepatotrophic substances were bypassed around a single 
liver, they would be returned to it in diluted form in direct relation to the 
total hepatic blood-flow. 
The natural deduction from our earlier studies was that many of the 
secrets of the Eck fistula were manifestations of an altered hormone envi- 
ronment in which the most important change was deprivation of the liver 
of direct access to endogenous insulin. The experiments of a recent 
preliminary communication %d of this more complete report directly 
tested that hypothesis and with unequivocal results. 
Non-hypoglyczmic insulin infusions for four days Into the tied-off 
left portal vein after Eck fistula greatly reduced the left lobar hepatocyte 
atrophq. permitted the ultrastructure of the protected liver cells to remain 
essentially normal. and caused a threefold increase in the number of left 
lobar hepatocytec undergoing mitosis. There was no sptllover effect in the 
right lobes. Glucagon by itself dtd not cause any of these changes, and it 
did not potentiate them when added to insulin at a 211 molar insulin/ 
glucagon ratio. At a dose 100 times greater. glucagon may actually have 
reduced the benefit from insulin. 
Thus it has been established that "hepat~c insul~nopenia" is the most 
important element in the liver Injury of Eck fistula. It is Ironic that this 
answer was so close to detection all the tlme. Hahn et all4 definitely 
emphasised more than 80 years ago that. unless the portal vein was ligated 
above the last portal branch dunng the performance of Eck fistula, their 
dogs remained quite normal. This highest rehsel drains the pancreas, but 
of course the endocrinological significance of that fact was not then 
known. Because of that same ignorance of hormones, speculat~on by Rous 
and LanmoreXwas vague about the possibtlity as they saw it in 1920 that 
portal blood might have special liver-supporting constituents. A perplex- 
ing observation of our o u n  from almost 20 years ago contained a strong 
clue.-'It was noticed that dogs with Eck fistula plus insulin-treated alloxan 
diabetes remained in much better health than animals with Eck fistulaalone 
In that the diabettc dogs gamed \*eight and were spared all evidence of 
encephalopathy. The now-obvious explanat~on is that peripheral insulin 
concentrations of two or three times nomial are required in diabetics to 
malntaln nonnoglycsrrita when insulin is given systemically,:Yhus inad- 
vertently providing a compensatory hepatic arterial increase in the 
hormone. Conversely. in untreated alloxm-diabet~c rats w ~ t h  unaltered 
hepatic circulation. Reaben. Peter4on. and Reaveny ha\e  demonstrated 
acute ultrastructural changes in the liber cells that were remarkably like 
those caused b! Eck fistula. 
In the past we have emphasized ' " that multiple factors including 
collaborating hormone5 as hell  as nutnentt undoubtedly contrtbute to the 
total hepatotrophtc effects of portal blood. It would be regrettable now if 
the her) claritq with uhtch insultn has emerged as a pnncipal portal 
hepatotrophic substance were to obscure the search for contributory 
factors. The obbervatton that the insultn protection in our experiments was 
not quite complete may be a reflectton of missing ancillary substances al- 
though thi.; could also be expla~ned b) the inability of ~nfusion pumps to 
make appropriate ph)siological modulat~ons of deliber). 
Hous \e r .  it 1s particularl~ in the area of cell growth control and 
regeneration that efforts must not be nude  to u5e insul~n as a monolithic 
explanation for eventhlng. 'Th~s can be made clear with some observa- 
ttons about hepatoc!te reneual under differ~ng portoprival cond~tions. In 
Ii\ers of Eck fiatula dogs ofthe present stud). in rat I~vers after portacaval 
5hunt:'and In the ponopri\al hepatic fragments of double 11ver modelsRq 
the atrophic and ~nsulin-.;timed hepatoc!tes h a ~ e  been demonstrated by 
autoradtographq to h a ~ e  rnltosis-ratea that paradoxtcall! uere  three or four 
times normal. The stimulu$ for the 10%-grade h)ptrplasia is unknown, but 
it is presumably a response to an increased hepatocyte death-rate. The 
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provision of exogenous insulin in the present studies or of endogenous 
insulin in the complicated double liver fragment experimentsXUprovoked 
a sustained burst of proliferation beyond the already heightened mitotic 
background. 
These results were consistent with those in the important study by 
Younger, King, and Steiner2'who allowed rats to be alloxan-diabetic for 
a month before treatine them with insulin. Althoueh the livers were 
- - 
thought to already contain a higher than normal number of hepatocytes, the 
proliferative response to insulin was spectacular, being similar to that after 
68% liver resection. However, younger and his coll~agues'"a1so showed 
that diabetic rats retained a potent although subnormal ability to regenerate 
their livers after an actual hepatic resection even if insulin treatment was 
withheld. Accordingly, it is unlikely that any single control factor will be 
the sole explanation of regeneration. Holley" and Leffert" have sum- 
marised the dozens of substances, hormonal (including insulin) and others, 
that can initiate and regulate cell growth in tissue-culture systems. There 
is no reason to doubt the relevance of their comments concerning the com- 
~lexi t ies  of growth control to in-vivo situations. 
- 
Even so, the prospect seems promising of favourably influencing 
regeneration and recovery after acute liver injury in laboratory animals and 
ultimately in man by the simple expedient of intraportal insulin therapy. 
Earlier,' "[sic] we speculated that insulin for this purpose might have an 
augmented benefit if combined with glucagon. A recent study on regenera- 
tion by Bucher and Swaffie1d':has provided support for such combination 
therapy. However, the failure in our studies reported herein, as well as in 
past equally well-controlled ones, "'"'[sic] to identify a beneficial additive 
role of glucagon, coupled with the slight possibility that in high doses it 
might have even cancelled some of the insulin benefit, would cause us 
either to omit glucagon or to use it in small amounts only. 
As such possibilities are coniidered, the relevance of canine portal 
physiology to man will be raised. It has been pointed out elsewhere' that 
the same general light and electron microscopic changes have now been 
seen after portal diversion in the livers of rats, dogs, baboons, and humans 
with some variation in degree. Thus, the hepatic injury of Eck fistula is 
common to all species so far studied. Fortunately, the most serious 
metabolic consequences have seemed to selectively spare rats and man, a 
species difference that has made it feasible to perform the procedure with 
benefit to patients with glycogen-storage disease-and homozygous type- 
I1 hyperlipidremia." These applications accept a trade-off of distinctly 
suboptimal conditions of liver perfusion in return for metabolic improve- 
ments that almost certainly derive from the ~uboptimal  condition^.^^ " '4 
[sic]A similar weighing of gains and losses is necessary for the traditional 
indications for shunting operations in patients with oesophageal varices 
who retain hepatopetal portal flow. An obvious argument can be mounted 
for a Warren-type operation which preserves much of the residual splan- 
chnic flow to the liver including that returning from the pancreas." 
Appreciation that there is a broader interplay between the liver and 
pancreas than the classical metabolic ones of Madison'9nd Felig and 
Wahren"shou1d have ramifications in understanding the complications of 
diabetes mellitus. the pathogenesis of liver disease, and numerous other 
clinical problems as has been pointed out by others.'"." 
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Karel B. Absolon R~chard Lillehei (1928-1981) 
Dr. Karel Absolon was a young surgeon at the University of Minnesota. He had a profound 
interest in transplantation and hepatic surgery. His description of the first attempt at auxiliary liver 
transplantation was given at a conference in Lyon, France in May, 1965. Absolon, also a student oT 
medical history and the author of a biography of Billroth, is in private practice in Washingtion, D.C. 
The senior faculty member was Richard Lillehei, one of transplantation surgery's great pioneers 
and the first to attempt clinical pancreas and intestinal transplantation. Lillehei died on 1 April, 1981 
while training for the Boston Marathon. He was 53 years old. 
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Experimental and clinical heterotopic liver homotransplantation 
Revue Internationale d'Hepatologie, 15: 148 1-90, 1965 
Karel B. Absolon, Patrick F. Hagihara, Ward 0. Griffen, Jr. and Richard C. Lillehei 
Direct therapy of malignant tumors of the liver would necessitate 
excision of the organ and its replacement.' 21n benign diseases of the liver, 
such as cirrhosis in adults and biliary atresia in infants, which eventually 
results in hepatic failure, heterotopic liver implantation while the recipient 
liver is left intact may be the approach of choice. The first successful whole 
organ heterotopic canine liver homograft procedure was performed by 
Welch and his associates" and inspired a heterotopic liver homograft 
operation developed by the authors.' 
The procedure previously tested on dogs consisted of placing the 
liver in the left side of the abdomen after splenectomy to gain space. 
Arterial inflow to the homograft was accomplished by anastomosing the 
hepatic artery to the aorta or its branches and venous outflow from the 
homograft by anastomosing the inferior vena cava of the graft to the 
inferior vena cava of the recipient. In dogs the graft portal vein was either 
tied or anastomosed to the ponal vein of the recipient. In order to 
decompress the transplant, in case of proplonged ischemia which led to 
high resistance to blood inflow the portal vein graft was anastomosed to the 
graft inferior vena cava. The common duct was drained of its bile 
externally for functional evaluation. Azathioprine and Predisolone ad- 
ministration produced prolongation of graft function. In dogs with their 
own bile duct obstructed. these drugs prolonged bilirubin clearance by the 
graft. While some grafts under such therapy showed the typical mononu- 
clear infiltration characteristic of rejection, other [grafts] remained histol- 
ogically normal.' 
Case Report  
Preoperarive status. 
T.K.: A 13-month old infant was the product of a non-complicated 
spontaneous vertex deliver).. He did well at home until four weeks when 
he developed icterus associated with dark urine and clay colored stools. At 
the age of 8 weeks an exploratory laparotomy was performed at an outside 
hospital facility which showed no evidence of extrahepatic b ~ l e  ducts. The 
postoperative course was uneventful and the condition of the patient 
remained unchanged. At the age of 5 months he was admitted to the 
University of Minnesota Hospital for re-evaluation. 
The physical examination revealed a jaundiced male infant in mod- 
erate respiratory distress and a distinct hepatic fetor, a distended, tense, 
fluid-containing abdomen and hepatosplenomegaly. Surgical re-explora- 
tion revealed a partial bowel malrotation and a rudimentary gall bladder 
containing clear mucoid material with no evidence of extrahepatic ducts. 
A biopsy of the liver revealed distorsion of normal architecture with 
enlarged portal spaces and confluent bands of fibrous tissue (Fig. 1 A). The 
liver parenchyma was divided into irregular nodules. The hepatic cell 
cytoplasm as well as the intra-lobular bile ducts contained abundant bile 
pigment. Within fibrous bands were numerous proliferating, newly 
formed bile ducts. 
The laboratory findings revealed a urinalysis with I+ albumin and 
qualitatively positive bilirubin. The hemoglobin was 10.5 gm.%, leuko- 
cytes were 11,600 per cu. mm. with 4 1% neutrophils and 5 1% lympho- 
cytes. The prothrombin time was 13.2 seconds with a control of 11.4 
seconds. A blood sugar of 76 mg.% and a total protein of 6.9 gm% with 
albumin of 3.4 gm.% and globulin of 3.5 g m . 8  was measured. 
At the age of 11 months the patient was re-admitted for liver 
transplantation. The child had been maintaind on bile salts, 0.2 gm. three 
times a day and vitamins. In the interim, this lethargic, anorectic infant 
rapidly deteriorated after reaching a maximum weight of 16 lbs. and 
showed increasing jaundice. He had suffered multiple upper respiratory 
infections, otitis, bronchitis and pneumonia. The physical examination 
revealed a grossly retarded infant with no evidence of teeth. unable to roll, 
sit or vocalize. It appeared dyspneic and othopneic with yellow pale skin 
and decreased turgor. The respiratory rate was increased, the chest excur- 
sions shallow and grunting. The liver, which at the age of 5 months was 
palpable 5 cm. below the right costal margin. now was felt some 5 cm. 
lower; the liver edge was firm and sharp. The spleen was felt 6 cm. below 
the costal margin. approximately the same level as at the age of 5 months. 
The chest x-rays revealed changes in the right middle lung field compatible 
with bronchopneumonia. 
The laboratory findings showed in the period six months prior.to 
admission (Fig. 4) fluctuation of serum alkaline phosphatase levels from 
75 to 220 King Armstrong (K.A.) units per cent with an average of 152.4 
CLIO CHIRURGICA 
Fig. 1.- A. Upper: Patient's own liver characteristic of extra hepatic biliary atresia. 
B. Lower: Liver homograft, 13 days after implantation. 
K.A. units per cent. The total serum protein at the age of 5 months was 6.9 
gm.%. (NG: 3.413.5 gm.%) and now had changed to 6.2 gm.% (AIG: 2.71 
3.5 gm%). The serum bilirubin varied from 8 to 9 units, the cephalin 
cholesterol was 2+ and the total cholesterol was 314 to 273 mg.%. The 
serum glutamic oxaloacetic transaminase varied from 124 to 274 pyruvic 
units per ml. (P.U.)(Av. 199.8 P.U./ml.) The serum glutamic pyruvic 
transaminase was determined on two occasions and was measured at 301 
and 497 P.U./ml. Sputum cultures showed a varied flora (beta-hemolytic 
Streptococci, ~seudomonas Aeruginosa and Klebsiella organisms). ~ f t e r  
admission for consideration for trans~lantation, this overation had to be de- 
ferred several times because of the patient's serious condition punctuated 
by recurrent episodes of semi-coma, pneumonitis, and partial intestinal 
obstruction. The patient's course was characterized by periods of electro- 
lyte imbalance such as hyponatremia, perhaps conditioned by administra- 
tion of diuretics and Aldactone and moderate anemia and leukocytosis 
which represented his response to various infections. Progressive jaundice 
associated with anemia necessitated support with blood and human serum 
albumin transfusions. The bilirubin during the last month prior to transpla- 
nation varied from 11.5 to 36 mg.% total (av. 21 mg.%) and 5 to 20 mg.% 
one minute (av. 10.7 mg.%). The prothrombin time on several occasions 
was slightly elevated, reaching the highest level of 15.2 seconds with a 
control of 10.8 seconds. 
Operation: 
On November 3, 1964 a heterotopic liver graft procedure was 
performed. The liver was removed from a 2 112 year old patient suffering 
from complete transposition of the great vessels and dextrocardia with 
situs inversus. The recipient weighed 7 kg. and the blood group was 0 Rh- 
(C-, D+, hr+); the female donor weighed 9 kg. and had an A+, Rh+ (C, D, 
E, hr+) blood group. 
Preparation of donor: The donor was placed on complete cardiac 
bypass utilizing the DeWall bubble oxygenator and a Mustard operation 
was performed for corrective repair of transposition of the great vessels 
under moderate hypothermia (Rectal T. 33°C. and esophageal 19-25°C.) 
The perfusion rate was 500-810 ml. of blood per minute for 109 minutes. 
Four attempts at discontinuing the bypass were unsuccessful and the heart 
did not resume blood pressure sustaining action despite vigorous meas- 
ures. While under total body perfusion the legal permit to remove the liver 
for grafting was obtained. Five hundred ml. of 0.9% salt solution and 150 
ml. of 5% dextrose in water and 500 ml. whole blood were added to the 
perfusate as well as antibiotics, 25 mg. Chlorpromazine and 18 mg. 
Dibenzyline. The perfusion was continued under deep hypothermia (10- 
13" C at 180-300 ml./min. flow rate) for 4 hours until the recipient was 
ready to receive the graft. 
A midline incision from the xiphoid process to the pubis in addition 
to the bilateral transverse sternal thoracotomy used for the unsuccessful 
cardiac operation gave good exposure. The liver was displaced to the left 
of the normal position, as is typical of a situs inversus. As the venous return 
from the lower half of the body was through the femoral vein, the thoracic 
portion of the vena cava could be ligated soon [sic] after freeing the trian- 
gular ligaments of the liver. Easy access to the common hepatic artery was 
obtained after transection of the esophagus and the gastrohepatic ligament. 
The vessels of the celiac axis were dissected, the splenic and left gastric 
arteries divided. The portal vein and infradiaphragmatic vena cava were 
dissected and an end-to-side portacaval shunt established. At this point the 
recipient was ready to receive the homograft. Blood was drained from the 
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Fig. 2.- Heterotopic liver homotransplantation. A - Recipient liver. - B -Donor liver. - IVC 
- Donor Inferior Vena Cava. HA - Donor Hepatic Artery. - LIV - Racient Left Iliac Vein. 
perfusion system and replaced with a chilled solution of 500 ml. 5% 
dextrose in water and 5% low molecular weight Dextran. After removal of 
the graft in vitro perfusion was started through the hepatic artery and portal 
vein for 8 minutes with a chilled solution of Tis-u-Sol, 5% low molecular 
weight Dextran and 5% dextrose in water buffered with bicarbonate and 
Tris to a pH of 7.4. All blood and the anticoagulant were thus flushed from 
the organ. 
Preparation of the recipent and liver transplantation: (Fig. 2, 3) 
Through an oblique abdominal incision, the peritoneal cavity was entered 
after freeing the left colon, ligating the inferior mesenteric artery and 
isolating the aorta, vena cava and iliac vessels; a splenectomy was 
performed. Since more space was needed, a left nephrectomy was [sic] 
done. Interestingly, the left iliac vein was of larger caliber than the vena 
cava. The vena cava of the graft serving as its venous outflow (opposite to 
the normal flow) was therefore anastomosed end-to-side to the iliac vein. 
The hepatic artery with a cuff of aorta was anastomosed end-to-end to the 
iliac artery (Fig. 2). Normal blood perfusion was established after 37 
minutes of ischemia which included 8 minutes of washing out the organ. 
Since the graft common duct was unusually small, a cholecystojejunos- 
tomy just beyond the ligament of Treitz u a s  done to provide the outflow 
tract from the graft. The total blood [sic] loss was 50 ml. and the patient 
tolerated the procedure well. 
Postoperative course: (Fig. 4) For immunosuppression the patient 
was placed on Azathioprine 4 mg./kglday and prophylactic antibiotics. In 
addition he received 25 mg. Prednisolone on the day of operation and 25 
mg. Conisone. For the next t h o  days. 8 mg, of Cortisone was given and 
replaced subsequently with 7.5 mg. Prednisolone daily in 3 divided doses. 
The patient received 50 R tissue dose of cobalt ionizing radiation to the area 
of the liver homograft. 
The patient started having stools of normal color and infant charac- 
ter on the second postoperative day at which time some oral administration 
was initiated. The serum bilirubin decreased to 2.1 mg.%/min. and 4.1 
mg.% total on the 7th postoperative day. Serum glutamic oxalacetic and 
pyruvic transaminase levels elevated preoperatively, increased remarka- 
bly at f i s t ,  but then regressed toward preoperative levels on the 4th 
postoperative day. (SGOT, SGPT- 2031483 P.U.1ml.j. 
On the 9th postoperative day the infant developped [sic] signs of 
peritoneal irritation with ascites. The transaminase levels increased again 
(SGOTISGPT-165511705 P.U.lml.) as well as the serum bilirubin (lmin/ 
total-5.318.5 mg.%). Drainage of bile accumulation from a sloughed stump 
of the homograft common duct resulted in a decrease of transaminase 
levels (SGOTISGPT 831332 P.U.1ml.j and serum bilirubin ( I  minltotal 2.41 
6.0 mg.%). Blood, peritoneal and spinal fluid cultures revealed Klebsiella 
infection to which the patient succumbed on the 13th postoperative day 
despite massive antibiotic therapy and continuing liver homograft func- 
tion. On post monem examination the liver was uell preserved grossly and 
histologically (Fig. IB). The vascular anastomoses were patent and angi- 
ograms of the vessels showed a normal pattern (Fig. 5).  
Other laboratory findings: Three postoperative urinalyses showed 
traces of albumin and white blood cells: the urine bilirubin was positive 
twice and negative on two occasions. The uhite blood cell count varied 
from 13-37 thousand with predominant neutrophils. No coagulation defect 
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Fig. 3.- Heterotopic liver homotransplantation. - Note incision and 
position of heterotopic graft 1 week post operative. 
was noted clinically. The platelets were counted at 39-364 thousand/cmm 
and the prothrombin time varied from normal to 6 3 4  normal. The partial 
thromboplastin time and a thromboelastograni were within normal limits. 
The erythrocyte sedimentation rate was slightly elevated. The alkaline 
phosphatase levels in the serum ranged from 25 to 115 K.A.L.C/c and the 
total proteins varied from 4.3 to 4.9 gm.Q (AIG-2.311.8 to 2.712.2 gm.%). 
A moderate hyponatremia continued in the postoperative period. 
Discussion. 
Attempts at liver transplantation appear most justified in progressive 
liver failure due to noncancerou, affections. if early death IS pred~ciable. 
Heterotopic homotransplantation appears to be the procedure of choice in 
cirrhosis or billary atresia, as the recipients may not require total hepatec- 
tomy. It is a less traumatic and techn~cally demanding operative procedure; 
vascualr anastomoses are accomplished while the host \,essels are serially 
interrupted. Bypass and anticoagulation are not required as is the case with 
orthotopic liver homografts. The retention of the host's liver provides 
some hepatic function during the establishment of the homograft. A 
homograft may provide a temporary respite which may be lifesaving in 
case the recipient liver possesses an! potential to recover. 
The desirability [sic] of accomplishing liker homograft decompres- 
sion by portacaval anastomosis must be weighed against the advantages of 
having portal flow through the homograft a\  m q  be accomplished by an 
anastomosis between the graft portal vein and the reclplent portal skstem. 
Ischemia may not be as deleterious to the human liver as it is to the dog 
liver.'Further clinical inquiries are btimulatrd b! the exper~mental results 
of Starrl et a1 in dogs u h o  have shoun 11fe sustaining graft function of many 
months duration.' 
The difficulty of obtalnlng 11ver graft, u ~ l l  nece\iarily hamper 
efforts in this area of cl~nlcal transplantation uork. Su~table donors such as 
infants dying of cardiac abnonnal~ties coninionl) have \ i ~ e r a l  anomalies 
making dissection techn~cnllq d~fficult .  In two other liifarlts uith biliary 
atresia in whom attempts at li\er transplantation it ere made. the donor liver 
was unsuitable because of either size or grosb changri produced by a 
prolonged period of iachemla. 
Serum bil~rubm I e ~ s l s  are an Inaccurate method of e~aluat lng liver 
homograft funct~on. Serum tran\arnlna\e and alkal~ne pho\phatase levels 
are nonspec~fic.The general c o n d ~ t ~ o n  f the parlent and the presence of 
bile In the stools are the iimple\r procedures. R ~ l s  b~ l~ rub ln  content and 
concentration are the mo\r rel~able i~horaror) procedure. u ~ t h  uhich to 
follou homograft function.'E.;ternal blle drainage and an internal anasto- 
mosis would appear the most practical solution in the management of a 
heterotopic liver homograft in patients with biliary atresia. 
The immunosuppressire regimen ui th  Azathioprine and steroids 
was a contributory factor in the fatal infectious compl~cation in this infant. 
The desirability [sic] of exploring other methods of homograft tolerance 
production such as lymphoresis through the thoracic duct with the resulting 
development of 1yrnphoc)topenia and h>poglobulinernia IS becoming 
quite evident.-'Such mechanical agency in combination uith immunosup- 
pressive chemicals of a different nature or reduced dosage ui l l  become the 
approach of choice. 
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Fig. 5.- Postmortem angiogram of hepatic homograft. Upper: hepatic vein. - Middle: portal 
vein. - Lower: hepatic artery. 
Summary. 
The problems of heterotopic liver transplantation in the human were 
discussed and related to experimental studies in the dogs. A heterotopic 
liver homotransplant appears the optimal grafting method in the applica- 
tion of this type of experimental therapy to infants with biliary atresia. 
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Charlie Halgrimson was a resident in surgery at the Universityof Colorado when there was great 
interest in the potential use of auxiliary liver transplantation. His experimental studies showing that 
host portacaval shunt protects the liver graft and a description of several clinical trials of auxiliary 
transplantation were given at the Central Surgical Association in 1966. The practical problems and 
probable limited value of auxiliary liver transplantation were evident. Halgrimson subsequently 
served as Vice Chairrrian of the Department of Surgery from 1972 to 1980 and as Acting Chairman 
thereafter. He now is Associate Dean of the University of Colorado School of Medicine, Denver, 
Colorado. 
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Auxiliary liver transplantation: effect of host portacaval shunt 
Archives of Surgery, 93: 107- 18, 1966 
Charles G. Halgrimson, Thomas L. Marchioro, Tanous D. Faris, Ken A. Porter, George N. Peters and Thomas E. Starzl 
This report is concerned with a further evaluation of auxiliary canine 
homotransplantation of the liver and with the attempted application of such 
a procedure for the treatment of three patients. 
Methods  
There were 33 mongrel dogs weighing 17.7 to 22.2 kg (average, 17.5 
kg) (39 to 49  Ib [average. 38.5 Ib]) used as recipients. The experiment was 
completed in 11 animals. The other 22 died early of anesthetic, technical, 
and septic complications and are excluded from further discussion. In the 
1 1 test dogs the donors (weight 9.5 to 20 kg [21 to 44 Ib]) were smaller than 
their recipients. the average weight being 13.6 kg (30 Ib). The general 
surgical techniques and the studies obtained postoperatively were similar 
to those described in previous publications.' The average ischemia time 
for the cooled homografts was 34 minutes. Postoperatively. 2 to 8 m a g  
azathioprine were administered daily. 
All animals received a completely diverting ponacaval shunt. 
Immediately thereafter, the homotransplantation was performed. The 
animals are grouped into two categories. 
Group I (Eight Animals).- Both of the inflowing vessels to the 
homograft were proved to be patent b) premortem angiograms and by 
autopsy studies (Fig. 1, A) .  
Group 2 (ThreeAninia1si.- The inferior vena caval to portal venous 
anastomosis was shown to be occluded (Fig. 1. B) .  In these experiments, 
both the autologous liver and the homograft had only an arterial blood 
supply. 
Results 
General Ohser~  arions.- There was no significant difference in the 
postoperative clinical course between the two groups of animals. Dogs of 
group 1 lost an average of 2.4 kg (5.3 Ib) compared to 3.6 kg (7.9 Ib) in 
group 2. All animals had transient rises in serum glutamic oxaloacetic 
transaminase (SGOT) and serum glutamic pqruvic transamlnase (SGPT) 
with return to normal f o r ~ a r y i n g  periods before death or sacrifice; changes 
in alkaline phosphatase here  similar but did not return to normal. Proeres- 
. . - 
sive anemia h a s  invariably noted. 
Group I ..ln~niuIs.- Terminall) t u o  of the eight animals became 
jaundiced, uith maximum bilirubin5 of 5.1 and 8.2 mg/100 cc. respec- 
tively. The dogs lived for 24 to 150 days (average 58 days). Two were killed 
in apparent good health; two died of unknown causes; and four died of 
infection. 
At autopsy the host livers appeared somewhat small but were 
otherwise nom~a l .  Similarly, some degree of gross atrophy affected the ho- 
mografts. The weights of the homografts and the autologous livers (24 to 
150 days after transplantation) are listed in Table 1. Marked homograft 
atrophy was present in only one animal. Since the donor animals were 
generally smaller than the recipients. these postmortem liver measure- 
ments were related to the total body weights of the respective animals at the 
time of transplantation. The weights of the homografts in relation to the 
original donor body weights averaged 2.03%. The mean ratio of autolo- 
gous liver weights to the original recipient body weights was 1.79%. Since 
the predicted liver weights per total body weight ratio should be approxi- 
TABLE 1.--Dogs With Patent  Portal  17enous and 
Hepatic Arter ial  In f iow  :o the  H o m o g r a f t  
-- 
F e t g h t  of Weight of 
Dog Sorrival ,  Transplsnt .  nos t  Liver. 
No. D a y  G m  G m  
I 
2 
3 
4 
5 
6 
8 
Average 
- 
Au:opsg tr3nsplanc liver n c l g h t  per donor body weight; 
2.03 %. 
Autopsy host iirer weigh1 per host body a e l g h i  a t  time of 
operation: 1.79 %. 
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Fig. 1.- Experimental design of auxiliary canlne homotransplantation of the liver, in conjunction with host portacaval shunt. (A)  
Group 1 Series: Note that the homograft receives a double blood supply, the portal inflow being of systemic venous origin. Except for the 
host portacaval shunt, the procedure is essentially that described by WelchVB) Group 2 Series: In these dogs the portal venous anastomosis 
clotted. Thus, both the host liver and homograft received only an arterial blood supply. 
mately 2.8%, "it seems likely that both organs underwent relative atrophy. 
the host liver slightly more than the homograft. 
His to~~urholo ,q~ of Group I Atzirnu1s.- The eight host livers exam- 
ined at autopsy, 24 to 150 days after operation. all showed atrophy of the 
centrilobular hepatocbtes accompanied by collapse of the central pan of 
the lobular reticulin framework (Fig. 2). Similar changes were present in 
the one biopsy that was obtalned at 35 days. Seven cf the eight livers 
contained moderate to large quantities of hemvriderm ir! the Kupffer cells. 
Centrilobular cholestasis with bile "thronib~" was present in four of the 
livers. 
In s i r  of the eight transplanted l~vers  examined at autopsy there u a \  
absence ofhepatocytes and cornplete col lape of the lobular reticulin. The 
liver cells were replaced by mesenchymal cclls. Portal tracts and central 
canals were crowded together, Areas of hemorrhage and cellular inf~ltra- 
tion, either mononuclear or polymorphonuclear, were frequent. Of the t u o  
less severely affected liver,, one from a dog dying at 24 clay\ (dog 5 )  
showed necrosis of the centrilobular and midronal 1iepatoc)tes together 
with collapse of the  central part of the lobular reticulin frameuork, but no 
cellular infiltration or cholestaal\. The other. frorn an animal killed at 63 
days (dog 8). shoued atrophh of the centrilobular hepatocytes, increased 
central and portal connective tissue. and bands of retlculin which linked 
portal tracts and cut acres\ lobules producing pseudolobules. A arnall 
number of mononuclear cells were Fre\ent in the portal tract\ of thi\ 
homograft. but only about 1 0 5  of the\e posses\ed p>ronlnophil~c ksto- 
plasm. There was cholesta\~s. some proliferat1011 of brle ductules in the 
portal areas. and much hernoldenn in inac'roph3ge\. Siniilar. though I s s  
severe. changes mere present in thi\ aninid's homograft \\hen i t  \ \a\  
biopsied at 35 days (Flg. 3). 
Group 2 Atiininis.-- Lone of the ari~nials became jaundiced at any 
time; two were killed after l i b  and I05 d q \  and the third d ~ e d  of 
pneumonia after 73 days. 
Two of the three host livers were small but were otherwise normal. 
The homograft livers showed a marked degree of atrophy but maintained 
normal gross architecture (Table 2). The weights of the homografts in 
relation to the original donor body weights averaged 0.72%. whereas the 
average weight ratio of autologous livers to the original recipient body 
weights was 1.52%. When compared to predicted weights, both sets of 
livers 5houed atrophy, affecting the transplant more than the host organ. 
Histopathology of Group 2 Animals.- The three host livers exam- 
ined at autopsy. 73 to 136 days after operation, all showed atrophy of hepa- 
tocytes. moat prominent centrally but present to a lesser degree in the other 
zones of the lobules. T l l ~ r  was accompanied by collapse of the central 
retlculin and accumulatiori of fat in the hepatocytes. Similar changes were 
present i i ~  the t u o  biopsie, that were examined at 35 days. Cholestasis was 
present in two livers. 
In two of the three auxil~ar) transplants the hepatocytes had disap- 
peared leaving onl! mesenchymal c e l l  and the collapsed. condensed 
lobular fr:ime\\ork of the liver. The third transplant. from a dog ( 1) killed 
at 130 dabs, \bowed increased reticul~n and fibrous tissue in the portal areas 
arid around the central ~ e i n i .  Connective tlssue strands joined portal tracts 
and cut across lobules forniing pseudolobules, hlan) mononuclear cells 
were present In the portal tract\. The c!topIatm of about 30'? of these was 
pyronin-posltlve, and s e ~ e r a l  of the cells were in niito\is. Macrophages in 
the ponal area> contained large amounts of hemosiderin. S e ~ e r a l  of the 
hepatlc arteries a c r e  narroued b> fibrous intimal thickening. The biopsy 
obtalned from t h ~ \  li \er at 35 d a > \  showed more cellular i~filrration and 
1es.i arterial darnase i F ~ g .  1). 
Report of Cases 
Case 1 -A  50->ear-old man was knoun to ha\e  alcoholic clrrhosls 
slnce 1957 In October 1964, he developed ~ntermlttent any stools and 
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Fig. 2.- Own liver of dog 8 from group 1. Atrophy of the centrilobular hepatocytes has permitted collapse of the central part 
of the lobular reticulin framework (arrow) (reticulin stain, X 80). 
Fig. 3.- Biopsy at 35 days of auxiliary hepatic homograft from dog 8 (group 1) .  The lobular reticulin framework is normal. 
Twenty-eight days later this liver showed increased central and portal connective tissue and some pseudolobules (reticulin stain, X 80). 
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TABLE 2.-Dogs Wi th  Patent Hepatic Arterial 
Subblv Onlv 
Weight of Weight of 
Dog Survival, Transplant, Host Liver, 
No. Days Gm Gm 
1 138 82 232 
2 i 3  36 150 
3 105 150 410 
-4verages 105 S9 164 
Autopsy ~ransplant liver weight per donor body weight: 
0.n %. 
Autopsy host liver weight p r  host body weight at time of 
operation: 1.52 %. 
jaundice. Physical examination after admission on Jan 26, 1965, revealed 
a tremulous, icteric, wasted man with an increased abdominal venous 
pattern, an enlarged tender liver, ascites, palmar erythema, bilateral 
varicose veins, and peripheral edema. Hematocrit reading was 42%; leu- 
kocyte count, 5 , 1 0 0 ~ ~  mm; total serum bilirubin, 22.5 mg/100cc with 14.5 
mg/100 cc direct; total serum protein, 6.6 gm/100 cc; albumin, 2.69 gml 
100 cc; gamma-globulin, 1.68 gm/100 cc; alkaline phosphatase, 7.55 
Bessey Lowry units; SGOT, 240 Sigma-Frankel units; prothrombin time, 
61%; 4+ urine bile; blood urea nitrogen (BUN), 11 mg/100 cc; and fasting 
blood sugar, 90 mg/100 cc. There was progressive deterioration of liver 
function with increasing mental confusion; bilirubin rose to almost 40 mg/ 
100 cc (Fig. 5). On the 22nd hospital day, he began to bleed massively from 
esophageal varices. An emergency end-to-side portacaval shunt was 
performed with prompt cessation of the hemorrhage. He became disori- 
ented on the second postoperative day. 
Three days after performance of the portacaval shunt, a cadaveric 
auxiliary hepatic homograft was placed in the right paravertebral gutter. 
Both donor and recipient were A positive blood type. The donor was a 79- 
year-old man who died after a cardiac arrest in the operating room. External 
and internal cardiac massage were carried out for 105 minutes before death 
was pronounced. Total body perfusion was then started with an electrolyte- 
primed extra-corporeal circuit into which a cooling coil was in~orporated.~ 
After 108 minutes of extracorporeal perfusion, the liver was removed and 
further perfused with intraportal cooled lactated Ringer's solution. Forty- 
seven minutes later the homograft was revascularized in the recipient, at- 
taching the celiac axis to the side of the terminal aorta. Portal venous inflow 
was from the distal end of the transected terminal inferior vena cava. 
Hepatic venous outflow was provided by anastomosing the suprahepatic 
donor vena cava to the proximal end of the transected recipient vena cava. 
Roux-en-Y internal biliary drainage to the jejunum was established. 
A tracheostomy was performed immediately after surgery because of 
severe respiratory distress. Postoperatively, there was an almost immedi- 
ate clearing of his sensorium. Bilirubin and prothrombin times were 
strikingly improved (Fig. 5); other liver functions were not markedly 
altered. His immunosuppressive regimen is depicted in Fig. 5. 
During most of the next three weeks, he remained lethargic but 
oriented. There were numerous postoperative complications including 
several bouts of gastrointestinal hemorrhage, urinary retention, reversible 
failure, electrolyte abnormalities, and purulent tracheobronchitis due to 
Pseudornonas aeruginosa and Staphylococcus aureus. In addition, ho- 
mograft rejection was diagnosed and treated on the eighth postoperative 
day, after which there was slow deterioration of function. Progressive 
leukopenia was observed from the 1 1 th day onward. Death occurred on the 
22nd day after transplantation. 
At autopsy, the immediate cause of death was thought to be ne- 
crotizing bronchopneumonia with multiple pulmonary abscesses. The 
Fig. 4.- Biopsy at 35 days of auxiliary hepatic homograft from dog 1 (group 2). The normal lobular architecture has been 
disrupted by bands of connective tissue which link portal tracts and some central veins. There is increased reticulin in the portal areas 
and around the central veins (reticulin stain, X 80). 
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Fig. 5.- Clinical course of patient 1. Note the sharp fall in serum bilirubin after auxiliary homotransplan- 
tation, as well as the sustained improvement in prothrombin time. Later, the bilirubinemia slowly increased at 
a time when rejection was thought to be present. Severe leukopenia ensued late in the second week and neces- 
sitated withdrawal of azathioprine. 
homograft was grossly well preserved, weighing 1,400 gm. His own 
cirrhotic liver weighed 1.600 gm. Six liters of ascites were present. 
Histologically the portal tracts, particularly the smaller ones, were 
infiltrated by mononuclear cells (Fig. 6).  Between 5% to 10% of the 
invaders were primitive "blastu-like lymphoid cells with pyroninophilic 
cytoplasm. Several of the smaller hepatic artery branches showed foci of 
fibrinoid necrosis in their walls. A few of the larger bile ducts and many of 
the smaller ducts contained bile casts and there was prominent centrilobu- 
lar cholestasis. The hepatocytes were depleted of glycogen and the cen- 
trilobular cells contained excess lipofuscin and some bile pigment. Those 
hepatocytes immediately adjacent to the central vein were atrophic. There 
was also a slight increa5e in portal connective tissue, and many of the large 
branches of the hepatic artery showed reduplication of the internal elastic 
lamina sometimes accompanied by fibroelastic intimal thickening. These 
latter changes had in all probabilitq occurred in the donor before the liver 
was transplanted. 
Case 2.- A 47 year-old white man had a diagnosis of alcoholic 
cirrhosis established by percutaneous liver biopsy in November 1964. He 
was admitted May 28. 1965. with a one-month history of jaundice, 
anorexia. night sweats, and progressive anemia. He had a large, tender 
liver, an enlarged spleen, moderate ascites, spider angiomata, palmar 
erythema. mental confusion, and 2+ guaiac positive stools. The hematocrit 
reading was 33%: reticulocyte count. 21.3%: total serum bilirubin. 22.2 
mgI100 cc with 12.8 nigll00 cc direct: cholesterol. 250 mgll0O cc; total 
protein. 6.2 gmi100 cc: albumin. 3.10 gmi100 cc: gamma-globulin, 1.28 
gml100cc: SGOT. 190 SFunits: alkaline phosphatase. 9.25 Bessey Lowry 
units: prothrombin time. 32% increahing to 38% after parenteral phytona- 
dione: fasting blood sugar. I02 mgll00 cc: and BCN. 3 mgil00 cc. During 
the first month of hospitalization his cond~tion deterlorated with an 
increase in the serum bilirubin (to 27 mg/lOO cc), ascites. abdominal pain, 
pleural effusion, and the development of fever of unknown origin. After 
five weeks he suddenly became stuporous prompting consideration of 
auxiliary homotransplantation. 
In preparation for this, a side-to-side portacaval shunt (Fig. 7) and 
splenectomy were performed on July 4, 1965, at which time he was found 
to have 5,000 cc of ascitic fluid and portal hypertension. On the following 
day a cadaveric hepatic homograft was transplanted into his right iliac 
fossa by a slightly different method (Fig 8)  than that used in case 1. The 
donor was a 12-year-old boy who died from cerebrai trauma. Both donor 
and recipient were 0 blood type. The liver was cooled with cold lactated 
Ringer's following 40 minutes of external cardiac massage. Arterial 
revascularization was completed three hours after the donor death, and the 
portal inflow was completed 45 minutes later. 
The immunosuppressive regimen is summarized in Fig. 9, as well as 
the postoperative liver functions. Bilirubin fell to a low of 4.5 mg1100 cc. 
A rejection crisis was diagnosed at four days, after which jaundiced 
deepened. Nevertheless, he was able to resume a full diet and his general 
condition was excellent until progressive leukopenia developed late in the 
third postoperative week. Subsequently he had intermittent episodes of 
fever, gastrointestinal bleeding, and confusion. On the 3 1 st postoperative 
day he was reexplored for persistent gastrointestinal bleeding; vagotomy 
and pyloroplasty were performed although a localized site of bleeding was 
not identified. Terminally he continued to bleed, became anuric and 
hypotensive, and deseloped radiographic evidence of bilateral pneumoni- 
tis. He died at 33 days. 
At autops>, the patient was shown to have Pneumocystis carinii and 
cytomegalic inclusion ~nfestation of the lungs. Most of the small bowel and 
colon were denuded of epithelium secondary to invasive monilial entero- 
colitis: this was apparentl) respons~ble for the hemorrhage. The homograft 
weighed 1.100 gm: the patient's own cirrhotic l ~ v e r  weighed 1,300 gm. 
Histologicallq, there was hemorrhagic necrosis of the centrilobular hepa- 
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Fig. 6.- Auxiliary human hepatic homograft 22 days after transplantation (case 1). The portal tract (arrow) is infiltrated 
by mononuclear cells and several of the smaller bile ducts contain casts. There is central cholestasis, excess lipofuscin in the 
central hepatocytes, and atrophy of the liver cells adjacent to the central vein (lower right) (hematoxylin and eosin, X 80). 
Fig. 8.- Actual auxiliary transplantation (Stage 2). (A) Prepared operative field before receipt of homograft. 
(B) Completed operation. Note that the right external iliac vein provides the portal venous inflow. Hepatic venous 
outflow is into the transected vena cava. 
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Fig. 10.- Auxiliary human hepatic homograft 34 days after transplantation (case 2). The centrilobular 
hepatocytes are necrotic (arrow) and there are fat droplets in the liver cells in the midzonal and peripheral parts 
of the lobule. There is no cellular infiltration (hematoxylin and eosin, X 80). 
that the homograft atrophy is prevented and instead there is shrinkage of 
the host liver.2 Apparently the splanchnic venous blood contains a hepa- 
totropic ~ubs tance~. '~  essential for maintenance of the morphologic and 
functional integrity of hepatic tissue. That organ which has first exposure 
to splanchnic venous blood operates at a physiologic advantage; the other 
organ becomes atrophic. 
Clinically, provision of a splanchnic venous inflow for the homograft 
may often not be technically feasible. The animal studies herein reported 
were designed to test a compromise procedure in which neither the 
homograft nor the autologous liver was directly perfused with nonhepatic 
splanchnic venous blood. Instead, the autologous liver received only an 
arterial blood supply. In contrast, the homograft had the additional advan- 
tage of also having a portal venous inflow even though this was of systemic 
venous origin. 
The results of these experiments indicate that host portacaval shunt 
does, in fact, have some protective affect upon the homograft, a possibil- 
ity f i s t  suggested by the experiments of Marchioro2 and Thomford." A 
similar opinion was recently expressed by Tretbar and his associates on the 
basis of experiments resembling those of the present study," but since 
maximum survival in their dogs was only 37 days, it might have been 
argued that the time of follow-up was too short to permit valid conclusions. 
Even though the magnitude of the atrophic process in the homograft 
seemed to be reduced, with observations for as long as 150 days, the results 
in the present study indicate that it is not prevented. Furthermore, the 
ultimate degree of injury was often severe, and far more extensive than in 
either orthotopic homograftsf6 studied at a comparable time or in auxiliary 
homografts provided with nonhepatic splanchnic venous i n f l ~ w . ~  The 
operation is thus an imperfect one even under these circumstances. In the 
three experiments in which both the homograft and the autologous liver 
had only an arterial supply, the degree of transplant atrophy was even more 
striking as might be predicted since only the transplant is subject to the 
ravages of rejection. 
In the clinical cases, it might be expected that the environment for the 
homograft would be even more favorable because of the further loss of 
competitive potential by the diseased host liver. Whether this was actually 
true is impossible to say inasmuch as death occurred at too early a time to 
assess the development of atrophic changes. The degree of histologic 
injury was, however, somewhat greater than in previously examined 
human orthotopic liver homografts." 
In view of these incompletely understood physiologic considera- 
tions, the future value of such auxiliary operations is uncertain. In addition, 
technical problems constitute a further hazard, as exemplified in case 3. 
These derive from the necessity of placing a large additional organ into an 
abdomen which may already be overcrowded by hepatomegaly or sple- 
nomegaly. At least eight other attempts at auxiliary hepatic homotrans- 
plantation are known to have been made in various centers; in some of these 
unreported cases, similar mechanical problems were encountered. 
Finally, the clinical potential of liver homotransplantation by any 
heterotopic method or with an orthotopic procedure will be limited as long 
as dependence is placed upon presently available immunosuppressive 
regimens. The two patients in the present study who survived operation 
both died as the direct consequence of drug toxicity and resultant sepsis. 
The deficiencies of current therapy and suggestions for future improve- 
ments are discussed el~ewhere. '~ 
Summary 
In normal dogs, receiving immunosuppressive therapy, auxiliary 
liver homografts undergo rapid atrophy if they are not provided with a 
portal venous inflow from the splanchnic bed. In 11 dogs, the influence of 
host portacaval shunt in preventing this transplant shrinkage was studied. 
In eight experiments, the homograft received both an hepatic arterial 
inflow, as well as a portal supply with venous blood returning from the h i d  
quarters; in the other three, only an arterial supply was present. In all 11 
dogs, the host liver had solely an arterial supply. The animals were 
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Fig. 11.- Technique used for attempted transplantation in case 3. Note that the homograft is facing medially. The splenic vein 
and common iliac artery are anastomosed to the homograft portal vein and hepatic artery, respectively. Note also the angulation near 
the origin of the left common iliac artery. This was responsible for the technical failure of the transplant. 
followed for 24 to 150 days. 
The results indicate that host portacaval anastomosis has a modest 
protective effect upon the homograft. Transplant atrophy was partially 
prevented when the homograft had a double blood supply; it was not 
influenced when both the homoeraft and the host liver each had onlv an ar- 
- 
terial supply. In all cases moderate atrophy was observed in the autologous 
livers, suggesting that the protective effect was at least partly at the expense 
of injury to the host hepatic tissue. The long-term preservation of the 
homografts emphasize that the operation is not ideal from a physiologic 
point of view. 
Using operations designed to provide the homografts with a physi- 
ologic advantage, three attempts at clinical auxiliary transplantation were 
made. Two adult patients with cirrhosis sunived for 22 and 34 days after 
operation, both eventuall) dying of sepsis. In these cases. there was 
unequivocal evidence of homograft function. A third attempt in a child 
with congenital biliary atresia resulted in technical failure. The specific 
deficiencies of auxiliary transplantation procedures are discussed. 
This study was supported by grants AM 06283. AX1 06344. HE07735, AM 
07772. A1 04152, FR 00051, and FR 00069 from the US Public Health 
Service and by agrant froni the Medlcal Research Council of Great Britain. 
Generic and  Trade Names of Drugs 
Azathioprine - Imitrut~ 
Prednisone - Deliasone. Deltru. .Metic orten. Paracorr 
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AUXILIARY LIVER TRANSPLANTATION AND HEPATOTROPHIC PHYSIOLOGY 
Joseph Fortner 
This detailed account of a truly successful auxiliary liver transplantation was unique at the time 
and has been duplicated only once since. Fortner's operation was on 13 December 1972. The portal 
vein of the auxiliary liver was revascularized from the superior mesenteric vein of the recipient. 
Fortner studied the interplay between the grafted and host livers, including changes in liver size as 
rejection or other factors supervened. The clinical observations were explained by the previous 
animal research on hepatotrophic physiology. The recipient was four years old. He now lives in 
Phoenix , Arizona and is a junior in high school. Dr. Fortner still practices at the Memorial Sloan- 
Kettering Cancer Center in New York City, is Professor of Surgery at Cornell University Medical 
College and President of the General Motors Cancer Research Foundation. 
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Clinical liver heterotopic (auxiliary) transplantation 
Surgery, 74: 739-51, 1973 
Joseph G. Fortner, David W. Kinne, Man Hei Shiu, William S. Howland, Dong K. Kim, El B. Castro, 
Samuel D. J.  Yeh, Richard S. Benua and Solveig Krumins 
Pessimism regarding rlinical auxiliary liver grafts is no longer 
justified for the liver has been transplanted successfirlly to a heterotopic 
position in three patients. Space for the ausiliary liver M,as achieved by 
three different methods: pneumoperiton~~un~, osc Ites, clrid ahdonirni~l  all 
reconstruction done ~ ' i t h  the use o fa  prosthetirfiln~ composed ofpolyerh- 
ylene and Marlex-. The right purui,ertehral gutter  as fbunil to he a 
satisfactory sile,for all three grafts. 5planc.hr1ic hlooclflow was rllrected 
preferentially rhroqh the donor 1i1,er either hy liycrtior~ o f  the recipient's 
superior mesenterlt vern provimul to tlic gruff or ir7c.r-euwd l,uscular 
resistance secondary to intrakepatlc or e.rtraheparic. host diseuse. Moni- 
toring the allogr-aft H.US by c.linri 01 r i ~ u l ~ ~ ~ l t i ~ n ,  S C Y U ~ I  hrochen~ico/ esri- 
mates of li~~er,fur~rrion. 'Y",Tc, 1i1 er .s(,uns, and t h y n ~ t l ~ n r  uprnkr oj c.ultured 
peripherul blood Iynrphoc?t~s. Ininlirrre supprr~s.~iori uppeur~~d optimal 
with Cytoxan, low dosage of pr.~~rfn~sorie. aliort courses of high-dose 
merhyprednisolone, arid high rioscrgc c;f'at~t~h~oncin Iy rpho~jte ,globulin 
(ALG). This h p e  ofIli,er grufr seems prcfcr-uhle to fire or.thoro~~ic. ?raft for 
selected patients ~ , i r h  liver di.seu.re. 
Liver transplantation to the heterotopic (auxiliaw) position can avoid 
the inherent risks of recipient hepatectom). especially in patients with 
noncancerous but fatall) damaged libers. In some instances. the recipient's 
liver might even serve a temporar) supportive function du r~ng  a rejection 
episode. 
The heterotopic (auxiliar)) li\er allograft paws problems quite 
different from those of the orthotopicall) placed graft. These can be c l a -  
sified as mechanical. physiological, and immunological. and the) have 
been studied in three patients at Memorlal Sloan-Kettering Cancer Center. 
All three graftc functioned satl,factoril) : two of the three patients survived 
the early traniplantation period: one u h o  \unibed for eight months has 
been referred to previously."and one has been d~rcharged from the hospital 
and is well three months later. One patient died on the thin)-,eventh 
posttransplant day of sepsis from an enteric fistula. Prior to thls cornmu- 
nication, of 35 patlents uith a heterotopic graft reponed to the .ACSmIH 
Registry.' the longest survivor had I ~ \ e d  33 da)s. 
Case Reports 
Case 1. A 72-year-old woman had a localized but unresectable 
adenocarcinoma involving the common hepatic and intrahepatic bile 
ducts. Serum total bilirubin was 15.6 mg. percent; conjugated bilirubin was 
12.78 mg. percent: alkaline phoqphatase was 263 1.U.: serum glutamic ox- 
Fig. I .- Vascular and bilian anastomoses in Case 1. The auxiliary 
h e r  allograft was placed in the right paravenebral region. Note bile duct 
carcinoma constricting reclplent ponal vein. H A .  Hepatic artery; IVC, 
inferior vena caba: SWl. supenor me\entenc bein: .S1. splenic vein. 
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Fig. 2.- Clinical course of Case 1, a 72-year-old woman. Note mild rejection on Day 142 which reversed 
with increased immunosuppression. 
aloacetic transaminase (SGOT) was 117 Karmen units; total protein was 
8.3 Gm. percent; and albumin was 3.3 Gm. percent. The auxiliary liver 
allograft was a palliative measure for uncontrollable itching and jaundice. 
It was performed on April 26,1969. with the donor liver coming from a 19- 
year-old man. Leukocyte typing* with approximately 70 antisera using 
both microagglutination and microcytotoxicity tests indicated unshared 
leukocyte antigens to be: donor HL-A 2 and recipient HL-A 5 and 6A. A 
direct cross-match was negative. Both donor and recipient were ABO 
group A. The liver was removed from the donor bq a technique described 
elsewhere: After the patient's ascending colon was reflected medially, the 
graft was placed in the right paravertebral gutter with the dome toward the 
right flank and its suprahepatic caval stump ligated (Fig. I ) .  An end-to-side 
anastomosis was carried out of donor to host vena cava, donor to host 
superior mesenteric vein. and a segment of donor aorta with attached celiac 
axis and hepatic artery to recipient aorta. The cold ischemic time was one 
hour and 55 minutes. The donor had been maintained normotensive until 
cold perfusion of the liver was started so that there  as no warm ischemic 
time. On establishing blood flow, the liver allograft appeared pink imme- 
diately and promptly secreted bile. The gallbladder of the graft was anas- 
tomosed to an upper loop of recipient jejunum. The abdominal wall could 
not be approximated so a synthetic prosthesis composed of an outer layer 
of Marlex mesh and an inner layer of a sheet of polyethylene was used to 
bridge the musculofascial gap. Skin closure was accomplished after 
extensive undermining. 
The patient tolerated the procedure well as indicated bg a dramatic 
and sustained reduction in the serum bilirubin levels frcm preoperative 
values to 1.6 mg. percent on the second postoperative day. The relentless 
itching disappeared completel) . 
During the initial postoperative period. there were a number of 
serious com~lications which included severe but temDorarv central nerv- A e 
ous system dysfunction followed by renal failure requiring hemodialysis, 
massive gastrointestinal bleeding, pneumonitis, septicemia, wound dis- 
ruption, and congestive cardiac failure. The causes and management of 
these episodes were complex and bore a direct relationship to the patient's 
advanced age, basic disease. and the difficulties in closure of the wound. 
Nevertheless, she recovered from these complications, and good allograft 
function persisted throughout her protracted convalescence. Mild jaundice 
was noticed during a late rejection episode 142 days after transplantation 
which was controlled with increased immune suppression (Fig. 2).  Seven 
months after transplantation. small bowel fistulas developed in the granu- 
lating abdominal wound, and she died suddenly as the result of massive 
gastrointestinal hemorrhage on Dec. 22, 1969, 240 days after transplanta- 
tion. 
At necropsy. the massive bleeding was found to have occurred frorn 
a benign gastric ulcer. The patient's own liver weighed 1,250 Gm., was 
firm and fibrotic. and contained a number of bile duct5 filled with 
inspissated, greenish material. Multiple abscesses were present in the liver 
parenchyma. At the hilum, scirrhous cancer had invaded and sharply 
constricted the portal vein. The heterotopic auxiliary liver graft weighed 
1,260 Gm. and had a homogeneous glistening red brown appearance with 
no identifiable areas of necrosis (Fig. 3). The bile ducts appeared normal 
and all the vascular and the cholecystojejunal anastomoses were patent. 
Histologically, the liver allograft appeared essentially normal except for 
sinusoidal dilatation and narrowing of hepatic cords secondary to conges- 
tion. There was minimal round cell infiltration in the portal areas. The 
vessels were normal and patent. and there was no cholestasis. Reticulin 
stains confirmed the absence of graft atrophy. The cancer had remained 
localized and there were no metastases. 
Case 2. A 42-gear-old \soman de~e loped  hepatlt~s ~n March, 1965 
* Performed at the Leulocbte Tbp,ng Laborator) Department of  Serology and Masswe hematemes~s occurred In October. 1967. and h a s  treated else- 
Genetics, The Neb York Blood Center, l e u  York, N. Y. where by a spleno-renal shunt. There were no further eplsodes of bleeding. 
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Fig. 3.- The bisected donor liver is on the left; the bisected recipient liver is on the right. 
Note the similar size of the two livers and normal appearance of the allograft. 
On admission to Memorial Hospital on June 23, 1969, a diagnosis of 
chronic active hepatitis was made, and she was placed on medical manage- 
ment with restriction in both salt and protein intake. The patient did well 
for more than two years but then required seven hospital admissions over 
a five-month period because of coma or impending coma. Her last 
admission was on April 13,1972, when after recovery on medical manage- 
ment, the risks of future irreversible coma were so great that she remained 
in the hospital. Just prior to transplantation, serum biochemical values 
were: total bilirubin, 2.62 mg. percent; alkaline phosphatase, 3 12 U.; lactic 
dehydrogenase (LDH), 339 U.; SGOT, 126 U.; total protein, 4.18 Gm. 
percent; albumin, 2.8 Gm. percent; total cholesterol, 129 mg. percent; and 
free cholesterol, 37 mg. percent. She was found to have cardiomyopathy 
and was digitalized. The absence of ascites in this patient caused concern 
about space for fitting a second liver into the abdomen. Distention of the 
abdominal wall by pneumoperitoneum was started on May 14,1972, with 
500 C.C. of air being injected. This amount was gradually increased during 
weekly injections until she was able to tolerate 3,500 C.C. of air without 
undue discomfort. This was continued until Oct. 28, 1972, when an 
auxiliary liver transplantation was carried out. 
The donor was a 55-year-old woman with ABO blood group 0 ;  the 
recipient was an A. Leukocyte testing with approximately 60 antisera 
using a microcytotoxicity test revealed no leukocyte antigens in common. 
A direct cross-match was negative. One-way mixed lymphocyte culture 
(MLC) studies 2 revealed low stimulation of recipient lymphocytes in 
reaction mixtures with various concentrations of donor lymphocytes. 
Reciprocal mixtures showed high stimulation at equal concentrations. 
The recipient had a markedly increased collateral circulation, al- 
though the portal pressure measured only 150 mm. of water on opening the 
abdomen. The procedure differed from that described in Case 1 in that the 
suprahepatic vena cava of the donor was closed by using a continuous No. 
4-0 vascular suture (Fig. 4). An end-to-side anastomosis of donor superior 
mesenteric vein to the larger of the two primary branches of the recipient's 
superior mesenteric vein was performed. This recipient branch was then 
ligated cephalad so that splanchnic blood was diverted through the graft. 
A Carrel aortic patch was used to anastomose donor celiac axis to the 
recipient's aorta just above the iliac bifurcation. Upon release of the 
clamps, bile was noted to come promptly from the common bile duct. The 
end of the common bile duct was ligated, and a No. 12 T tube was inserted 
into the common duct for external drainage. A cholecystojejunostomy was 
formed between a loop of jejunum 12 inches from the ligament of Treitz 
and the junction of the middle and lower thirds of the donor gallbladder. 
There was severe bleeding from an artery in the gallbladder wall at the time 
of the anastomosis so that good perfusion of the gallbladder appeared to be 
present. A gastrostomy was performed, and the abdominal wall was 
capable of being closed readily without tension. There was no warm 
ischemic time for the liver. Cold ischemic time established in the recipient, 
as measured from start of portal vein infusion until blood flow, was one 
hour and 55 minutes. 
Initially, the patient's postoperative course (Fig. 5) was essentially 
uneventful, and she was eating a soft diet by the seventh postoperative day. 
Evidence of gastrointestinal fistula developed on the ninth postoperative 
day which eventually proved to be from an opening in the posterior wall 
Fig. 4.- Vascular and biliary anastomoses of Case 2. Note that the 
recipient's superior mesenteric vein has been ligated distal to the graft. See 
legend to Fig. 1 for meanings of abbreviations. 
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Fig. 5.- Clinical course of Case 2, a 42-year-old woman. Note sharp 
elevation of bilirubin at Day 10 which was likely secondary to mechanical Fig. 6.-Clinical course of Case 3, a 5-year-old boy. Note abnormal 
biliary tract obstruction and sepsis. AI,G was withheld early because of liver chemistries on the twenty-fourth day, suggesting mild rejection 
thrombocytopenia. which was reversed. 
of the gallbladder about 2 cm. away from the cholecystojejunostomy. The 
patient became increasingly icteric and septic, requiring two laparotomies 
for drainage, biliary diversion. and gastrointestinal repair. The donor liver 
appeared bile stained but otherwise normal in appearance and consistency 
at these operations. 
The patient improved initially but went into septic shock and died on 
the thirty-seventh post-transplant day. Multiple determinations of SH 
antigen and antibody throughout her course were negative, despite the 
immunosuppression. Pertinent necrospy findings were generalized perito- 
nitis and multiple abscesses throughout the abdominal cavity and in 
multiple organs. The donor liver weighed 1,725 Gm., and the recipient 
liver weighed 800 Gm. The latter was hobnailed in appearance with 
widespread areas of fibrosis and multiple nodules of regenerating liver pa- 
renchyma. With vascular anastomoses patent, areas of hepatic infarction 
were considered secondary to prolonged septic shock. Cytomegalic virus 
was isolated from the left lung and the serosa of small bowel. Monilial 
abscesses were present in the heart. kidneys. and brain. Histologically, 
gross findings were confirmed. The donor liver showed features of sepsis 
consisting of acute patchy hemorrhagic necrosis and widespread centri- 
lobular hemorrhage and necrosis. Bile stasis was present. 
Case 3. A 4- 112-year-old boy was admitted to Memorial Hospital for 
the ninth time on Nov. 21. 1972. He had undergone an exploratory 
operation elsewhere at four months of age for jaundice and found to have 
absent extrahepatic and intrahepatic'bile ducts. Repeated bouts of massive 
upper gastrointestinal bleeding necessitated a shunting procedure. A side- 
to-side splenorenal shunt was done on Oct. 28, 197 I ,  with ligation of the 
splenic artery but w~thout splenectomy, dropping the portal pressure from 
480 to 320 mm. H .0  (mesenteric vein). There was no further gastrointes- 
tinal bleeding for several months. but his general condition slowl) deterio- 
rated. Ascites developed, pruritis was severe and unrelenting. jaundice was 
marked, and there was splenomegaly. Massive gastrointestinal bleeding 
occurred in October and again in November, 1972, ceasing spontaneously 
just prior to transplantation. 
Representative of his serum values prior to the most recent bleeding 
episode were: total bilirubin, 34 mg. percent; direct bilirubin, 23 mg. 
percent; alkaline phosphatase, 284 U.: LDH, 252 U.; SGOT, 228 U.; total 
protein, 5 Gm. percent, albumin, 3.1 Gm. percent. A ""Tc liver scan 
showed a small liver measuring 14 by 13 cm., with very poor isotope 
uptake. 
On Dec. 13, 1972. a 12-year-old male donor became available. The 
donor was ABO type 0 and the recipient was A. Leukocyte typing using 
about 60 antisera in microcytotoxicity testing revealed no leukocyte 
antigens to be shared. One-way MLC testing' showed similar values to 
those obtained in Case 2 for the mixture in which recipient cells served as 
responders. There was minimal activity in the reciprocal mixture, how- 
ever. 
Removal of the donor liver was as described previously.. The 
recipient's markedly distended abdomen contained about 2,000 C.C. of 
clear ascitic fluid. Portal pressure prior to placement of the allograft was 
380 mm. H?O and at the end of the procedure, portal pressure was 300 mm. 
H1O. The auxilian liver was placed in the right paravertebral gutter as 
described for Case 2 with some modifications. Donor s~~pe r io r  mesenteric 
vein was anastomosed, end to side, to the largest main branch of the 
recipient's superior mesenteric vein. The latter was not ligated, however. 
The gallbladder was removed. A Roux-en-Y limb of upperjejunum, 25 cm. 
in length. was fashioned and an end-to-side choledochojejunostomy con- 
structed. A No. 12 T tube was placed in the common bile duct. A 
gastrostomy was made and the abdomen was closed with tension ~ h i c h  
\baas judged to be acceptable. The volume of donor liver wa, approximately 
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Fig. 7.- Liver scans ("""Tc sulfur col lo~d)  preoperatis,ely (A) and six 
months after tran~plantation (B) In Case I .  Note uniform uptake in allograft 
(B, lower portionj which shows no evidence of atrophy. 
that of the 2,000 c.c. of ascitic fluid uhlch had been present. The cold 
ischemic time was one hour and 35 mlnutes. There was no barm ischemic 
time. 
Hir postoperatlve course was uneventful (Fig. 6). The poor nutrl- 
tional status of the recipient caused us to place him on Intravenous hyper- 
alimentation on the second postoperative da) .  This \\as diwontinued on 
the eighteenth postoperatlve daq. The gastrostom? was occluded on the 
eighth postoperative day. and oral feedings were started on the fourteenth 
postoperative day. He h a  been on a regular d ~ e t  slnce the tuenty-f~rst 
posttransplant day. active and \hob lng marked dei elopment in personality 
and strength. The T tube was remo\ed on rhe f~ftk-fourth postoperative 
day, and he was d~scharged from the ho\p~tal on the \~xt!-nlnth posttrans- 
plant day bith a total b~lirubln of about I mg. percent? 
blechanical Features 
The f ~ t t ~ n g  ot a ieiorid l i ~ e r  Into an abdornen can be d~fficult 
Abdomlnal wall closure u a \  pos\~ble  In Case 1 onl) b! u\lng \ )n thet~c 
matenal Breakdo~bn of the wound oiiurred and h a ,  the source of man\ 
*The patlent I \  prs\rntl) I I \  ing dnd well nine monthc dftsr transplantation uith 
a serum tordl h~l~rubi~i of 0.6 rns per ceilt. 
complications throughout the patient's eight-month posttransplantation 
survival period. An ideal setting existed in Case 3 in whom the presence of 
ascites and the a\ailability of  small donor liver made closure of the ab- 
dominal wall possible w ~ t h  primary healing of the uound. Space limita- 
tions created by the absence of ahcites in Ca\e ? were compensated for by 
using pneumoperitoneum. This procedure \\as most s a t~s fac ton  and 
created adequate space for the a u x ~ l ~ a ~  I~ver .  
Placenient of the cillograft in the right para\,ertebral region was 
chosen for all three patients. This site ieerni des~rable because of its 
contour. the ease u ~ t h  uhlch 11 can be prepared to recei\e the graft, and its 
proximit! to itructuret ebsential for eitabl~shlng the transplant. This ar- 
rangement ii  similar to that \\hich Rengoechea-Gorizalez and associates' 
used in canine studlet. Other authors' ' ha\e  placed the graft in the pelvis, 
central abdomen. splenic bed. or either flank In both cltnical and experi- 
mental auxiliarq liver transplantarion. Clin~cal Pallure has occurred in \ome 
case\ becau\e of kinklng of blood \essel\ or ~nsuf t ic~ent  space. 
Ph>siological Considerations 
Vascular circuitq for the grafts IS indicated in Figs. 1 and 4. 
Experimental studies have ~ndicated that prevention of auxiliary liver graft 
atrophy is a major problem. '  ' I '  A variet! of phys~ological fac- 
t o r s ~ ~  t: I-:I>:I appear to influence the integr~tq of the auxiliary graft but 
optimal conditions for the graft appear to be met u hen there are alterations 
in splanchnic venous blood flou so that the transplanted liber receives 
blood preferentiall) to the recipient', li\er. Rile duct obstruction of the 
host liver seems to potentiate t h ~ s . ' " "  Cate I presented such a s~tuation: a
natural pathological setting of the cancer cornpletcl) blocking the extra- 
hepatic bile ducts as well as constrlctlng. aelect~vel!. the portal veln. Graft 
atrophy was avoided and a homeo\tatic balance h a \  achie\ed by the donor 
and recipient I~vers as ~ndicated b) thelr t in i~lar i t~es  at necropsy (Fig. 3). 
Preoperative and six-nionth postoperati~e livzr scans ('"'Tc sulfur colloid) 
are shown in Fig. 7 .  There was no ev~dence of gratt atrophy durlng the 
entire posttransplant per~od.  
Liver cfll dysfunction pro\ ided an adbantape for the graft in Case 2. 
Extrahepat~c h ~ l ~ a r y  tract oh\truction \*a\ ab\ent. and the portal pressure 
wa\ apparentl) normal. A splenorenal \hunt had beer1 done previousl) with 
apparent decompression of the splanchn~c bed. In order to obtain preferen- 
tial splanchnic blood flou through the donor 11\cr. 11gat1on %a \  done of the 
anastomosed prirnar) brarlch of superlor niesenteric bein on its cephalad 
side (toward the r ec~p~en t ' s  Il \erJ.  Increa\ed di\ten\ion of the grdft iupe- 
rior niesetiteric vein was noreti ~rnmediately after t h ~ s  l~gature was placed. 
There was no e\ idence of \a\cular comprorniie of the inte\tine. .Atrophy 
of the graft waa not apparent during ~ t s  37 da) sun .~ \a l .  Serial ""'Tc sulfur 
colloid liver scans were performed ~mnled~atelq before transplantat~on and 
serially thereafter (Fig. 8 ) .  There \bere no change\ ev~tfent in \17e of the 
auxiliar) h e r .  maxlnial counting rate\, or in the relationship het\*.een 
uptakes in the auxiliaq I~ver  anti marrow. Dbnamic studies of sulfur 
colloid uptake in the donor I~ver  at \ a r ~ o u t  intenals were al\o camed out. 
The\e shoired lower rnaxirnal counting rates of the auxiliary liver and a 
slower rate of ln~t la l  slope of liver uptake on the teventeenth day, suggest- 
ing rejection or \ome other ahnonnalit) (Fig. ( I ) .  L.ptaLe \ d u e s  rose to a 
maxirnum b! the taent!-fourth da).  The presence of wpsis, severe 
hemol)s~\ .  and b~iiark tract ob\truction ~iiakes interpretation of these 
find~ngs tiifflcult. Apparent nnprovernenr In rad~ocol lo~d uptake comcided 
bith treatment for su\pected reject~on arid dra~nage of a retroperitoneal 
ahice,\. These prel~m~rlar) obaen ar~ons  demonstrate a good blood supply 
to the graft a \  lr~dlcared b! \at~\factor) i o l l o ~ d  uptake and ma) be ubeful 
in differentiatirig vanou\ c o n ~ p l ~ c a t ~ o n s  e countered In 1:ver transplants. 
Bl l~ar?  litretia aiid '1 niarkcdl ele\ated portal pre\\ure were pre\ent 
In Case 3. .A przvlou. \~de - to - s~de  splenorenal \hunt way of quest~onable 
patenc! repeated ep~ \ode \  of bleeding froni esophaeeal barices uere  
pre\ent ju\t p r~or  to tra~l\plaitation. The increa\ed \a\cular resistance in 
the r ec~p~enr ' \  li\er \bould appear to shunt \planchn~c blood preferentially 
through the donor l i ~ c r .  Dl\t,~l I~gation oi  the \uperior rne\enterlc \?in was 
therefore not perfomled. Sequential l i \er \can, \rere obrainable from the 
fifth posttr;in\pl,~nt da! to these\ enr! -hecorid cia) ( F I ~ .  101. These rc\ealed 
a decreare in s ~ z e  ofrhe patient'\ o\in ii\er of about i O  percent on the fifth 
da) \ \ ~ h  a funher decrenw to abour 5 0  percent of or~ginal s17e during the 
latter part uf the \tuch. Slow but \tead) decrea.? In \pleen \lze w3i noted 
also. a ~ t h  a 20 percent reduct~on ahout the tirenr~eth potttransplant cia) and 
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Fig. 8.- T c  sulfur colloid liver scans of Case 2. Note good uptake of donor liver throughout 
her course and the small size of her own liver. A, Preoperative anterior scan. B, Preoperative posterior 
scan. C, Third posttransplant day, anterior scan. D, Third posttransplant day, ksteriorbcan. E, 
Eleventh posttransplant day. F, Eighteenth posttransplant day. G, Twenty-first posttransplant day. 
H, Twenty-eighth posttransplant day. 
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Fig. 9.- Dynamic studies of 9hTc sulfur colloid uptake by transplant liver. Relative counting 
rates of the transplant liver were calculated with the use of the base line of uptake obtained on the 
sixth posttransplant day from immediately after injection to 15 minutes. 
a 30 percent reduction by the sixty-fifth day. The radioactivity in the spleen 
was 2.6 times that of the auxiliary liver on the fifth post-transplant day. By 
the twenty-third day, the maximal counting rate of the spleen was similar 
to that of the auxiliary liver. Subsequently, it has decreased even further so 
that the maximal counting rate in the auxiliary liver exceeds the splenic 
uptake. This suggests improved reticuloendothelial function of the grafted 
liver and possible shunting of blood to the grafted liver away from the 
spleen. These findings support the thesis that increased vascular resistance 
in the recipient's llver has diverted splanchnic blood through the dcnor 
liver preferentially. The significance of increases of maximal liver uptake 
on the twenty-third and fifty-first day is not clear, although there was some 
clinical evidence of mild allograft rejection during the fourth posttrans- 
plant week. The radionuclide in the liver has remained homogeneous, and 
the relationship between uptake of auxiliary liver and spleen has remained 
satisfactory. On the fifth posttransplant day, the transplanted liver meas- 
ured 18 cm. high and 15 cm. wide with a surface area of 216 cm.' On the 
fifty-eighth postoperative day, the liver measured 19 by 11 cm. with a 194 
cm.' surface area. These differences are not significant. 
Immuno lo~ ica l  Considerations 
D 
Monitoring the auxiliary liver graft has been by clinical evaluation, 
serum biochemical estimations of liver function. serial "-Tc liver scanning, 
and testing of in vitro thymidine uptake of peripheral blood lymphocytes~ 
Results of liver function tests must be evaluated with the use of abnormal 
pretransplant values as a base line. Elevation in the alkaline phosphatase, 
LDH, SGOT, and 5' nucleotidase, for example. may be secondary to 
changes in the recipient's liver rather than to any abnormalities in the 
auxiliary graft. Serial changes rather than absolute values are the important 
features. Serum bilirubin levels appear to be especially useful in detecting 
rejection, although its elevation may be due to other causes. 
We have found spontaneous in vitro 'H-thymidine incorporation by 
blood leukocytes to be a useful corroboration test. A modification of the 
technique of Hersh and associates1' was used. Thymidine uptake was 
sharply increased on the thirteenth posttransplant day in Case 3 (Fig. 11). 
Clinical and biochemical signs of rejection were not seen until the twenty- 
third posttransplant day. when a sharp elevation in serum alkaline 
phosphatase and some elevation in billtubin levels developed. This was 
treated by a six-day course of a daily bolus of 300 mg. of meth) lprednisone 
given intravenously. There was a gradual reversal of these abnormalities. 
By the forthy-first posttransplant day, there was no clinical or biochemical 
evidence of rejection, and normal levels of spontaneous leukocyte reactiv- 
ity were found. These findings continue to the present. The presence of 
sepsis and severe hemolysis in Case 2 made cell culture studies d~fficult o 
interpret. Lymphocyte reactiv~ty was at a normal le\el through the tenth 
posttransplant day. durmg which time there was no clinical or b~ochemical 
evidence of rejection. Enteric fistula and sep5is then debeloped. Lympho- 
cyte testing thereafter showed a sharp increase in immediate reading which 
could be ascribed to sepsis. Lymphocyte reactl\ity studies were incom- 
plete in Case 1. 
Immunosuppression was by equine antilymphocyte globulin,* ster- 
oids, and azathioprinet for the first two patients. Cyclophosphamide 
(Cytoxan) was used instead of azathioprine in Case 3 (Fig. 6). Recent data 
from our l ab~ra to ry ,~  as well as that of others'""indicate cyclophospha- 
mide is preferable to azathioprine in cases in which liver dysfunction may 
exist. Dosage for Cytoxan was as recommended by Starzl and a s~oc ia t e s '~  
for orthotopic liver transplants. Prednisone has been used in lower doses 
for Cases 2 and 3 than previously%cause of the potential of fatal 
infectious complications. The diminished dosage has been compensated 
for by uslng large doses of methylpredniosolone (1 Gm, in adults; 20 mg. 
per kilogram in children) given intravenously daily for the first five 
pocttransplant days. This dosage has been repeated without any sign of 
rejection. Equlne antilymphocyte globulin has been given at unusually 
high dosage levels particularly for the most recent patient (Case 3). 
Conclusion 
Clin~cal iver heterotopic (aux~liary) allografts function well when 
splanchnic blood flow is directed preferentially to them. Functional com- 
petition appears to exist between donor and recipient I~vers.  A balanced 
state seems to have been achieved in the first patient where donor and 
recipient liver weighed essentially the same after eight months. Progres- 
sive shrinkage of recipient liver and spleen on serial scanning of the third 
patient dunng the initial posttransplant period supports this thesis. Vascu- 
lar circuitry must be individualized according to the recipient's pathology. 
Steps must be taken to ach~eve preferential splanchn~c blood flow for the 
transplant if portal hypertension does not exist. 
Differentiation of rejection from other possible complications re- 
mains difficult. Immune suppression haa been improved by substituting 
Cytoxan for azathioprine. more judicious use of steroids. and improved 
ALG given at high dosage. Further clinical use of the heterotopic (auxil- 
iarq ) liver allograft Is indicated. 
We are ~ndebted to Dr. Schwick and Dr. Heide for their generosity in 
making Behringwerke ALG akailable. 
References 
I .  American Medical Association: ACSNIH Organ Transplant Regis- 
try. J.A.M.A. 221: 1386. 1972. 
2. Bach, F. H.. and Voynob. N. K.: One-\*ny stimulation in mixed 
leukocyte cultures. Science 153: 535. 1966. 
3. Beaudoin. J. G.. Slapak. Xf. N.. Phillips. A t .  J . .  Chandrasskaran, A. 
K. .  and XlacLean. L. D.: Function ot'aux~linr) I~ver  allografts, Surg. 
Gynecol. Obstet. 130: 622, 1970. 
* ALG obtained from tho sourcer: C'nivers~ty of Minnesota (MAG); and 
donated b) Behnnguerhe .AG. 
+ Suppiled h) Burrough\-Wellcome. Inc Re\earch Tnangle Park, N.C. 
AUXILIARY LIVER TRANSPLANTATION AND HEPATOTROPHIC PHYSIOLOGY 
Fig. 10.- Sequential -Tc sulfur colloid liver scans on Case 3. A, Preoperative anterior scan. B, 
Preoperative posterior scan. C,  Fifth posttransplant day, anterior scan. D, Fifth posttransplant day, 
posterior scan. E, Twenty-seventh posttransplant day. F, Fifty-eighth posttransplant day. G ,  Sixty-fifth 
posttransplant day. H, Seventy-second posttransplant day. Note changes in relative sizes of spleen and 
recipient liver. The latter appears to be sharply decreased in size from the preoperative period. 
CLIO CHIRURGICA 
20r TOTAL BILIRUBIN (Serum) 
ALKALINE PHOSPATASE (Serum) 
IMMEDIATE IN VlTRO LEUKOCYTE 
DNA SYNTHESIS 
6 
nu zr LEUKOCYTE DNA SYNTHESIS 
AFTER 2 DAYS 
IN CULTURE 
t 
Transplant 
Fig. 11.- In vitro tritiated thymidine incorporation by peripheral 
blood lymphocytes is correlated a i th  serum bilirubin and alkaline 
phosphatase values in Case 3. Mild rejection reaction may have been 
predicted by the leukocyte studies. 
4.  Bengoechea-Gonzelez, E., Awane, Y., and Reemtsma, K.: Experi- 
mental auxiliary liver homotransplantation. Arch. Surg.. 94: I ,  1967. 
5. Calne, R. Y.: Surgical aspects of clinical liver transplantation in 14 
cases, Br. J. Surg. 56: 729. 1969. 
6. Fortner, J. G., Beattie, E. J.. Jr.. Shiu, M. H. ,  Kawano N., and 
Howland, W.  S.: Orthotopic and heterotopic liver homografts in 
man, Ann. Surg. 172: 23, 1970. 
Fortner, J.  G. .  Shiu. M.  H.. Howland, W .  S. .  and Beattie. E. J., Jr.: The 
donor in human liver transplantation. Surg. Gynecol. Obstect. 130: 
988, 1970. 
Fortner. J. G.. Sichuk. G.. Litwln. S. D., and Beattie. E. J., Jr.: 
Immunolog~cal respon5er to an intestinal allograft a i t h  HL-A iden- 
tical donor-recipient. Tran\plantation 13: 53  1 .  1972. 
Hess, F.. Jerusalem. C.. and van der Hyde. M. K.: Advantages of 
auxiliary liver homotransplantation In rat\. Arch. Surg. 104: 76, 
1972. 
Hersh, E. M.. Butler. W. T.. Rossen. R. D.. and Morgen, R. 0.: 
Lymphocyte activation: A rapid test to predict allograft rejection, 
Nature 266: 757. 1970. 
Marchioro. T. L., Porter. K .  A, ,  D~zhln\on. T. C.. Faris. T. D., and 
Starzl. T. E.:  Phqs~ologlcal requirement for auxiliar) liver ho- 
motransplantation. Surg. Gynecol. Ob5tet. 12 1 : 17. 1965. 
Marchioro. T. L., Porter. K. A, .  Brohn. B. I.. Otte. J .  B..  and Starzl, 
T. E.: The effect of partial portacaval tran\position on the canine 
liver. Surge5 61: 723. 1967. 
Mitchell. C .  G.. Eddleston. A. L. U'. F.. Smith, M. G.  M., and 
Williams. R.: Serurn imniunosuppre\\ive activity due to azathi- 
oprine and its relation to hepatic iunctlon atter liver transplantation, 
Lancet I: 1196. 1970. 
Shiu. M. H.. Monahan, W. G.,  and Fortner. J. G.: Unpublished data. 
Slapak, M.  M. .  Beaudoln. J. C.. Lee. H. M.. and Hume, D. M.: 
Auxiliary liver honiotransplantation. .4rch. Surg. 100: 3 1, 1970. 
Starrl, T. E., and Putnam, C. W.: Experience In hepatic transplanta- 
tion, Philadelphia, 1969. W.  B. Saunder\ Company. pp. 492-527. 
Starzl,T. E. ,  March1oro.T. L.. Huntleb. K. T.. R~tkind,  D.. Rowlands, 
D. T., Jr., Dickinson, T. C., and Waddell. W.  R.: Experimental and 
clinical homotransplantation of the liver. Ann. N. Y. Acad. Sci. 120: 
739, 1964. 
Starzl, T. E.. Penn. I.. Schroter. G.. Putnam. C. W.. Halprimson, C. 
G., Martineau. G., Arnemiya, H.. and Groth, C. G.: Cyclophospha- 
mide and human organ transplantation. Lancet 2.  70, 1971. 
Tretbar. L. T., Beken. E. G.. and Herrnann. R. E.: The effects of 
portacaval shunt and portal flow occlusion on canlne auxiliary liver 
homotransplantation, Surgery 61 : 733. 1967. 
van der Hyde. M. N. ,  and Schalm, L.: Auxil~ary Ilver-graft without 
portal blood. Br. J. Surg. 5 5 :  113. 1968. 
Wexler, M. J.. Farkouh. E. F.. Farrer. P. A,. Slapak, M. M.  and 
MacLean. L. D.: Auxiliaq liver transplantation: A successful model 
without portal blood or ponacaval shunt, Ann. Surg. 175: 357, 1972. 
AUXILIARY LIVER TRANSPLANTATION AND HEPATOTROPHIC PHYSIOLOGY 
Shunzaburo lwatsuki 
Epilogue 
Between March, 1980 and July, 1987, 1,000 patients underwent liver replacement under 
cyclosporine therapy by the team that originally had worked at the University of Colorado. This 
experience was preceded by 170 patients who received liver grafts from 1963-80 with azathioprine 
and steroid therapy, with or without ALG. A report of this total experience was presented by 
Shunzaburo lwatsuki at an International Transplant Meeting in Pittsburgh in September, 1987. 
Dr. lwatsuki was born in Nagoya, Japan in 1940. He trained in the United States in hepatology 
and in surgery after already having been fully trained in his native country. He became a fellow in 
transplantation at the University of Colorado from 1971-3 and returned for an additional transplan- 
tation fellowship in 1979-80, lwatsuki became one of the most extraordinarily well-trained and 
experienced surgeons in the world. He became a major force in developing the field of liver 
transplantation and, of equal importance, in training other surgeons who have proliferated liver 
transplant technology all over the world. 
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Experience in 1,000 liver transplants under Cyclosporine-steroid 
therapy: A survival report 
Transplanratioiz Pi-oceedings, 20: 498-504, 1988 
S. Iwatsuki, T. E. Starzl, S. Todd, R. D. GorCon, C. 0. Esquivel, A. G. Tzakis. L. Makowka, J. W. Marsh, 
B. Koneru, A. Stieber. G. Kiintmalm and B. Husberg 
Since the first human liver transplantation in Denver on March 1, 
1963, numerous refinements in surgical techniques and in perioperative 
care have been made, the n~echansim of graft rejection has been more 
precisely understood, and safer and more effective immunosuppressive 
agents have been discovered. ' Now, in 1987, it is well accepted that liver 
transplantation is often the only effective therapy for man) advanced liver 
diseases. 
We will report here. as a landmark of our continuing effort\, the 
survival of patients with various end-stage l~ve r  disea$es after liver trans- 
plantation from our own experience in 1.000 hepatic homograft recipients 
under cyclosporine-stero~d therapy. 
Case Materials and Methods 
Since the introduction of cyclosporine-steroid therapy for our liver 
recipients in March 1980, 1.000 patients received liver homografts for 
various end-stage liver diseases by July 1987 at our institutes in Denver (in 
1980), in Pittsburgh (slnce 1981). and Dallas (since 1985). 
Of the 1.000 liver recipient\, 666 w ere adults of age 18 years or older, 
and 334 were chlldren of the age5 younger than 18 )ears. The youngest 
I~ver  ecipient \*a 26 da)s old. and the olde\t one wah 76 years old at the 
time of transplantation. The number5 of patients in vnrlous age groups are 
listed in Table 1. 
The liver diseases of adult recipients and those of pediatric recipients 
Table 1. Number of Patients tn Various Age Groups. and 1- to &Year Survival Rates 
Actuarial Suvwal 1%) 
Age (v' No Patients 1 year 2 y e a s  3 p a s  4 years 5 years 
0- 1 30 63 55  49 3 7 37 
1-2 40  66 66 66 66 66 
2-3 48 70 6 8 6 5 6 5 65 
3-4 3 5 7 1 6 8 6 8 68 68 
4-5 2 9 5 8 58 58 58 58 
5-10 84  7 8 74 7 2 7 2 68 
10-18 68 8 0  7 9 76 7 6 76 
18-30 128 77 73 66 5 8 58 
30-40 160 77 75 7 0 64  6 0  
40-50 209 7 5 7 3 70 7 0 70  
50-60 121 7 6 70 6 1 6 1 6 1 
60-70 47 5 9 56 56 - - 
70 and older 1 100 - - - - 
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Table 2. Liver Diseases of Adult Recipients 
k a x  No. Pettents 
C~nhosls (postnecrot~c, myptogen- 
IC, alcohol~ci 
Postneaotlc and vyptogenlc 
H8,Ag posltlve 
Alcohol~c 
Pr~mary bll~ary urrhos~s 
Prtmary sclerosing cholang~tts 
L~ver-based Inborn metabdlc errors 
(Alphe 1 -ant!trypsln def~cmncy. 
W~lson s, etcl 
Primary hepatlc mal~gnancy 
Fulmlnant hepat~c fallwe 
Secondary btllary clnhos~s 
Bud&Ch~ar~ syndrwne 
- 
' 0 1 2 3 4 5 6  
YEAR 
Fig. 1 .-Overall actuarial survival rates of 1,000 patients treated 
with cyclosporine-sreroid therapy in comparison with overall actual sur- 
vival rates of 170 patients treated with azathioprine-steroid therapy. 
Bile duct cancer 10 
7 before 1980. Since 1981, the survival rates of adult and of pediatric Secondan/ hepatc mal~gnancy recipients are identical under cyclosporine-steroid therapy (Figure 2). 
O t k s "  11 The survival rates of various age groups of recipients were compared 
*Cystic fibros~s (31, adenomatos~s (2) ,  biltary avesia, in Table 1. The survival rates of children under the age of 1 year and those 
cryptococcal chdang~t~s, congenital hepatic fibros~s, pdycys- of adults aged 60 years or older were significantly lower than overall 
ttc d~sease, trauma, lymphoangiomatosis. survival rates of pediatric and adult recipients, respectively. The survival rates were comoared among three most common liver 
are listed in Table 2 and Table 3, according to the incidence. Three most 
common liver diseases among adult recipients were (1) postnecrotic 
cirrhosis (including chronic active hepatitis and cryptogenic cirrhosis), (2) 
primary biliary cirrhosis, and (3) primary sclerosing cholangitis. Those of 
pediatric recipients were (1) biliary atresia (including extrahepatic and 
intrahepatic type, biliary hypoplasia and Alagille's syndrome), (2) liver- 
based inborn metabolic errors (alpha-1-antitrypsin deficiency disease, 
Wilson's disease, tyrosinemia. and others), and (3) postnecrotic cirrhosis. 
The survival data were analyzed as of September 1, 1987, using the 
method of Kaplan-Meier. The statistical comparisons were made by the 
methods of Breslow and of Mantel-Cox. The difference was considered as 
significant when the P value was less then .05. 
Results 
Overall survival rates of the 1,000 recipients treated with cy- 
closporine-steroid therapy were three times higher than those of 170 pa- 
tients treated with azathioprine-steroids before 1980. One- to 5-year 
survival rates were 74%, 71%. 6 7 8 , 6 5 7 ~ ~  and 64%, respectively, as shown 
in Fig. 1. Five percent to 10% survival superiority of the pediatric 
recipients had existed for pediatric recipients during the azathioprine era 
Table 3. Liver Diseases of Pediatric Recipients 
81l1ary atresla 
Ltver-based Inborn metabolic errors 
(Alpha- 1 -antltrypsln deflcmncy, WII- 
son's, etc) 
Cnhosls (postnecrot~c and wyptogen~cl 
Famlllal c W s t a t ~ c  synckome 
Fulm~nant hepat~c fa~lure 
Secondary b~l~ary c~rrhos~s 
Congen~tal hepat~c fibrosis 
Pnmary hepatlc mal~gnancy 
Budd-Ch~ar~ synborne 
Neonatal hepat~tls 
Others' 
*Pr~mary scleros~ng chdang~t~s, trauma, focal nodular 
hyperplas~a, ~nflammatory pseudotumor. 
- 
diseases of adult recipients (Fig. 3) and among those of pediatric recipients 
with different diseases (Fig. 4). Survival rates of adult recipients who had 
postnecrotic or cryptogenic cirrhosis, those with primary biliary cirrhosis, 
and those of primary sclerosing cholangitis were nearly identical (Fig. 3). 
In pediatric recipients, survival rates of children with biliary atresia, those 
of liver-based inborn metabolic errors, and those of postnecrotic or  
cryptogenic cirrhosis were also similar (Fig. 4). 
The influence of hepatitis B antigen (HBsAg) upon survival after 
liver transplantation and the recurrence of hepatitis B in the graft liver were 
studied. Among 276 recipients who had postnecrotic or cryptogenic 
cirrhosis, 36 patients were postive for HBsAg and the remaining 240 were 
negative for HBsAg before transplantation. One- to 5-year survival rates 
of B virus carriers were 57%,48%, 40%,40%, and40%, and those without 
the carrier state were 78%, 77%, 74%,71%, and 71 %. Thus, survival rates 
of the patients with HBsAg were significantly worse than those of the 
patients without HBsAg (Fig. 5). 
Recurrence of hepatitis B was examined among 24 patients who had 
had HBsAg-positive postnecrotic cirrhosis before transplantation and who 
survived more than 3 months after transplantation. Five of the 24 patients 
died between 4 and 15 months, and four of the five died because of 
recurrent hepatitis B. Eleven of the 24 patients are alive between 6 months 
and 6 years with or after recovery from hepatitis B recurrence. Eight of the 
24 patients are alive without recurrence between 4 and 12 months. Only 
one patient has become HBsAg negative after transplantation during a 
short observation period of 7 months. This patient had perioperative alpha 
interferon therapy. 
Fifty-three of the 1,000 patients received liver transplantation in the 
presence of primary hepatic malignancy other than bile duct carcinoma. 
Transplantation for 36 of these 53 patients was primarily to treat advanced 
hepatic malignancy that could not be resected by conventional techniques 
of subtotal hepatectomy. Eighteen of the 36 patients had hepatoma, eight 
had fibrolamellar hepatoma. eight had epitheloid hemangioendothelioma, 
one had cholangiosarcoma, and another had angiosarcoma. 
For 17 of the 53 patients, liver transplantation was primarily to treat 
liver failure, and the malignant neoplasm in the diseased liver could have 
been resected by subtotal hepatectomy, if the liver was not terminally 
diseased. Fifteen of these 17 patients had hepatoma, one had fibrolamellar 
hepatoma and another had mixed cholangiohepatoma. 
One- to 5-year survival rates of the 36 patients who received liver 
graft for the principal indication of malignancy were 65%, 50%, 2970, 
29%. and 29%. respectively (Fig. 5). The survival rates of 18 patients with 
hepatoma were ldwer than those of eight patients with kbrolamellar 
hepatoma and those of eight patients with epitheloid hemangioendotheli- 
oma (Fig. 7). 
- 
Recurrence of primary hepatic malignancy after liver transplantation 
354 was examined among 27 of the 36 patients, who survived more than 6 
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Fig. 2.-Nearly identical survival rates between 666 adult recipients 
and 334 pediatric recipients since 1980. 
months. Tumor recurrence was observed in 13 of the 27 6-month survivors. 
Seven of 1 I patients with hepatoma had tumor recurrence, and three of 
which occurred within I year. Three of seven patients with fibromellar 
hepatoma had recurrence. All of the recurrences were diagnosed more than 
a year after transplantation. Similarly, the t n o  (of eight) patients with 
epitheloid hemangioendothelioma had recurrences more than a year after 
transplantation. One patient with cholangiocarcinoma died from metasta- 
ses 31 months after transplantation, 8 months after tumor recurrence. 
Of the 17 patients who received liver grafts primarily for liver failure 
and whose livers harbored hepatic malignancy, o111y one died from 
recurrence of hepatoma. The remaining 16 patients are alive. free of tumor 
between 3 months to 6 years. The chronic survival of 17 of 17 patients. with 
only one late death is noteworthy. 
There were ten recipients who had carcinoma of the bile duct. In eight 
patients bile duct carcinoma was associated with primar). sclerosing 
cholangitis, and in the remaining two patients the lesions were the so-called 
Klatskin tumors. One patient wtth Klatskin turnor died within a month 
from transplant complications, and another died frorn recurrence 8 months 
after transplantation. Of the eight patients who had bile duct carcinoma 
associated with sclerosing cholangitis, one died from trar~splant complica- 
tions within 1 month, four patients died from tumor recurrence in 4, 12, 14. 
and 16 months after transplantation, and three patients were alive free of 
tumor in 12. 13, and 14 months, No patient with bile duct carcinoma has 
lived 2 years after transplantation in this series. 
There were seven patients who received liver transplantation for 
secondary hepatic malignancy. Three of the seven patients died. The first 
patient with carcinoid tumor of the small intestine died from transplant 
complications within three months, the second patient with carcinoid 
tumor of the small intestine and adenocarcinoma of the bile duct died in 6 
months from recurrence of the bile duct cancer. and the third patient with 
adenocarcinoma of unknown primary site died frorn recurrence 21 months 
after transplantation. The remaining four of the seven patients are alive and 
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Fig. 4.- Sunnival rates of pediatric recipients with liver-based 
inborn metabolic errors were nearly identical to those with postnecrotic or 
cryptogenic cirrhosis. Survival rates of children with biliary atresia were 
slightly lower than the other two diseases, but the difference was not 
statistically different. 
free of tumor. One patient with glucagonoma, which was initially diag- 
nosed as a hepatoma with lymphnode metastasis. is alive after 21 months, 
and another patient with glucagonoma is alive 10 months after transplan- 
tation. One patient with gastrinoma is alive free of tumor in 2 months. One 
patient with leiomyosarcoma of the small intestine is alive, but with 
recurrent tumor after 15 month\. 
Discussion 
Our first comprehensive report on liver transplantation using cy- 
closporine-steroid therapy in 1982 involved only 67 patients (41 adults and 
26 children), but it had already predicted a vast improvement of survival 
after liver transplantation. The article had a strong influence upon the 
practice of hepatology. Five years later. this report, involving 1,000 
patients. confirma the earlier assesqment. The survival rate? of 74% at 1 
year and 6 4 8  at 5 years are convincing enough to consider liver transplan- 
tation as an ultimate therapy for various end-stage liver diseases. Unless 
agents that are more effective and safer than cyclo?porine are used, further 
significant improvement of overall survival may not be expected, because 
liver transplantation will be applied for patients of even higher risk than 
now. However, substantial Improvements can be achieved in some areas. 
The survival rates after liver transplantation arnong children under 1 
year of age are lower than those of older children. One of the main reasons 
for this Ir technical difficulty due to the small structures. The incidence of 
hepatic arterial thrornbosls 1s higher in this age group than older groups. 
Further technical refinenientr. intraoperative use of electromagnetic flow- 
meters, restricted use of pcrioperative coagulation factorr and a proper 
antlcoagulation therapy will reduce the incidence of technical failures. The 
lack of small sized pediatric organ donor is another reason of lower 
survival rates in this age group. Public education to raise awareness of 
YEAR 
Fig. 5.- Survival rates of patients with HBsAg-positive, postne- 
~ i g .  3.- Survival comparison among adult lecipients with three 
,lotic cirrhosis were significantly lower than those with HBsAg-negative 
most common diseases (postnecrotic cirrhosis. primary biliary cirrhosis, postnecrotic cirrhosis, 
and primary sclerosing cholangitis) did not show any statistical difference. 
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Fig. 6.- Survival rates of patients who received transplantation for 
primary liver malignancy were poor. However, survival rates of patients 
who had transplantation primarily for liver failure and whose advanced 
cirrhosis contained small malignancies were excellent. 
urgent need of organ donation must be continued. Reduced size liver 
grafting, such as left lateral segment of a larger liver into a small pediatric 
recipient, can be carried out without significant additional risk as reported 
in this forum. This approach should decrease the waiting period for a 
proper donor organ, and thus the operation can be performed before an 
infant becomes too sick to have successful transplantation. 
The survival rates of patients older than 60 years old are also lower 
than those of younger adults. Further experience in selecting elderly 
candidates will establish more accurate criteria of adequate cardiovascu- 
lar, pulmonary, and neurologic functions for liver transplantation. 
There were no statistical differences in survival rates among the most 
common diseases in adult recipients (postnecrotis cirrhosis, primary 
biliary cirrhosis, and primary sclerosing cholangitis) and among those in 
pediatric recipients (biliary atresia, liver-based inborn metabolic errors. 
and postnecrotic cirrhosis). However, slightly lower survival rates among 
children with biliary atresia are directly or indirectly caused by an unsuc- 
cessful portoenterostomy and unwise attempts of its revision before 
transplantation. Although many children with extrahepatic biliary atresia 
have been saved by portoenterostomy when it was done by proper 
technique while the liver was still relatvely normal, there are many other 
unfortunate children whose condition deteriorated rather rapidly because 
of unsuccessful attempts of the operation. It is not unusual that a child had 
had several abdominal operations, such as attempts of portoenterostomy, 
revisions of enterostomy, drainage of abdominal abscesses, and operations 
for bowel obstmction before transplantation. It is also not unusual that 
children with intrahepatic atresia or other nonextrahepatic type of biliary 
atresia, such as Alagille's syndrome, had a portoenterostomy and that 
children with well established cirrhosis and portal hypertension have 
received the operation. The portoenterostomy should only be performed by 
experienced surgeons at the institutes where jaundice-free success rate has 
been more than 70%. As liver transplantation has become a practical option 
for children with biliary atresia, indications of portoenterostomy and its 
rare revision must be strictly followed. 
The survival rates of patients with hepatitis B surface antigen positive 
cirrhosis were significantly lower than those of patients with HBsAg- 
negative postnecrotic cirrhosis. Recurrence of viral hepatitis B was a 
general rule despite our efforts at perioperative use of anti-hepatitis B 
immunoglobulin therapy and ongoing alpha interferon therapy. The recur- 
rence of hepatitis B was the direct or indirect cause of death in four of five 
late deaths among the 36 patients. It is worthwhile to note that 12 of the 3 6  
patients died within 3 months from various complications related to 
transplantation, but not from recurrence of hepatitis B. Actually, this high 
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Fig. 7.- Survival rates of patients with hepatoma (HCC) were 
significantly lower than those with fibrolamellar hepatoma (FL-HCC) and 
those with epitheloid hemangioendothelioma (EHE). 
early mortality among chronic hepatitis B virus carriers influenced the 
survival rates more significantly than the mortality related to recurrent 
hepatitis B. Immunologic impairment of chronic HBsAg camers could 
play a significant role in early mortality. Thus, further investigations are 
needed not only for antiviral therapy, but also for the means to decrease 
early mortality that was probably not directly related to hepatitis B virus. 
Recurrence of hepatic malignancy after transplantation resulted in 
lower survival rates of patients who received liver grafts for cancer than 
those of patients without hepatic malignancy. However, the mere presence 
of a small, incidental hepatic malignancy in the advanced cirrhosis did ndt 
influence the survival rates. When liver transplantation was performed to 
treat a large hepatocellular carcinoma that could not be resected by a 
conventional technique of subtotal hepatectomy, the tumor all too fre- 
quently recurred within 1 year. For the last few years, adjuvant 
chemotherapy with adriamycin has been applied for these patients as soon 
as the condition of the patients and the graft became stable, usually 1 or 2 
months after transplantation. During this small and short exercise, there 
has been at least no significant adverse effects of adjuvant chemotherapy. 
Safer and more effective adjuvant chemotherapy andlor immunotherapy 
are needed to prevent tumor recurrence. The prognosis of fibrolamellar 
hepatoma and epitheloid hemangioendothelioma are better than that of 
hepatoma, as indicated by better survival rates, and later and lower 
incidence of recurrence. 
In this series of 1,000 patients, there has been no 2-year survivor who 
had bile duct cancer. The recurrence of the tumor within a year has been 
frequent. The facts that bile duct cancer was found in eight of 81 patients 
with primary sclerosing cholangitis (10% incidence) and that the survival 
of these eight patients was extremely poor strongly indicate the need of 
earlier transplantation for the patients with long standing sclerosing 
cholangitis. 
In general, metastatic liver tumors constitute a poor indication for 
liver transplantation. However, over the years, seven such patients had 
liver replacement accidentally or knowingly because of an unusually 
indolent clinical course. The survival rates of these highly selected patients 
were better than generally expected. particularly if the metastases are from 
pancreatic islet tumors and from carcinoid tumors. 
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Each volume in the series, Clio Chirurgica, is composed of papers that were important in the development of ideas 
in a sub-specialty area of surgery. This volume, Liver Transplantation, is the fifteenth in the series. It is unique because 
the field is new and because the primary author, Thomas E. Starzl, has been involved in the development of liver 
transplantation from its inception. 
The events all are recent-they took place during the past 32 years. The papers, preceded by the authors' inciteful 
comments, describe the problems posed by transplantation of such a complex organ as the liver. 
First, there was the question of location. What were the advantages and disadvantages of an orthotopic versus a 
heterotopic graft? The result was surprising. Although the orthotopic graft proved to be best suited for clinical 
application, investigation of the causes for failure of the heterotopic (auxiliary) graft yielded important information 
regarding hepatic physiology. It opened an entire field of so-called "hepatotrophic physiology". 
Secondly, there were the problems of graft preservation, donor selection, operative technique and immunosuppres- 
sion. These issues, with the exception of operative technique with regard to veno-venous bypass, were addressed more 
or less hand-in-hand with renal transplantation and are described in detail in the companion volume in this series, Renal 
Transplantation. Yet, even after these problems were overcome, liver transplantation could not be applied widely in 
clinical practice. Immunosuppression was not adequate. But that changed with the introduction of cyclosporine. When 
it was administerec! in conjunction with steroids, the results of liver transplantation improved dramatically. 
Number Fifteen in a Series 
ISBN 0-941 432-46-7 Slivergirl, Inc 
